source,citation,relation,ID,title,authors,journal,year,fulltext_online_link,fulltext_location
10.1056~NEJMoa011232,National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997;26:Suppl 1:2S10S.,references,10.1002/hep.22946,National Institutes of Health consensus development conference statement: Management of hepatitis B,"[[u'Michael', u'F.', u'Sorrell'], [u'Edward', u'A.', u'Belongia'], [u'Jose', u'', u'Costa'], [u'Ilana', u'F.', u'Gareen'], [u'Jean', u'L.', u'Grem'], [u'John', u'M.', u'Inadomi'], [u'Earl', u'R.', u'Kern'], [u'James', u'A.', u'McHugh'], [u'Gloria', u'M.', u'Petersen'], [u'Michael', u'F.', u'Rein'], [u'Doris', u'B.', u'Strader'], [u'Hartwell', u'T.', u'Trotter']]",Hepatology,2009,"[u'http://www.annals.org/content/150/2/104.full.pdf', u'http://gidiv.ucsf.edu/course/things/sorrel.pdf', u'http://doi.wiley.com/10.1002/hep.22946', u'http://www.hepcfocus.com/Content/pdf/NIH_Consensus-Management_of_HepatitisB.pdf']","[{u'Name': u'Clinical Outcome', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5965}, {u'Name': u'Global Health', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 16518}, {u'Name': u'Health Professionals', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17614}, {u'Name': u'Hepatitis B', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17862}, {u'Name': u'Hepatitis B Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17867}, {u'Name': u'Liver Disease', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 23148}, {u'Name': u'Liver Enzyme', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 23150}, {u'Name': u'pegylated interferon', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 30505}, {u'Name': u'Randomized Controlled Trial', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 34323}, {u'Name': u'Systematic Literature Review', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 41240}, {u'Name': u'United States', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 43479}, {u'Name': u'Hepatocellular Carcinoma', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 56398}, {u'Name': u'National Institute of Health', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 63297}, {u'Name': u'tenofovir disoproxil fumarate', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 71142}]"
10.1002/hep.22946,"Manns, M., McHutchison, J., Gordon, S., et. al, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, Lancet, 2001",cited-by,10.1016/S0140-6736(01)06102-5,Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial,"[['Michael', 'P', 'Manns'], ['John', 'G', 'McHutchison'], ['Stuart', 'C', 'Gordon'], ['Vinod', 'K', 'Rustgi'], ['Mitchell', '', 'Shiffman'], ['Robert', '', 'Reindollar'], ['Zachary', 'D', 'Goodman'], ['Kenneth', '', 'Koury'], ['Mei-Hsiu', '', 'Ling'], ['Janice', 'K', 'Albrecht']]",Lancet,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0140673601061025', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673601061025']",
10.1002/hep.22946,"Breaux, K., Khattak, K., Velez, M., et. al, Hepatitis C Virus Infection–Related Morbidity and Mortality among Patients with Human Immunodeficiency Virus Infection, Clinical Infectious Diseases, 2001",cited-by,10.1086/321819,Hepatitis C Virus Infection–Related Morbidity and Mortality among Patients with Human Immunodeficiency Virus Infection,"[['Katharine', '', 'Breaux'], ['Kamran', '', 'Khattak'], ['Maria', '', 'Velez'], ['Boris', '', 'Yoffe']]",Clinical Infectious Diseases,2001,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/321819'],
10.1002/hep.22946,"Pawlotsky, J., , Use and interpretation of virological tests for hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36815,Use and interpretation of virological tests for hepatitis C,"[['Jean-Michel', '', 'Pawlotsky']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Use%20And%20Interpretation%20Of%20Virological%20Tests%20For%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360709', u'http://doi.wiley.com/10.1053/jhep.2002.36815']",
10.1002/hep.22946,", Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, 2000",cited-by,10.1086/313842,Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus,[],Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313842'],
10.1002/hep.22946,"Dienstag, J., , The role of liver biopsy in chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36381,The role of liver biopsy in chronic hepatitis C,"[['Jules', 'L.', 'Dienstag']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Role%20Of%20Liver%20Biopsy%20In%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36381', u'http://doi.wiley.com/10.1002/hep.1840360720']",
10.1002/hep.22946,"Pawlotsky, J., , Therapy of hepatitis C: From empiricism to eradication, Hepatology, 2006",cited-by,10.1002/hep.21064,Therapy of hepatitis C: From empiricism to eradication,"[['Jean-Michel', '', 'Pawlotsky']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21064'],
10.1002/hep.22946,"Spiegel, B., Younossi, Z., Hays, R., et. al, Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment, Hepatology, 2005",cited-by,10.1002/hep.20659,Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment,"[['Brennan', 'M. R.', 'Spiegel'], ['Zobair', 'M.', 'Younossi'], ['Ron', 'D.', 'Hays'], ['Dennis', '', 'Revicki'], ['Sean', '', 'Robbins'], ['Fasiha', '', 'Kanwal']]",Hepatology,2005,"[u'http://www.researchcore.org/publications/docs/spiegel_hepatology.pdf', u'http://doi.wiley.com/10.1002/hep.20659']",
10.1002/hep.22946,"Fontana, R., Israel, J., LeClair, P., et. al, Iron reduction before and during interferon therapy of chronic hepatitis�C: Results of a multicenter, randomized, controlled trial, Hepatology, 2000",cited-by,10.1002/hep.510310325,"Iron reduction before and during interferon therapy of chronic hepatitis�C: Results of a multicenter, randomized, controlled trial","[['Robert', 'J.', 'Fontana'], ['Jonathan', '', 'Israel'], ['Paula', '', 'LeClair'], ['Barbara', 'F.', 'Banner'], ['Kristina', '', 'Tortorelli'], ['Norman', '', 'Grace'], ['Robert', 'A.', 'Levine'], ['Gale', '', 'Fiarman'], ['Michael', '', 'Thiim'], ['Anthony', 'S.', 'Tavill'], ['Herbert', 'L.', 'Bonkovsky']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310325'],
10.1002/hep.22946,"Jen, J., Glue, P., Gupta, S., et. al, Population Pharmacokinetic and Pharmacodynamic Analysis of Ribavirin in Patients With Chronic Hepatitis C, Therapeutic Drug Monitoring, 2000",cited-by,10.1097/00007691-200010000-00010,Population Pharmacokinetic and Pharmacodynamic Analysis of Ribavirin in Patients With Chronic Hepatitis C,"[['J.', 'Frank', 'Jen'], ['Paul', '', 'Glue'], ['Samir', '', 'Gupta'], ['Demetris', '', 'Zambas'], ['Gerald', '', 'Hajian']]",Therapeutic Drug Monitoring,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007691-200010000-00010'],
10.1002/hep.22946,"Monto, A., Patel, K., Bostrom, A., et. al, Risks of a range of alcohol intake on hepatitis C-related fibrosis, Hepatology, 2004",cited-by,10.1002/hep.20127,Risks of a range of alcohol intake on hepatitis C-related fibrosis,"[['Alexander', '', 'Monto'], ['Keyur', '', 'Patel'], ['Alan', '', 'Bostrom'], ['Stephen', '', 'Pianko'], ['Paul', '', 'Pockros'], ['John', 'G.', 'McHutchison'], ['Teresa', 'L.', 'Wright']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo00012.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/hepcinfo00012.pdf', u'http://doi.wiley.com/10.1002/hep.20127']",
10.1002/hep.22946,"Reichard, O., Glaumann, H., Frydén, A., et. al, Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80129-9,Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon,"[['Olle', '', 'Reichard'], ['Hans', '', 'Glaumann'], ['Aril', '', 'Fryd\xc3\xa9n'], ['Gunnar', '', 'Norkrans'], ['Rune', '', 'Wejst\xc3\xa5l'], ['Ola', '', 'Weiland']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899801299', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899801299']",
10.1002/hep.22946,", A., , P., , Intrafamilial transmission of hepatitis C virus: a systematic review, Journal of Viral Hepatitis, 2000",cited-by,10.1046/j.1365-2893.2000.00203.x,Intrafamilial transmission of hepatitis C virus: a systematic review,"[['Ackerman', '', ''], ['Paltiel', '', '']]",Journal of Viral Hepatitis,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2000.00203.x'],
10.1002/hep.22946,"Schaefer, M., Heinz, A., Backmund, M., , Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?, Addiction, 2004",cited-by,10.1111/j.1360-0443.2004.00821.x,Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?,"[['Martin', '', 'Schaefer'], ['Andreas', '', 'Heinz'], ['Markus', '', 'Backmund']]",Addiction,2004,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1360-0443.2004.00821.x'],
10.1002/hep.22946,"Shiffman, M., , Retreatment of patients with chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36816,Retreatment of patients with chronic hepatitis C,"[['Mitchell', 'L.', 'Shiffman']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Retreatment%20Of%20Patients%20With%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36816', u'http://doi.wiley.com/10.1002/hep.1840360717']",
10.1002/hep.22946,"Sonnenberg, F., Gregory, P., Yomtovian, R., et. al, The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterialinfection with allogeneic transfusion, Transfusion, 1999",cited-by,10.1046/j.1537-2995.1999.39080808.x,The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterialinfection with allogeneic transfusion,"[['F.', 'A.', 'Sonnenberg'], ['P.', '', 'Gregory'], ['R.', '', 'Yomtovian'], ['L.', 'B.', 'Russell'], ['W.', '', 'Tierney'], ['M.', '', 'Kosmin'], ['J.', 'L.', 'Carson']]",Transfusion,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.1999.39080808.x'],
10.1002/hep.22946,"PATEL, K., LAJOIE, A., HEATON, S., et. al, Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C, Journal of Gastroenterology and Hepatology, 2003",cited-by,10.1046/j.1440-1746.2003.02930.x,Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C,"[['KEYUR', '', 'PATEL'], ['ADRIANNE', '', 'LAJOIE'], ['SHANON', '', 'HEATON'], ['STEPHEN', '', 'PIANKO'], ['CYNTHIA', 'A', 'BEHLING'], ['DAVID', '', 'BYLUND'], ['PAULJ', '', 'POCKROS'], ['LAWRENCE', 'M', 'BLATT'], ['ANDREW', '', 'CONRAD'], ['JOHN', 'G', 'MCHUTCHISON']]",Journal of Gastroenterology and Hepatology,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2003.02930.x'],
10.1002/hep.22946,"Cheung, R., Currie, S., Shen, H., et. al, Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility, Acceptance, and Outcomes, American Journal of Gastroenterology, 2005",cited-by,10.1111/j.1572-0241.2005.00240.x,"Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility, Acceptance, and Outcomes","[['Ramsey', 'C.', 'Cheung'], ['Sue', '', 'Currie'], ['Hui', '', 'Shen'], ['Samuel', 'B.', 'Ho'], ['Edmund', 'J.', 'Bini'], ['Bhupinderjit', 'S.', 'Anand'], ['Norbert', '', 'Br\xc3\xa4u'], ['Teresa', 'L.', 'Wright']]",American Journal of Gastroenterology,2005,"[u'http://dx.doi.org/10.1111/j.1572-0241.2005.00240.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2005.00240.x']",
10.1002/hep.22946,"Strader, D., , Understudied populations with hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36991,Understudied populations with hepatitis C,"[['Doris', 'B.', 'Strader']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Understudied%20Populations%20With%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36991', u'http://doi.wiley.com/10.1002/hep.1840360729']",
10.1002/hep.22946,"Bini, E., Bräu, N., Currie, S., et. al, Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection, American Journal of Gastroenterology, 2005",cited-by,10.1111/j.1572-0241.2005.41860.x,"Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection","[['Edmund', 'J.', 'Bini'], ['Norbert', '', 'Br\xc3\xa4u'], ['Sue', '', 'Currie'], ['Hui', '', 'Shen'], ['Bhupinderjit', 'S.', 'Anand'], ['Ke-Qin', '', 'Hu'], ['Lennox', '', 'Jeffers'], ['Samuel', 'B.', 'Ho'], ['David', '', 'Johnson'], ['Warren', 'N.', 'Schmidt'], ['Paul', '', 'King'], ['Ramsey', '', 'Cheung'], ['Timothy', 'R.', 'Morgan'], ['Joseph', '', 'Awad'], ['Marcos', '', 'Pedrosa'], ['Kyong-Mi', '', 'Chang'], ['Ayse', '', 'Aytaman'], ['Franz', '', 'Simon'], ['Curt', '', 'Hagedorn'], ['Richard', '', 'Moseley'], ['Jawad', '', 'Ahmad'], ['Charles', '', 'Mendenhall'], ['Bradford', '', 'Waters'], ['Doris', '', 'Strader'], ['Anna', 'W.', 'Sasaki'], ['Stephen', '', 'Rossi'], ['Teresa', 'L.', 'Wright']]",American Journal of Gastroenterology,2005,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2005.41860.x', u'http://dx.doi.org/10.1111/j.1572-0241.2005.41860.x']",
10.1002/hep.22946,"Hall, C., Charlebois, E., Hahn, J., et. al, Hepatitis C virus infection in san francisco’s HIV-infected urban poor, Journal of General Internal Medicine, 2004",cited-by,10.1111/j.1525-1497.2004.30613.x,Hepatitis C virus infection in san francisco’s HIV-infected urban poor,"[['Christopher', 'S.', 'Hall'], ['Edwin', 'D.', 'Charlebois'], ['Judith', 'A.', 'Hahn'], ['Andrew', 'R.', 'Moss'], ['David', 'R.', 'Bangsberg']]",Journal of General Internal Medicine,2004,"[u'http://www.springerlink.com/index/m6p738m3221243v1.pdf', u'http://www.springerlink.com/content/m6p738m3221243v1', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1525-1497.2004.30613.x']",
10.1002/hep.22946,"Civeira, M., Prieto, J., , Early predictors of response to treatment in patients with chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80409-7,Early predictors of response to treatment in patients with chronic hepatitis C,"[['Maria-Pilar', '', 'Civeira'], ['Jesus', '', 'Prieto']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899804097', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899804097']",
10.1002/hep.22946,"Lin, O., Keeffe, E., , CURRENT TREATMENT STRATEGIES FOR CHRONIC HEPATITIS B AND C, Annual Review of Medicine, 2001",cited-by,10.1146/annurev.med.52.1.29,CURRENT TREATMENT STRATEGIES FOR CHRONIC HEPATITIS B AND C,"[['Otto', 'S.', 'Lin'], ['Emmet', 'B.', 'Keeffe']]",Annual Review of Medicine,2001,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.med.52.1.29'],
10.1002/hep.22946,"Fireman, M., Blackwell, A., Hauser, P., , Addressing Tri‐Morbidity (Hepatitis C, Psychiatric Disorders, and Substance Use): The Importance of Routine Mental Health Screening as a Component of a Comanagement Model of Care, Clinical Infectious Diseases, 2005",cited-by,10.1086/427442,"Addressing Tri‐Morbidity (Hepatitis C, Psychiatric Disorders, and Substance Use): The Importance of Routine Mental Health Screening as a Component of a Comanagement Model of Care","[['Marian', '', 'Fireman'], ['Aaron', '', 'Blackwell'], ['Peter', '', 'Hauser']]",Clinical Infectious Diseases,2005,"[u'http://www.uoregon.edu/~ablackwe/Documents/Fireman-tri-morbidity.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427442']",
10.1002/hep.22946,"Shehab, T., Sonnad, S., Lok, A., , Management of hepatitis C patients by primary care physicians in the USA: results of a national survey, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00310.x,Management of hepatitis C patients by primary care physicians in the USA: results of a national survey,"[['T.', 'M.', 'Shehab'], ['S.', 'S.', 'Sonnad'], ['A.', 'S. F.', 'Lok']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00310.x'],
10.1002/hep.22946,"Siddiqui, F., Mutchnick, M., Kinzie, J., et. al, Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.03633.x,Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy,"[['Firdous', '', 'Siddiqui'], ['Milton', '', 'Mutchnick'], ['Joseph', '', 'Kinzie'], ['Rene', '', 'Peleman'], ['Paul', '', 'Naylor'], ['Murray', '', 'Ehrinpreis']]",American Journal of Gastroenterology,2001,"[u'http://dx.doi.org/10.1111/j.1572-0241.2001.03633.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.03633.x']",
10.1002/hep.22946,"Pereira, A., Sanz, C., , A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40101182.x,A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols,"[['Arturo', '', 'Pereira'], ['Cristina', '', 'Sanz']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40101182.x'],
10.1002/hep.22946,"Soriano, V., Garcìa-Samaniego, J., Rodrìguez-Rosado, R., et. al, Hepatitis C and HIV infection: biological, clinical, and therapeutic implications, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80387-0,"Hepatitis C and HIV infection: biological, clinical, and therapeutic implications","[['Vincent', '', 'Soriano'], ['Javier', '', 'Garc\xc3\xaca-Samaniego'], ['Rafael', '', 'Rodr\xc3\xacguez-Rosado'], ['Juan', '', 'Gonz\xc3\xa0lez'], ['Jos\xc3\xa9', '', 'Pedreira']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803870', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803870']",
10.1002/hep.22946,"LEE, C., DUSHEIKO, G., , The natural history and antiviral treatment of hepatitis C in haemophilia, Haemophilia, 2002",cited-by,10.1046/j.1365-2516.2002.00620.x,The natural history and antiviral treatment of hepatitis C in haemophilia,"[['C.', '', 'LEE'], ['G.', '', 'DUSHEIKO']]",Haemophilia,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.2002.00620.x'],
10.1002/hep.22946,"Michielsen, P., Francque, S., Dongen, J., , Viral hepatitis and hepatocellular carcinoma, World Journal of Surgical Oncology, 2005",cited-by,10.1186/1477-7819-3-27,Viral hepatitis and hepatocellular carcinoma,"[['Peter', 'P', 'Michielsen'], ['Sven', 'M', 'Francque'], ['Jurgen', 'L van', 'Dongen']]",World Journal of Surgical Oncology,2005,"[u'http://www.wjso.com/content/3/1/27', u'http://www.biomedcentral.com/content/pdf/1477-7819-3-27.pdf', u'http://www.springerlink.com/content/e52gl2u463863316']",
10.1002/hep.22946,"Fultz, S., Justice, A., Butt, A., et. al, Testing, Referral, and Treatment Patterns for Hepatitis C Virus Coinfection in a Cohort of Veterans with Human Immunodeficiency Virus Infection, Clinical Infectious Diseases, 2003",cited-by,10.1086/374049,"Testing, Referral, and Treatment Patterns for Hepatitis C Virus Coinfection in a Cohort of Veterans with Human Immunodeficiency Virus Infection","[['Shawn', 'L.', 'Fultz'], ['Amy', 'C.', 'Justice'], ['Adeel', 'A.', 'Butt'], ['Linda', '', 'Rabeneck'], ['Sharon', '', 'Weissman']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/374049'],
10.1002/hep.22946,"CRONE, C., GABRIEL, G., , Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications, Journal of Psychiatric Practice, 2003",cited-by,10.1097/00131746-200303000-00002,"Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications","[['CATHERINE', '', 'CRONE'], ['GEOFFREY', 'M.', 'GABRIEL']]",Journal of Psychiatric Practice,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00131746-200303000-00002'],
10.1002/hep.22946,"Dodig, M., Tavill, A., , Hepatitis C and Human Immunodeficiency Virus Coinfections, Journal of Clinical Gastroenterology, 2001",cited-by,10.1097/00004836-200111000-00005,Hepatitis C and Human Immunodeficiency Virus Coinfections,"[['Milan', '', 'Dodig'], ['Anthony', 'S.', 'Tavill']]",Journal of Clinical Gastroenterology,2001,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200111000-00005'],
10.1002/hep.22946,"Sagnelli, E., Coppola, N., Scolastico, C., et. al, Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment, Journal of Medical Virology, 2001",cited-by,10.1002/jmv.2090,Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment,"[['Evangelista', '', 'Sagnelli'], ['Nicola', '', 'Coppola'], ['Carlo', '', 'Scolastico'], ['Anna', 'Rita', 'Mogavero'], ['Maria', '', 'Stanzione'], ['Pietro', '', 'Filippini'], ['Francesca', 'Maria', 'Felaco'], ['Felice', '', 'Piccinino']]",Journal of Medical Virology,2001,[u'http://doi.wiley.com/10.1002/jmv.2090'],
10.1002/hep.22946,"Pockros, P., , Developments in the treatment of chronic hepatitis C, Expert Opinion on Investigational Drugs, 2002",cited-by,10.1517/13543784.11.4.515,Developments in the treatment of chronic hepatitis C,"[['Paul', 'J', 'Pockros']]",Expert Opinion on Investigational Drugs,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.11.4.515'],
10.1002/hep.22946,"McHutchison, J., Giannelli, G., Nyberg, L., et. al, A Pilot Study of Daily Subcutaneous Interleukin10 in Patients with Chronic Hepatitis C Infection, Journal of Interferon and Cytokine Research, 1999",cited-by,10.1089/107999099312939,A Pilot Study of Daily Subcutaneous Interleukin10 in Patients with Chronic Hepatitis C Infection,"[['J.', 'G.', 'McHutchison'], ['G.', '', 'Giannelli'], ['L.', '', 'Nyberg'], ['L.', 'M.', 'Blatt'], ['K.', '', 'Waite'], ['P.', '', 'Mischkot'], ['S.', '', 'Pianko'], ['A.', '', 'Conrad'], ['P.', '', 'Grint']]",Journal of Interferon and Cytokine Research,1999,[u'http://www.liebertonline.com/doi/abs/10.1089%2F107999099312939'],
10.1002/hep.22946,"Maticicr, M., Poljak, M., Kramar, B., et. al, Detection of Hepatitis C Virus RNA From Gingival Crevicular Fluid and Its Relation to Virus Presence in Saliva, Journal of Periodontology, 2001",cited-by,10.1902/jop.2001.72.1.11,Detection of Hepatitis C Virus RNA From Gingival Crevicular Fluid and Its Relation to Virus Presence in Saliva,"[['Mojca', '', 'Maticicr'], ['Mario', '', 'Poljak'], ['Barbara', '', 'Kramar'], ['Katja', '', 'Seme'], ['Vladimir', '', 'Brinovec'], ['Jelka', '', 'Meglic-Volkar'], ['Branko', '', 'Zakotnik'], ['Uros', '', 'Skaleric']]",Journal of Periodontology,2001,[u'http://www.joponline.org/doi/abs/10.1902/jop.2001.72.1.11'],
10.1002/hep.22946,"Lee, S., Sherman, M., , Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00286.x,Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values,"[['Samuel', 'S.', 'Lee'], ['Morris', '', 'Sherman']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00286.x'],
10.1002/hep.22946,"SINHA, M., DAS, A., , Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children, Pediatric Infectious Disease Journal, 2000",cited-by,10.1097/00006454-200001000-00006,Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children,"[['MADHUMITA', '', 'SINHA'], ['ANANYA', '', 'DAS']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200001000-00006'],
10.1002/hep.22946,"Ohki, T., Tateishi, R., Sato, T., et. al, Obesity Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients, Clinical Gastroenterology and Hepatology, 2008",cited-by,10.1016/j.cgh.2008.02.012,Obesity Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients,"[['Takamasa', '', 'Ohki'], ['Ryosuke', '', 'Tateishi'], ['Takahisa', '', 'Sato'], ['Ryota', '', 'Masuzaki'], ['Jun', '', 'Imamura'], ['Tadashi', '', 'Goto'], ['Noriyo', '', 'Yamashiki'], ['Hideo', '', 'Yoshida'], ['Fumihiko', '', 'Kanai'], ['Naoya', '', 'Kato'], ['Shuichiro', '', 'Shiina'], ['Haruhiko', '', 'Yoshida'], ['Takao', '', 'Kawabe'], ['Masao', '', 'Omata']]",Clinical Gastroenterology and Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1542356508001249', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356508001249']",
10.1002/hep.22946,"Mehta, S., Genberg, B., Astemborski, J., et. al, Limited Uptake of Hepatitis C Treatment Among Injection Drug Users, Journal of Community Health, 2008",cited-by,10.1007/s10900-007-9083-3,Limited Uptake of Hepatitis C Treatment Among Injection Drug Users,"[['Shruti', 'H.', 'Mehta'], ['Becky', 'L.', 'Genberg'], ['Jacquie', '', 'Astemborski'], ['Ravi', '', 'Kavasery'], ['Gregory', 'D.', 'Kirk'], ['David', '', 'Vlahov'], ['Steffanie', 'A.', 'Strathdee'], ['David', 'L.', 'Thomas']]",Journal of Community Health,2008,"[u'http://www.springerlink.com/content/4810t14745862574', u'http://www.springerlink.com/index/4810t14745862574.pdf', u'http://www.springerlink.com/index/10.1007/s10900-007-9083-3', u'http://www.springerlink.com/index/pdf/10.1007/s10900-007-9083-3']",
10.1002/hep.22946,"Talal, A., Weisz, K., Hau, T., et. al, A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-α, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.04149.x,A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-α,"[['A.', 'H.', 'Talal'], ['K.', '', 'Weisz'], ['T.', '', 'Hau'], ['S.', '', 'Kreiswirth'], ['D.', 'T.', 'Dieterich']]",American Journal of Gastroenterology,2001,"[u'http://dx.doi.org/10.1111/j.1572-0241.2001.04149.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.04149.x']",
10.1002/hep.22946,"Shin, J., Teitel, J., Swain, M., et. al, A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful?, American Journal of Hematology, 2005",cited-by,10.1002/ajh.20263,A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful?,"[['Jennifer', 'L.', 'Shin'], ['Jerome', '', 'Teitel'], ['Mark', 'G.', 'Swain'], ['Vincent', 'G.', 'Bain'], ['Paul', 'C.', 'Adams'], ['Kenneth', '', 'Croitoru'], ['Kevork', '', 'Peltekian'], ['Frank', '', 'Schweiger'], ['Martin', 'E.', 'Simons'], ['E.', 'Jenny', 'Heathcote']]",American Journal of Hematology,2005,[u'http://doi.wiley.com/10.1002/ajh.20263'],
10.1002/hep.22946,"Murray, K., Finn, L., Taylor, S., et. al, Liver Histology and Alanine Aminotransferase Levels in Children and Adults with Chronic Hepatitis C Infection, Journal of Pediatric Gastroenterology and Nutrition, 2005",cited-by,10.1097/01.mpg.0000179758.82919.1f,Liver Histology and Alanine Aminotransferase Levels in Children and Adults with Chronic Hepatitis C Infection,"[['Karen', 'F', 'Murray'], ['Laura', 'S', 'Finn'], ['Shari', 'L', 'Taylor'], ['Kristy', 'D', 'Seidel'], ['Anne', 'M', 'Larson']]",Journal of Pediatric Gastroenterology and Nutrition,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200511000-00013'],
10.1002/hep.22946,"Makris, M., Baglin, T., Dusheiko, G., et. al, Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia, Haemophilia, 2001",cited-by,10.1046/j.1365-2516.2001.00527.x,"Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia","[['M.', '', 'Makris'], ['T.', '', 'Baglin'], ['G.', '', 'Dusheiko'], ['P.', 'L. F.', 'Giangrande'], ['C.', 'A.', 'Lee'], ['C.', 'A.', 'Ludlam'], ['F.', 'E.', 'Preston'], ['H.', 'G.', 'Watson'], ['J.', 'T.', 'Wilde'], ['M.', '', 'Winter']]",Haemophilia,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.2001.00527.x'],
10.1002/hep.22946,"Chevaliez, S., Pawlotsky, J., , Interferon-based therapy of hepatitis C, Advanced Drug Delivery Reviews, 2007",cited-by,10.1016/j.addr.2007.07.002,Interferon-based therapy of hepatitis C,"[['St\xc3\xa9phane', '', 'Chevaliez'], ['Jean-Michel', '', 'Pawlotsky']]",Advanced Drug Delivery Reviews,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X07001287', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X07001287']",
10.1002/hep.22946,"Yu, A., Cheung, R., Keeffe, E., , Hepatitis B Vaccines, Infectious Disease Clinics of North America, 2006",cited-by,10.1016/j.idc.2006.01.004,Hepatitis B Vaccines,"[['Andy', 'S.', 'Yu'], ['Ramsey', 'C.', 'Cheung'], ['Emmet', 'B.', 'Keeffe']]",Infectious Disease Clinics of North America,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0891552006000055', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552006000055']",
10.1002/hep.22946,"Fattovich, G., Ribero, M., Pantalena, M., et. al, Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00291.x,Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe,"[['G.', '', 'Fattovich'], ['M.', 'L.', 'Ribero'], ['M.', '', 'Pantalena'], ['G.', '', 'Diodati'], ['P.', '', 'Almasio'], ['F.', '', 'Nevens'], ['F.', '', 'Tremolada'], ['F.', '', 'Degos'], ['J.', '', 'Rai'], ['A.', '', 'Solinas'], ['D.', '', 'Mura'], ['A.', '', 'Tocco'], ['I.', '', 'Zagni'], ['F.', '', 'Fabris'], ['L.', '', 'Lomonaco'], ['F.', '', 'Noventa'], ['G.', '', 'Realdi'], ['S.', 'W.', 'Schalm'], ['A.', '', 'Tagger']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00291.x'],
10.1002/hep.22946,"Slowik, M., Jhaveri, R., , Hepatitis B and C Viruses in Infants and Young Children, Seminars in Pediatric Infectious Diseases, 2005",cited-by,10.1053/j.spid.2005.06.009,Hepatitis B and C Viruses in Infants and Young Children,"[['May', 'K.', 'Slowik'], ['Ravi', '', 'Jhaveri']]",Seminars in Pediatric Infectious Diseases,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1045187005000713', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187005000713']",
10.1002/hep.22946,"Theodore, D., Fried, M., Kleiner, D., et. al, Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C, Haemophilia, 2004",cited-by,10.1111/j.1365-2516.2004.00919.x,Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C,"[['D.', '', 'Theodore'], ['M.', 'W.', 'Fried'], ['D.', 'E.', 'Kleiner'], ['B.', 'L.', 'Kroner'], ['J.', 'J.', 'Goedert'], ['M.', 'E.', 'Eyster'], ['S.', 'P.', 'Faust'], ['K.', 'E.', 'Sherman'], ['C.', 'M.', 'Kessler'], ['C.', '', 'Francis'], ['L.', 'M.', 'Aledort']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2516.2004.00919.x'],
10.1002/hep.22946,"Modi, M., Martin, N., Heathcote, J., et. al, Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy, Expert Opinion on Investigational Drugs, 2001",cited-by,10.1517/13543784.10.12.2201,Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy,"[['Marlene', '', 'Modi'], ['Nancy', '', 'Martin'], ['Jenny', 'E', 'Heathcote'], ['Keith', '', 'Nieforth'], ['Stefan', '', 'Zeuzem']]",Expert Opinion on Investigational Drugs,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.10.12.2201'],
10.1002/hep.22946,"Carithers, R., , Liver transplantation, Liver Transplantation, 2000",cited-by,10.1002/lt.500060122,Liver transplantation,"[['Robert', 'L.', 'Carithers']]",Liver Transplantation,2000,[u'http://doi.wiley.com/10.1002/lt.500060122'],
10.1002/hep.22946,"Chuang, W., Sarkodie, F., Brown, C., et. al, Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20848,Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population,"[['Wing', 'Chia-Ming', 'Chuang'], ['Francis', '', 'Sarkodie'], ['Colin', 'J.', 'Brown'], ['Shirley', '', 'Owusu-Ofori'], ['Juliette', '', 'Brown'], ['Chengyao', '', 'Li'], ['Cristina', '', 'Navarrete'], ['Paul', '', 'Klenerman'], ['Jean-Pierre', '', 'Allain']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20848'],
10.1002/hep.22946,"Asselah, T., Martinot, M., Cazals-Hatem, D., et. al, Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00327.x,Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels,"[['T.', '', 'Asselah'], ['M.', '', 'Martinot'], ['D.', '', 'Cazals-Hatem'], ['N.', '', 'Boyer'], ['A.', '', 'Auperin'], ['V.', 'Le', 'Breton'], ['S.', '', 'Erlinger'], ['C.', '', 'Degott'], ['D.', '', 'Valla'], ['P.', '', 'Marcellin']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00327.x'],
10.1002/hep.22946,"Wong, J., Poynard, T., Ling, M., et. al, Cost-effectiveness of 24 or 48 weeks of interferon α-2b alone or with ribavirin as initial treatment of chronic hepatitis c, American Journal of Gastroenterology, 2000",cited-by,10.1111/j.1572-0241.2000.2089_1.x,Cost-effectiveness of 24 or 48 weeks of interferon α-2b alone or with ribavirin as initial treatment of chronic hepatitis c,"[['John', 'B.', 'Wong'], ['Thierry', '', 'Poynard'], ['Mei-Hsiu', '', 'Ling'], ['Janice', 'K.', 'Albrecht'], ['Stephen', 'G.', 'Pauker']]",American Journal of Gastroenterology,2000,"[u'http://dx.doi.org/10.1111/j.1572-0241.2000.2089_1.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2000.2089_1.x']",
10.1002/hep.22946,"McCaughan, G., Zekry, A., , Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection, Transplant Infectious Disease, 2000",cited-by,10.1034/j.1399-3062.2000.020403.x,Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection,"[['G.', 'W.', 'McCaughan'], ['A.', '', 'Zekry']]",Transplant Infectious Disease,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1399-3062.2000.020403.x'],
10.1002/hep.22946,"Degos, F., Daurat, V., Chevret, S., et. al, Reinforced regiment of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomized trial, Journal of Hepatology, 1998",cited-by,10.1016/S0168-8278(98)80007-X,Reinforced regiment of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomized trial,"[['Fran\xc3\xa7oise', '', 'Degos'], ['V\xc3\xa9ronique', '', 'Daurat'], ['Sylvie', '', 'Chevret'], ['Sophie', '', 'Gayno'], ['Anne', '', 'Bastie'], ['Ghassan', '', 'Riachi'], ['Isabelle', '', 'Bartolomei-Portal'], ['Karl', '', 'Barange'], ['Joseph', '', 'Moussalli'], ['Sylvie', '', 'Naveau'], ['Fran\xc3\xa7ois', '', 'Bailly'], ['Philippe', '', 'Chaumet-Riffaud'], ['Claude', '', 'Chastang']]",Journal of Hepatology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S016882789880007X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882789880007X']",
10.1002/hep.22946,"Saab, S., Lee, C., Shpaner, A., et. al, Seroepidemiology of hepatitis A in patients with chronic liver disease, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00551.x,Seroepidemiology of hepatitis A in patients with chronic liver disease,"[['S.', '', 'Saab'], ['C.', '', 'Lee'], ['A.', '', 'Shpaner'], ['A.', 'B.', 'Ibrahim']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2005.00551.x'],
10.1002/hep.22946,", Z., , Treatment of chronic hepatitis C virus infection in patients with cirrhosis, Journal of Viral Hepatitis, 2000",cited-by,10.1046/j.1365-2893.2000.00229.x,Treatment of chronic hepatitis C virus infection in patients with cirrhosis,"[['Zeuzem', '', '']]",Journal of Viral Hepatitis,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2000.00229.x'],
10.1002/hep.22946,"Forns, X., Bukh, J., , THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS, Clinics in Liver Disease, 1999",cited-by,10.1016/S1089-3261(05)70234-8,THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS,"[['Xavier', '', 'Forns'], ['Jens', '', 'Bukh']]",Clinics in Liver Disease,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702348', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702348']",
10.1002/hep.22946,"Laras, A., Zacharakis, G., Hadziyannis, S., , Absence of the negative strand of GBV-C/HGV RNA from the liver, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80094-4,Absence of the negative strand of GBV-C/HGV RNA from the liver,"[['Andreas', '', 'Laras'], ['George', '', 'Zacharakis'], ['Stephanos', 'J', 'Hadziyannis']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899800944', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899800944']",
10.1002/hep.22946,"Chainuvati, S., Khalid, S., Kancir, S., et. al, Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders+, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00681.x,Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders+,"[['S.', '', 'Chainuvati'], ['S.', 'K.', 'Khalid'], ['S.', '', 'Kancir'], ['M.', '', 'Shea'], ['J.', '', 'Edwards'], ['M.', '', 'Sernyak'], ['S.', '', 'Wongcharatrawee'], ['G.', '', 'Garcia-Tsao']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00681.x'],
10.1002/hep.22946,"Katayama, K., Kasahara, A., Sasaki, Y., et. al, Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00274.x,Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance,"[['K.', '', 'Katayama'], ['A.', '', 'Kasahara'], ['Y.', '', 'Sasaki'], ['T.', '', 'Kashiwagi'], ['M.', '', 'Naito'], ['M.', '', 'Masuzawa'], ['M.', '', 'Katoh'], ['H.', '', 'Yoshihara'], ['T.', '', 'Kamada'], ['T.', '', 'Mukuda'], ['T.', '', 'Hijioka'], ['M.', '', 'Hori'], ['N.', '', 'Hayashi']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00274.x'],
10.1002/hep.22946,"KEE, K., LEE, C., WANG, J., et. al, Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis, Journal of Gastroenterology and Hepatology, 2006",cited-by,10.1111/j.1440-1746.2005.03947.x,"Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis","[['KWONG-MING', '', 'KEE'], ['CHUAN-MO', '', 'LEE'], ['JING-HOUNG', '', 'WANG'], ['HUNG-DA', '', 'TUNG'], ['CHI-SIN', '', 'CHANGCHIEN'], ['SHENG-NAN', '', 'LU'], ['PEI-WEN', '', 'WANG']]",Journal of Gastroenterology and Hepatology,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2005.03947.x'],
10.1002/hep.22946,"Myers, R., Hilsden, R., Lee, S., , Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00288.x,Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C,"[['R.', 'P.', 'Myers'], ['R.', 'J.', 'Hilsden'], ['S.', 'S.', 'Lee']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00288.x'],
10.1002/hep.22946,", Hepatitis C: A Hepatologist's Approach to an Infectious Disease, Clinical Infectious Diseases, 2001",cited-by,10.1086/323128,Hepatitis C: A Hepatologist's Approach to an Infectious Disease,[],Clinical Infectious Diseases,2001,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/323128'],
10.1002/hep.22946,"Angelico, M., Cepparulo, M., Barlattani, A., et. al, Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2000",cited-by,10.1046/j.1365-2036.2000.00857.x,Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C,"[['M.', '', 'Angelico'], ['M.', '', 'Cepparulo'], ['A.', '', 'Barlattani'], ['A.', '', 'Liuti'], ['S.', '', 'Gentile'], ['M.', '', 'Hurtova'], ['D.', '', 'Ombres'], ['P.', '', 'Guarascio'], ['G.', '', 'Rocchi'], ['F.', '', 'Angelico']]",Alimentary Pharmacology & Therapeutics,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2000.00857.x'],
10.1002/hep.22946,"Callum, J., Pinkerton, P., Coovadia, A., et. al, An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40101169.x,An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients,"[['Jeannie', 'L.', 'Callum'], ['Peter', 'H.', 'Pinkerton'], ['Ahmed', 'S.', 'Coovadia'], ['Anne', 'E.', 'Thomson'], ['Frankie', '', 'Dewsbury']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40101169.x'],
10.1002/hep.22946,"Poynard, T., Moussali, J., Ratziu, V., et. al, Effects of interferon therapy in “non responder” patients with chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80397-3,Effects of interferon therapy in “non responder” patients with chronic hepatitis C,"[['T.', '', 'Poynard'], ['J.', '', 'Moussali'], ['V.', '', 'Ratziu'], ['C.', '', 'Regimbeau'], ['P.', '', 'Opolon']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803973', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803973']",
10.1002/hep.22946,"Levy, G., Adamson, G., Phillips, M., et. al, Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity, Hepatology, 2006",cited-by,10.1002/hep.21072,Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity,"[['Gary', 'A.', 'Levy'], ['Gord', '', 'Adamson'], ['M.', 'James', 'Phillips'], ['Louise', 'A.', 'Scrocchi'], ['Laisum', '', 'Fung'], ['Pieter', '', 'Biessels'], ['Nancy', 'F.', 'Ng'], ['Anand', '', 'Ghanekar'], ['Andrea', '', 'Rowe'], ['Max', 'Xuezhong', 'Ma'], ['Adam', '', 'Levy'], ['Cheryl', '', 'Koscik'], ['William', '', 'He'], ['Reginald', '', 'Gorczynski'], ['Steve', '', 'Brookes'], ['Caroline', '', 'Woods'], ['Ian', 'D.', 'McGilvray'], ['David', '', 'Bell']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21072'],
10.1002/hep.22946,"Dawson, M., McCarthy, P., Walsh, M., et. al, Transjugular liver biopsy is a safe and effective intervention to guide management for patients with a congenital bleeding disorder infected with hepatitis C, Internal Medicine Journal, 2005",cited-by,10.1111/j.1445-5994.2005.00877.x,Transjugular liver biopsy is a safe and effective intervention to guide management for patients with a congenital bleeding disorder infected with hepatitis C,"[['M.', 'A.', 'Dawson'], ['P.', 'H.', 'McCarthy'], ['M.', 'E.', 'Walsh'], ['C.', 'A.', 'McLean'], ['K.', '', 'Thomson'], ['S.', '', 'Roberts']]",Internal Medicine Journal,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2005.00877.x'],
10.1002/hep.22946,"Zein, C., Zein, N., , Advances in therapy for hepatitis C infection, Microbes and Infection, 2002",cited-by,10.1016/S1286-4579(02)01651-9,Advances in therapy for hepatitis C infection,"[['Claudia', 'O', 'Zein'], ['Nizar', 'N', 'Zein']]",Microbes and Infection,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1286457902016519', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457902016519']",
10.1002/hep.22946,"Iacono, L., , D., , F., et. al, Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy, Alimentary Pharmacology & Therapeutics, 2000",cited-by,10.1046/j.1365-2036.2000.00713.x,Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy,"[['Lo', '', 'Iacono'], ['Diago', '', ''], ['Fernandez-Bermejo', '', ''], ['Vega', '', ''], ['Sanz', '', ''], ['Borque', '', ''], ['Garcia-Buey', '', ''], ['Garcia-Monzon', '', ''], ['Pedreira', '', ''], ['Moreno-Otero', '', '']]",Alimentary Pharmacology & Therapeutics,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2000.00713.x'],
10.1002/hep.22946,", A., , P., , L., et. al, Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland, Haemophilia, 1999",cited-by,10.1046/j.1365-2516.1999.00332.x,Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland,"[['Adamowicz-Salach', '', ''], ['Pawelec', '', ''], ['Loch', '', ''], ['Zdzieblowska-Pawinska', '', ''], ['Brojer', '', ''], ['Walewska-Zielecka', '', ''], ['Rokicka-Milewska', '', '']]",Haemophilia,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.1999.00332.x'],
10.1002/hep.22946,"Zarski, J., Leroy, V., , Counselling patients with hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80390-0,Counselling patients with hepatitis C,"[['Jean-Pierre', '', 'Zarski'], ['Vincent', '', 'Leroy']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803900', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803900']",
10.1002/hep.22946,"Hui, A., , Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2009",cited-by,10.1016/j.cgh.2009.05.025,Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B,"[['Alex', 'Yui', 'Hui']]",Clinical Gastroenterology and Hepatology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1542356509004856', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356509004856']",
10.1002/hep.22946,"Saab, S., Niho, H., Comulada, S., et. al, Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis, Liver International, 2005",cited-by,10.1111/j.1478-3231.2005.01120.x,Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis,"[['Sammy', '', 'Saab'], ['Henry', '', 'Niho'], ['Scott', '', 'Comulada'], ['Jonathan', '', 'Hiatt'], ['Francisco', '', 'Durazo'], ['Steven', '', 'Han'], ['Douglas', 'G.', 'Farmer'], ['Curtis', '', 'Holt'], ['Hasan', '', 'Yersiz'], ['Leonard', 'I.', 'Goldstein'], ['R.', 'Mark', 'Ghobrial'], ['Ronald', 'W.', 'Busuttil']]",Liver International,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1478-3231.2005.01120.x'],
10.1002/hep.22946,"Chuang, W., Dai, C., Chen, S., et. al, Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan, Liver International, 2004",cited-by,10.1111/j.1478-3231.2004.0954.x,Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan,"[['Wan-Long', '', 'Chuang'], ['Chia-Yen', '', 'Dai'], ['Shinn-Cherng', '', 'Chen'], ['Li-Po', '', 'Lee'], ['Zu-Yau', '', 'Lin'], ['Ming-Yuh', '', 'Hsieh'], ['Liang-Yen', '', 'Wang'], ['Ming-Lung', '', 'Yu'], ['Wen-Yu', '', 'Chang']]",Liver International,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1478-3231.2004.0954.x'],
10.1002/hep.22946,"Rich, J., Dickinson, B., Merriman, N., et. al, Hepatitis C Virus Infection Related to Anabolic-Androgenic Steroid Injection in a Recreational Weight Lifter, American Journal of Gastroenterology, 1998",cited-by,10.1111/j.1572-0241.1998.01598.x,Hepatitis C Virus Infection Related to Anabolic-Androgenic Steroid Injection in a Recreational Weight Lifter,"[['Josiah', 'D.', 'Rich'], ['Brian', 'P.', 'Dickinson'], ['Nathan', 'A.', 'Merriman'], ['Timothy', 'P.', 'Flanigan']]",American Journal of Gastroenterology,1998,"[u'http://dx.doi.org/10.1111/j.1572-0241.1998.01598.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.1998.01598.x']",
10.1002/hep.22946,"Liu, J., Iloeje, U., , Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-Up Study, Gastroenterology, 2010",cited-by,10.1053/j.gastro.2010.04.048,Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-Up Study,"[['Jessica', '', 'Liu'], ['Uchenna', 'H.', 'Iloeje']]",Gastroenterology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0016508510006566', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508510006566']",
10.1002/hep.22946,"Hammond, S., Borchelt, A., Ukomadu, C., et. al, Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2009",cited-by,10.1016/j.bbmt.2009.05.001,Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation,"[['Sarah', 'P.', 'Hammond'], ['Anne', 'Marie', 'Borchelt'], ['Chinweike', '', 'Ukomadu'], ['Vincent', 'T.', 'Ho'], ['Lindsey', 'R.', 'Baden'], ['Francisco', 'M.', 'Marty']]",Biology of Blood and Marrow Transplantation,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1083879109002195', u'http://linkinghub.elsevier.com/retrieve/pii/S1083879109002195']",
10.1002/hep.22946,"Wurst, F., Dürsteler-MacFarland, K., Auwaerter, V., et. al, Assessment of Alcohol Use Among Methadone Maintenance Patients by Direct Ethanol Metabolites and Self-Reports, Alcoholism-clinical and Experimental Research, 2008",cited-by,10.1111/j.1530-0277.2008.00724.x,Assessment of Alcohol Use Among Methadone Maintenance Patients by Direct Ethanol Metabolites and Self-Reports,"[['Friedrich', 'Martin', 'Wurst'], ['Kenneth', 'M.', 'D\xc3\xbcrsteler-MacFarland'], ['Volker', '', 'Auwaerter'], ['Sonja', '', 'Ergovic'], ['Natasha', '', 'Thon'], ['Michel', '', 'Yegles'], ['Claudia', '', 'Halter'], ['Wolfgang', '', 'Weinmann'], ['Gerhard', 'A.', 'Wiesbeck']]",Alcoholism-clinical and Experimental Research,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1530-0277.2008.00724.x'],
10.1002/hep.22946,"Evon, D., Verma, A., Dougherty, K., et. al, High Deferral Rates and Poorer Treatment Outcomes for HCV Patients with Psychiatric and Substance Use Comorbidities, Digestive Diseases and Sciences, 2007",cited-by,10.1007/s10620-006-9669-0,High Deferral Rates and Poorer Treatment Outcomes for HCV Patients with Psychiatric and Substance Use Comorbidities,"[['Donna', 'M.', 'Evon'], ['Amit', '', 'Verma'], ['Karen', 'A.', 'Dougherty'], ['Betty', '', 'Batey'], ['Mark', '', 'Russo'], ['Steven', '', 'Zacks'], ['Roshan', '', 'Shrestha'], ['Michael', 'W.', 'Fried']]",Digestive Diseases and Sciences,2007,"[u'http://www.springerlink.com/content/q05354156604w8q3', u'http://www.springerlink.com/index/10.1007/s10620-006-9669-0', u'http://www.springerlink.com/index/pdf/10.1007/s10620-006-9669-0']",
10.1002/hep.22946,"Jiang, Z., Yamauchi, K., Yoshioka, K., et. al, Support Vector Machine-Based Feature Selection for Classification of Liver Fibrosis Grade in Chronic Hepatitis C, Journal of Medical Systems, 2006",cited-by,10.1007/s10916-006-9023-2,Support Vector Machine-Based Feature Selection for Classification of Liver Fibrosis Grade in Chronic Hepatitis C,"[['Zheng', '', 'Jiang'], ['Kazunobu', '', 'Yamauchi'], ['Kentaro', '', 'Yoshioka'], ['Kazuma', '', 'Aoki'], ['Susumu', '', 'Kuroyanagi'], ['Akira', '', 'Iwata'], ['Jun', '', 'Yang'], ['Kai', '', 'Wang']]",Journal of Medical Systems,2006,"[u'http://www.springerlink.com/content/d4126x254327r863', u'http://www.springerlink.com/index/d4126x254327r863.pdf', u'http://dx.doi.org/10.1007/s10916-006-9023-2', u'http://www.informatik.uni-trier.de/~ley/db/journals/jms/jms30.html#JiangYYAKIYW06', u'http://www.springerlink.com/index/10.1007/s10916-006-9023-2', u'http://www.springerlink.com/index/pdf/10.1007/s10916-006-9023-2']",
10.1002/hep.22946,"BINI, E., MEHANDRU, S., , Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels, Alimentary Pharmacology & Therapeutics, 2006",cited-by,10.1111/j.1365-2036.2006.02819.x,Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels,"[['E.', 'J.', 'BINI'], ['S.', '', 'MEHANDRU']]",Alimentary Pharmacology & Therapeutics,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2006.02819.x'],
10.1002/hep.22946,"Kabir, A., Alavian, S., Keyvani, H., , Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study, Comparative Hepatology, 2006",cited-by,10.1186/1476-5926-5-4,Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study,"[['Ali', '', 'Kabir'], ['Seyed-Moayed', '', 'Alavian'], ['Hussein', '', 'Keyvani']]",Comparative Hepatology,2006,"[u'http://www.springerlink.com/index/53134j74v4015454.pdf', u'http://www.springerlink.com/content/53134j74v4015454', u'http://www.biomedcentral.com/content/pdf/1476-5926-5-4.pdf', u'http://www.comparative-hepatology.com/content/5/1/4']",
10.1002/hep.22946,"Hatem, C., Minello, A., Bresson-Hadni, S., et. al, Is the management of hepatitis C patients appropriate? A population-based study, Alimentary Pharmacology & Therapeutics, 2005",cited-by,10.1111/j.1365-2036.2005.02393.x,Is the management of hepatitis C patients appropriate? A population-based study,"[['C.', '', 'Hatem'], ['A.', '', 'Minello'], ['S.', '', 'Bresson-Hadni'], ['V.', '', 'Jooste'], ['P.', '', 'Evrard'], ['B.', '', 'Obert'], ['C.', '', 'Lepage'], ['C.', '', 'Bonithon-Kopp'], ['J.', '', 'Faivre'], ['E.', '', 'Monnet'], ['J.-P.', '', 'Miguet'], ['P.', '', 'Hillon']]",Alimentary Pharmacology & Therapeutics,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2005.02393.x'],
10.1002/hep.22946,"Lee, S., , Indicators and predictors of response to anti-viral therapy in chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2003",cited-by,10.1046/j.1365-2036.2003.01463.x,Indicators and predictors of response to anti-viral therapy in chronic hepatitis C,"[['S.', 'S.', 'Lee']]",Alimentary Pharmacology & Therapeutics,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2003.01463.x'],
10.1002/hep.22946,"Vrolijk, J., Bekkering, F., Brouwer, J., et. al, High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00408.x,High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy,"[['J.', 'M.', 'Vrolijk'], ['F.', 'C.', 'Bekkering'], ['J.', 'T.', 'Brouwer'], ['B.', 'E.', 'Hansen'], ['S.', 'W.', 'Schalm']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00408.x'],
10.1002/hep.22946,"Lim, J., Wooten, D., Siegel, R., et. al, Amantadine in treatment of chronic hepatitis C virus infection?, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00622.x,Amantadine in treatment of chronic hepatitis C virus infection?,"[['J.', 'K.', 'Lim'], ['D.', '', 'Wooten'], ['R.', '', 'Siegel'], ['R.', 'C.', 'Cheung']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00622.x'],
10.1002/hep.22946,"Kim, T., Kim, K., Lim, Y., et. al, Prediction of Treatment Outcome in Chronic Hepatitis C Patients Based on Early Viral Dynamics during High-Dose Induction Interferon and Ribavirin Therapy, Intervirology, 2005",cited-by,10.1159/000084600,Prediction of Treatment Outcome in Chronic Hepatitis C Patients Based on Early Viral Dynamics during High-Dose Induction Interferon and Ribavirin Therapy,"[['Tae', 'Hun', 'Kim'], ['Kyung', 'A.', 'Kim'], ['Young', 'Seok', 'Lim'], ['Geum-youn', '', 'Gwak'], ['Jung-Hwan', '', 'Yoon'], ['Gyeong', 'Hoon', 'Kang'], ['Hyo-Suk', '', 'Lee']]",Intervirology,2005,"[u'http://www.karger.com/doi/10.1159/000084600', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000084600']",
10.1002/hep.22946,"Sievert, W., , Management issues in chronic viral hepatitis: Hepatitis C, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02725.x,Management issues in chronic viral hepatitis: Hepatitis C,"[['William', '', 'Sievert']]",Journal of Gastroenterology and Hepatology,2002,"[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/management issues in chronic viral hepatitis-hepatitis c.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02725.x']",
10.1002/hep.22946,", G., , V., , A., et. al, Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2000",cited-by,10.1046/j.1365-2036.2000.00792.x,Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C,"[['Garcia-Escano', '', ''], ['Valdivielso', '', ''], ['Alcantara', '', ''], ['Sanchez-Chaparro', '', ''], ['Gonzalez-Santos', '', '']]",Alimentary Pharmacology & Therapeutics,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2000.00792.x'],
10.1002/hep.22946,"Meijer, K., Smid, W., Meer, J., , Treatment of chronic hepatitis C in haemophilia patients, Haemophilia, 2000",cited-by,10.1046/j.1365-2516.2000.00398.x,Treatment of chronic hepatitis C in haemophilia patients,"[['K.', '', 'Meijer'], ['W.', 'M.', 'Smid'], ['J.', 'Van Der', 'Meer']]",Haemophilia,2000,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1365-2516.2000.00398.x'],
10.1002/hep.22946,"Barbaro, B., Manfredi, R., Bombardieri, G., et. al, Correlation of MRI liver volume and Doppler sonographic portal hemodynamics with histologic findings in patients with chronic hepatitis C, Journal of Clinical Ultrasound, 2000",cited-by,10.1002/1097-0096(200011/12)28:9<461::AID-JCU3>3.0.CO;2-5,Correlation of MRI liver volume and Doppler sonographic portal hemodynamics with histologic findings in patients with chronic hepatitis C,"[['Brunella', '', 'Barbaro'], ['Riccardo', '', 'Manfredi'], ['Giuseppe', '', 'Bombardieri'], ['Fabio', 'Maria', 'Vecchio'], ['Giovanni', '', 'Palazzoni'], ['Anna', 'Paola', 'Mancini'], ['Stefano', '', ""Dall'Argine""], ['Pasquale', '', 'Marano']]",Journal of Clinical Ultrasound,2000,[u'http://doi.wiley.com/10.1002/1097-0096%28200011/12%2928%3A9%3C461%3A%3AAID-JCU3%3E3.0.CO%3B2-5'],
10.1002/hep.22946,"Khalili, M., Denham, C., Perrillo, R., , Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C, American Journal of Gastroenterology, 2000",cited-by,10.1111/j.1572-0241.2000.02025.x,Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C,"[['Mandana', '', 'Khalili'], ['Cheryl', '', 'Denham'], ['Robert', '', 'Perrillo']]",American Journal of Gastroenterology,2000,"[u'http://dx.doi.org/10.1111/j.1572-0241.2000.02025.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2000.02025.x']",
10.1002/hep.22946,"Rust, C., Gores, G., , Does Hepatitis C Cause Liver Injury by Pathways Associated With Mitochondrial Dysfunction?, American Journal of Gastroenterology, 1999",cited-by,10.1111/j.1572-0241.1999.02003.x,Does Hepatitis C Cause Liver Injury by Pathways Associated With Mitochondrial Dysfunction?,"[['Christian', '', 'Rust'], ['Gregory', 'J.', 'Gores']]",American Journal of Gastroenterology,1999,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.1999.02003.x', u'http://dx.doi.org/10.1111/j.1572-0241.1999.02003.x']",
10.1002/hep.22946,"Epstein, J., , Alternative strategies in assuring blood safety: An Overview, Biologicals, 2010",cited-by,10.1016/j.biologicals.2009.10.009,Alternative strategies in assuring blood safety: An Overview,"[['Jay', 'S.', 'Epstein']]",Biologicals,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1045105609001596', u'http://linkinghub.elsevier.com/retrieve/pii/S1045105609001596']",
10.1002/hep.22946,"Ho, S., Groessl, E., Dollarhide, A., et. al, Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models, American Journal of Gastroenterology, 2008",cited-by,10.1111/j.1572-0241.2008.01877.x,Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models,"[['Samuel', 'B.', 'Ho'], ['Erik', '', 'Groessl'], ['Adrian', '', 'Dollarhide'], ['Shannon', '', 'Robinson'], ['David', '', 'Kravetz'], ['Eric', '', 'Dieperink']]",American Journal of Gastroenterology,2008,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2008.01877.x', u'http://dx.doi.org/10.1111/j.1572-0241.2008.01877.x']",
10.1002/hep.22946,"Moreno-Monteagudo, J., Castro, A., Pedro, A., et. al, Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers, Alimentary Pharmacology & Therapeutics, 2002",cited-by,10.1046/j.1365-2036.2002.01162.x,Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers,"[['J.', 'A.', 'Moreno-Monteagudo'], ['A.', '', 'Castro'], ['A.', 'De', 'Pedro'], ['J.', 'A.', 'Lorenzo'], ['M.', '', 'Fernandez-Bermejo'], ['S.', '', 'Lopez'], ['L.', '', 'Garcia-Buey'], ['M.', 'J.', 'Borque'], ['J.', 'D.', 'Pedreira'], ['R.', '', 'Moreno-Otero']]",Alimentary Pharmacology & Therapeutics,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2002.01162.x'],
10.1002/hep.22946,"Pereira, A., , Health and economic consequences of HCV lookback, Transfusion, 2001",cited-by,10.1046/j.1537-2995.2001.41060832.x,Health and economic consequences of HCV lookback,"[['Arturo', '', 'Pereira']]",Transfusion,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2001.41060832.x'],
10.1056~NEJMoa011232,"Detre KM, Belle SH, Lombardero M. Liver transplantation for chronic viral hepatitis. Viral Hepatitis Rev 1996;2:219-28.",references,NOT found in MAS
10.1056~NEJMoa011232,"Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.",references,10.1056/NEJM199908193410802,"The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994","[[u'Miriam', u'J.', u'Alter'], [u'Deanna', u'', u'Kruszon-Moran'], [u'Omana', u'V.', u'Nainan'], [u'Geraldine', u'M.', u'McQuillan'], [u'Fengxiang', u'', u'Gao'], [u'Linda', u'A.', u'Moyer'], [u'Richard', u'A.', u'Kaslow'], [u'Harold', u'S.', u'Margolis']]",New England Journal of Medicine,1999,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199908193410802'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'United States', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 43479}]"
10.1056/NEJM199908193410802,"Manns, M., McHutchison, J., Gordon, S., et. al, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, Lancet, 2001",cited-by,10.1016/S0140-6736(01)06102-5,Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial,"[['Michael', 'P', 'Manns'], ['John', 'G', 'McHutchison'], ['Stuart', 'C', 'Gordon'], ['Vinod', 'K', 'Rustgi'], ['Mitchell', '', 'Shiffman'], ['Robert', '', 'Reindollar'], ['Zachary', 'D', 'Goodman'], ['Kenneth', '', 'Koury'], ['Mei-Hsiu', '', 'Ling'], ['Janice', 'K', 'Albrecht']]",Lancet,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0140673601061025', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673601061025']",
10.1056/NEJM199908193410802,"Strader, D., Wright, T., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20119,"Diagnosis, management, and treatment of hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2004,"[u'http://www.natap.org/2004/pdf/AASLD_Prac._Guide_Hep_C.pdf', u'http://www.hiv.ch/rubriken/hep/US_GL_Hep_C.pdf', u'http://www.texasliver.com/docs/management%20of%20hepatitis%20c%203.pdf', u'http://doi.wiley.com/10.1002/hep.20119']",
10.1056/NEJM199908193410802,"Browning, J., Szczepaniak, L., Dobbins, R., et. al, Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity, Hepatology, 2004",cited-by,10.1002/hep.20466,Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity,"[['Jeffrey', 'D.', 'Browning'], ['Lidia', 'S.', 'Szczepaniak'], ['Robert', '', 'Dobbins'], ['Pamela', '', 'Nuremberg'], ['Jay', 'D.', 'Horton'], ['Jonathan', 'C.', 'Cohen'], ['Scott', 'M.', 'Grundy'], ['Helen', 'H.', 'Hobbs']]",Hepatology,2004,"[u'http://gidiv.ucsf.edu/course/things/browning.pdf', u'http://doi.wiley.com/10.1002/hep.20466']",
10.1056/NEJM199908193410802,"Lai, C., Ratziu, V., Yuen, M., et. al, Viral hepatitis B, Lancet, 2003",cited-by,10.1016/S0140-6736(03)15108-2,Viral hepatitis B,"[['Ching', 'Lung', 'Lai'], ['Vlad', '', 'Ratziu'], ['Man-Fung', '', 'Yuen'], ['Thierry', '', 'Poynard']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603151082', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603151082', u'https://www.msu.edu/~rosenb98/MS3/Int Med/Viral Hepatitis B - Lancet.pdf', u'http://www.temple.edu/imreports/reading/gi - hepc.pdf', u'http://www.temple.edu/imreports/reading/gi - hepb.pdf']",
10.1056/NEJM199908193410802,"Shepard, C., Finelli, L., Alter, M., , Global epidemiology of hepatitis C virus infection, Lancet Infectious Diseases, 2005",cited-by,10.1016/S1473-3099(05)70216-4,Global epidemiology of hepatitis C virus infection,"[['Colin', 'W', 'Shepard'], ['Lyn', '', 'Finelli'], ['Miriam', 'J', 'Alter']]",Lancet Infectious Diseases,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1473309905702164', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309905702164']",
10.1056/NEJM199908193410802,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
10.1056/NEJM199908193410802,"sandler, R., Everhart, J., Donowitz, M., et. al, The burden of selected digestive diseases in the United States, Gastroenterology, 2002",cited-by,10.1053/gast.2002.32978,The burden of selected digestive diseases in the United States,"[['Robert', 'S.', 'sandler'], ['James', 'E.', 'Everhart'], ['Mark', '', 'Donowitz'], ['Elizabeth', '', 'Adams'], ['Kelly', '', 'Cronin'], ['Clifford', '', 'Goodman'], ['Eric', '', 'Gemmen'], ['Shefali', '', 'Shah'], ['Aida', '', 'Avdic'], ['Robert', '', 'Rubin']]",Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0016508502749652', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508502749652']",
10.1056/NEJM199908193410802,"Armstrong, G., Wasley, A., Simard, E., et. al, The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002, , 0",cited-by,"10365342The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002","The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002","[['Gregory', 'L.', 'Armstrong'], ['Annemarie', '', 'Wasley'], ['Edgar', 'P.', 'Simard'], ['Geraldine', 'M.', 'McQuillan'], ['Wendi', 'L.', 'Kuhnert'], ['Miriam', 'J.', 'Alter']]",,0,[u'http://www.annals.org/content/144/10/705.full.pdf'],
10.1056/NEJM199908193410802,"Poynard, T., McHutchison, J., Manns, M., et. al, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 2002",cited-by,10.1053/gast.2002.33023,Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C,"[['Thierry', '', 'Poynard'], ['John', '', 'McHutchison'], ['Michael', '', 'Manns'], ['Christian', '', 'Trepo'], ['Karen', '', 'Lindsay'], ['Zachary', '', 'Goodman'], ['Mei-Hsiu', '', 'Ling'], ['Janice', '', 'Albrecht']]",Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S001650850234959X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850234959X']",
10.1056/NEJM199908193410802,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1056/NEJM199908193410802,"Yu, E., Carnie, J., Heeren, T., , Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis, Clinical Infectious Diseases, 2001",cited-by,10.1086/321909,Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis,"[['E.', '', 'Yu'], ['J.', '', 'Carnie'], ['T.', '', 'Heeren']]",Clinical Infectious Diseases,2001,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/321909'],
10.1056/NEJM199908193410802,"Fattovich, G., Stroffolini, T., Zagni, I., et. al, Hepatocellular carcinoma in cirrhosis: Incidence and risk factors, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.09.014,Hepatocellular carcinoma in cirrhosis: Incidence and risk factors,"[['Giovanna', '', 'Fattovich'], ['Tommaso', '', 'Stroffolini'], ['Irene', '', 'Zagni'], ['Francesco', '', 'Donato']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504015938', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504015938']",
10.1056/NEJM199908193410802,"Sherman, K., Rouster, S., Chung, R., et. al, Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross‐Sectional Analysis of the US Adult AIDS Clinical Trials Group, Clinical Infectious Diseases, 2002",cited-by,10.1086/339042,Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross‐Sectional Analysis of the US Adult AIDS Clinical Trials Group,"[['Kenneth', 'E.', 'Sherman'], ['Susan', 'D.', 'Rouster'], ['Raymond', 'T.', 'Chung'], ['Natasa', '', 'Rajicic']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/339042'],
10.1056/NEJM199908193410802,"Thio, C., Seaberg, E., Skolasky, R., et. al, HIV1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS), Lancet, 2002",cited-by,10.1016/S0140-6736(02)11913-1,"HIV1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","[['Chloe', 'L', 'Thio'], ['Eric', 'C', 'Seaberg'], ['Richard', '', 'Skolasky'], ['John', '', 'Phair'], ['Barbara', '', 'Visscher'], ['Alvaro', '', 'Mu\xc3\xb1oz'], ['David', 'L', 'Thomas']]",Lancet,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0140673602119131', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673602119131']",
10.1056/NEJM199908193410802,"Peyron, R., Laurent, B., García-Larrea, L., , Functional imaging of brain responses to pain. A review and meta-analysis (2000), Neurophysiologie Clinique-clinical Neurophysiology, 2000",cited-by,10.1016/S0987-7053(00)00227-6,Functional imaging of brain responses to pain. A review and meta-analysis (2000),"[['R.', '', 'Peyron'], ['B.', '', 'Laurent'], ['L.', '', 'Garc\xc3\xada-Larrea']]",Neurophysiologie Clinique-clinical Neurophysiology,2000,[u'http://www.sciencedirect.com/science/article/pii/S0987705300002276'],
10.1056/NEJM199908193410802,"Armstrong, G., Alter, M., McQuillan, G., et. al, The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States, Hepatology, 2000",cited-by,10.1002/hep.510310332,The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States,"[['Gregory', 'L.', 'Armstrong'], ['Miriam', 'J.', 'Alter'], ['Geraldine', 'M.', 'McQuillan'], ['Harold', 'S.', 'Margolis']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310332'],
10.1056/NEJM199908193410802,"Mehta, S., Cox, A., Hoover, D., et. al, Protection against persistence of hepatitis C, Lancet, 2002",cited-by,10.1016/S0140-6736(02)08435-0,Protection against persistence of hepatitis C,"[['Shruti', 'H', 'Mehta'], ['Andrea', '', 'Cox'], ['Donald', 'R', 'Hoover'], ['Xiao-Hong', '', 'Wang'], ['Qing', '', 'Mao'], ['Stuart', '', 'Ray'], ['Steffanie', 'A', 'Strathdee'], ['David', '', 'Vlahov'], ['David', 'L', 'Thomas']]",Lancet,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0140673602084350', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673602084350']",
10.1056/NEJM199908193410802,"Kim, W., , The burden of hepatitis C in the United States, Hepatology, 2002",cited-by,10.1053/jhep.2002.36791,The burden of hepatitis C in the United States,"[['W.', 'Ray', 'Kim']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Burden%20Of%20Hepatitis%20C%20In%20The%20US.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36791', u'http://doi.wiley.com/10.1002/hep.1840360705']",
10.1056/NEJM199908193410802,"Patton, H., Patel, K., Behling, C., et. al, The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients, Journal of Hepatology, 2004",cited-by,10.1016/j.jhep.2003.11.004,The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients,"[['Heather', 'M', 'Patton'], ['Keyur', '', 'Patel'], ['Cynthia', '', 'Behling'], ['David', '', 'Bylund'], ['Lawrence', 'M', 'Blatt'], ['Marc', '', 'Vall\xc3\xa9e'], ['Shanon', '', 'Heaton'], ['Andrew', '', 'Conrad'], ['Paul', 'J', 'Pockros'], ['John', 'G', 'McHutchison']]",Journal of Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803005828', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803005828']",
10.1056/NEJM199908193410802,"Lonardo, A., Adinolfi, L., Loria, P., et. al, Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2003.11.020,Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease,"[['Amedeo', '', 'Lonardo'], ['Luigi', 'E.', 'Adinolfi'], ['Paola', '', 'Loria'], ['Nicola', '', 'Carulli'], ['Giuseppe', '', 'Ruggiero'], ['Christopher', 'P.', 'Day']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503018304', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503018304']",
10.1056/NEJM199908193410802,"Navarro, V., Senior, J., , Drug-Related Hepatotoxicity, New England Journal of Medicine, 2006",cited-by,10.1056/NEJMra052270,Drug-Related Hepatotoxicity,"[['Victor', 'J.', 'Navarro'], ['John', 'R.', 'Senior']]",New England Journal of Medicine,2006,"[u'http://www.nejm.org/doi/abs/10.1056/NEJMra052270', u'http://www.med.upenn.edu/gastro/documents/NEJMdrughepatotoxicity.pdf']",
10.1056/NEJM199908193410802,"Alter, M., , Prevention of spread of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36389,Prevention of spread of hepatitis C,"[['Miriam', 'J.', 'Alter']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Prevention%20Of%20Spread%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360712', u'http://doi.wiley.com/10.1053/jhep.2002.36389']",
10.1056/NEJM199908193410802,"Kim, W., Jr, R., Terrault, N., et. al, Burden of liver disease in the United States: Summary of a workshop, Hepatology, 2002",cited-by,10.1053/jhep.2002.34734,Burden of liver disease in the United States: Summary of a workshop,"[['W.', 'Ray', 'Kim'], ['Robert', 'S. Brown', 'Jr'], ['Norah', 'A.', 'Terrault'], ['Hashem', '', 'El-Serag']]",Hepatology,2002,"[u'https://www250.safesecureweb.com/hcvadvocate/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Burden.pdf', u'http://www.sciencedirect.com/science/article/pii/S0270913902000265', u'http://www.hcvadvocate.org/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Burden.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.34734']",
10.1056/NEJM199908193410802,"Dienstag, J., McHutchison, J., , American Gastroenterological Association Technical Review on the Management of Hepatitis C, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2005.11.010,American Gastroenterological Association Technical Review on the Management of Hepatitis C,"[['Jules', 'L.', 'Dienstag'], ['John', 'G.', 'McHutchison']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505022705', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505022705']",
10.1056/NEJM199908193410802,"Hinrichsen, H., Benhamou, Y., Wedemeyer, H., et. al, Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.08.002,"Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients","[['Holger', '', 'Hinrichsen'], ['Yves', '', 'Benhamou'], ['Heiner', '', 'Wedemeyer'], ['Markus', '', 'Reiser'], ['Roel', 'E.', 'Sentjens'], ['Jos\xc3\xa9', 'L.', 'Calleja'], ['Xavier', '', 'Forns'], ['Andreas', '', 'Erhardt'], ['Jens', '', 'Cr\xc3\xb6nlein'], ['Ricardo', 'L.', 'Chaves'], ['Chan-Loi', '', 'Yong'], ['Gerhard', '', 'Nehmiz'], ['Gerhard', 'G.', 'Steinmann']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504013915', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504013915']",
10.1056/NEJM199908193410802,"Sulkowski, M., Thomas, D., , Hepatitis C in the HIV-Infected Person, , 2003",cited-by,5168375Hepatitis C in the HIV-Infected Person,Hepatitis C in the HIV-Infected Person,"[['Mark', 'S.', 'Sulkowski'], ['David', 'L.', 'Thomas']]",,2003,[u'http://www.annals.org/content/138/3/197.full.pdf'],
10.1056/NEJM199908193410802,"Lanford, R., Guerra, B., Lee, H., et. al, Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.1092-1104.2003,"Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons","[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Helen', '', 'Lee'], ['Devron', 'R.', 'Averett'], ['Brad', '', 'Pfeiffer'], ['Deborah', '', 'Chavez'], ['Lena', '', 'Notvall'], ['Catherine', '', 'Bigger']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/2/1092.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.1092-1104.2003']",
10.1056/NEJM199908193410802,"Alter, M., , Epidemiology of hepatitis C virus infection, , 2007",cited-by,5936784Epidemiology of hepatitis C virus infection,Epidemiology of hepatitis C virus infection,"[['Miriam', 'J', 'Alter']]",,2007,"[u'http://www.wjgnet.com/1007-9327/13/2436.pdf', u'http://wjg.wjgnet.com/1007-9327/13/2436.pdf']",
10.1056/NEJM199908193410802,"McGlynn, K., Tsao, L., Hsing, A., et. al, International trends and patterns of primary liver cancer, International Journal of Cancer, 2001",cited-by,10.1002/ijc.1456,International trends and patterns of primary liver cancer,"[['Katherine', 'A.', 'McGlynn'], ['Lilian', '', 'Tsao'], ['Ann', 'W.', 'Hsing'], ['Susan', 'S.', 'Devesa'], ['Joseph', 'F.', 'Fraumeni']]",International Journal of Cancer,2001,[u'http://doi.wiley.com/10.1002/ijc.1456'],
10.1056/NEJM199908193410802,"Poynard, T., Yuen, M., Ratzin, V., et. al, Viral hepatitis C, Lancet, 2003",cited-by,10.1016/S0140-6736(03)15109-4,Viral hepatitis C,"[['Thierry', '', 'Poynard'], ['Man-Fung', '', 'Yuen'], ['Vlad', '', 'Ratzin'], ['Ching', 'Lung', 'Lai']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603151094', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603151094']",
10.1056/NEJM199908193410802,"Sylvestre, D., , Treating hepatitis C in methadone maintenance patients: an interim analysis, Drug and Alcohol Dependence, 2002",cited-by,10.1016/S0376-8716(02)00010-8,Treating hepatitis C in methadone maintenance patients: an interim analysis,"[['Diana', 'L', 'Sylvestre']]",Drug and Alcohol Dependence,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0376871602000108', u'http://linkinghub.elsevier.com/retrieve/pii/S0376871602000108']",
10.1056/NEJM199908193410802,"Williams, I., , Epidemiology of hepatitis C in the United States, American Journal of Medicine, 1999",cited-by,10.1016/S0002-9343(99)00373-3,Epidemiology of hepatitis C in the United States,"[['Ian', '', 'Williams']]",American Journal of Medicine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0002934399003733', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934399003733']",
10.1056/NEJM199908193410802,"Hilsabeck, R., Perry, W., Hassanein, T., , Neuropsychological impairment in patients with chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.31257,Neuropsychological impairment in patients with chronic hepatitis C,"[['Robin', 'C.', 'Hilsabeck'], ['William', '', 'Perry'], ['Tarek', 'I.', 'Hassanein']]",Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0270913902601235', u'http://www.psic.info/FERENCI hepCpsycho1.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.31257']",
10.1056/NEJM199908193410802,"Day, C., Lauer, G., Robbins, G., et. al, Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12584-12595.2002,Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection,"[['Cheryl', 'L.', 'Day'], ['Georg', 'M.', 'Lauer'], ['Gregory', 'K.', 'Robbins'], ['Barbara', '', 'McGovern'], ['Alysse', 'G.', 'Wurcel'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12584-12595.2002', u'http://jvi.asm.org/cgi/reprint/76/24/12584.pdf']",
10.1056/NEJM199908193410802,"Radkowski, M., Gallegos-Orozco, J., Jablonska, J., et. al, Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20518,Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C,"[['Marek', '', 'Radkowski'], ['Juan', 'F.', 'Gallegos-Orozco'], ['Joanna', '', 'Jablonska'], ['Thomas', 'V.', 'Colby'], ['Bozena', '', 'Walewska-Zielecka'], ['Joanna', '', 'Kubicka'], ['Jeffrey', '', 'Wilkinson'], ['Debra', '', 'Adair'], ['Jorge', '', 'Rakela'], ['Tomasz', '', 'Laskus']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20518'],
10.1056/NEJM199908193410802,"Radziewicz, H., Ibegbu, C., Fernandez, M., et. al, Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression, Journal of Virology, 2007",cited-by,10.1128/JVI.02021-06,Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression,"[['Henry', '', 'Radziewicz'], ['Chris', 'C.', 'Ibegbu'], ['Marina', 'L.', 'Fernandez'], ['Kimberly', 'A.', 'Workowski'], ['Kamil', '', 'Obideen'], ['Mohammad', '', 'Wehbi'], ['Holly', 'L.', 'Hanson'], ['James', 'P.', 'Steinberg'], ['David', '', 'Masopust'], ['E.', 'John', 'Wherry'], ['John', 'D.', 'Altman'], ['Barry', 'T.', 'Rouse'], ['Gordon', 'J.', 'Freeman'], ['Rafi', '', 'Ahmed'], ['Arash', '', 'Grakoui']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/6/2545.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02021-06']",
10.1056/NEJM199908193410802,"Tan, S., Katze, M., , How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A, Virology, 2001",cited-by,10.1006/viro.2001.0885,How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A,"[['Seng-Lai', '', 'Tan'], ['Michael', 'G.', 'Katze']]",Virology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0042682201908852', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682201908852']",
10.1056/NEJM199908193410802,"Groves, F., Linet, M., Travis, L., et. al, Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995, , 2000",cited-by,6808278Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995,Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995,"[['Frank', 'D.', 'Groves'], ['Martha', 'S.', 'Linet'], ['Lois', 'B.', 'Travis'], ['Susan', 'S.', 'Devesa']]",,2000,[u'http://jnci.oxfordjournals.org/cgi/reprint/92/15/1240.pdf'],
10.1056/NEJM199908193410802,"BELTRAMI, E., WILLIAMS, I., SHAPIRO, C., et. al, Risk and Management of Blood-Borne Infections in Health Care Workers, Clinical Microbiology Reviews, 2000",cited-by,10.1128/CMR.13.3.385-407.2000,Risk and Management of Blood-Borne Infections in Health Care Workers,"[['ELISE', 'M.', 'BELTRAMI'], ['IAN', 'T.', 'WILLIAMS'], ['CRAIG', 'N.', 'SHAPIRO'], ['MARY', 'E.', 'CHAMBERLAND']]",Clinical Microbiology Reviews,2000,"[u'http://www.heart-intl.net/HEART/Legal/Comp/Risk&ManagementforH2000.pdf', u'http://cmr.asm.org/cgi/reprint/13/3/385.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.13.3.385-407.2000']",
10.1056/NEJM199908193410802,"Zdilar, D., Franco-Bronson, K., Buchler, N., et. al, Hepatitis C, interferon alfa, and depression, Hepatology, 2000",cited-by,10.1053/jhep.2000.7880,"Hepatitis C, interferon alfa, and depression","[['Darko', '', 'Zdilar'], ['Kathleen', '', 'Franco-Bronson'], ['Nancy', '', 'Buchler'], ['Joseph', 'A.', 'Locala'], ['Zobair', 'M.', 'Younossi']]",Hepatology,2000,"[u'http://www.hcvu.org/mlib/2007_03_15-Zdilar-HCV_and_Depression.pdf', u'http://doi.wiley.com/10.1053/jhep.2000.7880']",
10.1056/NEJM199908193410802,"Shaib, Y., El-Serag, H., Davila, J., et. al, Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study, Gastroenterology, 2005",cited-by,10.1053/j.gastro.2004.12.048,Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study,"[['Yasser', 'H.', 'Shaib'], ['Hashem', 'B.', 'El-Serag'], ['Jessica', 'A.', 'Davila'], ['Robert', '', 'Morgan'], ['Katherine', 'A.', 'McGlynn']]",Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504023510', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504023510']",
10.1056/NEJM199908193410802,"Gossop, M., Marsden, J., Stewart, D., et. al, The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results, Addiction, 2003",cited-by,10.1046/j.1360-0443.2003.00296.x,The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results,"[['Michael', '', 'Gossop'], ['John', '', 'Marsden'], ['Duncan', '', 'Stewart'], ['Tara', '', 'Kidd']]",Addiction,2003,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1360-0443.2003.00296.x'],
10.1056/NEJM199908193410802,"Falck-Ytter, Y., Kale, H., Mullen, K., et. al, Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C, , 0",cited-by,10164197Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C,Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C,"[['Yngve', '', 'Falck-Ytter'], ['Hemangi', '', 'Kale'], ['Kevin', 'D.', 'Mullen'], ['Steedman', 'A.', 'Sarbah'], ['Lucian', '', 'Sorescu'], ['Arthur', 'J.', 'McCullough']]",,0,[],
10.1056/NEJM199908193410802,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1056/NEJM199908193410802,"Muir, A., Bornstein, J., Killenberg, P., , Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites, , 2010",cited-by,11009079Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites,Peginterferon Alfa-2b and Ribavirin for the Treatment of Chronic Hepatitis C in Blacks and Non-Hispanic Whites,"[['Andrew', 'J.', 'Muir'], ['Jeffrey', 'D.', 'Bornstein'], ['Paul', 'G.', 'Killenberg']]",,2010,"[u'http://content.nejm.org/cgi/reprint/350/22/2265.pdf', u'http://intl-content.nejm.org/cgi/reprint/350/22/2265.pdf', u'http://nejm.highwire.org/cgi/reprint/350/22/2265.pdf', u'https://content.nejm.org/cgi/reprint/350/22/2265.pdf']",
10.1056/NEJM199908193410802,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1056/NEJM199908193410802,"Memon, M., Memon, M., , Hepatitis C: an epidemiological review, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00329.x,Hepatitis C: an epidemiological review,"[['M.', 'I.', 'Memon'], ['M.', 'A.', 'Memon']]",Journal of Viral Hepatitis,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1365-2893.2002.00329.x'],
10.1056/NEJM199908193410802,"Dore, G., Law, M., MacDonald, M., et. al, Epidemiology of hepatitis C virus infection in Australia, Journal of Clinical Virology, 2003",cited-by,10.1016/S1386-6532(02)00116-6,Epidemiology of hepatitis C virus infection in Australia,"[['Gregory', 'J', 'Dore'], ['Matthew', '', 'Law'], ['Margaret', '', 'MacDonald'], ['John', 'M', 'Kaldor']]",Journal of Clinical Virology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1386653202001166', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001166']",
10.1056/NEJM199908193410802,"Tedaldi, E., Baker, R., Moorman, A., et. al, Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy, Clinical Infectious Diseases, 2003",cited-by,10.1086/345953,Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy,"[['Ellen', 'M.', 'Tedaldi'], ['Rose', 'K.', 'Baker'], ['Anne', 'C.', 'Moorman'], ['Carlos', 'F.', 'Alzola'], ['Jack', '', 'Furhrer'], ['Robert', 'E.', 'McCabe'], ['Kathleen', 'C.', 'Wood'], ['Scott', 'D.', 'Holmberg']]",Clinical Infectious Diseases,2003,"[u'http://www.idsociety.org/assets/0/18/312/924/BCE26E40-98BF-4FD9-92BF-109333663306.pdf', u'http://www.hivma.org/assets/0/18/312/924/BCE26E40-98BF-4FD9-92BF-109333663306.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/345953']",
10.1056/NEJM199908193410802,"Hauri, A., Armstrong, G., Hutin, Y., , The global burden of disease attributable to contaminated injections given in health care settings, International Journal of Std & Aids, 2004",cited-by,10.1258/095646204322637182,The global burden of disease attributable to contaminated injections given in health care settings,"[['Anja', 'M', 'Hauri'], ['Gregory', 'L', 'Armstrong'], ['Yvan', 'J F', 'Hutin']]",International Journal of Std & Aids,2004,"[u'http://uqconnect.net/signfiles/Files/HauriEtAlGBDInjections2004.pdf', u'http://ijsa.rsmjournals.com/cgi/doi/10.1258/095646204322637182']",
10.1056/NEJM199908193410802,"BORGAONKAR, M., IRVINE, E., , Quality of life measurement in gastrointestinal and liver disorders, Gut, 2000",cited-by,10.1136/gut.47.3.444,Quality of life measurement in gastrointestinal and liver disorders,"[['M', 'R', 'BORGAONKAR'], ['E', 'J', 'IRVINE']]",Gut,2000,"[u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.47.3.444']",
10.1056/NEJM199908193410802,"Laumann, A., Derick, A., , Tattoos and body piercings in the United States: A national data set, Journal of The American Academy of Dermatology, 2006",cited-by,10.1016/j.jaad.2006.03.026,Tattoos and body piercings in the United States: A national data set,"[['Anne', 'E.', 'Laumann'], ['Amy', 'J.', 'Derick']]",Journal of The American Academy of Dermatology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0190962206008310', u'http://linkinghub.elsevier.com/retrieve/pii/S0190962206008310']",
10.1056/NEJM199908193410802,"Sanyal, A., Contos, M., Sterling, R., et. al, Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome, American Journal of Gastroenterology, 2003",cited-by,10.1016/S0002-9270(03)00551-3,Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome,"[['Arun', 'J', 'Sanyal'], ['Melissa', 'J', 'Contos'], ['Richard', 'K', 'Sterling'], ['Velimir', 'A', 'Luketic'], ['Mitchell', 'L', 'Shiffman'], ['R.', 'Todd', 'Stravitz'], ['A.', 'Scott', 'Mills']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003005513', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003005513']",
10.1056/NEJM199908193410802,"Dube, S., Felitti, V., Dong, M., et. al, Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use: The Adverse Childhood Experiences Study, , 2010",cited-by,"5056114Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use: The Adverse Childhood Experiences Study","Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use: The Adverse Childhood Experiences Study","[['Shanta', 'R.', 'Dube'], ['Vincent', 'J.', 'Felitti'], ['Maxia', '', 'Dong'], ['Daniel', 'P.', 'Chapman'], ['Wayne', 'H.', 'Giles'], ['Robert', 'F.', 'Anda']]",,2010,[u'http://www.likestilling.com/psykologi/artikler/ACE/ACE-7.pdf'],
10.1056/NEJM199908193410802,", Hepatitis C in African Americans: Summary of a Workshop, Gastroenterology, 2000",cited-by,10.1053/gast.2000.19582,Hepatitis C in African Americans: Summary of a Workshop,[],Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500697871', u'http://www.natap.org/2000/aasld/gastrent.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500697871']",
10.1056/NEJM199908193410802,"BACKMUND, M., MEYER, K., ZIELONKA, M., et. al, Treatment of Hepatitis C Infection in Injection Drug Users, , 0",cited-by,12082892Treatment of Hepatitis C Infection in Injection Drug Users,Treatment of Hepatitis C Infection in Injection Drug Users,"[['MARKUS', '', 'BACKMUND'], ['K', 'IRSTEN', 'MEYER'], ['M', 'ICHAEL VON', 'ZIELONKA'], ['DIETER', '', 'EICHENLAUB']]",,0,"[u'http://www.hcvu.org/mlib/2007_03_15-Backmund.pdf', u'http://hepcproject.typepad.com/hep_c_project/hepidu.pdf']",
10.1056/NEJM199908193410802,"HILSABECK, R., HASSANEIN, T., CARLSON, M., et. al, Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C, Journal of The International Neuropsychological Society, 2003",cited-by,10.1017/S1355617703960048,Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C,"[['ROBIN', 'C.', 'HILSABECK'], ['TAREK', 'I.', 'HASSANEIN'], ['MEGHAN', 'D.', 'CARLSON'], ['ELIZABETH', 'A.', 'ZIEGLER'], ['WILLIAM', '', 'PERRY']]",Journal of The International Neuropsychological Society,2003,"[u'http://nbmu.ucsd.edu/Faculty/WilliamPerry/Liver.pdf', u'http://www.journals.cambridge.org/abstract_S1355617703960048']",
10.1056/NEJM199908193410802,"Cha, C., Ruo, L., Fong, Y., et. al, Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation, Transactions of The ... Meeting of The American Surgical Association, 2003",cited-by,10.1097/01.sla.0000086548.84705.ef,Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation,"[['Charles', 'H.', 'Cha'], ['Leyo', '', 'Ruo'], ['Yuman', '', 'Fong'], ['William', 'R.', 'Jarnagin'], ['Jinru', '', 'Shia'], ['Leslie', 'H.', 'Blumgart'], ['Ronald', 'P.', 'DeMatteo']]",Transactions of The ... Meeting of The American Surgical Association,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00153307-200301210-00002'],
10.1056/NEJM199908193410802,"Bellentani, S., Tiribelli, C., , The spectrum of liver disease in the general population: lesson from the Dionysos study, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00151-9,The spectrum of liver disease in the general population: lesson from the Dionysos study,"[['Stefano', '', 'Bellentani'], ['Claudio', '', 'Tiribelli']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801001519', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801001519']",
10.1056/NEJM199908193410802,"Gisbert, J., Garcı́a-Buey, L., Pajares, J., et. al, Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis, Gastroenterology, 2003",cited-by,10.1053/j.gastro.2003.09.025,Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis,"[['Javier', 'P', 'Gisbert'], ['Luisa', '', 'Garc\xc4\xb1\xcc\x81a-Buey'], ['Jos\xc3\xa9', 'Mar\xc4\xb1\xcc\x81a', 'Pajares'], ['Ricardo', '', 'Moreno-Otero']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503015178', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503015178']",
10.1056/NEJM199908193410802,"Kraus, M., Schafer, A., Faller, H., et. al, Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2002",cited-by,10.1046/j.1365-2036.2002.01265.x,Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C,"[['M.', 'R.', 'Kraus'], ['A.', '', 'Schafer'], ['H.', '', 'Faller'], ['H.', '', 'Csef'], ['M.', '', 'Scheurlen']]",Alimentary Pharmacology & Therapeutics,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2002.01265.x'],
10.1056/NEJM199908193410802,"Wang, C., Pflugheber, J., Sumpter, R., et. al, Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication, Journal of Virology, 2003",cited-by,10.1128/JVI.77.7.3898-3912.2003,Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication,"[['Chunfu', '', 'Wang'], ['Jill', '', 'Pflugheber'], ['Rhea', '', 'Sumpter'], ['D.', 'L.', 'Sodora'], ['D.', '', 'Hui'], ['G.', 'C.', 'Sen'], ['M.', '', 'Gale']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/7/3898.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.7.3898-3912.2003']",
10.1056/NEJM199908193410802,"Balkau, B., Vernay, M., Mhamdi, L., et. al, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study, Diabetes & Metabolism, 2003",cited-by,10.1016/S1262-3636(07)70067-8,The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study,"[['B', '', 'Balkau'], ['M', '', 'Vernay'], ['L', '', 'Mhamdi'], ['M', '', 'Novak'], ['D', '', 'Arondel'], ['S', '', 'Vol'], ['J', '', 'Tichet'], ['E', '', 'Eschw\xc3\xa8ge']]",Diabetes & Metabolism,2003,"[u'http://www.ibms.sinica.edu.tw/~pan/risk/document/The%20incidence%20and%20persistence%20of%20the%20NCEP%20metabolic%20syndrome.pdf', u'http://www.sciencedirect.com/science/article/pii/S1262363607700678', u'http://linkinghub.elsevier.com/retrieve/pii/S1262363607700678']",
10.1056/NEJM199908193410802,"Fleming, C., Craven, D., Thornton, D., et. al, Hepatitis C Virus and Human Immunodeficiency Virus Coinfection in an Urban Population: Low Eligibility for Interferon Treatment, Clinical Infectious Diseases, 2003",cited-by,10.1086/344907,Hepatitis C Virus and Human Immunodeficiency Virus Coinfection in an Urban Population: Low Eligibility for Interferon Treatment,"[['Catherine', 'A.', 'Fleming'], ['Donald', 'E.', 'Craven'], ['David', '', 'Thornton'], ['Sheila', '', 'Tumilty'], ['David', '', 'Nunes']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/344907'],
10.1056/NEJM199908193410802,"Cheung, R., , Epidemiology of hepatitis C virus infection in American veterans, American Journal of Gastroenterology, 2000",cited-by,10.1111/j.1572-0241.2000.01854.x,Epidemiology of hepatitis C virus infection in American veterans,"[['Ramsey', 'C.', 'Cheung']]",American Journal of Gastroenterology,2000,"[u'http://dx.doi.org/10.1111/j.1572-0241.2000.01854.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2000.01854.x']",
10.1056/NEJM199908193410802,"Alberti, A., Benvegnù, L., , Management of hepatitis C, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00008-4,Management of hepatitis C,"[['Alfredo', '', 'Alberti'], ['Luisa', '', 'Benvegn\xc3\xb9']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803000084', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803000084']",
10.1056/NEJM199908193410802,"Thorpe, L., Ouellet, L., Hershow, R., et. al, Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment, , 0",cited-by,6647437Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment,Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment,"[['Lorna', 'E.', 'Thorpe'], ['Lawrence', 'J.', 'Ouellet'], ['Ronald', '', 'Hershow'], ['Susan', 'L.', 'Bailey'], ['Ian', 'T.', 'Williams'], ['John', '', 'Williamson'], ['Edgar', 'R.', 'Monterroso'], ['Richard', 'S.', 'Garfein']]",,0,[u'http://aje.oxfordjournals.org/cgi/reprint/155/7/645.pdf'],
10.1056/NEJM199908193410802,"Chander, G., Sulkowski, M., Jenckes, M., et. al, Treatment of chronic hepatitis C: A systematic review, Hepatology, 2002",cited-by,10.1053/jhep.2002.37146,Treatment of chronic hepatitis C: A systematic review,"[['Geetanjali', '', 'Chander'], ['Mark', 'S.', 'Sulkowski'], ['Mollie', 'W.', 'Jenckes'], ['Michael', 'S.', 'Torbenson'], ['H.', 'Franklin', 'Herlong'], ['Eric', 'B.', 'Bass'], ['Kelly', 'A.', 'Gebo']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Treatment%20Of%20Chronic%20Hepatitis%20C%20%20%20A%20Systematic%20Review.pdf', u'http://doi.wiley.com/10.1002/hep.1840360718', u'http://doi.wiley.com/10.1053/jhep.2002.37146']",
10.1056/NEJM199908193410802,"Schuppan, D., Krebs, A., Bauer, M., et. al, Hepatitis C and liver fibrosis, Cell Death and Differentiation, 2003",cited-by,10.1038/sj.cdd.4401163,Hepatitis C and liver fibrosis,"[['D', '', 'Schuppan'], ['A', '', 'Krebs'], ['M', '', 'Bauer'], ['E', 'G', 'Hahn']]",Cell Death and Differentiation,2003,"[u'http://www.nature.com/doifinder/10.1038/sj.cdd.4401163', u'http://dx.doi.org/10.1038/sj.cdd.4401163']",
10.1056/NEJM199908193410802,"Wiley, T., Brown, J., Chan, J., , Hepatitis C infection in African Americans: its natural history and histological progression, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05555.x,Hepatitis C infection in African Americans: its natural history and histological progression,"[['Thelma', 'E.', 'Wiley'], ['Jennifer', '', 'Brown'], ['Juliana', '', 'Chan']]",American Journal of Gastroenterology,2002,"[u'http://dx.doi.org/10.1111/j.1572-0241.2002.05555.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05555.x']",
10.1056/NEJM199908193410802,"Dufour, D., Lott, J., Nolte, F., et. al, Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests, , 0",cited-by,12139478Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests,Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests,"[['D.', 'Robert', 'Dufour'], ['John', 'A.', 'Lott'], ['Frederick', 'S.', 'Nolte'], ['David', 'R.', 'Gretch'], ['Raymond', 'S.', 'Koff'], ['Leonard', 'B.', 'Seeff']]",,0,[u'http://www.med.upenn.edu/gastro/documents/ClinicalChem2000_2027-49.pdf'],
10.1056/NEJM199908193410802,"Parekh, S., Anania, F., , Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2007.03.055,Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease,"[['Samir', '', 'Parekh'], ['Frank', 'A.', 'Anania']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0016508507005811', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508507005811']",
10.1056/NEJM199908193410802,"Marcello, T., Grakoui, A., Machlin, E., et. al, Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.09.052,Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics,"[['Tobias', '', 'Marcello'], ['Arash', '', 'Grakoui'], ['Erica', 'S.', 'Machlin'], ['Sergei', 'V.', 'Kotenko'], ['Margaret', 'R.', 'Macdonald'], ['Charles', 'M.', 'Rice']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506022207', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506022207']",
10.1056/NEJM199908193410802,"Zein, N., , Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.11.025,"Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study","[['Nizar', 'N.', 'Zein']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804005446', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804005446']",
10.1056/NEJM199908193410802,"Hepburn, M., Hepburn, L., Cantu, N., et. al, Differences in treatment outcome for hepatitis C among ethnic groups, American Journal of Medicine, 2004",cited-by,10.1016/j.amjmed.2004.02.043,Differences in treatment outcome for hepatitis C among ethnic groups,"[['Matthew', 'J', 'Hepburn'], ['Lisa', 'M', 'Hepburn'], ['Norma', 'S', 'Cantu'], ['Maria', 'G', 'Lapeer'], ['Eric', 'J', 'Lawitz']]",American Journal of Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304002736', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304002736']",
10.1056/NEJM199908193410802,"Dominitz, J., Boyko, E., Koepsell, T., et. al, Elevated prevalence of hepatitis C infection in users of United States veterans medical centers, Hepatology, 2005",cited-by,10.1002/hep.20502,Elevated prevalence of hepatitis C infection in users of United States veterans medical centers,"[['Jason', 'A.', 'Dominitz'], ['Edward', 'J.', 'Boyko'], ['Thomas', 'D.', 'Koepsell'], ['Patrick', 'J.', 'Heagerty'], ['Charles', '', 'Maynard'], ['Jennifer', 'L.', 'Sporleder']]",Hepatology,2005,"[u'http://hepatitis-central.com/hcv/info/2004/va/elevatedprevalence.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/va/elevatedprevalence.pdf', u'http://doi.wiley.com/10.1002/hep.20502']",
10.1056/NEJM199908193410802,"Jacobson, K., Murray, K., Zellos, A., et. al, An Analysis of Published Trials of Interferon Monotherapy in Children With Chronic Hepatitis C, Journal of Pediatric Gastroenterology and Nutrition, 2002",cited-by,10.1097/00005176-200201000-00013,An Analysis of Published Trials of Interferon Monotherapy in Children With Chronic Hepatitis C,"[['Karen', 'R.', 'Jacobson'], ['Karen', '', 'Murray'], ['Aglaia', '', 'Zellos'], ['Kathleen', 'B.', 'Schwarz']]",Journal of Pediatric Gastroenterology and Nutrition,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200201000-00013'],
10.1056/NEJM199908193410802,"Caldwell, S., Harris, D., Patrie, J., et. al, Is NASH underdiagnosed among African Americans?, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05795.x,Is NASH underdiagnosed among African Americans?,"[['Stephen', 'H.', 'Caldwell'], ['Danielle', 'M.', 'Harris'], ['James', 'T.', 'Patrie'], ['Elizabeth', 'E.', 'Hespenheide']]",American Journal of Gastroenterology,2002,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05795.x', u'http://dx.doi.org/10.1111/j.1572-0241.2002.05795.x']",
10.1056/NEJM199908193410802,"Fontana, R., Moyer, C., Sonnad, S., et. al, Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.03473.x,Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C,"[['Robert', 'J.', 'Fontana'], ['Cheryl', 'A.', 'Moyer'], ['Seema', '', 'Sonnad'], ['Anna', 'S. F.', 'Lok'], ['Naomi', '', 'Sneed-Pee'], ['John', '', 'Walsh'], ['Steven', '', 'Klein'], ['Steven', '', 'Webster']]",American Journal of Gastroenterology,2001,"[u'http://dx.doi.org/10.1111/j.1572-0241.2001.03473.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.03473.x']",
10.1056/NEJM199908193410802,"Yi, M., Bodola, F., Lemon, S., , Subgenomic Hepatitis C Virus Replicons Inducing Expression of a Secreted Enzymatic Reporter Protein, Virology, 2002",cited-by,10.1006/viro.2002.1652,Subgenomic Hepatitis C Virus Replicons Inducing Expression of a Secreted Enzymatic Reporter Protein,"[['MinKyung', '', 'Yi'], ['Francis', '', 'Bodola'], ['Stanley', 'M.', 'Lemon']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0042682202916521', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682202916521']",
10.1056/NEJM199908193410802,"Hussain, K., Fontana, R., Moyer, C., et. al, Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.04133.x,Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C,"[['Khozema', 'B.', 'Hussain'], ['Robert', 'J.', 'Fontana'], ['Cheryl', 'A.', 'Moyer'], ['Grace', 'L.', 'Su'], ['Naomi', '', 'Sneed-Pee'], ['Anna', 'S. F.', 'Lok']]",American Journal of Gastroenterology,2001,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.04133.x', u'http://dx.doi.org/10.1111/j.1572-0241.2001.04133.x']",
10.1056/NEJM199908193410802,"Hong, Z., Cameron, C., Walker, M., et. al, A Novel Mechanism to Ensure Terminal Initiation by Hepatitis C Virus NS5B Polymerase, Virology, 2001",cited-by,10.1006/viro.2001.0948,A Novel Mechanism to Ensure Terminal Initiation by Hepatitis C Virus NS5B Polymerase,"[['Zhi', '', 'Hong'], ['Craig', 'E.', 'Cameron'], ['Michelle', 'P.', 'Walker'], ['Christian', '', 'Castro'], ['Nanhua', '', 'Yao'], ['Johnson', 'Y. N.', 'Lau'], ['Weidong', '', 'Zhong']]",Virology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0042682201909481', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682201909481']",
10.1056/NEJM199908193410802,"HAHN, J., PAGE-SHAFER, K., LUM, P., et. al, Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San Francisco, , 0",cited-by,5975409Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San Francisco,Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San Francisco,"[['JUDITH', 'A.', 'HAHN'], ['KIMBERLY', '', 'PAGE-SHAFER'], ['PAULA', 'J.', 'LUM'], ['KRISTEN', '', 'OCHOA'], ['ANDREW', 'R.', 'MOSS']]",,0,[u'https://php10.ucsf.edu/ufostudy/pdfs/Hahn_2001.pdf'],
10.1056/NEJM199908193410802,"Fontana, R., Hussain, K., Schwartz, S., et. al, Emotional distress in chronic hepatitis C patients not receiving antiviral therapy, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(01)00280-X,Emotional distress in chronic hepatitis C patients not receiving antiviral therapy,"[['Robert', 'J.', 'Fontana'], ['Khozema', 'B.', 'Hussain'], ['Steven', 'M.', 'Schwartz'], ['Cheryl', 'A.', 'Moyer'], ['Grace', 'L.', 'Su'], ['Anna', 'S. F.', 'Lok']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S016882780100280X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780100280X']",
10.1056/NEJM199908193410802,"Lin, W., Choe, W., Hiasa, Y., et. al, Hepatitis C virus expression suppresses interferon signaling by degrading STAT1, Gastroenterology, 2005",cited-by,10.1053/j.gastro.2005.02.006,Hepatitis C virus expression suppresses interferon signaling by degrading STAT1,"[['Wenyu', '', 'Lin'], ['Won', 'Hyeok', 'Choe'], ['Yoichi', '', 'Hiasa'], ['Yoshitaka', '', 'Kamegaya'], ['Jason', 'T.', 'Blackard'], ['Emmett', 'V.', 'Schmidt'], ['Raymond', 'T.', 'Chung']]",Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505001757', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505001757']",
10.1056/NEJM199908193410802,"Zou, S., Dodd, R., Stramer, S., et. al, Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States, New England Journal of Medicine, 2004",cited-by,10.1056/NEJMoa032510,"Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States","[['Shimian', '', 'Zou'], ['Roger', 'Y.', 'Dodd'], ['Susan', 'L.', 'Stramer'], ['D.', 'Michael', 'Strong']]",New England Journal of Medicine,2004,"[u""http://www.aebt.org/web/investigacion/2004investigacion/zou'04.pdf"", u'http://www.nejm.org/doi/abs/10.1056/NEJMoa032510']",
10.1056/NEJM199908193410802,"Salomon, J., Weinstein, M., Hammitt, J., et. al, Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population, , 2003",cited-by,6310042Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population,Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population,"[['Joshua', 'A.', 'Salomon'], ['Milton', 'C.', 'Weinstein'], ['James', 'K.', 'Hammitt'], ['Sue', 'J.', 'Goldie']]",,2003,[u'http://www.hsph.harvard.edu/faculty/joshua-salomon/files/Salomon_CostEffectivenessHCVTx_JAMA2003.pdf'],
10.1056/NEJM199908193410802,"Meyers, C., Seeff, L., Stehman-Breen, C., et. al, Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00828-X,"Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD","[['Catherine', 'M.', 'Meyers'], ['Leonard', 'B.', 'Seeff'], ['Catherine', 'O.', 'Stehman-Breen'], ['Jay', 'H.', 'Hoofnagle']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S027263860300828X', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as027263860300828x', u'http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/Hep C and GN AJKD 05.pdf']",
10.1056/NEJM199908193410802,"Jonas, M., , Children with hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36799,Children with hepatitis C,"[['Maureen', 'M.', 'Jonas']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Children%20With%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360722', u'http://doi.wiley.com/10.1053/jhep.2002.36799']",
10.1056/NEJM199908193410802,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1056/NEJM199908193410802,"Elazar, M., Cheong, K., Liu, P., et. al, Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication, Journal of Virology, 2003",cited-by,10.1128/JVI.77.10.6055-6061.2003,Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication,"[['Menashe', '', 'Elazar'], ['Kwang', 'Ho', 'Cheong'], ['Ping', '', 'Liu'], ['Harry', 'B.', 'Greenberg'], ['Charles', 'M.', 'Rice'], ['Jeffrey', 'S.', 'Glenn']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/10/6055.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.10.6055-6061.2003']",
10.1056/NEJM199908193410802,"Vecchia, C., Lucchini, F., Franceschi, S., et. al, Trends in mortality from primary liver cancer in Europe, European Journal of Cancer, 2000",cited-by,10.1016/S0959-8049(00)00052-6,Trends in mortality from primary liver cancer in Europe,"[['C', 'La', 'Vecchia'], ['F', '', 'Lucchini'], ['S', '', 'Franceschi'], ['E', '', 'Negri'], ['F', '', 'Levi']]",European Journal of Cancer,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0959804900000526', u'http://linkinghub.elsevier.com/retrieve/pii/S0959804900000526']",
10.1056/NEJM199908193410802,"Krause, G., Trepka, M., Whisenhunt, R., et. al, Nosocomial Transmission of Hepatitis C Virus Associated With the Use of Multidose Saline Vials, Infection Control and Hospital Epidemiology, 2003",cited-by,10.1086/502176,Nosocomial Transmission of Hepatitis C Virus Associated With the Use of Multidose Saline Vials,"[['Gerard', '', 'Krause'], ['Mary', 'Jo', 'Trepka'], ['Robert', 'S.', 'Whisenhunt'], ['Dolly', '', 'Katz'], ['Omana', '', 'Nainan'], ['Steven', 'T.', 'Wiersma'], ['Richard', 'S.', 'Hopkins']]",Infection Control and Hospital Epidemiology,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502176'],
10.1056/NEJM199908193410802,"Pendino, G., Mariano, A., Surace, P., et. al, Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean town, Hepatology, 2005",cited-by,10.1002/hep.20689,Prevalence and etiology of altered liver tests: A population-based survey in a Mediterranean town,"[['Gaspare', 'Maria', 'Pendino'], ['Andrea', '', 'Mariano'], ['Pasquale', '', 'Surace'], ['Carmelo', 'Antonio', 'Caserta'], ['Maria', 'Teresa', 'Fiorillo'], ['Angela', '', 'Amante'], ['Stefania', '', 'Bruno'], ['Carmelo', '', 'Mangano'], ['Irene', '', 'Polito'], ['Fulvia', '', 'Amato'], ['Rodolfo', '', 'Cotichini'], ['Tommaso', '', 'Stroffolini'], ['Alfonso', '', 'Mele']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20689'],
10.1056/NEJM199908193410802,"Negri, E., Little, D., Boiocchi, M., et. al, B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: A systematic review, International Journal of Cancer, 2004",cited-by,10.1002/ijc.20205,B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: A systematic review,"[['Eva', '', 'Negri'], [""D'Anna"", '', 'Little'], ['Mauro', '', 'Boiocchi'], ['Carlo', 'La', 'Vecchia'], ['Silvia', '', 'Franceschi']]",International Journal of Cancer,2004,[u'http://doi.wiley.com/10.1002/ijc.20205'],
10.1056/NEJM199908193410802,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1056/NEJM199908193410802,"Davis, G., , Current therapy for chronic hepatitis C, Gastroenterology, 2000",cited-by,10.1016/S0016-5085(00)70009-6,Current therapy for chronic hepatitis C,"[['Gary', 'L.', 'Davis']]",Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500700096', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500700096']",
10.1056/NEJM199908193410802,"Sy, T., Jamal, M., , Epidemiology of Hepatitis C Virus (HCV) Infection, , 0",cited-by,11833109Epidemiology of Hepatitis C Virus (HCV) Infection,Epidemiology of Hepatitis C Virus (HCV) Infection,"[['Theodore', '', 'Sy'], ['M.', 'Mazen', 'Jamal']]",,0,[u'http://www.medsci.org/v03p0041.pdf'],
10.1056/NEJM199908193410802,"Ansaldi, F., Bruzzone, B., Salmaso, S., et. al, Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20376,Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy,"[['Filippo', '', 'Ansaldi'], ['Bianca', '', 'Bruzzone'], ['Stefania', '', 'Salmaso'], ['Maria', 'Cristina', 'Rota'], ['Paolo', '', 'Durando'], ['Roberto', '', 'Gasparini'], ['Giancarlo', '', 'Icardi']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20376'],
10.1056/NEJM199908193410802,"Marshall, D., Kleinman, S., Wong, J., et. al, Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States, Vox Sanguinis, 2004",cited-by,10.1111/j.0042-9007.2004.00379.x,"Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States","[['D.', 'A.', 'Marshall'], ['S.', 'H.', 'Kleinman'], ['J.', 'B.', 'Wong'], ['J.', 'P.', 'AuBuchon'], ['D.', 'T.', 'Grima'], ['N.', 'A.', 'Kulin'], ['M.', 'C.', 'Weinstein']]",Vox Sanguinis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.0042-9007.2004.00379.x'],
10.1056~NEJMoa011232,"Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000;20:17-35.",references,10.1055/s-2000-9505,"Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome","[[u'Harvey', u'J.', u'Alter'], [u'Leonard', u'B.', u'Seeff']]",Seminars in Liver Disease,2000,[u'http://www.thieme-connect.de/DOI/DOI?10.1055/s-2000-9505'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Long-term Outcome', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 23451}]"
10.1055/s-2000-9505,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1055/s-2000-9505,"GUO, J., BICHKO, V., SEEGER, C., , Effect of Alpha Interferon on the Hepatitis C Virus Replicon, Journal of Virology, 2001",cited-by,10.1128/JVI.75.18.8516-8523.2001,Effect of Alpha Interferon on the Hepatitis C Virus Replicon,"[['JU-TAO', '', 'GUO'], ['VADIM', 'V.', 'BICHKO'], ['CHRISTOPH', '', 'SEEGER']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/18/8516.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.18.8516-8523.2001']",
10.1055/s-2000-9505,"Crispe, I., , Hepatic T cells and liver tolerance, Nature Reviews Immunology, 2003",cited-by,10.1038/nri981,Hepatic T cells and liver tolerance,"[['Ian', 'Nicholas', 'Crispe']]",Nature Reviews Immunology,2003,"[u'http://www.nature.com/doifinder/10.1038/nri981', u'http://dx.doi.org/10.1038/nri981']",
10.1055/s-2000-9505,"Ghany, M., Strader, D., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009",cited-by,10.1002/hep.22759,"Diagnosis, management, and treatment of hepatitis C: An update","[['Marc', 'G.', 'Ghany'], ['Doris', 'B.', 'Strader'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2009,"[u'http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/diagnosis_of_hep_c_update.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Hepatitis%20C%20UPDATE.pdf', u'http://www.sklid.com/news/uploadfiles/20094122357635.pdf', u'http://www.coloradoguidelines.org/pdf/hepatitisbc/Diagnosis_of_HEP_C_Update_Aug%20_09.pdf', u'http://www.paml.com/Files/Miscellaneous/Hep%20C%20Diagnosis,Manage,Treatment%20Apr%202009.pdf', u'http://doi.wiley.com/10.1002/hep.22759', u'http://zuberi.biz/guidelines/AASLD_HEP_C_2009.pdf']",
10.1055/s-2000-9505,"PERLEMUTER, G., SABILE, A., LETTERON, P., et. al, Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis, Faseb Journal, 2002",cited-by,10.1096/fj.01-0396com,Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis,"[['GABRIEL', '', 'PERLEMUTER'], ['ABDELMAJID', '', 'SABILE'], ['PHILIPPE', '', 'LETTERON'], ['GIOVANNA', '', 'VONA'], ['YVES', '', 'CHRETIEN'], ['KAZUHIKO', '', 'KOIKE'], ['DOMINIQUE', '', 'PESSAYRE'], ['JOHN', '', 'CHAPMAN'], ['GIOVANNA', '', 'BARBA'], ['CHRISTIAN', '', 'BRECHOT']]",Faseb Journal,2002,"[u'http://www.fasebj.org/cgi/reprint/16/2/185.pdf', u'http://www.fasebj.org/cgi/doi/10.1096/fj.01-0396com']",
10.1055/s-2000-9505,"BIGGER, C., BRASKY, K., LANFORD, R., , DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.7059-7066.2001,DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection,"[['CATHERINE', 'B.', 'BIGGER'], ['KATHLEEN', 'M.', 'BRASKY'], ['ROBERT', 'E.', 'LANFORD']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/15/7059.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.7059-7066.2001']",
10.1055/s-2000-9505,"Marcellin, P., Asselah, T., Boyer, N., , Fibrosis and disease progression in hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36993,Fibrosis and disease progression in hepatitis C,"[['Patrick', '', 'Marcellin'], ['Tarik', '', 'Asselah'], ['Nathalie', '', 'Boyer']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Fibrosis%20And%20Disease%20Progression%20In%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360707', u'http://doi.wiley.com/10.1053/jhep.2002.36993']",
10.1055/s-2000-9505,"Rushbrook, S., Ward, S., Unitt, E., et. al, Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7852-7859.2005,Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection,"[['Simon', 'M.', 'Rushbrook'], ['Scott', 'M.', 'Ward'], ['Esther', '', 'Unitt'], ['Sarah', 'L.', 'Vowler'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Graeme', 'J. M.', 'Alexander']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7852.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7852-7859.2005']",
10.1055/s-2000-9505,"Lanford, R., Guerra, B., Lee, H., et. al, Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.1092-1104.2003,"Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons","[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Helen', '', 'Lee'], ['Devron', 'R.', 'Averett'], ['Brad', '', 'Pfeiffer'], ['Deborah', '', 'Chavez'], ['Lena', '', 'Notvall'], ['Catherine', '', 'Bigger']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/2/1092.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.1092-1104.2003']",
10.1055/s-2000-9505,"Houghton, M., Abrignani, S., , Prospects for a vaccine against the hepatitis C virus, Nature, 2005",cited-by,10.1038/nature04081,Prospects for a vaccine against the hepatitis C virus,"[['Michael', '', 'Houghton'], ['Sergio', '', 'Abrignani']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04081', u'http://adsabs.harvard.edu/abs/2005Natur.436..961H', u'http://dx.doi.org/10.1038/nature04081']",
10.1055/s-2000-9505,"Bigger, C., Guerra, B., Brasky, K., et. al, Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees, Journal of Virology, 2004",cited-by,10.1128/JVI.78.24.13779-13792.2004,Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees,"[['Catherine', 'B.', 'Bigger'], ['Bernadette', '', 'Guerra'], ['Kathleen', 'M.', 'Brasky'], ['Gene', '', 'Hubbard'], ['Michael', 'R.', 'Beard'], ['Bruce', 'A.', 'Luxon'], ['Stanley', 'M.', 'Lemon'], ['Robert', 'E.', 'Lanford']]",Journal of Virology,2004,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.24.13779-13792.2004'],
10.1055/s-2000-9505,"Murray, K., Carithers, R., , AASLD practice guidelines: Evaluation of the patient for liver transplantation, Hepatology, 2005",cited-by,10.1002/hep.20704,AASLD practice guidelines: Evaluation of the patient for liver transplantation,"[['Karen', 'F.', 'Murray'], ['Robert', 'L.', 'Carithers']]",Hepatology,2005,"[u'http://sfgh.medicine.ucsf.edu/education/resed/intern_half_day/pdf/aasld_gtransplant.pdf', u'http://gastro.dom.uab.edu/Fellow_Articles/fellowsreadinglisthep/Liver%20transplantation.pdf', u'http://www.doencasdofigado.com.br/guide_lines/evalu_patient_livertransplantation.pdf', u'http://www.eloizaquintela.com.br/guide_lines/evalu_patient_livertransplantation.pdf', u'http://hpblondon.com/06_resources/assets/Evaluating%20patient%20EC55D.pdf', u'http://www.hsg.gr/guidelines/1295.pdf', u'http://www.hpblondon.com/01_liver/01_4_transplantation/assets/Evaluating%20patient%20EC55D.pdf', u'http://www.aasld.org/practiceguidelines/documents/practice%20guidelines/evalu_patient_livertransplantationpg.pdf', u'http://publish.aasld.org/practiceguidelines/Documents/Practice%20Guidelines/evalu_patient_livertransplantationpg.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/Liver%20Transplant.pdf', u'http://publish.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/Liver%20Transplant.pdf', u'http://doi.wiley.com/10.1002/hep.20704']",
10.1055/s-2000-9505,"Hauri, A., Armstrong, G., Hutin, Y., , The global burden of disease attributable to contaminated injections given in health care settings, International Journal of Std & Aids, 2004",cited-by,10.1258/095646204322637182,The global burden of disease attributable to contaminated injections given in health care settings,"[['Anja', 'M', 'Hauri'], ['Gregory', 'L', 'Armstrong'], ['Yvan', 'J F', 'Hutin']]",International Journal of Std & Aids,2004,"[u'http://uqconnect.net/signfiles/Files/HauriEtAlGBDInjections2004.pdf', u'http://ijsa.rsmjournals.com/cgi/doi/10.1258/095646204322637182']",
10.1055/s-2000-9505,"Khakoo, S., Carrington, M., , KIR and disease: a model system or system of models?, Immunological Reviews, 2006",cited-by,10.1111/j.1600-065X.2006.00459.x,KIR and disease: a model system or system of models?,"[['Salim', 'I.', 'Khakoo'], ['Mary', '', 'Carrington']]",Immunological Reviews,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.2006.00459.x'],
10.1055/s-2000-9505,"Chisari, F., , Unscrambling hepatitis C virus-host interactions, Nature, 2005",cited-by,10.1038/nature04076,Unscrambling hepatitis C virus-host interactions,"[['Francis', 'V.', 'Chisari']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04076', u'http://dx.doi.org/10.1038/nature04076', u'http://adsabs.harvard.edu/abs/2005Natur.436..930C']",
10.1055/s-2000-9505,"Tellinghuisen, T., Rice, C., , Interaction between hepatitis C virus proteins and host cell factors, Current Opinion in Microbiology, 2002",cited-by,10.1016/S1369-5274(02)00341-7,Interaction between hepatitis C virus proteins and host cell factors,"[['Timothy', 'L', 'Tellinghuisen'], ['Charles', 'M', 'Rice']]",Current Opinion in Microbiology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1369527402003417', u'http://linkinghub.elsevier.com/retrieve/pii/S1369527402003417']",
10.1055/s-2000-9505,"Lin, R., Lacoste, J., Nakhaei, P., et. al, Dissociation of a MAVS/IPS1/VISA/Cardif-IKK  Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage, Journal of Virology, 2006",cited-by,10.1128/JVI.02495-05,Dissociation of a MAVS/IPS1/VISA/Cardif-IKK  Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage,"[['Rongtuan', '', 'Lin'], ['Judith', '', 'Lacoste'], ['Peyman', '', 'Nakhaei'], ['Qiang', '', 'Sun'], ['Long', '', 'Yang'], ['Suzanne', '', 'Paz'], ['Peter', '', 'Wilkinson'], ['Ilkka', '', 'Julkunen'], ['Damien', '', 'Vitour'], ['Eliane', '', 'Meurs'], ['John', '', 'Hiscott']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/12/6072.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02495-05']",
10.1055/s-2000-9505,"Hiscott, J., Nguyen, T., Arguello, M., et. al, Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses, Oncogene, 2006",cited-by,10.1038/sj.onc.1209941,Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses,"[['J', '', 'Hiscott'], ['T-L', 'A', 'Nguyen'], ['M', '', 'Arguello'], ['P', '', 'Nakhaei'], ['S', '', 'Paz']]",Oncogene,2006,"[u'http://www.nature.com/doifinder/10.1038/sj.onc.1209941', u'http://dx.doi.org/10.1038/sj.onc.1209941']",
10.1055/s-2000-9505,"Schuppan, D., Krebs, A., Bauer, M., et. al, Hepatitis C and liver fibrosis, Cell Death and Differentiation, 2003",cited-by,10.1038/sj.cdd.4401163,Hepatitis C and liver fibrosis,"[['D', '', 'Schuppan'], ['A', '', 'Krebs'], ['M', '', 'Bauer'], ['E', 'G', 'Hahn']]",Cell Death and Differentiation,2003,"[u'http://www.nature.com/doifinder/10.1038/sj.cdd.4401163', u'http://dx.doi.org/10.1038/sj.cdd.4401163']",
10.1055/s-2000-9505,"Schwer, B., Ren, S., Pietschmann, T., et. al, Targeting of Hepatitis C Virus Core Protein to Mitochondria through a Novel C-Terminal Localization Motif, Journal of Virology, 2004",cited-by,10.1128/JVI.78.15.7958-7968.2004,Targeting of Hepatitis C Virus Core Protein to Mitochondria through a Novel C-Terminal Localization Motif,"[['Bjorn', '', 'Schwer'], ['Shaotang', '', 'Ren'], ['Thomas', '', 'Pietschmann'], ['J.', '', 'Kartenbeck'], ['K.', '', 'Kaehlcke'], ['R.', '', 'Bartenschlager'], ['T.', 'S. B.', 'Yen'], ['M.', '', 'Ott']]",Journal of Virology,2004,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.15.7958-7968.2004'],
10.1055/s-2000-9505,"Colina, R., Casane, D., Vasquez, S., et. al, Evidence of intratypic recombination in natural populations of hepatitis C virus, Journal of General Virology, 2004",cited-by,10.1099/vir.0.19472-0,Evidence of intratypic recombination in natural populations of hepatitis C virus,"[['Rodney', '', 'Colina'], ['Didier', '', 'Casane'], ['Silvia', '', 'Vasquez'], ['Laura', '', 'Garcia-Aguirre'], ['Ausberto', '', 'Chunga'], ['Hector', '', 'Romero'], ['Baldip', '', 'Khan'], ['Juan', '', 'Cristina']]",Journal of General Virology,2004,"[u'http://vir.sgmjournals.org/cgi/reprint/85/1/31.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/vir.0.19472-0']",
10.1055/s-2000-9505,"Lanford, R., Guerra, B., Chavez, D., et. al, Cross-Genotype Immunity to Hepatitis C Virus, Journal of Virology, 2004",cited-by,10.1128/JVI.78.3.1575-1581.2004,Cross-Genotype Immunity to Hepatitis C Virus,"[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Deborah', '', 'Chavez'], ['Catherine', '', 'Bigger'], ['Kathleen', 'M.', 'Brasky'], ['Xiao-Hong', '', 'Wang'], ['Stuart', 'C.', 'Ray'], ['David', 'L.', 'Thomas']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/3/1575.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.3.1575-1581.2004']",
10.1055/s-2000-9505,"Castet, V., Fournier, C., Soulier, A., et. al, Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, 2002",cited-by,10.1128/JVI.76.16.8189-8199.2002,Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro,"[['Valerie', '', 'Castet'], ['Chantal', '', 'Fournier'], ['Alexandre', '', 'Soulier'], ['Rozenn', '', 'Brillet'], ['Joliette', '', 'Coste'], ['Dominique', '', 'Larrey'], ['Daniel', '', 'Dhumeaux'], ['Patrick', '', 'Maurel'], ['J.-M.', '', 'Pawlotsky']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/16/8189.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.16.8189-8199.2002']",
10.1055/s-2000-9505,"Thomson, M., Nascimbeni, M., Havert, M., et. al, The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.862-870.2003,The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity,"[['Michael', '', 'Thomson'], ['Michelina', '', 'Nascimbeni'], ['Michael', 'B.', 'Havert'], ['Marian', '', 'Major'], ['Sophia', '', 'Gonzales'], ['Harvey', '', 'Alter'], ['Stephen', 'M.', 'Feinstone'], ['Krishna', 'K.', 'Murthy'], ['Barbara', '', 'Rehermann'], ['T.', 'Jake', 'Liang']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.862-870.2003', u'http://jvi.asm.org/cgi/reprint/77/2/862.pdf']",
10.1055/s-2000-9505,"Malcolm, B., Liu, R., Lahser, F., et. al, SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.50.3.1013-1020.2006,"SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells","[['B.', 'A.', 'Malcolm'], ['R.', '', 'Liu'], ['F.', '', 'Lahser'], ['S.', '', 'Agrawal'], ['B.', '', 'Belanger'], ['N.', '', 'Butkiewicz'], ['R.', '', 'Chase'], ['F.', '', 'Gheyas'], ['A.', '', 'Hart'], ['D.', '', 'Hesk'], ['P.', '', 'Ingravallo'], ['C.', '', 'Jiang'], ['R.', '', 'Kong'], ['J.', '', 'Lu'], ['J.', '', 'Pichardo'], ['A.', '', 'Prongay'], ['A.', '', 'Skelton'], ['X.', '', 'Tong'], ['S.', '', 'Venkatraman'], ['E.', '', 'Xia'], ['V.', '', 'Girijavallabhan'], ['F.', 'G.', 'Njoroge']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/3/1013.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.50.3.1013-1020.2006']",
10.1055/s-2000-9505,"Jara, P., Resti, M., Hierro, L., et. al, Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children, Clinical Infectious Diseases, 2003",cited-by,10.1086/345908,Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children,"[['Paloma', '', 'Jara'], ['Massimo', '', 'Resti'], ['Loreto', '', 'Hierro'], ['Raffaella', '', 'Giacchino'], ['Cristiana', '', 'Barbera'], ['Lucia', '', 'Zancan'], ['Carlo', '', 'Crivellaro'], ['Etienne', '', 'Sokal'], ['Chiara', '', 'Azzari'], ['Maria', '', 'Guido'], ['Flavia', '', 'Bortolotti']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/345908'],
10.1055/s-2000-9505,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1055/s-2000-9505,"Owsianka, A., Timms, J., Tarr, A., et. al, Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding, Journal of Virology, 2006",cited-by,10.1128/JVI.00271-06,Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding,"[['Ania', 'M.', 'Owsianka'], ['Judith', 'M.', 'Timms'], ['Alexander', 'W.', 'Tarr'], ['Richard', 'J. P.', 'Brown'], ['Timothy', 'P.', 'Hickling'], ['Aleksandra', '', 'Szwejk'], ['Krystyna', '', 'Bienkowska-Szewczyk'], ['Brian', 'J.', 'Thomson'], ['Arvind', 'H.', 'Patel'], ['Jonathan', 'K.', 'Ball']]",Journal of Virology,2006,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00271-06'],
10.1055/s-2000-9505,"Ludwig, I., Lekkerkerker, A., Depla, E., et. al, Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation, Journal of Virology, 2004",cited-by,10.1128/JVI.78.15.8322-8332.2004,Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation,"[['Irene', 'S.', 'Ludwig'], ['Annemarie', 'N.', 'Lekkerkerker'], ['Erik', '', 'Depla'], ['Fons', '', 'Bosman'], ['R.', 'J. P.', 'Musters'], ['S.', '', 'Depraetere'], ['Kooijk', 'van', 'Y'], ['T.', 'B. H.', 'Geijtenbeek']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/15/8322.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.15.8322-8332.2004']",
10.1055/s-2000-9505,"Lorenz, I., Dentzer, T., Marcotrigiano, J., et. al, Structure of the catalytic domain of the hepatitis C virus NS2-3 protease, Nature, 2006",cited-by,10.1038/nature04975,Structure of the catalytic domain of the hepatitis C virus NS2-3 protease,"[['Ivo', 'C.', 'Lorenz'], ['Thomas', 'G.', 'Dentzer'], ['Joseph', '', 'Marcotrigiano'], ['Charles', 'M.', 'Rice']]",Nature,2006,"[u'http://www.nature.com/doifinder/10.1038/nature04975', u'http://dx.doi.org/10.1038/nature04975']",
10.1055/s-2000-9505,"WEINER, A., PALIARD, X., SELBY, M., et. al, Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.7142-7148.2001,Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity,"[['AMY', 'J.', 'WEINER'], ['XAVIER', '', 'PALIARD'], ['MARK', 'J.', 'SELBY'], ['ANGELICA', '', 'MEDINA-SELBY'], ['DORIS', '', 'COIT'], ['STEVE', '', 'NGUYEN'], ['JOE', '', 'KANSOPON'], ['CHRISTOPHER', 'L.', 'ARIAN'], ['PHILIP', '', 'NG'], ['JEFFERY', '', 'TUCKER'], ['CHUN-TING', '', 'LEE'], ['NOELLE', 'K.', 'POLAKOS'], ['JANG', '', 'HAN'], ['SHIRLEY', '', 'WONG'], ['HUI-HUA', '', 'LU'], ['STEVE', '', 'ROSENBERG'], ['KATHY', 'M.', 'BRASKY'], ['DAVID', '', 'CHIEN'], ['GEORGE', '', 'KUO'], ['M.', '', 'Houghton']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.7142-7148.2001', u'http://jvi.asm.org/cgi/reprint/75/15/7142.pdf']",
10.1055/s-2000-9505,"Benson, C., Kaplan, J., Masur, H., et. al, Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America, Clinical Infectious Diseases, 2005",cited-by,10.1086/427906,"Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America","[['Constance', 'A.', 'Benson'], ['Jonathan', 'E.', 'Kaplan'], ['Henry', '', 'Masur'], ['Alice', '', 'Pau'], ['King', 'K.', 'Holmes']]",Clinical Infectious Diseases,2005,"[u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA.pdf', u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA000875.pdf', u'http://medicine.georgetown.edu/residency/idarticles/hivopportunistic.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427906']",
10.1055/s-2000-9505,"Santantonio, T., Fasano, M., Sinisi, E., et. al, Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.11.021,Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance,"[['Teresa', '', 'Santantonio'], ['Massimo', '', 'Fasano'], ['Emanuele', '', 'Sinisi'], ['Angela', '', 'Guastadisegni'], ['Caterina', '', 'Casalino'], ['Michele', '', 'Mazzola'], ['Ruggiero', '', 'Francavilla'], ['Giuseppe', '', 'Pastore']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804005380', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804005380']",
10.1055/s-2000-9505,"Everson, G., Hoefs, J., Seeff, L., et. al, Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial, Hepatology, 2006",cited-by,10.1002/hep.21440,Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial,"[['Gregory', 'T.', 'Everson'], ['John', 'C.', 'Hoefs'], ['Leonard', 'B.', 'Seeff'], ['Herbert', 'L.', 'Bonkovsky'], ['Deepa', '', 'Naishadham'], ['Mitchell', 'L.', 'Shiffman'], ['Jeffrey', 'A.', 'Kahn'], ['Anna', 'S. F.', 'Lok'], ['Adrian', 'M. Di', 'Bisceglie'], ['William', 'M.', 'Lee'], ['Jules', 'L.', 'Dienstag'], ['Marc', 'G.', 'Ghany'], ['Chihiro', '', 'Morishima']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21440'],
10.1055/s-2000-9505,"Raison, C., Broadwell, S., Borisov, A., et. al, Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C, Brain Behavior and Immunity, 2005",cited-by,10.1016/j.bbi.2004.05.001,Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C,"[['Charles', 'L.', 'Raison'], ['Sherry', 'D.', 'Broadwell'], ['Andrey', 'S.', 'Borisov'], ['Amita', 'K.', 'Manatunga'], ['Lucile', '', 'Capuron'], ['Bobbi', 'J.', 'Woolwine'], ['Ira', 'M.', 'Jacobson'], ['Charles', 'B.', 'Nemeroff'], ['Andrew', 'H.', 'Miller']]",Brain Behavior and Immunity,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0889159104000698', u'http://linkinghub.elsevier.com/retrieve/pii/S0889159104000698']",
10.1055/s-2000-9505,"Guo, J., Zhu, Q., Seeger, C., , Cytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic Replicons, Journal of Virology, 2003",cited-by,10.1128/JVI.77.20.10769-10779.2003,Cytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic Replicons,"[['Ju-Tao', '', 'Guo'], ['Qing', '', 'Zhu'], ['Christoph', '', 'Seeger']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/20/10769.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.20.10769-10779.2003']",
10.1055/s-2000-9505,"Pillonel, J., Laperche, S., Saura, C., et. al, Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000, Transfusion, 2002",cited-by,10.1046/j.1537-2995.2002.00155.x,Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000,"[['Josiane', '', 'Pillonel'], ['Syria', '', 'Laperche'], ['Christine', '', 'Saura'], ['Jean-Claude', '', 'Desenclos'], ['Anne-Marie', '', 'Courouce']]",Transfusion,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2002.00155.x'],
10.1055/s-2000-9505,"Tanaka, J., Kumagai, J., Katayama, K., et. al, Sex and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000, Intervirology, 2004",cited-by,10.1159/000076640,"Sex and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000","[['Junko', '', 'Tanaka'], ['Junko', '', 'Kumagai'], ['Keiko', '', 'Katayama'], ['Yutaka', '', 'Komiya'], ['Masaaki', '', 'Mizui'], ['Retsuji', '', 'Yamanaka'], ['Kou', '', 'Suzuki'], ['Yuzo', '', 'Miyakawa'], ['Hiroshi', '', 'Yoshizawa']]",Intervirology,2004,"[u'http://www.online.karger.com/doi/10.1159/000076640', u'http://www.karger.com/doi/10.1159/000076640']",
10.1055/s-2000-9505,"Jiang, D., Guo, H., Xu, C., et. al, Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus, Journal of Virology, 2008",cited-by,10.1128/JVI.02113-07,Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus,"[['Dong', '', 'Jiang'], ['Haitao', '', 'Guo'], ['Chunxiao', '', 'Xu'], ['Jinhong', '', 'Chang'], ['Lijuan', '', 'Wang'], ['Timothy', 'M.', 'Block'], ['Ju-Tao', '', 'Guo']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/4/1665.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02113-07']",
10.1055/s-2000-9505,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1055/s-2000-9505,"Lanford, R., Bigger, C., , Advances in Model Systems for Hepatitis C Virus Research, Virology, 2002",cited-by,10.1006/viro.2001.1316,Advances in Model Systems for Hepatitis C Virus Research,"[['Robert', 'E.', 'Lanford'], ['Catherine', '', 'Bigger']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0042682201913169', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682201913169']",
10.1055/s-2000-9505,"Li, Y., Zhang, T., Ho, C., et. al, Natural killer cells inhibit hepatitis C virus expression, Journal of Leukocyte Biology, 2004",cited-by,10.1189/jlb.0604372,Natural killer cells inhibit hepatitis C virus expression,"[['Yuan', '', 'Li'], ['Ting', '', 'Zhang'], ['Chun', '', 'Ho'], ['Jordan', 'S.', 'Orange'], ['Steven', 'D.', 'Douglas'], ['Wen-Zhe', '', 'Ho']]",Journal of Leukocyte Biology,2004,"[u'http://www.jleukbio.org/cgi/reprint/76/6/1171.pdf', u'http://www.jleukbio.org/cgi/rapidpdf/jlb.0604372v1.pdf', u'http://www.jleukbio.org/cgi/doi/10.1189/jlb.0604372']",
10.1055/s-2000-9505,"O’Hagan, D., Singh, M., Dong, C., et. al, Cationic microparticles are a potent delivery system for a HCV DNA vaccine, Vaccine, 2004",cited-by,10.1016/j.vaccine.2004.06.037,Cationic microparticles are a potent delivery system for a HCV DNA vaccine,"[['Derek', 'T.', 'O\xe2\x80\x99Hagan'], ['Manmohan', '', 'Singh'], ['Christine', '', 'Dong'], ['Mildred', '', 'Ugozzoli'], ['Kim', '', 'Berger'], ['Edward', '', 'Glazer'], ['Mark', '', 'Selby'], ['Mark', '', 'Wininger'], ['Philip', '', 'Ng'], ['Kevin', '', 'Crawford'], ['Xavier', '', 'Paliard'], ['Steven', '', 'Coates'], ['Michael', '', 'Houghton']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04005250', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04005250']",
10.1055/s-2000-9505,"Klintmalm, G., Washburn, W., Rudich, S., et. al, Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV3 study, Liver Transplantation, 2007",cited-by,10.1002/lt.21182,Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV3 study,"[['Goran', 'B. G.', 'Klintmalm'], ['W.', 'Kenneth', 'Washburn'], ['Steven', 'M.', 'Rudich'], ['Thomas', 'G.', 'Heffron'], ['Lewis', 'W.', 'Teperman'], ['Carlos', '', 'Fasola'], ['Devin', 'E.', 'Eckhoff'], ['George', 'J.', 'Netto'], ['Eliezer', '', 'Katz']]",Liver Transplantation,2007,[u'http://doi.wiley.com/10.1002/lt.21182'],
10.1055/s-2000-9505,"Shin, E., Seifert, U., Kato, T., et. al, Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection, Journal of Clinical Investigation, 2006",cited-by,10.1172/JCI29832DS1,Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection,"[['Eui-Cheol', '', 'Shin'], ['Ulrike', '', 'Seifert'], ['Takanobu', '', 'Kato'], ['Charles', 'M.', 'Rice'], ['Stephen', 'M.', 'Feinstone'], ['Peter-M.', '', 'Kloetzel'], ['Barbara', '', 'Rehermann']]",Journal of Clinical Investigation,2006,"[u'http://www.jci.org/cgi/doi/10.1172/JCI29832', u'http://www.jci.org/cgi/content/full/JCI29832/DC1']",
10.1055/s-2000-9505,"Melhem, A., Stern, M., Shibolet, O., et. al, Treatment of Chronic Hepatitis C Virus Infection via Antioxidants: Results of a Phase I Clinical Trial, Journal of Clinical Gastroenterology, 2005",cited-by,10.1097/01.mcg.0000174023.73472.29,Treatment of Chronic Hepatitis C Virus Infection via Antioxidants: Results of a Phase I Clinical Trial,"[['Alla', '', 'Melhem'], ['Mirela', '', 'Stern'], ['Oren', '', 'Shibolet'], ['Eran', '', 'Israeli'], ['Zvi', '', 'Ackerman'], ['Orit', '', 'Pappo'], ['Nilla', '', 'Hemed'], ['Mina', '', 'Rowe'], ['Hana', '', 'Ohana'], ['George', '', 'Zabrecky'], ['Robert', '', 'Cohen'], ['Yaron', '', 'Ilan']]",Journal of Clinical Gastroenterology,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200509000-00017'],
10.1055/s-2000-9505,"Shinozaki, K., Ebert, O., Kournioti, C., et. al, Oncolysis of Multifocal Hepatocellular Carcinoma in the Rat Liver by Hepatic Artery Infusion of Vesicular Stomatitis Virus, Molecular Therapy, 2004",cited-by,10.1016/j.ymthe.2003.12.004,Oncolysis of Multifocal Hepatocellular Carcinoma in the Rat Liver by Hepatic Artery Infusion of Vesicular Stomatitis Virus,"[['Katsunori', '', 'Shinozaki'], ['Oliver', '', 'Ebert'], ['Chryssanthi', '', 'Kournioti'], ['Yun-Sheng', '', 'Tai'], ['Savio', 'L. C.', 'Woo']]",Molecular Therapy,2004,"[u'http://dx.doi.org/10.1016/j.ymthe.2003.12.004', u'http://www.nature.com/doifinder/10.1016/j.ymthe.2003.12.004']",
10.1055/s-2000-9505,"Gates, A., Isken, O., Behrens, S., et. al, Replication Studies Using Genotype 1a Subgenomic Hepatitis C Virus Replicons, Journal of Virology, 2003",cited-by,10.1128/JVI.77.9.5352-5359.2003,Replication Studies Using Genotype 1a Subgenomic Hepatitis C Virus Replicons,"[['Adam', 'T.', 'Gates'], ['Olaf', '', 'Isken'], ['Sven-Erik', '', 'Behrens'], ['Robert', 'T.', 'Sarisky']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.9.5352-5359.2003', u'http://jvi.asm.org/cgi/reprint/77/9/5352.pdf']",
10.1055/s-2000-9505,"Zhou, Y., Bartels, D., Hanzelka, B., et. al, Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00863-07,Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease,"[['Yi', '', 'Zhou'], ['Doug', 'J.', 'Bartels'], ['Brian', 'L.', 'Hanzelka'], ['Ute', '', 'Muh'], ['Yunyi', '', 'Wei'], ['Hui-May', '', 'Chu'], ['Ann', 'M.', 'Tigges'], ['Debra', 'L.', 'Brennan'], ['B.', 'Govinda', 'Rao'], ['Lora', '', 'Swenson'], ['Ann', 'D.', 'Kwong'], ['Chao', '', 'Lin']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/1/110.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00863-07']",
10.1055/s-2000-9505,"Zhang, P., Wu, C., Mihalik, K., et. al, Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma, Proceedings of The National Academy of Sciences, 2007",cited-by,10.1073/pnas.0703039104,Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma,"[['P.', '', 'Zhang'], ['C.', 'G.', 'Wu'], ['K.', '', 'Mihalik'], ['M.', 'L.', 'Virata-Theimer'], ['M.-y.', 'W.', 'Yu'], ['H.', 'J.', 'Alter'], ['S.', 'M.', 'Feinstone']]",Proceedings of The National Academy of Sciences,2007,[u'http://www.pnas.org/cgi/doi/10.1073/pnas.0703039104'],
10.1055/s-2000-9505,"Zhu, H., Dong, H., Eksioglu, E., et. al, Hepatitis C Virus Triggers Apoptosis of a Newly Developed Hepatoma Cell Line Through Antiviral Defense System, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2007.09.017,Hepatitis C Virus Triggers Apoptosis of a Newly Developed Hepatoma Cell Line Through Antiviral Defense System,"[['Haizhen', '', 'Zhu'], ['Huijia', '', 'Dong'], ['Erika', '', 'Eksioglu'], ['Alan', '', 'Hemming'], ['Mengde', '', 'Cao'], ['James', 'M.', 'Crawford'], ['David', 'R.', 'Nelson'], ['Chen', '', 'Liu']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0016508507016587', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508507016587']",
10.1055/s-2000-9505,"Giannini, E., Fasoli, A., Chiarbonello, B., et. al, 13C-Aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection, Alimentary Pharmacology & Therapeutics, 2002",cited-by,10.1046/j.1365-2036.2002.01200.x,13C-Aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection,"[['E.', '', 'Giannini'], ['A.', '', 'Fasoli'], ['B.', '', 'Chiarbonello'], ['F.', '', 'Malfatti'], ['P.', '', 'Romagnoli'], ['F.', '', 'Botta'], ['E.', '', 'Testa'], ['S.', '', 'Polegato'], ['A.', '', 'Fumagalli'], ['R.', '', 'Testa']]",Alimentary Pharmacology & Therapeutics,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2002.01200.x'],
10.1055/s-2000-9505,"Okuse, C., Rinaudo, J., Farrar, K., et. al, Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2004.09.002,Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy,"[['Chiaki', '', 'Okuse'], ['Jo', 'Ann', 'Rinaudo'], ['Kristine', '', 'Farrar'], ['Frances', '', 'Wells'], ['Brent', 'E.', 'Korba']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166354204002207', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354204002207']",
10.1055/s-2000-9505,"Ali, S., Pellerin, C., Lamarre, D., et. al, Hepatitis C Virus Subgenomic Replicons in the Human Embryonic Kidney 293 Cell Line, Journal of Virology, 2004",cited-by,10.1128/JVI.78.1.491-501.2004,Hepatitis C Virus Subgenomic Replicons in the Human Embryonic Kidney 293 Cell Line,"[['Samir', '', 'Ali'], ['Charles', '', 'Pellerin'], ['Daniel', '', 'Lamarre'], ['George', '', 'Kukolj']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/1/491.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.1.491-501.2004']",
10.1055/s-2000-9505,"Kato, T., Date, T., Miyamoto, M., et. al, Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System, , 2005",cited-by,5881992Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System,Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System,"[['Takanobu', '', 'Kato'], ['Tomoko', '', 'Date'], ['Michiko', '', 'Miyamoto'], ['Masaya', '', 'Sugiyama'], ['Yasuhito', '', 'Tanaka'], ['Etsuro', '', 'Orito'], ['Tomoyoshi', '', 'Ohno'], ['Kanji', '', 'Sugihara'], ['Izumi', '', 'Hasegawa'], ['Kei', '', 'Fujiwara'], ['Kiyoaki', '', 'Ito'], ['Atsushi', '', 'Ozasa'], ['Masashi', '', 'Mizokami'], ['Takaji', '', 'Wakita']]",,2005,[u'http://jcm.asm.org/cgi/reprint/43/11/5679.pdf'],
10.1055/s-2000-9505,"Mohan, P., Colvin, C., Glymph, C., et. al, Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children, Journal of Pediatrics, 2007",cited-by,10.1016/j.jpeds.2006.11.037,Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children,"[['Parvathi', '', 'Mohan'], ['Camilla', '', 'Colvin'], ['Chevelle', '', 'Glymph'], ['Roma', 'R.', 'Chandra'], ['David', 'E.', 'Kleiner'], ['Kantilal', 'M.', 'Patel'], ['Naomi', 'L. C.', 'Luban'], ['Harvey', 'J.', 'Alter']]",Journal of Pediatrics,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0022347606011103', u'http://linkinghub.elsevier.com/retrieve/pii/S0022347606011103']",
10.1055/s-2000-9505,"Lanford, R., Guerra, B., Lee, H., et. al, Genomic response to interferon-α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics, Hepatology, 2006",cited-by,10.1002/hep.21167,Genomic response to interferon-α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics,"[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Helen', '', 'Lee'], ['Deborah', '', 'Chavez'], ['Kathleen', 'M.', 'Brasky'], ['Catherine', 'B.', 'Bigger']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21167'],
10.1055/s-2000-9505,"Yoshizawa, H., Tanaka, J., Miyakawa, Y., , National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population, Intervirology, 2006",cited-by,10.1159/000087257,National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population,"[['Hiroshi', '', 'Yoshizawa'], ['Junko', '', 'Tanaka'], ['Yuzo', '', 'Miyakawa']]",Intervirology,2006,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000087257', u'http://www.karger.com/doi/10.1159/000087257']",
10.1055/s-2000-9505,"Hutchinson, S., Bird, S., Goldberg, D., , Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland, Hepatology, 2005",cited-by,10.1002/hep.20836,Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland,"[['Sharon', 'J.', 'Hutchinson'], ['Sheila', 'M.', 'Bird'], ['David', 'J.', 'Goldberg']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20836'],
10.1055/s-2000-9505,"Guo, J., Sohn, J., Zhu, Q., et. al, Mechanism of the interferon alpha response against hepatitis C virus replicons, Virology, 2004",cited-by,10.1016/j.virol.2004.04.031,Mechanism of the interferon alpha response against hepatitis C virus replicons,"[['Ju-Tao', '', 'Guo'], ['Ji', 'A', 'Sohn'], ['Qing', '', 'Zhu'], ['Christoph', '', 'Seeger']]",Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0042682204002909', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682204002909']",
10.1055/s-2000-9505,"Durantel, D., Carrouee-Durantel, S., Branza-Nichita, N., et. al, Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea Virus, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.2.497-504.2004,"Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea Virus","[['David', '', 'Durantel'], ['Sandra', '', 'Carrouee-Durantel'], ['Norica', '', 'Branza-Nichita'], ['Raymond', 'A.', 'Dwek'], ['Nicole', '', 'Zitzmann']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/2/497.pdf', u'http://aac.highwire.org/cgi/reprint/48/2/497.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.2.497-504.2004']",
10.1055/s-2000-9505,"Kew, M., Francois, G., Lavanchy, D., et. al, Prevention of hepatitis C virus infection, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00492.x,Prevention of hepatitis C virus infection,"[['M.', '', 'Kew'], ['G.', '', 'Francois'], ['D.', '', 'Lavanchy'], ['H.', '', 'Margolis'], ['P.', 'Van', 'Damme'], ['P.', '', 'Grob'], ['J.', '', 'Hallauer'], ['D.', '', 'Shouval'], ['G.', '', 'Leroux-Roels'], ['A.', '', 'Meheus']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00492.x'],
10.1055/s-2000-9505,"Perlemuter, G., Lettéron, P., Carnot, F., et. al, Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00414-8,Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model,"[['Gabriel', '', 'Perlemuter'], ['Philippe', '', 'Lett\xc3\xa9ron'], ['Fran\xc3\xa7oise', '', 'Carnot'], ['Flora', '', 'Zavala'], ['Dominique', '', 'Pessayre'], ['Bertrand', '', 'Nalpas'], ['Christian', '', 'Br\xc3\xa9chot']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004148', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004148']",
10.1055/s-2000-9505,"Chang, C., Chen, K., Lai, M., et. al, Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2002",cited-by,10.1046/j.1365-2036.2002.01326.x,Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C,"[['C.', 'H.', 'Chang'], ['K.', 'Y.', 'Chen'], ['M.', 'Y.', 'Lai'], ['K.', 'A.', 'Chan']]",Alimentary Pharmacology & Therapeutics,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2002.01326.x'],
10.1055/s-2000-9505,"Razvi, S., Schneider, L., Jonas, M., et. al, Outcome of Intravenous Immunoglobulin-Transmitted Hepatitis C Virus Infection in Primary Immunodeficiency, Clinical Immunology, 2001",cited-by,10.1006/clim.2001.5132,Outcome of Intravenous Immunoglobulin-Transmitted Hepatitis C Virus Infection in Primary Immunodeficiency,"[['Samiya', '', 'Razvi'], ['Lynda', '', 'Schneider'], ['Maureen', 'M.', 'Jonas'], ['Charlotte', '', 'Cunningham-Rundles']]",Clinical Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1521661601951320', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661601951320']",
10.1055/s-2000-9505,"Yagi, S., Mori, K., Tanaka, E., et. al, Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20469,Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients,"[['Shintaro', '', 'Yagi'], ['Kenich', '', 'Mori'], ['Eiji', '', 'Tanaka'], ['Akihiro', '', 'Matsumoto'], ['Fumiko', '', 'Sunaga'], ['Kendo', '', 'Kiyosawa'], ['Kenjiro', '', 'Yamaguchi']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20469'],
10.1055/s-2000-9505,"Stramer, S., , US NAT yield: where are we after 2 years?, Transfusion Medicine, 2002",cited-by,10.1046/j.1365-3148.2002.00387.x,US NAT yield: where are we after 2 years?,"[['S.', 'L.', 'Stramer']]",Transfusion Medicine,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-3148.2002.00387.x'],
10.1055/s-2000-9505,"Broering, R., Wu, J., Meng, Z., et. al, Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.01.028,Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication,"[['Ruth', '', 'Broering'], ['Jun', '', 'Wu'], ['Zhongji', '', 'Meng'], ['Philip', '', 'Hilgard'], ['Mengji', '', 'Lu'], ['Martin', '', 'Trippler'], ['Agnes', '', 'Szczeponek'], ['Guido', '', 'Gerken'], ['Joerg', 'F.', 'Schlaak']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808001293', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808001293']",
10.1055/s-2000-9505,"Hladik, W., Kataaha, P., Mermin, J., et. al, Prevalence and screening costs of hepatitis C virus among Ugandan blood donors, Tropical Medicine & International Health, 2006",cited-by,10.1111/j.1365-3156.2006.01643.x,Prevalence and screening costs of hepatitis C virus among Ugandan blood donors,"[['W.', '', 'Hladik'], ['P.', '', 'Kataaha'], ['J.', '', 'Mermin'], ['M.', '', 'Purdy'], ['G.', '', 'Otekat'], ['E.', '', 'Lackritz'], ['M.', 'J.', 'Alter'], ['R.', '', 'Downing']]",Tropical Medicine & International Health,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-3156.2006.01643.x'],
10.1055/s-2000-9505,"Zhang, T., Li, Y., Lai, J., et. al, Alcohol Potentiates Hepatitis C Virus Replicon Expression, , 0",cited-by,5686359Alcohol Potentiates Hepatitis C Virus Replicon Expression,Alcohol Potentiates Hepatitis C Virus Replicon Expression,"[['Ting', '', 'Zhang'], ['Yuan', '', 'Li'], ['Jian-Ping', '', 'Lai'], ['Steven', 'D.', 'Douglas'], ['David', 'S.', 'Metzger'], ['Charles', 'P.', ""O'Brien""], ['Wen-Zhe', '', 'Ho']]",,0,[u'http://www.hepatitis-central.com/hcv/info/2003/july/hepcinfo57.pdf'],
10.1055/s-2000-9505,"Sezaki, H., Suzuki, F., Kawamura, Y., et. al, Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads, Digestive Diseases and Sciences, 2009",cited-by,10.1007/s10620-008-0500-y,Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads,"[['Hitomi', '', 'Sezaki'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Tetsuya', '', 'Hosaka'], ['Norio', '', 'Akuta'], ['Masahiro', '', 'Kobayashi'], ['Yoshiyuki', '', 'Suzuki'], ['Satoshi', '', 'Saitoh'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Yuzo', '', 'Miyakawa'], ['Hiromitsu', '', 'Kumada']]",Digestive Diseases and Sciences,2009,"[u'http://www.springerlink.com/content/e63232l537q8128t', u'http://www.springerlink.com/index/e63232l537q8128t.pdf', u'http://www.springerlink.com/index/10.1007/s10620-008-0500-y', u'http://www.springerlink.com/index/pdf/10.1007/s10620-008-0500-y']",
10.1055/s-2000-9505,"Zhu, Z., Wilson, A., Mathahs, M., et. al, Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury, Hepatology, 2008",cited-by,10.1002/hep.22491,Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury,"[['Zhaowen', '', 'Zhu'], ['Anne', 'T.', 'Wilson'], ['M.', 'Meleah', 'Mathahs'], ['Feng', '', 'Wen'], ['Kyle', 'E.', 'Brown'], ['Bruce', 'A.', 'Luxon'], ['Warren', 'N.', 'Schmidt']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.22491'],
10.1055/s-2000-9505,"Sibal, L., Samson, K., , Nonhuman Primates: A Critical Role in Current Disease Research, , 0",cited-by,5905632Nonhuman Primates: A Critical Role in Current Disease Research,Nonhuman Primates: A Critical Role in Current Disease Research,"[['Louis', 'R.', 'Sibal'], ['Kurt', 'J.', 'Samson']]",,0,[],
10.1055/s-2000-9505,"Garaigorta, U., Chisari, F., , Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation, Cell Host & Microbe, 2009",cited-by,10.1016/j.chom.2009.11.004,Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation,"[['Urtzi', '', 'Garaigorta'], ['Francis', 'V.', 'Chisari']]",Cell Host & Microbe,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1931312809003813', u'http://linkinghub.elsevier.com/retrieve/pii/S1931312809003813']",
10.1055/s-2000-9505,"Tanamly, M., Tadros, F., Labeeb, S., et. al, Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results, Digestive and Liver Disease, 2004",cited-by,10.1016/j.dld.2004.06.015,Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results,"[['M.', 'D.', 'Tanamly'], ['F.', '', 'Tadros'], ['S.', '', 'Labeeb'], ['H.', '', 'Makld'], ['M.', '', 'Shehata'], ['N.', '', 'Mikhail'], ['M.', '', 'Abdel-Hamid'], ['L.', '', 'Abu-Baki'], ['A.', '', 'Medhat'], ['L.', 'S.', 'Magder'], ['N.', 'H.', 'Afdhal'], ['G.', 'T.', 'Strickland']]",Digestive and Liver Disease,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1590865804003020', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865804003020']",
10.1055/s-2000-9505,"Seeff, L., , Why is there such difficulty in defining the natural history of hepatitis C?, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40101161.x,Why is there such difficulty in defining the natural history of hepatitis C?,"[['Leonard', 'B.', 'Seeff']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40101161.x'],
10.1055/s-2000-9505,"Melhem, A., Stern, M., Shibolet, O., et. al, Treatment of Chronic Hepatitis C Virus Infection via Antioxidants Results of a Phase I Clinical Trial, , 0",cited-by,11825028Treatment of Chronic Hepatitis C Virus Infection via Antioxidants Results of a Phase I Clinical Trial,Treatment of Chronic Hepatitis C Virus Infection via Antioxidants Results of a Phase I Clinical Trial,"[['Alla', '', 'Melhem'], ['Mirela', '', 'Stern'], ['Oren', '', 'Shibolet'], ['Eran', '', 'Israeli'], ['Zvi', '', 'Ackerman'], ['Orit', '', 'Pappo'], ['Nilla', '', 'Hemed'], ['Mina', '', 'Rowe'], ['Hana', '', 'Ohana'], ['George', '', 'Zabrecky'], ['Robert', '', 'Cohen'], ['Yaron', '', 'Ilan']]",,0,[u'http://lynes.mcb.uconn.edu/mcb355/2006/03/15/hcv_antioxidant_melhem.pdf'],
10.1055/s-2000-9505,"Mühlberger, N., Schwarzer, R., Lettmeier, B., et. al, HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality, BMC Public Health, 2009",cited-by,10.1186/1471-2458-9-34,"HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality","[['Nikolai', '', 'M\xc3\xbchlberger'], ['Ruth', '', 'Schwarzer'], ['Beate', '', 'Lettmeier'], ['Gaby', '', 'Sroczynski'], ['Stefan', '', 'Zeuzem'], ['Uwe', '', 'Siebert']]",BMC Public Health,2009,"[u'http://publikationen.ub.uni-frankfurt.de/volltexte/2009/6421/pdf/1471_2458_9_34.pdf', u'http://www.springerlink.com/index/v3483446u5tv0952.pdf', u'http://www.springerlink.com/content/v3483446u5tv0952', u'http://www.biomedcentral.com/1471-2458/9/34', u'http://www.biomedcentral.com/content/pdf/1471-2458-9-34.pdf']",
10.1055/s-2000-9505,"Soriano, V., Mocroft, A., Rockstroh, J., et. al, Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe, Journal of Infectious Diseases, 2008",cited-by,10.1086/592171,"Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in Europe","[['Vincent', '', 'Soriano'], ['Amanda', '', 'Mocroft'], ['Juergen', '', 'Rockstroh'], ['Bruno', '', 'Ledergerber'], ['Brygida', '', 'Knysz'], ['Saulius', '', 'Chaplinskas'], ['Lars', '', 'Peters'], ['Anders', '', 'Karlsson'], ['Christine', '', 'Katlama'], ['Carlos', '', 'Toro'], ['Bernd', '', 'Kupfer'], ['Martin', '', 'Vogel'], ['Jens', '', 'Lundgren']]",Journal of Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/592171'],
10.1055/s-2000-9505,"Kim, C., Jung, J., Wakita, T., et. al, Monitoring the Antiviral Effect of Alpha Interferon on Individual Cells, Journal of Virology, 2007",cited-by,10.1128/JVI.02824-06,Monitoring the Antiviral Effect of Alpha Interferon on Individual Cells,"[['Chon', 'Saeng', 'Kim'], ['Jong', 'Ha', 'Jung'], ['Takaji', '', 'Wakita'], ['Seung', 'Kew', 'Yoon'], ['Sung', 'Key', 'Jang']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/16/8814.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02824-06']",
10.1055/s-2000-9505,"Lanford, R., Guerra, B., Bigger, C., et. al, Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus, Hepatology, 2007",cited-by,10.1002/hep.21776,Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus,"[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Catherine', 'B.', 'Bigger'], ['Helen', '', 'Lee'], ['Deborah', '', 'Chavez'], ['Kathleen', 'M.', 'Brasky']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21776'],
10.1055/s-2000-9505,"Salomon, J., Weinstein, M., Hammitt, J., et. al, Empirically Calibrated Model of Hepatitis C Virus Infection in the United States, , 0",cited-by,11211119Empirically Calibrated Model of Hepatitis C Virus Infection in the United States,Empirically Calibrated Model of Hepatitis C Virus Infection in the United States,"[['Joshua', 'A.', 'Salomon'], ['Milton', 'C.', 'Weinstein'], ['James', 'K.', 'Hammitt'], ['Sue', 'J.', 'Goldie']]",,0,[u'http://aje.oxfordjournals.org/cgi/reprint/156/8/761.pdf'],
10.1055/s-2000-9505,"Castello, G., Scala, S., Palmieri, G., et. al, HCV-related hepatocellular carcinoma: From chronic inflammation to cancer, Clinical Immunology, 2010",cited-by,10.1016/j.clim.2009.10.007,HCV-related hepatocellular carcinoma: From chronic inflammation to cancer,"[['Giuseppe', '', 'Castello'], ['Stefania', '', 'Scala'], ['Giuseppe', '', 'Palmieri'], ['Steven', 'A.', 'Curley'], ['Francesco', '', 'Izzo']]",Clinical Immunology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S152166160900847X', u'http://linkinghub.elsevier.com/retrieve/pii/S152166160900847X']",
10.1055/s-2000-9505,"Sainz, B., Chisari, F., , Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells, Journal of Virology, 2006",cited-by,10.1128/JVI.01059-06,"Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells","[['Bruno', '', 'Sainz'], ['F.', 'V.', 'Chisari']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/20/10253.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01059-06']",
10.1055/s-2000-9505,"Umemura, T., Wang, R., Schechterly, C., et. al, Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C, Hepatology, 2006",cited-by,10.1002/hep.20917,Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C,"[['Takeji', '', 'Umemura'], ['Richard', 'Y.-H.', 'Wang'], ['Cathy', '', 'Schechterly'], ['J.', 'Wai-Kuo', 'Shih'], ['Kendo', '', 'Kiyosawa'], ['Harvey', 'J.', 'Alter']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.20917'],
10.1055/s-2000-9505,"Prabhu, R., Garry, R., Dash, S., , Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes, Virology Journal, 2006",cited-by,10.1186/1743-422X-3-100,Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes,"[['Ramesh', '', 'Prabhu'], ['Robert', 'F', 'Garry'], ['Srikanta', '', 'Dash']]",Virology Journal,2006,"[u'http://www.springerlink.com/content/63500850r02528u1', u'http://www.biomedcentral.com/content/pdf/1743-422X-3-100.pdf', u'http://www.virologyj.com/content/3/1/100', u'http://www.springerlink.com/index/63500850r02528u1.pdf']",
10.1055/s-2000-9505,"Shin, E., Protzer, U., Untergasser, A., et. al, Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C, Journal of Virology, 2005",cited-by,10.1128/JVI.79.21.13412-13420.2005,Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C,"[['Eui-Cheol', '', 'Shin'], ['Ulrike', '', 'Protzer'], ['Andreas', '', 'Untergasser'], ['Stephen', 'M.', 'Feinstone'], ['Charles', 'M.', 'Rice'], ['Dana', '', 'Hasselschwert'], ['Barbara', '', 'Rehermann']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/21/13412.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.21.13412-13420.2005']",
10.1055/s-2000-9505,"Franchini, M., Rossetti, G., Tagliaferri, A., et. al, The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders, , 0",cited-by,11250222The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders,The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders,"[['Massimo', '', 'Franchini'], ['Gina', '', 'Rossetti'], ['Annarita', '', 'Tagliaferri'], ['Franco', '', 'Capra'], ['Elena', 'de', 'Maria'], ['Corrado', '', 'Pattacini'], ['Giuseppe', '', 'Lippi'], ['Giuliana', 'Lo', 'Cascio'], ['Marzia', 'de', 'Gironcoli'], ['Giorgio', '', 'Gandini']]",,0,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/98/6/1836.pdf'],
10.1055/s-2000-9505,"Zhang, P., Zhong, L., Struble, E., et. al, Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity, Proceedings of The National Academy of Sciences, 2009",cited-by,10.1073/pnas.0902749106,Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity,"[['Pei', '', 'Zhang'], ['Lilin', '', 'Zhong'], ['Evi', 'Budo', 'Struble'], ['Hisayoshi', '', 'Watanabe'], ['Alla', '', 'Kachko'], ['Kathleen', '', 'Mihalik'], ['Maria', 'Luisa', 'Virata-Theimer'], ['Harvey', 'J.', 'Alter'], ['Stephen', '', 'Feinstone'], ['Marian', '', 'Major']]",Proceedings of The National Academy of Sciences,2009,"[u'http://www.pnas.org/cgi/doi/10.1073/pnas.0902749106', u'http://adsabs.harvard.edu/abs/2009PNAS..106.7537Z']",
10.1055/s-2000-9505,"Khokhar, O., Lewis, J., , Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?, Digestive Diseases and Sciences, 2007",cited-by,10.1007/s10620-006-9579-1,Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?,"[['Omar', 'S.', 'Khokhar'], ['James', 'H.', 'Lewis']]",Digestive Diseases and Sciences,2007,"[u'http://www.springerlink.com/index/e3x402652jx33230.pdf', u'http://www.springerlink.com/content/e3x402652jx33230', u'http://www.springerlink.com/index/10.1007/s10620-006-9579-1', u'http://www.springerlink.com/index/pdf/10.1007/s10620-006-9579-1']",
10.1055/s-2000-9505,"Zhu, Q., Oei, Y., Mendel, D., et. al, Novel Robust Hepatitis C Virus Mouse Efficacy Model, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00413-06,Novel Robust Hepatitis C Virus Mouse Efficacy Model,"[['Qing', '', 'Zhu'], ['Yoko', '', 'Oei'], ['Dirk', 'B.', 'Mendel'], ['Evelyn', 'N.', 'Garrett'], ['Montesa', 'B.', 'Patawaran'], ['Paul', 'W.', 'Hollenbach'], ['Sharon', 'L.', 'Aukerman'], ['Amy', 'J.', 'Weiner']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/10/3260.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00413-06']",
10.1055/s-2000-9505,"Pembrey, L., Newell, M., Tovo, P., , The management of HCV infected pregnant women and their children European paediatric HCV network, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.06.002,The management of HCV infected pregnant women and their children European paediatric HCV network,"[['Lucy', '', 'Pembrey'], ['Marie-Louise', '', 'Newell'], ['Pier-Angelo', '', 'Tovo']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805004174', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805004174']",
10.1055/s-2000-9505,"Ismail, N., Fish, G., Smith, M., , Laboratory Evaluation of a Fully Automated Chemiluminescence Immunoassay for Rapid Detection of HBsAg, Antibodies to HBsAg, and Antibodies to Hepatitis C Virus, , 2004",cited-by,"10347260Laboratory Evaluation of a Fully Automated Chemiluminescence Immunoassay for Rapid Detection of HBsAg, Antibodies to HBsAg, and Antibodies to Hepatitis C Virus","Laboratory Evaluation of a Fully Automated Chemiluminescence Immunoassay for Rapid Detection of HBsAg, Antibodies to HBsAg, and Antibodies to Hepatitis C Virus","[['Nahed', '', 'Ismail'], ['Geoffrey', 'E.', 'Fish'], ['Michael', 'B.', 'Smith']]",,2004,[u'http://jcm.asm.org/cgi/reprint/42/2/610.pdf'],
10.1055/s-2000-9505,"Kasprzak, A., Adamek, A., , Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis, Hepatology Research, 2008",cited-by,10.1111/j.1872-034X.2007.00261.x,"Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis","[['Aldona', '', 'Kasprzak'], ['Agnieszka', '', 'Adamek']]",Hepatology Research,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1872-034X.2007.00261.x'],
10.1055/s-2000-9505,"Reiss, D., Avila-campillo, I., Thorsson, V., et. al, Tools enabling the elucidation of molecular pathways active in human disease: Application to Hepatitis C virus infection, BMC Bioinformatics, 2005",cited-by,10.1186/1471-2105-6-154,Tools enabling the elucidation of molecular pathways active in human disease: Application to Hepatitis C virus infection,"[['David', 'J.', 'Reiss'], ['Iliana', '', 'Avila-campillo'], ['Vesteinn', '', 'Thorsson'], ['Benno', '', 'Schwikowski'], ['Timothy', '', 'Galitski']]",BMC Bioinformatics,2005,"[u'http://dx.doi.org/10.1186/1471-2105-6-154', u'http://www.springerlink.com/index/n2k13r1760760732.pdf', u'http://www.biomedcentral.com/1471-2105/6/154', u'http://www.biomedcentral.com/content/pdf/1471-2105-6-154.pdf', u'http://www.springerlink.com/content/n2k13r1760760732', u'http://www.informatik.uni-trier.de/~ley/db/journals/bmcbi/bmcbi6.html#ReissATSG05']",
10.1055/s-2000-9505,"Siebert, U., Sroczynski, G., , Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: A health technology assessment commissioned by the German Federal Ministry of Health and Social Security, International Journal of Technology Assessment in Health Care, 2005",cited-by,10.1017/S0266462305050075,Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: A health technology assessment commissioned by the German Federal Ministry of Health and Social Security,"[['Uwe', '', 'Siebert'], ['Gaby', '', 'Sroczynski']]",International Journal of Technology Assessment in Health Care,2005,[u'http://www.journals.cambridge.org/abstract_S0266462305050075'],
10.1055/s-2000-9505,"Kuehne, F., Bethe, U., Freedberg, K., et. al, Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients Clinical Benefits and Cost-effectiveness, , 2002",cited-by,12350609Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients Clinical Benefits and Cost-effectiveness,Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients Clinical Benefits and Cost-effectiveness,"[['Felicitas', 'C.', 'Kuehne'], ['Ullrich', '', 'Bethe'], ['Kenneth', '', 'Freedberg'], ['Sue', 'J.', 'Goldie']]",,2002,[u'http://archinte.ama-assn.org/cgi/reprint/162/22/2545.pdf'],
10.1055/s-2000-9505,"Page-Shafer, K., Pappalardo, B., Tobler, L., et. al, Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates, , 0",cited-by,6522537Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates,Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates,"[['Kimberly', '', 'Page-Shafer'], ['Brandee', 'L.', 'Pappalardo'], ['Leslie', 'H.', 'Tobler'], ['Bruce', 'H.', 'Phelps'], ['Brian', 'R.', 'Edlin'], ['Andrew', 'R.', 'Moss'], ['Teresa', 'L.', 'Wright'], ['David', 'J.', 'Wright'], ['Thomas', 'R.', ""O'Brien""], ['Sally', '', 'Caglioti'], ['Michael', 'P.', 'Busch']]",,0,[u'http://jcm.asm.org/cgi/reprint/46/2/499.pdf'],
10.1055/s-2000-9505,"Machida, K., Keck, Z., Lai, M., et. al, Therapeutic Control of Hepatitis C Virus: The Role of Neutralizing Monoclonal Antibodies, , 0",cited-by,10.1007/978-3-540-72146-8_1,Therapeutic Control of Hepatitis C Virus: The Role of Neutralizing Monoclonal Antibodies,"[['K.', '', 'Machida'], ['Z.', 'Y.', 'Keck'], ['M.', 'M. C.', 'Lai'], ['J.', 'K.', 'Ball'], ['A.', 'H.', 'Patel'], ['S.', 'K. H.', 'Foung']]",,0,"[u'http://www.springerlink.com/content/k32h1731064m87h8', u'http://www.springerlink.com/index/k32h1731064m87h8.pdf']",
10.1055/s-2000-9505,"Weigand, K., Stremmel, W., Encke, J., , Treatment of hepatitis C virus infection, , 2007",cited-by,6934404Treatment of hepatitis C virus infection,Treatment of hepatitis C virus infection,"[['Kilian', '', 'Weigand'], ['Wolfgang', '', 'Stremmel'], ['Jens', '', 'Encke']]",,2007,[u'http://www.wjgnet.com/1007-9327/13/1897.pdf'],
10.1056~NEJMoa011232,"Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.",references,10.1016/S0140-6736(96)07642-8,Natural history of liver fibrosis progression in patients with chronic hepatitis C,"[[u'Thierry', u'', u'Poynard'], [u'Pierre', u'', u'Bedossa'], [u'Pierre', u'', u'Opolon']]",Lancet,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0140673696076428', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673696076428']","[{u'Name': u'Chronic Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5702}, {u'Name': u'Liver Fibrosis', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 23154}, {u'Name': u'Natural History', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 27121}]"
10.1016/S0140-6736(96)07642-8,"Poynard, T., Marcellin, P., Lee, S., et. al, Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus, Lancet, 1998",cited-by,10.1016/S0140-6736(98)07124-4,Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus,"[['Thierry', '', 'Poynard'], ['Patrick', '', 'Marcellin'], ['Samuel', 'S', 'Lee'], ['Christian', '', 'Niederau'], ['Gerald', 'S', 'Minuk'], ['Gaetano', '', 'Ideo'], ['Vincent', '', 'Bain'], ['Jenny', '', 'Heathcote'], ['Stefan', '', 'Zeuzem'], ['Christian', '', 'Trepo'], ['Janice', '', 'Albrecht']]",Lancet,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0140673698071244', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673698071244']",
10.1016/S0140-6736(96)07642-8,"Strader, D., Wright, T., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20119,"Diagnosis, management, and treatment of hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2004,"[u'http://www.natap.org/2004/pdf/AASLD_Prac._Guide_Hep_C.pdf', u'http://www.hiv.ch/rubriken/hep/US_GL_Hep_C.pdf', u'http://www.texasliver.com/docs/management%20of%20hepatitis%20c%203.pdf', u'http://doi.wiley.com/10.1002/hep.20119']",
10.1016/S0140-6736(96)07642-8,"Shepard, C., Finelli, L., Alter, M., , Global epidemiology of hepatitis C virus infection, Lancet Infectious Diseases, 2005",cited-by,10.1016/S1473-3099(05)70216-4,Global epidemiology of hepatitis C virus infection,"[['Colin', 'W', 'Shepard'], ['Lyn', '', 'Finelli'], ['Miriam', 'J', 'Alter']]",Lancet Infectious Diseases,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1473309905702164', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309905702164']",
10.1016/S0140-6736(96)07642-8,"Bica, I., McGovern, B., Dhar, R., et. al, Increasing Mortality Due to End‐Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection, Clinical Infectious Diseases, 2001",cited-by,10.1086/318501,Increasing Mortality Due to End‐Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection,"[['Ioana', '', 'Bica'], ['Barbara', '', 'McGovern'], ['Rakesh', '', 'Dhar'], ['David', '', 'Stone'], ['Katherine', '', 'McGowan'], ['Rochelle', '', 'Scheib'], ['David', 'R.', 'Snydman']]",Clinical Infectious Diseases,2001,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/318501'],
10.1016/S0140-6736(96)07642-8,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
10.1016/S0140-6736(96)07642-8,"Bataller, R., Brenner, D., , Liver fibrosis, Journal of Clinical Investigation, 2005",cited-by,10.1172/JCI24282,Liver fibrosis,"[['Ram\xc3\xb3n', '', 'Bataller'], ['David', 'A.', 'Brenner']]",Journal of Clinical Investigation,2005,[u'http://www.jci.org/articles/view/24282'],
10.1016/S0140-6736(96)07642-8,"Friedman, S., , Liver fibrosis - from bench to bedside, , 2003",cited-by,5673443Liver fibrosis - from bench to bedside,Liver fibrosis - from bench to bedside,"[['Scott', 'L.', 'Friedman']]",,2003,[u'http://www.liver-nash.com/pdf/liver-fibrosis.pdf'],
10.1016/S0140-6736(96)07642-8,"Benhamou, Y., Bochet, M., Martino, V., et. al, Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients, Hepatology, 1999",cited-by,10.1002/hep.510300409,Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients,"[['Yves', '', 'Benhamou'], ['Marie', '', 'Bochet'], ['Vincent', 'Di', 'Martino'], ['Frederic', '', 'Charlotte'], ['Felipe', '', 'Azria'], ['Anne', '', 'Coutellier'], ['Michel', '', 'Vidaud'], ['Pierre', '', 'Opolon'], ['Christine', '', 'Katlama'], ['Thierry', '', 'Poynard']]",Hepatology,1999,"[u'http://www.hcvu.org/mlib/2007_03_15-Benhamou_Coinfection_Fibrosis_Progression.pdf', u'http://doi.wiley.com/10.1002/hep.510300409']",
10.1016/S0140-6736(96)07642-8,"Poynard, T., McHutchison, J., Manns, M., et. al, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 2002",cited-by,10.1053/gast.2002.33023,Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C,"[['Thierry', '', 'Poynard'], ['John', '', 'McHutchison'], ['Michael', '', 'Manns'], ['Christian', '', 'Trepo'], ['Karen', '', 'Lindsay'], ['Zachary', '', 'Goodman'], ['Mei-Hsiu', '', 'Ling'], ['Janice', '', 'Albrecht']]",Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S001650850234959X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850234959X']",
10.1016/S0140-6736(96)07642-8,"Yu, E., Carnie, J., Heeren, T., , Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis, Clinical Infectious Diseases, 2001",cited-by,10.1086/321909,Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis,"[['E.', '', 'Yu'], ['J.', '', 'Carnie'], ['T.', '', 'Heeren']]",Clinical Infectious Diseases,2001,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/321909'],
10.1016/S0140-6736(96)07642-8,"Berenguer, M., Ferrell, L., Watson, J., et. al, HCV-related fibrosis progression following liver transplantation: increase in recent years, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80231-7,HCV-related fibrosis progression following liver transplantation: increase in recent years,"[['Marina', '', 'Berenguer'], ['Linda', '', 'Ferrell'], ['Jessica', '', 'Watson'], ['Martin', '', 'Prieto'], ['Michael', '', 'Kim'], ['Miguel', '', 'Ray\xc3\xb3n'], ['Juan', '', 'C\xc3\xb3rdoba'], ['Antonio', '', 'Herola'], ['Nancy', '', 'Ascher'], ['Jos\xc3\xa9', '', 'Mir'], ['Joaqu\xc3\xadn', '', 'Berenguer'], ['Teresa', 'L', 'Wright']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800802317', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800802317']",
10.1016/S0140-6736(96)07642-8,"Poynard, T., Ratziu, V., Charlotte, F., et. al, Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(00)00097-0,Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C,"[['Thierry', '', 'Poynard'], ['Vlad', '', 'Ratziu'], ['Fr\xc3\xa9d\xc3\xa9ric', '', 'Charlotte'], ['Zachary', '', 'Goodman'], ['John', '', 'McHutchison'], ['Janice', '', 'Albrecht']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800000970', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800000970']",
10.1016/S0140-6736(96)07642-8,"Hui, J., Sud, A., Farrell, G., et. al, Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression, Gastroenterology, 2003",cited-by,10.1053/j.gastro.2003.08.032,Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression,"[['Jason', 'M', 'Hui'], ['Archana', '', 'Sud'], ['Geoffrey', 'C', 'Farrell'], ['Priyanka', '', 'Bandara'], ['Karen', '', 'Byth'], ['James', 'G', 'Kench'], ['Geoffrey', 'W', 'McCaughan'], ['Jacob', '', 'George']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503015166', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503015166']",
10.1016/S0140-6736(96)07642-8,"Liang, T., Rehermann, B., Seeff, L., et. al, Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C, , 2000",cited-by,"6738512Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","[['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann'], ['Leonard', 'B.', 'Seeff'], ['Jay', 'H.', 'Hoofnagle']]",,2000,[u'http://www.annals.org/content/132/4/296.full.pdf'],
10.1016/S0140-6736(96)07642-8,"Colloredo, G., Guido, M., Sonzogni, A., et. al, Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00191-0,"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease","[['Guido', '', 'Colloredo'], ['Maria', '', 'Guido'], ['Aurelio', '', 'Sonzogni'], ['Gioacchino', '', 'Leandro']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803001910', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803001910']",
10.1016/S0140-6736(96)07642-8,"Ghany, M., Strader, D., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009",cited-by,10.1002/hep.22759,"Diagnosis, management, and treatment of hepatitis C: An update","[['Marc', 'G.', 'Ghany'], ['Doris', 'B.', 'Strader'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2009,"[u'http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/diagnosis_of_hep_c_update.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Hepatitis%20C%20UPDATE.pdf', u'http://www.sklid.com/news/uploadfiles/20094122357635.pdf', u'http://www.coloradoguidelines.org/pdf/hepatitisbc/Diagnosis_of_HEP_C_Update_Aug%20_09.pdf', u'http://www.paml.com/Files/Miscellaneous/Hep%20C%20Diagnosis,Manage,Treatment%20Apr%202009.pdf', u'http://doi.wiley.com/10.1002/hep.22759', u'http://zuberi.biz/guidelines/AASLD_HEP_C_2009.pdf']",
10.1016/S0140-6736(96)07642-8,"Ikeda, M., Yi, M., Li, K., et. al, Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells, Journal of Virology, 2002",cited-by,10.1128/JVI.76.6.2997-3006.2002,Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells,"[['Masanori', '', 'Ikeda'], ['MinKyung', '', 'Yi'], ['Kui', '', 'Li'], ['Stanley', 'M.', 'Lemon']]",Journal of Virology,2002,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.6.2997-3006.2002'],
10.1016/S0140-6736(96)07642-8,"Darby, S., Ewart, D., Giangrande, P., et. al, Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C, Lancet, 1997",cited-by,10.1016/S0140-6736(97)05413-5,Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C,"[['Sarah', 'C', 'Darby'], ['David', 'W', 'Ewart'], ['Paul', 'LF', 'Giangrande'], ['Rosemary', 'JD', 'Spooner'], ['Charles', 'R', 'Rizza'], ['Geoffrey', 'M', 'Dusheiko'], ['Christine', 'A', 'Lee'], ['Christopher', 'A', 'Ludlam'], ['F', 'Eric', 'Preston']]",Lancet,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0140673697054135', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673697054135']",
10.1016/S0140-6736(96)07642-8,"Forns, X., Llovet, J., Aponte, J., et. al, Identification of Chronic Hepatitis C Patients Without Hepatic Fibrosis by a Simple Predictive Model, , 2002",cited-by,10211481Identification of Chronic Hepatitis C Patients Without Hepatic Fibrosis by a Simple Predictive Model,Identification of Chronic Hepatitis C Patients Without Hepatic Fibrosis by a Simple Predictive Model,"[['Xavier', '', 'Forns'], ['Josep', 'M.', 'Llovet'], ['John', '', 'Aponte'], ['LlorencQuint', '\xc2\xb4', 'o'], ['Eva', 'Mart\xc3\xb5 \xc2\xb4', 'nez-Bauer'], ['Miquel', '', 'Bruguera'], ['Jose', 'Maria', 'Sanchez-Tapias'], ['Juan', '', 'Rodes']]",,2002,"[u'http://www.axsan.it/pdf/Forns.pdf', u'http://hepato.com/i52009.pdf']",
10.1016/S0140-6736(96)07642-8,"Mathurin, P., Mouquet, C., Poynard, T., et. al, Impact of hepatitis B and C virus on kidney transplantation outcome, Hepatology, 1999",cited-by,10.1002/hep.510290123,Impact of hepatitis B and C virus on kidney transplantation outcome,"[['Philippe', '', 'Mathurin'], ['Catherine', '', 'Mouquet'], ['Thierry', '', 'Poynard'], ['Cheickna', '', 'Sylla'], ['Hadjira', '', 'Benalia'], ['Catherine', '', 'Fretz'], ['Vincent', '', 'Thibault'], ['Brigitte', '', 'Bernard'], ['Pierre', '', 'Opolon'], ['Pierre', '', 'Coriat'], ['Marc', 'Olivier', 'Bitker']]",Hepatology,1999,[u'http://doi.wiley.com/10.1002/hep.510290123'],
10.1016/S0140-6736(96)07642-8,"Freeman, A., Dore, G., Law, M., et. al, Estimating progression to cirrhosis in chronic hepatitis C virus infection, Hepatology, 2001",cited-by,10.1053/jhep.2001.27831,Estimating progression to cirrhosis in chronic hepatitis C virus infection,"[['Anthony', 'J.', 'Freeman'], ['Gregory', 'J.', 'Dore'], ['Matthew', 'G.', 'Law'], ['Max', '', 'Thorpe'], ['Jan', 'Von', 'Overbeck'], ['Andrew', 'R.', 'Lloyd'], ['George', '', 'Marinos'], ['John', 'M.', 'Kaldor']]",Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270913901810934', u'http://www.sciencedirect.com/science/article/pii/S0270913901333190', u'http://doi.wiley.com/10.1053/jhep.2001.27831']",
10.1016/S0140-6736(96)07642-8,"Imbert-Bismut, F., Ratziu, V., Pieroni, L., et. al, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, , 0",cited-by,11627041Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study,Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study,"[['Fran\xc3\xa7oise', '', 'Imbert-Bismut'], ['Vlad', '', 'Ratziu'], ['Laurence', '', 'Pieroni'], ['Frederic', '', 'Charlotte'], ['Yves', '', 'Benhamou'], ['Thierry', '', 'Poynard']]",,0,"[u'https://loinc.org/meetings/20050606/public-laboratory-workshop-committee-meeting-06-06-2005/handout_h.pdf', u'http://www.natap.org/2001/apr/p_f_index.pdf', u'http://loinc.org/meetings/20050606/public-laboratory-workshop-committee-meeting-06-06-2005/handout_h.pdf']",
10.1016/S0140-6736(96)07642-8,"Marcellin, P., Asselah, T., Boyer, N., , Fibrosis and disease progression in hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36993,Fibrosis and disease progression in hepatitis C,"[['Patrick', '', 'Marcellin'], ['Tarik', '', 'Asselah'], ['Nathalie', '', 'Boyer']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Fibrosis%20And%20Disease%20Progression%20In%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360707', u'http://doi.wiley.com/10.1053/jhep.2002.36993']",
10.1016/S0140-6736(96)07642-8,"Leandro, G., Mangia, A., Hui, J., et. al, Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.03.014,"Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data","[['Gioacchino', '', 'Leandro'], ['Alessandra', '', 'Mangia'], ['Jason', '', 'Hui'], ['Paolo', '', 'Fabris'], ['Guido', '', 'Colloredo'], ['Luigi', 'E.', 'Adinolfi'], ['Tarik', '', 'Asselah'], ['Julie', 'R.', 'Jonsson'], ['Antonina', '', 'Smedile'], ['Norah', '', 'Terrault'], ['Valerio', '', 'Pazienza'], ['Maria', 'Teresa', 'Giordani'], ['Emiliano', '', 'Giostra'], ['Aurelio', '', 'Sonzogni'], ['Giuseppe', '', 'Ruggiero'], ['Patrick', '', 'Marcellin'], ['Elizabeth', 'E.', 'Powell'], ['Jacob', '', 'George'], ['Francesco', '', 'Negro']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506005634', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506005634']",
10.1016/S0140-6736(96)07642-8,"Shiffman, M., Hofmann, C., Contos, M., et. al, A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia, Gastroenterology, 1999",cited-by,10.1016/S0016-5085(99)70402-6,"A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia","[['Mitchell', 'L.', 'Shiffman'], ['Charlotte', 'M.', 'Hofmann'], ['Melissa', 'J.', 'Contos'], ['Velimir', 'A.', 'Luketic'], ['Arun', 'J.', 'Sanyal'], ['Richard', 'K.', 'Sterling'], ['Andrea', '', 'Ferreira-Gonzalez'], ['A.', 'Scott', 'Mills'], ['Carlton', '', 'Garret']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0016508599704026', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508599704026']",
10.1016/S0140-6736(96)07642-8,"Gandon, Y., Olivié, D., Guyader, D., et. al, Non-invasive assessment of hepatic iron stores by MRI, Lancet, 2004",cited-by,10.1016/S0140-6736(04)15436-6,Non-invasive assessment of hepatic iron stores by MRI,"[['Y', '', 'Gandon'], ['D', '', 'Olivi\xc3\xa9'], ['D', '', 'Guyader'], ['C', '', 'Aub\xc3\xa9'], ['F', '', 'Oberti'], ['V', '', 'Sebille'], ['Y', '', 'Deugnier']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0140673604154366', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673604154366']",
10.1016/S0140-6736(96)07642-8,"Dienstag, J., McHutchison, J., , American Gastroenterological Association Technical Review on the Management of Hepatitis C, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2005.11.010,American Gastroenterological Association Technical Review on the Management of Hepatitis C,"[['Jules', 'L.', 'Dienstag'], ['John', 'G.', 'McHutchison']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505022705', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505022705']",
10.1016/S0140-6736(96)07642-8,"Berenguer, M., López-Labrador, F., Wright, T., , Hepatitis C and liver transplantation, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00179-9,Hepatitis C and liver transplantation,"[['Marina', '', 'Berenguer'], ['F.', 'Xavier', 'L\xc3\xb3pez-Labrador'], ['Teresa', 'L.', 'Wright']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801001799', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801001799']",
10.1016/S0140-6736(96)07642-8,"Sulkowski, M., Thomas, D., , Hepatitis C in the HIV-Infected Person, , 2003",cited-by,5168375Hepatitis C in the HIV-Infected Person,Hepatitis C in the HIV-Infected Person,"[['Mark', 'S.', 'Sulkowski'], ['David', 'L.', 'Thomas']]",,2003,[u'http://www.annals.org/content/138/3/197.full.pdf'],
10.1016/S0140-6736(96)07642-8,"Sobesky, R., Mathurin, P., Charlotte, F., et. al, Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view, Gastroenterology, 1999",cited-by,10.1016/S0016-5085(99)70135-6,Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view,"[['Rodolphe', '', 'Sobesky'], ['Philippe', '', 'Mathurin'], ['Frederic', '', 'Charlotte'], ['Joseph', '', 'Moussalli'], ['Martine', '', 'Olivi'], ['Michel', '', 'Vidaud'], ['Vlad', '', 'Ratziu'], ['Pierre', '', 'Opolon'], ['Thierry', '', 'Poynard']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0016508599701356', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508599701356']",
10.1016/S0140-6736(96)07642-8,"Li, D., Friedman, S., , Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy, Journal of Gastroenterology and Hepatology, 1999",cited-by,10.1046/j.1440-1746.1999.01928.x,Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy,"[['Dan', '', 'Li'], ['Scott', '', 'Friedman']]",Journal of Gastroenterology and Hepatology,1999,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1440-1746.1999.01928.x'],
10.1016/S0140-6736(96)07642-8,"McGlynn, K., Tsao, L., Hsing, A., et. al, International trends and patterns of primary liver cancer, International Journal of Cancer, 2001",cited-by,10.1002/ijc.1456,International trends and patterns of primary liver cancer,"[['Katherine', 'A.', 'McGlynn'], ['Lilian', '', 'Tsao'], ['Ann', 'W.', 'Hsing'], ['Susan', 'S.', 'Devesa'], ['Joseph', 'F.', 'Fraumeni']]",International Journal of Cancer,2001,[u'http://doi.wiley.com/10.1002/ijc.1456'],
10.1016/S0140-6736(96)07642-8,"Poynard, T., Mathurin, P., Lai, C., et. al, A comparison of fibrosis progression in chronic liver diseases, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(02)00413-0,A comparison of fibrosis progression in chronic liver diseases,"[['Thierry', '', 'Poynard'], ['Philippe', '', 'Mathurin'], ['Ching-Lung', '', 'Lai'], ['Dominique', '', 'Guyader'], ['Ren\xc3\xa9e', '', 'Poupon'], ['Marie-H\xc3\xa9l\xc3\xa8ne', '', 'Tainturier'], ['Robert', 'P.', 'Myers'], ['Mona', '', 'Muntenau'], ['Vlad', '', 'Ratziu'], ['Michael', '', 'Manns'], ['Arndt', '', 'Vogel'], ['Fr\xc3\xa9d\xc3\xa9rique', '', 'Capron'], ['Antonio', '', 'Chedid'], ['Pierre', '', 'Bedossa']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802004130', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802004130']",
10.1016/S0140-6736(96)07642-8,"Donato, F., Tagger, A., Gelatti, U., et. al, Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and Women, American Journal of Epidemiology, 2002",cited-by,10.1093/aje/155.4.323,Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and Women,"[['F.', '', 'Donato'], ['A.', '', 'Tagger'], ['U.', '', 'Gelatti'], ['G.', '', 'Parrinello'], ['P.', '', 'Boffetta'], ['A.', '', 'Albertini'], ['A.', '', 'Decarli'], ['P.', '', 'Trevisi'], ['M.', 'L.', 'Ribero'], ['C.', '', 'Martelli'], ['S.', '', 'Porru'], ['G.', '', 'Nardi']]",American Journal of Epidemiology,2002,"[u'http://aje.oxfordjournals.org/cgi/reprint/155/4/323.pdf', u'http://aje.oupjournals.org/cgi/doi/10.1093/aje/155.4.323']",
10.1016/S0140-6736(96)07642-8,"Poynard, T., Yuen, M., Ratzin, V., et. al, Viral hepatitis C, Lancet, 2003",cited-by,10.1016/S0140-6736(03)15109-4,Viral hepatitis C,"[['Thierry', '', 'Poynard'], ['Man-Fung', '', 'Yuen'], ['Vlad', '', 'Ratzin'], ['Ching', 'Lung', 'Lai']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603151094', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603151094']",
10.1016/S0140-6736(96)07642-8,", Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, 2000",cited-by,10.1086/313842,Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus,[],Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313842'],
10.1016/S0140-6736(96)07642-8,"Dienstag, J., , The role of liver biopsy in chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36381,The role of liver biopsy in chronic hepatitis C,"[['Jules', 'L.', 'Dienstag']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Role%20Of%20Liver%20Biopsy%20In%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36381', u'http://doi.wiley.com/10.1002/hep.1840360720']",
10.1016/S0140-6736(96)07642-8,"Bisceglie, A., , Hepatitis C, Lancet, 1998",cited-by,10.1016/S0140-6736(97)07361-3,Hepatitis C,"[['Adrian', 'M Di', 'Bisceglie']]",Lancet,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0140673697073613', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673697073613']",
10.1016/S0140-6736(96)07642-8,"El-Serag, H., , Epidemiology of Hepatocellular Carcinoma, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70155-0,Epidemiology of Hepatocellular Carcinoma,"[['Hashem', 'B.', 'El-Serag']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105701550', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105701550']",
10.1016/S0140-6736(96)07642-8,"Yoshida, H., Shiratori, Y., Moriyama, M., et. al, Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan, , 0",cited-by,10207334Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan,Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan,"[['Haruhiko', '', 'Yoshida'], ['Yasushi', '', 'Shiratori'], ['Mitsuhiko', '', 'Moriyama'], ['Yasuyuki', '', 'Arakawa'], ['Tatsuya', '', 'Ide'], ['Michio', '', 'Sat'], ['Osami', '', 'Inoue'], ['Michitami', '', 'Yano'], ['Motohiko', '', 'Tanaka'], ['Shigetoshi', '', 'Fujiyama'], ['Shuhei', '', 'Nishiguchi'], ['Tetsuo', '', 'Kuroki'], ['Fumio', '', 'Imazeki'], ['Osamu', '', 'Yokosuka'], ['Shingo', '', 'Kinoyama'], ['Gotaro', '', 'Yamada'], ['Masao', '', 'Omat']]",,0,[u'http://www.annals.org/content/131/3/174.full.pdf'],
10.1016/S0140-6736(96)07642-8,"Falck-Ytter, Y., Kale, H., Mullen, K., et. al, Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C, , 0",cited-by,10164197Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C,Surprisingly Small Effect of Antiviral Treatment in Patients with Hepatitis C,"[['Yngve', '', 'Falck-Ytter'], ['Hemangi', '', 'Kale'], ['Kevin', 'D.', 'Mullen'], ['Steedman', 'A.', 'Sarbah'], ['Lucian', '', 'Sorescu'], ['Arthur', 'J.', 'McCullough']]",,0,[],
10.1016/S0140-6736(96)07642-8,"Fontana, R., Lok, A., , Noninvasive monitoring of patients with chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36800,Noninvasive monitoring of patients with chronic hepatitis C,"[['Robert', 'J.', 'Fontana'], ['Anna', 'S. F.', 'Lok']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Noninvasive%20Monitoring%20Of%20Patients%20With%20Chronic%20Hepatitis%20C.pdf', u'http://www.trio-media.de/jesjournal/down/noninvasive.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36800', u'http://doi.wiley.com/10.1002/hep.1840360708']",
10.1016/S0140-6736(96)07642-8,"Fassio, E., Álvarez, E., Domínguez, N., et. al, Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies, Hepatology, 2004",cited-by,10.1002/hep.1840400411,Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies,"[['Eduardo', '', 'Fassio'], ['Estela', '', '\xc3\x81lvarez'], ['Nora', '', 'Dom\xc3\xadnguez'], ['Graciela', '', 'Landeira'], ['Cristina', '', 'Longo']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.1840400411'],
10.1016/S0140-6736(96)07642-8,"Paradis, V., Youssef, N., Dargère, D., et. al, Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas, Human Pathology, 2001",cited-by,10.1053/hupa.2001.22747,"Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas","[['Val\xc3\xa9rie', '', 'Paradis'], ['Nelly', '', 'Youssef'], ['Delphine', '', 'Darg\xc3\xa8re'], ['Nathalie', '', 'B\xc3\xa2'], ['Franck', '', 'Bonvoust'], ['Jean', '', 'Deschatrette'], ['Pierre', '', 'Bedossa']]",Human Pathology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0046817701865631', u'http://linkinghub.elsevier.com/retrieve/pii/S0046817701865631']",
10.1016/S0140-6736(96)07642-8,"Adams, L., Bulsara, M., Rossi, E., et. al, Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection, , 2005",cited-by,5791886Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection,Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection,"[['Leon', 'A.', 'Adams'], ['Max', '', 'Bulsara'], ['Enrico', '', 'Rossi'], ['Bastiaan', '', 'DeBoer'], ['David', '', 'Speers'], ['Jacob', '', 'George'], ['James', '', 'Kench'], ['Geoffrey', '', 'Farrell'], ['Geoffrey', 'W.', 'McCaughan'], ['Gary', 'P.', 'Jeffrey']]",,2005,"[u'http://www.clinchem.org/cgi/reprint/51/10/1867.pdf', u'http://www.clinchem.org/cgi/reprint/clinchem.2005.048389v1.pdf']",
10.1016/S0140-6736(96)07642-8,"Hillebrandt, S., Wasmuth, H., Weiskirchen, R., et. al, Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans, Nature Genetics, 2005",cited-by,10.1038/ng1599,Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans,"[['Sonja', '', 'Hillebrandt'], ['Hermann', 'E', 'Wasmuth'], ['Ralf', '', 'Weiskirchen'], ['Claus', '', 'Hellerbrand'], ['Hildegard', '', 'Keppeler'], ['Alexa', '', 'Werth'], ['Ramin', '', 'Schirin-Sokhan'], ['Gabriele', '', 'Wilkens'], ['Andreas', '', 'Geier'], ['Johann', '', 'Lorenzen'], ['J\xc3\xb6rg', '', 'K\xc3\xb6hl'], ['Axel', 'M', 'Gressner'], ['Siegfried', '', 'Matern'], ['Frank', '', 'Lammert']]",Nature Genetics,2005,"[u'http://www.nature.com/doifinder/10.1038/ng1599', u'http://dx.doi.org/10.1038/ng1599']",
10.1016/S0140-6736(96)07642-8,"Pol, S., Lamorthe, B., Thi, N., et. al, Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users, Journal of Hepatology, 1998",cited-by,10.1016/S0168-8278(98)80341-3,Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users,"[['Stanislas', '', 'Pol'], ['Barbara', '', 'Lamorthe'], ['Ngoc', 'Trinh', 'Thi'], ['Val\xc3\xa9rie', '', 'Thiers'], ['Fran\xc3\xa7oise', '', 'Carnot'], ['Herv\xc3\xa9', '', 'Zylberberg'], ['Pierre', '', 'Berthelot'], ['Christian', '', 'Br\xc3\xa9chot'], ['Bertrand', '', 'Nalpas']]",Journal of Hepatology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0168827898803413', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827898803413']",
10.1016/S0140-6736(96)07642-8,"Anstee, Q., Goldin, R., , Mouse models in non-alcoholic fatty liver disease and steatohepatitis research, International Journal of Experimental Pathology, 2006",cited-by,10.1111/j.0959-9673.2006.00465.x,Mouse models in non-alcoholic fatty liver disease and steatohepatitis research,"[['Quentin', 'M.', 'Anstee'], ['Robert', 'D.', 'Goldin']]",International Journal of Experimental Pathology,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.0959-9673.2006.00465.x'],
10.1016/S0140-6736(96)07642-8,"Gane, E., , The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients, Liver Transplantation, 2003",cited-by,10.1053/jlts.2003.50248,The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients,"[['Edward', '', 'Gane']]",Liver Transplantation,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1527646503808377', u'http://doi.wiley.com/10.1053/jlts.2003.50248']",
10.1016/S0140-6736(96)07642-8,"Boyer, N., Marcellin, P., , Pathogenesis, diagnosis and management of hepatitis C, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80419-5,"Pathogenesis, diagnosis and management of hepatitis C","[['Nathalie', '', 'Boyer'], ['Patrick', '', 'Marcellin']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800804195', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800804195']",
10.1016/S0140-6736(96)07642-8,"Lee, W., Dienstag, J., Lindsay, K., et. al, Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders, Controlled Clinical Trials, 2004",cited-by,10.1016/j.cct.2004.08.003,Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders,"[['William', 'M.', 'Lee'], ['Jules', 'L.', 'Dienstag'], ['Karen', 'L.', 'Lindsay'], ['Anna', 'S.', 'Lok'], ['Herbert', 'L.', 'Bonkovsky'], ['Mitchell', 'L.', 'Shiffman'], ['Gregory', 'T.', 'Everson'], ['Adrian', 'M. Di', 'Bisceglie'], ['Timothy', 'R.', 'Morgan'], ['Marc', 'G.', 'Ghany'], ['Chihiro', '', 'Morishima'], ['Elizabeth', 'C.', 'Wright'], ['James', 'E.', 'Everhart']]",Controlled Clinical Trials,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0197245604000728', u'http://linkinghub.elsevier.com/retrieve/pii/S0197245604000728']",
10.1016/S0140-6736(96)07642-8,"Leroy, V., Monier, F., Bottari, S., et. al, Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid, American Journal of Gastroenterology, 2004",cited-by,10.1111/j.1572-0241.2004.04055.x,"Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid","[['Vincent', '', 'Leroy'], ['Frederique', '', 'Monier'], ['Serge', '', 'Bottari'], ['Candice', '', 'Trocme'], ['Nathalie', '', 'Sturm'], ['Marie-No\xc3\xablle', '', 'Hilleret'], ['Francoise', '', 'Morel'], ['Jean-Pierre', '', 'Zarski']]",American Journal of Gastroenterology,2004,"[u'http://dx.doi.org/10.1111/j.1572-0241.2004.04055.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2004.04055.x']",
10.1016/S0140-6736(96)07642-8,"Peters, M., Terrault, N., , Alcohol use and hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36811,Alcohol use and hepatitis C,"[['Marion', 'G.', 'Peters'], ['Norah', 'A.', 'Terrault']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Alcohol%20Use%20And%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360728', u'http://doi.wiley.com/10.1053/jhep.2002.36811']",
10.1016/S0140-6736(96)07642-8,"Khan, M., Farrell, G., Byth, K., et. al, Which patients with hepatitis C develop liver complications?, Hepatology, 2000",cited-by,10.1002/hep.510310236,Which patients with hepatitis C develop liver complications?,"[['Mahbub', 'H.', 'Khan'], ['Geoffrey', 'C.', 'Farrell'], ['Karen', '', 'Byth'], ['Rita', '', 'Lin'], ['Martin', '', 'Weltman'], ['Jacob', '', 'George'], ['Dev', '', 'Samarasinghe'], ['James', '', 'Kench'], ['Songal', '', 'Kaba'], ['Evelyn', '', 'Crewe'], ['Chris', '', 'Liddle']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310236'],
10.1016/S0140-6736(96)07642-8,"Marcellin, P., , Hepatitis C: the clinical spectrum of the disease, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80368-7,Hepatitis C: the clinical spectrum of the disease,"[['Patrick', '', 'Marcellin']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803687', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803687']",
10.1016/S0140-6736(96)07642-8,"Sud, A., Hui, J., Farrell, G., et. al, Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index, Hepatology, 2004",cited-by,10.1002/hep.20207,Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index,"[['Archana', '', 'Sud'], ['Jason', 'M.', 'Hui'], ['Geoffrey', 'C.', 'Farrell'], ['Priyanka', '', 'Bandara'], ['James', 'G.', 'Kench'], ['Carolyn', '', 'Fung'], ['Rita', '', 'Lin'], ['Dev', '', 'Samarasinghe'], ['Christopher', '', 'Liddle'], ['Geoffrey', 'W.', 'McCaughan'], ['Jacob', '', 'George']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20207'],
10.1016/S0140-6736(96)07642-8,"Arizcorreta, A., Diaz, F., Roldan, R., , Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus, Clinical Infectious Diseases, 2003",cited-by,10.1086/367643,Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus,"[['Ana', '', 'Arizcorreta'], ['Fernando', '', 'Diaz'], ['Rafael', '', 'Roldan']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/367643'],
10.1016/S0140-6736(96)07642-8,"García-Samaniego, J., Rodríguez, M., Berenguer, J., et. al, Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.03374.x,Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C,"[['Javier', '', 'Garc\xc3\xada-Samaniego'], ['Manuel', '', 'Rodr\xc3\xadguez'], ['Juan', '', 'Berenguer'], ['Rafael', '', 'Rodr\xc3\xadguez-Rosado'], ['Jorge', '', 'Carb\xc3\xb3'], ['V\xc3\xadctor', '', 'Asensi'], ['Vicente', '', 'Soriano']]",American Journal of Gastroenterology,2001,"[u'http://dx.doi.org/10.1111/j.1572-0241.2001.03374.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.03374.x']",
10.1016/S0140-6736(96)07642-8,"Schuppan, D., Afdhal, N., , Liver cirrhosis, Lancet, 2008",cited-by,10.1016/S0140-6736(08)60383-9,Liver cirrhosis,"[['Detlef', '', 'Schuppan'], ['Nezam', 'H', 'Afdhal']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608603839', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608603839']",
10.1016/S0140-6736(96)07642-8,"Thomas, D., , Hepatitis C and human immunodeficiency virus infection, Hepatology, 2002",cited-by,10.1053/jhep.2002.36380,Hepatitis C and human immunodeficiency virus infection,"[['David', 'L.', 'Thomas']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Hepatitis%20C%20And%20Human%20Immunodeficiency%20Virus%20Infection.pdf', u'http://doi.wiley.com/10.1002/hep.1840360726', u'http://doi.wiley.com/10.1053/jhep.2002.36380']",
10.1016/S0140-6736(96)07642-8,"Thursz, M., Yallop, R., Goldin, R., et. al, Influence of MHC class II genotype on outcome of infection with hepatitis C virus, Lancet, 1999",cited-by,10.1016/S0140-6736(99)91443-5,Influence of MHC class II genotype on outcome of infection with hepatitis C virus,"[['Mark', '', 'Thursz'], ['Rhiannon', '', 'Yallop'], ['Robert', '', 'Goldin'], ['Christian', '', 'Trepo'], ['Howard', 'C', 'Thomas']]",Lancet,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699914435', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699914435']",
10.1016/S0140-6736(96)07642-8,"Fattovich, G., Pantalena, M., Zagni, I., et. al, Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients, American Journal of Gastroenterology, 2002",cited-by,10.1016/S0002-9270(02)05474-6,Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients,"[['Giovanna', '', 'Fattovich'], ['Maurizio', '', 'Pantalena'], ['Irene', '', 'Zagni'], ['Giuseppe', '', 'Realdi'], ['Solko', 'W', 'Schalm'], ['Erik', '', 'Christensen']]",American Journal of Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0002927002054746', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927002054746']",
10.1016/S0140-6736(96)07642-8,"Shiratori, Y., Shiina, S., Teratani, T., et. al, Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus, , 2003",cited-by,13621285Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus,Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus,"[['Yasushi', '', 'Shiratori'], ['Shuichiro', '', 'Shiina'], ['Takuma', '', 'Teratani'], ['Masatoshi', '', 'Imamura'], [""Shun'"", 'taro', 'Obi'], [""Shin'"", 'pei', 'Sato'], ['Yukihiro', '', 'Koike'], ['Haruhiko', '', 'Yoshida'], ['Masao', '', 'Omata']]",,2003,[u'http://www.annals.org/content/138/4/299.full.pdf'],
10.1016/S0140-6736(96)07642-8,"Ong, J., Younossi, Z., Speer, C., et. al, Chronic hepatitis C and superimposed nonalcoholic fatty liver disease, Liver International, 2001",cited-by,10.1034/j.1600-0676.2001.021004266.x,Chronic hepatitis C and superimposed nonalcoholic fatty liver disease,"[['Janus', 'P.', 'Ong'], ['Zobair', 'M.', 'Younossi'], ['Christian', '', 'Speer'], ['Arrel', '', 'Olano'], ['Terry', '', 'Gramlich'], ['Navdeep', '', 'Boparai']]",Liver International,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-0676.2001.021004266.x'],
10.1016/S0140-6736(96)07642-8,"Friedman, S., Bansal, M., , Reversal of hepatic fibrosis — Fact or fantasy?, Hepatology, 2006",cited-by,10.1002/hep.20974,Reversal of hepatic fibrosis — Fact or fantasy?,"[['Scott', 'L.', 'Friedman'], ['Meena', 'B.', 'Bansal']]",Hepatology,2006,"[u'http://doi.wiley.com/10.1002/hep.20974', u'http://www.hepatitistechnologies.com/images/reversal_of_hepatic_fibrosis.pdf']",
10.1016/S0140-6736(96)07642-8,"Spiegel, B., Younossi, Z., Hays, R., et. al, Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment, Hepatology, 2005",cited-by,10.1002/hep.20659,Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment,"[['Brennan', 'M. R.', 'Spiegel'], ['Zobair', 'M.', 'Younossi'], ['Ron', 'D.', 'Hays'], ['Dennis', '', 'Revicki'], ['Sean', '', 'Robbins'], ['Fasiha', '', 'Kanwal']]",Hepatology,2005,"[u'http://www.researchcore.org/publications/docs/spiegel_hepatology.pdf', u'http://doi.wiley.com/10.1002/hep.20659']",
10.1016/S0140-6736(96)07642-8,"Benhamou, Y., Puoti, M., Berenguer, J., et. al, Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study, Clinical Infectious Diseases, 2004",cited-by,10.1086/380130,Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus–Infected Patients with Chronic Hepatitis C: A European Collaborative Study,"[['Yves', '', 'Benhamou'], ['Massimo', '', 'Puoti'], ['Juan', '', 'Berenguer'], ['Jose', '', 'Mallolas'], ['Carmen', '', 'Quereda'], ['Ana', '', 'Arizcorreta'], ['Antonio', '', 'Gonzalez'], ['Jurgen', '', 'Rockstroh'], ['Victor', '', 'Asensi'], ['Pilar', '', 'Miralles'], ['Montse', '', 'Laguno'], ['Leonor', '', 'Moreno'], ['Jose', 'Antonio', 'Giron'], ['Martin', '', 'Vogel'], ['Marina', '', 'Nunez'], ['Miriam', '', 'Romero'], ['Santiago', '', 'Moreno'], ['Juan', 'Jose de la', 'Cruz'], ['Vincent', '', 'Soriano']]",Clinical Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/380130'],
10.1016/S0140-6736(96)07642-8,"Ortiz, V., Berenguer, M., Rayón, J., et. al, Contribution of obesity to hepatitis C-related fibrosis progression, American Journal of Gastroenterology, 2002",cited-by,10.1016/S0002-9270(02)04352-6,Contribution of obesity to hepatitis C-related fibrosis progression,"[['Vicente', '', 'Ortiz'], ['Marina', '', 'Berenguer'], ['Jos\xc3\xa9', 'M', 'Ray\xc3\xb3n'], ['Domingo', '', 'Carrasco'], ['Joaqu\xc4\xb1\xcc\x81n', '', 'Berenguer']]",American Journal of Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0002927002043526', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927002043526']",
10.1016/S0140-6736(96)07642-8,", Hepatitis C in African Americans: Summary of a Workshop, Gastroenterology, 2000",cited-by,10.1053/gast.2000.19582,Hepatitis C in African Americans: Summary of a Workshop,[],Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500697871', u'http://www.natap.org/2000/aasld/gastrent.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500697871']",
10.1016/S0140-6736(96)07642-8,"London, W., , Epidemiology and natural history of hepatocellular carcinoma, Best Practice & Research in Clinical Gastroenterology, 2005",cited-by,10.1016/j.bpg.2004.10.004,Epidemiology and natural history of hepatocellular carcinoma,"[['W.', 'Thomas', 'London']]",Best Practice & Research in Clinical Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1521691804001465', u'http://linkinghub.elsevier.com/retrieve/pii/S1521691804001465']",
10.1016/S0140-6736(96)07642-8,"Rockey, D., Bissell, D., , Noninvasive measures of liver fibrosis, Hepatology, 2006",cited-by,10.1002/hep.21046,Noninvasive measures of liver fibrosis,"[['Don', 'C.', 'Rockey'], ['D.', 'Montgomery', 'Bissell']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21046'],
10.1016/S0140-6736(96)07642-8,"Hézode, C., Roudot-Thoraval, F., Nguyen, S., et. al, Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20733,Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C,"[['Christophe', '', 'H\xc3\xa9zode'], ['Fran\xc3\xa7oise', '', 'Roudot-Thoraval'], ['Son', '', 'Nguyen'], ['Pascale', '', 'Grenard'], ['Boris', '', 'Julien'], ['Elie-Serge', '', 'Zafrani'], ['Jean-Michel', '', 'Pawlostky'], ['Daniel', '', 'Dhumeaux'], ['Sophie', '', 'Lotersztajn'], ['Ariane', '', 'Mallat']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20733'],
10.1016/S0140-6736(96)07642-8,"Thomas, D., Seeff, L., , Natural History of Hepatitis C, Clinics in Liver Disease, 2005",cited-by,10.1016/j.cld.2005.05.003,Natural History of Hepatitis C,"[['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Clinics in Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105000358', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105000358']",
10.1016/S0140-6736(96)07642-8,"McKiernan, S., Hagan, R., Curry, M., et. al, Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source, Hepatology, 2004",cited-by,10.1002/hep.20261,"Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source","[['Susan', 'M.', 'McKiernan'], ['Richard', '', 'Hagan'], ['Michael', '', 'Curry'], ['George', 'S. A.', 'McDonald'], ['Alan', '', 'Kelly'], ['Niamh', '', 'Nolan'], ['Anne', '', 'Walsh'], ['John', '', 'Hegarty'], ['Emer', '', 'Lawlor'], ['Dermot', '', 'Kelleher']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20261'],
10.1016/S0140-6736(96)07642-8,"Booth, J., OGrady, J., Neuberger, J., , Clinical guidelines on the management of hepatitis C, Gut, 2001",cited-by,10.1136/gut.49.suppl_1.I1,Clinical guidelines on the management of hepatitis C,"[['J', 'C L', 'Booth'], ['J', '', 'OGrady'], ['J', '', 'Neuberger']]",Gut,2001,"[u'http://gut.bmj.com/cgi/doi/10.1136/gut.49.suppl_1.I1', u'http://dx.doi.org/']",
10.1016/S0140-6736(96)07642-8,"Bonacini, M., Govindarajan, S., Blatt, L., et. al, Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA, Journal of Viral Hepatitis, 1999",cited-by,10.1046/j.1365-2893.1999.00153.x,Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA,"[['M.', '', 'Bonacini'], ['S.', '', 'Govindarajan'], ['L.', 'M.', 'Blatt'], ['P.', '', 'Schmid'], ['A.', '', 'Conrad'], ['K.', 'L.', 'Lindsay']]",Journal of Viral Hepatitis,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.1999.00153.x'],
10.1016/S0140-6736(96)07642-8,"Jain, S., Pemberton, P., Smith, A., et. al, Oxidative stress in chronic hepatitis C: not just a feature of late stage disease, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00060-0,Oxidative stress in chronic hepatitis C: not just a feature of late stage disease,"[['Sanjiv', 'K.', 'Jain'], ['Philip', 'W.', 'Pemberton'], ['Alexander', '', 'Smith'], ['Raymond', 'F. T.', 'McMahon'], ['Peter', 'C.', 'Burrows'], ['Ali', '', 'Aboutwerat'], ['Thomas', 'W.', 'Warnes']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802000600', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802000600']",
10.1016/S0140-6736(96)07642-8,"Monto, A., Patel, K., Bostrom, A., et. al, Risks of a range of alcohol intake on hepatitis C-related fibrosis, Hepatology, 2004",cited-by,10.1002/hep.20127,Risks of a range of alcohol intake on hepatitis C-related fibrosis,"[['Alexander', '', 'Monto'], ['Keyur', '', 'Patel'], ['Alan', '', 'Bostrom'], ['Stephen', '', 'Pianko'], ['Paul', '', 'Pockros'], ['John', 'G.', 'McHutchison'], ['Teresa', 'L.', 'Wright']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo00012.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/hepcinfo00012.pdf', u'http://doi.wiley.com/10.1002/hep.20127']",
10.1016/S0140-6736(96)07642-8,"Poynard, T., Halfon, P., Castera, L., et. al, Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages, , 2007",cited-by,5248309Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages,Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages,"[['Thierry', '', 'Poynard'], ['Philippe', '', 'Halfon'], ['Laurent', '', 'Castera'], ['Mona', '', 'Munteanu'], ['Francoise', '', 'Imbert-Bismut'], ['Vlad', '', 'Ratziu'], ['Yves', '', 'Benhamou'], ['Marc', '', 'Bourliere']]",,2007,"[u'http://www.clinchem.org/cgi/reprint/53/9/1615.pdf', u'http://www.clinchem.org/cgi/reprint/clinchem.2007.085795v1.pdf']",
10.1016/S0140-6736(96)07642-8,"Wiley, T., Brown, J., Chan, J., , Hepatitis C infection in African Americans: its natural history and histological progression, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05555.x,Hepatitis C infection in African Americans: its natural history and histological progression,"[['Thelma', 'E.', 'Wiley'], ['Jennifer', '', 'Brown'], ['Juliana', '', 'Chan']]",American Journal of Gastroenterology,2002,"[u'http://dx.doi.org/10.1111/j.1572-0241.2002.05555.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05555.x']",
10.1016/S0140-6736(96)07642-8,"Poynard, T., Cacoub, P., Ratziu, V., et. al, Fatigue in patients with chronic hepatitis C, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00364.x,Fatigue in patients with chronic hepatitis C,"[['T.', '', 'Poynard'], ['P.', '', 'Cacoub'], ['V.', '', 'Ratziu'], ['R.', 'P.', 'Myers'], ['M.', 'H.', 'Dezailles'], ['A.', '', 'Mercadier'], ['P.', '', 'Ghillani'], ['F.', '', 'Charlotte'], ['J.', 'C.', 'Piette'], ['J.', '', 'Moussalli']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00364.x'],
10.1016/S0140-6736(96)07642-8,"Huang, H., Shiffman, M., Friedman, S., et. al, A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C, Hepatology, 2007",cited-by,10.1002/hep.21695,A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C,"[['Hongjin', '', 'Huang'], ['Mitchell', 'L.', 'Shiffman'], ['Scott', '', 'Friedman'], ['Ramasubbu', '', 'Venkatesh'], ['Natalie', '', 'Bzowej'], ['Olivia', 'T.', 'Abar'], ['Charles', 'M.', 'Rowland'], ['Joseph', 'J.', 'Catanese'], ['Diane', 'U.', 'Leong'], ['John', 'J.', 'Sninsky'], ['Thomas', 'J.', 'Layden'], ['Teresa', 'L.', 'Wright'], ['Thomas', '', 'White'], ['Ramsey', 'C.', 'Cheung']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21695'],
10.1016/S0140-6736(96)07642-8,"Pol, S., Fontaine, H., Carnot, F., et. al, Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients, Journal of Hepatology, 1998",cited-by,10.1016/S0168-8278(98)80173-6,Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients,"[['Stanislas', '', 'Pol'], ['H\xc3\xa9l\xc3\xa8ne', '', 'Fontaine'], ['Fran\xc3\xa7oise', '', 'Carnot'], ['Herv\xc3\xa9', '', 'Zylberberg'], ['Pierre', '', 'Berthelot'], ['Christian', '', 'Br\xc3\xa9chot'], ['Bertrand', '', 'Nalpas']]",Journal of Hepatology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0168827898801736', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827898801736']",
10.1016/S0140-6736(96)07642-8,"Bissell, D., , Chronic liver injury, TGF-β, and cancer, , 2001",cited-by,"5066725Chronic liver injury, TGF-β, and cancer","Chronic liver injury, TGF-β, and cancer","[['D.', 'Montgomery', 'Bissell']]",,2001,"[u'http://www.e-emm.or.kr/article/article_files/emm33-4-1.pdf', u'http://www.e-emm.org/article/article_files/emm33-4-1.pdf']",
10.1016/S0140-6736(96)07642-8,"SHIFFMAN, M., HOFMANN, C., CONTOS, M., et. al, A Randomized, Controlled Trial of Maintenance Interferon Therapy for Patients With Chronic Hepatitis C Virus and Persistent Viremia, , 0",cited-by,"10188699A Randomized, Controlled Trial of Maintenance Interferon Therapy for Patients With Chronic Hepatitis C Virus and Persistent Viremia","A Randomized, Controlled Trial of Maintenance Interferon Therapy for Patients With Chronic Hepatitis C Virus and Persistent Viremia","[['MITCHELL', 'L.', 'SHIFFMAN'], ['CHARLOTTE', 'M.', 'HOFMANN'], ['MELISSA', 'J.', 'CONTOS'], ['VELIMIR', 'A.', 'LUKETIC'], ['ARUN', 'J.', 'SANYAL'], ['RICHARD', 'K.', 'STERLING'], ['ANDREA', '', 'FERREIRA-GONZALEZ'], ['A.', 'SCOTT', 'MILLS'], ['CARLTON', '', 'GARRET']]",,0,[u'http://www.unc.edu/~cassara/documents/articles/maintenance%20interferon.pdf'],
10.1016/S0140-6736(96)07642-8,"Westin, J., Lagging, L., Spak, F., et. al, Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00356.x,Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection,"[['J.', '', 'Westin'], ['L.', 'M.', 'Lagging'], ['F.', '', 'Spak'], ['N.', '', 'Aires'], ['E.', '', 'Svensson'], ['M.', '', 'Lindh'], ['A.', 'P.', 'Dhillon'], ['G.', '', 'Norkrans'], ['R.', '', 'Wejstal']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00356.x'],
10.1016/S0140-6736(96)07642-8,"Barrett, S., Goh, J., Coughlan, B., et. al, The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection, Gut, 2001",cited-by,10.1136/gut.49.3.423,The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection,"[['S', '', 'Barrett'], ['J', '', 'Goh'], ['B', '', 'Coughlan'], ['E', '', 'Ryan'], ['S', '', 'Stewart'], ['A', '', 'Cockram'], ['J', 'C', 'OKeane'], ['J', '', 'Crowe']]",Gut,2001,"[u'http://gut.bmj.com/cgi/doi/10.1136/gut.49.3.423', u'http://dx.doi.org/']",
10.1016/S0140-6736(96)07642-8,"Poynard, T., Zoulim, F., Ratziu, V., et. al, Longitudinal Assessment of Histology Surrogate Markers (FibroTest–ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection, American Journal of Gastroenterology, 2005",cited-by,10.1111/j.1572-0241.2005.41957.x,Longitudinal Assessment of Histology Surrogate Markers (FibroTest–ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection,"[['Thierry', '', 'Poynard'], ['Fabien', '', 'Zoulim'], ['Vlad', '', 'Ratziu'], ['Fran\xc3\xa7oise', '', 'Degos'], ['Francoise', '', 'Imbert-Bismut'], ['Paul', '', 'Deny'], ['Paul', '', 'Landais'], ['Abdelkader', 'El', 'Hasnaoui'], ['Alain', '', 'Slama'], ['Patrick', '', 'Blin'], ['Vincent', '', 'Thibault'], ['Parviz', '', 'Parvaz'], ['Mona', '', 'Munteanu'], ['Christian', '', 'Trepo']]",American Journal of Gastroenterology,2005,"[u'http://dx.doi.org/10.1111/j.1572-0241.2005.41957.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2005.41957.x']",
10.1016/S0140-6736(96)07642-8,"Salomon, J., Weinstein, M., Hammitt, J., et. al, Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population, , 2003",cited-by,6310042Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population,Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population,"[['Joshua', 'A.', 'Salomon'], ['Milton', 'C.', 'Weinstein'], ['James', 'K.', 'Hammitt'], ['Sue', 'J.', 'Goldie']]",,2003,[u'http://www.hsph.harvard.edu/faculty/joshua-salomon/files/Salomon_CostEffectivenessHCVTx_JAMA2003.pdf'],
10.1016/S0140-6736(96)07642-8,"Jara, P., Resti, M., Hierro, L., et. al, Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children, Clinical Infectious Diseases, 2003",cited-by,10.1086/345908,Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children,"[['Paloma', '', 'Jara'], ['Massimo', '', 'Resti'], ['Loreto', '', 'Hierro'], ['Raffaella', '', 'Giacchino'], ['Cristiana', '', 'Barbera'], ['Lucia', '', 'Zancan'], ['Carlo', '', 'Crivellaro'], ['Etienne', '', 'Sokal'], ['Chiara', '', 'Azzari'], ['Maria', '', 'Guido'], ['Flavia', '', 'Bortolotti']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/345908'],
10.1016/S0140-6736(96)07642-8,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1016/S0140-6736(96)07642-8,"Verma, S., Govindarajan, S., Kanel, G., et. al, Do Type and Duration of Antiretroviral Therapy Attenuate Liver Fibrosis in HIV–Hepatitis C Virus–Coinfected Patients?, Clinical Infectious Diseases, 2006",cited-by,10.1086/499055,Do Type and Duration of Antiretroviral Therapy Attenuate Liver Fibrosis in HIV–Hepatitis C Virus–Coinfected Patients?,"[['Sumita', '', 'Verma'], ['Sugantha', '', 'Govindarajan'], ['Gary', '', 'Kanel'], ['Kathleen', '', 'Squires'], ['Maurizio', '', 'Bonacini']]",Clinical Infectious Diseases,2006,"[u'https://www.idsociety.org/assets/0/18/312/924/CED927E5-74BB-4C48-A977-3D734FDD01C6.pdf', u'http://www.hivma.org/assets/0/18/312/924/CED927E5-74BB-4C48-A977-3D734FDD01C6.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/499055']",
10.1016/S0140-6736(96)07642-8,"Ortiz, V., Berenguer, M., Rayón, J., et. al, Contribution of obesity to hepatitis C-related fibrosis progression, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05995.x,Contribution of obesity to hepatitis C-related fibrosis progression,"[['Vicente', '', 'Ortiz'], ['Marina', '', 'Berenguer'], ['Jos\xc3\xa9', 'M', 'Ray\xc3\xb3n'], ['Domingo', '', 'Carrasco'], ['Joaqu\xc3\xadn', '', 'Berenguer']]",American Journal of Gastroenterology,2002,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05995.x', u'http://dx.doi.org/10.1111/j.1572-0241.2002.05995.x']",
10.1016/S0140-6736(96)07642-8,"Murakami, C., McDonald, G., Strasser, S., et. al, Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors, , 2010",cited-by,14245661Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors,Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors,"[['Carol', 'S.', 'Murakami'], ['George', 'B.', 'McDonald'], ['Simone', 'I.', 'Strasser'], ['Keith', 'M.', 'Sullivan'], ['David', '', 'Myerson'], ['Catherine', 'L.', 'Spurgeon'], ['Barry', '', 'Storer'], ['H.', '', 'Gary']]",,2010,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/93/10/3259.pdf'],
10.1016/S0140-6736(96)07642-8,"Goedert, J., Eyster, M., Lederman, M., et. al, End-stage liver disease in persons with hemophilia and transfusion-associated infections, , 2002",cited-by,6993724End-stage liver disease in persons with hemophilia and transfusion-associated infections,End-stage liver disease in persons with hemophilia and transfusion-associated infections,"[['James', 'J.', 'Goedert'], ['M.', 'Elaine', 'Eyster'], ['Michael', 'M.', 'Lederman'], ['Titica', '', 'Mandalaki'], ['Philippe', 'de', 'Moerloose'], ['Gilbert', 'C.', 'White'], ['Anne', 'L.', 'Angiolillo'], ['Naomi', 'L. C.', 'Luban'], ['Kenneth', 'E.', 'Sherman'], ['Marilyn', '', 'Manco-Johnson'], ['Liliana', '', 'Preiss'], ['Cindy', '', 'Leissinger'], ['Craig', 'M.', 'Kessler'], ['Alan', 'R.', 'Cohen'], ['Donna', '', 'DiMichele'], ['Margaret', 'W.', 'Hilgartner'], ['Louis', 'M.', 'Aledort'], ['Barbara', 'L.', 'Kroner'], ['Philip', 'S.', 'Rosenberg'], ['Angelos', '', 'Hatzakis']]",,2002,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/100/5/1584.pdf'],
10.1016/S0140-6736(96)07642-8,"Gewaltig, J., Mangasser-Stephan, K., Gartung, C., et. al, Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis, Clinica Chimica Acta, 2002",cited-by,10.1016/S0009-8981(01)00738-0,Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis,"[['Jan', '', 'Gewaltig'], ['Kerstin', '', 'Mangasser-Stephan'], ['Carsten', '', 'Gartung'], ['Stefan', '', 'Biesterfeld'], ['Axel', 'M', 'Gressner']]",Clinica Chimica Acta,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0009898101007380', u'http://linkinghub.elsevier.com/retrieve/pii/S0009898101007380']",
10.1016/S0140-6736(96)07642-8,"Spaulding, A., Greene, C., Davidson, K., et. al, Hepatitis C in State Correctional Facilities, Preventive Medicine, 1999",cited-by,10.1006/pmed.1998.0418,Hepatitis C in State Correctional Facilities,"[['Anne', '', 'Spaulding'], ['Carolyn', '', 'Greene'], ['Kerith', '', 'Davidson'], ['Michelle', '', 'Schneidermann'], ['Josiah', '', 'Rich']]",Preventive Medicine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0091743598904182', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743598904182']",
10.1016/S0140-6736(96)07642-8,"Amin, J., Law, M., Bartlett, M., et. al, Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study, Lancet, 2006",cited-by,10.1016/S0140-6736(06)69374-4,Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study,"[['Janaki', '', 'Amin'], ['Matthew', 'G', 'Law'], ['Mark', '', 'Bartlett'], ['John', 'M', 'Kaldor'], ['Gregory', 'J', 'Dore']]",Lancet,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0140673606693744', u'http://www.hep.org.au/documents/2006CauseOfDeath.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673606693744']",
10.1016/S0140-6736(96)07642-8,"Anderson, K., Guest, J., Rimland, D., , Hepatitis C Virus Coinfection Increases Mortality in HIV‐Infected Patients in the Highly Active Antiretroviral Therapy Era: Data from the HIV Atlanta VA Cohort Study, Clinical Infectious Diseases, 2004",cited-by,10.1086/425360,Hepatitis C Virus Coinfection Increases Mortality in HIV‐Infected Patients in the Highly Active Antiretroviral Therapy Era: Data from the HIV Atlanta VA Cohort Study,"[['Katie', 'B.', 'Anderson'], ['Jodie', 'L.', 'Guest'], ['David', '', 'Rimland']]",Clinical Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/425360'],
10.1016/S0140-6736(96)07642-8,"Bedossa, P., Paradis, V., , Liver extracellular matrix in health and disease, Journal of Pathology, 2003",cited-by,10.1002/path.1397,Liver extracellular matrix in health and disease,"[['Pierre', '', 'Bedossa'], ['Val\xc3\xa9rie', '', 'Paradis']]",Journal of Pathology,2003,[u'http://doi.wiley.com/10.1002/path.1397'],
10.1056~NEJMoa011232,"Delwaide J, Bourgeois N, Gerard C, Wain E, Vaira D, Belaiche J. Treatment of acute hepatitis C with interferon a-2b prevents chronicity. Hepatology 1999;30:Suppl:264A. abstract.",references,NOT found in MAS
10.1056~NEJMoa011232,Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 1999;340:1228-33.,references,10.1056/NEJM199904223401602,Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin,"[[u'Elizabeth', u'', u'Kenny-Walsh']]",New England Journal of Medicine,1999,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199904223401602'],"[{u'Name': u'Clinical Outcome', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5965}, {u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}]"
10.1056/NEJM199904223401602,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
10.1056/NEJM199904223401602,"Forman, L., Lewis, J., Berlin, J., et. al, The association between hepatitis C infection and survival after orthotopic liver transplantation, Gastroenterology, 2002",cited-by,10.1053/gast.2002.32418,The association between hepatitis C infection and survival after orthotopic liver transplantation,"[['Lisa', 'M.', 'Forman'], ['James', 'D.', 'Lewis'], ['Jesse', 'A.', 'Berlin'], ['Harold', 'I.', 'Feldman'], ['Michael', 'R.', 'Lucey']]",Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0016508502603853', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508502603853']",
10.1056/NEJM199904223401602,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1056/NEJM199904223401602,"Poynard, T., Ratziu, V., Charlotte, F., et. al, Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(00)00097-0,Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C,"[['Thierry', '', 'Poynard'], ['Vlad', '', 'Ratziu'], ['Fr\xc3\xa9d\xc3\xa9ric', '', 'Charlotte'], ['Zachary', '', 'Goodman'], ['John', '', 'McHutchison'], ['Janice', '', 'Albrecht']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800000970', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800000970']",
10.1056/NEJM199904223401602,"Okuda, K., , Hepatocellular carcinoma, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80428-6,Hepatocellular carcinoma,"[['Kunio', '', 'Okuda']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800804286', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800804286']",
10.1056/NEJM199904223401602,"Liang, T., Rehermann, B., Seeff, L., et. al, Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C, , 2000",cited-by,"6738512Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","[['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann'], ['Leonard', 'B.', 'Seeff'], ['Jay', 'H.', 'Hoofnagle']]",,2000,[u'http://www.annals.org/content/132/4/296.full.pdf'],
10.1056/NEJM199904223401602,"Ghany, M., Strader, D., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009",cited-by,10.1002/hep.22759,"Diagnosis, management, and treatment of hepatitis C: An update","[['Marc', 'G.', 'Ghany'], ['Doris', 'B.', 'Strader'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2009,"[u'http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/diagnosis_of_hep_c_update.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Hepatitis%20C%20UPDATE.pdf', u'http://www.sklid.com/news/uploadfiles/20094122357635.pdf', u'http://www.coloradoguidelines.org/pdf/hepatitisbc/Diagnosis_of_HEP_C_Update_Aug%20_09.pdf', u'http://www.paml.com/Files/Miscellaneous/Hep%20C%20Diagnosis,Manage,Treatment%20Apr%202009.pdf', u'http://doi.wiley.com/10.1002/hep.22759', u'http://zuberi.biz/guidelines/AASLD_HEP_C_2009.pdf']",
10.1056/NEJM199904223401602,"Freeman, A., Dore, G., Law, M., et. al, Estimating progression to cirrhosis in chronic hepatitis C virus infection, Hepatology, 2001",cited-by,10.1053/jhep.2001.27831,Estimating progression to cirrhosis in chronic hepatitis C virus infection,"[['Anthony', 'J.', 'Freeman'], ['Gregory', 'J.', 'Dore'], ['Matthew', 'G.', 'Law'], ['Max', '', 'Thorpe'], ['Jan', 'Von', 'Overbeck'], ['Andrew', 'R.', 'Lloyd'], ['George', '', 'Marinos'], ['John', 'M.', 'Kaldor']]",Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270913901810934', u'http://www.sciencedirect.com/science/article/pii/S0270913901333190', u'http://doi.wiley.com/10.1053/jhep.2001.27831']",
10.1056/NEJM199904223401602,"Thomas, D., Thio, C., Martin, M., et. al, Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, 2009",cited-by,10.1038/nature08463,Genetic variation in IL28B and spontaneous clearance of hepatitis C virus,"[['David', 'L.', 'Thomas'], ['Chloe', 'L.', 'Thio'], ['Maureen', 'P.', 'Martin'], ['Ying', '', 'Qi'], ['Dongliang', '', 'Ge'], ['Colm', '', ""O'Huigin""], ['Judith', '', 'Kidd'], ['Kenneth', '', 'Kidd'], ['Salim', 'I.', 'Khakoo'], ['Graeme', '', 'Alexander'], ['James', 'J.', 'Goedert'], ['Gregory', 'D.', 'Kirk'], ['Sharyne', 'M.', 'Donfield'], ['Hugo', 'R.', 'Rosen'], ['Leslie', 'H.', 'Tobler'], ['Michael', 'P.', 'Busch'], ['John', 'G.', 'McHutchison'], ['David', 'B.', 'Goldstein'], ['Mary', '', 'Carrington']]",Nature,2009,"[u'http://cmbi.bjmu.edu.cn/news/report/2009/pdf/med09_08_4.pdf', u'http://info.med.yale.edu/genetics/kkidd/488.pdf', u'http://adsabs.harvard.edu/abs/2009Natur.461..798T', u'http://dx.doi.org/10.1038/nature08463', u'http://www.nature.com/doifinder/10.1038/nature08463']",
10.1056/NEJM199904223401602,"Marcellin, P., Asselah, T., Boyer, N., , Fibrosis and disease progression in hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36993,Fibrosis and disease progression in hepatitis C,"[['Patrick', '', 'Marcellin'], ['Tarik', '', 'Asselah'], ['Nathalie', '', 'Boyer']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Fibrosis%20And%20Disease%20Progression%20In%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360707', u'http://doi.wiley.com/10.1053/jhep.2002.36993']",
10.1056/NEJM199904223401602,"Sulkowski, M., Thomas, D., , Hepatitis C in the HIV-Infected Person, , 2003",cited-by,5168375Hepatitis C in the HIV-Infected Person,Hepatitis C in the HIV-Infected Person,"[['Mark', 'S.', 'Sulkowski'], ['David', 'L.', 'Thomas']]",,2003,[u'http://www.annals.org/content/138/3/197.full.pdf'],
10.1056/NEJM199904223401602,"Dienstag, J., , The role of liver biopsy in chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36381,The role of liver biopsy in chronic hepatitis C,"[['Jules', 'L.', 'Dienstag']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Role%20Of%20Liver%20Biopsy%20In%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36381', u'http://doi.wiley.com/10.1002/hep.1840360720']",
10.1056/NEJM199904223401602,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1056/NEJM199904223401602,"Khan, M., Farrell, G., Byth, K., et. al, Which patients with hepatitis C develop liver complications?, Hepatology, 2000",cited-by,10.1002/hep.510310236,Which patients with hepatitis C develop liver complications?,"[['Mahbub', 'H.', 'Khan'], ['Geoffrey', 'C.', 'Farrell'], ['Karen', '', 'Byth'], ['Rita', '', 'Lin'], ['Martin', '', 'Weltman'], ['Jacob', '', 'George'], ['Dev', '', 'Samarasinghe'], ['James', '', 'Kench'], ['Songal', '', 'Kaba'], ['Evelyn', '', 'Crewe'], ['Chris', '', 'Liddle']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310236'],
10.1056/NEJM199904223401602,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1056/NEJM199904223401602,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1056/NEJM199904223401602,"McKiernan, S., Hagan, R., Curry, M., et. al, Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source, Hepatology, 2004",cited-by,10.1002/hep.20261,"Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source","[['Susan', 'M.', 'McKiernan'], ['Richard', '', 'Hagan'], ['Michael', '', 'Curry'], ['George', 'S. A.', 'McDonald'], ['Alan', '', 'Kelly'], ['Niamh', '', 'Nolan'], ['Anne', '', 'Walsh'], ['John', '', 'Hegarty'], ['Emer', '', 'Lawlor'], ['Dermot', '', 'Kelleher']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20261'],
10.1056/NEJM199904223401602,"Thio, C., Gao, X., Goedert, J., et. al, HLA-Cw*04 and Hepatitis C Virus Persistence, Journal of Virology, 2002",cited-by,10.1128/JVI.76.10.4792-4797.2002,HLA-Cw*04 and Hepatitis C Virus Persistence,"[['Chloe', 'L.', 'Thio'], ['Xiaojiang', '', 'Gao'], ['James', 'J.', 'Goedert'], ['David', '', 'Vlahov'], ['Kenrad', 'E.', 'Nelson'], ['Margaret', 'W.', 'Hilgartner'], ['Stephen', 'J.', ""O'Brien""], ['Peter', '', 'Karacki'], ['Jacquie', '', 'Astemborski'], ['Mary', '', 'Carrington'], ['David', 'L.', 'Thomas'], ['Presbyterian', '', 'Hospital-Cornell']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/10/4792.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.10.4792-4797.2002']",
10.1056/NEJM199904223401602,"Simmonds, P., , The origin and evolution of hepatitis viruses in humans, , 0",cited-by,12032682The origin and evolution of hepatitis viruses in humans,The origin and evolution of hepatitis viruses in humans,"[['Peter', '', 'Simmonds']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/82/4/693.pdf'],
10.1056/NEJM199904223401602,"Barrett, S., Goh, J., Coughlan, B., et. al, The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection, Gut, 2001",cited-by,10.1136/gut.49.3.423,The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection,"[['S', '', 'Barrett'], ['J', '', 'Goh'], ['B', '', 'Coughlan'], ['E', '', 'Ryan'], ['S', '', 'Stewart'], ['A', '', 'Cockram'], ['J', 'C', 'OKeane'], ['J', '', 'Crowe']]",Gut,2001,"[u'http://gut.bmj.com/cgi/doi/10.1136/gut.49.3.423', u'http://dx.doi.org/']",
10.1056/NEJM199904223401602,"Casiraghi, M., Paschale, M., Biffi, R., et. al, Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth, Hepatology, 2004",cited-by,10.1002/hep.20030,Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth,"[['Maria', 'Antonietta', 'Casiraghi'], ['Massimo', 'De', 'Paschale'], ['Renato', '', 'Biffi'], ['Agnese', '', 'Assi'], ['Giorgio', '', 'Binelli'], ['Alessandro', 'Remo', 'Zanetti']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo416.pdf', u'http://doi.wiley.com/10.1002/hep.20030']",
10.1056/NEJM199904223401602,"Ray, S., Fanning, L., Wang, X., et. al, Divergent and convergent evolution after a common-source outbreak of hepatitis C virus, , 2005",cited-by,6782247Divergent and convergent evolution after a common-source outbreak of hepatitis C virus,Divergent and convergent evolution after a common-source outbreak of hepatitis C virus,"[['Stuart', 'C.', 'Ray'], ['Liam', '', 'Fanning'], ['Xiao-Hong', '', 'Wang'], ['Dale', 'M.', 'Netski'], ['Elizabeth', '', 'Kenny-Walsh'], ['David', 'L.', 'Thomas']]",,2005,[],
10.1056/NEJM199904223401602,"Meyers, C., Seeff, L., Stehman-Breen, C., et. al, Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00828-X,"Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD","[['Catherine', 'M.', 'Meyers'], ['Leonard', 'B.', 'Seeff'], ['Catherine', 'O.', 'Stehman-Breen'], ['Jay', 'H.', 'Hoofnagle']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S027263860300828X', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as027263860300828x', u'http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/Hep C and GN AJKD 05.pdf']",
10.1056/NEJM199904223401602,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1056/NEJM199904223401602,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1056/NEJM199904223401602,"Freeman, A., Law, M., Kaldor, J., et. al, Predicting progression to cirrhosis in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00436.x,Predicting progression to cirrhosis in chronic hepatitis C virus infection,"[['A.', 'J.', 'Freeman'], ['M.', 'G.', 'Law'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00436.x'],
10.1056/NEJM199904223401602,"Benson, C., Kaplan, J., Masur, H., et. al, Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America, Clinical Infectious Diseases, 2005",cited-by,10.1086/427906,"Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America","[['Constance', 'A.', 'Benson'], ['Jonathan', 'E.', 'Kaplan'], ['Henry', '', 'Masur'], ['Alice', '', 'Pau'], ['King', 'K.', 'Holmes']]",Clinical Infectious Diseases,2005,"[u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA.pdf', u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA000875.pdf', u'http://medicine.georgetown.edu/residency/idarticles/hivopportunistic.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427906']",
10.1056/NEJM199904223401602,"Yee, L., , Host genetic determinants in hepatitis C virus infection, Genes and Immunity, 2004",cited-by,10.1038/sj.gene.6364090,Host genetic determinants in hepatitis C virus infection,"[['L', 'J', 'Yee']]",Genes and Immunity,2004,"[u'http://dx.doi.org/10.1038/sj.gene.6364090', u'http://www.nature.com/doifinder/10.1038/sj.gene.6364090']",
10.1056/NEJM199904223401602,"Gilleece, Y., Browne, R., Asboe, D., et. al, Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24Week Course of Pegylated Interferon and Ribavirin, Jaids-journal of Acquired Immune Deficiency Syndromes, 2005",cited-by,10.1097/01.qai.0000174930.64145.a9,Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24Week Course of Pegylated Interferon and Ribavirin,"[['Yvonne', 'C', 'Gilleece'], ['Rita', 'E', 'Browne'], ['David', '', 'Asboe'], ['Mark', '', 'Atkins'], ['Sundhiya', '', 'Mandalia'], ['Mark', '', 'Bower'], ['Brian', 'G', 'Gazzard'], ['Mark', 'R', 'Nelson']]",Jaids-journal of Acquired Immune Deficiency Syndromes,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00126334-200509010-00007'],
10.1056/NEJM199904223401602,"Forton, D., Taylor-Robinson, S., Thomas, H., , Cerebral dysfunction in chronic hepatitis C infection, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00416.x,Cerebral dysfunction in chronic hepatitis C infection,"[['D.', 'M.', 'Forton'], ['S.', 'D.', 'Taylor-Robinson'], ['H.', 'C.', 'Thomas']]",Journal of Viral Hepatitis,2003,"[u'http://borderline.gotdns.org/jvh_416.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00416.x']",
10.1056/NEJM199904223401602,"Wright, M., Goldin, R., Hellier, S., et. al, Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection, Gut, 2003",cited-by,10.1136/gut.52.8.1206,Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection,"[['M', '', 'Wright'], ['R', '', 'Goldin'], ['S', '', 'Hellier'], ['S', '', 'Knapp'], ['A', '', 'Frodsham'], ['B', '', 'Hennig'], ['A', '', 'Hill'], ['R', '', 'Apple'], ['S', '', 'Cheng'], ['H', '', 'Thomas'], ['M', '', 'Thursz']]",Gut,2003,"[u'http://www.well.ox.ac.uk/hill/docs/HCV-FactorVligand_Wright2003.pdf', u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.52.8.1206']",
10.1056/NEJM199904223401602,"Anthony, P., , Hepatocellular carcinoma: an overview, Histopathology, 2001",cited-by,10.1046/j.1365-2559.2001.01188.x,Hepatocellular carcinoma: an overview,"[['P', 'P', 'Anthony']]",Histopathology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2559.2001.01188.x'],
10.1056/NEJM199904223401602,"Pearlman, B., , Hepatitis C treatment update, American Journal of Medicine, 2004",cited-by,10.1016/j.amjmed.2004.03.024,Hepatitis C treatment update,"[['Brian', 'L.', 'Pearlman']]",American Journal of Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304003407', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304003407']",
10.1056/NEJM199904223401602,"Golden, J., O'Dwyer, A., Conroy, R., , Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors, General Hospital Psychiatry, 2005",cited-by,10.1016/j.genhosppsych.2005.06.006,"Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors","[['Jeannette', '', 'Golden'], ['Anne', 'Marie', ""O'Dwyer""], ['Ron\xc3\xa1n', 'M.', 'Conroy']]",General Hospital Psychiatry,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0163834305001076', u'http://www.oatc.ca/research/depression.and.anxiety.in.patients.with.hep.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0163834305001076']",
10.1056/NEJM199904223401602,"Wiese, M., Grüngreiff, K., Güthoff, W., et. al, Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.04.007,Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study,"[['Manfred', '', 'Wiese'], ['Kurt', '', 'Gr\xc3\xbcngreiff'], ['Wolfgang', '', 'G\xc3\xbcthoff'], ['Michael', '', 'Lafrenz'], ['Ute', '', 'Oesen'], ['Heiner', '', 'Porst']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S016882780500317X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780500317X']",
10.1056/NEJM199904223401602,"Poynard, T., Ratziu, V., Benhamou, Y., et. al, Natural history of HCV infection, Best Practice & Research in Clinical Gastroenterology, 2000",cited-by,10.1053/bega.1999.0071,Natural history of HCV infection,"[['Thierry', '', 'Poynard'], ['Vlad', '', 'Ratziu'], ['Yves', '', 'Benhamou'], ['Pierre', '', 'Opolon'], ['Patrice', '', 'Cacoub'], ['Pierre', '', 'Bedossa']]",Best Practice & Research in Clinical Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1521691899900719', u'http://linkinghub.elsevier.com/retrieve/doi/10.1053/bega.1999.0071']",
10.1056/NEJM199904223401602,"Wong, J., Koff, R., , Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C A Cost-Effectiveness Analysis, , 0",cited-by,11847113Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C A Cost-Effectiveness Analysis,Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C A Cost-Effectiveness Analysis,"[['John', 'B.', 'Wong'], ['Raymond', 'S.', 'Koff']]",,0,[u'http://www.annals.org/cgi/reprint/133/9/665.pdf'],
10.1056/NEJM199904223401602,"Dore, G., Freeman, A., Law, M., et. al, Is severe liver disease a common outcome for people with chronic hepatitisC?, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02730.x,Is severe liver disease a common outcome for people with chronic hepatitisC?,"[['Gregory', 'J', 'Dore'], ['Anthony', 'J', 'Freeman'], ['Matthew', '', 'Law'], ['JohnM', '', 'Kaldor']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02730.x'],
10.1056/NEJM199904223401602,"Thein, H., Yi, Q., Dore, G., et. al, Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression, Hepatology, 2008",cited-by,10.1002/hep.22375,Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression,"[['Hla-Hla', '', 'Thein'], ['Qilong', '', 'Yi'], ['Gregory', 'J.', 'Dore'], ['Murray', 'D.', 'Krahn']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.22375'],
10.1056/NEJM199904223401602,"Pybus, O., Rambaut, A., , Evolutionary analysis of the dynamics of viral infectious disease, Nature Reviews Genetics, 2009",cited-by,10.1038/nrg2583,Evolutionary analysis of the dynamics of viral infectious disease,"[['Oliver', 'G.', 'Pybus'], ['Andrew', '', 'Rambaut']]",Nature Reviews Genetics,2009,"[u'http://www.nature.com/doifinder/10.1038/nrg2583', u'http://dx.doi.org/10.1038/nrg2583']",
10.1056/NEJM199904223401602,"Goulding, C., O'Connell, P., Murray, F., , Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition, , 2001",cited-by,10.1097/00042737-200105000-00008,"Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition","[['Carol', '', 'Goulding'], ['Paul', '', ""O'Connell""], ['Frank', 'E.', 'Murray']]",,2001,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-200105000-00008'],
10.1056/NEJM199904223401602,"Latour, R., Levy, V., Asselah, T., et. al, Long-term outcome of hepatitis C infection after bone marrow transplantation, , 2004",cited-by,7004472Long-term outcome of hepatitis C infection after bone marrow transplantation,Long-term outcome of hepatitis C infection after bone marrow transplantation,"[['Regis', 'Peffault de', 'Latour'], ['Vincent', '', 'Levy'], ['Tarik', '', 'Asselah'], ['Patrick', '', 'Marcellin'], ['Catherine', '', 'Scieux'], ['Lionel', '', 'Ades'], ['Richard', '', 'Traineau'], ['Agnes', '', 'Devergie']]",,2004,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/5/1618.pdf'],
10.1056/NEJM199904223401602,"Heathcote, J., Main, J., , Treatment of hepatitis C, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00600.x,Treatment of hepatitis C,"[['J.', '', 'Heathcote'], ['J.', '', 'Main']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2005.00600.x'],
10.1056/NEJM199904223401602,"Martino, V., Lebray, P., Myers, R., et. al, Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure, Hepatology, 2004",cited-by,10.1002/hep.20463,Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure,"[['Vincent', 'Di', 'Martino'], ['Pascal', '', 'Lebray'], ['Robert', 'P.', 'Myers'], ['Emmanuelle', '', 'Pannier'], ['Joseph', '', 'Moussalli'], ['Dominique', '', 'Thabut'], ['Catherine', '', 'Buffet'], ['Thierry', '', 'Poynard']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20463'],
10.1056/NEJM199904223401602,"Henderson, D., Magnuson, W., , Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.3.546-568.2003,Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting,"[['David', 'K.', 'Henderson'], ['Warren', 'G.', 'Magnuson']]",Clinical Microbiology Reviews,2003,"[u'http://cmr.asm.org/cgi/reprint/16/3/546.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.3.546-568.2003']",
10.1056/NEJM199904223401602,"Rustgi, V., , The epidemiology of hepatitis C infection in the United States, Journal of Gastroenterology, 2007",cited-by,10.1007/s00535-007-2064-6,The epidemiology of hepatitis C infection in the United States,"[['Vinod', 'K.', 'Rustgi']]",Journal of Gastroenterology,2007,"[u'http://www.springerlink.com/content/q7vq67646m677427', u'http://www.springerlink.com/index/q7vq67646m677427.pdf', u'http://www.springerlink.com/index/10.1007/s00535-007-2064-6', u'http://www.springerlink.com/index/pdf/10.1007/s00535-007-2064-6']",
10.1056/NEJM199904223401602,"Makiyama, A., Itoh, Y., Kasahara, A., et. al, Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy, Cancer, 2004",cited-by,10.1002/cncr.20537,Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy,"[['Akiko', '', 'Makiyama'], ['Yoshito', '', 'Itoh'], ['Akinori', '', 'Kasahara'], ['Yasuharu', '', 'Imai'], ['Sumio', '', 'Kawata'], ['Kentaro', '', 'Yoshioka'], ['Hirohito', '', 'Tsubouchi'], ['Kendo', '', 'Kiyosawa'], ['Shinichi', '', 'Kakumu'], ['Kiwamu', '', 'Okita'], ['Norio', '', 'Hayashi'], ['Takeshi', '', 'Okanoue']]",Cancer,2004,[u'http://doi.wiley.com/10.1002/cncr.20537'],
10.1056/NEJM199904223401602,"Lin, O., Keeffe, E., , CURRENT TREATMENT STRATEGIES FOR CHRONIC HEPATITIS B AND C, Annual Review of Medicine, 2001",cited-by,10.1146/annurev.med.52.1.29,CURRENT TREATMENT STRATEGIES FOR CHRONIC HEPATITIS B AND C,"[['Otto', 'S.', 'Lin'], ['Emmet', 'B.', 'Keeffe']]",Annual Review of Medicine,2001,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.med.52.1.29'],
10.1056/NEJM199904223401602,"Krantz, E., Klarquist, J., Krows, M., et. al, Acute Hepatitis C in a Contemporary US Cohort: Modes of Acquisition and Factors Influencing Viral Clearance, Journal of Infectious Diseases, 2007",cited-by,10.1086/522608,Acute Hepatitis C in a Contemporary US Cohort: Modes of Acquisition and Factors Influencing Viral Clearance,"[['Elizabeth', '', 'Krantz'], ['Jared', '', 'Klarquist'], ['Meighan', '', 'Krows'], ['Lanamarie', '', 'McBride'], ['Hanne', '', 'Thiede'], ['Anna', '', 'Wald']]",Journal of Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/522608'],
10.1056/NEJM199904223401602,"Shehab, T., Sonnad, S., Lok, A., , Management of hepatitis C patients by primary care physicians in the USA: results of a national survey, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00310.x,Management of hepatitis C patients by primary care physicians in the USA: results of a national survey,"[['T.', 'M.', 'Shehab'], ['S.', 'S.', 'Sonnad'], ['A.', 'S. F.', 'Lok']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00310.x'],
10.1056/NEJM199904223401602,"Feld, J., Liang, T., , Hepatitis C — identifying patients with progressive liver injury, Hepatology, 2006",cited-by,10.1002/hep.21065,Hepatitis C — identifying patients with progressive liver injury,"[['Jordan', 'J.', 'Feld'], ['T.', 'Jake', 'Liang']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21065'],
10.1056/NEJM199904223401602,"Forton, D., Taylor-Robinson, S., Thomas, H., , Central nervous system changes in hepatitis C virus infection, European Journal of Gastroenterology & Hepatology, 2006",cited-by,10.1097/00042737-200604000-00005,Central nervous system changes in hepatitis C virus infection,"[['Daniel', 'M.', 'Forton'], ['Simon', 'D.', 'Taylor-Robinson'], ['Howard', 'C.', 'Thomas']]",European Journal of Gastroenterology & Hepatology,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-200604000-00005'],
10.1056/NEJM199904223401602,"LEE, C., DUSHEIKO, G., , The natural history and antiviral treatment of hepatitis C in haemophilia, Haemophilia, 2002",cited-by,10.1046/j.1365-2516.2002.00620.x,The natural history and antiviral treatment of hepatitis C in haemophilia,"[['C.', '', 'LEE'], ['G.', '', 'DUSHEIKO']]",Haemophilia,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.2002.00620.x'],
10.1056/NEJM199904223401602,"Burton, J., Sonnenberg, A., Rosen, H., , Retransplantation for recurrent hepatitis C in the MELD era: Maximizing utility, Liver Transplantation, 2004",cited-by,10.1002/lt.20259,Retransplantation for recurrent hepatitis C in the MELD era: Maximizing utility,"[['James', 'R.', 'Burton'], ['Amnon', '', 'Sonnenberg'], ['Hugo', 'R.', 'Rosen']]",Liver Transplantation,2004,"[u'http://www.uchsc.edu/gastro/documents/pub_h_rosen/Rosen_4.pdf', u'http://www.uchsc.edu/gastro/documents/Burton_3.pdf', u'http://doi.wiley.com/10.1002/lt.20259']",
10.1056/NEJM199904223401602,"Higuchi, M., Tanaka, E., Kiyosawa, K., , Epidemiology and Clinical Aspects on Hepatitis C, , 0",cited-by,10910108Epidemiology and Clinical Aspects on Hepatitis C,Epidemiology and Clinical Aspects on Hepatitis C,"[['Makoto', '', 'Higuchi'], ['Eiji', '', 'Tanaka'], ['Kendo', '', 'Kiyosawa']]",,0,[u'http://www.nih.go.jp/JJID/R-19.pdf'],
10.1056/NEJM199904223401602,"Myers, R., Patel, K., Pianko, S., et. al, The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00387.x,The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C,"[['R.', 'P.', 'Myers'], ['K.', '', 'Patel'], ['S.', '', 'Pianko'], ['T.', '', 'Poynard'], ['J.', 'G.', 'McHutchison']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00387.x'],
10.1056/NEJM199904223401602,"Stein, M., Charuvastra, A., Maksad, J., et. al, A randomized trial of a brief alcohol intervention for needle exchangers (BRAINE), Addiction, 2002",cited-by,10.1046/j.1360-0443.2002.00102.x,A randomized trial of a brief alcohol intervention for needle exchangers (BRAINE),"[['Michael', 'D.', 'Stein'], ['Anthony', '', 'Charuvastra'], ['Jina', '', 'Maksad'], ['Bradley', 'J.', 'Anderson']]",Addiction,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1360-0443.2002.00102.x'],
10.1056/NEJM199904223401602,"Pinzani, M., Romanelli, R., Magli, S., , Progression of fibrosis in chronic liver diseases: time to tally the score, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00055-1,Progression of fibrosis in chronic liver diseases: time to tally the score,"[['Massimo', '', 'Pinzani'], ['Roberto', 'G', 'Romanelli'], ['Sabrina', '', 'Magli']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801000551', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801000551']",
10.1056/NEJM199904223401602,"Akuta, N., Suzuki, F., Kawamura, Y., et. al, Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis, Hepatology, 2007",cited-by,10.1002/hep.21836,Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis,"[['Norio', '', 'Akuta'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Hitomi', '', 'Sezaki'], ['Yoshiyuki', '', 'Suzuki'], ['Tetsuya', '', 'Hosaka'], ['Masahiro', '', 'Kobayashi'], ['Mariko', '', 'Kobayashi'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Hiromitsu', '', 'Kumada']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21836'],
10.1056/NEJM199904223401602,"Boccato, S., Pistis, R., Noventa, F., et. al, Fibrosis progression in initially mild chronic hepatitis C, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00683.x,Fibrosis progression in initially mild chronic hepatitis C,"[['S.', '', 'Boccato'], ['R.', '', 'Pistis'], ['F.', '', 'Noventa'], ['M.', '', 'Guido'], ['L.', '', 'Benvegnu'], ['A.', '', 'Alberti']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00683.x'],
10.1056/NEJM199904223401602,"Forton, D., Allsop, J., Cox, I., et. al, A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection, Aids, 2005",cited-by,10.1097/01.aids.0000192071.72948.77,A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection,"[['Daniel', 'M', 'Forton'], ['Joanna', 'M', 'Allsop'], ['I', 'Jane', 'Cox'], ['Gavin', '', 'Hamilton'], ['Keith', '', 'Wesnes'], ['Howard', 'C', 'Thomas'], ['Simon', 'D', 'Taylor-Robinson']]",Aids,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-200510003-00010'],
10.1056/NEJM199904223401602,"Saito, H., Tad, S., Nakamoto, N., et. al, Efficacy of non-invasive elastometry on staging of hepatic fibrosis, , 2004",cited-by,5997031Efficacy of non-invasive elastometry on staging of hepatic fibrosis,Efficacy of non-invasive elastometry on staging of hepatic fibrosis,"[['Hidetsugu', '', 'Saito'], ['Shinichiro', '', 'Tad'], ['Nobuhiro', '', 'Nakamoto'], ['Kumi', '', 'Kitamura'], ['Hitomi', '', 'Horikawa'], ['Satoshi', '', 'Kurita'], ['Yoshimasa', '', 'Saito'], ['Hirokata', '', 'Iwai'], ['Hiromasa', '', 'Ishii']]",,2004,[u'http://www.axsan.it/pdf/HepatolRes04Saito.pdf'],
10.1056/NEJM199904223401602,"Piasecki, B., Lewis, J., Reddy, K., et. al, Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population, Hepatology, 2004",cited-by,10.1002/hep.1840400419,"Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population","[['Barbara', 'A.', 'Piasecki'], ['James', 'D.', 'Lewis'], ['K.', 'Rajender', 'Reddy'], ['Scarlett', 'L.', 'Bellamy'], ['Steven', 'B.', 'Porter'], ['Robert', 'M.', 'Weinrieb'], ['Donald', 'D.', 'Stieritz'], ['Kyong-Mi', '', 'Chang']]",Hepatology,2004,"[u'http://www.cceb.upenn.edu/~sbellamy/piasecki.pdf', u'http://doi.wiley.com/10.1002/hep.20384', u'http://doi.wiley.com/10.1002/hep.1840400419']",
10.1056/NEJM199904223401602,"Meyer, K., Basu, A., Przysiecki, C., et. al, Complement-Mediated Enhancement of Antibody Function for Neutralization of Pseudotype Virus Containing Hepatitis C Virus E2 Chimeric Glycoprotein, Journal of Virology, 2002",cited-by,10.1128/jvi.76.5.2150-2158.2002,Complement-Mediated Enhancement of Antibody Function for Neutralization of Pseudotype Virus Containing Hepatitis C Virus E2 Chimeric Glycoprotein,"[['Keith', '', 'Meyer'], ['Arnab', '', 'Basu'], ['Craig', 'T.', 'Przysiecki'], ['L.', 'Martin', 'Lagging'], ['Adrian', 'M. Di', 'Bisceglie'], ['Anthony', 'J.', 'Conley'], ['Ranjit', '', 'Ray']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/5/2150.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/jvi.76.5.2150-2158.2002']",
10.1056/NEJM199904223401602,"Herrine, S., , Approach to the Patient with Chronic Hepatitis C Virus Infection, , 2002",cited-by,13100579Approach to the Patient with Chronic Hepatitis C Virus Infection,Approach to the Patient with Chronic Hepatitis C Virus Infection,"[['Steven', 'K.', 'Herrine']]",,2002,[u'http://www.medicine.nevada.edu/residency/lasvegas/internalmed/documents/approachtoptwithchronichepcannals.pdf'],
10.1056/NEJM199904223401602,"Yoshizawa, H., Tanaka, J., Miyakawa, Y., , National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population, Intervirology, 2006",cited-by,10.1159/000087257,National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population,"[['Hiroshi', '', 'Yoshizawa'], ['Junko', '', 'Tanaka'], ['Yuzo', '', 'Miyakawa']]",Intervirology,2006,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000087257', u'http://www.karger.com/doi/10.1159/000087257']",
10.1056/NEJM199904223401602,"Izopet, J., Sandres-Sauné, K., Kamar, N., et. al, Incidence of HCV infection in French hemodialysis units: A prospective study, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20415,Incidence of HCV infection in French hemodialysis units: A prospective study,"[['Jacques', '', 'Izopet'], ['Karine', '', 'Sandres-Saun\xc3\xa9'], ['Nassim', '', 'Kamar'], ['Gilles', '', 'Salama'], ['Martine', '', 'Dubois'], ['Christophe', '', 'Pasquier'], ['Lionel', '', 'Rostaing']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20415'],
10.1056/NEJM199904223401602,"McMahon, B., Hennessy, T., Christensen, C., et. al, Epidemiology and risk factors for hepatitis C in Alaska Natives, Hepatology, 2004",cited-by,10.1002/hep.20046,Epidemiology and risk factors for hepatitis C in Alaska Natives,"[['Brian', 'J.', 'McMahon'], ['Thomas', 'W.', 'Hennessy'], ['Carol', '', 'Christensen'], ['Dana', '', 'Bruden'], ['Daniel', 'G.', 'Sullivan'], ['Chriss', '', 'Homan'], ['Heike', '', 'Deubner'], ['Michael', 'G.', 'Bruce'], ['Stephen', '', 'Livingston'], ['James', '', 'Williams'], ['David', 'R.', 'Gretch']]",Hepatology,2004,"[u'http://www.anthc.org/chs/crs/hep/upload/a2004-001.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo970.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/hepcinfo970.pdf', u'http://doi.wiley.com/10.1002/hep.20046']",
10.1056/NEJM199904223401602,"Tanaka, H., Tsukuma, H., Yamano, H., et. al, Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus, International Journal of Cancer, 2004",cited-by,10.1002/ijc.20507,"Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus","[['Hideo', '', 'Tanaka'], ['Hideaki', '', 'Tsukuma'], ['Hajime', '', 'Yamano'], ['Akira', '', 'Oshima'], ['Hirotoshi', '', 'Shibata']]",International Journal of Cancer,2004,[u'http://doi.wiley.com/10.1002/ijc.20507'],
10.1056/NEJM199904223401602,"Wilkinson, J., Radkowski, M., Laskus, T., , Hepatitis C Virus Neuroinvasion: Identification of Infected Cells, Journal of Virology, 2009",cited-by,10.1128/JVI.01890-08,Hepatitis C Virus Neuroinvasion: Identification of Infected Cells,"[['Jeffrey', '', 'Wilkinson'], ['Marek', '', 'Radkowski'], ['Tomasz', '', 'Laskus']]",Journal of Virology,2009,"[u'http://jvi.asm.org/cgi/reprint/83/3/1312.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01890-08']",
10.1056/NEJM199904223401602,"Schoot, C., Hahn, S., Chitty, L., , Non-invasive prenatal diagnosis and determination of fetal Rh status, Seminars in Fetal & Neonatal Medicine, 2008",cited-by,10.1016/j.siny.2007.12.012,Non-invasive prenatal diagnosis and determination of fetal Rh status,"[['C.', 'Ellen van der', 'Schoot'], ['Sinuhe', '', 'Hahn'], ['Lyn', 'S.', 'Chitty']]",Seminars in Fetal & Neonatal Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1744165X07001588', u'http://linkinghub.elsevier.com/retrieve/pii/S1744165X07001588']",
10.1056/NEJM199904223401602,"Hutchinson, S., Bird, S., Goldberg, D., , Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland, Hepatology, 2005",cited-by,10.1002/hep.20836,Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland,"[['Sharon', 'J.', 'Hutchinson'], ['Sheila', 'M.', 'Bird'], ['David', 'J.', 'Goldberg']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20836'],
10.1056/NEJM199904223401602,"Campbell, M., Reddy, K., , The evolving role of liver biopsy, Alimentary Pharmacology & Therapeutics, 2004",cited-by,10.1111/j.1365-2036.2004.02071.x,The evolving role of liver biopsy,"[['M.', 'S.', 'Campbell'], ['K.', 'R.', 'Reddy']]",Alimentary Pharmacology & Therapeutics,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2004.02071.x'],
10.1056/NEJM199904223401602,"Lagging, L., Westin, J., Svensson, E., et. al, Progression of fibrosis in untreated patients with hepatitis C virus infection, Liver International, 2002",cited-by,10.1034/j.1600-0676.2002.01623.x,Progression of fibrosis in untreated patients with hepatitis C virus infection,"[['L.', 'Martin', 'Lagging'], ['Johan', '', 'Westin'], ['Elisabeth', '', 'Svensson'], ['Nibia', '', 'Aires'], ['Amar', 'P.', 'Dhillon'], ['Magnus', '', 'Lindh'], ['Rune', '', 'Wejstal'], ['Gunnar', '', 'Norkrans']]",Liver International,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-0676.2002.01623.x'],
10.1056/NEJM199904223401602,"Kramer, L., Hofer, H., Bauer, E., et. al, Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection, Aids, 2005",cited-by,10.1097/01.aids.0000192075.26314.87,Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection,"[['Ludwig', '', 'Kramer'], ['Harald', '', 'Hofer'], ['Edith', '', 'Bauer'], ['Georg', '', 'Funk'], ['Elisabeth', '', 'Formann'], ['Petra', '', 'Steindl-Munda'], ['Peter', '', 'Ferenci']]",Aids,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-200510003-00014'],
10.1056/NEJM199904223401602,"Akuta, N., Suzuki, F., Hirakawa, M., et. al, Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin, Hepatology, 2010",cited-by,10.1002/hep.23690,Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin,"[['Norio', '', 'Akuta'], ['Fumitaka', '', 'Suzuki'], ['Miharu', '', 'Hirakawa'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Hitomi', '', 'Sezaki'], ['Yoshiyuki', '', 'Suzuki'], ['Tetsuya', '', 'Hosaka'], ['Masahiro', '', 'Kobayashi'], ['Mariko', '', 'Kobayashi'], ['Satoshi', '', 'Saitoh'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Kazuaki', '', 'Chayama'], ['Yusuke', '', 'Nakamura'], ['Hiromitsu', '', 'Kumada']]",Hepatology,2010,[u'http://doi.wiley.com/10.1002/hep.23690'],
10.1056/NEJM199904223401602,"Bernardin, F., Tobler, L., Walsh, I., et. al, Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia, Hepatology, 2008",cited-by,10.1002/hep.22184,Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia,"[['Flavien', '', 'Bernardin'], ['Leslie', '', 'Tobler'], ['Irina', '', 'Walsh'], ['Joan', 'Dunn', 'Williams'], ['Mike', '', 'Busch'], ['Eric', '', 'Delwart']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.22184'],
10.1056/NEJM199904223401602,"Delwaide, J., Bourgeois, N., Gerard, C., et. al, Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response, Alimentary Pharmacology & Therapeutics, 2004",cited-by,10.1111/j.1365-2036.2004.02023.x,Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response,"[['J.', '', 'Delwaide'], ['N.', '', 'Bourgeois'], ['C.', '', 'Gerard'], ['S.', 'De', 'Maeght'], ['F.', '', 'Mokaddem'], ['E.', '', 'Wain'], ['B.', '', 'Bastens'], ['J.', '', 'Fevery'], ['M.', '', 'Gehenot'], ['O.', 'Le', 'Moine'], ['J.', 'P.', 'Martinet'], ['G.', '', 'Robaeys'], ['B.', '', 'Servais'], ['M.', 'Van', 'Gossum'], ['H.', 'Van', 'Vlierberghe']]",Alimentary Pharmacology & Therapeutics,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2004.02023.x'],
10.1056/NEJM199904223401602,"Kew, M., Francois, G., Lavanchy, D., et. al, Prevention of hepatitis C virus infection, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00492.x,Prevention of hepatitis C virus infection,"[['M.', '', 'Kew'], ['G.', '', 'Francois'], ['D.', '', 'Lavanchy'], ['H.', '', 'Margolis'], ['P.', 'Van', 'Damme'], ['P.', '', 'Grob'], ['J.', '', 'Hallauer'], ['D.', '', 'Shouval'], ['G.', '', 'Leroux-Roels'], ['A.', '', 'Meheus']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00492.x'],
10.1056/NEJM199904223401602,"Blackard, J., Shata, M., Shire, N., et. al, Acute hepatitis C virus infection: A chronic problem, Hepatology, 2008",cited-by,10.1002/hep.21902,Acute hepatitis C virus infection: A chronic problem,"[['Jason', 'T.', 'Blackard'], ['M.', 'Tarek', 'Shata'], ['Norah', 'J.', 'Shire'], ['Kenneth', 'E.', 'Sherman']]",Hepatology,2008,"[u'http://www.med.upenn.edu/gastro/documents/HepatologyAcuteHCV.pdf', u'http://texasliver.typepad.com/dr_joe_galatis_blog/files/hcv_review_2008.pdf', u'http://doi.wiley.com/10.1002/hep.21902']",
10.1056/NEJM199904223401602,"Hilsabeck, R., Hassanein, T., Perry, W., , Biopsychosocial predictors of fatigue in chronic hepatitis C, Journal of Psychosomatic Research, 2005",cited-by,10.1016/j.jpsychores.2004.07.003,Biopsychosocial predictors of fatigue in chronic hepatitis C,"[['Robin', 'C.', 'Hilsabeck'], ['Tarek', 'I.', 'Hassanein'], ['William', '', 'Perry']]",Journal of Psychosomatic Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0022399904005173', u'http://linkinghub.elsevier.com/retrieve/pii/S0022399904005173']",
10.1056/NEJM199904223401602,"Curry, M., Golden-Mason, L., Doherty, D., et. al, Expansion of innate CD5 pos B cells expressing high levels of CD81 in hepatitis C virus infected liver, , 2003",cited-by,13550638Expansion of innate CD5 pos B cells expressing high levels of CD81 in hepatitis C virus infected liver,Expansion of innate CD5 pos B cells expressing high levels of CD81 in hepatitis C virus infected liver,"[['Michael', 'P.', 'Curry'], ['Lucy', '', 'Golden-Mason'], ['Derek', 'G.', 'Doherty'], ['Tina', '', 'Deignan'], ['Suzanne', '', 'Norris'], ['Margaret', '', 'Duffy'], ['Niamh', '', 'Nolan'], ['William', '', 'Hall'], ['John', 'E.', 'Hegarty'], ['Cliona', '', ""O'Farrelly""]]",,2003,[u'http://webpages.csus.edu/~aenstrom/5.pdf'],
10.1056/NEJM199904223401602,"Cotler, S., Patil, R., McNutt, R., et. al, Patients’ values for health states associated with hepatitis c and physicians’ estimates of those values, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.04132.x,Patients’ values for health states associated with hepatitis c and physicians’ estimates of those values,"[['Scott', 'J.', 'Cotler'], ['Raj', '', 'Patil'], ['Robert', 'A.', 'McNutt'], ['Theodore', '', 'Speroff'], ['Geraldine', '', 'Banaad-Omiotek'], ['Daniel', 'R.', 'Ganger'], ['Howard', '', 'Rosenblate'], ['Suman', '', 'Kaur'], ['Sheldon', '', 'Cotler'], ['Donald', 'M.', 'Jensen']]",American Journal of Gastroenterology,2001,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.04132.x', u'http://dx.doi.org/10.1111/j.1572-0241.2001.04132.x']",
10.1056/NEJM199904223401602,"Goedert, J., Brown, D., Hoots, K., et. al, Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia, Haemophilia, 2004",cited-by,10.1111/j.1365-2516.2004.00997.x,Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia,"[['J.', 'J.', 'Goedert'], ['D.', 'L.', 'Brown'], ['K.', '', 'Hoots'], ['K.', 'E.', 'Sherman']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2516.2004.00997.x'],
10.1056/NEJM199904223401602,"Weber, D., Rutala, W., , The Emerging Nosocomial Pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori , and Hepatitis C: Epidemiology, Environmental Survival, Efficacy of Disinfection, and Control Measures, Infection Control and Hospital Epidemiology, 2001",cited-by,10.1086/501907,"The Emerging Nosocomial Pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori , and Hepatitis C: Epidemiology, Environmental Survival, Efficacy of Disinfection, and Control Measures","[['David', 'J.', 'Weber'], ['William', 'A.', 'Rutala']]",Infection Control and Hospital Epidemiology,2001,"[u'http://www.unc.edu/depts/spice/dis/ICHE-2001-May-p306.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/501907']",
10.1056/NEJM199904223401602,"Fanning, L., Kenny-Walsh, E., Levis, J., et. al, Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study, Hepatology, 2000",cited-by,10.1002/hep.510310133,Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study,"[['Liam', '', 'Fanning'], ['Elizabeth', '', 'Kenny-Walsh'], ['John', '', 'Levis'], ['Kingshuk', 'Roy', 'Choudhury'], ['Bridin', '', 'Cannon'], ['Margaret', '', 'Sheehan'], ['Michael', '', 'Whelton'], ['Fergus', '', 'Shanahan']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310133'],
10.1056/NEJM199904223401602,"Nagayama, K., Kurosaki, M., Enomoto, N., et. al, Characteristics of hepatitis C viral genome associated with disease progression, Hepatology, 2000",cited-by,10.1002/hep.510310327,Characteristics of hepatitis C viral genome associated with disease progression,"[['Kazuyoshi', '', 'Nagayama'], ['Masayuki', '', 'Kurosaki'], ['Nobuyuki', '', 'Enomoto'], ['Yuka', '', 'Miyasaka'], ['Fumiaki', '', 'Marumo'], ['Chifumi', '', 'Sato']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310327'],
10.1056/NEJM199904223401602,"Sezaki, H., Suzuki, F., Kawamura, Y., et. al, Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads, Digestive Diseases and Sciences, 2009",cited-by,10.1007/s10620-008-0500-y,Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads,"[['Hitomi', '', 'Sezaki'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Tetsuya', '', 'Hosaka'], ['Norio', '', 'Akuta'], ['Masahiro', '', 'Kobayashi'], ['Yoshiyuki', '', 'Suzuki'], ['Satoshi', '', 'Saitoh'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Yuzo', '', 'Miyakawa'], ['Hiromitsu', '', 'Kumada']]",Digestive Diseases and Sciences,2009,"[u'http://www.springerlink.com/content/e63232l537q8128t', u'http://www.springerlink.com/index/e63232l537q8128t.pdf', u'http://www.springerlink.com/index/10.1007/s10620-008-0500-y', u'http://www.springerlink.com/index/pdf/10.1007/s10620-008-0500-y']",
10.1056/NEJM199904223401602,"Forton, D., Hamilton, G., Allsop, J., et. al, Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.03.022,Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study,"[['Daniel', 'M.', 'Forton'], ['Gavin', '', 'Hamilton'], ['Joanna', 'M.', 'Allsop'], ['Vijay', 'P.', 'Grover'], ['Keith', '', 'Wesnes'], ['Catherine', '', 'O\xe2\x80\x99Sullivan'], ['Howard', 'C.', 'Thomas'], ['Simon', 'D.', 'Taylor-Robinson']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808002286', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808002286']",
10.1056/NEJM199904223401602,"Levine, R., Sanderson, S., Murray, F., et. al, Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D, Clinical Gastroenterology and Hepatology, 2006",cited-by,10.1016/j.cgh.2006.05.028,Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D,"[['Robert', 'A.', 'Levine'], ['Schuyler', 'O.', 'Sanderson'], ['Frank', '', 'Murray'], ['Elaine', '', 'Kay'], ['John', '', 'Hegarty'], ['Niamh', '', 'Nolan'], ['Dermot', '', 'Kelleher'], ['George', '', 'Mcdonald'], ['J.', 'Conor', 'O\xe2\x80\x99Keane'], ['John', '', 'Crowe']]",Clinical Gastroenterology and Hepatology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1542356506004976', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356506004976']",
10.1056/NEJM199904223401602,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
10.1056/NEJM199904223401602,"Cotler, S., Layden, J., Neumann, A., et. al, First phase hepatitis c viral kinetics in previous nonresponders patients, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00401.x,First phase hepatitis c viral kinetics in previous nonresponders patients,"[['S.', 'J.', 'Cotler'], ['J.', 'E.', 'Layden'], ['A.', 'U.', 'Neumann'], ['D.', 'M.', 'Jensen']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00401.x'],
10.1056/NEJM199904223401602,"Sagmeister, M., Renner, E., Mullhaupt, B., et. al, Simulation of hepatitis C based on a mandatory reporting system, European Journal of Gastroenterology & Hepatology, 2002",cited-by,10.1097/00042737-200201000-00006,Simulation of hepatitis C based on a mandatory reporting system,"[['Markus', '', 'Sagmeister'], ['Eberhard', 'L.', 'Renner'], ['Beat', '', 'Mullhaupt'], ['John', 'B.', 'Wong']]",European Journal of Gastroenterology & Hepatology,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-200201000-00006'],
10.1056/NEJM199904223401602,"Montes-Cano, M., García-Lozano, J., Abad-Molina, C., et. al, Interleukin28B genetic variants and hepatitis virus infection by different viral genotypes, Hepatology, 2010",cited-by,10.1002/hep.23624,Interleukin28B genetic variants and hepatitis virus infection by different viral genotypes,"[['Marco', 'Antonio', 'Montes-Cano'], ['Jos\xc3\xa9', 'Ra\xc3\xbal', 'Garc\xc3\xada-Lozano'], ['Cristina', '', 'Abad-Molina'], ['Manuel', '', 'Romero-G\xc3\xb3mez'], ['Natalia', '', 'Barroso'], ['Jos\xc3\xa9', '', 'Aguilar-Reina'], ['Antonio', '', 'N\xc3\xba\xc3\xb1ez-Rold\xc3\xa1n'], ['Mar\xc3\xada', 'Francisca', 'Gonz\xc3\xa1lez-Escribano']]",Hepatology,2010,[u'http://doi.wiley.com/10.1002/hep.23624'],
10.1056/NEJM199904223401602,"Akuta, N., Suzuki, F., Hirakawa, M., et. al, A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response, Journal of Medical Virology, 2009",cited-by,10.1002/jmv.21400,A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response,"[['Norio', '', 'Akuta'], ['Fumitaka', '', 'Suzuki'], ['Miharu', '', 'Hirakawa'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Hitomi', '', 'Sezaki'], ['Yoshiyuki', '', 'Suzuki'], ['Tetsuya', '', 'Hosaka'], ['Masahiro', '', 'Kobayashi'], ['Mariko', '', 'Kobayashi'], ['Satoshi', '', 'Saitoh'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Hiromitsu', '', 'Kumada']]",Journal of Medical Virology,2009,[u'http://doi.wiley.com/10.1002/jmv.21400'],
10.1056/NEJM199904223401602,"Sartori, M., Andorno, S., Rigamonti, C., et. al, Chronic hepatitis C is mild in menstruating women, Journal of Gastroenterology and Hepatology, 2000",cited-by,10.1046/j.1440-1746.2000.02368.x,Chronic hepatitis C is mild in menstruating women,"[['Massimo', '', 'Sartori'], ['Silvano', '', 'Andorno'], ['Cristina', '', 'Rigamonti'], ['Elena', '', 'Grossini'], ['Gabriella', '', 'Nicosia'], ['Renzo', '', 'Boldorini']]",Journal of Gastroenterology and Hepatology,2000,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1440-1746.2000.02368.x'],
10.1056/NEJM199904223401602,"Seeff, L., , Why is there such difficulty in defining the natural history of hepatitis C?, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40101161.x,Why is there such difficulty in defining the natural history of hepatitis C?,"[['Leonard', 'B.', 'Seeff']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40101161.x'],
10.1056/NEJM199904223401602,"Chuang, W., Sarkodie, F., Brown, C., et. al, Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20848,Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population,"[['Wing', 'Chia-Ming', 'Chuang'], ['Francis', '', 'Sarkodie'], ['Colin', 'J.', 'Brown'], ['Shirley', '', 'Owusu-Ofori'], ['Juliette', '', 'Brown'], ['Chengyao', '', 'Li'], ['Cristina', '', 'Navarrete'], ['Paul', '', 'Klenerman'], ['Jean-Pierre', '', 'Allain']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20848'],
10.1056/NEJM199904223401602,"Burton, J., Rosen, H., , Liver Retransplantation for Hepatitis C Virus Recurrence: A Survey of Liver Transplant Programs in the United States, Clinical Gastroenterology and Hepatology, 2005",cited-by,10.1016/S1542-3565(05)00158-8,Liver Retransplantation for Hepatitis C Virus Recurrence: A Survey of Liver Transplant Programs in the United States,"[['James', 'R.', 'Burton'], ['Hugo', 'R.', 'Rosen']]",Clinical Gastroenterology and Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1542356505001588', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356505001588']",
10.1056/NEJM199904223401602,"Butt, A., , Hepatitis C virus infection: the new global epidemic, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.241,Hepatitis C virus infection: the new global epidemic,"[['Adeel', 'A', 'Butt']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.241'],
10.1056~NEJMoa011232,"Calleri G, Colombatto P, Gozzelino M, et al. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial. Ital J Gastroenterol Hepatol 1998;30:181-4.",references,NOT found in MAS
10.1056~NEJMoa011232,"Parana R, Vitvitski L, Andrade Z, et al. Acute sporadic non-A, non-B hepatitis in northeastern Brazil: etiology and natural history. Hepatology 1999;30:289-93.",references,10.1002/hep.510300143,"Acute sporadic nonA, non-B hepatitis in Northeastern Brazil: Etiology and natural history","[[u'Ludmila', u'', u'Vitvitski'], [u'Zilton', u'', u'Andrade'], [u'Christian', u'', u'Trepo'], [u'Helma', u'', u'Cotrim'], [u'Pascale', u'', u'Bertillon'], [u'Fernanda', u'', u'Silva'], [u'Luciana', u'', u'Silva'], [u'Irismar', u'R. de', u'Oliveira'], [u'Luis', u'', u'Lyra']]",Hepatology,1999,[u'http://doi.wiley.com/10.1002/hep.510300143'],"[{u'Name': u'Natural History', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 27121}, {u'Name': u'Northeastern Brazil', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 28421}]"
10.1002/hep.510300143,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1002/hep.510300143,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1002/hep.510300143,"Santantonio, T., Sinisi, E., Guastadisegni, A., et. al, Natural course of acute hepatitis C: a long-term prospective study, Digestive and Liver Disease, 2003",cited-by,10.1016/S1590-8658(03)00007-0,Natural course of acute hepatitis C: a long-term prospective study,"[['T', '', 'Santantonio'], ['E', '', 'Sinisi'], ['A', '', 'Guastadisegni'], ['C', '', 'Casalino'], ['M', '', 'Mazzola'], ['A', '', 'Gentile'], ['G', '', 'Leandro'], ['G', '', 'Pastore']]",Digestive and Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1590865803000070', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865803000070']",
10.1002/hep.510300143,"Nishioka, S., Gyorkos, T., , Tattoos as risk factors for transfusion-transmitted diseases, International Journal of Infectious Diseases, 2001",cited-by,10.1016/S1201-9712(01)90045-1,Tattoos as risk factors for transfusion-transmitted diseases,"[['S\xc3\xa9rgio', 'de A.', 'Nishioka'], ['Theresa', 'W.', 'Gyorkos']]",International Journal of Infectious Diseases,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1201971201900451', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971201900451']",
10.1002/hep.510300143,"VIANA, S., PARANA, R., MOREIRA, R., et. al, HIGH PREVALENCE OF HEPATITIS B VIRUS AND HEPATITIS D VIRUS IN THE WESTERN BRAZILIAN AMAZON, , 2005",cited-by,5551333HIGH PREVALENCE OF HEPATITIS B VIRUS AND HEPATITIS D VIRUS IN THE WESTERN BRAZILIAN AMAZON,HIGH PREVALENCE OF HEPATITIS B VIRUS AND HEPATITIS D VIRUS IN THE WESTERN BRAZILIAN AMAZON,"[['SEBASTIAO', '', 'VIANA'], ['RAYMUNDO', '', 'PARANA'], ['REGINA', 'CELIA', 'MOREIRA'], ['ADRIANA', 'PARISE', 'COMPRI'], ['VANISE', '', 'MACEDO']]",,2005,[u'http://intl.ajtmh.org/cgi/reprint/73/4/808.pdf'],
10.1002/hep.510300143,"Hofer, H., Neufeld, J., Oesterreicher, C., et. al, Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV1 infection, Genes and Immunity, 2005",cited-by,10.1038/sj.gene.6364168,Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV1 infection,"[['H', '', 'Hofer'], ['J', 'B', 'Neufeld'], ['C', '', 'Oesterreicher'], ['P', '', 'Grundtner'], ['F', '', 'Wrba'], ['A', '', 'Gangl'], ['P', '', 'Ferenci'], ['C', '', 'Gasche']]",Genes and Immunity,2005,"[u'http://www.nature.com/doifinder/10.1038/sj.gene.6364168', u'http://dx.doi.org/10.1038/sj.gene.6364168']",
10.1002/hep.510300143,"Uto, H., Stuver, S., Hayashi, K., et. al, Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study, Hepatology, 2009",cited-by,10.1002/hep.23002,Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study,"[['Hirofumi', '', 'Uto'], ['Sherri', 'O.', 'Stuver'], ['Katsuhiro', '', 'Hayashi'], ['Kotaro', '', 'Kumagai'], ['Fumisato', '', 'Sasaki'], ['Shuji', '', 'Kanmura'], ['Masatsugu', '', 'Numata'], ['Akihiro', '', 'Moriuchi'], ['Susumu', '', 'Hasegawa'], ['Makoto', '', 'Oketani'], ['Akio', '', 'Ido'], ['Kazunori', '', 'Kusumoto'], ['Satoru', '', 'Hasuike'], ['Kenji', '', 'Nagata'], ['Michinori', '', 'Kohara'], ['Hirohito', '', 'Tsubouchi']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.23002'],
10.1002/hep.510300143,"Carrilho, F., Clemente, C., Silva, L., , Epidemiology of hepatitis A and E virus infection in Brazil, , 2005",cited-by,10.1157/13072011,Epidemiology of hepatitis A and E virus infection in Brazil,"[['F.', 'J.', 'Carrilho'], ['C.', 'Mendes', 'Clemente'], ['L.', 'C. da', 'Silva']]",,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0210570505714400', u'http://linkinghub.elsevier.com/retrieve/pii/S0210570505714400']",
10.1002/hep.510300143,"GONCALES, N., PINHO, J., MOREIRA, R., et. al, Hepatitis E Virus Immunoglobulin G Antibodies in Different Populations in Campinas, Brazil, Clinical and Vaccine Immunology, 2000",cited-by,10.1128/CDLI.7.5.813-816.2000,"Hepatitis E Virus Immunoglobulin G Antibodies in Different Populations in Campinas, Brazil","[['NEIVA', 'S. L.', 'GONCALES'], ['JOAO', 'RENATO R.', 'PINHO'], ['REGINA', 'C.', 'MOREIRA'], ['CLAUDIA', 'P.', 'SARACENI'], ['ANGELA', 'M. M.', 'SPINA'], ['RAQUEL', 'B.', 'STUCCHI'], ['AIRTON', 'D. RIBEIRO', 'FILHO'], ['LUIS', 'A.', 'MAGNA'], ['FERNANDO', 'L. GONCALES', 'JUNIOR']]",Clinical and Vaccine Immunology,2000,"[u'http://cdli.asm.org/cgi/reprint/7/5/813.pdf', u'http://cvi.asm.org/cgi/reprint/7/5/813.pdf', u'http://cdli.asm.org/cgi/doi/10.1128/CDLI.7.5.813-816.2000']",
10.1002/hep.510300143,"Hung, C., Lu, S., Wang, J., et. al, Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.049,Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study,"[['Chao-Hung', '', 'Hung'], ['Sheng-Nan', '', 'Lu'], ['Jing-Houng', '', 'Wang'], ['Shu-Fen', '', 'Hung'], ['Chien-Hung', '', 'Chen'], ['Tsung-Hui', '', 'Hu'], ['Chuan-Mo', '', 'Lee'], ['Chi-Sin', '', 'Changchien']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000868', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000868']",
10.1002/hep.510300143,"Paraná, R., Andrade, Z., Freitas, L., et. al, Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease?, International Journal of Infectious Diseases, 2003",cited-by,10.1016/S1201-9712(03)90056-7,"Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease?","[['Raymundo', '', 'Paran\xc3\xa1'], ['Zilton', '', 'Andrade'], ['Luiz', 'A. R. de', 'Freitas'], ['Rog\xc3\xa9rio', '', 'Santos-Jesus'], ['Mitermayer', '', 'Reis'], ['Helma', '', 'Cotrim'], ['Simone', '', 'Cunha'], ['Christian', '', 'Trepo']]",International Journal of Infectious Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1201971203900567', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971203900567']",
10.1002/hep.510300143,"Chams, V., Fournier-Wirth, C., Chabanel, A., et. al, Le virus GB-C ou virus « dit » de l’hépatite G est-il impliqué en pathologie humaine ?, Transfusion Clinique Et Biologique, 2003",cited-by,10.1016/S1246-7820(03)00095-8,Le virus GB-C ou virus « dit » de l’hépatite G est-il impliqué en pathologie humaine ?,"[['V.', '', 'Chams'], ['C.', '', 'Fournier-Wirth'], ['A.', '', 'Chabanel'], ['P.', '', 'Herv\xc3\xa9'], ['C.', '', 'Tr\xc3\xa9po']]",Transfusion Clinique Et Biologique,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1246782003000958', u'http://linkinghub.elsevier.com/retrieve/pii/S1246782003000958']",
10.1002/hep.510300143,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1002/hep.510300143,"Chemin, I., Merle, P., Parana, R., et. al, Hépatites d'étiologie inconnue, , 2004",cited-by,10.1016/j.emchep.2004.01.001,Hépatites d'étiologie inconnue,"[['I', '', 'Chemin'], ['P', '', 'Merle'], ['R', '', 'Parana'], ['C', '', 'Trepo']]",,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1638622104000053', u'http://linkinghub.elsevier.com/retrieve/pii/S1638622104000053']",
10.1002/hep.510300143,"Moreira-Silva, S., Frauches, D., Almeida, A., et. al, Acute liver failure in children: observations in Vitória, Espírito Santo State, Brazil Insuficiência hepática aguda na criança: observações em Vitória, Estado do Espírito Santo, Brasil, , 0",cited-by,"11307818Acute liver failure in children: observations in Vitória, Espírito Santo State, Brazil Insuficiência hepática aguda na criança: observações em Vitória, Estado do Espírito Santo, Brasil","Acute liver failure in children: observations in Vitória, Espírito Santo State, Brazil Insuficiência hepática aguda na criança: observações em Vitória, Estado do Espírito Santo, Brasil","[['Sandra', 'F.', 'Moreira-Silva'], ['Diana', 'O.', 'Frauches'], ['Alba', 'L.', 'Almeida'], ['Hayd\xc3\xa9e', 'F. M. S.', 'Mendon\xc3\xa7a'], ['Fausto', '', 'Edmundo'], ['L.', '', 'Pereira']]",,0,"[u'http://www.transpatica.org.br/moreira.pdf', u'http://www.scielo.br/pdf/rsbmt/v35n5/13167.pdf']",
10.1056~NEJMoa011232,"Pape GR, Gerlach TJ, Diepolder HM, Gruner N, Jung M, Santantonio T. Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepat 1999;6:Suppl 1:36-40.",references,10.1046/j.1365-2893.1999.00006.x,Role of the specific T-cell response for clearance and control of hepatitis C virus,"[[u'G.', u'R.', u'Pape'], [u'T.', u'J.', u'Gerlach'], [u'H.', u'M.', u'Diepolder'], [u'N.', u'', u'Gruner'], [u'M.-C.', u'', u'Jung'], [u'T.', u'', u'Santantonio']]",Journal of Viral Hepatitis,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.1999.00006.x'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}]"
10.1046/j.1365-2893.1999.00006.x,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1046/j.1365-2893.1999.00006.x,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1046/j.1365-2893.1999.00006.x,"Grabowska, A., Lechner, F., Klenerman, P., et. al, Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200108)31:8<2388::AID-IMMU2388>3.0.CO;2-L,Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection,"[['Anna', 'M.', 'Grabowska'], ['Franziska', '', 'Lechner'], ['Paul', '', 'Klenerman'], ['Paddy', 'J.', 'Tighe'], ['Stephen', '', 'Ryder'], ['Jonathan', 'K.', 'Ball'], ['Brian', 'J.', 'Thomson'], ['William', 'L.', 'Irving'], ['R.', 'Adrian', 'Robins']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200108%2931%3A8%3C2388%3A%3AAID-IMMU2388%3E3.0.CO%3B2-L'],
10.1046/j.1365-2893.1999.00006.x,"HAGAN, H., JARLAIS, D., , HIV and HCV Infection among Injecting Drug Users, , 2000",cited-by,5640707HIV and HCV Infection among Injecting Drug Users,HIV and HCV Infection among Injecting Drug Users,"[['HOLLY', '', 'HAGAN'], ['DON', 'C. DES', 'JARLAIS']]",,2000,"[u'http://www.mssm.edu/msjournal/67/page423_428.pdf', u'http://www.drugpolicy.org/docUploads/meth423.pdf']",
10.1046/j.1365-2893.1999.00006.x,"Saunier, B., Triyatni, M., Ulianich, L., et. al, Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes, Journal of Virology, 2003",cited-by,10.1128/JVI.77.1.546-559.2003,Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes,"[['Bertrand', '', 'Saunier'], ['Miriam', '', 'Triyatni'], ['Luca', '', 'Ulianich'], ['Padma', '', 'Maruvada'], ['Paul', '', 'Yen'], ['Leonard', 'D.', 'Kohn']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/1/546.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.1.546-559.2003']",
10.1046/j.1365-2893.1999.00006.x,"Sester, M., Sester, U., Gärtner, B., et. al, Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent Virus, Journal of Virology, 2002",cited-by,10.1128/JVI.76.8.3748-3755.2002,Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent Virus,"[['Martina', '', 'Sester'], ['Urban', '', 'Sester'], ['Barbara', '', 'G\xc3\xa4rtner'], ['Boris', '', 'Kubuschok'], ['Matthias', '', 'Girndt'], ['Andreas', '', 'Meyerhans'], ['Hans', '', 'K\xc3\xb6hler']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/8/3748.pdf', u'http://www.uniklinik-saarland.de/mediadb/Uniklinik_Homburg/Kliniken/Nephrologie/PDFs/Sester-M._2002_J.-Virol.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.8.3748-3755.2002']",
10.1046/j.1365-2893.1999.00006.x,"Rautenschlein, S., Yeh, H., Njenga, M., et. al, Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery, Archives of Virology, 2002",cited-by,10.1007/s705-002-8320-2,Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery,"[['S.', '', 'Rautenschlein'], ['H.-Y.', '', 'Yeh'], ['M.', 'K.', 'Njenga'], ['J.', 'M.', 'Sharma']]",Archives of Virology,2002,"[u'http://www.springerlink.com/content/0ne9h4qjqd6tumad', u'http://www.springerlink.com/index/0ne9h4qjqd6tumad.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s705-002-8320-2', u'http://www.springerlink.com/index/pdf/10.1007/s705-002-8320-2']",
10.1046/j.1365-2893.1999.00006.x,"Wang, J., Layden, T., Eckels, D., , Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response, Human Immunology, 2003",cited-by,10.1016/S0198-8859(03)00070-3,Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response,"[['Jane', 'H', 'Wang'], ['Thomas', 'J', 'Layden'], ['David', 'D', 'Eckels']]",Human Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0198885903000703', u'http://linkinghub.elsevier.com/retrieve/pii/S0198885903000703']",
10.1046/j.1365-2893.1999.00006.x,"Arribillaga, L., Cerio, A., Sarobe, P., et. al, Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00456-5,Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus,"[['Laura', '', 'Arribillaga'], ['Ascensi\xc3\xb3n', 'L\xc3\xb3pez D\xc4\xb1\xcc\x81az de', 'Cerio'], ['Pablo', '', 'Sarobe'], ['Noelia', '', 'Casares'], ['Marta', '', 'Gorraiz'], ['Africa', '', 'Vales'], ['Oscar', '', 'Bruna-Romero'], ['Francisco', '', 'Borr\xc3\xa1s-Cuesta'], ['Glaucia', '', 'Paranhos-Baccala'], ['Jes\xc3\xbas', '', 'Prieto'], ['Juan', '', 'Ruiz'], ['Juan', 'Jos\xc3\xa9', 'Lasarte']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02004565', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02004565']",
10.1046/j.1365-2893.1999.00006.x,"Soo, H., Garzino-Demo, A., Hong, W., et. al, Expression of a Full-Length Hepatitis C Virus cDNA Up-Regulates the Expression of CC Chemokines MCP-1 and RANTES, Virology, 2002",cited-by,10.1006/viro.2002.1617,Expression of a Full-Length Hepatitis C Virus cDNA Up-Regulates the Expression of CC Chemokines MCP-1 and RANTES,"[['Hui', 'Meng', 'Soo'], ['Alfredo', '', 'Garzino-Demo'], ['Wanjin', '', 'Hong'], ['Yin', 'Hwee', 'Tan'], ['Yee', 'Joo', 'Tan'], ['Phuay-Yee', '', 'Goh'], ['Seng', 'Gee', 'Lim'], ['Siew', 'Pheng', 'Lim']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S004268220291617X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268220291617X']",
10.1046/j.1365-2893.1999.00006.x,"He, H., Messer, R., Sakaguchi, S., et. al, Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.21.11641-11647.2004,Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection,"[['Hong', '', 'He'], ['Ronald', 'J.', 'Messer'], ['Shimon', '', 'Sakaguchi'], ['Guojun', '', 'Yang'], ['Shelly', 'J.', 'Robertson'], ['Kim', 'J.', 'Hasenkrug']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/21/11641.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.21.11641-11647.2004']",
10.1046/j.1365-2893.1999.00006.x,"Rico, M., Quiroga, J., Subirá, D., et. al, Features of the CD4 + T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(01)00281-1,Features of the CD4 + T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels,"[['Miguel', 'A', 'Rico'], ['Juan', 'A', 'Quiroga'], ['Dolores', '', 'Subir\xc3\xa1'], ['Esteban', '', 'Garcia'], ['Susana', '', 'Casta\xc3\xb1\xc3\xb3n'], ['Matti', '', 'S\xc3\xa4llberg'], ['Geert', '', 'Leroux-Roels'], ['Ola', '', 'Weiland'], ['Margarita', '', 'Pardo'], ['Vicente', '', 'Carre\xc3\xb1o']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801002811', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801002811']",
10.1046/j.1365-2893.1999.00006.x,"Yeo, A., Ghany, M., Conry-Cantilena, C., et. al, Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00302.x,Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers,"[['A.', 'E. T.', 'Yeo'], ['M.', '', 'Ghany'], ['C.', '', 'Conry-Cantilena'], ['J.', 'C.', 'Melpolder'], ['D.', 'E.', 'Kleiner'], ['J.', 'W. K.', 'Shih'], ['J.', 'H.', 'Hoofnagle'], ['H.', 'J.', 'Alter']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00302.x'],
10.1046/j.1365-2893.1999.00006.x,"Li, W., Li, J., Lorne, D., et. al, Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities, Journal of General Virology, 2006",cited-by,10.1099/vir.0.81364-0,Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities,"[['Wen', '', 'Li'], ['Jie', '', 'Li'], ['D.', '', 'Lorne'], ['J.', '', 'Tyrrell'], ['Babita', '', 'Agrawal']]",Journal of General Virology,2006,"[u'http://vir.sgmjournals.org/cgi/reprint/87/1/61.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/vir.0.81364-0']",
10.1046/j.1365-2893.1999.00006.x,"Somsouk, M., Lauer, G., Casson, D., et. al, Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00391-3,Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression,"[['Ma', '', 'Somsouk'], ['Georg', 'M', 'Lauer'], ['Deborah', '', 'Casson'], ['Adam', '', 'Terella'], ['Cheryl', 'L', 'Day'], ['Bruce', 'D', 'Walker'], ['Raymond', 'T', 'Chung']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503003913', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503003913']",
10.1046/j.1365-2893.1999.00006.x,"Blackard, J., Shata, M., Shire, N., et. al, Acute hepatitis C virus infection: A chronic problem, Hepatology, 2008",cited-by,10.1002/hep.21902,Acute hepatitis C virus infection: A chronic problem,"[['Jason', 'T.', 'Blackard'], ['M.', 'Tarek', 'Shata'], ['Norah', 'J.', 'Shire'], ['Kenneth', 'E.', 'Sherman']]",Hepatology,2008,"[u'http://www.med.upenn.edu/gastro/documents/HepatologyAcuteHCV.pdf', u'http://texasliver.typepad.com/dr_joe_galatis_blog/files/hcv_review_2008.pdf', u'http://doi.wiley.com/10.1002/hep.21902']",
10.1046/j.1365-2893.1999.00006.x,"Robertson, S., Hasenkrug, K., , The role of virus-induced regulatory T cells in immunopathology, Springer Seminars in Immunopathology, 2006",cited-by,10.1007/s00281-006-0019-2,The role of virus-induced regulatory T cells in immunopathology,"[['Shelly', 'J.', 'Robertson'], ['Kim', 'J.', 'Hasenkrug']]",Springer Seminars in Immunopathology,2006,"[u'http://www.springerlink.com/index/672413278323615h.pdf', u'http://www.springerlink.com/content/672413278323615h', u'http://www.springerlink.com/index/10.1007/s00281-006-0019-2', u'http://www.springerlink.com/index/pdf/10.1007/s00281-006-0019-2']",
10.1046/j.1365-2893.1999.00006.x,"Arribillaga, L., Sarobe, P., Arina, A., et. al, Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.02.003,Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus,"[['Laura', '', 'Arribillaga'], ['Pablo', '', 'Sarobe'], ['Ainhoa', '', 'Arina'], ['Marta', '', 'Gorraiz'], ['Francisco', '', 'Borr\xc3\xa1s-Cuesta'], ['Juan', '', 'Ruiz'], ['Jes\xc3\xbas', '', 'Prieto'], ['Lieping', '', 'Chen'], ['Ignacio', '', 'Melero'], ['Juan', 'Jos\xc3\xa9', 'Lasarte']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05002628', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05002628']",
10.1046/j.1365-2893.1999.00006.x,"HIOE, C., TUEN, M., CHIEN, P., et. al, Inhibition of Human Immunodeficiency Virus Type 1 gp120 Presentation to CD4 T Cells by Antibodies Specific for the CD4 Binding Domain of gp120, Journal of Virology, 2001",cited-by,10.1128/JVI.75.22.10950-10957.2001,Inhibition of Human Immunodeficiency Virus Type 1 gp120 Presentation to CD4 T Cells by Antibodies Specific for the CD4 Binding Domain of gp120,"[['CATARINA', 'E.', 'HIOE'], ['MICHAEL', '', 'TUEN'], ['PETER', 'C.', 'CHIEN'], ['G.', '', 'Jones'], ['S.', '', 'Ratto-Kim'], ['P.', 'J.', 'Norris'], ['W.', 'J.', 'Moretto'], ['D.', 'F.', 'Nixon'], ['M.', 'K.', 'Gorny'], ['S.', '', 'Zolla-Pazner']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.22.10950-10957.2001', u'http://jvi.asm.org/cgi/reprint/75/22/10950.pdf']",
10.1046/j.1365-2893.1999.00006.x,"Lancaster, T., Sanders, E., Christie, J., et. al, Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00330.x,Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection,"[['T.', '', 'Lancaster'], ['E.', '', 'Sanders'], ['J.', 'M. L.', 'Christie'], ['C.', '', 'Brooks'], ['S.', '', 'Green'], ['W.', 'M. C.', 'Rosenberg']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00330.x'],
10.1046/j.1365-2893.1999.00006.x,"Nikolaeva, L., Blokhina, N., Tsurikova, N., et. al, Virus-specific antibody titres in different phases of hepatitis C virus infection, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00369.x,Virus-specific antibody titres in different phases of hepatitis C virus infection,"[['L.', 'I.', 'Nikolaeva'], ['N.', 'P.', 'Blokhina'], ['N.', 'N.', 'Tsurikova'], ['N.', 'V.', 'Voronkova'], ['M.', 'I.', 'Miminoshvili'], ['D.', 'M.', 'Braginsky'], ['O.', 'N.', 'Yastrebova'], ['O.', 'B.', 'Booynitskaya'], ['O.', 'V.', 'Isaeva'], ['M.', 'I.', 'Michailov'], ['A.', 'I.', 'Archakov']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00369.x'],
10.1046/j.1365-2893.1999.00006.x,"Sreenarasimhaiah, J., Jaramillo, A., Crippin, J., et. al, Concomitant augmentation of type 1 CD4 + and CD8 + T-cell responses during successful interferon-α and ribavirin treatment for chronic hepatitis C virus infection, Human Immunology, 2003",cited-by,10.1016/S0198-8859(03)00041-7,Concomitant augmentation of type 1 CD4 + and CD8 + T-cell responses during successful interferon-α and ribavirin treatment for chronic hepatitis C virus infection,"[['Jayaprakash', '', 'Sreenarasimhaiah'], ['Andr\xc3\xa9s', '', 'Jaramillo'], ['Jeffrey', '', 'Crippin'], ['Mauricio', '', 'Lisker-Melman'], ['William', 'C', 'Chapman'], ['T', '', 'Mohanakumar']]",Human Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0198885903000417', u'http://linkinghub.elsevier.com/retrieve/pii/S0198885903000417']",
10.1046/j.1365-2893.1999.00006.x,"Nisii, C., Tempestilli, M., Agrati, C., et. al, Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infection, Journal of Hepatology, 2006",cited-by,10.1016/j.jhep.2005.10.023,Accumulation of dysfunctional effector CD8+T cells in the liver of patients with chronic HCV infection,"[['Carla', '', 'Nisii'], ['Massimo', '', 'Tempestilli'], ['Chiara', '', 'Agrati'], ['Fabrizio', '', 'Poccia'], ['Guido', '', 'Tocci'], ['Maria', 'Antonella', 'Longo'], ['Gianpiero', '', ""D'Offizi""], ['Roberto', '', 'Tersigni'], ['Oreste', 'Lo', 'Iacono'], ['Giorgio', '', 'Antonucci'], ['Alessandra', '', 'Oliva']]",Journal of Hepatology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805007634', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805007634']",
10.1046/j.1365-2893.1999.00006.x,"Xiang, M., Eisenbach, C., Lupu, C., et. al, Induction of Antigen-Specific Immune Responses in Vivo After Vaccination with Dendritic Cells Transduced with Adenoviral Vectors Encoding Hepatitis C Virus NS3, Viral Immunology, 2006",cited-by,10.1089/vim.2006.19.210,Induction of Antigen-Specific Immune Responses in Vivo After Vaccination with Dendritic Cells Transduced with Adenoviral Vectors Encoding Hepatitis C Virus NS3,"[['Ming', '', 'Xiang'], ['Christoph', '', 'Eisenbach'], ['Catalin', 'Mario', 'Lupu'], ['Evelyn', '', 'Ernst'], ['Wolfgang', '', 'Stremmel'], ['Jens', '', 'Encke']]",Viral Immunology,2006,[u'http://www.liebertonline.com/doi/abs/10.1089/vim.2006.19.210'],
10.1046/j.1365-2893.1999.00006.x,"Jessner, W., Watkins-Riedel, T., Formann, E., et. al, Hepatitis C viral dynamics: basic concept and clinical significance, Journal of Clinical Virology, 2002",cited-by,10.1016/S1386-6532(02)00194-4,Hepatitis C viral dynamics: basic concept and clinical significance,"[['Wolfgang', '', 'Jessner'], ['Thomas', '', 'Watkins-Riedel'], ['Elisabeth', '', 'Formann'], ['Petra', '', 'Steindl-Munda'], ['Peter', '', 'Ferenci']]",Journal of Clinical Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1386653202001944', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001944']",
10.1046/j.1365-2893.1999.00006.x,"Yin, L., Zhu, W., Wei, L., et. al, Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection, , 2004",cited-by,6760615Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection,Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection,"[['Li-Min', '', 'Yin'], ['Wan-Fu', '', 'Zhu'], ['Lai', '', 'Wei'], ['Xiao-Yuan', '', 'Xu'], ['De-Gui', '', 'Sun'], ['Yan-Bin', '', 'Wang'], ['Wen-Mei', '', 'Fan'], ['Min', '', 'Yu'], ['Xiu-Lan', '', 'Tian'], ['Qi-Xin', '', 'Wang'], ['Yan', '', 'Gao'], ['Hui', '', 'Zhuang']]",,2004,[u'http://www.wjgnet.com/1007-9327/10/2330.pdf'],
10.1046/j.1365-2893.1999.00006.x,"Bouzgarrou, N., Hassen, E., Farhat, K., et. al, Combined analysis of interferon-γ and interleukin-10 gene polymorphisms and chronic hepatitis C severity, Human Immunology, 2009",cited-by,10.1016/j.humimm.2009.01.019,Combined analysis of interferon-γ and interleukin-10 gene polymorphisms and chronic hepatitis C severity,"[['Nadia', '', 'Bouzgarrou'], ['Elham', '', 'Hassen'], ['Karim', '', 'Farhat'], ['Olfa', '', 'Bahri'], ['Sallouha', '', 'Gabbouj'], ['Nadia', '', 'Maamouri'], ['Nabil', 'Ben', 'Mami'], ['Hammouda', '', 'Saffar'], ['Abdelhalim', '', 'Trabelsi'], ['Henda', '', 'Triki'], ['Lotfi', '', 'Chouchane']]",Human Immunology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S019888590900024X', u'http://linkinghub.elsevier.com/retrieve/pii/S019888590900024X']",
10.1046/j.1365-2893.1999.00006.x,"Wang, T., Blatt, L., Seiwert, S., , Immunomodulatory Activities of IFN1b in Combination with Type I IFN: Implications for the Use of IFN1b in the Treatment of Chronic HCV Infections, Journal of Interferon and Cytokine Research, 2006",cited-by,10.1089/jir.2006.26.473,Immunomodulatory Activities of IFN1b in Combination with Type I IFN: Implications for the Use of IFN1b in the Treatment of Chronic HCV Infections,"[['Tony', '', 'Wang'], ['Lawrence', 'M.', 'Blatt'], ['Scott', 'D.', 'Seiwert']]",Journal of Interferon and Cytokine Research,2006,[u'http://www.liebertonline.com/doi/abs/10.1089/jir.2006.26.473'],
10.1046/j.1365-2893.1999.00006.x,"Zhou, Y., Lukes, Y., Anderson, J., et. al, Hepatitis C virus E2 envelope protein induces dendritic cell maturation, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2007.00879.x,Hepatitis C virus E2 envelope protein induces dendritic cell maturation,"[['Y.', '', 'Zhou'], ['Y.', '', 'Lukes'], ['J.', '', 'Anderson'], ['B.', '', 'Fileta'], ['B.', '', 'Reinhardt'], ['M.', '', 'Sjogren']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2007.00879.x'],
10.1046/j.1365-2893.1999.00006.x,"Potthoff, A., Sarhaddar, J., Wiegand, J., et. al, Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse, Hepatology Research, 2005",cited-by,10.1016/j.hepres.2004.11.007,Spontaneous resolution of chronic hepatitis C virus infection after antiviral treatment and relapse,"[['Andrej', '', 'Potthoff'], ['Jasmin', '', 'Sarhaddar'], ['Johannes', '', 'Wiegand'], ['Ralf', '', 'Lichtinghagen'], ['Christoph', '', 'Sarrazin'], ['Ayse', '', 'Ciner'], ['Johannes', '', 'Hadem'], ['Christian', '', 'Trautwein'], ['Michael', 'Peter', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Hepatology Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1386634604003262', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634604003262']",
10.1046/j.1365-2893.1999.00006.x,"Carlos, M., Yamamura, Y., Vu, Q., et. al, Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b, Clinical Immunology, 2004",cited-by,10.1016/j.clim.2003.11.012,Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b,"[['Maria', 'P', 'Carlos'], ['Yasuhiro', '', 'Yamamura'], ['Quynh', '', 'Vu'], ['Kendra', '', 'Conzen'], ['David', 'E', 'Anderson'], ['Jos\xc3\xa9', 'V', 'Torres']]",Clinical Immunology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1521661603003231', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661603003231']",
10.1046/j.1365-2893.1999.00006.x,"Leleu, M., Pouvelle-Moratille, S., Farci, S., et. al, Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins, European Journal of Immunology, 2007",cited-by,10.1002/eji.200636783,Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins,"[['M\xc3\xa9lanie', '', 'Leleu'], ['Sandra', '', 'Pouvelle-Moratille'], ['Sandrine', '', 'Farci'], ['Muriel', '', 'Andrieu'], ['Claude', '', 'Auriault'], ['Andr\xc3\xa9', '', 'M\xc3\xa9nez'], ['Bertrand', '', 'Georges'], ['Bernard', '', 'Maillere']]",European Journal of Immunology,2007,[u'http://doi.wiley.com/10.1002/eji.200636783'],
10.1046/j.1365-2893.1999.00006.x,"Cohen, S., Tuen, M., Hioe, C., , Propagation of CD4+ T Cells Specific for HIV Type 1 Envelope gp120 from Chronically HIV Type 1Infected Subjects, Aids Research and Human Retroviruses, 2003",cited-by,10.1089/088922203769232593,Propagation of CD4+ T Cells Specific for HIV Type 1 Envelope gp120 from Chronically HIV Type 1Infected Subjects,"[['Sandra', '', 'Cohen'], ['Michael', '', 'Tuen'], ['Catarina', 'E.', 'Hioe']]",Aids Research and Human Retroviruses,2003,[u'http://www.liebertonline.com/doi/abs/10.1089%2F088922203769232593'],
10.1046/j.1365-2893.1999.00006.x,"Morin, T., Pariente, A., Lahmek, P., et. al, Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort, European Journal of Gastroenterology & Hepatology, 2010",cited-by,10.1097/MEG.0b013e328330a8e8,"Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort","[['Thierry', '', 'Morin'], ['Alexandre', '', 'Pariente'], ['Pierre', '', 'Lahmek'], ['Christian', '', 'Rabaud'], ['Christine', '', 'Silvain'], ['Jean', 'Fran\xc3\xa7ois', 'Cadranel']]",European Journal of Gastroenterology & Hepatology,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-201002000-00006'],
10.1046/j.1365-2893.1999.00006.x,"Langhans, B., Braunschweiger, I., Nischalke, H., et. al, Presentation of the HCV-derived lipopeptide LP20–44 by dendritic cells enhances function of in vitro-generated CD4 + T cells via up-regulation of TLR2, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.01.057,Presentation of the HCV-derived lipopeptide LP20–44 by dendritic cells enhances function of in vitro-generated CD4 + T cells via up-regulation of TLR2,"[['Bettina', '', 'Langhans'], ['Ingrid', '', 'Braunschweiger'], ['Hans-Dieter', '', 'Nischalke'], ['Jacob', '', 'Nattermann'], ['Tilman', '', 'Sauerbruch'], ['Ulrich', '', 'Spengler']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06000946', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06000946']",
10.1046/j.1365-2893.1999.00006.x,"Trivedi, H., Plummer, F., Anzala, A., et. al, Resistance to HIV1 infection among African sex workers is associated with global hyporesponsiveness in interleukin4 production, Faseb Journal, 2001",cited-by,10.1096/fj.00-0619fje,Resistance to HIV1 infection among African sex workers is associated with global hyporesponsiveness in interleukin4 production,"[['Harsha', 'N.', 'Trivedi'], ['Francis', 'A.', 'Plummer'], ['Aggrey', 'O.', 'Anzala'], ['Ephantus', '', 'Njagi'], ['Job', 'J.', 'Bwayo'], ['Elizabeth', 'N.', 'Ngugi'], ['Joanne', 'E.', 'Embree'], ['Kent', 'T.', 'HayGlass']]",Faseb Journal,2001,"[u'http://www.fasebj.org/cgi/reprint/00-0619fjev1.pdf', u'http://www.fasebj.org/cgi/doi/10.1096/fj.00-0619fje']",
10.1046/j.1365-2893.1999.00006.x,"PAWLOTSKY, J., , Virus de l'hépatite C et réponse immunitaire, , 2001",cited-by,6890072Virus de l'hépatite C et réponse immunitaire,Virus de l'hépatite C et réponse immunitaire,"[['Jean-Michel', '', 'PAWLOTSKY']]",,2001,"[u'http://www.snfge.org/01-bibliotheque/0j-seminaire/pdf/2001/2001-mod0-15.pdf', u'http://www.snfge.asso.fr/01-Bibliotheque/0J-Seminaire/pdf/2001/2001-mod0-15.pdf']",
10.1046/j.1365-2893.1999.00006.x,"Perrella, A., Grattacaso, S., d'Antonio, A., et. al, Evidence of hepatitis C virus–specific interferon gamma–positive T cells in health care workers in an infectious disease department, American Journal of Infection Control, 2009",cited-by,10.1016/j.ajic.2008.08.003,Evidence of hepatitis C virus–specific interferon gamma–positive T cells in health care workers in an infectious disease department,"[['Alessandro', '', 'Perrella'], ['Stella', '', 'Grattacaso'], ['Anna', '', ""d'Antonio""], ['Luigi', '', 'Atripaldi'], ['Costanza', '', 'Sbreglia'], ['MariaRosaria', '', 'Gnarini'], ['Pio', '', 'Conti'], ['Jacopo', '', 'Vecchiet'], ['Oreste', '', 'Perrella']]",American Journal of Infection Control,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0196655308007554', u'http://linkinghub.elsevier.com/retrieve/pii/S0196655308007554']",
10.1046/j.1365-2893.1999.00006.x,"Perrella, A., Arenga, G., Pisaniello, D., et. al, Elevated CD4 +/CD25 + T-cell Frequency and Function During Hepatitis C Virus Recurrence After Liver Transplantation, Transplantation Proceedings, 2009",cited-by,10.1016/j.transproceed.2009.01.112,Elevated CD4 +/CD25 + T-cell Frequency and Function During Hepatitis C Virus Recurrence After Liver Transplantation,"[['A.', '', 'Perrella'], ['G.', '', 'Arenga'], ['D.', '', 'Pisaniello'], ['B.', '', 'Rampone'], ['G.', 'G. Di', 'Costanzo'], ['L.', '', 'Atripaldi'], ['C.', '', 'Esposito'], ['E.', 'Di', 'Florio'], ['O.', '', 'Perrella'], ['O.', '', 'Cuomo']]",Transplantation Proceedings,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0041134509002929', u'http://linkinghub.elsevier.com/retrieve/pii/S0041134509002929']",
10.1046/j.1365-2893.1999.00006.x,"Hung, C., Lu, S., Wang, J., et. al, Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.049,Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study,"[['Chao-Hung', '', 'Hung'], ['Sheng-Nan', '', 'Lu'], ['Jing-Houng', '', 'Wang'], ['Shu-Fen', '', 'Hung'], ['Chien-Hung', '', 'Chen'], ['Tsung-Hui', '', 'Hu'], ['Chuan-Mo', '', 'Lee'], ['Chi-Sin', '', 'Changchien']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000868', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000868']",
10.1046/j.1365-2893.1999.00006.x,"Gao, M., Wang, H., Wang, Y., et. al, HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4 + Th1 cell responses in vivo, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.04.004,HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4 + Th1 cell responses in vivo,"[['Ming', '', 'Gao'], ['Hai-Ping', '', 'Wang'], ['Yan-Ning', '', 'Wang'], ['Yong', '', 'Zhou'], ['Quan-Li', '', 'Wang']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0600418X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0600418X']",
10.1046/j.1365-2893.1999.00006.x,"Nascimbeni, M., Rehermann, B., , Chronic HCV infection and the clonality of intrahepatic T cells, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00121-1,Chronic HCV infection and the clonality of intrahepatic T cells,"[['Michelina', '', 'Nascimbeni'], ['Barbara', '', 'Rehermann']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803001211', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803001211']",
10.1046/j.1365-2893.1999.00006.x,"Bouzgarrou, N., Hassen, E., Bahri, O., et. al, Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients, Hepatology International, 2011",cited-by,10.1007/s12072-010-9232-0,Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients,"[['Nadia', '', 'Bouzgarrou'], ['Elham', '', 'Hassen'], ['Olfa', '', 'Bahri'], ['Sallouha', '', 'Gabbouj'], ['Nabil', 'Ben', 'Mami'], ['Henda', '', 'Triki'], ['Lotfi', '', 'Chouchane']]",Hepatology International,2011,"[u'http://www.springerlink.com/index/7944749104980647.pdf', u'http://www.springerlink.com/content/7944749104980647']",
10.1046/j.1365-2893.1999.00006.x,"Wang, Y., Milliman, H., Connor, D., et. al, Modification of polymers using multilayered “smart pellet” additives: Part II, Polymer, 2011",cited-by,10.1016/j.polymer.2011.04.036,Modification of polymers using multilayered “smart pellet” additives: Part II,"[['Yuxin', '', 'Wang'], ['Henry', 'W.', 'Milliman'], ['Daniel', 'M.', 'Connor'], ['Nathan', 'A.', 'Mehl'], ['David', 'A.', 'Schiraldi']]",Polymer,2011,[u'http://www.sciencedirect.com/science/article/pii/S0032386111003284'],
10.1046/j.1365-2893.1999.00006.x,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1046/j.1365-2893.1999.00006.x,"Bouzgarrou, N., Hassen, E., Gabbouj, S., et. al, Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients, Gastroenterologie Clinique Et Biologique, 2010",cited-by,10.1016/j.gcb.2010.03.008,Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients,"[['N.', '', 'Bouzgarrou'], ['E.', '', 'Hassen'], ['S.', '', 'Gabbouj'], ['E.', '', 'Schvoerer'], ['N.', 'Ben', 'Mami'], ['H.', '', 'Triki'], ['L.', '', 'Chouchane']]",Gastroenterologie Clinique Et Biologique,2010,"[u'http://www.sciencedirect.com/science/article/pii/S039983201000120X', u'http://linkinghub.elsevier.com/retrieve/pii/S039983201000120X']",
10.1046/j.1365-2893.1999.00006.x,"Lalazar, G., Ilan, Y., , Histamine dihydrochloride: actions and efficacy in the treatment of chronic hepatitis C infection, Expert Review of Anti-infective Therapy, 2006",cited-by,10.1586/14787210.4.3.377,Histamine dihydrochloride: actions and efficacy in the treatment of chronic hepatitis C infection,"[['Gadi', '', 'Lalazar'], ['Yaron', '', 'Ilan']]",Expert Review of Anti-infective Therapy,2006,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.4.3.377'],
10.1046/j.1365-2893.1999.00006.x,"Levorsen, A., Aasland, O., , PHP34 PHYSICIANS' ATTITUDES TO AND EXPERIENCE WITH INCREASED USE OF INDIVIDUAL REIMBURSEMENT VERSUS GENERAL REIMBURSEMENT OF NEW IMPORTANT PHARMACEUTICALS, Value in Health, 2006",cited-by,10.1016/S1098-3015(10)63252-4,PHP34 PHYSICIANS' ATTITUDES TO AND EXPERIENCE WITH INCREASED USE OF INDIVIDUAL REIMBURSEMENT VERSUS GENERAL REIMBURSEMENT OF NEW IMPORTANT PHARMACEUTICALS,"[['A', '', 'Levorsen'], ['OG', '', 'Aasland']]",Value in Health,2006,[u'http://www.sciencedirect.com/science/article/pii/S1098301510632524'],
10.1046/j.1365-2893.1999.00006.x,"Blut, A., , Hepatitis C Virus (HCV), , 2003",cited-by,57386774Hepatitis C Virus (HCV),Hepatitis C Virus (HCV),"[['Arbeitskreis', '', 'Blut']]",,2003,[],
10.1046/j.1365-2893.1999.00006.x,"Marinho, R., Pinto, R., Santos, M., et. al, Evidence for Prostaglandin-Producing Supressor Cells in HCV Patients with Normal ALT, Digestive Diseases and Sciences, 2002",cited-by,10.1023/A:1017911918332,Evidence for Prostaglandin-Producing Supressor Cells in HCV Patients with Normal ALT,"[['Rui', '', 'Marinho'], ['Ruth', '', 'Pinto'], ['Maria', 'Livia', 'Santos'], ['Miguel', 'Carneiro de', 'Moura']]",Digestive Diseases and Sciences,2002,"[u'http://www.springerlink.com/index/7pa8d5bre4auvywk.pdf', u'http://www.springerlink.com/content/7pa8d5bre4auvywk']",
10.1046/j.1365-2893.1999.00006.x,"Cooper, S., Glenn, J., Greenberg, H., , Host–microbe interactions: viruses, Current Opinion in Microbiology, 2000",cited-by,10.1016/S1369-5274(00)00105-3,Host–microbe interactions: viruses,"[['Stewart', 'S', 'Cooper'], ['Jeffery', '', 'Glenn'], ['Harry', 'B', 'Greenberg']]",Current Opinion in Microbiology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1369527400001053', u'http://linkinghub.elsevier.com/retrieve/pii/S1369527400001053']",
10.1056~NEJMoa011232,"Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000;32:91-6.",references,10.1053/jhep.2000.8169,Low Frequency of Cirrhosis in a Hepatitis C (Genotype 1b) Single-Source Outbreak in Germany: A 20Year Multicenter Study,"[[u'Manfred', u'', u'Wiese'], [u'Frieder', u'', u'Berr'], [u'Michael', u'', u'Lafrenz'], [u'Heiner', u'', u'Porst'], [u'Ute', u'', u'Oesen']]",Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0270913900040635', u'http://doi.wiley.com/10.1053/jhep.2000.8169']","[{u'Name': u'Chronic Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5702}, {u'Name': u'East Germany', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 11397}, {u'Name': u'Hepatitis B', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17862}, {u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Young Women', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 45652}, {u'Name': u'Low Frequency', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 59811}, {u'Name': u'Low Risk', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 60324}]"
10.1053/jhep.2000.8169,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
10.1053/jhep.2000.8169,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1053/jhep.2000.8169,"Ghany, M., Strader, D., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009",cited-by,10.1002/hep.22759,"Diagnosis, management, and treatment of hepatitis C: An update","[['Marc', 'G.', 'Ghany'], ['Doris', 'B.', 'Strader'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2009,"[u'http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/diagnosis_of_hep_c_update.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Hepatitis%20C%20UPDATE.pdf', u'http://www.sklid.com/news/uploadfiles/20094122357635.pdf', u'http://www.coloradoguidelines.org/pdf/hepatitisbc/Diagnosis_of_HEP_C_Update_Aug%20_09.pdf', u'http://www.paml.com/Files/Miscellaneous/Hep%20C%20Diagnosis,Manage,Treatment%20Apr%202009.pdf', u'http://doi.wiley.com/10.1002/hep.22759', u'http://zuberi.biz/guidelines/AASLD_HEP_C_2009.pdf']",
10.1053/jhep.2000.8169,"Freeman, A., Dore, G., Law, M., et. al, Estimating progression to cirrhosis in chronic hepatitis C virus infection, Hepatology, 2001",cited-by,10.1053/jhep.2001.27831,Estimating progression to cirrhosis in chronic hepatitis C virus infection,"[['Anthony', 'J.', 'Freeman'], ['Gregory', 'J.', 'Dore'], ['Matthew', 'G.', 'Law'], ['Max', '', 'Thorpe'], ['Jan', 'Von', 'Overbeck'], ['Andrew', 'R.', 'Lloyd'], ['George', '', 'Marinos'], ['John', 'M.', 'Kaldor']]",Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270913901810934', u'http://www.sciencedirect.com/science/article/pii/S0270913901333190', u'http://doi.wiley.com/10.1053/jhep.2001.27831']",
10.1053/jhep.2000.8169,"Marcellin, P., Asselah, T., Boyer, N., , Fibrosis and disease progression in hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36993,Fibrosis and disease progression in hepatitis C,"[['Patrick', '', 'Marcellin'], ['Tarik', '', 'Asselah'], ['Nathalie', '', 'Boyer']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Fibrosis%20And%20Disease%20Progression%20In%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360707', u'http://doi.wiley.com/10.1053/jhep.2002.36993']",
10.1053/jhep.2000.8169,"Kim, W., Jr, R., Terrault, N., et. al, Burden of liver disease in the United States: Summary of a workshop, Hepatology, 2002",cited-by,10.1053/jhep.2002.34734,Burden of liver disease in the United States: Summary of a workshop,"[['W.', 'Ray', 'Kim'], ['Robert', 'S. Brown', 'Jr'], ['Norah', 'A.', 'Terrault'], ['Hashem', '', 'El-Serag']]",Hepatology,2002,"[u'https://www250.safesecureweb.com/hcvadvocate/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Burden.pdf', u'http://www.sciencedirect.com/science/article/pii/S0270913902000265', u'http://www.hcvadvocate.org/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Burden.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.34734']",
10.1053/jhep.2000.8169,"Dienstag, J., , The role of liver biopsy in chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36381,The role of liver biopsy in chronic hepatitis C,"[['Jules', 'L.', 'Dienstag']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Role%20Of%20Liver%20Biopsy%20In%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36381', u'http://doi.wiley.com/10.1002/hep.1840360720']",
10.1053/jhep.2000.8169,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1053/jhep.2000.8169,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1053/jhep.2000.8169,"Wedemeyer, H., He, X., Nascimbeni, M., et. al, Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1, , 0",cited-by,11243134Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,"[['Heiner', '', 'Wedemeyer'], ['Xiao-Song', '', 'He'], ['Michelina', '', 'Nascimbeni'], ['Anthony', 'R.', 'Davis'], ['Harry', 'B.', 'Greenberg'], ['Jay', 'H.', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Harvey', '', 'Alter'], ['Barbara', '', 'Rehermann']]",,0,[u'http://www.jimmunol.org/cgi/reprint/169/6/3447.pdf'],
10.1053/jhep.2000.8169,"London, W., , Epidemiology and natural history of hepatocellular carcinoma, Best Practice & Research in Clinical Gastroenterology, 2005",cited-by,10.1016/j.bpg.2004.10.004,Epidemiology and natural history of hepatocellular carcinoma,"[['W.', 'Thomas', 'London']]",Best Practice & Research in Clinical Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1521691804001465', u'http://linkinghub.elsevier.com/retrieve/pii/S1521691804001465']",
10.1053/jhep.2000.8169,"Thomas, D., Seeff, L., , Natural History of Hepatitis C, Clinics in Liver Disease, 2005",cited-by,10.1016/j.cld.2005.05.003,Natural History of Hepatitis C,"[['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Clinics in Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105000358', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105000358']",
10.1053/jhep.2000.8169,"Muzzi, A., Leandro, G., Rubbia-Brandt, L., et. al, Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.09.022,Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients,"[['Alba', '', 'Muzzi'], ['Gioacchino', '', 'Leandro'], ['Laura', '', 'Rubbia-Brandt'], ['Richard', '', 'James'], ['Olivia', '', 'Keiser'], ['Raffaele', '', 'Malinverni'], ['Jean-Fran\xc3\xa7ois', '', 'Dufour'], ['Beat', '', 'Helbling'], ['Antoine', '', 'Hadengue'], ['Jean-Jacques', '', 'Gonvers'], ['Beat', '', 'M\xc3\xbcllhaupt'], ['Andreas', '', 'Cerny'], ['Mario', 'U.', 'Mondelli'], ['Francesco', '', 'Negro']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004696', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004696']",
10.1053/jhep.2000.8169,"Alberti, A., Benvegnù, L., , Management of hepatitis C, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00008-4,Management of hepatitis C,"[['Alfredo', '', 'Alberti'], ['Luisa', '', 'Benvegn\xc3\xb9']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803000084', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803000084']",
10.1053/jhep.2000.8169,"Schuppan, D., Krebs, A., Bauer, M., et. al, Hepatitis C and liver fibrosis, Cell Death and Differentiation, 2003",cited-by,10.1038/sj.cdd.4401163,Hepatitis C and liver fibrosis,"[['D', '', 'Schuppan'], ['A', '', 'Krebs'], ['M', '', 'Bauer'], ['E', 'G', 'Hahn']]",Cell Death and Differentiation,2003,"[u'http://www.nature.com/doifinder/10.1038/sj.cdd.4401163', u'http://dx.doi.org/10.1038/sj.cdd.4401163']",
10.1053/jhep.2000.8169,"Huang, H., Shiffman, M., Friedman, S., et. al, A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C, Hepatology, 2007",cited-by,10.1002/hep.21695,A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C,"[['Hongjin', '', 'Huang'], ['Mitchell', 'L.', 'Shiffman'], ['Scott', '', 'Friedman'], ['Ramasubbu', '', 'Venkatesh'], ['Natalie', '', 'Bzowej'], ['Olivia', 'T.', 'Abar'], ['Charles', 'M.', 'Rowland'], ['Joseph', 'J.', 'Catanese'], ['Diane', 'U.', 'Leong'], ['John', 'J.', 'Sninsky'], ['Thomas', 'J.', 'Layden'], ['Teresa', 'L.', 'Wright'], ['Thomas', '', 'White'], ['Ramsey', 'C.', 'Cheung']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21695'],
10.1053/jhep.2000.8169,"Simmonds, P., , The origin and evolution of hepatitis viruses in humans, , 0",cited-by,12032682The origin and evolution of hepatitis viruses in humans,The origin and evolution of hepatitis viruses in humans,"[['Peter', '', 'Simmonds']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/82/4/693.pdf'],
10.1053/jhep.2000.8169,"Casiraghi, M., Paschale, M., Biffi, R., et. al, Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth, Hepatology, 2004",cited-by,10.1002/hep.20030,Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth,"[['Maria', 'Antonietta', 'Casiraghi'], ['Massimo', 'De', 'Paschale'], ['Renato', '', 'Biffi'], ['Agnese', '', 'Assi'], ['Giorgio', '', 'Binelli'], ['Alessandro', 'Remo', 'Zanetti']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo416.pdf', u'http://doi.wiley.com/10.1002/hep.20030']",
10.1053/jhep.2000.8169,"Meyers, C., Seeff, L., Stehman-Breen, C., et. al, Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00828-X,"Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD","[['Catherine', 'M.', 'Meyers'], ['Leonard', 'B.', 'Seeff'], ['Catherine', 'O.', 'Stehman-Breen'], ['Jay', 'H.', 'Hoofnagle']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S027263860300828X', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as027263860300828x', u'http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/Hep C and GN AJKD 05.pdf']",
10.1053/jhep.2000.8169,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1053/jhep.2000.8169,"Freeman, A., Law, M., Kaldor, J., et. al, Predicting progression to cirrhosis in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00436.x,Predicting progression to cirrhosis in chronic hepatitis C virus infection,"[['A.', 'J.', 'Freeman'], ['M.', 'G.', 'Law'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00436.x'],
10.1053/jhep.2000.8169,"Roth, W., Weber, M., Buhr, S., et. al, Yield of HCV and HIV1 NAT after screening of 3.6 million blood donations in central Europe, Transfusion, 2002",cited-by,10.1046/j.1537-2995.2002.00129.x,Yield of HCV and HIV1 NAT after screening of 3.6 million blood donations in central Europe,"[['W.', 'Kurt', 'Roth'], ['Marijke', '', 'Weber'], ['Sylvia', '', 'Buhr'], ['Christian', '', 'Drosten'], ['Wolfgang', '', 'Weichert'], ['Walid', '', 'Sireis'], ['Doris', '', 'Hedges'], ['Erhard', '', 'Seifried']]",Transfusion,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2002.00129.x'],
10.1053/jhep.2000.8169,"Planas, R., Ballesté, B., Álvarez, M., et. al, Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients, Journal of Hepatology, 2004",cited-by,10.1016/j.jhep.2004.01.005,Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients,"[['Ramon', '', 'Planas'], ['Bel\xc3\xa9n', '', 'Ballest\xc3\xa9'], ['Marco', 'Antonio', '\xc3\x81lvarez'], ['Monica', '', 'Rivera'], ['Silvia', '', 'Montoliu'], ['Josep', 'Anton', 'Galeras'], ['Justiniano', '', 'Santos'], ['Susanna', '', 'Coll'], ['Rosa', 'Maria', 'Morillas'], ['Ricard', '', 'Sol\xc3\xa0']]",Journal of Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804000145', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804000145']",
10.1053/jhep.2000.8169,"Wiese, M., Grüngreiff, K., Güthoff, W., et. al, Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.04.007,Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study,"[['Manfred', '', 'Wiese'], ['Kurt', '', 'Gr\xc3\xbcngreiff'], ['Wolfgang', '', 'G\xc3\xbcthoff'], ['Michael', '', 'Lafrenz'], ['Ute', '', 'Oesen'], ['Heiner', '', 'Porst']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S016882780500317X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780500317X']",
10.1053/jhep.2000.8169,"Thein, H., Yi, Q., Dore, G., et. al, Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression, Hepatology, 2008",cited-by,10.1002/hep.22375,Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression,"[['Hla-Hla', '', 'Thein'], ['Qilong', '', 'Yi'], ['Gregory', 'J.', 'Dore'], ['Murray', 'D.', 'Krahn']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.22375'],
10.1053/jhep.2000.8169,"Brown, R., Gaglio, P., , Scope of worldwide hepatitis C problem, Liver Transplantation, 2003",cited-by,10.1053/jlts.2003.50244,Scope of worldwide hepatitis C problem,"[['Robert', 'S.', 'Brown'], ['Paul', 'J.', 'Gaglio']]",Liver Transplantation,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1527646503807232', u'http://doi.wiley.com/10.1053/jlts.2003.50244']",
10.1053/jhep.2000.8169,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1053/jhep.2000.8169,"Mohamed, M., Abdel-Hamid, M., Mikhail, N., et. al, Intrafamilial transmission of hepatitis C in Egypt, Hepatology, 2005",cited-by,10.1002/hep.20811,Intrafamilial transmission of hepatitis C in Egypt,"[['Mostafa', 'K.', 'Mohamed'], ['Mohamed', '', 'Abdel-Hamid'], ['Nabiel', 'N.', 'Mikhail'], ['Fatma', '', 'Abdel-Aziz'], ['Ahmed', '', 'Medhat'], ['Laurence', 'S.', 'Magder'], ['Alan', 'D.', 'Fix'], ['G.', 'Thomas', 'Strickland']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20811'],
10.1053/jhep.2000.8169,"Lanford, R., Bigger, C., , Advances in Model Systems for Hepatitis C Virus Research, Virology, 2002",cited-by,10.1006/viro.2001.1316,Advances in Model Systems for Hepatitis C Virus Research,"[['Robert', 'E.', 'Lanford'], ['Catherine', '', 'Bigger']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0042682201913169', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682201913169']",
10.1053/jhep.2000.8169,"Martino, V., Lebray, P., Myers, R., et. al, Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure, Hepatology, 2004",cited-by,10.1002/hep.20463,Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure,"[['Vincent', 'Di', 'Martino'], ['Pascal', '', 'Lebray'], ['Robert', 'P.', 'Myers'], ['Emmanuelle', '', 'Pannier'], ['Joseph', '', 'Moussalli'], ['Dominique', '', 'Thabut'], ['Catherine', '', 'Buffet'], ['Thierry', '', 'Poynard']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20463'],
10.1053/jhep.2000.8169,"Freeman, A., Marinos, G., Ffrench, R., et. al, Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001",cited-by,10.1046/j.1440-1711.2001.01036.x,Immunopathogenesis of hepatitis C virus infection,"[['Anthony', 'J', 'Freeman'], ['George', '', 'Marinos'], ['Rosemary', 'A', 'Ffrench'], ['Andrew', 'R', 'Lloyd']]",Immunology and Cell Biology,2001,"[u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2001.01036.x', u'http://dx.doi.org/10.1046/j.1440-1711.2001.01036.x']",
10.1053/jhep.2000.8169,"Kanzler, S., Baumann, M., Schirmacher, P., et. al, Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00314.x,Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta,"[['S.', '', 'Kanzler'], ['M.', '', 'Baumann'], ['P.', '', 'Schirmacher'], ['V.', '', 'Dries'], ['E.', '', 'Bayer'], ['G.', '', 'Gerken'], ['H.-P.', '', 'Dienes'], ['A.', 'W.', 'Lohse']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00314.x'],
10.1053/jhep.2000.8169,"Missiha, S., Ostrowski, M., Heathcote, E., , Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008",cited-by,10.1053/j.gastro.2008.02.069,Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors,"[['Sharif', 'B.', 'Missiha'], ['Mario', '', 'Ostrowski'], ['E.', 'Jenny', 'Heathcote']]",Gastroenterology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S001650850800348X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850800348X']",
10.1053/jhep.2000.8169,"Dalgard, O., Egeland, A., Skaug, K., et. al, Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection, Hepatology, 2004",cited-by,10.1002/hep.20014,Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection,"[['Olav', '', 'Dalgard'], ['Atle', '', 'Egeland'], ['Kjell', '', 'Skaug'], ['Kostas', '', 'Vilimas'], ['Tore', '', 'Steen']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo397.pdf', u'http://www.hcvu.org/mlib/2007_03_15-Dalgard_Hepatology_2004.pdf', u'http://doi.wiley.com/10.1002/hep.20014']",
10.1053/jhep.2000.8169,"Bialek, S., Terrault, N., , The Changing Epidemiology and Natural History of Hepatitis C Virus Infection, Clinics in Liver Disease, 2006",cited-by,10.1016/j.cld.2006.08.003,The Changing Epidemiology and Natural History of Hepatitis C Virus Infection,"[['Stephanie', 'R.', 'Bialek'], ['Norah', 'A.', 'Terrault']]",Clinics in Liver Disease,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1089326106000183', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326106000183']",
10.1053/jhep.2000.8169,"Feld, J., Liang, T., , Hepatitis C — identifying patients with progressive liver injury, Hepatology, 2006",cited-by,10.1002/hep.21065,Hepatitis C — identifying patients with progressive liver injury,"[['Jordan', 'J.', 'Feld'], ['T.', 'Jake', 'Liang']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21065'],
10.1053/jhep.2000.8169,"Neuman, M., Benhamou, J., Malkiewicz, I., et. al, Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00343.x,Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis,"[['M.', 'G.', 'Neuman'], ['J.', 'P.', 'Benhamou'], ['I.', 'M.', 'Malkiewicz'], ['A.', '', 'Ibrahim'], ['D.', 'C.', 'Valla'], ['M.', '', 'Martinot-Peignoux'], ['T.', '', 'Asselah'], ['M.', '', 'Bourliere'], ['G.', 'G.', 'Katz'], ['N.', 'H.', 'Shear'], ['P.', '', 'Marcellin']]",Journal of Viral Hepatitis,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1365-2893.2002.00343.x'],
10.1053/jhep.2000.8169,"Myers, R., Patel, K., Pianko, S., et. al, The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00387.x,The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C,"[['R.', 'P.', 'Myers'], ['K.', '', 'Patel'], ['S.', '', 'Pianko'], ['T.', '', 'Poynard'], ['J.', 'G.', 'McHutchison']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00387.x'],
10.1053/jhep.2000.8169,"Cornberg, M., Wedemeyer, H., Manns, M., , Treatment of chronic hepatitis C with PEGylated interferon and ribavirin, Current Gastroenterology Reports, 2002",cited-by,10.1007/s11894-002-0034-y,Treatment of chronic hepatitis C with PEGylated interferon and ribavirin,"[['Markus', '', 'Cornberg'], ['Heiner', '', 'Wedemeyer'], ['Michael', 'P.', 'Manns']]",Current Gastroenterology Reports,2002,"[u'http://www.springerlink.com/index/763g5k122367nu04.pdf', u'http://www.springerlink.com/content/763g5k122367nu04', u'http://www.springerlink.com/index/10.1007/s11894-002-0034-y', u'http://www.springerlink.com/index/pdf/10.1007/s11894-002-0034-y']",
10.1053/jhep.2000.8169,"Pellicano, R., Mazzaferro, V., Grigioni, W., et. al, Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma, , 2004",cited-by,6462951Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma,Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma,"[['Rinaldo', '', 'Pellicano'], ['Vincenzo', '', 'Mazzaferro'], ['Walter', 'Franco', 'Grigioni'], ['Miguel', 'Angel', 'Cutufia'], ['Sharmila', '', 'Fagoonee'], ['Lorenzo', '', 'Silengo'], ['Mario', '', 'Rizzetto'], ['Antonio', '', 'Ponzetto']]",,2004,[u'http://www.wjgnet.com/1007-9327/10/598.pdf'],
10.1053/jhep.2000.8169,"Mueller, T., Mas-Marques, A., Sarrazin, C., et. al, Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection, Journal of Hepatology, 2004",cited-by,10.1016/j.jhep.2004.06.021,Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection,"[['Tobias', '', 'Mueller'], ['Andreas', '', 'Mas-Marques'], ['Christoph', '', 'Sarrazin'], ['Manfred', '', 'Wiese'], ['Juliane', '', 'Halangk'], ['Heiko', '', 'Witt'], ['Golo', '', 'Ahlenstiel'], ['Ulrich', '', 'Spengler'], ['Uwe', '', 'Goebel'], ['Bertram', '', 'Wiedenmann'], ['Eckart', '', 'Schreier'], ['Thomas', '', 'Berg']]",Journal of Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804002776', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804002776']",
10.1053/jhep.2000.8169,"Tanaka, H., Tsukuma, H., Yamano, H., et. al, Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus, International Journal of Cancer, 2004",cited-by,10.1002/ijc.20507,"Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus","[['Hideo', '', 'Tanaka'], ['Hideaki', '', 'Tsukuma'], ['Hajime', '', 'Yamano'], ['Akira', '', 'Oshima'], ['Hirotoshi', '', 'Shibata']]",International Journal of Cancer,2004,[u'http://doi.wiley.com/10.1002/ijc.20507'],
10.1053/jhep.2000.8169,"Hutchinson, S., Bird, S., Goldberg, D., , Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland, Hepatology, 2005",cited-by,10.1002/hep.20836,Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland,"[['Sharon', 'J.', 'Hutchinson'], ['Sheila', 'M.', 'Bird'], ['David', 'J.', 'Goldberg']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20836'],
10.1053/jhep.2000.8169,"Campbell, M., Reddy, K., , The evolving role of liver biopsy, Alimentary Pharmacology & Therapeutics, 2004",cited-by,10.1111/j.1365-2036.2004.02071.x,The evolving role of liver biopsy,"[['M.', 'S.', 'Campbell'], ['K.', 'R.', 'Reddy']]",Alimentary Pharmacology & Therapeutics,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2004.02071.x'],
10.1053/jhep.2000.8169,"Wedemeyer, H., Wiegand, J., Cornberg, M., et. al, Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20221,Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C,"[['Heiner', '', 'Wedemeyer'], ['Johannes', '', 'Wiegand'], ['Markus', '', 'Cornberg'], ['Michael', 'P.', 'Manns']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20221'],
10.1053/jhep.2000.8169,"Bernardin, F., Tobler, L., Walsh, I., et. al, Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia, Hepatology, 2008",cited-by,10.1002/hep.22184,Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia,"[['Flavien', '', 'Bernardin'], ['Leslie', '', 'Tobler'], ['Irina', '', 'Walsh'], ['Joan', 'Dunn', 'Williams'], ['Mike', '', 'Busch'], ['Eric', '', 'Delwart']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.22184'],
10.1053/jhep.2000.8169,"Seifert, U., Liermann, H., Racanelli, V., et. al, Hepatitis C virus mutation affects proteasomal epitope processing, Journal of Clinical Investigation, 2004",cited-by,10.1172/JCI20985,Hepatitis C virus mutation affects proteasomal epitope processing,"[['Ulrike', '', 'Seifert'], ['Heike', '', 'Liermann'], ['Vito', '', 'Racanelli'], ['Anne', '', 'Halenius'], ['Manfred', '', 'Wiese'], ['Heiner', '', 'Wedemeyer'], ['Thomas', '', 'Ruppert'], ['Kay', '', 'Rispeter'], ['Peter', '', 'Henklein'], ['Alice', '', 'Sijts'], ['Hartmut', '', 'Hengel'], ['Peter-M.', '', 'Kloetzel'], ['Barbara', '', 'Rehermann']]",Journal of Clinical Investigation,2004,[u'http://www.jci.org/articles/view/20985'],
10.1053/jhep.2000.8169,"Kew, M., Francois, G., Lavanchy, D., et. al, Prevention of hepatitis C virus infection, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00492.x,Prevention of hepatitis C virus infection,"[['M.', '', 'Kew'], ['G.', '', 'Francois'], ['D.', '', 'Lavanchy'], ['H.', '', 'Margolis'], ['P.', 'Van', 'Damme'], ['P.', '', 'Grob'], ['J.', '', 'Hallauer'], ['D.', '', 'Shouval'], ['G.', '', 'Leroux-Roels'], ['A.', '', 'Meheus']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00492.x'],
10.1053/jhep.2000.8169,"Tillmann, H., Thompson, A., Patel, K., et. al, A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice, Gastroenterology, 2010",cited-by,10.1053/j.gastro.2010.07.005,A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice,"[['Hans', 'L.', 'Tillmann'], ['Alex', 'J.', 'Thompson'], ['Keyur', '', 'Patel'], ['Manfred', '', 'Wiese'], ['Hannelore', '', 'Tenckhoff'], ['Hans', 'D.', 'Nischalke'], ['Yuliya', '', 'Lokhnygina'], ['Ulrike', '', 'Kullig'], ['Uwe', '', 'G\xc3\xb6bel'], ['Emanuela', '', 'Capka'], ['Johannes', '', 'Wiegand'], ['Ingolf', '', 'Schiefke'], ['Wolfgang', '', 'G\xc3\xbcthoff'], ['Kurt', '', 'Gr\xc3\xbcngreiff'], ['Ingrid', '', 'K\xc3\xb6nig'], ['Ulrich', '', 'Spengler'], ['Jeanette', '', 'McCarthy'], ['Kevin', 'V.', 'Shianna'], ['David', 'B.', 'Goldstein'], ['John', 'G.', 'McHutchison'], ['J\xc3\xb6rg', '', 'Timm'], ['Jacob', '', 'Nattermann']]",Gastroenterology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0016508510010474', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508510010474']",
10.1053/jhep.2000.8169,"Neumann-Haefelin, C., Frick, D., Wang, J., et. al, Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level, Journal of Virology, 2008",cited-by,10.1128/JVI.01700-07,Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level,"[['Christoph', '', 'Neumann-Haefelin'], ['David', 'N.', 'Frick'], ['Jing', 'Jing', 'Wang'], ['Oliver', 'G.', 'Pybus'], ['Shadi', '', 'Salloum'], ['Gagandeep', 'S.', 'Narula'], ['Anna', '', 'Eckart'], ['Andrea', '', 'Biezynski'], ['Thomas', '', 'Eiermann'], ['Paul', '', 'Klenerman'], ['Sergei', '', 'Viazov'], ['Michael', '', 'Roggendorf'], ['Robert', '', 'Thimme'], ['Markus', '', 'Reiser'], ['Jorg', '', 'Timm']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/7/3438.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01700-07']",
10.1053/jhep.2000.8169,"Tobler, L., Stramer, S., Lee, S., et. al, Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening, Transfusion, 2003",cited-by,10.1046/j.1537-2995.2003.00521.x,Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening,"[['Leslie', 'H.', 'Tobler'], ['Susan', 'L.', 'Stramer'], ['Stephen', 'R.', 'Lee'], ['Barbara', 'L.', 'Masecar'], ['Jon', 'E.', 'Peterson'], ['E.', 'Anne', 'Davis'], ['William', 'E.', 'Andrews'], ['Jaye', 'P.', 'Brodsky'], ['Steven', 'H.', 'Kleinman'], ['Bruce', 'H.', 'Phelps'], ['Michael', 'P.', 'Busch']]",Transfusion,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2003.00521.x'],
10.1053/jhep.2000.8169,"Sezaki, H., Suzuki, F., Kawamura, Y., et. al, Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads, Digestive Diseases and Sciences, 2009",cited-by,10.1007/s10620-008-0500-y,Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads,"[['Hitomi', '', 'Sezaki'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Tetsuya', '', 'Hosaka'], ['Norio', '', 'Akuta'], ['Masahiro', '', 'Kobayashi'], ['Yoshiyuki', '', 'Suzuki'], ['Satoshi', '', 'Saitoh'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Yuzo', '', 'Miyakawa'], ['Hiromitsu', '', 'Kumada']]",Digestive Diseases and Sciences,2009,"[u'http://www.springerlink.com/content/e63232l537q8128t', u'http://www.springerlink.com/index/e63232l537q8128t.pdf', u'http://www.springerlink.com/index/10.1007/s10620-008-0500-y', u'http://www.springerlink.com/index/pdf/10.1007/s10620-008-0500-y']",
10.1053/jhep.2000.8169,"Levine, R., Sanderson, S., Murray, F., et. al, Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D, Clinical Gastroenterology and Hepatology, 2006",cited-by,10.1016/j.cgh.2006.05.028,Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D,"[['Robert', 'A.', 'Levine'], ['Schuyler', 'O.', 'Sanderson'], ['Frank', '', 'Murray'], ['Elaine', '', 'Kay'], ['John', '', 'Hegarty'], ['Niamh', '', 'Nolan'], ['Dermot', '', 'Kelleher'], ['George', '', 'Mcdonald'], ['J.', 'Conor', 'O\xe2\x80\x99Keane'], ['John', '', 'Crowe']]",Clinical Gastroenterology and Hepatology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1542356506004976', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356506004976']",
10.1053/jhep.2000.8169,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
10.1053/jhep.2000.8169,", Epidemiology and Natural History of Hepatitis C Virus Infection in Injection Drug Users: Implications for Treatment, Clinical Infectious Diseases, 2005",cited-by,10.1086/427440,Epidemiology and Natural History of Hepatitis C Virus Infection in Injection Drug Users: Implications for Treatment,[],Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/427440'],
10.1053/jhep.2000.8169,"Everson, G., , Should we treat patients with chronic hepatitis C on the waiting list?, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.01.012,Should we treat patients with chronic hepatitis C on the waiting list?,"[['Gregory', 'T.', 'Everson']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805000656', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805000656']",
10.1053/jhep.2000.8169,"Seeff, L., , Why is there such difficulty in defining the natural history of hepatitis C?, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40101161.x,Why is there such difficulty in defining the natural history of hepatitis C?,"[['Leonard', 'B.', 'Seeff']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40101161.x'],
10.1053/jhep.2000.8169,"Okayama, A., Stuver, S., Tabor, E., et. al, Incident hepatitis C virus infection in a community-based population in Japan, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00331.x,Incident hepatitis C virus infection in a community-based population in Japan,"[['A.', '', 'Okayama'], ['S.', 'O.', 'Stuver'], ['E.', '', 'Tabor'], ['N.', '', 'Tachibana'], ['M.', '', 'Kohara'], ['N.', 'E.', 'Mueller'], ['H.', '', 'Tsubouchi']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00331.x'],
10.1053/jhep.2000.8169,"Teo, M., Hayes, P., , Management of hepatitis C, , 2004",cited-by,6544431Management of hepatitis C,Management of hepatitis C,"[['Marcus', '', 'Teo'], ['Peter', '', 'Hayes']]",,2004,[u'http://bmb.oxfordjournals.org/cgi/reprint/70/1/51.pdf'],
10.1053/jhep.2000.8169,"Eyster, M., Sanders, J., Goedert, J., , Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia, Haemophilia, 2004",cited-by,10.1046/j.1351-8216.2003.00836.x,Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia,"[['M.', 'E.', 'Eyster'], ['J.', '', 'Sanders'], ['J.', 'J.', 'Goedert']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1351-8216.2003.00836.x'],
10.1053/jhep.2000.8169,"Liu, C., Shau, W., Kao, J., et. al, Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study, Liver International, 2003",cited-by,10.1034/j.1600-0676.2003.00820.x,Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study,"[['Chun-Jen', '', 'Liu'], ['Wen-Yi', '', 'Shau'], ['Jia-Horng', '', 'Kao'], ['Ming-Yang', '', 'Lai'], ['Ding-Shinn', '', 'Chen']]",Liver International,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-0676.2003.00820.x'],
10.1053/jhep.2000.8169,"Everson, G., , Management of cirrhosis due to chronic hepatitis C, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.01.009,Management of cirrhosis due to chronic hepatitis C,"[['Gregory', 'T.', 'Everson']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805000565', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805000565']",
10.1053/jhep.2000.8169,"Hofer, H., Neufeld, J., Oesterreicher, C., et. al, Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV1 infection, Genes and Immunity, 2005",cited-by,10.1038/sj.gene.6364168,Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV1 infection,"[['H', '', 'Hofer'], ['J', 'B', 'Neufeld'], ['C', '', 'Oesterreicher'], ['P', '', 'Grundtner'], ['F', '', 'Wrba'], ['A', '', 'Gangl'], ['P', '', 'Ferenci'], ['C', '', 'Gasche']]",Genes and Immunity,2005,"[u'http://www.nature.com/doifinder/10.1038/sj.gene.6364168', u'http://dx.doi.org/10.1038/sj.gene.6364168']",
10.1053/jhep.2000.8169,"Leone, N., Pellicano, R., Brunello, F., et. al, Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma, Cancer Detection and Prevention, 2003",cited-by,10.1016/j.cdp.2003.07.004,Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma,"[['Nicola', '', 'Leone'], ['Rinaldo', '', 'Pellicano'], ['Franco', '', 'Brunello'], ['Miguel', 'Angel', 'Cutufia'], ['Mara', '', 'Berrutti'], ['Sharmila', '', 'Fagoonee'], ['Mario', '', 'Rizzetto'], ['Antonio', '', 'Ponzetto']]",Cancer Detection and Prevention,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0361090X03001375', u'http://linkinghub.elsevier.com/retrieve/pii/S0361090X03001375']",
10.1053/jhep.2000.8169,"Weissenborn, K., Tryc, A., Heeren, M., et. al, Hepatitis C virus infection and the brain, Metabolic Brain Disease, 2009",cited-by,10.1007/s11011-008-9130-5,Hepatitis C virus infection and the brain,"[['Karin', '', 'Weissenborn'], ['Anita', 'B.', 'Tryc'], ['Meike', '', 'Heeren'], ['Hans', '', 'Worthmann'], ['Henning', '', 'Pflugrad'], ['Georg', '', 'Berding'], ['Martin', '', 'Bokemeyer'], ['Hans', 'L.', 'Tillmann'], ['Annemarie', '', 'Goldbecker']]",Metabolic Brain Disease,2009,"[u'http://www.springerlink.com/index/g240138k113q160k.pdf', u'http://www.springerlink.com/content/g240138k113q160k', u'http://www.springerlink.com/index/10.1007/s11011-008-9130-5', u'http://www.springerlink.com/index/pdf/10.1007/s11011-008-9130-5']",
10.1053/jhep.2000.8169,"Elliott, L., Lloyd, A., Ziegler, J., et. al, Protective immunity against hepatitis C virus infection, Immunology and Cell Biology, 2006",cited-by,10.1111/j.1440-1711.2006.01427.x,Protective immunity against hepatitis C virus infection,"[['Lisa', 'N', 'Elliott'], ['Andrew', 'R', 'Lloyd'], ['John', 'B', 'Ziegler'], ['Rosemary', 'A', 'Ffrench']]",Immunology and Cell Biology,2006,"[u'http://dx.doi.org/10.1111/j.1440-1711.2006.01427.x', u'http://www.nature.com/doifinder/10.1111/j.1440-1711.2006.01427.x']",
10.1053/jhep.2000.8169,"Moradpour, D., Cerny, A., Heim, M., et. al, Hepatitis C: an update, , 0",cited-by,6251874Hepatitis C: an update,Hepatitis C: an update,"[['Darius', '', 'Moradpour'], ['Andreas', '', 'Cerny'], ['Markus', 'H.', 'Heim'], ['Hubert', 'E.', 'Blum']]",,0,[u'http://www.smw.ch/docs/pdf200x/2001/21/smw-06097.pdf'],
10.1053/jhep.2000.8169,"Salloum, S., Oniangue-Ndza, C., Neumann-Haefelin, C., et. al, Escape from HLA-B*08Restricted CD8 T Cells by Hepatitis C Virus Is Associated with Fitness Costs, Journal of Virology, 2008",cited-by,10.1128/JVI.00997-08,Escape from HLA-B*08Restricted CD8 T Cells by Hepatitis C Virus Is Associated with Fitness Costs,"[['Shadi', '', 'Salloum'], ['Cesar', '', 'Oniangue-Ndza'], ['Christoph', '', 'Neumann-Haefelin'], ['Laura', '', 'Hudson'], ['Silvia', '', 'Giugliano'], ['M.', 'aus dem', 'Siepen'], ['J.', '', 'Nattermann'], ['U.', '', 'Spengler'], ['G.', 'M.', 'Lauer'], ['M.', '', 'Wiese'], ['P.', '', 'Klenerman'], ['H.', '', 'Bright'], ['N.', '', 'Scherbaum'], ['R.', '', 'Thimme'], ['M.', '', 'Roggendorf'], ['S.', '', 'Viazov'], ['J.', '', 'Timm']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/23/11803.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00997-08']",
10.1053/jhep.2000.8169,"Uto, H., Stuver, S., Hayashi, K., et. al, Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study, Hepatology, 2009",cited-by,10.1002/hep.23002,Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study,"[['Hirofumi', '', 'Uto'], ['Sherri', 'O.', 'Stuver'], ['Katsuhiro', '', 'Hayashi'], ['Kotaro', '', 'Kumagai'], ['Fumisato', '', 'Sasaki'], ['Shuji', '', 'Kanmura'], ['Masatsugu', '', 'Numata'], ['Akihiro', '', 'Moriuchi'], ['Susumu', '', 'Hasegawa'], ['Makoto', '', 'Oketani'], ['Akio', '', 'Ido'], ['Kazunori', '', 'Kusumoto'], ['Satoru', '', 'Hasuike'], ['Kenji', '', 'Nagata'], ['Michinori', '', 'Kohara'], ['Hirohito', '', 'Tsubouchi']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.23002'],
10.1053/jhep.2000.8169,"Gaafary, M., Rekacewicz, C., Abdel-Rahman, A., et. al, Surveillance of acute hepatitis C in Cairo, Egypt, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20392,"Surveillance of acute hepatitis C in Cairo, Egypt","[['Maha', 'M. El', 'Gaafary'], ['Claire', '', 'Rekacewicz'], ['Amira', 'Gamal', 'Abdel-Rahman'], ['Mohamed', 'Farouk', 'Allam'], ['Mostafa', 'El', 'Hosseiny'], ['Mohamed', 'Abdel', 'Hamid'], ['Fran\xc3\xa7oise', '', 'Colombani'], ['Yehia', '', 'Sultan'], ['Saeed', '', 'El-Aidy'], ['Arnaud', '', 'Fontanet'], ['Mostafa', 'Kamal', 'Mohamed']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20392'],
10.1053/jhep.2000.8169,"Siepen, M., Lohmann, V., Wiese, M., et. al, Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture, Virology, 2005",cited-by,10.1016/j.virol.2005.03.012,Nonstructural protein 5A does not contribute to the resistance of hepatitis C virus replication to interferon alpha in cell culture,"[['Marc', 'aus dem', 'Siepen'], ['Volker', '', 'Lohmann'], ['Manfred', '', 'Wiese'], ['Stefan', '', 'Ross'], ['Michael', '', 'Roggendorf'], ['Sergei', '', 'Viazov']]",Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0042682205001698', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682205001698']",
10.1053/jhep.2000.8169,"Temple-Smith, M., Gifford, S., , The lived experience of men and women with hepatitis C: implications for support needs and health information, Australian Health Review, 2004",cited-by,10.1071/AH042720046,The lived experience of men and women with hepatitis C: implications for support needs and health information,"[['Meredith', '', 'Temple-Smith'], ['Sandra', '', 'Gifford']]",Australian Health Review,2004,"[u'http://www.publish.csiro.au/?act=view_file&file_id=AH042720046.pdf', u'http://www.publish.csiro.au/?paper=AH042720046']",
10.1053/jhep.2000.8169,"Soza, A., Arrese, M., González, R., et. al, Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C, , 0",cited-by,11050333Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C,Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C,"[['Alejandro', '', 'Soza'], ['Marco', '', 'Arrese'], ['Robinson', '', 'Gonz\xc3\xa1lez'], ['Manuel', '', 'Alvarez'], ['Rosa', 'Mar\xc3\xada', 'P\xc3\xa9rez'], ['Pablo', '', 'Cort\xc3\xa9s'], ['Alejandro', '', 'Patillo'], ['Arnoldo', '', 'Riquelme'], ['Juan', 'Carlos', 'Glasinovic']]",,0,[u'http://www.hepatitis.cl/articulos/2004-6-Clinical%20and%20epidemiological%20features%20of%20147%20Chilean%20patients%20with%20chronic%20hepatitis%20C.pdf'],
10.1053/jhep.2000.8169,"Pellicano, R., Ménard, A., Rizzetto, M., et. al, Helicobacter species and liver diseases: association or causation?, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70066-5,Helicobacter species and liver diseases: association or causation?,"[['Rinaldo', '', 'Pellicano'], ['Armelle', '', 'M\xc3\xa9nard'], ['Mario', '', 'Rizzetto'], ['Francis', '', 'M\xc3\xa9graud']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908700665', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908700665']",
10.1053/jhep.2000.8169,"Meyer, M., Lehmann, M., Cornberg, M., et. al, Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response, Virology Journal, 2007",cited-by,10.1186/1743-422X-4-58,Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response,"[['Manuela', 'F', 'Meyer'], ['Marc', '', 'Lehmann'], ['Markus', '', 'Cornberg'], ['Johannes', '', 'Wiegand'], ['Michael', 'P', 'Manns'], ['Christoph', '', 'Klade'], ['Heiner', '', 'Wedemeyer']]",Virology Journal,2007,"[u'http://www.biomedcentral.com/content/pdf/1743-422X-4-58.pdf', u'http://www.springerlink.com/content/4489130v12123l61', u'http://www.virologyj.com/content/4/1/58', u'http://www.springerlink.com/index/4489130v12123l61.pdf']",
10.1053/jhep.2000.8169,"Selcuk, H., Kanbay, M., Korkmaz, M., et. al, Distribution of HCV Genotypes in Patients with End-Stage Renal Disease According to Type of Dialysis Treatment, Digestive Diseases and Sciences, 2006",cited-by,10.1007/s10620-005-9025-9,Distribution of HCV Genotypes in Patients with End-Stage Renal Disease According to Type of Dialysis Treatment,"[['Haldun', '', 'Selcuk'], ['Mehmet', '', 'Kanbay'], ['Murat', '', 'Korkmaz'], ['Gurden', '', 'Gur'], ['Ali', '', 'Akcay'], ['Hande', '', 'Arslan'], ['Nurhan', '', 'Ozdemir'], ['Ugur', '', 'Yilmaz'], ['Sedat', '', 'Boyacioglu']]",Digestive Diseases and Sciences,2006,"[u'http://www.springerlink.com/content/f130t3807301r530', u'http://www.springerlink.com/index/f130t3807301r530.pdf', u'http://www.springerlink.com/index/10.1007/s10620-005-9025-9', u'http://www.springerlink.com/index/pdf/10.1007/s10620-005-9025-9']",
10.1053/jhep.2000.8169,"Hayashi, P., Bisceglie, A., , The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis, Medical Clinics of North America, 2005",cited-by,10.1016/j.mcna.2004.08.014,The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis,"[['Paul', 'H.', 'Hayashi'], ['Adrian', 'M. Di', 'Bisceglie']]",Medical Clinics of North America,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0025712504001361', u'http://linkinghub.elsevier.com/retrieve/pii/S0025712504001361']",
10.1053/jhep.2000.8169,"Yee, L., Knapp, S., Burgner, D., et. al, Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection, Genes and Immunity, 2004",cited-by,10.1038/sj.gene.6364054,Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection,"[['LJ', '', 'Yee'], ['S', '', 'Knapp'], ['D', '', 'Burgner'], ['BJW', '', 'Hennig'], ['AJ', '', 'Frodsham'], ['M', '', 'Wright'], ['HC', '', 'Thomas'], ['AVS', '', 'Hill']]",Genes and Immunity,2004,"[u'http://www.well.ox.ac.uk/hill/docs/HCV-NOS2A_Yee2004.pdf', u'http://dx.doi.org/10.1038/sj.gene.6364054', u'http://www.nature.com/doifinder/10.1038/sj.gene.6364054']",
10.1053/jhep.2000.8169,"WEDEMEYER, H., WIEGAND, J., CORNBERG, M., et. al, Polyethylene glycol-interferon: Current status in hepatitis C virus therapy, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.17.s3.26.x,Polyethylene glycol-interferon: Current status in hepatitis C virus therapy,"[['HEINER', '', 'WEDEMEYER'], ['JOHANNES', '', 'WIEGAND'], ['MARKUS', '', 'CORNBERG'], ['MICHAEL', 'P', 'MANNS']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.17.s3.26.x'],
10.1053/jhep.2000.8169,"Hu, S., Kyulo, N., Xia, V., et. al, Factors Associated With Hepatic Fibrosis In Patients With Chronic Hepatitis C: A Retrospective Study of a Large Cohort of U.S. Patients, Journal of Clinical Gastroenterology, 2009",cited-by,10.1097/MCG.0b013e31818be17c,Factors Associated With Hepatic Fibrosis In Patients With Chronic Hepatitis C: A Retrospective Study of a Large Cohort of U.S. Patients,"[['Shirley', 'X.', 'Hu'], ['Namgyal', 'L.', 'Kyulo'], ['Victor', 'W.', 'Xia'], ['Donald', 'J.', 'Hillebrand'], ['Ke-Qin', '', 'Hu']]",Journal of Clinical Gastroenterology,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200909000-00013'],
10.1053/jhep.2000.8169,"Fitzsimons, D., François, G., Alpers, K., et. al, Prevention of viral hepatitis in the Nordic countries and Germany, Scandinavian Journal of Infectious Diseases, 2005",cited-by,10.1080/00365540510043284,Prevention of viral hepatitis in the Nordic countries and Germany,"[['David', '', 'Fitzsimons'], ['Guido', '', 'Fran\xc3\xa7ois'], ['Katharina', '', 'Alpers'], ['Doris', '', 'Radun'], ['Johannes', '', 'Hallauer'], ['Wolfgang', '', 'Jilg'], ['Wolfram', '', 'Gerlich'], ['Lars', '', 'Rombo'], ['Hans', '', 'Blystad'], ['Hanne', '', 'N\xc3\xb8kleby'], ['Pierre', 'Van', 'Damme']]",Scandinavian Journal of Infectious Diseases,2005,[u'http://informahealthcare.com/doi/abs/10.1080/00365540510043284'],
10.1053/jhep.2000.8169,"Goulding, C., O'Brien, C., Egan, H., et. al, The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2006.00790.x,The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source,"[['C.', '', 'Goulding'], ['C.', '', ""O'Brien""], ['H.', '', 'Egan'], ['J.', 'E.', 'Hegarty'], ['G.', '', 'McDonald'], ['C.', '', ""O'Farrelly""], ['B.', '', 'White'], ['D.', '', 'Kelleher'], ['S.', '', 'Norris']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00790.x'],
10.1053/jhep.2000.8169,"Feliu, A., Carrion, J., Massaguer, A., et. al, Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2006.00714.x,Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection,"[['A.', '', 'Feliu'], ['J.', 'A.', 'Carrion'], ['A.', '', 'Massaguer'], ['E.', '', 'Martinez-Bauer'], ['M.', '', 'Garcia-Retortillo'], ['P.', '', 'Gonzalez'], ['J.', '', 'Costa'], ['J.', 'M.', 'Sanchez-Tapias'], ['X.', '', 'Forns']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00714.x'],
10.1053/jhep.2000.8169,"Hu, K., Yang, H., Lin, Y., et. al, Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States, , 2004",cited-by,5214963Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States,Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States,"[['Ke-Qin', '', 'Hu'], ['Huiying', '', 'Yang'], ['Ying-Chao', '', 'Lin'], ['Karen', 'L', 'Lindsay'], ['Allan', 'G', 'Redeker']]",,2004,[u'http://www.medsci.org/v01p0092.pdf'],
10.1053/jhep.2000.8169,"Tillmann, H., , Hepatitis C Virus Infection and the Brain, Metabolic Brain Disease, 2004",cited-by,10.1023/B:MEBR.0000043981.89134.39,Hepatitis C Virus Infection and the Brain,"[['Hans', 'L.', 'Tillmann']]",Metabolic Brain Disease,2004,"[u'http://www.springerlink.com/index/k45h11087j0hv160.pdf', u'http://www.springerlink.com/content/k45h11087j0hv160', u'http://www.springerlink.com/openurl.asp?id=doi:10.1023/B:MEBR.0000043981.89134.39']",
10.1053/jhep.2000.8169,"Goodgame, B., Shaheen, N., Galanko, J., et. al, The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?, American Journal of Gastroenterology, 2003",cited-by,10.1111/j.1572-0241.2003.07678.x,The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?,"[['Boone', '', 'Goodgame'], ['Nicholas', 'J.', 'Shaheen'], ['Joseph', '', 'Galanko'], ['Hashem', 'B.', 'El-Serag']]",American Journal of Gastroenterology,2003,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.07678.x', u'http://dx.doi.org/10.1111/j.1572-0241.2003.07678.x']",
10.1053/jhep.2000.8169,"Everson, G., , Management of cirrhosis due to chronic hepatitis C, , 0",cited-by,11025816Management of cirrhosis due to chronic hepatitis C,Management of cirrhosis due to chronic hepatitis C,"[['Gregory', 'T.', 'Everson']]",,0,[u'http://www.uchsc.edu/gastro/documents/pub_h_everson/Managment_of_cirrhosis_due_to_chronic_hepatitis_C.pdf'],
10.1053/jhep.2000.8169,"Kita, Y., Mizukoshi, E., Takamura, T., et. al, Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus, Metabolism-clinical and Experimental, 2007",cited-by,10.1016/j.metabol.2007.07.011,Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus,"[['Yuki', '', 'Kita'], ['Eishiro', '', 'Mizukoshi'], ['Toshinari', '', 'Takamura'], ['Masaru', '', 'Sakurai'], ['Yoshiko', '', 'Takata'], ['Kuniaki', '', 'Arai'], ['Tatsuya', '', 'Yamashita'], ['Yasunari', '', 'Nakamoto'], ['Shuichi', '', 'Kaneko']]",Metabolism-clinical and Experimental,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0026049507002739', u'http://linkinghub.elsevier.com/retrieve/pii/S0026049507002739']",
10.1053/jhep.2000.8169,"Fried, M., Kroner, B., Preiss, L., et. al, Hemophilic Siblings With Chronic Hepatitis C: Familial Aggregation of Spontaneous and Treatment-Related Viral Clearance, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.07.001,Hemophilic Siblings With Chronic Hepatitis C: Familial Aggregation of Spontaneous and Treatment-Related Viral Clearance,"[['Michael', 'W.', 'Fried'], ['Barbara', 'L.', 'Kroner'], ['Liliana', 'R.', 'Preiss'], ['Kirk', '', 'Wilhelmsen'], ['James', 'J.', 'Goedert']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S001650850601479X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850601479X']",
10.1053/jhep.2000.8169,"Everson, G., , Treatment of Hepatitis C in Patients Who Have Decompensated Cirrhosis, Clinics in Liver Disease, 2005",cited-by,10.1016/j.cld.2005.05.011,Treatment of Hepatitis C in Patients Who Have Decompensated Cirrhosis,"[['Gregory', 'T.', 'Everson']]",Clinics in Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105000437', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105000437']",
10.1053/jhep.2000.8169,"Sheehy, P., Scallan, M., Kenny-Walsh, E., et. al, A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR, Journal of Virological Methods, 2005",cited-by,10.1016/j.jviromet.2004.08.021,A strategy for obtaining near full-length HCV cDNA clones (assemblicons) by assembly PCR,"[['P.', '', 'Sheehy'], ['M.', '', 'Scallan'], ['E.', '', 'Kenny-Walsh'], ['F.', '', 'Shanahan'], ['L.', 'J.', 'Fanning']]",Journal of Virological Methods,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166093404002721', u'http://journals2005.pasteur.ac.ir/jvm/123(2).pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093404002721']",
10.1053/jhep.2000.8169,"Lédinghen, V., Trimoulet, P., Mannant, P., et. al, Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years), Journal of Hepatology, 2007",cited-by,10.1016/j.jhep.2006.07.029,Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years),"[['Victor', 'de', 'L\xc3\xa9dinghen'], ['Pascale', '', 'Trimoulet'], ['Paul-R\xc3\xa9gis', '', 'Mannant'], ['Francis', '', 'Dumas'], ['Patrick', '', 'Champbeno\xc3\xaet'], ['Christian', '', 'Baldit'], ['Juliette', '', 'Foucher'], ['Muriel', '', 'Faure'], ['Julien', '', 'Vergniol'], ['Laurent', '', 'Cast\xc3\xa9ra'], ['Julien', '', 'Bertet'], ['Herv\xc3\xa9', '', 'Fleury'], ['Patrice', '', 'Couzigou'], ['Pierre-Henri', '', 'Bernard']]",Journal of Hepatology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0168827806004636', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827806004636']",
10.1053/jhep.2000.8169,"Strader, D., Seeff, L., , Hepatitis C : A Brief Clinical Overview, , 2001",cited-by,5208454Hepatitis C : A Brief Clinical Overview,Hepatitis C : A Brief Clinical Overview,"[['Doris', 'B.', 'Strader'], ['Leonard', 'B.', 'Seeff']]",,2001,[u'http://dels-old.nas.edu/ilar_n/ilarjournal/42_2/Hep-C-Clin.pdf'],
10.1053/jhep.2000.8169,"Kobayashi, M., Akuta, N., Suzuki, F., et. al, Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b, Journal of Medical Virology, 2010",cited-by,10.1002/jmv.21629,Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b,"[['Mariko', '', 'Kobayashi'], ['Norio', '', 'Akuta'], ['Fumitaka', '', 'Suzuki'], ['Tetsuya', '', 'Hosaka'], ['Hitomi', '', 'Sezaki'], ['Masahiro', '', 'Kobayashi'], ['Yoshiyuki', '', 'Suzuki'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Sachiyo', '', 'Watahiki'], ['Rie', '', 'Mineta'], ['Satomi', '', 'Iwasaki'], ['Yuzo', '', 'Miyakawa'], ['Hiromitsu', '', 'Kumada']]",Journal of Medical Virology,2010,[u'http://doi.wiley.com/10.1002/jmv.21629'],
10.1053/jhep.2000.8169,"Irausquin, S., Hughes, A., , Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b, Virus Research, 2010",cited-by,10.1016/j.virusres.2009.11.001,Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b,"[['Stephanie', 'Jim\xc3\xa9nez', 'Irausquin'], ['Austin', 'L.', 'Hughes']]",Virus Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S016817020900402X', u'http://linkinghub.elsevier.com/retrieve/pii/S016817020900402X']",
10.1053/jhep.2000.8169,"Chen, S., Ni, Y., Chen, P., et. al, Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance, Journal of Viral Hepatitis, 2009",cited-by,10.1111/j.1365-2893.2009.01135.x,Low viraemia at enrollment in children with chronic hepatitis C favours spontaneous viral clearance,"[['S.-T.', '', 'Chen'], ['Y.-H.', '', 'Ni'], ['P.-J.', '', 'Chen'], ['H.-L.', '', 'Chen'], ['Y.-M.', '', 'Jeng'], ['M.-Y.', '', 'Lu'], ['J.-F.', '', 'Wu'], ['H.-Y.', '', 'Hsu'], ['M.-H.', '', 'Chang']]",Journal of Viral Hepatitis,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2009.01135.x'],
10.1053/jhep.2000.8169,"Piccinino, F., Coppola, N., , Antiviral treatment of HCV-related cirrhosis, Digestive and Liver Disease, 2007",cited-by,10.1016/S1590-8658(07)80019-3,Antiviral treatment of HCV-related cirrhosis,"[['Felice', '', 'Piccinino'], ['Nicola', '', 'Coppola']]",Digestive and Liver Disease,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1590865807800193', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865807800193']",
10.1053/jhep.2000.8169,"García-Samaniego, J., Forns, X., , Hepatitis C virus and human immunodeficiency virus: The Un-Won Battle, Hepatology, 2007",cited-by,10.1002/hep.21818,Hepatitis C virus and human immunodeficiency virus: The Un-Won Battle,"[['Javier', '', 'Garc\xc3\xada-Samaniego'], ['Xavier', '', 'Forns']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21818'],
10.1053/jhep.2000.8169,"Griffiths, P., , Progress towards interrupting intrauterine transmission of cytomegalovirus?, Reviews in Medical Virology, 2006",cited-by,10.1002/rmv.489,Progress towards interrupting intrauterine transmission of cytomegalovirus?,"[['PD', '', 'Griffiths']]",Reviews in Medical Virology,2006,[u'http://doi.wiley.com/10.1002/rmv.489'],
10.1053/jhep.2000.8169,"Morillas, R., Montoliu, S., Planas, R., , Hepatitis C, , 2005",cited-by,10.1016/S1134-2072(05)71167-1,Hepatitis C,"[['R.', 'M.', 'Morillas'], ['S.', '', 'Montoliu'], ['R.', '', 'Planas']]",,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1134207205711671', u'http://linkinghub.elsevier.com/retrieve/pii/S1134207205711671']",
10.1056~NEJMoa011232,"Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b in combination with ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: results of a randomized trial. Lancet 2001;358:958-65.",references,NOT found in MAS
10.1056~NEJMoa011232,"Fried MW, Shiffman ML, Reddy RK, et al. Pegylated (40 kDa) interferon alfa-2a (PEGASYS) in combination with ribavirin: efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study. Gastroenterology 2001;120:Suppl:A-55. abstract.",references,10.1016/S0016-5085(08)80271-5,"Pegylated (40kDa) interferon alfa-2a (PEGASYS ®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study","[[u'Michael', u'W.', u'Fried'], [u'Mitchell', u'L.', u'Shiffman'], [u'Rejender', u'K.', u'Reddy'], [u'Coleman', u'', u'Smith'], [u'George', u'', u'Marino'], [u'Femando', u'Goncales', u'Jr'], [u'Dieter', u'', u'Haeussinger'], [u'Moises', u'', u'Diago'], [u'Giampietro', u'', u'Carosl'], [u'Jean-Pierre', u'', u'Zarski'], [u'Joseph', u'', u'Hoffman'], [u'Jian', u'', u'Yu']]",Gastroenterology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0016508508802715', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508508802715']",[]
10.1016/S0016-5085(08)80271-5,"Chander, G., Sulkowski, M., Jenckes, M., et. al, Treatment of chronic hepatitis C: A systematic review, Hepatology, 2002",cited-by,10.1053/jhep.2002.37146,Treatment of chronic hepatitis C: A systematic review,"[['Geetanjali', '', 'Chander'], ['Mark', 'S.', 'Sulkowski'], ['Mollie', 'W.', 'Jenckes'], ['Michael', 'S.', 'Torbenson'], ['H.', 'Franklin', 'Herlong'], ['Eric', 'B.', 'Bass'], ['Kelly', 'A.', 'Gebo']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Treatment%20Of%20Chronic%20Hepatitis%20C%20%20%20A%20Systematic%20Review.pdf', u'http://doi.wiley.com/10.1002/hep.1840360718', u'http://doi.wiley.com/10.1053/jhep.2002.37146']",
10.1016/S0016-5085(08)80271-5,"Luxon, B., Grace, M., Brassard, D., et. al, Pegylated interferons for the treatment of chronic hepatitis C infection, Clinical Therapeutics, 2002",cited-by,10.1016/S0149-2918(02)80042-X,Pegylated interferons for the treatment of chronic hepatitis C infection,"[['Bruce', 'A.', 'Luxon'], ['Michael', '', 'Grace'], ['Diana', '', 'Brassard'], ['Ronald', '', 'Bordens']]",Clinical Therapeutics,2002,"[u'http://www.sciencedirect.com/science/article/pii/S014929180280042X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180280042X']",
10.1016/S0016-5085(08)80271-5,"Bonkovsky, H., Troy, N., McNeal, K., et. al, Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00305-7,Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C,"[['Herbert', 'L', 'Bonkovsky'], ['Nicole', '', 'Troy'], ['Kristina', '', 'McNeal'], ['Barbara', 'F', 'Banner'], ['Ashish', '', 'Sharma'], ['Jorge', '', 'Obando'], ['Savant', '', 'Mehta'], ['Raymond', 'S', 'Koff'], ['Qin', '', 'Liu'], ['Chung-Cheng', '', 'Hsieh']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802003057', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802003057']",
10.1016/S0016-5085(08)80271-5,"Nguyen, H., Miller, A., Dieperink, E., et. al, Spectrum of disease in U.S. veteran patients with hepatitis C, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05800.x,Spectrum of disease in U.S. veteran patients with hepatitis C,"[['Huy', 'A.', 'Nguyen'], ['April', 'I.', 'Miller'], ['Eric', '', 'Dieperink'], ['Mark', 'L.', 'Willenbring'], ['Lori', 'L.', 'Tetrick'], ['Janet', 'M.', 'Durfee'], ['Stephen', 'L.', 'Ewing'], ['Samuel', 'B.', 'Ho']]",American Journal of Gastroenterology,2002,"[u'http://dx.doi.org/10.1111/j.1572-0241.2002.05800.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05800.x']",
10.1016/S0016-5085(08)80271-5,"Charlton, M., , Natural history of hepatitis C and outcomes following liver transplantation, Clinics in Liver Disease, 2003",cited-by,10.1016/S1089-3261(03)00046-1,Natural history of hepatitis C and outcomes following liver transplantation,"[['Michael', '', 'Charlton']]",Clinics in Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1089326103000461', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326103000461']",
10.1016/S0016-5085(08)80271-5,"Myers, R., Patel, K., Pianko, S., et. al, The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00387.x,The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C,"[['R.', 'P.', 'Myers'], ['K.', '', 'Patel'], ['S.', '', 'Pianko'], ['T.', '', 'Poynard'], ['J.', 'G.', 'McHutchison']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00387.x'],
10.1016/S0016-5085(08)80271-5,"Reddy, K., Modi, M., Pedder, S., , Use of peginterferon alfa-2a (40 KD) (Pegasys ®) for the treatment of hepatitis C, Advanced Drug Delivery Reviews, 2002",cited-by,10.1016/S0169-409X(02)00028-5,Use of peginterferon alfa-2a (40 KD) (Pegasys ®) for the treatment of hepatitis C,"[['K.', 'Rajender', 'Reddy'], ['Marlene', 'W.', 'Modi'], ['Simon', '', 'Pedder']]",Advanced Drug Delivery Reviews,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X02000285', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X02000285']",
10.1016/S0016-5085(08)80271-5,"Mchutchison, J., , Hepatitis C advances in antiviral therapy: What is accepted treatment now?, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02777.x,Hepatitis C advances in antiviral therapy: What is accepted treatment now?,"[['John', 'G', 'Mchutchison']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02777.x'],
10.1016/S0016-5085(08)80271-5,"Mangia, A., Santoro, R., Piattelli, M., et. al, High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00140-X,High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis,"[['Alessandra', '', 'Mangia'], ['Rosanna', '', 'Santoro'], ['Marisa', '', 'Piattelli'], ['Gioacchino', '', 'Leandro'], ['Nicola', '', 'Minerva'], ['Mauro', '', 'Annese'], ['Donato', '', 'Bacca'], ['Fulvio', '', 'Spirito'], ['Vito', '', 'Carretta'], ['Francesco', '', 'Ventrella'], ['Marina', '', 'Cela'], ['Angelo', '', 'Andriulli']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S016882780200140X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780200140X']",
10.1016/S0016-5085(08)80271-5,"Shehab, T., Orrego, M., Chunduri, R., et. al, Identification and Management of Hepatitis C Patients in Primary Care Clinics, American Journal of Gastroenterology, 2003",cited-by,10.1111/j.1572-0241.2003.07331.x,Identification and Management of Hepatitis C Patients in Primary Care Clinics,"[['Thomas', 'M.', 'Shehab'], ['Mauricio', '', 'Orrego'], ['Renu', '', 'Chunduri'], ['Anna', 'S. F.', 'Lok']]",American Journal of Gastroenterology,2003,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.07331.x', u'http://dx.doi.org/10.1111/j.1572-0241.2003.07331.x']",
10.1016/S0016-5085(08)80271-5,"Iacono, O., , Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00184-2,Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?,"[['Oreste', 'Lo', 'Iacono']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801001842', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801001842']",
10.1016/S0016-5085(08)80271-5,"Zein, C., Zein, N., , Advances in therapy for hepatitis C infection, Microbes and Infection, 2002",cited-by,10.1016/S1286-4579(02)01651-9,Advances in therapy for hepatitis C infection,"[['Claudia', 'O', 'Zein'], ['Nizar', 'N', 'Zein']]",Microbes and Infection,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1286457902016519', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457902016519']",
10.1016/S0016-5085(08)80271-5,"Poynard, T., Marcellin, P., Bissery, A., et. al, Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00427.x,Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial,"[['T.', '', 'Poynard'], ['P.', '', 'Marcellin'], ['A.', '', 'Bissery'], ['R.', 'P.', 'Myers'], ['J.', '', 'Moussalli'], ['F.', '', 'Degos'], ['D.', '', 'Dhumeaux'], ['G.', '', 'Riachi'], ['J.', 'P.', 'Bronowicki'], ['P.', '', 'Brissot'], ['C.', '', 'Buffet'], ['L.', '', 'Serfaty'], ['S.', '', 'Naveau'], ['P.', '', 'Sogni'], ['M.', '', 'Beaugrand'], ['S.', '', 'Gayno'], ['D.', '', 'Larrey'], ['D.', '', 'Samuel'], ['C.', '', 'Eugene'], ['S.', '', 'Pol'], ['P.', '', 'Bedossa'], ['V.', '', 'Daurat'], ['P.', '', 'Chaumet-Riffaud']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00427.x'],
10.1016/S0016-5085(08)80271-5,"WEDEMEYER, H., WIEGAND, J., CORNBERG, M., et. al, Polyethylene glycol-interferon: Current status in hepatitis C virus therapy, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.17.s3.26.x,Polyethylene glycol-interferon: Current status in hepatitis C virus therapy,"[['HEINER', '', 'WEDEMEYER'], ['JOHANNES', '', 'WIEGAND'], ['MARKUS', '', 'CORNBERG'], ['MICHAEL', 'P', 'MANNS']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.17.s3.26.x'],
10.1016/S0016-5085(08)80271-5,"Fargion, S., Fracanzani, A., Valenti, L., , Treatment choices for people infected with HCV, , 2004",cited-by,6556526Treatment choices for people infected with HCV,Treatment choices for people infected with HCV,"[['Silvia', '', 'Fargion'], ['Anna', 'Ludovica', 'Fracanzani'], ['Luca', '', 'Valenti']]",,2004,"[u'http://jac.oxfordjournals.org/cgi/reprint/53/5/708.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkh170v1.pdf']",
10.1016/S0016-5085(08)80271-5,"Dantzler, T., Lawitz, E., , Treatment of chronic hepatitis C in nonresponders to previous therapy, Current Gastroenterology Reports, 2003",cited-by,10.1007/s11894-003-0013-y,Treatment of chronic hepatitis C in nonresponders to previous therapy,"[['Todd', 'E.', 'Dantzler'], ['Eric', 'J.', 'Lawitz']]",Current Gastroenterology Reports,2003,"[u'http://www.springerlink.com/index/a43847455t814q38.pdf', u'http://www.springerlink.com/content/a43847455t814q38', u'http://www.springerlink.com/index/10.1007/s11894-003-0013-y', u'http://www.springerlink.com/index/pdf/10.1007/s11894-003-0013-y']",
10.1016/S0016-5085(08)80271-5,"Sievert, W., , Management issues in chronic viral hepatitis: Hepatitis C, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02725.x,Management issues in chronic viral hepatitis: Hepatitis C,"[['William', '', 'Sievert']]",Journal of Gastroenterology and Hepatology,2002,"[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/management issues in chronic viral hepatitis-hepatitis c.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02725.x']",
10.1016/S0016-5085(08)80271-5,"Natov, S., Pereira, B., , Management of Hepatitis C Infection in Renal Transplant Recipients, American Journal of Transplantation, 2002",cited-by,10.1034/j.1600-6143.2002.20601.x,Management of Hepatitis C Infection in Renal Transplant Recipients,"[['Svetlozar', 'N.', 'Natov'], ['Brian', 'J. G.', 'Pereira']]",American Journal of Transplantation,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-6143.2002.20601.x'],
10.1016/S0016-5085(08)80271-5,"Fried, M., , ADVANCES IN THERAPY FOR CHRONIC HEPATITIS C, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70206-3,ADVANCES IN THERAPY FOR CHRONIC HEPATITIS C,"[['Michael', 'W.', 'Fried']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702063', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702063']",
10.1016/S0016-5085(08)80271-5,"Zeuzem, S., , Favourable and disappointing lessons from viral kinetics, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00167-8,Favourable and disappointing lessons from viral kinetics,"[['Stefan', '', 'Zeuzem']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802001678', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802001678']",
10.1016/S0016-5085(08)80271-5,"Wright, H., Alex, P., Nguyen, T., et. al, Multiplex Cytokine Profiling of Initial Therapeutic Response in Patients with Chronic Hepatitis C Virus Infection, Digestive Diseases and Sciences, 2005",cited-by,10.1007/s10620-005-2940-y,Multiplex Cytokine Profiling of Initial Therapeutic Response in Patients with Chronic Hepatitis C Virus Infection,"[['Harlan', '', 'Wright'], ['Philip', '', 'Alex'], ['Thuan', '', 'Nguyen'], ['Teddy', '', 'Bader'], ['Ahmet', '', 'Gurakar'], ['Anthony', '', 'Sebastian'], ['Liberty', '', 'Gonzales'], ['Gemma', '', 'Wallis'], ['Mark', '', 'Naylor'], ['Igor', '', 'Dozmorov'], ['Michael', '', 'Centola'], ['Bakr', '', 'Nour']]",Digestive Diseases and Sciences,2005,"[u'http://www.springerlink.com/index/fm68541gj0761013.pdf', u'http://www.springerlink.com/content/fm68541gj0761013', u'http://www.springerlink.com/index/10.1007/s10620-005-2940-y', u'http://www.springerlink.com/index/pdf/10.1007/s10620-005-2940-y']",
10.1016/S0016-5085(08)80271-5,"Zeuzem, S., Herrmann, E., , First-phase parameters in hepatitis C viral kinetics, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00375.x,First-phase parameters in hepatitis C viral kinetics,"[['Stefan', '', 'Zeuzem'], ['Eva', '', 'Herrmann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00375.x'],
10.1016/S0016-5085(08)80271-5,"Mati, M., , Hepatitis C virus infection: the dermatological perspective, , 0",cited-by,4952842Hepatitis C virus infection: the dermatological perspective,Hepatitis C virus infection: the dermatological perspective,"[['M.', '', 'Mati']]",,0,[u'http://ibmi.mf.uni-lj.si/acta-apa/acta-apa-03-1/3.pdf'],
10.1016/S0016-5085(08)80271-5,"Cornberg, M., Wedemeyer, H., Manns, M., , Pegylated interferons in combination with ribavirin for the treatment of chronic hepatitis C, Current Hepatitis Reports, 2003",cited-by,10.1007/s11901-003-0011-4,Pegylated interferons in combination with ribavirin for the treatment of chronic hepatitis C,"[['Markus', '', 'Cornberg'], ['Heiner', '', 'Wedemeyer'], ['Michael', 'P.', 'Manns']]",Current Hepatitis Reports,2003,"[u'http://www.springerlink.com/content/t3v147h44h2474xl', u'http://www.springerlink.com/index/t3v147h44h2474xl.pdf', u'http://www.springerlink.com/index/10.1007/s11901-003-0011-4', u'http://www.springerlink.com/index/pdf/10.1007/s11901-003-0011-4']",
10.1016/S0016-5085(08)80271-5,"Terrault, N., , Chronic hepatitis B, Current Treatment Options in Gastroenterology, 2001",cited-by,10.1007/s11938-001-0014-6,Chronic hepatitis B,"[['Norah', 'A.', 'Terrault']]",Current Treatment Options in Gastroenterology,2001,"[u'http://www.springerlink.com/index/7u5524tlv341774t.pdf', u'http://www.springerlink.com/content/7u5524tlv341774t', u'http://www.springerlink.com/index/10.1007/s11938-001-0014-6', u'http://www.springerlink.com/index/pdf/10.1007/s11938-001-0014-6']",
10.1016/S0016-5085(08)80271-5,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1016/S0016-5085(08)80271-5,"Carlsson, T., , HEPATITIS C VIRUS KINETICS DURING ANTIVIRAL TREATMENT, , 2004",cited-by,7031027HEPATITIS C VIRUS KINETICS DURING ANTIVIRAL TREATMENT,HEPATITIS C VIRUS KINETICS DURING ANTIVIRAL TREATMENT,"[['Tony', '', 'Carlsson']]",,2004,[u'http://diss.kib.ki.se/2004/91-7349-588-3/thesis.pdf'],
10.1016/S0016-5085(08)80271-5,"Capra, F., Maria, E., Franchini, M., et. al, Nonresponse to Interferon Monotherapy in HCV-Related Chronic Hepatitis: Results of Retreatment and Prognostic Factors, Digestive Diseases and Sciences, 2003",cited-by,10.1023/A:1022813531664,Nonresponse to Interferon Monotherapy in HCV-Related Chronic Hepatitis: Results of Retreatment and Prognostic Factors,"[['Franco', '', 'Capra'], ['Elena', 'De', 'Maria'], ['Massimo', '', 'Franchini'], ['Luigi', '', 'Marchiori'], ['Ulrich', '', 'Thalheimer'], ['Italo', '', 'Vantini']]",Digestive Diseases and Sciences,2003,"[u'http://www.springerlink.com/content/u72813tx355p8311', u'http://www.springerlink.com/index/u72813tx355p8311.pdf']",
10.1016/S0016-5085(08)80271-5,"Franciscus, A., Davis, G., , The NIH Consensus Conference on the Management of Hepatitis C: 2002. Part 3, , 0",cited-by,5758502The NIH Consensus Conference on the Management of Hepatitis C: 2002. Part 3,The NIH Consensus Conference on the Management of Hepatitis C: 2002. Part 3,"[['Alan', '', 'Franciscus'], ['Gary', 'L.', 'Davis']]",,0,"[u'https://www250.safesecureweb.com/hcvadvocate/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf3.pdf', u'https://www250.safesecureweb.com/hcvadvocate/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf2.pdf', u'http://www.hcvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf3.pdf', u'http://www.hcvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf2.pdf', u'http://www.hcvadvocate.org/news/newsupdates_pdf/2.2_conference_reports/nihconf4.pdf', u'http://www.hcvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf1.pdf']",
10.1016/S0016-5085(08)80271-5,"Twilley, L., Findlay, L., Seitsinger, D., et. al, Alberta Blood-borne Pathogens Surveillance Report Working Group, , 0",cited-by,11171418Alberta Blood-borne Pathogens Surveillance Report Working Group,Alberta Blood-borne Pathogens Surveillance Report Working Group,"[['Leslie', '', 'Twilley'], ['Linda', '', 'Findlay'], ['Doug', '', 'Seitsinger'], ['Gloria', '', 'Keays']]",,0,[u'http://www.health.alberta.ca/documents/bbp-surveillance-2003.pdf'],
10.1016/S0016-5085(08)80271-5,"Alberti, A., Benvegnù, L., Boccato, S., et. al, MANAGEMENT OF HCV RELATED LIVER DISEASE, , 0",cited-by,12971678MANAGEMENT OF HCV RELATED LIVER DISEASE,MANAGEMENT OF HCV RELATED LIVER DISEASE,"[['A.', '', 'Alberti'], ['L.', '', 'Benvegn\xc3\xb9'], ['S.', '', 'Boccato'], ['A.', '', 'Ferrari'], ['A.', '', 'Vario']]",,0,[u'http://www1.easl.ch/PGC/Alberti%20Benvegnu.pdf'],
10.1016/S0016-5085(08)80271-5,"Pasut, G., , PEGylated α interferons: two different strategies to achieve increased efficacy, , 0",cited-by,10.1007/978-3-7643-8679-5_12,PEGylated α interferons: two different strategies to achieve increased efficacy,"[['Gianfranco', '', 'Pasut']]",,0,"[u'http://www.springerlink.com/index/l403270751r88602.pdf', u'http://www.springerlink.com/content/l403270751r88602']",
10.1056~NEJMoa011232,"Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000;407:523-6.",references,10.1038/35035103,Immune control of HIV1 after early treatment of acute infection,"[[u'Eric', u'S.', u'Rosenberg'], [u'Marcus', u'', u'Altfeld'], [u'Samuel', u'H.', u'Poon'], [u'Mary', u'N.', u'Phillips'], [u'Barbara', u'M.', u'Wilkes'], [u'Robert', u'L.', u'Eldridge'], [u'Gregory', u'K.', u'Robbins'], [u'Richard', u'T.', u""D'Aquila""], [u'Philip', u'J. R.', u'Goulder'], [u'Bruce', u'D.', u'Walker']]",Nature,2000,"[u'http://www.nature.com/doifinder/10.1038/35035103', u'http://dx.doi.org/10.1038/35035103']",[]
10.1038/35035103,"Douek, D., Brenchley, J., Betts, M., et. al, HIV preferentially infects HIV-specific CD4+ T cells, Nature, 2002",cited-by,10.1038/417095a,HIV preferentially infects HIV-specific CD4+ T cells,"[['Daniel', 'C.', 'Douek'], ['Jason', 'M.', 'Brenchley'], ['Michael', 'R.', 'Betts'], ['David', 'R.', 'Ambrozak'], ['Brenna', 'J.', 'Hill'], ['Yukari', '', 'Okamoto'], ['Joseph', 'P.', 'Casazza'], ['Janaki', '', 'Kuruppu'], ['Kevin', '', 'Kunstman'], ['Steven', '', 'Wolinsky'], ['Zvi', '', 'Grossman'], ['Mark', '', 'Dybul'], ['Annette', '', 'Oxenius'], ['David', 'A.', 'Price'], ['Mark', '', 'Connors'], ['Richard', 'A.', 'Koup']]",Nature,2002,"[u'http://www.nature.com/doifinder/10.1038/417095a', u'http://dx.doi.org/10.1038/417095a', u'http://adsabs.harvard.edu/abs/2002Natur.417...95D']",
10.1038/35035103,"McMichael, A., Rowland-Jones, S., , Cellular immune responses to HIV, Nature, 2001",cited-by,10.1038/35073658,Cellular immune responses to HIV,"[['Andrew', 'J.', 'McMichael'], ['Sarah', 'L.', 'Rowland-Jones']]",Nature,2001,"[u'http://www.nature.com/doifinder/10.1038/35073658', u'http://dx.doi.org/10.1038/35073658']",
10.1038/35035103,"Richman, D., , HIV chemotherapy, Nature, 2001",cited-by,10.1038/35073673,HIV chemotherapy,"[['Douglas', 'D.', 'Richman']]",Nature,2001,"[u'http://www.nature.com/doifinder/10.1038/35073673', u'http://dx.doi.org/10.1038/35073673', u'http://adsabs.harvard.edu/abs/2001Natur.410..995R']",
10.1038/35035103,"Altfeld, M., Allen, T., Yu, X., et. al, HIV1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus, Nature, 2002",cited-by,10.1038/nature01200,HIV1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus,"[['Marcus', '', 'Altfeld'], ['Todd', 'M.', 'Allen'], ['Xu', 'G.', 'Yu'], ['Mary', 'N.', 'Johnston'], ['Deepak', '', 'Agrawal'], ['Bette', 'T.', 'Korber'], ['David', 'C.', 'Montefiori'], ['David', 'H.', ""O'Connor""], ['Ben', 'T.', 'Davis'], ['Paul', 'K.', 'Lee'], ['Erica', 'L.', 'Maier'], ['Jason', '', 'Harlow'], ['Philip', 'J. R.', 'Goulder'], ['Christian', '', 'Brander'], ['Eric', 'S.', 'Rosenberg'], ['Bruce', 'D.', 'Walker']]",Nature,2002,"[u'http://www.nature.com/doifinder/10.1038/nature01200', u'http://dx.doi.org/10.1038/nature01200', u'http://adsabs.harvard.edu/abs/2002Natur.420..434A']",
10.1038/35035103,"Sudarshi, D., Pao, D., Murphy, G., et. al, Missed opportunities for diagnosing primary HIV infection, Sexually Transmitted Infections, 2008",cited-by,10.1136/sti.2007.026963,Missed opportunities for diagnosing primary HIV infection,"[['D', '', 'Sudarshi'], ['D', '', 'Pao'], ['G', '', 'Murphy'], ['J', '', 'Parry'], ['G', '', 'Dean'], ['M', '', 'Fisher']]",Sexually Transmitted Infections,2008,"[u'http://sti.bmj.com/content/84/1/14.full.pdf', u'http://sti.bmj.com/cgi/doi/10.1136/sti.2007.026963', u'http://dx.doi.org/10.1136/sti.2007.026963']",
10.1038/35035103,"Migueles, S., Connors, M., , The role of CD4 + and CD8 + T cells in controlling HIV infection, Current Infectious Disease Reports, 2002",cited-by,10.1007/s11908-002-0014-2,The role of CD4 + and CD8 + T cells in controlling HIV infection,"[['Stephen', 'A.', 'Migueles'], ['Mark', '', 'Connors']]",Current Infectious Disease Reports,2002,"[u'http://www.springerlink.com/index/r84472t048w34467.pdf', u'http://www.springerlink.com/content/r84472t048w34467', u'http://www.springerlink.com/index/10.1007/s11908-002-0014-2', u'http://www.springerlink.com/index/pdf/10.1007/s11908-002-0014-2']",
10.1038/35035103,"Dybul, M., , Structured treatment interruption: Approaches and risks, Current Infectious Disease Reports, 2002",cited-by,10.1007/s11908-002-0059-2,Structured treatment interruption: Approaches and risks,"[['Mark', '', 'Dybul']]",Current Infectious Disease Reports,2002,"[u'http://www.springerlink.com/index/u502n14348320578.pdf', u'http://www.springerlink.com/content/u502n14348320578', u'http://www.springerlink.com/index/pdf/10.1007/s11908-002-0059-2', u'http://www.springerlink.com/index/10.1007/s11908-002-0059-2']",
10.1038/35035103,"Walmsley, S., Loutfy, M., , Can Structured Treatment Interruptions (STIs) Be Used as a Strategy to Decrease Total Drug Requirements and Toxicity in HIV Infection?, Journal of The International Association of Physicians in Aids Care (jiapac), 2002",cited-by,10.1177/154510970200100304,Can Structured Treatment Interruptions (STIs) Be Used as a Strategy to Decrease Total Drug Requirements and Toxicity in HIV Infection?,"[['Sharon', '', 'Walmsley'], ['Mona', '', 'Loutfy']]",Journal of The International Association of Physicians in Aids Care (jiapac),2002,"[u'http://jia.sagepub.com/cgi/doi/10.1177/154510970200100304', u'http://dx.doi.org/10.1177/154510970200100304']",
10.1038/35035103,"Banks, H., Davidian, M., Hu, S., et. al, Modelling HIV immune response and validation with clinical data, Journal of Biological Dynamics, 2008",cited-by,10.1080/17513750701813184,Modelling HIV immune response and validation with clinical data,"[['H.', 'T.', 'Banks'], ['M.', '', 'Davidian'], ['Shuhua', '', 'Hu'], ['Grace', 'M.', 'Kepler'], ['E.', 'S.', 'Rosenberg']]",Journal of Biological Dynamics,2008,"[u'http://dx.doi.org/10.1080/17513750701813184', u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/17513750701813184&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3']",
10.1038/35035103,"Yarhouse, M., , Working with Families Affected by HIV/AIDS, American Journal of Family Therapy, 2003",cited-by,10.1080/01926180301124,Working with Families Affected by HIV/AIDS,"[['Mark', 'A.', 'Yarhouse']]",American Journal of Family Therapy,2003,"[u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/01926180301124&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3', u'http://dx.doi.org/10.1080/01926180301124']",
10.1038/35035103,"McMichael, A., Rowland-Jones, S., , HIVBad news for stop–start therapy?, Nature, 2002",cited-by,10.1038/420371a,HIVBad news for stop–start therapy?,"[['Andrew', 'J.', 'McMichael'], ['Sarah', 'L.', 'Rowland-Jones']]",Nature,2002,"[u'http://www.nature.com/doifinder/10.1038/420371a', u'http://dx.doi.org/10.1038/420371a']",
10.1038/35035103,"Stekler, J., Collier, A., , Treatment of primary HIV, Current Infectious Disease Reports, 2002",cited-by,10.1007/s11908-002-0071-6,Treatment of primary HIV,"[['Joanne', '', 'Stekler'], ['Ann', '', 'Collier']]",Current Infectious Disease Reports,2002,"[u'http://www.springerlink.com/content/1825478216120485', u'http://www.springerlink.com/index/10.1007/s11908-002-0071-6', u'http://www.springerlink.com/index/pdf/10.1007/s11908-002-0071-6']",
10.1038/35035103,"Rowland-Jones, S., Silva, T., , Resisting Immune Exhaustion in HIV1 Infection, PLOS Medicine, 2008",cited-by,10.1371/journal.pmed.0050103,Resisting Immune Exhaustion in HIV1 Infection,"[['Sarah', '', 'Rowland-Jones'], ['Thushan', 'de', 'Silva']]",PLOS Medicine,2008,"[u'http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0050103', u'http://dx.doi.org/10.1371/journal.pmed.0050103']",
10.1038/35035103,"Koup, R., , Reconsidering Early HIV Treatment and Supervised Treatment Interruptions, PLOS Medicine, 2004",cited-by,10.1371/journal.pmed.0010041,Reconsidering Early HIV Treatment and Supervised Treatment Interruptions,"[['Richard', 'A.', 'Koup']]",PLOS Medicine,2004,"[u'http://dx.doi.org/10.1371/journal.pmed.0010041', u'http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0010041']",
10.1038/35035103,"Wit, F., Reiss, P., , When to start antiretroviral therapy and what to start with—a European perspective, Current Infectious Disease Reports, 2003",cited-by,10.1007/s11908-003-0013-y,When to start antiretroviral therapy and what to start with—a European perspective,"[['Ferdinand', 'W. N. M.', 'Wit'], ['Peter', '', 'Reiss']]",Current Infectious Disease Reports,2003,"[u'http://www.springerlink.com/index/8q47g03g263g174v.pdf', u'http://www.springerlink.com/content/8q47g03g263g174v', u'http://www.springerlink.com/index/pdf/10.1007/s11908-003-0013-y', u'http://www.springerlink.com/index/10.1007/s11908-003-0013-y']",
10.1038/35035103,"Evering, T., Mehandru, S., Racz, P., et. al, Absence of HIV1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection, PLOS Pathogens, 2012",cited-by,10.1371/journal.ppat.1002506,Absence of HIV1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection,"[['Teresa', 'H.', 'Evering'], ['Saurabh', '', 'Mehandru'], ['Paul', '', 'Racz'], ['Klara', '', 'Tenner-Racz'], ['Michael', 'A.', 'Poles'], ['Amir', '', 'Figueroa'], ['Hiroshi', '', 'Mohri'], ['Martin', '', 'Markowitz']]",PLOS Pathogens,2012,[u'http://dx.doi.org/10.1371/journal.ppat.1002506'],
10.1038/35035103,"Vassena, L., Miao, H., Cimbro, R., et. al, Treatment with IL7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques, PLOS Pathogens, 2012",cited-by,10.1371/journal.ppat.1002636,Treatment with IL7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques,"[['Lia', '', 'Vassena'], ['Huiyi', '', 'Miao'], ['Raffaello', '', 'Cimbro'], ['Mauro', 'S.', 'Malnati'], ['Giulia', '', 'Cassina'], ['Michael', 'A.', 'Proschan'], ['Vanessa', 'M.', 'Hirsch'], ['Bernard', 'A.', 'Lafont'], ['Michel', '', 'Morre'], ['Anthony', 'S.', 'Fauci'], ['Paolo', '', 'Lusso']]",PLOS Pathogens,2012,[u'http://dx.doi.org/10.1371/journal.ppat.1002636'],
10.1038/35035103,"Grijsen, M., Steingrover, R., Wit, F., et. al, No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial, PLOS Medicine, 2012",cited-by,10.1371/journal.pmed.1001196,No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial,"[['Marlous', 'L.', 'Grijsen'], ['Radjin', '', 'Steingrover'], ['Ferdinand', 'W. N. M.', 'Wit'], ['Suzanne', '', 'Jurriaans'], ['Annelies', '', 'Verbon'], ['Kees', '', 'Brinkman'], ['Marchina', 'E. van der', 'Ende'], ['Robin', '', 'Soetekouw'], ['Frank', 'de', 'Wolf'], ['Joep', 'M. A.', 'Lange'], ['Hanneke', '', 'Schuitemaker'], ['Jan', 'M.', 'Prins']]",PLOS Medicine,2012,[u'http://dx.doi.org/10.1371/journal.pmed.1001196'],
10.1038/35035103,"Ratcliff, T., Zlotnick, C., Cu-Uvin, S., et. al, Acceptance of HIV Antibody Testing Among Women in Domestic Violence Shelters, Journal of Hiv/aids & Social Services, 2012",cited-by,10.1080/15381501.2012.703555,Acceptance of HIV Antibody Testing Among Women in Domestic Violence Shelters,"[['Tanya', 'M.', 'Ratcliff'], ['Caron', '', 'Zlotnick'], ['Susan', '', 'Cu-Uvin'], ['Nanetta', '', 'Payne'], ['Kaye', '', 'Sly'], ['Timothy', '', 'Flanigan']]",Journal of Hiv/aids & Social Services,2012,[u'http://dx.doi.org/10.1080/15381501.2012.703555'],
10.1038/35035103,"Rosenberg, E., Graham, B., Chan, E., et. al, Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV1 Infection, PLOS One, 2010",cited-by,10.1371/journal.pone.0010555,Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV1 Infection,"[['Eric', 'S.', 'Rosenberg'], ['Barney', 'S.', 'Graham'], ['Ellen', 'S.', 'Chan'], ['Ronald', 'J.', 'Bosch'], ['Vicki', '', 'Stocker'], ['Janine', '', 'Maenza'], ['Martin', '', 'Markowitz'], ['Susan', '', 'Little'], ['Paul', 'E.', 'Sax'], ['Ann', 'C.', 'Collier'], ['Gary', '', 'Nabel'], ['Suzanne', '', 'Saindon'], ['Theresa', '', 'Flynn'], ['Daniel', '', 'Kuritzkes'], ['Dan', 'H.', 'Barouch'], ['Mario', 'A.', 'Ostrowski']]",PLOS One,2010,"[u'http://adsabs.harvard.edu/abs/2010PLoSO...510555R', u'http://dx.doi.org/10.1371/journal.pone.0010555']",
10.1038/35035103,"Schmid, A., Gianella, S., Wyl, V., et. al, Profound Depletion of HIV1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection, PLOS One, 2010",cited-by,10.1371/journal.pone.0013310,Profound Depletion of HIV1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection,"[['Adrian', '', 'Schmid'], ['Sara', '', 'Gianella'], ['Viktor', 'von', 'Wyl'], ['Karin', 'J.', 'Metzner'], ['Alexandra', 'U.', 'Scherrer'], ['Barbara', '', 'Nieder\xc3\xb6st'], ['Claudia', 'F.', 'Althaus'], ['Philip', '', 'Rieder'], ['Christina', '', 'Grube'], ['Beda', '', 'Joos'], ['Rainer', '', 'Weber'], ['Marek', '', 'Fischer'], ['Huldrych', 'F.', 'G\xc3\xbcnthard']]",PLOS One,2010,[u'http://dx.doi.org/10.1371/journal.pone.0013310'],
10.1038/35035103,"Kouyos, R., Gordon, S., Staprans, S., et. al, Similar Impact of CD8+ T Cell Responses on Early Virus Dynamics during SIV Infections of Rhesus Macaques and Sooty Mangabeys, PLOS Computational Biology, 2010",cited-by,10.1371/journal.pcbi.1000901,Similar Impact of CD8+ T Cell Responses on Early Virus Dynamics during SIV Infections of Rhesus Macaques and Sooty Mangabeys,"[['Roger', 'D.', 'Kouyos'], ['Shari', 'N.', 'Gordon'], ['Silvija', 'I.', 'Staprans'], ['Guido', '', 'Silvestri'], ['Roland', 'R.', 'Regoes']]",PLOS Computational Biology,2010,[u'http://dx.doi.org/10.1371/journal.pcbi.1000901'],
10.1038/35035103,"Sabado, R., Kavanagh, D., Kaufmann, D., et. al, In Vitro Priming Recapitulates In Vivo HIV1 Specific T Cell Responses, Revealing Rapid Loss of Virus Reactive CD4+ T Cells in Acute HIV1 Infection, PLOS One, 2009",cited-by,10.1371/journal.pone.0004256,"In Vitro Priming Recapitulates In Vivo HIV1 Specific T Cell Responses, Revealing Rapid Loss of Virus Reactive CD4+ T Cells in Acute HIV1 Infection","[['Rachel', 'Lubong', 'Sabado'], ['Daniel', 'G.', 'Kavanagh'], ['Daniel', 'E.', 'Kaufmann'], ['Karlhans', '', 'Fru'], ['Ethan', '', 'Babcock'], ['Eric', '', 'Rosenberg'], ['Bruce', '', 'Walker'], ['Jeffrey', '', 'Lifson'], ['Nina', '', 'Bhardwaj'], ['Marie', '', 'Larsson'], ['Derya', '', 'Unutmaz']]",PLOS One,2009,"[u'http://dx.doi.org/10.1371/journal.pone.0004256', u'http://adsabs.harvard.edu/abs/2009PLoSO...4.4256L']",
10.1038/35035103,"Kumarasamy, N., Flanigan, T., Vallabhaneni, S., et. al, A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India, Aids Care-psychological and Socio-medical Aspects of Aids/hiv, 2007",cited-by,10.1080/09540120701213849,A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India,"[['N.', '', 'Kumarasamy'], ['T.', 'P.', 'Flanigan'], ['S.', '', 'Vallabhaneni'], ['A.', 'J.', 'Cecelia'], ['P.', '', 'Christybai'], ['P.', '', 'Balakrishnan'], ['T.', '', 'Yepthom'], ['S.', '', 'Solomon'], ['C.', 'C. J.', 'Carpenter'], ['K.', 'H.', 'Mayer']]",Aids Care-psychological and Socio-medical Aspects of Aids/hiv,2007,"[u'http://dx.doi.org/10.1080/09540120701213849', u'http://www.informaworld.com/openurl?genre=article&doi=10.1080/09540120701213849&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3']",
10.1038/35035103,"Stebbing, J., Powles, T., Nelson, M., et. al, Significance of Variation Within HIV, EBV, and KSHV Subtypes, Journal of The International Association of Physicians in Aids Care (jiapac), 2006",cited-by,10.1177/1545109706290171,"Significance of Variation Within HIV, EBV, and KSHV Subtypes","[['Justin', '', 'Stebbing'], ['Tom', '', 'Powles'], ['Mark', '', 'Nelson'], ['Mark', '', 'Bower']]",Journal of The International Association of Physicians in Aids Care (jiapac),2006,"[u'http://jia.sagepub.com/cgi/doi/10.1177/1545109706290171', u'http://dx.doi.org/10.1177/1545109706290171']",
10.1038/35035103,"Soogoor, M., Daar, E., , Primary HIV1 infection: Diagnosis, pathogenesis, and treatment, Current Infectious Disease Reports, 2005",cited-by,10.1007/s11908-005-0075-0,"Primary HIV1 infection: Diagnosis, pathogenesis, and treatment","[['Malini', '', 'Soogoor'], ['Eric', 'S.', 'Daar']]",Current Infectious Disease Reports,2005,"[u'http://www.springerlink.com/content/323q6l3141226127', u'http://www.springerlink.com/index/10.1007/s11908-005-0075-0', u'http://www.springerlink.com/index/pdf/10.1007/s11908-005-0075-0']",
10.1038/35035103,"Blut, A., , Human Immunodeficiency Virus (HIV), , 2005",cited-by,57386932Human Immunodeficiency Virus (HIV),Human Immunodeficiency Virus (HIV),"[['Arbeitskreis', '', 'Blut']]",,2005,[],
10.1038/35035103,"Chan, S., Hulgan, T., D’Aquila, R., , The role of baseline HIV1 resistance testing in patients with established infection, Current Infectious Disease Reports, 2004",cited-by,10.1007/s11908-004-0015-4,The role of baseline HIV1 resistance testing in patients with established infection,"[['Suk-Yin', '', 'Chan'], ['Todd', '', 'Hulgan'], ['Richard', 'T.', 'D\xe2\x80\x99Aquila']]",Current Infectious Disease Reports,2004,"[u'http://www.springerlink.com/index/f025861r44608111.pdf', u'http://www.springerlink.com/content/f025861r44608111', u'http://www.springerlink.com/index/pdf/10.1007/s11908-004-0015-4', u'http://www.springerlink.com/index/10.1007/s11908-004-0015-4']",
10.1038/35035103,"Robinson, T., Nelson, R., Artis, D., et. al, Experimental Leishmania major Infection Suppresses HIV1 DNA Vaccine Induced Cellular Immune Response, Cells Tissues Organs, 2004",cited-by,10.1159/000079992,Experimental Leishmania major Infection Suppresses HIV1 DNA Vaccine Induced Cellular Immune Response,"[['Tara', 'M.', 'Robinson'], ['Robin', '', 'Nelson'], ['David', '', 'Artis'], ['Phillip', '', 'Scott'], ['Jean', 'D.', 'Boyer']]",Cells Tissues Organs,2004,"[u'http://www.online.karger.com/doi/10.1159/000079992', u'http://www.karger.com/doi/10.1159/000079992']",
10.1038/35035103,"Blut, A., , Human Immunodeficiency Virus (HIV), , 2004",cited-by,57386924Human Immunodeficiency Virus (HIV),Human Immunodeficiency Virus (HIV),"[['Arbeitskreis', '', 'Blut']]",,2004,[],
10.1038/35035103,"Kaufmann, D., Lichterfeld, M., Altfeld, M., et. al, Limited Durability of Viral Control following Treated Acute HIV Infection, PLOS Medicine, 2004",cited-by,10.1371/journal.pmed.0010036,Limited Durability of Viral Control following Treated Acute HIV Infection,"[['Daniel', 'E', 'Kaufmann'], ['Mathias', '', 'Lichterfeld'], ['Marcus', '', 'Altfeld'], ['Marylyn', 'M', 'Addo'], ['Mary', 'N', 'Johnston'], ['Paul', 'K', 'Lee'], ['Bradford', 'S', 'Wagner'], ['Elizabeth', 'T', 'Kalife'], ['Daryld', '', 'Strick'], ['Eric', 'S', 'Rosenberg'], ['Bruce', 'D', 'Walker']]",PLOS Medicine,2004,[u'http://dx.doi.org/10.1371/journal.pmed.0010036'],
10.1056~NEJMoa011232,"Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278:1447-50.",references,4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"[[u'E.', u'S.', u'Rosenberg'], [u'J.', u'M.', u'Billingsley'], [u'A.', u'M.', u'Caliendo'], [u'S.', u'L.', u'Boswell'], [u'P.', u'E.', u'Sax'], [u'S.', u'A.', u'Kalams'], [u'B.', u'D.', u'Walker']]",Science,1997,[],[]
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Day, C., Kaufmann, D., Kiepiela, P., et. al, PD1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, 2006",cited-by,10.1038/nature05115,PD1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression,"[['Cheryl', 'L.', 'Day'], ['Daniel', 'E.', 'Kaufmann'], ['Photini', '', 'Kiepiela'], ['Julia', 'A.', 'Brown'], ['Eshia', 'S.', 'Moodley'], ['Sharon', '', 'Reddy'], ['Elizabeth', 'W.', 'Mackey'], ['Joseph', 'D.', 'Miller'], ['Alasdair', 'J.', 'Leslie'], ['Chantal', '', 'Depierres'], ['Zenele', '', 'Mncube'], ['Jaikumar', '', 'Duraiswamy'], ['Baogong', '', 'Zhu'], ['Quentin', '', 'Eichbaum'], ['Marcus', '', 'Altfeld'], ['E.', 'John', 'Wherry'], ['Hoosen', 'M.', 'Coovadia'], ['Philip', 'J. R.', 'Goulder'], ['Paul', '', 'Klenerman'], ['Rafi', '', 'Ahmed'], ['Gordon', 'J.', 'Freeman'], ['Bruce', 'D.', 'Walker']]",Nature,2006,"[u'http://www.nature.com/doifinder/10.1038/nature05115', u'http://adsabs.harvard.edu/abs/2006Natur.443..350D', u'http://dx.doi.org/10.1038/nature05115']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Jin, X., Bauer, D., Tuttleton, S., et. al, Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques, , 1999",cited-by,11341029Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques,Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques,"[['Xia', '', 'Jin'], ['Daniel', 'E.', 'Bauer'], ['Sarah', 'E.', 'Tuttleton'], ['Sharon', '', 'Lewin'], ['Agegnehu', '', 'Gettie'], ['James', '', 'Blanchard'], ['Craig', 'E.', 'Irwin'], ['Jeffrey', 'T.', 'Safrit'], ['John', '', 'Mittler'], ['Leor', '', 'Weinberger'], ['Leondios', 'G.', 'Kostrikis'], ['Linqi', '', 'Zhang'], ['Alan', 'S.', 'Perelson'], ['David', 'D.', 'Ho']]",,1999,"[u'http://jem.rupress.org/cgi/reprint/189/6/991.pdf', u'http://mcb.berkeley.edu/courses/mcb137/exercises/Jin(1999).pdf', u'http://mcbwww.berkeley.edu/courses/mcb137/exercises/Jin(1999).pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"BETTS, M., AMBROZAK, D., DOUEK, D., et. al, Analysis of Total Human Immunodeficiency Virus (HIV)Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.24.11983-11991.2001,Analysis of Total Human Immunodeficiency Virus (HIV)Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection,"[['MICHAEL', 'R.', 'BETTS'], ['DAVID', 'R.', 'AMBROZAK'], ['DANIEL', 'C.', 'DOUEK'], ['SEBASTIAN', '', 'BONHOEFFER'], ['JASON', 'M.', 'BRENCHLEY'], ['JOSEPH', 'P.', 'CASAZZA'], ['RICHARD', 'A.', 'KOUP'], ['LOUIS', 'J.', 'PICKER']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/24/11983.pdf', u'http://www.tb1.ethz.ch/PublicationsEO/PDFpapers/Betts_JOURNAL_OF_VIROLOGY_2001_75_11983-11991.pdf', u'http://www.tb1.ethz.ch/Publications/PDFpapers/Betts_JOURNAL_OF_VIROLOGY_2001_75_11983-11991.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.24.11983-11991.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Zajac, A., Blattman, J., Murali-Krishna, K., et. al, Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function, , 0",cited-by,4068372Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function,Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function,"[['Allan', 'J.', 'Zajac'], ['Joseph', 'N.', 'Blattman'], ['Kaja', '', 'Murali-Krishna'], ['David', 'J. D.', 'Sourdive'], ['M.', '', 'Suresh'], ['John', 'D.', 'Altman'], ['Rafi', '', 'Ahmed']]",,0,"[u'http://www.microbio.uab.edu/mic740/papers/11232009/zajac.pdf', u'http://jem.rupress.org/cgi/reprint/188/12/2205.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Addo, M., Yu, X., Rathod, A., et. al, Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV1)Specific T-Cell Responses Directed against the Entire Expressed HIV1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load, Journal of Virology, 2003",cited-by,10.1128/JVI.77.3.2081-2092.2003,"Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV1)Specific T-Cell Responses Directed against the Entire Expressed HIV1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load","[['M.', 'M.', 'Addo'], ['X.', 'G.', 'Yu'], ['A.', '', 'Rathod'], ['D.', '', 'Cohen'], ['R.', 'L.', 'Eldridge'], ['D.', '', 'Strick'], ['M.', 'N.', 'Johnston'], ['C.', '', 'Corcoran'], ['A.', 'G.', 'Wurcel'], ['C.', 'A.', 'Fitzpatrick'], ['M.', 'E.', 'Feeney'], ['W.', 'R.', 'Rodriguez'], ['N.', '', 'Basgoz'], ['R.', '', 'Draenert'], ['David', 'R.', 'Stone'], ['C.', '', 'Brander'], ['P.', 'J. R.', 'Goulder'], ['E.', 'S.', 'Rosenberg'], ['M.', '', 'Altfeld'], ['B.', 'D.', 'Walker']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/3/2081.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.3.2081-2092.2003']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Hirsch, M., Clotet, B., Conway, B., et. al, Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel, Clinical Infectious Diseases, 2003",cited-by,10.1086/375597,Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel,"[['Martin', 'S.', 'Hirsch'], ['Bonaventura', '', 'Clotet'], ['Brian', '', 'Conway'], ['Daniel', 'R.', 'Kuritzkes'], ['Richard', 'T.', 'D\xe2\x80\x99Aquila'], ['Lisa', 'M.', 'Demeter'], ['Scott', 'M.', 'Hammer'], ['Victoria', 'A.', 'Johnson'], ['Clive', '', 'Loveday'], ['John', 'W.', 'Mellors'], ['Donna', 'M.', 'Jacobsen'], ['Douglas', 'D.', 'Richman']]",Clinical Infectious Diseases,2003,"[u'https://www.iasusa.org/pub/resistance2003.pdf', u'http://www.iasusa.org/pub/resistance2003.pdf', u'http://wwwnew.iasusa.org/pub/resistance2003.pdf', u'http://www.faetc.org/PDF/Final_Sets/Track1_Day1/MELENDEZ_ORRICK_ARV_Complications_Resistance_Handout.pdf', u'https://wwwnew.iasusa.org/pub/resistance2003.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/375597']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Silvestri, G., Sodora, D., Koup, R., et. al, Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia, Immunity, 2003",cited-by,10.1016/S1074-7613(03)00060-8,Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia,"[['Guido', '', 'Silvestri'], ['Donald', 'L.', 'Sodora'], ['Richard', 'A.', 'Koup'], ['Mirko', '', 'Paiardini'], ['Shawn', 'P.', ""O'Neil""], ['Harold', 'M.', 'McClure'], ['Silvija', 'I.', 'Staprans'], ['Mark', 'B.', 'Feinberg']]",Immunity,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1074761303000608', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761303000608']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Rose, N., Marx, P., Luckay, A., et. al, An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants, Cell, 2001",cited-by,10.1016/S0092-8674(01)00482-2,An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants,"[['Nina', 'F.', 'Rose'], ['Preston', 'A.', 'Marx'], ['Amara', '', 'Luckay'], ['Douglas', 'F.', 'Nixon'], ['Walter', 'J.', 'Moretto'], ['Sean', 'M.', 'Donahoe'], ['David', '', 'Montefiori'], ['Anjeanette', '', 'Roberts'], ['Linda', '', 'Buonocore'], ['John', 'K.', 'Rose']]",Cell,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0092867401004822', u'http://linkinghub.elsevier.com/retrieve/pii/S0092867401004822']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Kalams, S., Walker, B., , The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses, , 0",cited-by,3874073The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses,The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses,"[['Spyros', 'A.', 'Kalams'], ['Bruce', 'D.', 'Walker']]",,0,[],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Carpenter, C., Fischl, M., Hammer, S., et. al, Antiretroviral Therapy for HIV Infection in 1998 Updated Recommendations of the International AIDS Society-USA Panel, , 0",cited-by,11037335Antiretroviral Therapy for HIV Infection in 1998 Updated Recommendations of the International AIDS Society-USA Panel,Antiretroviral Therapy for HIV Infection in 1998 Updated Recommendations of the International AIDS Society-USA Panel,"[['Charles', 'C. J.', 'Carpenter'], ['Margaret', 'A.', 'Fischl'], ['Scott', 'M.', 'Hammer'], ['Martin', 'S.', 'Hirsch'], ['Donna', 'M.', 'Jacobsen'], ['David', 'A.', 'Katzenstein'], ['Julio', 'S. G.', 'Montaner'], ['Douglas', 'D.', 'Richman'], ['Michael', 'S.', 'Saag'], ['Robert', 'T.', 'Schooley'], ['Melanie', 'A.', 'Thompson'], ['Stefano', '', 'Vella'], ['Patrick', 'G.', 'Yeni'], ['Paul', 'A.', 'Volberding']]",,0,"[u'http://www.iasusa.org/pub/arv_1998.pdf', u'http://people.virginia.edu/~gct2r/library/JAMA_ARV_Rx_for_HIV_1998.pdf', u'http://wwwnew.iasusa.org/pub/arv_1998.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"KENT, S., ZHAO, A., BEST, S., et. al, Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus, , 1998",cited-by,12170710Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus,Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus,"[['STEPHEN', 'J.', 'KENT'], ['ANNE', '', 'ZHAO'], ['SUSAN', 'J.', 'BEST'], ['JENALLE', 'D.', 'CHANDLER'], ['DAVID', 'B.', 'BOYLE'], ['IAN', 'A.', 'RAMSHAW'], ['Macfarlane', '', 'Burnet'], ['John', '', 'Curtin']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/12/10180.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"HANKE, T., SAMUEL, R., BLANCHARD, T., et. al, Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen, , 1999",cited-by,13742845Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen,Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen,"[['TOMAS', '', 'HANKE'], ['RACHEL', 'V.', 'SAMUEL'], ['TOM', 'J.', 'BLANCHARD'], ['VERONICA', 'C.', 'NEUMANN'], ['TODD', 'M.', 'ALLEN'], ['JON', 'E.', 'BOYSON'], ['SALLY', 'A.', 'SHARPE'], ['NICOLA', '', 'COOK'], ['GEOFFREY', 'L.', 'SMITH'], ['DAVID', 'I.', 'WATKINS'], ['MARTIN', 'P.', 'CRANAGE'], ['ANDREW', 'J.', 'MCMICHAEL']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/9/7524.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Carpenter, C., Cooper, D., Fischl, M., et. al, Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society-USA Panel, , 0",cited-by,10020061Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society-USA Panel,Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society-USA Panel,"[['Charles', 'C. J.', 'Carpenter'], ['David', 'A.', 'Cooper'], ['Margaret', 'A.', 'Fischl'], ['Jose', 'M.', 'Gatell'], ['Brian', 'G.', 'Gazzard'], ['Scott', 'M.', 'Hammer'], ['Martin', 'S.', 'Hirsch'], ['Donna', 'M.', 'Jacobsen'], ['David', 'A.', 'Katzenstein'], ['Julio', 'S. G.', 'Montaner'], ['Douglas', 'D.', 'Richman'], ['Michael', 'S.', 'Saag'], ['Mauro', '', 'Schechter'], ['Robert', 'T.', 'Schooley'], ['Melanie', 'A.', 'Thompson'], ['Stefano', '', 'Vella'], ['Patrick', 'G.', 'Yeni'], ['Paul', 'A.', 'Volberding']]",,0,"[u'http://wwwnew.iasusa.org/pub/arv_2000.pdf', u'http://www.iasusa.org/pub/arv_2000.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Buchbinder, S., Mehrotra, D., Duerr, A., et. al, Efficacy assessment of a cell-mediated immunity HIV1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61591-3,"Efficacy assessment of a cell-mediated immunity HIV1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","[['Susan', 'P', 'Buchbinder'], ['Devan', 'V', 'Mehrotra'], ['Ann', '', 'Duerr'], ['Daniel', 'W', 'Fitzgerald'], ['Robin', '', 'Mogg'], ['David', '', 'Li'], ['Peter', 'B', 'Gilbert'], ['Javier', 'R', 'Lama'], ['Michael', '', 'Marmor'], ['Carlos', 'del', 'Rio'], ['M', 'Juliana', 'McElrath'], ['Danilo', 'R', 'Casimiro'], ['Keith', 'M', 'Gottesdiener'], ['Jeffrey', 'A', 'Chodakewitz'], ['Lawrence', '', 'Corey'], ['Michael', 'N', 'Robertson']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608615913', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608615913']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Brenchley, J., Karandikar, N., Betts, M., et. al, Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8 T cells, , 2003",cited-by,6508662Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8 T cells,Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8 T cells,"[['Jason', 'M.', 'Brenchley'], ['Nitin', 'J.', 'Karandikar'], ['Michael', 'R.', 'Betts'], ['David', 'R.', 'Ambrozak'], ['Brenna', 'J.', 'Hill'], ['Laura', 'E.', 'Crotty'], ['Joseph', 'P.', 'Casazza'], ['Janaki', '', 'Kuruppu'], ['Stephen', 'A.', 'Migueles'], ['Mark', '', 'Connors'], ['Mario', '', 'Roederer'], ['Daniel', 'C.', 'Douek'], ['Richard', 'A.', 'Koup']]",,2003,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/101/7/2711.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"OGG, G., JIN, X., BONHOEFFER, S., et. al, Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy, , 1999",cited-by,5026206Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy,Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy,"[['G.', 'S.', 'OGG'], ['X.', '', 'JIN'], ['S.', '', 'BONHOEFFER'], ['P.', '', 'MOSS'], ['M.', 'A.', 'NOWAK'], ['S.', '', 'MONARD'], ['J.', 'P.', 'SEGAL'], ['Y.', '', 'CAO'], ['S.', 'L.', 'ROWLAND-JONES'], ['A.', '', 'HURLEY'], ['M.', '', 'MARKOWITZ'], ['D.', 'D.', 'HO'], ['A.', 'J.', 'MCMICHAEL'], ['D.', 'F.', 'NIXON']]",,1999,"[u'http://www.tb1.ethz.ch/Publications/PDFpapers/Ogg_JOURNAL_OF_VIROLOGY_1999_73_797-800.pdf', u'http://jvi.asm.org/cgi/reprint/73/1/797.pdf', u'http://www.ped.fas.harvard.edu/people/faculty/publications_nowak/JVirol99a.pdf', u'http://www.fas.harvard.edu/~ped/people/faculty/publications_nowak/JVirol99a.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Ortiz, G., Nixon, D., Trkola, A., et. al, HIV1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy, Journal of Clinical Investigation, 1999",cited-by,10.1172/JCI7371,HIV1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy,"[['Gabriel', 'M.', 'Ortiz'], ['Douglas', 'F.', 'Nixon'], ['Alexandra', '', 'Trkola'], ['James', '', 'Binley'], ['Xia', '', 'Jin'], ['Sebastian', '', 'Bonhoeffer'], ['Peter', 'J.', 'Kuebler'], ['Sean', 'M.', 'Donahoe'], ['Marie-Ange', '', 'Demoitie'], ['William', 'M.', 'Kakimoto'], ['Tom', '', 'Ketas'], ['Brian', '', 'Clas'], ['Jonas', 'J.', 'Heymann'], ['Linqi', '', 'Zhang'], ['Yunzhen', '', 'Cao'], ['Arlene', '', 'Hurley'], ['John', 'P.', 'Moore'], ['David', 'D.', 'Ho'], ['Martin', '', 'Markowitz']]",Journal of Clinical Investigation,1999,"[u'http://www.tb1.ethz.ch/Publications/PDFpapers/Ortiz_JOURNAL_OF_CLINICAL_INVESTIGATION_1999_104_R13-R18.pdf', u'http://www.jci.org/articles/view/7371']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Altfeld, M., Rosenberg, E., Shankarappa, R., et. al, Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection, , 0",cited-by,2818688Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection,Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection,"[['Marcus', '', 'Altfeld'], ['Eric', 'S.', 'Rosenberg'], ['Raj', '', 'Shankarappa'], ['Joia', 'S.', 'Mukherjee'], ['Frederick', 'M.', 'Hecht'], ['Robert', 'L.', 'Eldridge'], ['Marylyn', 'M.', 'Addo'], ['Samuel', 'H.', 'Poon'], ['Mary', 'N.', 'Phillips'], ['Gregory', 'K.', 'Robbins'], ['Paul', 'E.', 'Sax'], ['Steve', '', 'Boswell'], ['James', 'O.', 'Kahn'], ['Christian', '', 'Brander'], ['Philip', 'J. R.', 'Goulder'], ['Jay', 'A.', 'Levy'], ['James', 'I.', 'Mullins'], ['Bruce', 'D.', 'Walker']]",,0,[u'http://jem.rupress.org/cgi/reprint/193/2/169.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"MCSHANE, H., BROOKES, R., GILBERT, S., et. al, Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis, Infection and Immunity, 2001",cited-by,10.1128/IAI.69.2.681-686.2001,Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis,"[['HELEN', '', 'MCSHANE'], ['ROGER', '', 'BROOKES'], ['SARAH', 'C.', 'GILBERT'], ['ADRIAN', 'V. S.', 'HILL']]",Infection and Immunity,2001,"[u'http://iai.asm.org/cgi/reprint/69/2/681.pdf', u'http://iai.asm.org/cgi/doi/10.1128/IAI.69.2.681-686.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Horton, H., Vogel, T., Carter, D., et. al, Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239, Journal of Virology, 2002",cited-by,10.1128/JVI.76.14.7187-7202.2002,Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239,"[['Helen', '', 'Horton'], ['Thorsten', 'U.', 'Vogel'], ['Donald', 'K.', 'Carter'], ['Kathy', '', 'Vielhuber'], ['Deborah', 'H.', 'Fuller'], ['Tim', '', 'Shipley'], ['James', 'T.', 'Fuller'], ['Kevin', 'J.', 'Kunstman'], ['Gerd', '', 'Sutter'], ['David', 'C.', 'Montefiori'], ['Volker', '', 'Erfle'], ['Ronald', 'C.', 'Desrosiers'], ['Nancy', '', 'Wilson'], ['Louis', 'J.', 'Picker'], ['Steven', 'M.', 'Wolinsky'], ['Chenxi', '', 'Wang'], ['David', 'B.', 'Allison'], ['David', 'I.', 'Watkins']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/14/7187.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.14.7187-7202.2002']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Harari, A., Petitpierre, S., Vallelian, F., et. al, Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy, , 2004",cited-by,6743478Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy,Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy,"[['Alexandre', '', 'Harari'], ['Stephanie', '', 'Petitpierre'], ['Florence', '', 'Vallelian'], ['Giuseppe', '', 'Pantaleo']]",,2004,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/3/966.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2003-04-1203v1.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Deeks, S., Walker, B., , Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy, Immunity, 2007",cited-by,10.1016/j.immuni.2007.08.010,Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy,"[['Steven', 'G.', 'Deeks'], ['Bruce', 'D.', 'Walker']]",Immunity,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1074761307004141', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761307004141']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Zinkernagel, R., , ON NATURAL AND ARTIFICIAL VACCINATIONS, Annual Review of Immunology, 2003",cited-by,10.1146/annurev.immunol.21.120601.141045,ON NATURAL AND ARTIFICIAL VACCINATIONS,"[['Rolf', 'M.', 'Zinkernagel']]",Annual Review of Immunology,2003,"[u'http://webpages.csus.edu/~aenstrom/10.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.21.120601.141045']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"QUINONES-MATEU, M., BALL, S., MAROZSAN, A., et. al, A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression, Journal of Virology, 2000",cited-by,10.1128/JVI.74.19.9222-9233.2000,A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression,"[['MIGUEL', 'E.', 'QUINONES-MATEU'], ['SARAH', 'C.', 'BALL'], ['ANDRE', 'J.', 'MAROZSAN'], ['VINCENT', 'S.', 'TORRE'], ['JAMIE', 'L.', 'ALBRIGHT'], ['GUIDO', '', 'VANHAM'], ['GUIDO', 'VAN DER', 'GROEN'], ['ROBERT', 'L.', 'COLEBUNDERS'], ['ERIC', 'J.', 'ARTS']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/19/9222.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.19.9222-9233.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Iyasere, C., Tilton, J., Johnson, A., et. al, Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin2 (IL2) Production and Is Recovered by Exogenous IL2, Journal of Virology, 2003",cited-by,10.1128/JVI.77.20.10900-10909.2003,Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin2 (IL2) Production and Is Recovered by Exogenous IL2,"[['Christiana', '', 'Iyasere'], ['John', 'C.', 'Tilton'], ['Alison', 'J.', 'Johnson'], ['Souheil', '', 'Younes'], ['Bader', '', 'Yassine-Diab'], ['Rafick-Pierre', '', 'Sekaly'], ['William', 'W.', 'Kwok'], ['Stephen', 'A.', 'Migueles'], ['Alisha', 'C.', 'Laborico'], ['W.', 'Lesley', 'Shupert'], ['Claire', 'W.', 'Hallahan'], ['Richard', 'T.', 'Davey'], ['M.', '', 'Dybul'], ['S.', '', 'Vogel'], ['J.', '', 'Metcalf'], ['M.', '', 'Connors']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/20/10900.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.20.10900-10909.2003']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"MANGASARIAN, A., PIGUET, V., WANG, J., et. al, Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking, , 1964",cited-by,13235388Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking,Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking,"[['ARAM', '', 'MANGASARIAN'], ['VINCENT', '', 'PIGUET'], ['JEN-KUEI', '', 'WANG'], ['YEN-LIANG', '', 'CHEN'], ['DIDIER', '', 'TRONO']]",,1964,[u'http://jvi.asm.org/cgi/reprint/73/3/1964.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"GOEPFERT, P., BANSAL, A., EDWARDS, B., et. al, A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon, Journal of Virology, 2000",cited-by,10.1128/JVI.74.21.10249-10255.2000,A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon,"[['PAUL', 'A.', 'GOEPFERT'], ['ANJU', '', 'BANSAL'], ['BRADLEY', 'H.', 'EDWARDS'], ['ILDEFONSO', '', 'TELLEZ'], ['SYLVIA', 'A.', 'MCPHERSON'], ['STEFFANIE', '', 'SABBAJ'], ['MARK', 'J.', 'MULLIGAN']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/21/10249.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.21.10249-10255.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Lieberman, J., Shankar, P., Manjunath, N., et. al, Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV1 infection, , 2001",cited-by,5936546Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV1 infection,Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV1 infection,"[['Judy', '', 'Lieberman'], ['Premlata', '', 'Shankar'], ['N.', '', 'Manjunath'], ['Jan', '', 'Andersson']]",,2001,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/98/6/1667.pdf', u'http://labs.idi.harvard.edu/lieberman/pdf/2001LiebBlood.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Younes, S., Yassine-Diab, B., Dumont, A., et. al, HIV1 Viremia Prevents the Establishment of Interleukin 2-producing HIVspecific Memory CD4 � T Cells Endowed with Proliferative Capacity, , 0",cited-by,10241450HIV1 Viremia Prevents the Establishment of Interleukin 2-producing HIVspecific Memory CD4 � T Cells Endowed with Proliferative Capacity,HIV1 Viremia Prevents the Establishment of Interleukin 2-producing HIVspecific Memory CD4 � T Cells Endowed with Proliferative Capacity,"[['Souheil-Antoine', '', 'Younes'], ['Bader', '', 'Yassine-Diab'], ['Alain', 'R.', 'Dumont'], ['Mohamed-Rachid', '', 'Boulassel'], ['Zvi', '', 'Grossman'], ['Jean-Pierre', '', 'Routy'], ['Rafick-Pierre', '', 'S\xc3\xa9kaly']]",,0,[u'http://jem.rupress.org/cgi/reprint/198/12/1909.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Wilson, N., Reed, J., Napoe, G., et. al, Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239, Journal of Virology, 2006",cited-by,10.1128/JVI.00171-06,Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239,"[['Nancy', 'A.', 'Wilson'], ['Jason', '', 'Reed'], ['Gnankang', 'S.', 'Napoe'], ['Shari', '', 'Piaskowski'], ['Andy', '', 'Szymanski'], ['Jessica', '', 'Furlott'], ['Edna', 'J.', 'Gonzalez'], ['Levi', 'J.', 'Yant'], ['Nicholas', 'J.', 'Maness'], ['Gemma', 'E.', 'May'], ['Taeko', '', 'Soma'], ['Matthew', 'R.', 'Reynolds'], ['Eva', '', 'Rakasz'], ['Richard', '', 'Rudersdorf'], ['Adrian', 'B.', 'McDermott'], ['David', 'H.', ""O'Connor""], ['Thomas', 'C.', 'Friedrich'], ['David', 'B.', 'Allison'], ['Amit', '', 'Patki'], ['Louis', 'J.', 'Picker'], ['Dennis', 'R.', 'Burton'], ['Jing', '', 'Lin'], ['Lingyi', '', 'Huang'], ['Deepa', '', 'Patel'], ['G.', '', 'Heindecker'], ['J.', '', 'Fan'], ['M.', '', 'Citron'], ['M.', '', 'Horton'], ['F.', '', 'Wang'], ['X.', '', 'Liang'], ['J.', 'W.', 'Shiver'], ['D.', 'R.', 'Casimiro'], ['D.', 'I.', 'Watkins']]",Journal of Virology,2006,"[u'http://labs.pathology.wisc.edu/oconnor/multimedia/lab_publications_assets/WilsonJV2006.pdf', u'http://jvi.asm.org/cgi/reprint/80/12/5875.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00171-06']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Finzi, D., Siliciano, R., , Viral Dynamics in HIV1 Infection, Cell, 1998",cited-by,10.1016/S0092-8674(00)81427-0,Viral Dynamics in HIV1 Infection,"[['Diana', '', 'Finzi'], ['Robert', 'F', 'Siliciano']]",Cell,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0092867400814270', u'http://linkinghub.elsevier.com/retrieve/pii/S0092867400814270']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Goulder, P., Altfeld, M., Rosenberg, E., et. al, Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection, , 0",cited-by,10950327Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection,Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection,"[['Philip', 'J. R.', 'Goulder'], ['Marcus', 'A.', 'Altfeld'], ['Eric', 'S.', 'Rosenberg'], ['Thi', '', 'Nguyen'], ['Yanhua', '', 'Tang'], ['Robert', 'L.', 'Eldridge'], ['Marylyn', 'M.', 'Addo'], ['Suqin', '', 'He'], ['Joia', 'S.', 'Muckerjee'], ['Mary', 'N.', 'Phillips'], ['Michael', '', 'Bunce'], ['Spyros', 'A.', 'Kalams'], ['Rafick', 'P.', 'Sekaly'], ['Bruce', 'D.', 'Walker'], ['Christian', '', 'Brander']]",,0,[u'http://jem.rupress.org/cgi/reprint/193/2/181.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Alimonti, J., Ball, T., Fowke, K., , Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS, Journal of General Virology, 2003",cited-by,10.1099/vir.0.19110-0,Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS,"[['Judie', 'B.', 'Alimonti'], ['T.', 'Blake', 'Ball'], ['Keith', 'R.', 'Fowke']]",Journal of General Virology,2003,"[u'http://vir.sgmjournals.org/cgi/reprint/84/7/1649.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/vir.0.19110-0']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Buchbinder, S., Mehrotra, D., Fitzgerald, D., et. al, Effi cacy assessment of a cell-mediated immunity HIV1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial, , 2008",cited-by,"5992628Effi cacy assessment of a cell-mediated immunity HIV1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","Effi cacy assessment of a cell-mediated immunity HIV1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","[['Susan', 'P', 'Buchbinder'], ['Devan', 'V', 'Mehrotra'], ['Daniel', 'W', 'Fitzgerald'], ['Robin', '', 'Mogg'], ['David', '', 'Li'], ['Peter', 'B', 'Gilbert'], ['Javier', 'R', 'Lama'], ['Michael', '', 'Marmor'], ['M', 'Juliana', 'McElrath'], ['Danilo', 'R', 'Casimiro'], ['Lawrence', '', 'Corey'], ['Michael', 'N', 'Robertson']]",,2008,[u'http://www.hvtn.org/media/Buchbinder_STEParticle_13Nov08.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Kaufmann, D., Bailey, P., Sidney, J., et. al, Comprehensive Analysis of Human Immunodeficiency Virus Type 1Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides, Journal of Virology, 2004",cited-by,10.1128/JVI.78.9.4463-4477.2004,Comprehensive Analysis of Human Immunodeficiency Virus Type 1Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides,"[['Daniel', 'E.', 'Kaufmann'], ['Paul', 'M.', 'Bailey'], ['John', '', 'Sidney'], ['Bradford', '', 'Wagner'], ['Philip', 'J.', 'Norris'], ['Mary', 'N.', 'Johnston'], ['Lisa', 'A.', 'Cosimi'], ['Marylyn', 'M.', 'Addo'], ['Mathias', '', 'Lichterfeld'], ['Marcus', '', 'Altfeld'], ['Nicole', '', 'Frahm'], ['Christian', '', 'Brander'], ['Alessandro', '', 'Sette'], ['Bruce', 'D.', 'Walker'], ['Eric', 'S.', 'Rosenberg']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/9/4463.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.9.4463-4477.2004']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Guadalupe, M., Sankaran, S., George, M., et. al, Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1Infected Patients Initiating Therapy during Primary or Chronic Infection, Journal of Virology, 2006",cited-by,10.1128/JVI.00120-06,Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1Infected Patients Initiating Therapy during Primary or Chronic Infection,"[['Moraima', '', 'Guadalupe'], ['Sumathi', '', 'Sankaran'], ['Michael', 'D.', 'George'], ['Elizabeth', '', 'Reay'], ['David', '', 'Verhoeven'], ['Barbara', 'L.', 'Shacklett'], ['Jason', '', 'Flamm'], ['Jacob', '', 'Wegelin'], ['Thomas', '', 'Prindiville'], ['Satya', '', 'Dandekar']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/16/8236.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00120-06']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"POPIK, W., HESSELGESSER, J., PITHA, P., , Binding of Human Immunodeficiency Virus Type 1 to CD4 and CXCR4 Receptors Differentially Regulates Expression of Inflammatory Genes and Activates the MEK/ERK Signaling Pathway, , 0",cited-by,12624707Binding of Human Immunodeficiency Virus Type 1 to CD4 and CXCR4 Receptors Differentially Regulates Expression of Inflammatory Genes and Activates the MEK/ERK Signaling Pathway,Binding of Human Immunodeficiency Virus Type 1 to CD4 and CXCR4 Receptors Differentially Regulates Expression of Inflammatory Genes and Activates the MEK/ERK Signaling Pathway,"[['WALDEMAR', '', 'POPIK'], ['JOSEPH', 'E.', 'HESSELGESSER'], ['PAULA', 'M.', 'PITHA']]",,0,[],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Mueller, Y., Rosa, S., Hutton, J., et. al, Increased CD95/Fas-Induced Apoptosis of HIV-Specific CD8 + T Cells, Immunity, 2001",cited-by,10.1016/S1074-7613(01)00246-1,Increased CD95/Fas-Induced Apoptosis of HIV-Specific CD8 + T Cells,"[['Yvonne', 'M', 'Mueller'], ['Stephen', 'C De', 'Rosa'], ['Justin', 'A', 'Hutton'], ['James', '', 'Witek'], ['Mario', '', 'Roederer'], ['John', 'D', 'Altman'], ['Peter', 'D', 'Katsikis']]",Immunity,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1074761301002461', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761301002461']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"LIFSON, J., ROSSIO, J., ARNAOUT, R., et. al, Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment, Journal of Virology, 2000",cited-by,10.1128/JVI.74.6.2584-2593.2000,Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment,"[['JEFFREY', 'D.', 'LIFSON'], ['JEFFREY', 'L.', 'ROSSIO'], ['RAMY', '', 'ARNAOUT'], ['LI', '', 'LI'], ['THOMAS', 'L.', 'PARKS'], ['DOUGLAS', 'K.', 'SCHNEIDER'], ['REBECCA', 'F.', 'KISER'], ['VICKY', 'J.', 'COALTER'], ['GENEVA', '', 'WALSH'], ['ROBERT', 'J.', 'IMMING'], ['BRADLEY', '', 'FISHER'], ['BERNARD', 'M.', 'FLYNN'], ['NORBERT', '', 'BISCHOFBERGER'], ['MICHAEL', '', 'PIATAK'], ['VANESSA', 'M.', 'HIRSCH'], ['MARTIN', 'A.', 'NOWAK'], ['DOMINIK', '', 'WODARZ']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/6/2584.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.6.2584-2593.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Douek, D., Picker, L., Koup, R., , TC ELL DYNAMICS IN HIV1 INFECTION, , 2003",cited-by,3833463TC ELL DYNAMICS IN HIV1 INFECTION,TC ELL DYNAMICS IN HIV1 INFECTION,"[['Daniel', 'C.', 'Douek'], ['Louis', 'J.', 'Picker'], ['Richard', 'A.', 'Koup']]",,2003,"[u'http://staff.science.uva.nl/~mdekkers/articles/Douek%20D%202003.pdf', u'http://ubik.microbiol.washington.edu/LabMtg/JournalClub/Douek265.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Goonetilleke, N., Moore, S., Dally, L., et. al, Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV1)Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV1 Gag Coupled to CD8+ T-Cell Epitopes, Journal of Virology, 2006",cited-by,10.1128/JVI.80.10.4717-4728.2006,Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV1)Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV1 Gag Coupled to CD8+ T-Cell Epitopes,"[['Nilu', '', 'Goonetilleke'], ['Stephen', '', 'Moore'], ['Len', '', 'Dally'], ['Nicola', '', 'Winstone'], ['Inese', '', 'Cebere'], ['Abdul', '', 'Mahmoud'], ['Susana', '', 'Pinheiro'], ['Geraldine', '', 'Gillespie'], ['Denise', '', 'Brown'], ['Vanessa', '', 'Loach'], ['Joanna', '', 'Roberts'], ['Ana', '', 'Guimaraes-Walker'], ['Peter', '', 'Hayes'], ['Kelley', '', 'Loughran'], ['Carole', '', 'Smith'], ['Jan', 'De', 'Bont'], ['Carl', '', 'Verlinde'], ['Danii', '', 'Vooijs'], ['Claudia', '', 'Schmidt'], ['Mark', '', 'Boaz'], ['Jill', '', 'Gilmour'], ['Pat', '', 'Fast'], ['Lucy', '', 'Dorrell'], ['Tomas', '', 'Hanke'], ['Andrew', 'J.', 'McMichael']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/10/4717.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.80.10.4717-4728.2006']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Mitsuyasu, R., Anton, P., Deeks, S., et. al, Prolonged survival and tissue trafficking following adoptive transfer of CD4z gene-modified autologous CD4 1 and CD81 T cells in human immunodeficiency virus-infected subjects, , 0",cited-by,12849124Prolonged survival and tissue trafficking following adoptive transfer of CD4z gene-modified autologous CD4 1 and CD81 T cells in human immunodeficiency virus-infected subjects,Prolonged survival and tissue trafficking following adoptive transfer of CD4z gene-modified autologous CD4 1 and CD81 T cells in human immunodeficiency virus-infected subjects,"[['Ronald', 'T.', 'Mitsuyasu'], ['Peter', 'A.', 'Anton'], ['Steven', 'G.', 'Deeks'], ['David', 'T.', 'Scadden'], ['Elizabeth', '', 'Connick'], ['Matthew', 'T.', 'Downs'], ['Andreas', '', 'Bakker'], ['Margo', 'R.', 'Roberts'], ['Carl', 'H.', 'June'], ['Sayeh', '', 'Jalali'], ['Andy', 'A.', 'Lin'], ['Rukmini', '', 'Pennathur-Das'], ['Kristen', 'M.', 'Hege']]",,0,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/96/3/785.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Emu, B., Sinclair, E., Favre, D., et. al, Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment, Journal of Virology, 2005",cited-by,10.1128/JVI.79.22.14169-14178.2005,"Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment","[['Brinda', '', 'Emu'], ['Elizabeth', '', 'Sinclair'], ['David', '', 'Favre'], ['Walter', 'J.', 'Moretto'], ['Priscilla', '', 'Hsue'], ['Rebecca', '', 'Hoh'], ['Jeffrey', 'N.', 'Martin'], ['Douglas', 'F.', 'Nixon'], ['Joseph', 'M.', 'McCune'], ['Steven', 'G.', 'Deeks']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/22/14169.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.22.14169-14178.2005']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Altfeld, M., Rosenberg, E., , The role of CD4 + T helper cells in the cytotoxic T lymphocyte response to HIV1, Current Opinion in Immunology, 2000",cited-by,10.1016/S0952-7915(00)00103-5,The role of CD4 + T helper cells in the cytotoxic T lymphocyte response to HIV1,"[['Marcus', '', 'Altfeld'], ['Eric', 'S', 'Rosenberg']]",Current Opinion in Immunology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500001035', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500001035']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Zhang, D., Shankar, P., Xu, Z., et. al, Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic, , 2003",cited-by,5150112Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic,Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic,"[['Dong', '', 'Zhang'], ['Premlata', '', 'Shankar'], ['Zhan', '', 'Xu'], ['Brooke', '', 'Harnisch'], ['Gang', '', 'Chen'], ['Christoph', '', 'Lange'], ['Sandra', 'J.', 'Lee'], ['Hernan', '', 'Valdez'], ['Michael', 'M.', 'Lederman'], ['Judy', '', 'Lieberman'], ['Cleveland', '', 'OH']]",,2003,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/101/1/226.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2002-03-0791v1.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Lichterfeld, M., Kaufmann, D., Yu, X., et. al, Loss of HIV1-specific CD8 � T Cell Proliferation after Acute HIV1 Infection and Restoration by Vaccine-induced HIV1-specific CD4 � T Cells, , 0",cited-by,11503544Loss of HIV1-specific CD8 � T Cell Proliferation after Acute HIV1 Infection and Restoration by Vaccine-induced HIV1-specific CD4 � T Cells,Loss of HIV1-specific CD8 � T Cell Proliferation after Acute HIV1 Infection and Restoration by Vaccine-induced HIV1-specific CD4 � T Cells,"[['Mathias', '', 'Lichterfeld'], ['Daniel', 'E.', 'Kaufmann'], ['Xu', 'G.', 'Yu'], ['Stanley', 'K.', 'Mui'], ['Marylyn', 'M.', 'Addo'], ['Mary', 'N.', 'Johnston'], ['Daniel', '', 'Cohen'], ['Gregory', 'K.', 'Robbins'], ['Eunice', '', 'Pae'], ['Galit', '', 'Alter'], ['Alysse', '', 'Wurcel'], ['David', '', 'Stone'], ['Eric', 'S.', 'Rosenberg'], ['Bruce', 'D.', 'Walker'], ['Marcus', '', 'Altfeld']]",,0,[u'http://jem.rupress.org/cgi/reprint/200/6/701.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Yang, O., Sarkis, P., Ali, A., et. al, Determinants of HIV1 Mutational Escape From Cytotoxic T Lymphocytes, , 2003",cited-by,6546026Determinants of HIV1 Mutational Escape From Cytotoxic T Lymphocytes,Determinants of HIV1 Mutational Escape From Cytotoxic T Lymphocytes,"[['Otto', 'O.', 'Yang'], ['Phuong', 'Thi Nguyen', 'Sarkis'], ['Ayub', '', 'Ali'], ['Jason', 'D.', 'Harlow'], ['Christian', '', 'Brander'], ['Spyros', 'A.', 'Kalams'], ['Bruce', 'D.', 'Walker']]",,2003,[u'http://jem.rupress.org/cgi/reprint/197/10/1365.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Cosma, A., Nagaraj, R., Bühler, S., et. al, Therapeutic vaccination with MVA-HIV1 nef elicits Nef-specific T-helper cell responses in chronically HIV1 infected individuals, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00538-3,Therapeutic vaccination with MVA-HIV1 nef elicits Nef-specific T-helper cell responses in chronically HIV1 infected individuals,"[['Antonio', '', 'Cosma'], ['Rashmi', '', 'Nagaraj'], ['Silja', '', 'B\xc3\xbchler'], ['Jorma', '', 'Hinkula'], ['Dirk', 'H.', 'Busch'], ['Gerd', '', 'Sutter'], ['Frank', 'D.', 'Goebel'], ['Volker', '', 'Erfle']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03005383', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03005383']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"TRIMBLE, L., SHANKAR, P., PATTERSON, M., et. al, Human Immunodeficiency Virus-Specific Circulating CD8 T Lymphocytes Have Down-Modulated CD3zeta and CD28, Key Signaling Molecules for T-Cell Activation, Journal of Virology, 2000",cited-by,10.1128/JVI.74.16.7320-7330.2000,"Human Immunodeficiency Virus-Specific Circulating CD8 T Lymphocytes Have Down-Modulated CD3zeta and CD28, Key Signaling Molecules for T-Cell Activation","[['LINDA', 'A.', 'TRIMBLE'], ['PREMLATA', '', 'SHANKAR'], ['MARK', '', 'PATTERSON'], ['JOHANNA', 'P.', 'DAILY'], ['J.', '', 'Lieberman']]",Journal of Virology,2000,"[u'http://labs.idi.harvard.edu/lieberman/pdf/2000TrimbleJV.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.16.7320-7330.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"KAUR, A., GRANT, R., MEANS, R., et. al, Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques, , 1998",cited-by,6975725Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques,Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques,"[['AMITINDER', '', 'KAUR'], ['ROBERT', 'M.', 'GRANT'], ['ROBERT', 'E.', 'MEANS'], ['HAROLD', '', 'MCCLURE'], ['MARK', '', 'FEINBERG'], ['R.', 'PAUL', 'JOHNSON']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/12/9597.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"ALEXANDER, L., WEISKOPF, E., GREENOUGH, T., et. al, Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive Infection, Journal of Virology, 2000",cited-by,10.1128/JVI.74.9.4361-4376.2000,Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive Infection,"[['LOUIS', '', 'ALEXANDER'], ['EMMA', '', 'WEISKOPF'], ['THOMAS', 'C.', 'GREENOUGH'], ['NATHAN', 'C.', 'GADDIS'], ['MARCY', 'R.', 'AUERBACH'], ['MICHAEL', 'H.', 'MALIM'], ['STEPHEN', 'J.', ""O'BRIEN""], ['BRUCE', 'D.', 'WALKER'], ['JOHN', 'L.', 'SULLIVAN'], ['RONALD', 'C.', 'DESROSIERS']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/9/4361.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.9.4361-4376.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"STAPRANS, S., DAILEY, P., ROSENTHAL, A., et. al, Simian Immunodeficiency Virus Disease Course Is Predicted by the Extent of Virus Replication during Primary Infection, , 1999",cited-by,13636128Simian Immunodeficiency Virus Disease Course Is Predicted by the Extent of Virus Replication during Primary Infection,Simian Immunodeficiency Virus Disease Course Is Predicted by the Extent of Virus Replication during Primary Infection,"[['SILVIJA', 'I.', 'STAPRANS'], ['PETER', 'J.', 'DAILEY'], ['ANN', '', 'ROSENTHAL'], ['CHRIS', '', 'HORTON'], ['ROBERT', 'M.', 'GRANT'], ['NICHOLAS', '', 'LERCHE'], ['MARK', 'B.', 'FEINBERG']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/6/4829.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"GAHERY-SEGARD, H., PIALOUX, G., CHARMETEAU, B., et. al, Multiepitopic B and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine, Journal of Virology, 2000",cited-by,10.1128/JVI.74.4.1694-1703.2000,Multiepitopic B and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine,"[['HANNE', '', 'GAHERY-SEGARD'], ['GILLES', '', 'PIALOUX'], ['BENEDICTE', '', 'CHARMETEAU'], ['SANDRINE', '', 'SERMET'], ['HUBERT', '', 'PONCELET'], ['MAURICE', '', 'RAUX'], ['A.', '', 'Tartar'], ['J.-P.', '', 'Levy'], ['H.', '', 'Gras-Masse'], ['J.-G.', '', 'Guillet']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/4/1694.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.4.1694-1703.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Gamadia, L., Remmerswaal, E., Weel, J., et. al, Primary immune responses to human CMV: a critical role for IFN--producing CD4 T cells in protection against CMV disease, , 2003",cited-by,6696621Primary immune responses to human CMV: a critical role for IFN--producing CD4 T cells in protection against CMV disease,Primary immune responses to human CMV: a critical role for IFN--producing CD4 T cells in protection against CMV disease,"[['Laila', 'E.', 'Gamadia'], ['Ester', 'B. M.', 'Remmerswaal'], ['Jan', 'F.', 'Weel'], ['W.', 'van', 'Lier']]",,2003,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/101/7/2686.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"CARCELAIN, G., TUBIANA, R., SAMRI, A., et. al, Transient Mobilization of Human Immunodeficiency Virus (HIV)Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.1.234-241.2001,Transient Mobilization of Human Immunodeficiency Virus (HIV)Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 Infection,"[['GUISLAINE', '', 'CARCELAIN'], ['ROLAND', '', 'TUBIANA'], ['ASSIA', '', 'SAMRI'], ['VINCENT', '', 'CALVEZ'], ['CONSTANCE', '', 'DELAUGERRE'], ['HENRI', '', 'AGUT'], ['CHRISTINE', '', 'KATLAMA'], ['BRIGITTE', '', 'AUTRAN']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/1/234.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.1.234-241.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Garber, D., Silvestri, G., Feinberg, M., , Prospects for an AIDS vaccine: three big questions, no easy answers, Lancet Infectious Diseases, 2004",cited-by,10.1016/S1473-3099(04)01056-4,"Prospects for an AIDS vaccine: three big questions, no easy answers","[['David', 'A', 'Garber'], ['Guido', '', 'Silvestri'], ['Mark', 'B', 'Feinberg']]",Lancet Infectious Diseases,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1473309904010564', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309904010564']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Zajac, A., Murali-Krishna, K., Blattman, J., et. al, Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4 + and CD8 + T cells, Current Opinion in Immunology, 1998",cited-by,10.1016/S0952-7915(98)80119-2,Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4 + and CD8 + T cells,"[['Allan', 'J', 'Zajac'], ['Kaja', '', 'Murali-Krishna'], ['Joseph', 'N', 'Blattman'], ['Rafi', '', 'Ahmed']]",Current Opinion in Immunology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0952791598801192', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791598801192']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Carcelain, G., Debré, P., Autran, B., , Reconstitution of CD4 + T lymphocytes in HIV-infected individuals following antiretroviral therapy, Current Opinion in Immunology, 2001",cited-by,10.1016/S0952-7915(00)00245-4,Reconstitution of CD4 + T lymphocytes in HIV-infected individuals following antiretroviral therapy,"[['Guislaine', '', 'Carcelain'], ['Patrice', '', 'Debr\xc3\xa9'], ['Brigitte', '', 'Autran']]",Current Opinion in Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500002454', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500002454']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Little, S., McLean, A., Spina, C., et. al, Viral Dynamics of Acute HIV1 Infection, , 0",cited-by,12236447Viral Dynamics of Acute HIV1 Infection,Viral Dynamics of Acute HIV1 Infection,"[['Susan', 'J.', 'Little'], ['Angela', 'R.', 'McLean'], ['Celsa', 'A.', 'Spina'], ['Douglas', 'D.', 'Richman'], ['Diane', 'V.', 'Havlir']]",,0,[u'http://jem.rupress.org/cgi/reprint/190/6/841.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"LUZURIAGA, K., MCMANUS, M., CATALINA, M., et. al, Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV1) Infection: Control of Viral Replication and Absence of Persistent HIV1Specific Immune Responses, Journal of Virology, 2000",cited-by,10.1128/JVI.74.15.6984-6991.2000,Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV1) Infection: Control of Viral Replication and Absence of Persistent HIV1Specific Immune Responses,"[['KATHERINE', '', 'LUZURIAGA'], ['MARGARET', '', 'MCMANUS'], ['MICHELLE', '', 'CATALINA'], ['SHANE', '', 'MAYACK'], ['MARK', '', 'SHARKEY'], ['MARIO', '', 'STEVENSON']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/15/6984.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.15.6984-6991.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Brander, C., Walker, B., , T lymphocyte responses in HIV1 infection: implications for vaccine development, Current Opinion in Immunology, 1999",cited-by,10.1016/S0952-7915(99)80076-4,T lymphocyte responses in HIV1 infection: implications for vaccine development,"[['Christian', '', 'Brander'], ['Bruce', 'D', 'Walker']]",Current Opinion in Immunology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0952791599800764', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791599800764']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Track, F., Garcıa, F., Plana, M., et. al, The virological and immunological consequences of structured treatment interruptions in chronic HIV1 infection, , 0",cited-by,5023380The virological and immunological consequences of structured treatment interruptions in chronic HIV1 infection,The virological and immunological consequences of structured treatment interruptions in chronic HIV1 infection,"[['Fast', '', 'Track'], ['Felipe', '', 'Garc\xc4\xb1a'], ['Montserrat', '', 'Plana'], ['Gabriel', 'M.', 'Ortiz'], ['Sebastian', '', 'Bonhoeffer'], ['Alex', '', 'Soriano'], ['Carmen', '', 'Vidal'], ['Anna', '', 'Cruceta'], ['Mireia', '', 'Arnedo'], ['Cristina', '', 'Gil'], ['Giuseppe', '', 'Pantaleo'], ['Toma', 'S', 'Pumarola'], ['Teresa', '', 'Gallart'], ['Douglas', 'F.', 'Nixon'], ['Jose', 'M.', 'Miro']]",,0,[],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Lauer, G., Nguyen, T., Day, C., et. al, Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses, Journal of Virology, 2002",cited-by,10.1128/JVI.76.6.2817-2826.2002,Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses,"[['Georg', 'M.', 'Lauer'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Theresa', '', 'Flynn'], ['Katherine', '', 'McGowan'], ['Eric', 'S.', 'Rosenberg'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Lemuel', '', 'Shattuck']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.6.2817-2826.2002', u'http://jvi.asm.org/cgi/reprint/76/6/2817.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"FORTHAL, D., LANDUCCI, G., DAAR, E., , Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.6953-6961.2001,Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells,"[['DONALD', 'N.', 'FORTHAL'], ['GARY', '', 'LANDUCCI'], ['ERIC', 'S.', 'DAAR']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/15/6953.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.6953-6961.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Gamadia, L., Rentenaar, R., Baars, P., et. al, Differentiation of cytomegalovirus-specific CD81 T cells in healthy and immunosuppressed virus carriers, , 2001",cited-by,6790565Differentiation of cytomegalovirus-specific CD81 T cells in healthy and immunosuppressed virus carriers,Differentiation of cytomegalovirus-specific CD81 T cells in healthy and immunosuppressed virus carriers,"[['Laila', 'E.', 'Gamadia'], ['Rob', 'J.', 'Rentenaar'], ['Paul', 'A.', 'Baars'], ['Ester', 'B. M.', 'Remmerswaal'], ['Jan', 'F. L.', 'Weel'], ['Mireille', '', 'Toebes'], ['Ton', 'N. M.', 'Schumacher'], ['W.', 'van', 'Lier']]",,2001,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/98/3/754.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Shearer, G., , HIV-Induced Immunopathogenesis, Immunity, 1998",cited-by,10.1016/S1074-7613(00)80656-1,HIV-Induced Immunopathogenesis,"[['Gene', 'M', 'Shearer']]",Immunity,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300806561', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300806561']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Li, B., Gladden, A., Altfeld, M., et. al, Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution, Journal of Virology, 2007",cited-by,10.1128/JVI.01231-06,Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution,"[['Bin', '', 'Li'], ['Adrianne', 'D.', 'Gladden'], ['Marcus', '', 'Altfeld'], ['John', 'M.', 'Kaldor'], ['David', 'A.', 'Cooper'], ['Anthony', 'D.', 'Kelleher'], ['Todd', 'M.', 'Allen']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01231-06', u'http://jvi.asm.org/cgi/reprint/81/1/193.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Novitsky, V., Rybak, N., McLane, M., et. al, Identification of Human Immunodeficiency Virus Type 1 Subtype C Gag, Tat, Rev, and Nef-Specific Elispot-Based Cytotoxic T-Lymphocyte Responses for AIDS Vaccine Design, Journal of Virology, 2001",cited-by,10.1128/JVI.75.19.9210-9228.2001,"Identification of Human Immunodeficiency Virus Type 1 Subtype C Gag, Tat, Rev, and Nef-Specific Elispot-Based Cytotoxic T-Lymphocyte Responses for AIDS Vaccine Design","[['V.', '', 'Novitsky'], ['N.', '', 'Rybak'], ['M.', 'F.', 'McLane'], ['P.', '', 'Gilbert'], ['P.', '', 'Chigwedere'], ['I.', '', 'Klein'], ['S.', '', 'Gaolekwe'], ['S.', 'Y.', 'Chang'], ['T.', '', 'Peter'], ['I.', '', 'Thior'], ['T.', '', ""Ndung'u""], ['F.', '', 'Vannberg'], ['B.', 'T.', 'Foley'], ['R.', '', 'Marlink'], ['T.', 'H.', 'Lee'], ['M.', '', 'Essex']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/19/9210.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.19.9210-9228.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"WILSON, C., PALMER, B., SOUTHWOOD, S., et. al, Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1Derived Helper T-Lymphocyte Epitopes, Journal of Virology, 2001",cited-by,10.1128/JVI.75.9.4195-4207.2001,Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1Derived Helper T-Lymphocyte Epitopes,"[['CARA', 'C.', 'WILSON'], ['BRENT', '', 'PALMER'], ['SCOTT', '', 'SOUTHWOOD'], ['JOHN', '', 'SIDNEY'], ['YUICHIRO', '', 'HIGASHIMOTO'], ['ETTORE', '', 'APPELLA'], ['ROBERT', '', 'CHESNUT'], ['ALESSANDRO', '', 'SETTE'], ['BRIAN', 'D.', 'LIVINGSTON']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/9/4195.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.9.4195-4207.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Pontesilli, O., Kerkhof-Garde, S., Miedema, F., , Functional T cell reconstruction and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy, Journal of The American Society of Nephrology, 1999",cited-by,10.1086/314837,Functional T cell reconstruction and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy,"[['Oscar', '', 'Pontesilli'], ['S.', 'R.', 'Kerkhof-Garde'], ['Frank', '', 'Miedema']]",Journal of The American Society of Nephrology,1999,"[u'http://www.amsterdamcohortstudies.org/data/99282590/fulltext99282590.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/314837']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Kim, J., Yang, J., Manson, K., et. al, Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL2, IFN-γ, or IL4 gene adjuvants, Vaccine, 2001",cited-by,10.1016/S0264-410X(00)00479-5,"Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL2, IFN-γ, or IL4 gene adjuvants","[['J.', 'Joseph', 'Kim'], ['Joo-Sung', '', 'Yang'], ['Kelledy', 'H.', 'Manson'], ['David', 'B.', 'Weiner']]",Vaccine,2001,"[u'http://vgxah.net/articles/vaccine19.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X00004795', u'http://www.vgxah.com/articles/vaccine19.pdf', u'http://vgxanimalhealth.net/articles/vaccine19.pdf', u'http://vgxanimalhealth.com/articles/vaccine19.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X00004795']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"HASENKRUG, K., BROOKS, D., DITTMER, U., , Critical Role for CD41 T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice, , 1998",cited-by,12032654Critical Role for CD41 T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice,Critical Role for CD41 T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice,"[['KIM', 'J.', 'HASENKRUG'], ['DIANE', 'M.', 'BROOKS'], ['ULF', '', 'DITTMER']]",,1998,[],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Goulder, P., Tang, Y., Brander, C., et. al, Functionally Inert HIV-specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children, , 0",cited-by,6754943Functionally Inert HIV-specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children,Functionally Inert HIV-specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children,"[['Philip', 'J. R.', 'Goulder'], ['Yanhua', '', 'Tang'], ['Christian', '', 'Brander'], ['Michael', 'R.', 'Betts'], ['Marcus', '', 'Altfeld'], ['Ken', '', 'Annamalai'], ['Alicja', '', 'Trocha'], ['Suqin', '', 'He'], ['Eric', 'S.', 'Rosenberg'], ['Graham', '', 'Ogg'], ['Christopher', 'A.', ""O'Callaghan""], ['Spyros', 'A.', 'Kalams'], ['Ross', 'E.', 'McKinney'], ['Kenneth', '', 'Mayer'], ['Richard', 'A.', 'Koup'], ['Stephen', 'I.', 'Pelton'], ['Sandra', 'K.', 'Burchett'], ['Kenneth', '', 'McIntosh'], ['Bruce', 'D.', 'Walker']]",,0,[u'http://jem.rupress.org/cgi/reprint/192/12/1819.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Girard, M., Osmanov, S., Kieny, M., , A review of vaccine research and development: The human immunodeficiency virus (HIV), Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.02.031,A review of vaccine research and development: The human immunodeficiency virus (HIV),"[['Marc', 'P.', 'Girard'], ['Saladin', 'K.', 'Osmanov'], ['Marie', 'Paule', 'Kieny']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06002167', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06002167']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Abel, K., Compton, L., Rourke, T., et. al, Simian-Human Immunodeficiency Virus SHIV89.6Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses, Journal of Virology, 2003",cited-by,10.1128/JVI.77.5.3099-3118.2003,Simian-Human Immunodeficiency Virus SHIV89.6Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses,"[['Kristina', '', 'Abel'], ['Lara', '', 'Compton'], ['Tracy', '', 'Rourke'], ['David', '', 'Montefiori'], ['Ding', '', 'Lu'], ['Kristina', '', 'Rothaeusler'], ['Linda', '', 'Fritts'], ['Kristen', '', 'Bost'], ['Christopher', 'J.', 'Miller']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/5/3099.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.5.3099-3118.2003']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Boaz, M., Waters, A., Murad, S., et. al, Presence of HIV1 Gag-Specific IFN-IL2 and CD28IL2 CD4 T Cell Responses Is Associated with Nonprogression in HIV1 Infection1, , 0",cited-by,12232117Presence of HIV1 Gag-Specific IFN-IL2 and CD28IL2 CD4 T Cell Responses Is Associated with Nonprogression in HIV1 Infection1,Presence of HIV1 Gag-Specific IFN-IL2 and CD28IL2 CD4 T Cell Responses Is Associated with Nonprogression in HIV1 Infection1,"[['Mark', 'J.', 'Boaz'], ['Anele', '', 'Waters'], ['Shahed', '', 'Murad'], ['Philippa', 'J.', 'Easterbrook'], ['Annapurna', '', 'Vyakarnam']]",,0,[u'http://www.jimmunol.org/cgi/reprint/169/11/6376.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Jin, X., Ramanathan, M., Barsoum, S., et. al, Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1Infected Patients Treated with Prolonged Highly Active Antiretroviral Therapy, Journal of Virology, 2002",cited-by,10.1128/jvi.76.5.2206-2216.2002,Safety and Immunogenicity of ALVAC vCP1452 and Recombinant gp160 in Newly Human Immunodeficiency Virus Type 1Infected Patients Treated with Prolonged Highly Active Antiretroviral Therapy,"[['Xia', '', 'Jin'], ['Murugappan', '', 'Ramanathan'], ['Shady', '', 'Barsoum'], ['Geoffrey', 'R.', 'Deschenes'], ['Lei', '', 'Ba'], ['James', '', 'Binley'], ['Daryl', '', 'Schiller'], ['Daniel', 'E.', 'Bauer'], ['Donald', 'C.', 'Chen'], ['Arlene', '', 'Hurley'], ['Lucette', '', 'Gebuhrer'], ['Raphaelle', 'El', 'Habib'], ['Pierre', '', 'Caudrelier'], ['Michel', '', 'Klein'], ['Linqi', '', 'Zhang'], ['David', 'D.', 'Ho'], ['Martin', '', 'Markowitz']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/5/2206.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/jvi.76.5.2206-2216.2002']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"DIOP, O., GUEYE, A., DIAS-TAVARES, M., et. al, High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys, Journal of Virology, 2000",cited-by,10.1128/JVI.74.16.7538-7547.2000,High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys,"[['OUSMANE', 'MADIAGNE', 'DIOP'], ['AISSATOU', '', 'GUEYE'], ['MARISA', '', 'DIAS-TAVARES'], ['CHRISTOPHER', '', 'KORNFELD'], ['ABDOURAHMANE', '', 'FAYE'], ['MICHEL', '', 'HUERRE'], ['SYLVIE', '', 'CORBET'], ['FRANCOISE', '', 'BARRE-SINOUSSI'], ['MICHAELA', 'C.', 'MULLER-TRUTWIN']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.16.7538-7547.2000', u'http://jvi.asm.org/cgi/reprint/74/16/7538.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Casimiro, D., Tang, A., Chen, L., et. al, Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene, Journal of Virology, 2003",cited-by,10.1128/JVI.77.13.7663-7668.2003,Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene,"[['Danilo', 'R.', 'Casimiro'], ['Aimin', '', 'Tang'], ['Ling', '', 'Chen'], ['Tong-Ming', '', 'Fu'], ['Robert', 'K.', 'Evans'], ['Mary-Ellen', '', 'Davies'], ['Daniel', 'C.', 'Freed'], ['William', '', 'Hurni'], ['Jose', 'M.', 'Aste-Amezaga'], ['Liming', '', 'Guan'], ['Romnie', '', 'Long'], ['Lingyi', '', 'Huang'], ['Virginia', '', 'Harris'], ['Denise', 'K.', 'Nawrocki'], ['Henryk', '', 'Mach'], ['Robert', 'D.', 'Troutman'], ['Lynne', 'A.', 'Isopi'], ['Krishna', 'K.', 'Murthy'], ['Karen', '', 'Rice'], ['Keith', 'A.', 'Wilson'], ['David', 'B.', 'Volkin'], ['Emilio', 'A.', 'Emini'], ['John', 'W.', 'Shiver']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/13/7663.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.13.7663-7668.2003']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Imami, N., Pires, A., Hardy, G., et. al, A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.18.9011-9023.2002,A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection,"[['Nesrina', '', 'Imami'], ['Antonio', '', 'Pires'], ['Gareth', '', 'Hardy'], ['Jamie', '', 'Wilson'], ['Brian', '', 'Gazzard'], ['Frances', '', 'Gotch']]",Journal of Virology,2002,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.18.9011-9023.2002'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"MONTEFIORI, D., HILL, T., VO, H., et. al, Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.21.10200-10207.2001,Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection,"[['DAVID', 'C.', 'MONTEFIORI'], ['TANYA', 'S.', 'HILL'], ['HA', 'T. T.', 'VO'], ['BRUCE', 'D.', 'WALKER'], ['E.', 'S.', 'Rosenberg']]",Journal of Virology,2001,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.21.10200-10207.2001'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Pozniak, A., Gazzard, B., Anderson, J., et. al, British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy, , 2003",cited-by,7024792British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy,British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy,"[['Anton', '', 'Pozniak'], ['Brian', '', 'Gazzard'], ['J', '', 'Anderson'], ['A', '', 'Babiker'], ['S', '', 'Collins'], ['M', '', 'Fisher'], ['M', '', 'Johnson'], ['S', '', 'Khoo'], ['C', '', 'Leen'], ['C', '', 'Loveday'], ['G', '', 'Moyle'], ['M', '', 'Nelson'], ['A', '', 'Phillips'], ['D', '', 'Pillay'], ['E', '', 'Wilkins'], ['I', '', 'Williams'], ['M', '', 'Youle']]",,2003,"[u'http://www.bhiva.org/documents/guidelines/treatment%20guidelines/archive/2003/treatment%20guidelines%202003.pdf', u'http://www.ahrn.net/library_upload/uploadfile/file2173.pdf']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"DYER, W., OGG, G., DEMOITIE, M., et. al, Strong Human Immunodeficiency Virus (HIV)Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1, , 1999",cited-by,11342123Strong Human Immunodeficiency Virus (HIV)Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1,Strong Human Immunodeficiency Virus (HIV)Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1,"[['WAYNE', 'B.', 'DYER'], ['GRAHAM', 'S.', 'OGG'], ['MARIE-ANGE', '', 'DEMOITIE'], ['XIA', '', 'JIN'], ['ANDREW', 'F.', 'GECZY'], ['SARAH', 'L.', 'ROWLAND-JONES'], ['ANDREW', 'J.', 'MCMICHAEL'], ['DOUGLAS', 'F.', 'NIXON'], ['JOHN', 'S.', 'SULLIVAN']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/1/436.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"SPIEGEL, H., OGG, G., DEFALCON, E., et. al, Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+ T Cells, Journal of Virology, 2000",cited-by,10.1128/JVI.74.2.1018-1022.2000,Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+ T Cells,"[['HANS', 'M. L.', 'SPIEGEL'], ['GRAHAM', 'S.', 'OGG'], ['ELIZABETH', '', 'DEFALCON'], ['MEGAN', 'E.', 'SHEEHY'], ['SIMON', '', 'MONARD'], ['PATRICK', 'A. J.', 'HASLETT'], ['GERALDINE', '', 'GILLESPIE'], ['SEAN', 'M.', 'DONAHOE'], ['HENRY', '', 'POLLACK'], ['WILLIAM', '', 'BORKOWSKY'], ['ANDREW', 'J.', 'MCMICHAEL'], ['DOUGLAS', 'F.', 'NIXON']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/2/1018.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.2.1018-1022.2000']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Wang, P., Sidney, J., Dow, C., et. al, A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach, PLOS Computational Biology, 2008",cited-by,10.1371/journal.pcbi.1000048.t006,A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach,"[['Peng', '', 'Wang'], ['John', '', 'Sidney'], ['Courtney', '', 'Dow'], ['Bianca', '', 'Moth\xc3\xa9'], ['Alessandro', '', 'Sette'], ['Bjoern', '', 'Peters']]",PLOS Computational Biology,2008,"[u'http://dx.plos.org/10.1371/journal.pcbi.1000048', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.g001', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.g002', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.t001', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.t002', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.t003', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.t004', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.t005', u'http://dx.plos.org/10.1371/journal.pcbi.1000048.t006']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Hanke, T., McMichael, A., Mwau, M., et. al, Development of a DNA-MVA/HIVA vaccine for Kenya, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00085-3,Development of a DNA-MVA/HIVA vaccine for Kenya,"[['Tom\xc3\xa1\xc5\xa1', '', 'Hanke'], ['Andrew', 'J', 'McMichael'], ['Matilu', '', 'Mwau'], ['Edmund', 'G.-T', 'Wee'], ['Inese', '', 'Ceberej'], ['Sandip', '', 'Patel'], ['Julian', '', 'Sutton'], ['Maxine', '', 'Tomlinson'], ['Rachel', 'V', 'Samuel']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02000853', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02000853']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Brandt, M., Chen, G., , Feedback Control of a Biodynamical Model of HIV1, , 2001",cited-by,1511792Feedback Control of a Biodynamical Model of HIV1,Feedback Control of a Biodynamical Model of HIV1,"[['Michael', 'E.', 'Brandt'], ['Guanrong', '', 'Chen']]",,2001,[u'http://www.divine-healing-prayers.com/support-files/hivarticle.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Komanduri, K., Donahoe, S., Moretto, W., et. al, Direct Measurement of CD4+ and CD8+ T-Cell Responses to CMV in HIV1Infected Subjects, Virology, 2001",cited-by,10.1006/viro.2000.0697,Direct Measurement of CD4+ and CD8+ T-Cell Responses to CMV in HIV1Infected Subjects,"[['Krishna', 'V.', 'Komanduri'], ['Sean', 'M.', 'Donahoe'], ['Walter', 'J.', 'Moretto'], ['Diane', 'K.', 'Schmidt'], ['Geraldine', '', 'Gillespie'], ['Graham', 'S.', 'Ogg'], ['Mario', '', 'Roederer'], ['Douglas', 'F.', 'Nixon'], ['Joseph', 'M.', 'McCune']]",Virology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0042682200906974', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682200906974']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Hel, Z., Tsai, W., Thornton, A., et. al, Potentiation of Simian Immunodeficiency Virus (SIV)Specific CD4 and CD8 T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen, , 0",cited-by,11547426Potentiation of Simian Immunodeficiency Virus (SIV)Specific CD4 and CD8 T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen,Potentiation of Simian Immunodeficiency Virus (SIV)Specific CD4 and CD8 T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen,"[['Zdenek', '', 'Hel'], ['Wen-Po', '', 'Tsai'], ['Arthur', '', 'Thornton'], ['Janos', '', 'Nacsa'], ['Laura', '', 'Giuliani'], ['Elzbieta', '', 'Tryniszewska'], ['Monita', '', 'Poudyal'], ['David', '', 'Venzon'], ['Xiaochi', '', 'Wang'], ['John', '', 'Altman'], ['David', 'I.', 'Watkins'], ['Wenhong', '', 'Lu'], ['Agneta', 'von', 'Gegerfelt'], ['Barbara', 'K.', 'Felber'], ['James', '', 'Tartaglia'], ['George', 'N.', 'Pavlakis'], ['Genoveffa', '', 'Franchini']]",,0,[u'http://www.jimmunol.org/cgi/reprint/167/12/7180.pdf'],
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Zurakowski, R., Teel, A., , A model predictive control based scheduling method for HIV therapy, Journal of Theoretical Biology, 2006",cited-by,10.1016/j.jtbi.2005.05.004,A model predictive control based scheduling method for HIV therapy,"[['Ryan', '', 'Zurakowski'], ['Andrew', 'R.', 'Teel']]",Journal of Theoretical Biology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0022519305002067', u'http://linkinghub.elsevier.com/retrieve/pii/S0022519305002067']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Schindler, M., Wurfl, S., Benaroch, P., et. al, Down-Modulation of Mature Major Histocompatibility Complex Class II and Up-Regulation of Invariant Chain Cell Surface Expression Are Well-Conserved Functions of Human and Simian Immunodeficiency Virus nef Alleles, Journal of Virology, 2003",cited-by,10.1128/JVI.77.19.10548-10556.2003,Down-Modulation of Mature Major Histocompatibility Complex Class II and Up-Regulation of Invariant Chain Cell Surface Expression Are Well-Conserved Functions of Human and Simian Immunodeficiency Virus nef Alleles,"[['Michael', '', 'Schindler'], ['Stephanie', '', 'Wurfl'], ['Philippe', '', 'Benaroch'], ['Thomas', 'C.', 'Greenough'], ['Rod', '', 'Daniels'], ['Philippa', '', 'Easterbrook'], ['Matthias', '', 'Brenner'], ['Jan', '', 'Munch'], ['Frank', '', 'Kirchhoff']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/19/10548.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.19.10548-10556.2003']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"MATANO, T., KANO, M., NAKAMURA, H., et. al, Rapid Appearance of Secondary Immune Responses and Protection from Acute CD4 Depletion after a Highly Pathogenic Immunodeficiency Virus Challenge in Macaques Vaccinated with a DNA Prime/Sendai Virus Vector Boost Regimen, Journal of Virology, 2001",cited-by,10.1128/JVI.75.23.11891-11896.2001,Rapid Appearance of Secondary Immune Responses and Protection from Acute CD4 Depletion after a Highly Pathogenic Immunodeficiency Virus Challenge in Macaques Vaccinated with a DNA Prime/Sendai Virus Vector Boost Regimen,"[['TETSURO', '', 'MATANO'], ['MUNEHIDE', '', 'KANO'], ['HIROMI', '', 'NAKAMURA'], ['AKIKO', '', 'TAKEDA'], ['YOSHIYUKI', '', 'NAGAI']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/23/11891.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.23.11891-11896.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Boyer, J., Chattergoon, M., Ugen, K., et. al, Enhancement of Cellular Immune Response in HIV1 Seropositive Individuals: A DNA-Based Trial, Clinical Immunology, 1999",cited-by,10.1006/clim.1998.4616,Enhancement of Cellular Immune Response in HIV1 Seropositive Individuals: A DNA-Based Trial,"[['Jean', 'D.', 'Boyer'], ['Michael', 'A.', 'Chattergoon'], ['Kenneth', 'E.', 'Ugen'], ['Ami', '', 'Shah'], ['Mosi', '', 'Bennett'], ['Adam', '', 'Cohen'], ['Susan', '', 'Nyland'], ['Kim', 'E.', 'Lacy'], ['Mark', 'L.', 'Bagarazzi'], ['Terry', 'J.', 'Higgins'], ['Yaela', '', 'Baine'], ['Richard', 'B.', 'Ciccarelli'], ['Richard', 'S.', 'Ginsberg'], ['Rob', 'Roy', 'MacGregor'], ['David', 'B.', 'Weiner']]",Clinical Immunology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1521661698946162', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661698946162']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Kassutto, S., Rosenberg, E., , Primary HIV Type 1 Infection, Clinical Infectious Diseases, 2004",cited-by,10.1086/420745,Primary HIV Type 1 Infection,"[['Sigall', '', 'Kassutto'], ['Eric', 'S.', 'Rosenberg']]",Clinical Infectious Diseases,2004,"[u'http://www.idsociety.org/assets/0/18/312/924/1B93C3A7-4828-41D0-878A-D1FC5A483059.pdf', u'http://www.kliinikum.ee/infektsioonikontrolliteenistus/doc/oppematerjalid/referaadid/cid38(1447).pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/420745']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Lange, C., Valdez, H., Medvik, K., et. al, CD4 + T-Lymphocyte Nadir and the Effect of Highly Active Antiretroviral Therapy on Phenotypic and Functional Immune Restoration in HIV1 Infection, Clinical Immunology, 2002",cited-by,10.1006/clim.2001.5164,CD4 + T-Lymphocyte Nadir and the Effect of Highly Active Antiretroviral Therapy on Phenotypic and Functional Immune Restoration in HIV1 Infection,"[['Christoph', 'G.', 'Lange'], ['Hernan', '', 'Valdez'], ['Kathy', '', 'Medvik'], ['Robert', '', 'Asaad'], ['Michael', 'M.', 'Lederman']]",Clinical Immunology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1521661601951642', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661601951642']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Liu, Y., McNevin, J., Cao, J., et. al, Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection, Journal of Virology, 2006",cited-by,10.1128/JVI.00575-06,Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection,"[['Yi', '', 'Liu'], ['John', '', 'McNevin'], ['Jianhong', '', 'Cao'], ['Hong', '', 'Zhao'], ['Indira', '', 'Genowati'], ['Kim', '', 'Wong'], ['Sherry', '', 'McLaughlin'], ['Matthew', 'D.', 'McSweyn'], ['Kurt', '', 'Diem'], ['Claire', 'E.', 'Stevens'], ['Janine', '', 'Maenza'], ['Hongxia', '', 'He'], ['David', 'C.', 'Nickle'], ['Daniel', '', 'Shriner'], ['Sarah', 'E.', 'Holte'], ['Ann', 'C.', 'Collier'], ['Lawrence', '', 'Corey'], ['M.', 'Juliana', 'McElrath'], ['James', 'I.', 'Mullins']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/19/9519.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00575-06']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Palmer, B., Boritz, E., Blyveis, N., et. al, Discordance between Frequency of Human Immunodeficiency Virus Type 1 (HIV1)Specific Gamma Interferon-Producing CD4+ T Cells and HIV1Specific Lymphoproliferation in HIV1Infected Subjects with Active Viral Replication, Journal of Virology, 2002",cited-by,10.1128/JVI.76.12.5925-5936.2002,Discordance between Frequency of Human Immunodeficiency Virus Type 1 (HIV1)Specific Gamma Interferon-Producing CD4+ T Cells and HIV1Specific Lymphoproliferation in HIV1Infected Subjects with Active Viral Replication,"[['B.', 'E.', 'Palmer'], ['E.', '', 'Boritz'], ['N.', '', 'Blyveis'], ['C.', 'C.', 'Wilson']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/12/5925.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.12.5925-5936.2002']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"ENGELMAYER, J., LARSSON, M., LEE, A., et. al, Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+ and CD4+ T-Cell Responses from Chronically Infected Individuals, Journal of Virology, 2001",cited-by,10.1128/JVI.75.5.2142-2153.2001,Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+ and CD4+ T-Cell Responses from Chronically Infected Individuals,"[['JOSE', '', 'ENGELMAYER'], ['MARIE', '', 'LARSSON'], ['ANDREW', '', 'LEE'], ['MARINA', '', 'LEE'], ['WILLIAM', 'I.', 'COX'], ['RALPH', 'M.', 'STEINMAN'], ['NINA', '', 'BHARDWAJ']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/5/2142.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.5.2142-2153.2001']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"Tang, J., LeBlanc, S., Enger, C., et. al, Consistent Associations of HLA Class I and II and Transporter Gene Products with Progression of Human Immunodeficiency Virus Type 1 Infection in Homosexual Men, Journal of Infectious Diseases, 1999",cited-by,10.1086/314862,Consistent Associations of HLA Class I and II and Transporter Gene Products with Progression of Human Immunodeficiency Virus Type 1 Infection in Homosexual Men,"[['James', '', 'Tang'], ['Susan', '', 'LeBlanc'], ['Cheryl', '', 'Enger'], ['Charles', '', 'Rivers'], ['Dean', '', 'Mann'], ['Frank', '', 'Miedema']]",Journal of Infectious Diseases,1999,"[u'http://www.amsterdamcohortstudies.org/data/99326726/fulltext99326726.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/314862']",
4067949Vigorous HIV1-specific CD41 T cell responses associated with control of viremia,"HAY, C., RUHL, D., BASGOZ, N., et. al, Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection, , 1999",cited-by,6803745Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection,Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection,"[['CHRISTINE', 'M.', 'HAY'], ['DEBBIE', 'J.', 'RUHL'], ['NESLI', 'O.', 'BASGOZ'], ['CARA', 'C.', 'WILSON'], ['JAMES', 'M.', 'BILLINGSLEY'], ['MARIA', 'PIA', 'DEPASQUALE'], ['RICHARD', 'T.', ""D'AQUILA""], ['STEVEN', 'M.', 'WOLINSKY'], ['JOHN', 'M.', 'CRAWFORD'], ['DAVID', 'C.', 'MONTEFIORI'], ['BRUCE', 'D.', 'WALKER']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/7/5509.pdf'],
10.1056~NEJMoa011232,Zinkernagel RM. Immunology taught by viruses. Science 1996;271: 173-8.,references,10.1126/science.271.5246.173,Immunology Taught by Viruses,"[[u'R.', u'M.', u'Zinkernagel']]",Science,1996,[u'http://www.sciencemag.org/cgi/doi/10.1126/science.271.5246.173'],[]
10.1126/science.271.5246.173,"Heise, C., Sampson-Johannes, A., Williams, A., et. al, ONYX015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents, Nature Medicine, 1997",cited-by,10.1038/nm0697-639,"ONYX015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","[['Carla', '', 'Heise'], ['Adam', '', 'Sampson-Johannes'], ['Angelica', '', 'Williams'], ['Frank', '', 'Mccormick'], ['Daniel', 'D. Von', 'Hoff'], ['David', 'H.', 'Kirn']]",Nature Medicine,1997,[u'http://www.nature.com/doifinder/10.1038/nm0697-639'],
10.1126/science.271.5246.173,"Schantz, T., Bensch, S., Grahn, M., et. al, Good genes, oxidative stress and condition-dependent sexual signals, Proceedings of The Royal Society B: Biological Sciences, 1999",cited-by,10.1098/rspb.1999.0597,"Good genes, oxidative stress and condition-dependent sexual signals","[['T.', 'v.', 'Schantz'], ['S.', '', 'Bensch'], ['M.', '', 'Grahn'], ['D.', '', 'Hasselquist'], ['H.', '', 'Wittzell']]",Proceedings of The Royal Society B: Biological Sciences,1999,"[u'http://www.georgealozano.com/papers/VonSchantz99.pdf', u'http://rspb.royalsocietypublishing.org/cgi/doi/10.1098/rspb.1999.0597', u'http://journals.royalsociety.org/index/10.1098/rspb.1999.0597']",
10.1126/science.271.5246.173,"Martin, F., Oliver, A., Kearney, J., , Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens, Immunity, 2001",cited-by,10.1016/S1074-7613(01)00129-7,Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens,"[['Flavius', '', 'Martin'], ['Alyce', 'M', 'Oliver'], ['John', 'F', 'Kearney']]",Immunity,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1074761301001297', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761301001297']",
10.1126/science.271.5246.173,"Abbas, A., Walker, L., , The enemy within: keeping self-reactive T cells at bay in the periphery, Nature Reviews Immunology, 2002",cited-by,10.1038/nri701,The enemy within: keeping self-reactive T cells at bay in the periphery,"[['Abul', 'K.', 'Abbas'], ['Lucy', 'S. K.', 'Walker']]",Nature Reviews Immunology,2002,"[u'http://www.nature.com/doifinder/10.1038/nri701', u'http://dx.doi.org/10.1038/nri701']",
10.1126/science.271.5246.173,"ROSENBERG, Z., FAUCI, A., , The Immunopathogenesis of HIV Infection, Advances in Immunology, 1989",cited-by,10.1016/S0065-2776(08)60665-3,The Immunopathogenesis of HIV Infection,"[['ZEDA', 'F.', 'ROSENBERG'], ['ANTHONY', 'S.', 'FAUCI']]",Advances in Immunology,1989,"[u'http://www.fasebj.org/cgi/reprint/5/10/2382.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0065277608606653', u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.50.1.825']",
10.1126/science.271.5246.173,"Carrington, M., O'Brien, S., , The Influence of HLA Genotype on AIDS, Annual Review of Medicine, 2003",cited-by,10.1146/annurev.med.54.101601.152346,The Influence of HLA Genotype on AIDS,"[['Mary', '', 'Carrington'], ['Stephen', 'J.', ""O'Brien""]]",Annual Review of Medicine,2003,[u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.med.54.101601.152346'],
10.1126/science.271.5246.173,"Zinkernagel, R., Ehl, S., Aichele, P., et. al, Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity, Immunological Reviews, 1997",cited-by,10.1111/j.1600-065X.1997.tb00969.x,Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity,"[['Rolf', 'M.', 'Zinkernagel'], ['Stephan', '', 'Ehl'], ['Peter', '', 'Aichele'], ['Stephan', '', 'Oehen'], ['Thomas', '', 'Kundig'], ['Hans', '', 'Hengartner']]",Immunological Reviews,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1997.tb00969.x'],
10.1126/science.271.5246.173,"Lehner, T., Wang, Y., Cranage, M., et. al, Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques, Nature Medicine, 1996",cited-by,10.1038/nm0796-767,Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques,"[['Thomas', '', 'Lehner'], ['Yufei', '', 'Wang'], ['Martin', '', 'Cranage'], ['Lesley', 'A.', 'Bergmeier'], ['Elaine', '', 'Mitchell'], ['Louisa', '', 'Tao'], ['Graham', '', 'Hall'], ['Mike', '', 'Dennis'], ['Nicola', '', 'Cook'], ['Roger', '', 'Brookes'], ['Linda', '', 'Klavinskis'], ['Ian', '', 'Jones'], ['Carl', '', 'Doyle'], ['Robert', '', 'Ward']]",Nature Medicine,1996,[u'http://www.nature.com/doifinder/10.1038/nm0796-767'],
10.1126/science.271.5246.173,"Sallusto, F., Lanzavecchia, A., , Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation, , 2010",cited-by,"6507754Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation","Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation","[['Federica', '', 'Sallusto'], ['Antonio', '', 'Lanzavecchia']]",,2010,[u'http://jem.rupress.org/cgi/reprint/189/4/611.pdf'],
10.1126/science.271.5246.173,"Ramshaw, I., Ramsay, A., , The prime-boost strategy: exciting prospects for improved vaccination, Immunology Today, 2000",cited-by,10.1016/S0167-5699(00)01612-1,The prime-boost strategy: exciting prospects for improved vaccination,"[['Ian', 'A', 'Ramshaw'], ['Alistair', 'J', 'Ramsay']]",Immunology Today,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0167569900016121', u'http://linkinghub.elsevier.com/retrieve/pii/S0167569900016121']",
10.1126/science.271.5246.173,"Bachmann, M., Zinkernagel, R., , NEUTRALIZING ANTIVIRAL B CELL RESPONSES, Annual Review of Immunology, 1997",cited-by,10.1146/annurev.immunol.15.1.235,NEUTRALIZING ANTIVIRAL B CELL RESPONSES,"[['Martin', 'F.', 'Bachmann'], ['Rolf', 'M.', 'Zinkernagel']]",Annual Review of Immunology,1997,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.15.1.235'],
10.1126/science.271.5246.173,"Fagnoni, F., Vescovini, R., Passeri, G., et. al, Shortage of circulating naive CD81 T cells provides new insights on immunodeficiency in aging, , 2000",cited-by,6502894Shortage of circulating naive CD81 T cells provides new insights on immunodeficiency in aging,Shortage of circulating naive CD81 T cells provides new insights on immunodeficiency in aging,"[['Francesco', 'F.', 'Fagnoni'], ['Rosanna', '', 'Vescovini'], ['Giovanni', '', 'Passeri'], ['Giovanni', '', 'Bologna'], ['Mario', '', 'Pedrazzoni'], ['Giampaolo', '', 'Lavagetto'], ['Amos', '', 'Casti'], ['Claudio', '', 'Franceschi'], ['Mario', '', 'Passeri'], ['Paolo', '', 'Sansoni']]",,2000,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/95/9/2860.pdf'],
10.1126/science.271.5246.173,"Ramshaw, I., Ramsay, A., Karupiah, G., et. al, Cytokines and immunity to viral infections, Immunological Reviews, 1997",cited-by,10.1111/j.1600-065X.1997.tb01011.x,Cytokines and immunity to viral infections,"[['Ian', 'A.', 'Ramshaw'], ['Alistair', 'J.', 'Ramsay'], ['Gunasegaran', '', 'Karupiah'], ['Michael', 'S.', 'Rolph'], ['Surendran', '', 'Mahalingam'], ['Janet', 'C.', 'Ruby']]",Immunological Reviews,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1997.tb01011.x'],
10.1126/science.271.5246.173,"Klenerman, P., Hill, A., , T cells and viral persistence: lessons from diverse infections, Nature Immunology, 2005",cited-by,10.1038/ni1241,T cells and viral persistence: lessons from diverse infections,"[['Paul', '', 'Klenerman'], ['Ann', '', 'Hill']]",Nature Immunology,2005,"[u'http://www.nature.com/doifinder/10.1038/ni1241', u'http://dx.doi.org/10.1038/ni1241']",
10.1126/science.271.5246.173,"Carrington, M., O'Brien, S., , THE INFLUENCE OF HLA GENOTYPE ON AIDS, , 2002",cited-by,6841270THE INFLUENCE OF HLA GENOTYPE ON AIDS,THE INFLUENCE OF HLA GENOTYPE ON AIDS,"[['Mary', '', 'Carrington'], ['Stephen', 'J.', ""O'Brien""]]",,2002,[u'http://www.microbiology.emory.edu/altman/f_BulletinBoards/July7_2003/Carrington.03.ARM.54.535.pdf'],
10.1126/science.271.5246.173,"Goulder, P., Altfeld, M., Rosenberg, E., et. al, Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection, Journal of Experimental Medicine, 2001",cited-by,10.1084/jem.193.2.181,Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection,"[['P.', 'J. R.', 'Goulder'], ['M.', 'A.', 'Altfeld'], ['E.', 'S.', 'Rosenberg'], ['T.', '', 'Nguyen'], ['Y.', '', 'Tang'], ['R.', 'L.', 'Eldridge'], ['M.', 'M.', 'Addo'], ['S.', '', 'He'], ['J.', 'S.', 'Muckerjee'], ['M.', 'N.', 'Phillips'], ['M.', '', 'Bunce'], ['S.', 'A.', 'Kalams'], ['R.', 'P.', 'Sekaly'], ['B.', 'D.', 'Walker'], ['C.', '', 'Brander']]",Journal of Experimental Medicine,2001,[u'http://www.jem.org/cgi/doi/10.1084/jem.193.2.181'],
10.1126/science.271.5246.173,"Zinkernagel, R., , ON NATURAL AND ARTIFICIAL VACCINATIONS, Annual Review of Immunology, 2003",cited-by,10.1146/annurev.immunol.21.120601.141045,ON NATURAL AND ARTIFICIAL VACCINATIONS,"[['Rolf', 'M.', 'Zinkernagel']]",Annual Review of Immunology,2003,"[u'http://webpages.csus.edu/~aenstrom/10.pdf', u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.21.120601.141045']",
10.1126/science.271.5246.173,"LIFSON, J., NOWAK, M., GOLDSTEIN, S., et. al, The Extent of Early Viral Replication Is a Critical Determinant of the Natural History of Simian Immunodeficiency Virus Infection, , 1997",cited-by,5556214The Extent of Early Viral Replication Is a Critical Determinant of the Natural History of Simian Immunodeficiency Virus Infection,The Extent of Early Viral Replication Is a Critical Determinant of the Natural History of Simian Immunodeficiency Virus Infection,"[['JEFFREY', 'D.', 'LIFSON'], ['MARTIN', 'A.', 'NOWAK'], ['SIMOY', '', 'GOLDSTEIN'], ['JEFFREY', 'L.', 'ROSSIO'], ['AUDREY', '', 'KINTER'], ['GABRIELA', '', 'VASQUEZ'], ['THERESA', 'A.', 'WILTROUT'], ['CHARLES', '', 'BROWN'], ['DOUGLAS', '', 'SCHNEIDER'], ['LINDA', '', 'WAHL'], ['ALUN', 'L.', 'LLOYD'], ['JON', '', 'WILLIAMS'], ['WILLIAM', 'R.', 'ELKINS'], ['ANTHONY', 'S.', 'FAUCI'], ['VANESSA', 'M.', 'HIRSCH']]",,1997,"[u'http://www4.ncsu.edu/~allloyd/pdf_files/j_virol_97.pdf', u'http://jvi.asm.org/cgi/reprint/71/12/9508.pdf', u'http://www.ped.fas.harvard.edu/people/faculty/publications_nowak/JVirol97c.pdf', u'http://www.fas.harvard.edu/~ped/people/faculty/publications_nowak/JVirol97c.pdf']",
10.1126/science.271.5246.173,"Boyle, J., Koniaras, C., Lew, A., , Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization, International Immunology, 1997",cited-by,10.1093/intimm/9.12.1897,Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization,"[['Jefferey', 'S.', 'Boyle'], ['Christina', '', 'Koniaras'], ['Andrew', 'M.', 'Lew']]",International Immunology,1997,"[u'http://intimm.oxfordjournals.org/cgi/reprint/9/12/1897.pdf', u'http://www.intimm.oupjournals.org/cgi/doi/10.1093/intimm/9.12.1897']",
10.1126/science.271.5246.173,"Graham, K., Lalani, A., Macen, J., et. al, The T1/35kDa Family of Poxvirus-Secreted Proteins Bind Chemokines and Modulate Leukocyte Influx into Virus-Infected Tissues, Virology, 1997",cited-by,10.1006/viro.1996.8423,The T1/35kDa Family of Poxvirus-Secreted Proteins Bind Chemokines and Modulate Leukocyte Influx into Virus-Infected Tissues,"[['Kathryn', 'A', 'Graham'], ['Alshad', 'S', 'Lalani'], ['Joanne', 'L', 'Macen'], ['Traci', 'L', 'Ness'], ['Michele', '', 'Barry'], ['Li-Ying', '', 'Liu'], ['Alexandra', '', 'Lucas'], ['Ian', '', 'Clark-Lewis'], ['Richard', 'W', 'Moyer'], ['Grant', '', 'Mcfadden']]",Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0042682296984238', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682296984238']",
10.1126/science.271.5246.173,"Zinkernagel, R., , Localization dose and time of antigens determine immune reactivity, Seminars in Immunology, 2000",cited-by,10.1006/smim.2000.0253,Localization dose and time of antigens determine immune reactivity,"[['Rolf', 'M.', 'Zinkernagel']]",Seminars in Immunology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1044532300902537', u'http://linkinghub.elsevier.com/retrieve/pii/S1044532300902537']",
10.1126/science.271.5246.173,"Mincheff, M., Tchakarov, S., Zoubak, S., et. al, Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I&sol;II Clinical Trial, European Urology, 2000",cited-by,10.1159/000020281,Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I&sol;II Clinical Trial,"[['Milcho', '', 'Mincheff'], ['Stoyan', '', 'Tchakarov'], ['Serguei', '', 'Zoubak'], ['Dmitri', '', 'Loukinov'], ['Chavdar', '', 'Botev'], ['Iskra', '', 'Altankova'], ['Georgi', '', 'Georgiev'], ['Stefan', '', 'Petrov'], ['Harold', 'T.', 'Meryman']]",European Urology,2000,"[u'http://www.karger.com/doi/10.1159/000020281', u'http://www.online.karger.com/doi/10.1159/000020281']",
10.1126/science.271.5246.173,"Goulder, P., Altfeld, M., Rosenberg, E., et. al, Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection, , 0",cited-by,10950327Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection,Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection,"[['Philip', 'J. R.', 'Goulder'], ['Marcus', 'A.', 'Altfeld'], ['Eric', 'S.', 'Rosenberg'], ['Thi', '', 'Nguyen'], ['Yanhua', '', 'Tang'], ['Robert', 'L.', 'Eldridge'], ['Marylyn', 'M.', 'Addo'], ['Suqin', '', 'He'], ['Joia', 'S.', 'Muckerjee'], ['Mary', 'N.', 'Phillips'], ['Michael', '', 'Bunce'], ['Spyros', 'A.', 'Kalams'], ['Rafick', 'P.', 'Sekaly'], ['Bruce', 'D.', 'Walker'], ['Christian', '', 'Brander']]",,0,[u'http://jem.rupress.org/cgi/reprint/193/2/181.pdf'],
10.1126/science.271.5246.173,"Akaike, T., Maeda, H., , Nitric oxide and virus infection, Immunology, 2000",cited-by,10.1046/j.1365-2567.2000.00142.x,Nitric oxide and virus infection,"[['T.', '', 'Akaike'], ['H.', '', 'Maeda']]",Immunology,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2567.2000.00142.x'],
10.1126/science.271.5246.173,"HAMMOND, S., COOK, S., LICHTENSTEIN, D., et. al, Maturation of the Cellular and Humoral Immune Responses to Persistent Infection in Horses by Equine Infectious Anemia Virus Is a Complex and Lengthy Process, , 1997",cited-by,5958207Maturation of the Cellular and Humoral Immune Responses to Persistent Infection in Horses by Equine Infectious Anemia Virus Is a Complex and Lengthy Process,Maturation of the Cellular and Humoral Immune Responses to Persistent Infection in Horses by Equine Infectious Anemia Virus Is a Complex and Lengthy Process,"[['SCOTT', 'A.', 'HAMMOND'], ['SHEILA', 'J.', 'COOK'], ['DREW', 'L.', 'LICHTENSTEIN'], ['CHARLES', 'J.', 'ISSEL'], ['ANDRONALD', 'C.', 'MONTELARO']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/5/3840.pdf'],
10.1126/science.271.5246.173,"IYENGAR, S., HILDRETH, J., SCHWARTZ, D., , Actin-Dependent Receptor Colocalization Required for Human Immunodeficiency Virus Entry into Host Cells, , 1998",cited-by,6759284Actin-Dependent Receptor Colocalization Required for Human Immunodeficiency Virus Entry into Host Cells,Actin-Dependent Receptor Colocalization Required for Human Immunodeficiency Virus Entry into Host Cells,"[['SUJATHA', '', 'IYENGAR'], ['JAMES', 'E. K.', 'HILDRETH'], ['DAVID', 'H.', 'SCHWARTZ']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/6/5251.pdf'],
10.1126/science.271.5246.173,"COLE, K., ROWLES, J., JAGERSKI, B., et. al, Evolution of Envelope-Specific Antibody Responses in Monkeys Experimentally Infected or Immunized with Simian Immunodeficiency Virus and Its Association with the Development of Protective Immunity, , 1997",cited-by,14235301Evolution of Envelope-Specific Antibody Responses in Monkeys Experimentally Infected or Immunized with Simian Immunodeficiency Virus and Its Association with the Development of Protective Immunity,Evolution of Envelope-Specific Antibody Responses in Monkeys Experimentally Infected or Immunized with Simian Immunodeficiency Virus and Its Association with the Development of Protective Immunity,"[['KELLY', 'STEFANO', 'COLE'], ['JENNIFER', 'L.', 'ROWLES'], ['BETH', 'A.', 'JAGERSKI'], ['MICHAEL', '', 'MURPHEY-CORB'], ['TAMI', '', 'UNANGST'], ['JANICE', 'E.', 'CLEMENTS'], ['JAMES', '', 'ROBINSON'], ['MICHAEL', 'S.', 'WYAND'], ['RONALD', 'C.', 'DESROSIERS'], ['RONALD', 'C.', 'MONTELARO']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/7/5069.pdf'],
10.1126/science.271.5246.173,"Zinkernagel, R., , On differences between immunity and immunological memory, Current Opinion in Immunology, 2002",cited-by,10.1016/S0952-7915(02)00367-9,On differences between immunity and immunological memory,"[['Rolf', 'M', 'Zinkernagel']]",Current Opinion in Immunology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0952791502003679', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791502003679']",
10.1126/science.271.5246.173,"Cerundolo, V., Dunbar, P., Klenerman, P., , Tracking T cells with tetramers: new tales from new tools, Nature Reviews Immunology, 2002",cited-by,10.1038/nri777,Tracking T cells with tetramers: new tales from new tools,"[['Vincenzo', '', 'Cerundolo'], ['P.', 'Rod', 'Dunbar'], ['Paul', '', 'Klenerman']]",Nature Reviews Immunology,2002,"[u'http://dx.doi.org/10.1038/nri777', u'http://www.nature.com/doifinder/10.1038/nri777']",
10.1126/science.271.5246.173,"MACKLIN, M., MCCABE, D., MCGREGOR, M., et. al, Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus, , 1998",cited-by,6535917Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus,Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus,"[['MICHAEL', 'D.', 'MACKLIN'], ['DENNIS', '', 'MCCABE'], ['MARTHA', 'W.', 'MCGREGOR'], ['VERONICA', '', 'NEUMANN'], ['TODD', '', 'MEYER'], ['ROBERT', '', 'CALLAN'], ['VIRGINIA', 'S.', 'HINSHAW'], ['WILLIAM', 'F.', 'SWAIN']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/2/1491.pdf'],
10.1126/science.271.5246.173,"Dean, M., Carrington, M., O'Brien, S., , BALANCED POLYMORPHISM SELECTED BY GENETIC VERSUS INFECTIOUS HUMAN DISEASE, Annual Review of Genomics and Human Genetics, 2002",cited-by,10.1146/annurev.genom.3.022502.103149,BALANCED POLYMORPHISM SELECTED BY GENETIC VERSUS INFECTIOUS HUMAN DISEASE,"[['Michael', '', 'Dean'], ['Mary', '', 'Carrington'], ['Stephen', 'J.', ""O'Brien""]]",Annual Review of Genomics and Human Genetics,2002,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.genom.3.022502.103149'],
10.1126/science.271.5246.173,"OU, R., ZHOU, S., HUANG, L., et. al, Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells, Journal of Virology, 2001",cited-by,10.1128/JVI.75.18.8407-8423.2001,Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells,"[['RONG', '', 'OU'], ['SHENGHUA', '', 'ZHOU'], ['LEI', '', 'HUANG'], ['DEMETRIUS', '', 'MOSKOPHIDIS']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.18.8407-8423.2001', u'http://jvi.asm.org/cgi/reprint/75/18/8407.pdf']",
10.1126/science.271.5246.173,"Grossman, Z., Paul, W., , Autoreactivity, dynamic tuning and selectivity, Current Opinion in Immunology, 2001",cited-by,10.1016/S0952-7915(01)00280-1,"Autoreactivity, dynamic tuning and selectivity","[['Zvi', '', 'Grossman'], ['William', 'E.', 'Paul']]",Current Opinion in Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0952791501002801', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791501002801']",
10.1126/science.271.5246.173,"Rahman, F., Heller, T., Sobao, Y., et. al, Effects of antiviral therapy on the cellular immune response in acute hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20253,Effects of antiviral therapy on the cellular immune response in acute hepatitis C,"[['Fareed', '', 'Rahman'], ['Theo', '', 'Heller'], ['Yuji', '', 'Sobao'], ['Eishiro', '', 'Mizukoshi'], ['Michelina', '', 'Nascimbeni'], ['Harvey', '', 'Alter'], ['Steven', '', 'Herrine'], ['Jay', '', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20253'],
10.1126/science.271.5246.173,"Ramiro, M., Zárate, J., Hanke, T., et. al, Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00032-X,Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK,"[['Maria', 'J.', 'Ramiro'], ['Juan', 'J.', 'Z\xc3\xa1rate'], ['Tobias', '', 'Hanke'], ['Dolores', '', 'Rodriguez'], ['Juan', 'R.', 'Rodriguez'], ['Mariano', '', 'Esteban'], ['Javier', '', 'Lucientes'], ['Juan', 'A.', 'Castillo'], ['Vicente', '', 'Larraga']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300032X', u'http://www.cnb.csic.es/~estebanlab/articles/Ramiro_Vaccine_2003.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300032X']",
10.1126/science.271.5246.173,"Storni, T., Kündig, T., Senti, G., et. al, Immunity in response to particulate antigen-delivery systems, Advanced Drug Delivery Reviews, 2005",cited-by,10.1016/j.addr.2004.09.008,Immunity in response to particulate antigen-delivery systems,"[['Tazio', '', 'Storni'], ['Thomas', 'M.', 'K\xc3\xbcndig'], ['Gabriela', '', 'Senti'], ['P\xc3\xa5l', '', 'Johansen']]",Advanced Drug Delivery Reviews,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X04002066', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X04002066']",
10.1126/science.271.5246.173,"Weinlich, G., Heine, M., Stössel, H., et. al, Entry Into Afferent Lymphatics and Maturation In Situ of Migrating Murine Cutaneous Dendritic Cells, Journal of Investigative Dermatology, 1998",cited-by,10.1046/j.1523-1747.1998.00161.x,Entry Into Afferent Lymphatics and Maturation In Situ of Migrating Murine Cutaneous Dendritic Cells,"[['Georg', '', 'Weinlich'], ['Martin', '', 'Heine'], ['Hella', '', 'St\xc3\xb6ssel'], ['Monica', '', 'Zanella'], ['Patrizia', '', 'Stoitzner'], ['Ulrike', '', 'Ortner'], ['Josef', '', 'Smolle'], ['Franz', '', 'Koch'], ['Norbert', 'T.', 'Sepp'], ['Gerold', '', 'Schuler'], ['Nikolaus', '', 'Romani']]",Journal of Investigative Dermatology,1998,"[u'http://dx.doi.org/10.1046/j.1523-1747.1998.00161.x', u'http://www.nature.com/doifinder/10.1046/j.1523-1747.1998.00161.x']",
10.1126/science.271.5246.173,"BAUDOUX, P., CARRAT, C., BESNARDEAU, L., et. al, Coronavirus Pseudoparticles Formed with Recombinant M and E Proteins Induce Alpha Interferon Synthesis by Leukocytes, , 1998",cited-by,10913629Coronavirus Pseudoparticles Formed with Recombinant M and E Proteins Induce Alpha Interferon Synthesis by Leukocytes,Coronavirus Pseudoparticles Formed with Recombinant M and E Proteins Induce Alpha Interferon Synthesis by Leukocytes,"[['PIERRE', '', 'BAUDOUX'], ['CHARLES', '', 'CARRAT'], ['LYDIA', '', 'BESNARDEAU'], ['BERNARD', '', 'CHARLEY'], ['HUBERT', '', 'LAUDE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/11/8636.pdf'],
10.1126/science.271.5246.173,"LIN, M., STOHLMAN, S., HINTON, A., , Mouse Hepatitis Virus Is Cleared from the Central Nervous Systems of Mice Lacking Perforin-Mediated Cytolysis, , 1997",cited-by,14155059Mouse Hepatitis Virus Is Cleared from the Central Nervous Systems of Mice Lacking Perforin-Mediated Cytolysis,Mouse Hepatitis Virus Is Cleared from the Central Nervous Systems of Mice Lacking Perforin-Mediated Cytolysis,"[['MARK', 'T.', 'LIN'], ['STEPHEN', 'A.', 'STOHLMAN'], ['ANDDAVID', 'R.', 'HINTON']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/1/383.pdf'],
10.1126/science.271.5246.173,"Pewe, L., Wu, G., Barnett, E., et. al, Cytotoxic T Cell–Resistant Variants Are Selected in a Virus-Induced Demyelinating Disease, Immunity, 1996",cited-by,10.1016/S1074-7613(00)80320-9,Cytotoxic T Cell–Resistant Variants Are Selected in a Virus-Induced Demyelinating Disease,"[['Lecia', '', 'Pewe'], ['Gregory', 'F', 'Wu'], ['Edward', 'M', 'Barnett'], ['Raymond', 'F', 'Castro'], ['Stanley', '', 'Perlman']]",Immunity,1996,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300803209', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300803209']",
10.1126/science.271.5246.173,"Ramsay, A., Kent, S., Strugnell, R., et. al, Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity, Immunological Reviews, 1999",cited-by,10.1111/j.1600-065X.1999.tb01341.x,"Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity","[['Alistair', 'J.', 'Ramsay'], ['Stephen', 'J.', 'Kent'], ['Richard', 'A.', 'Strugnell'], ['Andreas', '', 'Suhrbier'], ['Scott', 'A.', 'Thomson'], ['Ian', 'A.', 'Ramshaw'], ['Alisiarr', 'J.', 'Raima'], ['Andreas', '', 'Suhrbicr']]",Immunological Reviews,1999,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1999.tb01341.x'],
10.1126/science.271.5246.173,"Wiedmann, M., Liebert, U., Oesen, U., et. al, Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C, Hepatology, 2000",cited-by,10.1002/hep.510310134,Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C,"[['Marcus', '', 'Wiedmann'], ['Uwe', 'G.', 'Liebert'], ['Ute', '', 'Oesen'], ['Heiner', '', 'Porst'], ['Manfred', '', 'Wiese'], ['Sabine', '', 'Schroeder'], ['Ulrich', '', 'Halm'], ['Frieder', '', 'Berr']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310134'],
10.1126/science.271.5246.173,"Zhou, S., Ou, R., Huang, L., et. al, Critical Role for Perforin-, Fas/FasL-, and TNFR1-Mediated Cytotoxic Pathways in Down-Regulation of Antigen-Specific T Cells during Persistent Viral Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.2.829-840.2002,"Critical Role for Perforin-, Fas/FasL-, and TNFR1-Mediated Cytotoxic Pathways in Down-Regulation of Antigen-Specific T Cells during Persistent Viral Infection","[['Shenghua', '', 'Zhou'], ['Rong', '', 'Ou'], ['Lei', '', 'Huang'], ['Demetrius', '', 'Moskophidis']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/2/829.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.2.829-840.2002']",
10.1126/science.271.5246.173,"Weiskopf, D., Weinberger, B., Grubeck-Loebenstein, B., , The aging of the immune system, Transplant International, 2009",cited-by,10.1111/j.1432-2277.2009.00927.x,The aging of the immune system,"[['Daniela', '', 'Weiskopf'], ['Birgit', '', 'Weinberger'], ['Beatrix', '', 'Grubeck-Loebenstein']]",Transplant International,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1432-2277.2009.00927.x'],
10.1126/science.271.5246.173,"Kirn, D., McCormick, F., , Replicating viruses as selective cancer therapeutics, Molecular Medicine Today, 1996",cited-by,10.1016/S1357-4310(97)81456-6,Replicating viruses as selective cancer therapeutics,"[['David', 'H.', 'Kirn'], ['Frank', '', 'McCormick']]",Molecular Medicine Today,1996,"[u'http://www.sciencedirect.com/science/article/pii/S1357431097814566', u'http://linkinghub.elsevier.com/retrieve/pii/S1357431097814566']",
10.1126/science.271.5246.173,"Storni, T., Ruedl, C., Schwarz, K., et. al, Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects, , 0",cited-by,6262724Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects,Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects,"[['Tazio', '', 'Storni'], ['Christiane', '', 'Ruedl'], ['Katrin', '', 'Schwarz'], ['Reto', 'A.', 'Schwendener'], ['Wolfgang', 'A.', 'Renner'], ['Martin', 'F.', 'Bachmann']]",,0,[u'http://www.jimmunol.org/cgi/reprint/172/3/1777.pdf'],
10.1126/science.271.5246.173,"Stoitzner, P., Pfaller, K., Stössel, H., et. al, A Close-Up View of Migrating Langerhans Cells in the Skin, Journal of Investigative Dermatology, 2002",cited-by,10.1046/j.0022-202x.2001.01631.x,A Close-Up View of Migrating Langerhans Cells in the Skin,"[['Patrizia', '', 'Stoitzner'], ['Kristian', '', 'Pfaller'], ['Hella', '', 'St\xc3\xb6ssel'], ['Nikolaus', '', 'Romani']]",Journal of Investigative Dermatology,2002,"[u'http://dx.doi.org/10.1046/j.0022-202x.2001.01631.x', u'http://www.nature.com/doifinder/10.1046/j.0022-202x.2001.01631.x']",
10.1126/science.271.5246.173,"Prezzi, C., Francavilla, V., Schiaffella, E., et. al, Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I,Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection,"[['Caterina', '', 'Prezzi'], ['Vittorio', '', 'Francavilla'], ['Enrico', '', 'Schiaffella'], ['Luigi', '', 'Finocchi'], ['Guglielmo', '', 'Bruno'], ['Alessandro', '', 'Sette'], ['Sergio', '', 'Abrignani'], ['Vincenzo', '', 'Barnaba']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200103%2931%3A3%3C894%3A%3AAID-IMMU894%3E3.0.CO%3B2-I'],
10.1126/science.271.5246.173,"Akaike, T., , Role of free radicals in viral pathogenesis and mutation, Reviews in Medical Virology, 2001",cited-by,10.1002/rmv.303,Role of free radicals in viral pathogenesis and mutation,"[['Takaaki', '', 'Akaike']]",Reviews in Medical Virology,2001,[u'http://doi.wiley.com/10.1002/rmv.303'],
10.1126/science.271.5246.173,"Sheridan, I., Pybus, O., Holmes, E., et. al, High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3447-3454.2004,High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression,"[['Isabelle', '', 'Sheridan'], ['Oliver', 'G.', 'Pybus'], ['Edward', 'C.', 'Holmes'], ['Paul', '', 'Klenerman']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3447.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3447-3454.2004']",
10.1126/science.271.5246.173,"Jilbert, A., Botten, J., Miller, D., et. al, Characterization of Age and Dose-Related Outcomes of Duck Hepatitis B Virus Infection, Virology, 1998",cited-by,10.1006/viro.1998.9095,Characterization of Age and Dose-Related Outcomes of Duck Hepatitis B Virus Infection,"[['Allison', 'R.', 'Jilbert'], ['James', 'A.', 'Botten'], ['Darren', 'S.', 'Miller'], ['Edward', 'M.', 'Bertram'], ['Pauline', 'de la M.', 'Hall'], ['Ieva', '', 'Kotlarski'], ['Christopher', 'J.', 'Burrell']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S004268229899095X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268229899095X']",
10.1126/science.271.5246.173,"Triantafyllopoulou, A., Tapinos, N., Moutsopoulos, H., , Evidence for coxsackievirus infection in primary Sj�gren's syndrome, Arthritis and Rheumatism, 2004",cited-by,10.1002/art.20463,Evidence for coxsackievirus infection in primary Sj�gren's syndrome,"[['Antigoni', '', 'Triantafyllopoulou'], ['Nikos', '', 'Tapinos'], ['Haralampos', 'M.', 'Moutsopoulos']]",Arthritis and Rheumatism,2004,[u'http://doi.wiley.com/10.1002/art.20463'],
10.1126/science.271.5246.173,"Tortorella, D., Story, C., Huppa, J., et. al, Dislocation of Type I Membrane Proteins from the ER to the Cytosol Is Sensitive to Changes in Redox Potential, , 2010",cited-by,6951342Dislocation of Type I Membrane Proteins from the ER to the Cytosol Is Sensitive to Changes in Redox Potential,Dislocation of Type I Membrane Proteins from the ER to the Cytosol Is Sensitive to Changes in Redox Potential,"[['Domenico', '', 'Tortorella'], ['Craig', 'M.', 'Story'], ['Johannes', 'B.', 'Huppa'], ['Emmanuel', 'J. H. J.', 'Wiertz'], ['Thomas', 'R.', 'Jones'], ['Hidde', 'L.', 'Ploegh']]",,2010,[u'http://jcb.rupress.org/cgi/reprint/142/2/365.pdf'],
10.1126/science.271.5246.173,"Zinkernagel, R., Hengartner, H., , Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory', Immunological Reviews, 2006",cited-by,10.1111/j.0105-2896.2006.00402.x,Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory',"[['Rolf', 'M.', 'Zinkernagel'], ['Hans', '', 'Hengartner']]",Immunological Reviews,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.0105-2896.2006.00402.x'],
10.1126/science.271.5246.173,"Karrer, U., Althage, A., Odermatt, B., et. al, On the Key Role of Secondary Lymphoid Organs in Antiviral Immune Responses Studied in Alymphoplastic ( aly/aly ) and Spleenless ( Hox11 � / � ) Mutant Mice, , 0",cited-by,11932820On the Key Role of Secondary Lymphoid Organs in Antiviral Immune Responses Studied in Alymphoplastic ( aly/aly ) and Spleenless ( Hox11 � / � ) Mutant Mice,On the Key Role of Secondary Lymphoid Organs in Antiviral Immune Responses Studied in Alymphoplastic ( aly/aly ) and Spleenless ( Hox11 � / � ) Mutant Mice,"[['Urs', '', 'Karrer'], ['Alana', '', 'Althage'], ['Bernhard', '', 'Odermatt'], ['Charles', 'W. M.', 'Roberts'], ['Stanley', 'J.', 'Korsmeyer'], ['Shigeki', '', 'Miyawaki'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel']]",,0,[u'http://jem.rupress.org/cgi/reprint/185/12/2157.pdf'],
10.1126/science.271.5246.173,"Hirschowitz, E., Weaver, J., Hidalgo, G., et. al, Murine dendritic cells infected with adenovirus vectors show signs of activation, Gene Therapy, 2000",cited-by,10.1038/sj.gt.3301210,Murine dendritic cells infected with adenovirus vectors show signs of activation,"[['EA', '', 'Hirschowitz'], ['JD', '', 'Weaver'], ['GE', '', 'Hidalgo'], ['DE', '', 'Doherty']]",Gene Therapy,2000,"[u'http://www.nature.com/doifinder/10.1038/sj.gt.3301210', u'http://dx.doi.org/10.1038/sj.gt.3301210']",
10.1126/science.271.5246.173,"DosReis, G., , Cell-mediated immunity in experimental Trypanosoma cruzi infection, Parasitology Today, 1997",cited-by,10.1016/S0169-4758(97)01073-9,Cell-mediated immunity in experimental Trypanosoma cruzi infection,"[['G.', 'A.', 'DosReis']]",Parasitology Today,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0169475897010739', u'http://linkinghub.elsevier.com/retrieve/pii/S0169475897010739']",
10.1126/science.271.5246.173,"Zinkernagel, R., Starzl, T., , Transplantation tolerance from a historical perspective, Nature Reviews Immunology, 2001",cited-by,10.1038/35105088,Transplantation tolerance from a historical perspective,"[['Rolf', 'M.', 'Zinkernagel'], ['Thomas', 'E.', 'Starzl']]",Nature Reviews Immunology,2001,"[u'http://dx.doi.org/10.1038/35105088', u'http://www.nature.com/doifinder/10.1038/35105088']",
10.1126/science.271.5246.173,"Wong, H., Cheng, S., Sin, F., et. al, A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00212-8,A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2,"[['Ho-Tsun', '', 'Wong'], ['Samuel', 'Chak-Sum', 'Cheng'], ['Fion', 'Wan-Yee', 'Sin'], ['Ella', 'Wai-Ching', 'Chan'], ['Zu-Tian', '', 'Sheng'], ['Yong', '', 'Xie']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02002128', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02002128']",
10.1126/science.271.5246.173,"Haglund, K., Leiner, I., Kerksiek, K., et. al, Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env Proteins, Journal of Virology, 2002",cited-by,10.1128/JVI.76.15.7506-7517.2002,Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env Proteins,"[['Karl', '', 'Haglund'], ['Ingrid', '', 'Leiner'], ['Kristen', '', 'Kerksiek'], ['Linda', '', 'Buonocore'], ['Eric', '', 'Pamer'], ['John', 'K.', 'Rose']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/15/7506.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.15.7506-7517.2002']",
10.1126/science.271.5246.173,"BEN-ARI, Z., CZAJA, A., , Autoimmune hepatitis and its variant syndromes, Gut, 2001",cited-by,10.1136/gut.49.4.589,Autoimmune hepatitis and its variant syndromes,"[['Z', '', 'BEN-ARI'], ['A', 'J', 'CZAJA']]",Gut,2001,"[u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.49.4.589']",
10.1126/science.271.5246.173,"Legge, K., Braciale, T., , Lymph Node Dendritic Cells Control CD8 + T Cell Responses through Regulated FasL Expression, Immunity, 2005",cited-by,10.1016/j.immuni.2005.11.006,Lymph Node Dendritic Cells Control CD8 + T Cell Responses through Regulated FasL Expression,"[['Kevin', 'L.', 'Legge'], ['Thomas', 'J.', 'Braciale']]",Immunity,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1074761305003791', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761305003791']",
10.1126/science.271.5246.173,"Zhou, S., Ou, R., Huang, L., et. al, Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3578-3600.2004,Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection,"[['Shenghua', '', 'Zhou'], ['Rong', '', 'Ou'], ['Lei', '', 'Huang'], ['Graeme', 'E.', 'Price'], ['Demetrius', '', 'Moskophidis']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3578.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3578-3600.2004']",
10.1126/science.271.5246.173,"Barchet, W., Oehen, S., Klenerman, P., et. al, Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8+ T cellsin vivo, European Journal of Immunology, 2000",cited-by,10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K,Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8+ T cellsin vivo,"[['Winfried', '', 'Barchet'], ['Stephan', '', 'Oehen'], ['Paul', '', 'Klenerman'], ['Dominik', '', 'Wodarz'], ['Gennadii', '', 'Bocharov'], ['Alun', 'L.', 'Lloyd'], ['Martin', 'A.', 'Nowak'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel'], ['Stephan', '', 'Ehl']]",European Journal of Immunology,2000,"[u'http://www4.ncsu.edu/~allloyd/pdf_files/eur_j_immunol.pdf', u'http://doi.wiley.com/10.1002/%28SICI%291521-4141%28200005%2930%3A5%3C1356%3A%3AAID-IMMU1356%3E3.0.CO%3B2-K']",
10.1126/science.271.5246.173,"BALKOW, S., KERSTEN, A., TRAN, T., et. al, Concerted Action of the FasL/Fas and Perforin/Granzyme A and B Pathways Is Mandatory for the Development of Early Viral Hepatitis but Not for Recovery from Viral Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.18.8781-8791.2001,Concerted Action of the FasL/Fas and Perforin/Granzyme A and B Pathways Is Mandatory for the Development of Early Viral Hepatitis but Not for Recovery from Viral Infection,"[['SANDRA', '', 'BALKOW'], ['ASTRID', '', 'KERSTEN'], ['THANH', 'THAO', 'TRAN'], ['THOMAS', '', 'STEHLE'], ['PHILIPP', '', 'GROSSE'], ['CRISAN', '', 'MUSETEANU'], ['OLAF', '', 'UTERMOHLEN'], ['HANSPETER', '', 'PIRCHER'], ['FRITZ', 'VON', 'WEIZSACKER'], ['REINHARD', '', 'WALLICH'], ['ARNO', '', 'MULLBACHER'], ['MARKUS', 'M.', 'SIMON']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/18/8781.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.18.8781-8791.2001']",
10.1126/science.271.5246.173,"COLE, K., MURPHEY-CORB, M., NARAYAN, O., et. al, Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections, , 1998",cited-by,"6645535Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections","Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections","[['KELLY', 'STEFANO', 'COLE'], ['MICHAEL', '', 'MURPHEY-CORB'], ['OPENDRA', '', 'NARAYAN'], ['SANJAY', 'V.', 'JOAG'], ['GEORGE', 'M.', 'SHAW'], ['RONALD', 'C.', 'MONTELARO'], ['Marion', 'Merrell', 'Dow']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/10/7852.pdf'],
10.1126/science.271.5246.173,"Wiertz, E., Mukherjee, S., Ploegh, H., , Viruses use stealth technology to escape from the host immune system, Molecular Medicine Today, 1997",cited-by,10.1016/S1357-4310(96)10059-9,Viruses use stealth technology to escape from the host immune system,"[['Emmanuel', 'J. H. J.', 'Wiertz'], ['Siddhartha', '', 'Mukherjee'], ['Hidde', 'L.', 'Ploegh']]",Molecular Medicine Today,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1357431096100599', u'http://linkinghub.elsevier.com/retrieve/pii/S1357431096100599']",
10.1126/science.271.5246.173,"Wong, H., Cheng, S., Chan, E., et. al, Plasmids Encoding Foot-and-Mouth Disease Virus VP1 Epitopes Elicited Immune Responses in Mice and Swine and Protected Swine against Viral Infection, Virology, 2000",cited-by,10.1006/viro.2000.0607,Plasmids Encoding Foot-and-Mouth Disease Virus VP1 Epitopes Elicited Immune Responses in Mice and Swine and Protected Swine against Viral Infection,"[['H.', 'T.', 'Wong'], ['S.', 'C. S.', 'Cheng'], ['E.', 'W. C.', 'Chan'], ['Z.', 'T.', 'Sheng'], ['W.', 'Y.', 'Yan'], ['Z.', 'X.', 'Zheng'], ['Y.', '', 'Xie']]",Virology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S004268220090607X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268220090607X']",
10.1126/science.271.5246.173,"SCHWARZ, E., BADORFF, C., HIURA, T., et. al, NF-kB-Mediated Inhibition of Apoptosis Is Required for Encephalomyocarditis Virus Virulence: a Mechanism of Resistance in p50 Knockout Mice, , 1998",cited-by,6983300NF-kB-Mediated Inhibition of Apoptosis Is Required for Encephalomyocarditis Virus Virulence: a Mechanism of Resistance in p50 Knockout Mice,NF-kB-Mediated Inhibition of Apoptosis Is Required for Encephalomyocarditis Virus Virulence: a Mechanism of Resistance in p50 Knockout Mice,"[['EDWARD', 'M.', 'SCHWARZ'], ['CORNEL', '', 'BADORFF'], ['TIMOTHY', 'S.', 'HIURA'], ['RAINER', '', 'WESSELY'], ['ANNETTE', '', 'BADORFF'], ['INDER', 'M.', 'VERMA'], ['KIRK', 'U.', 'KNOWLTON']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/7/5654.pdf'],
10.1126/science.271.5246.173,"Pabst, H., Spady, D., Pilarski, L., et. al, Differential modulation of the immune response by breast- or formula-feeding of infants, Acta Paediatrica, 1997",cited-by,10.1111/j.1651-2227.1997.tb14900.x,Differential modulation of the immune response by breast- or formula-feeding of infants,"[['HF', '', 'Pabst'], ['DW', '', 'Spady'], ['LM', '', 'Pilarski'], ['MM', '', 'Carson'], ['JA', '', 'Beeler'], ['MP', '', 'Krezolek']]",Acta Paediatrica,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1651-2227.1997.tb14900.x'],
10.1126/science.271.5246.173,"Liu, X., Bai, X., Wen, J., et. al, B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8 � T Lymphocytes In Vivo, , 0",cited-by,"11027002B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8 � T Lymphocytes In Vivo","B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8 � T Lymphocytes In Vivo","[['Xingluo', '', 'Liu'], ['Xue-Feng', '', 'Bai'], ['Jing', '', 'Wen'], ['Jian-Xin', '', 'Gao'], ['Jinqing', '', 'Liu'], ['Ping', '', 'Lu'], ['Yin', '', 'Wang'], ['Pan', '', 'Zheng'], ['Yang', '', 'Liu']]",,0,[u'http://jem.rupress.org/cgi/reprint/194/9/1339.pdf'],
10.1126/science.271.5246.173,"RAYEVSKAYA, M., FRANKEL, F., , Systemic Immunity and Mucosal Immunity Are Induced against Human Immunodeficiency Virus Gag Protein in Mice by a New Hyperattenuated Strain of Listeria monocytogenes, Journal of Virology, 2001",cited-by,10.1128/JVI.75.6.2786-2791.2001,Systemic Immunity and Mucosal Immunity Are Induced against Human Immunodeficiency Virus Gag Protein in Mice by a New Hyperattenuated Strain of Listeria monocytogenes,"[['MARINA', 'V.', 'RAYEVSKAYA'], ['FRED', 'R.', 'FRANKEL']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/6/2786.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.6.2786-2791.2001']",
10.1126/science.271.5246.173,"LOHMAN, B., WELSH, R., , Apoptotic Regulation of T Cells and Absence of Immune Deficiency in Virus-Infected Gamma Interferon Receptor Knockout Mice, , 1998",cited-by,7028640Apoptotic Regulation of T Cells and Absence of Immune Deficiency in Virus-Infected Gamma Interferon Receptor Knockout Mice,Apoptotic Regulation of T Cells and Absence of Immune Deficiency in Virus-Infected Gamma Interferon Receptor Knockout Mice,"[['BARBARA', 'L.', 'LOHMAN'], ['RAYMOND', 'M.', 'WELSH']]",,1998,[],
10.1126/science.271.5246.173,"Vescovini, R., Telera, A., Fagnoni, F., et. al, Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8 + T cells, Experimental Gerontology, 2004",cited-by,10.1016/j.exger.2004.04.004,Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8 + T cells,"[['Rosanna', '', 'Vescovini'], ['Annarita', '', 'Telera'], ['Francesco', 'F', 'Fagnoni'], ['Claudia', '', 'Biasini'], ['Maria', 'Cristina', 'Medici'], ['Pierpaolo', '', 'Valcavi'], ['Patricia', 'di', 'Pede'], ['Gianluca', '', 'Lucchini'], ['Luca', '', 'Zanlari'], ['Giovanni', '', 'Passeri'], ['Franco', '', 'Zanni'], ['Carlo', '', 'Chezzi'], ['Claudio', '', 'Franceschi'], ['Paolo', '', 'Sansoni']]",Experimental Gerontology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0531556504001743', u'http://linkinghub.elsevier.com/retrieve/pii/S0531556504001743']",
10.1126/science.271.5246.173,"Aichele, P., Bachmann, M., Hengartner, H., et. al, Immunopathology or Organ-Specific Autoimmunity as a Consequence of Virus Infection, Immunological Reviews, 1996",cited-by,10.1111/j.1600-065X.1996.tb00909.x,Immunopathology or Organ-Specific Autoimmunity as a Consequence of Virus Infection,"[['Peter', '', 'Aichele'], ['Martin', 'F.', 'Bachmann'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel']]",Immunological Reviews,1996,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1996.tb00909.x'],
10.1126/science.271.5246.173,"Matzinger, P., , Essay 1: The Danger Model in Its Historical Context, Scandinavian Journal of Immunology, 2001",cited-by,10.1046/j.1365-3083.2001.00974.x,Essay 1: The Danger Model in Its Historical Context,"[['P.', '', 'Matzinger']]",Scandinavian Journal of Immunology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-3083.2001.00974.x'],
10.1126/science.271.5246.173,"Stoitzner, P., Zanella, M., Ortner, U., et. al, Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-a and IL1b, , 1999",cited-by,5248149Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-a and IL1b,Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-a and IL1b,"[['Patrizia', '', 'Stoitzner'], ['Monica', '', 'Zanella'], ['Ulrike', '', 'Ortner'], ['Michael', '', 'Lukas'], ['Andrea', '', 'Tagwerker'], ['Katrin', '', 'Janke'], ['Manfred', 'B.', 'Lutz'], ['Gerold', '', 'Schuler'], ['Bernd', '', 'Echtenacher'], ['Bernhard', '', 'Ryffel'], ['Franz', '', 'Koch'], ['Nikolaus', '', 'Romani']]",,1999,[u'http://www.jleukbio.org/cgi/reprint/66/3/462.pdf'],
10.1126/science.271.5246.173,"Antonio, E., Husmann, R., Hansen, R., et. al, Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen, Veterinary Immunology and Immunopathology, 1998",cited-by,10.1016/S0165-2427(97)00141-4,"Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen","[['Enric', 'Mateu de', 'Antonio'], ['Robert', 'J', 'Husmann'], ['Richard', '', 'Hansen'], ['Joan', 'K', 'Lunney'], ['David', '', 'Strom'], ['Stephen', '', 'Martin'], ['Federico', 'A', 'Zuckermann']]",Veterinary Immunology and Immunopathology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0165242797001414', u'http://linkinghub.elsevier.com/retrieve/pii/S0165242797001414']",
10.1126/science.271.5246.173,"King, C., , Transmission intensity and human immune responses to lymphatic filariasis, Parasite Immunology, 2001",cited-by,10.1046/j.1365-3024.2001.00395.x,Transmission intensity and human immune responses to lymphatic filariasis,"[['Christopher', 'L.', 'King']]",Parasite Immunology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-3024.2001.00395.x'],
10.1126/science.271.5246.173,"Azevedo, M., Yuan, L., Pouly, S., et. al, Cytokine Responses in Gnotobiotic Pigs after Infection with Virulent or Attenuated Human Rotavirus, Journal of Virology, 2006",cited-by,10.1128/JVI.80.1.372-382.2006,Cytokine Responses in Gnotobiotic Pigs after Infection with Virulent or Attenuated Human Rotavirus,"[['M.', 'S. P.', 'Azevedo'], ['L.', '', 'Yuan'], ['S.', '', 'Pouly'], ['A.', 'M.', 'Gonzales'], ['K.', 'I.', 'Jeong'], ['T.', 'V.', 'Nguyen'], ['L.', 'J.', 'Saif']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/1/372.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.80.1.372-382.2006']",
10.1126/science.271.5246.173,"FIANDER, A., TRISTRAM, A., DAVIDSON, E., et. al, Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial, International Journal of Gynecological Cancer, 2006",cited-by,10.1111/j.1525-1438.2006.00598.x,"Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial","[['A.', 'N.', 'FIANDER'], ['A.', 'J.', 'TRISTRAM'], ['E.', 'J.', 'DAVIDSON'], ['A.', 'E.', 'TOMLINSON'], ['S.', '', 'MAN'], ['P.', 'J.', 'BALDWIN'], ['J.', 'C.', 'STERLING'], ['H.', 'C.', 'KITCHENER']]",International Journal of Gynecological Cancer,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1438.2006.00598.x'],
10.1126/science.271.5246.173,"Brassard, D., Grace, M., Bordens, R., , Interferon as an immunotherapeutic protein, , 0",cited-by,11756092Interferon as an immunotherapeutic protein,Interferon as an immunotherapeutic protein,"[['Diana', 'L.', 'Brassard'], ['Michael', 'J.', 'Grace'], ['Ronald', 'W.', 'Bordens']]",,0,[u'http://www.jleukbio.org/cgi/reprint/71/4/565.pdf'],
10.1126/science.271.5246.173,"BLANCO, E., GARCIA-BRIONES, M., SANZ-PARRA, A., et. al, Identification of T-Cell Epitopes in Nonstructural Proteins of Foot-and-Mouth Disease Virus, Journal of Virology, 2001",cited-by,10.1128/JVI.75.7.3164-3174.2001,Identification of T-Cell Epitopes in Nonstructural Proteins of Foot-and-Mouth Disease Virus,"[['ESTHER', '', 'BLANCO'], ['MERCEDES', '', 'GARCIA-BRIONES'], ['ARANTZA', '', 'SANZ-PARRA'], ['PAULA', '', 'GOMES'], ['ELIANDRE', 'DE', 'OLIVEIRA'], ['MARI', 'LUZ', 'VALERO'], ['DAVID', '', 'ANDREU'], ['VICTORIA', '', 'LEY'], ['FRANCISCO', '', 'SOBRINO']]",Journal of Virology,2001,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.7.3164-3174.2001'],
10.1126/science.271.5246.173,"ZIMMERMANN, C., SEILER, P., ZINKERNAGEL, A., , Antiviral Immune Responses in CTLA4 Transgenic Mice, , 1997",cited-by,14324591Antiviral Immune Responses in CTLA4 Transgenic Mice,Antiviral Immune Responses in CTLA4 Transgenic Mice,"[['CHRISTINE', '', 'ZIMMERMANN'], ['PETER', '', 'SEILER'], ['ANDROLF', 'M.', 'ZINKERNAGEL']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/3/1802.pdf'],
10.1126/science.271.5246.173,"Gremion, C., Cerny, A., , Hepatitis C virus and the immune system: a concise review, Reviews in Medical Virology, 2005",cited-by,10.1002/rmv.466,Hepatitis C virus and the immune system: a concise review,"[['Christel', '', 'Gremion'], ['Andreas', '', 'Cerny']]",Reviews in Medical Virology,2005,[u'http://doi.wiley.com/10.1002/rmv.466'],
10.1126/science.271.5246.173,"Fändrich, F., Dresske, B., Bader, M., et. al, Embryonic stem cells share immune-privileged features relevant for tolerance induction, Journal of Molecular Medicine-jmm, 2002",cited-by,10.1007/s00109-002-0342-6,Embryonic stem cells share immune-privileged features relevant for tolerance induction,"[['Fred', '', 'F\xc3\xa4ndrich'], ['Bettina', '', 'Dresske'], ['Michael', '', 'Bader'], ['Maren', '', 'Schulze']]",Journal of Molecular Medicine-jmm,2002,"[u'http://www.springerlink.com/content/7jjl0cyvf1xxb6d2', u'http://www.springerlink.com/index/7jjl0cyvf1xxb6d2.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00109-002-0342-6', u'http://www.springerlink.com/index/pdf/10.1007/s00109-002-0342-6']",
10.1126/science.271.5246.173,"Pewzner-Jung, Y., Friedmann, D., Sonoda, E., et. al, B Cell Deletion, Anergy, and Receptor Editing in ""Knock In"" Mice Targeted with a Germline-Encoded or Somatically Mutated Anti-DNA Heavy Chain1, , 0",cited-by,"6244676B Cell Deletion, Anergy, and Receptor Editing in ""Knock In"" Mice Targeted with a Germline-Encoded or Somatically Mutated Anti-DNA Heavy Chain1","B Cell Deletion, Anergy, and Receptor Editing in ""Knock In"" Mice Targeted with a Germline-Encoded or Somatically Mutated Anti-DNA Heavy Chain1","[['Yael', '', 'Pewzner-Jung'], ['Dinorah', '', 'Friedmann'], ['Eiichiro', '', 'Sonoda'], ['Steffen', '', 'Jung'], ['Klaus', '', 'Rajewsky']]",,0,[u'http://www.jimmunol.org/cgi/reprint/161/9/4634.pdf'],
10.1126/science.271.5246.173,"Sanclemente, G., Gill, D., , Human papillomavirus molecular biology and pathogenesis, Journal of The European Academy of Dermatology and Venereology, 2002",cited-by,10.1046/j.1473-2165.2002.00419.x,Human papillomavirus molecular biology and pathogenesis,"[['G', '', 'Sanclemente'], ['DK', '', 'Gill']]",Journal of The European Academy of Dermatology and Venereology,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1473-2165.2002.00419.x'],
10.1126/science.271.5246.173,"Rautenschlein, S., Yeh, H., Sharma, J., , The role of T cells in protection by an inactivated infectious bursal disease virus vaccine, Veterinary Immunology and Immunopathology, 2002",cited-by,10.1016/S0165-2427(02)00202-7,The role of T cells in protection by an inactivated infectious bursal disease virus vaccine,"[['Silke', '', 'Rautenschlein'], ['H.-Y', '', 'Yeh'], ['J.', 'M', 'Sharma']]",Veterinary Immunology and Immunopathology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0165242702002027', u'http://linkinghub.elsevier.com/retrieve/pii/S0165242702002027']",
10.1126/science.271.5246.173,"Bastian, A., Schäfer, H., , Human α-defensin 1 (HNP-1) inhibits adenoviral infection in vitro, Regulatory Peptides, 2001",cited-by,10.1016/S0167-0115(01)00282-8,Human α-defensin 1 (HNP-1) inhibits adenoviral infection in vitro,"[['Andreas', '', 'Bastian'], ['Heiner', '', 'Sch\xc3\xa4fer']]",Regulatory Peptides,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0167011501002828', u'http://linkinghub.elsevier.com/retrieve/pii/S0167011501002828']",
10.1126/science.271.5246.173,"LIDBURY, B., MAHALINGAM, S., , Specific Ablation of Antiviral Gene Expression in Macrophages by Antibody-Dependent Enhancement of Ross River Virus Infection, Journal of Virology, 2000",cited-by,10.1128/JVI.74.18.8376-8381.2000,Specific Ablation of Antiviral Gene Expression in Macrophages by Antibody-Dependent Enhancement of Ross River Virus Infection,"[['BRETT', 'A.', 'LIDBURY'], ['SURENDRAN', '', 'MAHALINGAM']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/18/8376.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.18.8376-8381.2000']",
10.1126/science.271.5246.173,"Starzl, T., , History of Clinical Transplantation, World Journal of Surgery, 2000",cited-by,10.1007/s002680010124,History of Clinical Transplantation,"[['Thomas', 'E.', 'Starzl']]",World Journal of Surgery,2000,"[u'http://www.springerlink.com/content/9v0hdxewpmdq5vca', u'http://www.springerlink.com/index/9v0hdxewpmdq5vca.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s002680010124', u'http://www.springerlink.com/index/pdf/10.1007/s002680010124']",
10.1126/science.271.5246.173,"VARGA, S., WELSH, R., , High Frequency of Virus-Specific Interleukin2-Producing CD4+ T Cells and Th1 Dominance during Lymphocytic Choriomeningitis Virus Infection, Journal of Virology, 2000",cited-by,10.1128/JVI.74.9.4429-4432.2000,High Frequency of Virus-Specific Interleukin2-Producing CD4+ T Cells and Th1 Dominance during Lymphocytic Choriomeningitis Virus Infection,"[['STEVEN', 'M.', 'VARGA'], ['RAYMOND', 'M.', 'WELSH']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/9/4429.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.9.4429-4432.2000']",
10.1126/science.271.5246.173,"Sala, M., Wain-Hobson, S., , Are RNA Viruses Adapting or Merely Changing?, Journal of Molecular Evolution, 2000",cited-by,10.1007/s002390010062,Are RNA Viruses Adapting or Merely Changing?,"[['Monica', '', 'Sala'], ['Simon', '', 'Wain-Hobson']]",Journal of Molecular Evolution,2000,"[u'http://www.springerlink.com/index/91lm9qvkbpuwq7qw.pdf', u'http://www.springerlink.com/content/91lm9qvkbpuwq7qw']",
10.1126/science.271.5246.173,"Gruijl, T., Bontkes, H., Walboomers, J., et. al, Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome, , 1999",cited-by,13400838Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome,Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome,"[['Tanja', 'D. de', 'Gruijl'], ['Hetty', 'J.', 'Bontkes'], ['Jan', 'M. M.', 'Walboomers'], ['Pierre', '', 'Coursaget'], ['Marij', 'J.', 'Stukart'], ['Catherine', '', 'Dupuy'], ['Esther', '', 'Kueter'], ['H.', 'M.', 'Verheijen'], ['Theo', 'J. M.', 'Helmerhorst'], ['Margaret', 'F.', 'Duggan-Keen'], ['Peter', 'L.', 'Stern'], ['Chris', 'J. L. M.', 'Meijer'], ['Rik', 'J.', 'Scheper']]",,1999,[u'http://vir.sgmjournals.org/cgi/reprint/80/2/399.pdf'],
10.1126/science.271.5246.173,"Gherardi, M., Ramirez, J., Esteban, M., , IL12 and IL18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system, Journal of General Virology, 2003",cited-by,10.1099/vir.0.19120-0,IL12 and IL18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system,"[['M.', 'Magdalena', 'Gherardi'], ['Juan', 'C.', 'Ramirez'], ['Mariano', '', 'Esteban']]",Journal of General Virology,2003,"[u'http://vir.sgmjournals.org/cgi/reprint/84/8/1961.pdf', u'http://www.cnb.csic.es/~estebanlab/articles/Gherardi_JGenVirol_2003.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/vir.0.19120-0']",
10.1126/science.271.5246.173,"Johnsen, C., Botner, A., Kamstrup, S., et. al, Cytokine mRNA Profiles in Bronchoalveolar Cells of Piglets Experimentally Infected in Utero with Porcine Reproductive and Respiratory Syndrome Virus: Association of Sustained Expression of IFN and IL10 after Viral Clearance, Viral Immunology, 2002",cited-by,10.1089/088282402320914494,Cytokine mRNA Profiles in Bronchoalveolar Cells of Piglets Experimentally Infected in Utero with Porcine Reproductive and Respiratory Syndrome Virus: Association of Sustained Expression of IFN and IL10 after Viral Clearance,"[['C.', 'K.', 'Johnsen'], ['A.', '', 'Botner'], ['S.', '', 'Kamstrup'], ['P.', '', 'Lind'], ['J.', '', 'Nielsen']]",Viral Immunology,2002,[u'http://www.liebertonline.com/doi/abs/10.1089%2F088282402320914494'],
10.1126/science.271.5246.173,"Hunziker, I., Zurbriggen, R., Glueck, R., et. al, Perspectives: towards a peptide-based vaccine against hepatitis C virus, Molecular Immunology, 2001",cited-by,10.1016/S0161-5890(01)00083-9,Perspectives: towards a peptide-based vaccine against hepatitis C virus,"[['Isabelle', 'P.', 'Hunziker'], ['Rinaldo', '', 'Zurbriggen'], ['Reinhard', '', 'Glueck'], ['Olivier', 'B.', 'Engler'], ['J\xc3\xbcrg', '', 'Reichen'], ['Wen', 'Juan', 'Dai'], ['Werner', 'J.', 'Pichler'], ['Andreas', '', 'Cerny']]",Molecular Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0161589001000839', u'http://linkinghub.elsevier.com/retrieve/pii/S0161589001000839']",
10.1126/science.271.5246.173,"JONES, C., COSE, S., COLES, R., et. al, Herpes Simplex Virus Type 1Specific Cytotoxic T-Lymphocyte Arming Occurs within Lymph Nodes Draining the Site of Cutaneous Infection, Journal of Virology, 2000",cited-by,10.1128/JVI.74.5.2414-2419.2000,Herpes Simplex Virus Type 1Specific Cytotoxic T-Lymphocyte Arming Occurs within Lymph Nodes Draining the Site of Cutaneous Infection,"[['CLAERWEN', 'M.', 'JONES'], ['STEPHEN', 'C.', 'COSE'], ['RICHARD', 'M.', 'COLES'], ['ADAM', 'C.', 'WINTERHALTER'], ['ANDREW', 'G.', 'BROOKS'], ['WILLIAM', 'R.', 'HEATH'], ['FRANCIS', 'R.', 'CARBONE']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/5/2414.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.5.2414-2419.2000']",
10.1126/science.271.5246.173,"ZHOU, J., MONTEFIORI, C., , Antibody-Mediated Neutralization of Primary Isolates of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells Is Not Affected by the Initial Activation State of the Cells, , 1997",cited-by,14306170Antibody-Mediated Neutralization of Primary Isolates of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells Is Not Affected by the Initial Activation State of the Cells,Antibody-Mediated Neutralization of Primary Isolates of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells Is Not Affected by the Initial Activation State of the Cells,"[['JI', 'YING', 'ZHOU'], ['C.', '', 'MONTEFIORI']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/3/2512.pdf'],
10.1056~NEJMoa011232,"Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-61. [Erratum, Nature 1993;364:262.]",references,10.1038/362758a0,Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells,"[[u'Demetrius', u'', u'Moskophidis'], [u'Franziska', u'', u'Lechner'], [u'Hanspeter', u'', u'Pircher'], [u'Rolf', u'M.', u'Zinkernagel']]",Nature,1993,"[u'http://www.nature.com/doifinder/10.1038/362758a0', u'http://www.nature.com/doifinder/10.1038/364262a0', u'http://adsabs.harvard.edu/abs/1993Natur.362..758M']","[{u'Name': u'Cytotoxic T Cells', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 8883}, {u'Name': u'Immune System', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 19207}, {u'Name': u'Lymphocytic Choriomeningitis Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 59594}]"
10.1038/362758a0,"Murali-Krishna, K., Altman, J., Suresh, M., et. al, Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection, Immunity, 1998",cited-by,10.1016/S1074-7613(00)80470-7,Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection,"[['Kaja', '', 'Murali-Krishna'], ['John', 'D.', 'Altman'], ['M.', '', 'Suresh'], ['David', 'J. D.', 'Sourdive'], ['Allan', 'J.', 'Zajac'], ['Joseph', 'D.', 'Miller'], ['Jill', '', 'Slansky'], ['Rafi', '', 'Ahmed']]",Immunity,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300804707', u'http://www.kendallasmith.com/launch/Murali_Ahmed_1998.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300804707']",
10.1038/362758a0,"Wherry, E., Teichgräber, V., Becker, T., et. al, Lineage relationship and protective immunity of memory CD8 T cell subsets, Nature Immunology, 2003",cited-by,10.1038/ni889,Lineage relationship and protective immunity of memory CD8 T cell subsets,"[['E.', 'John', 'Wherry'], ['Volker', '', 'Teichgr\xc3\xa4ber'], ['Todd', 'C.', 'Becker'], ['David', '', 'Masopust'], ['Susan', 'M.', 'Kaech'], ['Rustom', '', 'Antia'], ['Ulrich', 'H. von', 'Andrian'], ['Rafi', '', 'Ahmed']]",Nature Immunology,2003,"[u'http://dx.doi.org/10.1038/ni889', u'http://www.nature.com/doifinder/10.1038/ni889']",
10.1038/362758a0,"Fisher, G., Rosenberg, F., Straus, S., et. al, Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell, 1995",cited-by,10.1016/0092-8674(95)90013-6,Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome,"[['Galen', 'H', 'Fisher'], ['Fredric', 'J', 'Rosenberg'], ['Stephen', 'E', 'Straus'], ['Janet', 'K', 'Dale'], ['Lindsay', 'A', 'Middelton'], ['Albert', 'Y', 'Lin'], ['Warren', '', 'Strober'], ['Michael', 'J', 'Lenardo'], ['Jennifer', 'M', 'Puck']]",Cell,1995,"[u'http://www.sciencedirect.com/science/article/pii/0092867495900136', u'http://linkinghub.elsevier.com/retrieve/pii/0092867495900136']",
10.1038/362758a0,"Iezzi, G., Karjalainen, K., Lanzavecchia, A., , The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells, Immunity, 1998",cited-by,10.1016/S1074-7613(00)80461-6,The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells,"[['Giandomenica', '', 'Iezzi'], ['Klaus', '', 'Karjalainen'], ['Antonio', '', 'Lanzavecchia']]",Immunity,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300804616', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300804616']",
10.1038/362758a0,"Zajac, A., Blattman, J., Murali-Krishna, K., et. al, Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function, , 0",cited-by,4068372Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function,Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function,"[['Allan', 'J.', 'Zajac'], ['Joseph', 'N.', 'Blattman'], ['Kaja', '', 'Murali-Krishna'], ['David', 'J. D.', 'Sourdive'], ['M.', '', 'Suresh'], ['John', 'D.', 'Altman'], ['Rafi', '', 'Ahmed']]",,0,"[u'http://www.microbio.uab.edu/mic740/papers/11232009/zajac.pdf', u'http://jem.rupress.org/cgi/reprint/188/12/2205.pdf']",
10.1038/362758a0,"Apostolou, I., Sarukhan, A., Klein, L., et. al, Origin of regulatory T cells with known specificity for antigen, Nature Immunology, 2002",cited-by,10.1038/ni816,Origin of regulatory T cells with known specificity for antigen,"[['Irina', '', 'Apostolou'], ['Adelaida', '', 'Sarukhan'], ['Ludger', '', 'Klein'], ['Harald', 'von', 'Boehmer']]",Nature Immunology,2002,"[u'http://www.nature.com/doifinder/10.1038/ni816', u'http://dx.doi.org/10.1038/ni816']",
10.1038/362758a0,"McMichael, A., Rowland-Jones, S., , Cellular immune responses to HIV, Nature, 2001",cited-by,10.1038/35073658,Cellular immune responses to HIV,"[['Andrew', 'J.', 'McMichael'], ['Sarah', 'L.', 'Rowland-Jones']]",Nature,2001,"[u'http://www.nature.com/doifinder/10.1038/35073658', u'http://dx.doi.org/10.1038/35073658']",
10.1038/362758a0,"Kagi, D., Ledermann, B., Burki, K., et. al, MOLECULAR MECHANISMS OF LYMPHOCYTE-MEDIATED CYTOTOXICITY AND THEIR ROLE IN IMMUNOLOGICAL PROTECTION AND PATHOGENESIS IN VIVO, Annual Review of Immunology, 1996",cited-by,10.1146/annurev.immunol.14.1.207,MOLECULAR MECHANISMS OF LYMPHOCYTE-MEDIATED CYTOTOXICITY AND THEIR ROLE IN IMMUNOLOGICAL PROTECTION AND PATHOGENESIS IN VIVO,"[['David', '', 'Kagi'], ['Birgit', '', 'Ledermann'], ['Kurt', '', 'Burki'], ['Rolf', 'M.', 'Zinkernagel'], ['Hans', '', 'Hengartner']]",Annual Review of Immunology,1996,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.14.1.207'],
10.1038/362758a0,"Kaech, S., Wherry, E., Ahmed, R., , VaccinesEffector and memory T-cell differentiation: implications for vaccine development, Nature Reviews Immunology, 2002",cited-by,10.1038/nri778,VaccinesEffector and memory T-cell differentiation: implications for vaccine development,"[['Susan', 'M.', 'Kaech'], ['E.', 'John', 'Wherry'], ['Rafi', '', 'Ahmed']]",Nature Reviews Immunology,2002,"[u'http://dx.doi.org/10.1038/nri778', u'http://www.nature.com/doifinder/10.1038/nri778']",
10.1038/362758a0,"Sprent, J., Surh, C., , T CELL MEMORY, Annual Review of Immunology, 2002",cited-by,10.1146/annurev.immunol.20.100101.151926,T CELL MEMORY,"[['Jonathan', '', 'Sprent'], ['Charles', 'D.', 'Surh']]",Annual Review of Immunology,2002,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.20.100101.151926'],
10.1038/362758a0,"Bevan, M., , Helping the CD8+ T-cell response, Nature Reviews Immunology, 2004",cited-by,10.1038/nri1413,Helping the CD8+ T-cell response,"[['Michael', 'J.', 'Bevan']]",Nature Reviews Immunology,2004,"[u'http://dx.doi.org/10.1038/nri1413', u'http://www.nature.com/doifinder/10.1038/nri1413']",
10.1038/362758a0,"Zinkernagel, R., Bachmann, M., Kundig, T., et. al, ON IMMUNOLOGICAL MEMORY, Annual Review of Immunology, 1996",cited-by,10.1146/annurev.immunol.14.1.333,ON IMMUNOLOGICAL MEMORY,"[['Rolf', 'M.', 'Zinkernagel'], ['Martin', 'F.', 'Bachmann'], ['Thomas', 'M.', 'Kundig'], ['Stephan', '', 'Oehen'], ['Hanspeter', '', 'Pirchet'], ['Hans', '', 'Hengartner']]",Annual Review of Immunology,1996,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.14.1.333'],
10.1038/362758a0,"Bowen, D., Walker, C., , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 2005",cited-by,10.1038/nature04079,Adaptive immune responses in acute and chronic hepatitis C virus infection,"[['David', 'G.', 'Bowen'], ['Christopher', 'M.', 'Walker']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04079', u'http://dx.doi.org/10.1038/nature04079']",
10.1038/362758a0,"Callan, M., Steven, N., Krausa, P., et. al, Large clonal expansions of CD8+ T cells in acute infectious mononucleosis, Nature Medicine, 1996",cited-by,10.1038/nm0896-906,Large clonal expansions of CD8+ T cells in acute infectious mononucleosis,"[['Margaret', 'F. C.', 'Callan'], ['Neil', '', 'Steven'], ['Pete', '', 'Krausa'], ['Jamie', 'D. K.', 'Wilson'], ['Paul', 'A. H.', 'Moss'], ['Geraldine', 'M.', 'Gillespie'], ['John', 'I.', 'Bell'], ['Alan', 'B.', 'Rickinson'], ['Andrew', 'J.', 'McMichael']]",Nature Medicine,1996,[u'http://www.nature.com/doifinder/10.1038/nm0896-906'],
10.1038/362758a0,"Doherty, P., Topham, D., Tripp, R., et. al, Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections, Immunological Reviews, 1997",cited-by,10.1111/j.1600-065X.1997.tb01010.x,Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections,"[['Peter', 'C.', 'Doherty'], ['David', 'J.', 'Topham'], ['Ralph', 'A.', 'Tripp'], ['Rhonda', 'D.', 'Cardin'], ['James', 'W', 'Brooks'], ['Philip', 'G.', 'Stevenson']]",Immunological Reviews,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1997.tb01010.x'],
10.1038/362758a0,"RINALDO, C., HUANG, X., FAN, Z., et. al, High Levels of Anti-Human Immunodeficiency Virus Type 1 (HIV1) Memory Cytotoxic T-Lymphocyte Activity and Low Viral Load Are Associated with Lack of Disease in HIV1Infected Long-Term Nonprogressors, , 1995",cited-by,14008693High Levels of Anti-Human Immunodeficiency Virus Type 1 (HIV1) Memory Cytotoxic T-Lymphocyte Activity and Low Viral Load Are Associated with Lack of Disease in HIV1Infected Long-Term Nonprogressors,High Levels of Anti-Human Immunodeficiency Virus Type 1 (HIV1) Memory Cytotoxic T-Lymphocyte Activity and Low Viral Load Are Associated with Lack of Disease in HIV1Infected Long-Term Nonprogressors,"[['CHARLES', '', 'RINALDO'], ['XIAO-LI', '', 'HUANG'], ['ZHENG', '', 'FAN'], ['MING', '', 'DING'], ['LISA', '', 'BELTZ'], ['ALISON', '', 'LOGAR'], ['DENNIS', '', 'PANICALI'], ['GAIL', '', 'MAZZARA'], ['JAMES', '', 'LIEBMANN'], ['MARTIN', '', 'COTTRILL'], ['ANDPHALGUNI', '', 'GUPTA']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/9/5838.pdf'],
10.1038/362758a0,"Doherty, P., , Progressive Loss of CD8 + T Cell-mediated Control of a ~/Herpesvirus in the Absence of CD4 + T Cells, , 1996",cited-by,6337216Progressive Loss of CD8 + T Cell-mediated Control of a ~/Herpesvirus in the Absence of CD4 + T Cells,Progressive Loss of CD8 + T Cell-mediated Control of a ~/Herpesvirus in the Absence of CD4 + T Cells,"[['Peter', 'C.', 'Doherty']]",,1996,[u'http://jem.rupress.org/cgi/reprint/184/3/863.pdf'],
10.1038/362758a0,"Holtschke, T., Löhler, J., Kanno, Y., et. al, Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene, Cell, 1996",cited-by,10.1016/S0092-8674(00)81348-3,Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene,"[['Thomas', '', 'Holtschke'], ['J\xc3\xbcrgen', '', 'L\xc3\xb6hler'], ['Yuka', '', 'Kanno'], ['Thomas', '', 'Fehr'], ['Nathalia', '', 'Giese'], ['Frank', '', 'Rosenbauer'], ['Jing', '', 'Lou'], ['Klaus-Peter', '', 'Knobeloch'], ['Lucia', '', 'Gabriele'], ['Jeffrey', 'F', 'Waring'], ['Martin', 'F', 'Bachmann'], ['Rolf', 'M', 'Zinkernagel'], ['Herbert', 'C', 'Morse'], ['Keiko', '', 'Ozato'], ['Ivan', '', 'Horak']]",Cell,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0092867400813483', u'http://linkinghub.elsevier.com/retrieve/pii/S0092867400813483']",
10.1038/362758a0,"Zinkernagel, R., Ehl, S., Aichele, P., et. al, Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity, Immunological Reviews, 1997",cited-by,10.1111/j.1600-065X.1997.tb00969.x,Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity,"[['Rolf', 'M.', 'Zinkernagel'], ['Stephan', '', 'Ehl'], ['Peter', '', 'Aichele'], ['Stephan', '', 'Oehen'], ['Thomas', '', 'Kundig'], ['Hans', '', 'Hengartner']]",Immunological Reviews,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1997.tb00969.x'],
10.1038/362758a0,"McMichael, A., Phillips, R., , ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROL, Annual Review of Immunology, 1997",cited-by,10.1146/annurev.immunol.15.1.271,ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROL,"[['Andrew', 'J.', 'McMichael'], ['Rodney', 'E.', 'Phillips']]",Annual Review of Immunology,1997,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.15.1.271'],
10.1038/362758a0,"Bachmann, M., McKall-Faienza, K., Schmits, R., et. al, Distinct Roles for LFA-1 and CD28 during Activation of Naive T Cells: Adhesion versus Costimulation, Immunity, 1997",cited-by,10.1016/S1074-7613(00)80376-3,Distinct Roles for LFA-1 and CD28 during Activation of Naive T Cells: Adhesion versus Costimulation,"[['Martin', 'F', 'Bachmann'], ['Kim', '', 'McKall-Faienza'], ['Rudolf', '', 'Schmits'], ['Denis', '', 'Bouchard'], ['Janine', '', 'Beach'], ['Daniel', 'E', 'Speiser'], ['Tak', 'W', 'Mak'], ['Pamela', 'S', 'Ohashi']]",Immunity,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300803763', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300803763']",
10.1038/362758a0,"Sytwu, H., Liblau, R., McDevitt, H., , The Roles of Fas/APO1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice, Immunity, 1996",cited-by,10.1016/S1074-7613(00)80306-4,The Roles of Fas/APO1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice,"[['Huey-Kang', '', 'Sytwu'], ['Roland', 'S', 'Liblau'], ['Hugh', 'O', 'McDevitt']]",Immunity,1996,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300803064', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300803064']",
10.1038/362758a0,"Blattman, J., Antia, R., Sourdive, D., et. al, Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells, , 2002",cited-by,3045858Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells,Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells,"[['Joseph', 'N.', 'Blattman'], ['Rustom', '', 'Antia'], ['David', 'J. D.', 'Sourdive'], ['Xiaochi', '', 'Wang'], ['Susan', 'M.', 'Kaech'], ['Kaja', '', 'Murali-Krishna'], ['John', 'D.', 'Altman'], ['Rafi', '', 'Ahmed']]",,2002,[u'http://jem.rupress.org/cgi/reprint/195/5/657.pdf'],
10.1038/362758a0,"Doherty, P., Christensen, J., , Accessing Complexity: The Dynamics of Virus-Specific T Cell Responses, Annual Review of Immunology, 2000",cited-by,10.1146/annurev.immunol.18.1.561,Accessing Complexity: The Dynamics of Virus-Specific T Cell Responses,"[['Peter', 'C.', 'Doherty'], ['Jan', 'P.', 'Christensen']]",Annual Review of Immunology,2000,[u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.immunol.18.1.561'],
10.1038/362758a0,"Lechner, F., Wong, D., Dunbar, P., et. al, Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus, , 0",cited-by,6871263Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus,Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus,"[['Franziska', '', 'Lechner'], ['David', 'K. H.', 'Wong'], ['P.', 'Rod', 'Dunbar'], ['Roger', '', 'Chapman'], ['Raymond', 'T.', 'Chung'], ['Paul', '', 'Dohrenwend'], ['Gregory', '', 'Robbins'], ['Rodney', '', 'Phillips'], ['Paul', '', 'Klenerman'], ['Bruce', 'D.', 'Walker']]",,0,[u'http://jem.rupress.org/cgi/reprint/191/9/1499.pdf'],
10.1038/362758a0,"Harris, N., Macpherson, A., , Interactions between commensal intestinal bacteria and the immune system, Nature Reviews Immunology, 2004",cited-by,10.1038/nri1373,Interactions between commensal intestinal bacteria and the immune system,"[['Nicola', 'L.', 'Harris'], ['Andrew', 'J.', 'Macpherson']]",Nature Reviews Immunology,2004,"[u'http://dx.doi.org/10.1038/nri1373', u'http://www.nature.com/doifinder/10.1038/nri1373']",
10.1038/362758a0,"Hofmeyr, S., , An Immunological Model of Distributed Detection and Its Application to Computer Security, , 1999",cited-by,243477An Immunological Model of Distributed Detection and Its Application to Computer Security,An Immunological Model of Distributed Detection and Its Application to Computer Security,"[['Steven', 'Andrew', 'Hofmeyr']]",,1999,[],
10.1038/362758a0,"Kyburz, D., Aichele, P., Speiser, D., et. al, T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides, European Journal of Immunology, 1993",cited-by,10.1002/eji.1830230834,T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides,"[['Diego', '', 'Kyburz'], ['Peter', '', 'Aichele'], ['Daniel', 'E.', 'Speiser'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkemagel'], ['Hanspeter', '', 'Pircher']]",European Journal of Immunology,1993,[u'http://doi.wiley.com/10.1002/eji.1830230834'],
10.1038/362758a0,"Gallimore, A., Glithero, A., Godkin, A., et. al, Induction and Exhaustion of Lymphocytic Choriomeningitis Virus-specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I-Peptide Complexes, , 0",cited-by,273313Induction and Exhaustion of Lymphocytic Choriomeningitis Virus-specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I-Peptide Complexes,Induction and Exhaustion of Lymphocytic Choriomeningitis Virus-specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I-Peptide Complexes,"[['Awen', '', 'Gallimore'], ['Ann', '', 'Glithero'], ['Andrew', '', 'Godkin'], ['Alain', 'C.', 'Tissot'], ['Andreas', '', 'Pl\xc3\xbcckthun'], ['Tim', '', 'Elliott'], ['Hans', '', 'Hengartner'], ['Rolf', '', 'Zinkernagel']]",,0,"[u'http://www.bioc.uzh.ch/plueckthun/pdf/APpub0142.pdf', u'http://www.bioc.unizh.ch/plueckthun/pdf/APpub0142.pdf', u'http://jem.rupress.org/cgi/reprint/187/9/1383.pdf']",
10.1038/362758a0,"Ramshaw, I., Ramsay, A., Karupiah, G., et. al, Cytokines and immunity to viral infections, Immunological Reviews, 1997",cited-by,10.1111/j.1600-065X.1997.tb01011.x,Cytokines and immunity to viral infections,"[['Ian', 'A.', 'Ramshaw'], ['Alistair', 'J.', 'Ramsay'], ['Gunasegaran', '', 'Karupiah'], ['Michael', 'S.', 'Rolph'], ['Surendran', '', 'Mahalingam'], ['Janet', 'C.', 'Ruby']]",Immunological Reviews,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1997.tb01011.x'],
10.1038/362758a0,"Wong, P., Pamer, E., , CD8 T CELL RESPONSES TO INFECTIOUS PATHOGENS, Annual Review of Immunology, 2003",cited-by,10.1146/annurev.immunol.21.120601.141114,CD8 T CELL RESPONSES TO INFECTIOUS PATHOGENS,"[['Phillip', '', 'Wong'], ['Eric', 'G.', 'Pamer']]",Annual Review of Immunology,2003,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.21.120601.141114'],
10.1038/362758a0,"Dittmer, U., He, H., Messer, R., et. al, Functional Impairment of CD8 + T Cells by Regulatory T Cells during Persistent Retroviral Infection, Immunity, 2004",cited-by,10.1016/S1074-7613(04)00054-8,Functional Impairment of CD8 + T Cells by Regulatory T Cells during Persistent Retroviral Infection,"[['Ulf', '', 'Dittmer'], ['Hong', '', 'He'], ['Ronald', 'J.', 'Messer'], ['Simone', '', 'Schimmer'], ['Anke', 'R. M.', 'Olbrich'], ['Claes', '', 'Ohlen'], ['Philip', 'D.', 'Greenberg'], ['Ingunn', 'M.', 'Stromnes'], ['Michihiro', '', 'Iwashiro'], ['Shimon', '', 'Sakaguchi'], ['Leonard', 'H.', 'Evans'], ['Karin', 'E.', 'Peterson'], ['Guojun', '', 'Yang'], ['Kim', 'J.', 'Hasenkrug']]",Immunity,2004,"[u'http://www.medmicro.wisc.edu/graduate/courses/900/archive/2004/pdf/spring/retroviral04302004.pdf', u'http://www.sciencedirect.com/science/article/pii/S1074761304000548', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761304000548', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761304001153']",
10.1038/362758a0,"Lee, K., Wang, E., Nielsen, M., et. al, Increased Vaccine-Specific T Cell Frequency After Peptide-Based Vaccination Correlates with Increased Susceptibility to In Vitro Stimulation But Does Not Lead to Tumor Regression, , 0",cited-by,10248340Increased Vaccine-Specific T Cell Frequency After Peptide-Based Vaccination Correlates with Increased Susceptibility to In Vitro Stimulation But Does Not Lead to Tumor Regression,Increased Vaccine-Specific T Cell Frequency After Peptide-Based Vaccination Correlates with Increased Susceptibility to In Vitro Stimulation But Does Not Lead to Tumor Regression,"[['Kang-Hun', '', 'Lee'], ['Ena', '', 'Wang'], ['Mai-Britt', '', 'Nielsen'], ['John', '', 'Wunderlich'], ['Steven', '', 'Migueles'], ['Mark', '', 'Connors'], ['Seth', 'M.', 'Steinberg'], ['Steven', 'A.', 'Rosenberg'], ['Francesco', 'M.', 'Marincola']]",,0,[u'http://www.jimmunol.org/cgi/reprint/163/11/6292.pdf'],
10.1038/362758a0,"DIEPOLDER, H., GERLACH, J., ZACHOVAL, R., et. al, Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection, Human Mutation, 1997",cited-by,12321077Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection,Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection,"[['HELMUT', 'M.', 'DIEPOLDER'], ['J', 'ORN-TILMAN', 'GERLACH'], ['REINHART', '', 'ZACHOVAL'], ['ROBERT', 'M.', 'HOFFMANN'], ['MARIA-CHRISTINA', '', 'JUNG'], ['EDDY', 'A.', 'WIERENGA'], ['SIEGFRIED', '', 'SCHOLZ'], ['TERESA', '', 'SANTANTONIO'], ['MICHAEL', '', 'HOUGHTON'], ['SCOTT', '', 'SOUTHWOOD'], ['ALESSANDRO', '', 'SETTE'], ['GERD', 'R.', 'PAPE']]",Human Mutation,1997,[u'http://jvi.asm.org/cgi/reprint/71/8/6011.pdf'],
10.1038/362758a0,"Sprent, J., Surh, C., , Generation and maintenance of memory T cells, Current Opinion in Immunology, 2001",cited-by,10.1016/S0952-7915(00)00211-9,Generation and maintenance of memory T cells,"[['Jonathan', '', 'Sprent'], ['Charles', 'D', 'Surh']]",Current Opinion in Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500002119', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500002119']",
10.1038/362758a0,"Lauer, G., Barnes, E., Lucas, M., et. al, High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.06.015,High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection,"[['Georg', 'M.', 'Lauer'], ['Eleanor', '', 'Barnes'], ['Michaela', '', 'Lucas'], ['Joerg', '', 'Timm'], ['Kei', '', 'Ouchi'], ['Arthur', 'Y.', 'Kim'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Deborah', 'R.', 'Casson'], ['Markus', '', 'Reiser'], ['Geoffrey', '', 'Dusheiko'], ['Todd', 'M.', 'Allen'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Paul', '', 'Klenerman']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504010364', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504010364']",
10.1038/362758a0,"MATLOUBIAN, M., SURESH, M., GLASS, A., et. al, A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection, , 1999",cited-by,13583790A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection,A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection,"[['MEHRDAD', '', 'MATLOUBIAN'], ['M.', '', 'SURESH'], ['ALISON', '', 'GLASS'], ['MARISA', '', 'GALVAN'], ['KIT', '', 'CHOW'], ['JASON', 'K.', 'WHITMIRE'], ['CRAIG', 'M.', 'WALSH'], ['WILLIAM', 'R.', 'CLARK'], ['RAFI', '', 'AHMED']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/3/2527.pdf'],
10.1038/362758a0,"MATLOUBIAN, M., , CD4+T Cells AreRequired ToSustain CD8+Cytotoxic T-Cell Responses during Chronic Viral Infection, , 1994",cited-by,14290387CD4+T Cells AreRequired ToSustain CD8+Cytotoxic T-Cell Responses during Chronic Viral Infection,CD4+T Cells AreRequired ToSustain CD8+Cytotoxic T-Cell Responses during Chronic Viral Infection,"[['MEHRDAD', '', 'MATLOUBIAN']]",,1994,[],
10.1038/362758a0,"Cohen, O., Kinter, A., Fauci, A., , Host factors in the pathogenesis of HIV disease, Immunological Reviews, 1997",cited-by,10.1111/j.1600-065X.1997.tb01005.x,Host factors in the pathogenesis of HIV disease,"[['Oren', 'J.', 'Cohen'], ['Audrey', '', 'Kinter'], ['Anthony', 'S.', 'Fauci']]",Immunological Reviews,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1997.tb01005.x'],
10.1038/362758a0,"Oka, Y., Elisseeva, O., Tsuboi, A., et. al, Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene ( WT1   ) product, Immunogenetics, 2000",cited-by,10.1007/s002510050018,Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene ( WT1   ) product,"[['Yoshihiro', '', 'Oka'], ['Olga', 'A.', 'Elisseeva'], ['Akihiro', '', 'Tsuboi'], ['Hiroyasu', '', 'Ogawa'], ['Hiroya', '', 'Tamaki'], ['Hanfen', '', 'Li'], ['Yusuke', '', 'Oji'], ['Eui', 'Ho', 'Kim'], ['Toshihiro', '', 'Soma'], ['Momotaro', '', 'Asada'], ['Kazuyuki', '', 'Ueda'], ['Etsuko', '', 'Maruya'], ['Hiroh', '', 'Saji'], ['Tadamitsu', '', 'Kishimoto'], ['Keiko', '', 'Udaka'], ['Haruo', '', 'Sugiyama']]",Immunogenetics,2000,"[u'http://www.springerlink.com/index/1dv4p3k9gjucxdwe.pdf', u'http://www.springerlink.com/content/1dv4p3k9gjucxdwe', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s002510050018', u'http://www.springerlink.com/index/pdf/10.1007/s002510050018']",
10.1038/362758a0,"Alexander-Miller, M., Leggatt, G., Sarin, A., et. al, Role of Antigen, CD8, and Cytotoxic T Lymphocyte (CTL) Avidity in High Dose Antigen Induction of Apoptosis of Effector CTL, , 1996",cited-by,"6171792Role of Antigen, CD8, and Cytotoxic T Lymphocyte (CTL) Avidity in High Dose Antigen Induction of Apoptosis of Effector CTL","Role of Antigen, CD8, and Cytotoxic T Lymphocyte (CTL) Avidity in High Dose Antigen Induction of Apoptosis of Effector CTL","[['Martha', 'A.', 'Alexander-Miller'], ['Graham', 'R.', 'Leggatt'], ['Apurva', '', 'Sarin'], ['Jay', 'A.', 'Berzofsky']]",,1996,[u'http://jem.rupress.org/cgi/reprint/184/2/485.pdf'],
10.1038/362758a0,"Sprent, J., Webb, S., , Intrathymic and extrathymic clonal deletion of T cells, Current Opinion in Immunology, 1995",cited-by,10.1016/0952-7915(95)80004-2,Intrathymic and extrathymic clonal deletion of T cells,"[['Jonathan', '', 'Sprent'], ['Susan', 'R', 'Webb']]",Current Opinion in Immunology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0952791595800042', u'http://linkinghub.elsevier.com/retrieve/pii/0952791595800042']",
10.1038/362758a0,"Silvestri, G., Fedanov, A., Germon, S., et. al, Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts, Journal of Virology, 2005",cited-by,10.1128/JVI.79.7.4043-4054.2005,Divergent Host Responses during Primary Simian Immunodeficiency Virus SIVsm Infection of Natural Sooty Mangabey and Nonnatural Rhesus Macaque Hosts,"[['Guido', '', 'Silvestri'], ['Andrew', '', 'Fedanov'], ['Stephanie', '', 'Germon'], ['Natalia', '', 'Kozyr'], ['William', 'J.', 'Kaiser'], ['David', 'A.', 'Garber'], ['Harold', '', 'McClure'], ['Mark', 'B.', 'Feinberg'], ['Silvija', 'I.', 'Staprans']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/7/4043.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.7.4043-4054.2005']",
10.1038/362758a0,"Curtsinger, J., Lins, D., Mescher, M., , Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function, , 0",cited-by,12438699Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function,Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function,"[['Julie', 'M.', 'Curtsinger'], ['Debra', 'C.', 'Lins'], ['Matthew', 'F.', 'Mescher']]",,0,[u'http://jem.rupress.org/cgi/reprint/197/9/1141.pdf'],
10.1038/362758a0,"Burkhart, C., Liu, G., Anderton, S., et. al, Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL10, International Immunology, 1999",cited-by,10.1093/intimm/11.10.1625,Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL10,"[['Christoph', '', 'Burkhart'], ['George', 'Y.', 'Liu'], ['Stephen', 'M.', 'Anderton'], ['Barbara', '', 'Metzler'], ['David', 'C.', 'Wraith']]",International Immunology,1999,"[u'http://intimm.oxfordjournals.org/cgi/reprint/11/10/1625.pdf', u'http://www.intimm.oupjournals.org/cgi/doi/10.1093/intimm/11.10.1625']",
10.1038/362758a0,"BATTEGAY, M., FIKES, J., BISCEGLIE, A., et. al, Patients with Chronic Hepatitis C Have Circulating Cytotoxic T Cells Which Recognize Hepatitis C Virus-Encoded Peptides Binding to HLA-A2.1 Molecules, , 1995",cited-by,13921056Patients with Chronic Hepatitis C Have Circulating Cytotoxic T Cells Which Recognize Hepatitis C Virus-Encoded Peptides Binding to HLA-A2.1 Molecules,Patients with Chronic Hepatitis C Have Circulating Cytotoxic T Cells Which Recognize Hepatitis C Virus-Encoded Peptides Binding to HLA-A2.1 Molecules,"[['MANUEL', '', 'BATTEGAY'], ['JOHN', '', 'FIKES'], ['ADRIAN', 'M. DI', 'BISCEGLIE'], ['PEGGY', 'A.', 'WENTWORTH'], ['ALESSANDRO', '', 'SETTE'], ['ESTEBAN', '', 'CELIS'], ['WEI-MEI', '', 'CHING'], ['ARASH', '', 'GRAKOUI'], ['CHARLES', 'M.', 'RICE'], ['KAZUTAKA', '', 'KUROKOHCHI'], ['JAY', 'A.', 'BERZOFSKY'], ['JAY', 'H.', 'HOOFNAGLE'], ['STEPHEN', 'M.', 'FEINSTONE'], ['ANDTOSHITAKA', '', 'AKATSUKA']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/4/2462.pdf'],
10.1038/362758a0,"Sprent, J., , Immunological memory, Current Opinion in Immunology, 1997",cited-by,10.1016/S0952-7915(97)80084-2,Immunological memory,"[['Jonathan', '', 'Sprent']]",Current Opinion in Immunology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0952791597800842', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791597800842']",
10.1038/362758a0,"Wong, P., Pamer, E., , Feedback Regulation of Pathogen-Specific T Cell Priming, Immunity, 2003",cited-by,10.1016/S1074-7613(03)00081-5,Feedback Regulation of Pathogen-Specific T Cell Priming,"[['Phillip', '', 'Wong'], ['Eric', 'G', 'Pamer']]",Immunity,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1074761303000815', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761303000815']",
10.1038/362758a0,"Selin, L., Vergilis, K., Welsh, R., et. al, Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections, , 1996",cited-by,6333787Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections,Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections,"[['Liisa', 'K.', 'Selin'], ['Kristin', '', 'Vergilis'], ['Raymond', 'M.', 'Welsh'], ['Sharon', 'R.', 'Nahill']]",,1996,"[u'http://jem.rupress.org/cgi/reprint/183/6/2489.pdf', u'http://escholarship.umassmed.edu/gsbs_sp/1091', u'http://jem.rupress.org/cgi/content/abstract/183/6/2489']",
10.1038/362758a0,"Castellino, F., Germain, R., , COOPERATION BETWEEN CD4+ AND CD8+ T CELLS: When, Where, and How, Annual Review of Immunology, 2006",cited-by,10.1146/annurev.immunol.23.021704.115825,"COOPERATION BETWEEN CD4+ AND CD8+ T CELLS: When, Where, and How","[['Flora', '', 'Castellino'], ['Ronald', 'N.', 'Germain']]",Annual Review of Immunology,2006,[u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.immunol.23.021704.115825'],
10.1038/362758a0,"Badovinac, V., Harty, J., , Shaping and reshaping CD8+ T-cell memory, Nature Reviews Immunology, 2008",cited-by,10.1038/nri2251,Shaping and reshaping CD8+ T-cell memory,"[['Vladimir', 'P.', 'Badovinac'], ['John', 'T.', 'Harty']]",Nature Reviews Immunology,2008,"[u'http://dx.doi.org/10.1038/nri2251', u'http://www.nature.com/doifinder/10.1038/nri2251']",
10.1038/362758a0,"Bruno, L., Kirberg, J., Boehmer, H., , On the cellular basis of immunological T cell memory, Immunity, 1995",cited-by,10.1016/1074-7613(95)90077-2,On the cellular basis of immunological T cell memory,"[['Ludovica', '', 'Bruno'], ['J\xc3\xb6rg', '', 'Kirberg'], ['Harald', 'von', 'Boehmer']]",Immunity,1995,"[u'http://www.sciencedirect.com/science/article/pii/1074761395900772', u'http://linkinghub.elsevier.com/retrieve/pii/1074761395900772']",
10.1038/362758a0,"McNally, J., Zarozinski, C., LIN, M., et. al, Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses, Journal of Virology, 2001",cited-by,10.1128/JVI.75.13.5965-5976.2001,Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses,"[['James', 'M.', 'McNally'], ['Christopher', 'C.', 'Zarozinski'], ['MEEI-YUN', '', 'LIN'], ['Michael', 'A.', 'Brehm'], ['Hong', 'D.', 'Chen'], ['Raymond', 'M.', 'Welsh']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/13/5965.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.13.5965-5976.2001', u'http://escholarship.umassmed.edu/gsbs_sp/839', u'http://dx.doi.org/10.1128/JVI.75.13.5965-5976.2001']",
10.1038/362758a0,"Doherty, P., Topham, D., Tripp, R., , Establishment and Persistence of Virus-Specific CD4+ and CD8+ T Cell Memory, Immunological Reviews, 1996",cited-by,10.1111/j.1600-065X.1996.tb00694.x,Establishment and Persistence of Virus-Specific CD4+ and CD8+ T Cell Memory,"[['Peter', 'C.', 'Doherty'], ['David', 'J.', 'Topham'], ['Ralph', 'A.', 'Tripp']]",Immunological Reviews,1996,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1996.tb00694.x'],
10.1038/362758a0,"Most, R., Murali-Krishna, K., Whitton, J., et. al, Identification of D b- and K b-Restricted Subdominant Cytotoxic T-Cell Responses in Lymphocytic Choriomeningitis Virus-Infected Mice, Virology, 1998",cited-by,10.1006/viro.1997.8934,Identification of D b- and K b-Restricted Subdominant Cytotoxic T-Cell Responses in Lymphocytic Choriomeningitis Virus-Infected Mice,"[['Robbert', 'G. van der', 'Most'], ['Kaja', '', 'Murali-Krishna'], ['J.', 'Lindsay', 'Whitton'], ['Carla', '', 'Oseroff'], ['Jeff', '', 'Alexander'], ['Scott', '', 'Southwood'], ['John', '', 'Sidney'], ['Robert', 'W.', 'Chesnut'], ['Alessandro', '', 'Sette'], ['Rafi', '', 'Ahmed']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682297989340', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682297989340']",
10.1038/362758a0,"Lanzavecchia, A., Sallusto, F., , Opinion-decision making in the immune systemProgressive differentiation and selection of the fittest in the immune response, Nature Reviews Immunology, 2002",cited-by,10.1038/nri959,Opinion-decision making in the immune systemProgressive differentiation and selection of the fittest in the immune response,"[['Antonio', '', 'Lanzavecchia'], ['Federica', '', 'Sallusto']]",Nature Reviews Immunology,2002,"[u'http://www.nature.com/doifinder/10.1038/nri959', u'http://dx.doi.org/10.1038/nri959']",
10.1038/362758a0,"Melief, C., Kast, W., , T-Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes, Immunological Reviews, 1995",cited-by,10.1111/j.1600-065X.1995.tb00081.x,T-Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes,"[['Cornelis', 'J. M.', 'Melief'], ['W.', 'Martin', 'Kast']]",Immunological Reviews,1995,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1995.tb00081.x'],
10.1038/362758a0,"Oxenius, A., Zinkernagel, R., Hengartner, H., , Comparison of Activation versus Induction of Unresponsiveness of Virus-Specific CD4 + and CD8 + T Cells upon Acute versus Persistent Viral Infection, Immunity, 1998",cited-by,10.1016/S1074-7613(00)80628-7,Comparison of Activation versus Induction of Unresponsiveness of Virus-Specific CD4 + and CD8 + T Cells upon Acute versus Persistent Viral Infection,"[['Annette', '', 'Oxenius'], ['Rolf', 'M', 'Zinkernagel'], ['Hans', '', 'Hengartner']]",Immunity,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300806287', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300806287']",
10.1038/362758a0,"MARTINS, L., LAU, L., ASANO, M., et. al, DNA vaccination against persistent viral infection, , 1995",cited-by,2979383DNA vaccination against persistent viral infection,DNA vaccination against persistent viral infection,"[['LIVIA', 'PEDROZA', 'MARTINS'], ['LISA', 'L.', 'LAU'], ['MARY', 'S.', 'ASANO'], ['R', '', 'Ahmed']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/4/2574.pdf'],
10.1038/362758a0,"OU, R., ZHOU, S., HUANG, L., et. al, Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells, Journal of Virology, 2001",cited-by,10.1128/JVI.75.18.8407-8423.2001,Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells,"[['RONG', '', 'OU'], ['SHENGHUA', '', 'ZHOU'], ['LEI', '', 'HUANG'], ['DEMETRIUS', '', 'MOSKOPHIDIS']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.18.8407-8423.2001', u'http://jvi.asm.org/cgi/reprint/75/18/8407.pdf']",
10.1038/362758a0,"Hwang, I., Huang, J., Kishimoto, H., et. al, T Cells Can Use Either T Cell Receptor or CD28 Receptors to Absorb and Internalize Cell Surface Molecules Derived from Antigen-presenting Cells, , 0",cited-by,6990519T Cells Can Use Either T Cell Receptor or CD28 Receptors to Absorb and Internalize Cell Surface Molecules Derived from Antigen-presenting Cells,T Cells Can Use Either T Cell Receptor or CD28 Receptors to Absorb and Internalize Cell Surface Molecules Derived from Antigen-presenting Cells,"[['Inkyu', '', 'Hwang'], ['Jing-Feng', '', 'Huang'], ['Hidehiro', '', 'Kishimoto'], ['Anders', '', 'Brunmark'], ['Per', 'A.', 'Peterson'], ['Michael', 'R.', 'Jackson'], ['Charles', 'D.', 'Surh'], ['Zeling', '', 'Cai'], ['Jonathan', '', 'Sprent']]",,0,[u'http://jem.rupress.org/cgi/reprint/191/7/1137.pdf'],
10.1038/362758a0,"Zajac, A., Murali-Krishna, K., Blattman, J., et. al, Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4 + and CD8 + T cells, Current Opinion in Immunology, 1998",cited-by,10.1016/S0952-7915(98)80119-2,Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4 + and CD8 + T cells,"[['Allan', 'J', 'Zajac'], ['Kaja', '', 'Murali-Krishna'], ['Joseph', 'N', 'Blattman'], ['Rafi', '', 'Ahmed']]",Current Opinion in Immunology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0952791598801192', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791598801192']",
10.1038/362758a0,"Aichele, P., Brduscha-Riem, K., Oehen, S., et. al, Peptide Antigen Treatment of Naive and Virus-Immune Mice: Antigen-Specific Tolerance Versus Immunopathology, Immunity, 1997",cited-by,10.1016/S1074-7613(00)80340-4,Peptide Antigen Treatment of Naive and Virus-Immune Mice: Antigen-Specific Tolerance Versus Immunopathology,"[['Peter', '', 'Aichele'], ['Karin', '', 'Brduscha-Riem'], ['Stephan', '', 'Oehen'], ['Bernhard', '', 'Odermatt'], ['Rolf', 'M', 'Zinkernagel'], ['Hans', '', 'Hengartner'], ['Hanspeter', '', 'Pircher']]",Immunity,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300803404', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300803404']",
10.1038/362758a0,"Goldstein, G., , HIV–1 Tat protein as a potential AIDS vaccine, Nature Medicine, 1996",cited-by,10.1038/nm0996-960,HIV–1 Tat protein as a potential AIDS vaccine,"[['Gideon', '', 'Goldstein']]",Nature Medicine,1996,[u'http://www.nature.com/doifinder/10.1038/nm0996-960'],
10.1038/362758a0,"Shin, H., Wherry, E., , CD8 T cell dysfunction during chronic viral infection, Current Opinion in Immunology, 2007",cited-by,10.1016/j.coi.2007.06.004,CD8 T cell dysfunction during chronic viral infection,"[['Haina', '', 'Shin'], ['E', 'John', 'Wherry']]",Current Opinion in Immunology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0952791507001082', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791507001082']",
10.1038/362758a0,"Fuller, M., Zajac, A., , Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1, , 0",cited-by,5555246Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1,Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1,"[['Michael', 'J.', 'Fuller'], ['Allan', 'J.', 'Zajac']]",,0,[u'http://www.jimmunol.org/cgi/reprint/170/1/477.pdf'],
10.1038/362758a0,"LUZURIAGA, K., MCMANUS, M., CATALINA, M., et. al, Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV1) Infection: Control of Viral Replication and Absence of Persistent HIV1Specific Immune Responses, Journal of Virology, 2000",cited-by,10.1128/JVI.74.15.6984-6991.2000,Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV1) Infection: Control of Viral Replication and Absence of Persistent HIV1Specific Immune Responses,"[['KATHERINE', '', 'LUZURIAGA'], ['MARGARET', '', 'MCMANUS'], ['MICHELLE', '', 'CATALINA'], ['SHANE', '', 'MAYACK'], ['MARK', '', 'SHARKEY'], ['MARIO', '', 'STEVENSON']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/15/6984.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.15.6984-6991.2000']",
10.1038/362758a0,"Macpherson, A., Ciurea, A., Freigang, S., et. al, Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections, Nature Immunology, 2003",cited-by,10.1038/ni911,Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections,"[['Andrew', 'J.', 'Macpherson'], ['Adrian', '', 'Ciurea'], ['Stefan', '', 'Freigang'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel'], ['Lukas', '', 'Hunziker'], ['Mike', '', 'Recher']]",Nature Immunology,2003,"[u'http://www.nature.com/doifinder/10.1038/ni911', u'http://dx.doi.org/10.1038/ni911']",
10.1038/362758a0,"Callan, M., Fazou, C., Yang, H., et. al, CD8+ T-cell selection, function, and death in the primary immune response in vivo, Journal of Clinical Investigation, 2000",cited-by,10.1172/JCI10590,"CD8+ T-cell selection, function, and death in the primary immune response in vivo","[['Margaret', 'F. C.', 'Callan'], ['Chrysoula', '', 'Fazou'], ['Hongbing', '', 'Yang'], ['Tim', '', 'Rostron'], ['Kathryn', '', 'Poon'], ['Chris', '', 'Hatton'], ['Andrew', 'J.', 'McMichael']]",Journal of Clinical Investigation,2000,[u'http://www.jci.org/articles/view/10590'],
10.1038/362758a0,"Haring, J., Badovinac, V., Harty, J., , Inflaming the CD8 + T Cell Response, Immunity, 2006",cited-by,10.1016/j.immuni.2006.07.001,Inflaming the CD8 + T Cell Response,"[['Jodie', 'S.', 'Haring'], ['Vladimir', 'P.', 'Badovinac'], ['John', 'T.', 'Harty']]",Immunity,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1074761306003098', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761306003098']",
10.1038/362758a0,"BORROW, P., TOUGH, D., ETO, D., et. al, CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD81 Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection, , 1998",cited-by,11600729CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD81 Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection,CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD81 Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection,"[['PERSEPHONE', '', 'BORROW'], ['DAVID', 'F.', 'TOUGH'], ['DANELLE', '', 'ETO'], ['ANTOINETTE', '', 'TISHON'], ['IQBAL', 'S.', 'GREWAL'], ['JONATHAN', '', 'SPRENT'], ['RICHARD', 'A.', 'FLAVELL'], ['MICHAEL', 'B. A.', 'OLDSTONE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/9/7440.pdf'],
10.1038/362758a0,"MORTARA, L., LETOURNEUR, F., GRAS-MASSE, H., et. al, Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine, , 1998",cited-by,6644646Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine,Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine,"[['LORENZO', '', 'MORTARA'], ['FRANCK', '', 'LETOURNEUR'], ['HELENE', '', 'GRAS-MASSE'], ['ALAIN', '', 'VENET'], ['JEAN-GERARD', '', 'GUILLET'], ['ISABELLE', '', 'BOURGAULT-VILLADA']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/2/1403.pdf'],
10.1038/362758a0,"HASENKRUG, K., BROOKS, D., DITTMER, U., , Critical Role for CD41 T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice, , 1998",cited-by,12032654Critical Role for CD41 T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice,Critical Role for CD41 T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice,"[['KIM', 'J.', 'HASENKRUG'], ['DIANE', 'M.', 'BROOKS'], ['ULF', '', 'DITTMER']]",,1998,[],
10.1038/362758a0,"Recher, M., Junt, T., Hengartner, H., , Inverse correlation between IL7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation, European Journal of Immunology, 2005",cited-by,10.1002/eji.200425828,Inverse correlation between IL7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation,"[['Mike', '', 'Recher'], ['Tobias', '', 'Junt'], ['Hans', '', 'Hengartner']]",European Journal of Immunology,2005,"[u'http://infoscience.epfl.ch/record/143013/files/2005_Inverse%20correlation%20between%20IL-7%20receptor%20expression%20and%20CD8%20T%20cell%20exhaustion%20during%20persistent%20antigen%20stimulation.pdf', u'http://doi.wiley.com/10.1002/eji.200425828']",
10.1038/362758a0,"Seiler, P., Aichele, P., Odermatt, B., et. al, Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection, European Journal of Immunology, 1997",cited-by,10.1002/eji.1830271023,Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection,"[['Peter', '', 'Seiler'], ['Peter', '', 'Aichele'], ['Bernhard', '', 'Odermatt'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel'], ['Reto', 'A.', 'Schwendener']]",European Journal of Immunology,1997,[u'http://doi.wiley.com/10.1002/eji.1830271023'],
10.1038/362758a0,"TOPHAM, D., DOHERTY, P., , Clearance of an Influenza A Virus by CD41 T Cells Is Inefficient in the Absence of B Cells, , 0",cited-by,12343322Clearance of an Influenza A Virus by CD41 T Cells Is Inefficient in the Absence of B Cells,Clearance of an Influenza A Virus by CD41 T Cells Is Inefficient in the Absence of B Cells,"[['DAVID', 'J.', 'TOPHAM'], ['PETER', 'C.', 'DOHERTY']]",,0,[u'http://jvi.asm.org/cgi/reprint/72/1/882.pdf'],
10.1038/362758a0,"Ludewig, B., Junt, T., Hengartner, H., et. al, Dendritic cells in autoimmune diseases, Current Opinion in Immunology, 2001",cited-by,10.1016/S0952-7915(01)00275-8,Dendritic cells in autoimmune diseases,"[['Burkhard', '', 'Ludewig'], ['Tobias', '', 'Junt'], ['Hans', '', 'Hengartner'], ['Rolf', 'M', 'Zinkernagel']]",Current Opinion in Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0952791501002758', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791501002758']",
10.1038/362758a0,"WELSH, R., MARKEES, T., WODA, B., et. al, Virus-Induced Abrogation of Transplantation Tolerance Induced by Donor-Specific Transfusion and Anti-CD154 Antibody, Journal of Virology, 2000",cited-by,10.1128/JVI.74.5.2210-2218.2000,Virus-Induced Abrogation of Transplantation Tolerance Induced by Donor-Specific Transfusion and Anti-CD154 Antibody,"[['RAYMOND', 'M.', 'WELSH'], ['THOMAS', 'G.', 'MARKEES'], ['BRUCE', 'A.', 'WODA'], ['KEITH', 'A.', 'DANIELS'], ['MICHAEL', 'A.', 'BREHM'], ['JOHN', 'P.', 'MORDES'], ['DALE', 'L.', 'GREINER'], ['ALDO', 'A.', 'ROSSINI']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/5/2210.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.5.2210-2218.2000']",
10.1038/362758a0,"Neumann-Haefelin, C., Blum, H., Chisari, F., et. al, T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005",cited-by,10.1016/j.jcv.2004.05.008,T cell response in hepatitis C virus infection,"[['C.', '', 'Neumann-Haefelin'], ['H.', 'E.', 'Blum'], ['F.', 'V.', 'Chisari'], ['R.', '', 'Thimme']]",Journal of Clinical Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S138665320400157X', u'http://linkinghub.elsevier.com/retrieve/pii/S138665320400157X']",
10.1038/362758a0,"Woodland, D., Dutton, R., , Heterogeneity of CD4 + and CD8 + T cells, Current Opinion in Immunology, 2003",cited-by,10.1016/S0952-7915(03)00037-2,Heterogeneity of CD4 + and CD8 + T cells,"[['David', 'L', 'Woodland'], ['Richard', 'W', 'Dutton']]",Current Opinion in Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0952791503000372', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791503000372']",
10.1038/362758a0,"KAGI, D., LEDERMANN, B., BURKI, K., et. al, Lymphocyte-mediated Cytotoxicity in vitro and in vivo: Mechanisms and Significance, Immunological Reviews, 1995",cited-by,10.1111/j.1600-065X.1995.tb00686.x,Lymphocyte-mediated Cytotoxicity in vitro and in vivo: Mechanisms and Significance,"[['DAVID', '', 'KAGI'], ['BIRGIT', '', 'LEDERMANN'], ['KURT', '', 'BURKI'], ['ROL', 'F M.', 'ZINKERNAGEL'], ['HANS', '', 'HENGARTNER']]",Immunological Reviews,1995,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1995.tb00686.x'],
10.1038/362758a0,"Ameisen, J., Estaquier, J., Idziorek, T., , From AIDS to Parasite Infection: Pathogen-Mediated Subversion of Programmed Cell Death as a Mechanism for Immune Dysregulation, Immunological Reviews, 1994",cited-by,10.1111/j.1600-065X.1994.tb00882.x,From AIDS to Parasite Infection: Pathogen-Mediated Subversion of Programmed Cell Death as a Mechanism for Immune Dysregulation,"[['Jean', 'Claude', 'Ameisen'], ['Jerome', '', 'Estaquier'], ['Thierry', '', 'Idziorek']]",Immunological Reviews,1994,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1994.tb00882.x'],
10.1038/362758a0,"Virgin, H., Wherry, E., Ahmed, R., , Redefining Chronic Viral Infection, Cell, 2009",cited-by,10.1016/j.cell.2009.06.036,Redefining Chronic Viral Infection,"[['Herbert', 'W.', 'Virgin'], ['E.', 'John', 'Wherry'], ['Rafi', '', 'Ahmed']]",Cell,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0092867409007831', u'http://linkinghub.elsevier.com/retrieve/pii/S0092867409007831']",
10.1038/362758a0,"Wakefield, A., Ekbom, A., Dhillon, A., et. al, Crohn's disease: Pathogenesis and persistent measles virus infection, Gastroenterology, 1995",cited-by,10.1016/0016-5085(95)90467-0,Crohn's disease: Pathogenesis and persistent measles virus infection,"[['Andrew', 'J.', 'Wakefield'], ['Anders', '', 'Ekbom'], ['Amar', 'P.', 'Dhillon'], ['R.', 'Michael', 'Pittilo'], ['Roy', 'E.', 'Pounder']]",Gastroenterology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0016508595904670', u'http://linkinghub.elsevier.com/retrieve/pii/0016508595904670']",
10.1038/362758a0,"Lin, M., Welsh, R., , Stability and Diversity of T Cell Receptor Repertoire Usage during Lymphocytic Choriomeningitis Virus Infection of Mice, , 0",cited-by,6746706Stability and Diversity of T Cell Receptor Repertoire Usage during Lymphocytic Choriomeningitis Virus Infection of Mice,Stability and Diversity of T Cell Receptor Repertoire Usage during Lymphocytic Choriomeningitis Virus Infection of Mice,"[['Meei', 'Yun', 'Lin'], ['Raymond', 'M.', 'Welsh']]",,0,[],
10.1038/362758a0,"Yi, J., Du, M., Zajac, A., , A Vital Role for Interleukin21 in the Control of a Chronic Viral Infection, Science, 2009",cited-by,10.1126/science.1175194,A Vital Role for Interleukin21 in the Control of a Chronic Viral Infection,"[['J.', 'S.', 'Yi'], ['M.', '', 'Du'], ['A.', 'J.', 'Zajac']]",Science,2009,[u'http://www.sciencemag.org/cgi/doi/10.1126/science.1175194'],
10.1038/362758a0,"Selin, L., Welsh, R., , Plasticity of T Cell Memory Responses to Viruses, Immunity, 2004",cited-by,10.1016/S1074-7613(03)00356-X,Plasticity of T Cell Memory Responses to Viruses,"[['Liisa', 'K', 'Selin'], ['Raymond', 'M', 'Welsh']]",Immunity,2004,"[u'http://www.sciencedirect.com/science/article/pii/S107476130300356X', u'http://linkinghub.elsevier.com/retrieve/pii/S107476130300356X']",
10.1038/362758a0,"Doo, E., Liang, T., , Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection, Gastroenterology, 2001",cited-by,10.1053/gast.2001.22454,Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection,"[['Edward', '', 'Doo'], ['T.', 'Jake', 'Liang']]",Gastroenterology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0016508501839081', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508501839081']",
10.1038/362758a0,"Wodarz, D., Klenerman, P., Nowak, M., , Dynamics of cytotoxic T-lymphocyte exhaustion, Proceedings of The Royal Society B: Biological Sciences, 1998",cited-by,10.1098/rspb.1998.0282,Dynamics of cytotoxic T-lymphocyte exhaustion,"[['Dominik', '', 'Wodarz'], ['Paul', '', 'Klenerman'], ['Martin', 'A.', 'Nowak']]",Proceedings of The Royal Society B: Biological Sciences,1998,"[u'http://www.fas.harvard.edu/~ped/people/faculty/publications_nowak/ProcRoySoc98a.pdf', u'http://rspb.royalsocietypublishing.org/cgi/doi/10.1098/rspb.1998.0282', u'http://journals.royalsociety.org/index/10.1098/rspb.1998.0282']",
10.1038/362758a0,"Bründler, M., Aichele, P., Bachmann, M., et. al, Immunity to viruses in B cell-deficient mice: Influence of antibodies on virus persistence and on T cell memory, European Journal of Immunology, 1996",cited-by,10.1002/eji.1830260943,Immunity to viruses in B cell-deficient mice: Influence of antibodies on virus persistence and on T cell memory,"[['Marie-Anne', '', 'Br\xc3\xbcndler'], ['Peter', '', 'Aichele'], ['Martin', '', 'Bachmann'], ['Daisuke', '', 'Kitamura'], ['Klaus', '', 'Rajewsky'], ['Rolf', 'M.', 'Zinkernagel']]",European Journal of Immunology,1996,[u'http://doi.wiley.com/10.1002/eji.1830260943'],
10.1038/362758a0,"MOSKOPHIDIS, D., ZINKERNAGEL, A., , Immunobiology of Cytotoxic T-Cell Escape Mutants of Lymphocytic Choriomeningitis Virus, , 1995",cited-by,14088504Immunobiology of Cytotoxic T-Cell Escape Mutants of Lymphocytic Choriomeningitis Virus,Immunobiology of Cytotoxic T-Cell Escape Mutants of Lymphocytic Choriomeningitis Virus,"[['DEMETRIUS', '', 'MOSKOPHIDIS'], ['ANDROLF', 'M.', 'ZINKERNAGEL']]",,1995,[u'http://jvi.asm.org/cgi/reprint/69/4/2187.pdf'],
10.1038/362758a0,"STEVENSON, P., DOHERTY, P., , Kinetic Analysis of the Specific Host Response to a Murine Gammaherpesvirus, , 1998",cited-by,6639040Kinetic Analysis of the Specific Host Response to a Murine Gammaherpesvirus,Kinetic Analysis of the Specific Host Response to a Murine Gammaherpesvirus,"[['PHILIP', 'G.', 'STEVENSON'], ['PETER', 'C.', 'DOHERTY']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/2/943.pdf'],
10.1038/362758a0,"Wick, M., Dubey, P., Koeppen, H., et. al, Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy, , 0",cited-by,11203393Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy,Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy,"[['Maresa', '', 'Wick'], ['Purnima', '', 'Dubey'], ['Hartmut', '', 'Koeppen'], ['Christopher', 'T.', 'Siegel'], ['Patrick', 'E.', 'Fields'], ['Lieping', '', 'Chen'], ['Jeffrey', 'A.', 'Bluestone'], ['Hans', '', 'Schreiber']]",,0,[],
10.1038/362758a0,"Kerkau, T., Bacik, I., Bennink, J., et. al, The Human Immunodeficiency Virus Type 1 (HIV1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules, , 2010",cited-by,6918631The Human Immunodeficiency Virus Type 1 (HIV1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules,The Human Immunodeficiency Virus Type 1 (HIV1) Vpu Protein Interferes with an Early Step in the Biosynthesis of Major Histocompatibility Complex (MHC) Class I Molecules,"[['Thomas', '', 'Kerkau'], ['Igor', '', 'Bacik'], ['Jack', 'R.', 'Bennink'], ['Jonathan', 'W.', 'Yewdell'], ['Thomas', '', 'H\xc3\xbcnig'], ['Anneliese', '', 'Schimpl'], ['Ulrich', '', 'Schubert']]",,2010,[],
10.1038/362758a0,"Berzofsky, J., Ahlers, J., Derby, M., et. al, Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections, Immunological Reviews, 1999",cited-by,10.1111/j.1600-065X.1999.tb01336.x,Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections,"[['Jay', 'A.', 'Berzofsky'], ['Jeffrey', 'D.', 'Ahlers'], ['Michael', 'A.', 'Derby'], ['C.', 'David', 'Pendleton'], ['Tatsumi', '', 'Arichi'], ['Igor', 'M.', 'Belyakov']]",Immunological Reviews,1999,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1999.tb01336.x'],
10.1038/362758a0,"Thimme, R., Lohmann, V., Weber, F., , A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2005.12.001,A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus,"[['Robert', '', 'Thimme'], ['Volker', '', 'Lohmann'], ['Friedemann', '', 'Weber']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205002603', u'http://umanitoba.ca/faculties/medicine/units/medical_microbiology/Courses/MicroPath97.705/PDF/Thimme_HCV9_3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205002603']",
10.1038/362758a0,"Zinkernagel, R., Hengartner, H., , Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory', Immunological Reviews, 2006",cited-by,10.1111/j.0105-2896.2006.00402.x,Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory',"[['Rolf', 'M.', 'Zinkernagel'], ['Hans', '', 'Hengartner']]",Immunological Reviews,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.0105-2896.2006.00402.x'],
10.1038/362758a0,"Klein, L., Kyewski, B., , ""Promiscuous"" expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity?, Journal of Molecular Medicine-jmm, 2000",cited-by,10.1007/s001090000146,"""Promiscuous"" expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity?","[['Ludger', '', 'Klein'], ['Bruno', '', 'Kyewski']]",Journal of Molecular Medicine-jmm,2000,"[u'http://www.springerlink.com/content/xbg6bv4q364hyrv5', u'http://www.springerlink.com/index/xbg6bv4q364hyrv5.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s001090000146', u'http://www.springerlink.com/index/pdf/10.1007/s001090000146']",
10.1038/362758a0,"HAY, C., RUHL, D., BASGOZ, N., et. al, Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection, , 1999",cited-by,6803745Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection,Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection,"[['CHRISTINE', 'M.', 'HAY'], ['DEBBIE', 'J.', 'RUHL'], ['NESLI', 'O.', 'BASGOZ'], ['CARA', 'C.', 'WILSON'], ['JAMES', 'M.', 'BILLINGSLEY'], ['MARIA', 'PIA', 'DEPASQUALE'], ['RICHARD', 'T.', ""D'AQUILA""], ['STEVEN', 'M.', 'WOLINSKY'], ['JOHN', 'M.', 'CRAWFORD'], ['DAVID', 'C.', 'MONTEFIORI'], ['BRUCE', 'D.', 'WALKER']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/7/5509.pdf'],
10.1038/362758a0,"Herrath, M., Oldstone, M., , Virus-induced autoimmune disease, Current Opinion in Immunology, 1996",cited-by,10.1016/S0952-7915(96)80019-7,Virus-induced autoimmune disease,"[['Matthias', 'G von', 'Herrath'], ['Michael', 'BA', 'Oldstone']]",Current Opinion in Immunology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S0952791596800197', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791596800197']",
10.1056~NEJMoa011232,"Oxenius A, Zinkernagel RM, Hengartner H. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 1998; 9:449-57.",references,10.1016/S1074-7613(00)80628-7,Comparison of Activation versus Induction of Unresponsiveness of Virus-Specific CD4 + and CD8 + T Cells upon Acute versus Persistent Viral Infection,"[[u'Annette', u'', u'Oxenius'], [u'Rolf', u'M', u'Zinkernagel'], [u'Hans', u'', u'Hengartner']]",Immunity,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1074761300806287', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300806287']","[{u'Name': u'cd4+ t cell', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5073}, {u'Name': u'cd8+ t cell', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5078}, {u'Name': u'Functional Status', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 15407}, {u'Name': u'Viral Infection', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 44236}, {u'Name': u'Lymphocytic Choriomeningitis Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 59594}, {u'Name': u'Persistently Infected', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 65617}, {u'Name': u'Recombinant Vaccinia Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 68239}]"
10.1016/S1074-7613(00)80628-7,"Schwartz, R., , T CELL ANERGY, Annual Review of Immunology, 2003",cited-by,10.1146/annurev.immunol.21.120601.141110,T CELL ANERGY,"[['Ronald', 'H.', 'Schwartz']]",Annual Review of Immunology,2003,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.21.120601.141110'],
10.1016/S1074-7613(00)80628-7,"Darrah, P., Patel, D., Luca, P., et. al, Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major, Nature Medicine, 2007",cited-by,10.1038/nm1592,Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major,"[['Patricia', 'A', 'Darrah'], ['Dipti', 'T', 'Patel'], ['Paula', 'M De', 'Luca'], ['Ross', 'W B', 'Lindsay'], ['Dylan', 'F', 'Davey'], ['Barbara', 'J', 'Flynn'], ['S\xc3\xb8ren', 'T', 'Hoff'], ['Peter', '', 'Andersen'], ['Steven', 'G', 'Reed'], ['Sheldon', 'L', 'Morris'], ['Mario', '', 'Roederer'], ['Robert', 'A', 'Seder']]",Nature Medicine,2007,"[u'http://dx.doi.org/10.1038/nm1592', u'http://www.nature.com/doifinder/10.1038/nm1592']",
10.1016/S1074-7613(00)80628-7,"Ruland, J., Duncan, G., Elia, A., et. al, Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube Closure, Cell, 2001",cited-by,10.1016/S0092-8674(01)00189-1,Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube Closure,"[['J\xc3\xbcrgen', '', 'Ruland'], ['Gordon', 'S', 'Duncan'], ['Andrew', '', 'Elia'], ['Ivan', 'del Barco', 'Barrantes'], ['Linh', '', 'Nguyen'], ['Sue', '', 'Plyte'], ['Douglas', 'G', 'Millar'], ['Denis', '', 'Bouchard'], ['Andrew', '', 'Wakeham'], ['Pamela', 'S', 'Ohashi'], ['Tak', 'W', 'Mak']]",Cell,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0092867401001891', u'http://linkinghub.elsevier.com/retrieve/pii/S0092867401001891']",
10.1016/S1074-7613(00)80628-7,"Biggelaar, A., Ree, R., Rodrigues, L., et. al, Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10, Lancet, 2000",cited-by,10.1016/S0140-6736(00)03206-2,Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10,"[['Anita', 'HJ van den', 'Biggelaar'], ['Ronald', 'van', 'Ree'], ['Laura', 'C', 'Rodrigues'], ['Bertrand', '', 'Lell'], ['Andr\xc3\xa9', 'M', 'Deelder'], ['Peter', 'G', 'Kremsner'], ['Maria', '', 'Yazdanbakhsh']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600032062', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600032062']",
10.1016/S1074-7613(00)80628-7,"Harris, N., Macpherson, A., , Interactions between commensal intestinal bacteria and the immune system, Nature Reviews Immunology, 2004",cited-by,10.1038/nri1373,Interactions between commensal intestinal bacteria and the immune system,"[['Nicola', 'L.', 'Harris'], ['Andrew', 'J.', 'Macpherson']]",Nature Reviews Immunology,2004,"[u'http://dx.doi.org/10.1038/nri1373', u'http://www.nature.com/doifinder/10.1038/nri1373']",
10.1016/S1074-7613(00)80628-7,"Younes, S., Yassine-Diab, B., Dumont, A., et. al, HIV1 Viremia Prevents the Establishment of Interleukin 2-producing HIVspecific Memory CD4 � T Cells Endowed with Proliferative Capacity, , 0",cited-by,10241450HIV1 Viremia Prevents the Establishment of Interleukin 2-producing HIVspecific Memory CD4 � T Cells Endowed with Proliferative Capacity,HIV1 Viremia Prevents the Establishment of Interleukin 2-producing HIVspecific Memory CD4 � T Cells Endowed with Proliferative Capacity,"[['Souheil-Antoine', '', 'Younes'], ['Bader', '', 'Yassine-Diab'], ['Alain', 'R.', 'Dumont'], ['Mohamed-Rachid', '', 'Boulassel'], ['Zvi', '', 'Grossman'], ['Jean-Pierre', '', 'Routy'], ['Rafick-Pierre', '', 'S\xc3\xa9kaly']]",,0,[u'http://jem.rupress.org/cgi/reprint/198/12/1909.pdf'],
10.1016/S1074-7613(00)80628-7,"Zinkernagel, R., , On differences between immunity and immunological memory, Current Opinion in Immunology, 2002",cited-by,10.1016/S0952-7915(02)00367-9,On differences between immunity and immunological memory,"[['Rolf', 'M', 'Zinkernagel']]",Current Opinion in Immunology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0952791502003679', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791502003679']",
10.1016/S1074-7613(00)80628-7,"Selin, L., Lin, M., Kraemer, K., et. al, Attrition of T Cell Memory, Immunity, 1999",cited-by,10.1016/S1074-7613(00)80147-8,Attrition of T Cell Memory,"[['Liisa', 'K.', 'Selin'], ['Meei', 'Y.', 'Lin'], ['Kristy', 'A.', 'Kraemer'], ['Drew', 'M.', 'Pardoll'], ['Jonathan', 'P.', 'Schneck'], ['Steven', 'M.', 'Varga'], ['Paul', 'A.', 'Santolucito'], ['Amelia', 'K.', 'Pinto'], ['Raymond', 'M.', 'Welsh']]",Immunity,1999,"[u'http://www.pathology2.jhu.edu/schnecklab/pdf/ref_34.pdf', u'http://www.sciencedirect.com/science/article/pii/S1074761300801478', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761300801478']",
10.1016/S1074-7613(00)80628-7,"OU, R., ZHOU, S., HUANG, L., et. al, Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells, Journal of Virology, 2001",cited-by,10.1128/JVI.75.18.8407-8423.2001,Critical Role for Alpha/Beta and Gamma Interferons in Persistence of Lymphocytic Choriomeningitis Virus by Clonal Exhaustion of Cytotoxic T Cells,"[['RONG', '', 'OU'], ['SHENGHUA', '', 'ZHOU'], ['LEI', '', 'HUANG'], ['DEMETRIUS', '', 'MOSKOPHIDIS']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.18.8407-8423.2001', u'http://jvi.asm.org/cgi/reprint/75/18/8407.pdf']",
10.1016/S1074-7613(00)80628-7,"Fuller, M., Zajac, A., , Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1, , 0",cited-by,5555246Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1,Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1,"[['Michael', 'J.', 'Fuller'], ['Allan', 'J.', 'Zajac']]",,0,[u'http://www.jimmunol.org/cgi/reprint/170/1/477.pdf'],
10.1016/S1074-7613(00)80628-7,"Lauer, G., Nguyen, T., Day, C., et. al, Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses, Journal of Virology, 2002",cited-by,10.1128/JVI.76.6.2817-2826.2002,Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses,"[['Georg', 'M.', 'Lauer'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Theresa', '', 'Flynn'], ['Katherine', '', 'McGowan'], ['Eric', 'S.', 'Rosenberg'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Lemuel', '', 'Shattuck']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.6.2817-2826.2002', u'http://jvi.asm.org/cgi/reprint/76/6/2817.pdf']",
10.1016/S1074-7613(00)80628-7,"Yi, J., Du, M., Zajac, A., , A Vital Role for Interleukin21 in the Control of a Chronic Viral Infection, Science, 2009",cited-by,10.1126/science.1175194,A Vital Role for Interleukin21 in the Control of a Chronic Viral Infection,"[['J.', 'S.', 'Yi'], ['M.', '', 'Du'], ['A.', 'J.', 'Zajac']]",Science,2009,[u'http://www.sciencemag.org/cgi/doi/10.1126/science.1175194'],
10.1016/S1074-7613(00)80628-7,"Kopf, M., Coyle, A., Schmitz, N., et. al, Inducible Costimulator Protein (ICOS) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection, , 0",cited-by,11493766Inducible Costimulator Protein (ICOS) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection,Inducible Costimulator Protein (ICOS) Controls T Helper Cell Subset Polarization after Virus and Parasite Infection,"[['Manfred', '', 'Kopf'], ['Anthony', 'J.', 'Coyle'], ['Nicole', '', 'Schmitz'], ['Marijke', '', 'Barner'], ['Annette', '', 'Oxenius'], ['Awen', '', 'Gallimore'], ['Jose-Carlos', '', 'Gutierrez-Ramos'], ['Martin', 'F.', 'Bachmann']]",,0,[u'http://jem.rupress.org/cgi/reprint/192/1/53.pdf'],
10.1016/S1074-7613(00)80628-7,"Maizels, R., Holland, M., Falcone, F., et. al, Vaccination against helminth parasites - the ultimate challenge for vaccinologists?, Immunological Reviews, 1999",cited-by,10.1111/j.1600-065X.1999.tb01345.x,Vaccination against helminth parasites - the ultimate challenge for vaccinologists?,"[['Rick', 'M.', 'Maizels'], ['Martin', 'J.', 'Holland'], ['Franco', 'H.', 'Falcone'], ['Xing-Xing', '', 'Zang'], ['Maria', '', 'Yazdanbakhsh']]",Immunological Reviews,1999,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1999.tb01345.x'],
10.1016/S1074-7613(00)80628-7,"Brooks, D., Teyton, L., Oldstone, M., et. al, Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.16.10514-10527.2005,Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection,"[['David', 'G.', 'Brooks'], ['Luc', '', 'Teyton'], ['Michael', 'B. A.', 'Oldstone'], ['Dorian', 'B.', 'McGavern']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/16/10514.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.16.10514-10527.2005']",
10.1016/S1074-7613(00)80628-7,"Zhou, S., Ou, R., Huang, L., et. al, Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3578-3600.2004,Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection,"[['Shenghua', '', 'Zhou'], ['Rong', '', 'Ou'], ['Lei', '', 'Huang'], ['Graeme', 'E.', 'Price'], ['Demetrius', '', 'Moskophidis']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3578.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3578-3600.2004']",
10.1016/S1074-7613(00)80628-7,"Demotte, N., Stroobant, V., Courtoy, P., et. al, Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes, Immunity, 2008",cited-by,10.1016/j.immuni.2008.01.011,Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes,"[['Nathalie', '', 'Demotte'], ['Vincent', '', 'Stroobant'], ['Pierre', 'J.', 'Courtoy'], ['Patrick', 'Van Der', 'Smissen'], ['Didier', '', 'Colau'], ['Immanuel', 'F.', 'Luescher'], ['Claire', '', 'Hivroz'], ['Julie', '', 'Nicaise'], ['Jean-Luc', '', 'Squifflet'], ['Michel', '', 'Mourad'], ['Dani\xc3\xa8le', '', 'Godelaine'], ['Thierry', '', 'Boon'], ['Pierre', 'van der', 'Bruggen']]",Immunity,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1074761308000708', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761308000708']",
10.1016/S1074-7613(00)80628-7,"Engelhard, V., Brickner, A., Zarling, A., , Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire, Molecular Immunology, 2002",cited-by,10.1016/S0161-5890(02)00096-2,Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire,"[['Victor', 'H.', 'Engelhard'], ['Anthony', 'G.', 'Brickner'], ['Angela', 'L.', 'Zarling']]",Molecular Immunology,2002,"[u'http://www.icb.ufmg.br/biq/lbcd/prodabi5/grupos/hugo_deise_liza/pagina/mhc19.pdf', u'http://www.sciencedirect.com/science/article/pii/S0161589002000962', u'http://linkinghub.elsevier.com/retrieve/pii/S0161589002000962']",
10.1016/S1074-7613(00)80628-7,"Lee, I., Li, W., Hisert, K., et. al, Inhibition of Interleukin 2 Signaling and Signal Transducer and Activator of Transcription (STAT)5 Activation during T Cell Receptor-mediated Feedback Inhibition of T Cell Expansion, , 2010",cited-by,7025109Inhibition of Interleukin 2 Signaling and Signal Transducer and Activator of Transcription (STAT)5 Activation during T Cell Receptor-mediated Feedback Inhibition of T Cell Expansion,Inhibition of Interleukin 2 Signaling and Signal Transducer and Activator of Transcription (STAT)5 Activation during T Cell Receptor-mediated Feedback Inhibition of T Cell Expansion,"[['In-Hong', '', 'Lee'], ['Wai', 'Ping', 'Li'], ['Katherine', 'B.', 'Hisert'], ['Lionel', 'B.', 'Ivashkiv']]",,2010,[u'http://jem.rupress.org/cgi/reprint/190/9/1263.pdf'],
10.1016/S1074-7613(00)80628-7,"VARGA, S., WELSH, R., , High Frequency of Virus-Specific Interleukin2-Producing CD4+ T Cells and Th1 Dominance during Lymphocytic Choriomeningitis Virus Infection, Journal of Virology, 2000",cited-by,10.1128/JVI.74.9.4429-4432.2000,High Frequency of Virus-Specific Interleukin2-Producing CD4+ T Cells and Th1 Dominance during Lymphocytic Choriomeningitis Virus Infection,"[['STEVEN', 'M.', 'VARGA'], ['RAYMOND', 'M.', 'WELSH']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/9/4429.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.9.4429-4432.2000']",
10.1016/S1074-7613(00)80628-7,"HARING, J., PEWE, L., PERLMAN, S., , High-Magnitude, Virus-Specific CD4 T-Cell Response in the Central Nervous System of Coronavirus-Infected Mice, Journal of Virology, 2001",cited-by,10.1128/JVI.75.6.3043-3047.2001,"High-Magnitude, Virus-Specific CD4 T-Cell Response in the Central Nervous System of Coronavirus-Infected Mice","[['JODIE', 'S.', 'HARING'], ['LECIA', 'L.', 'PEWE'], ['STANLEY', '', 'PERLMAN']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/6/3043.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.6.3043-3047.2001']",
10.1016/S1074-7613(00)80628-7,"Welsh, R., McNally, J., , Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections, Current Opinion in Microbiology, 1999",cited-by,10.1016/S1369-5274(99)80067-8,"Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections","[['Raymond', 'M', 'Welsh'], ['James', 'M', 'McNally']]",Current Opinion in Microbiology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1369527499800678', u'http://linkinghub.elsevier.com/retrieve/pii/S1369527499800678']",
10.1016/S1074-7613(00)80628-7,"Hunziker, L., Klenerman, P., Ehl, S., , Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells, European Journal of Immunology, 2002",cited-by,10.1002/1521-4141(200202)32:2<374::AID-IMMU374>3.0.CO;2-9,Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells,"[['Lukas', '', 'Hunziker'], ['Paul', '', 'Klenerman'], ['Stephan', '', 'Ehl']]",European Journal of Immunology,2002,[u'http://doi.wiley.com/10.1002/1521-4141%28200202%2932%3A2%3C374%3A%3AAID-IMMU374%3E3.0.CO%3B2-9'],
10.1016/S1074-7613(00)80628-7,"Zinkernagel, R., Planz, O., Ehl, S., et. al, General and specific immunosuppression caused by antiviral T-cell responses, Immunological Reviews, 1999",cited-by,10.1111/j.1600-065X.1999.tb01300.x,General and specific immunosuppression caused by antiviral T-cell responses,"[['Rolf', 'M.', 'Zinkernagel'], ['Oliver', '', 'Planz'], ['Stephan', '', 'Ehl'], ['Manuel', '', 'Battegay'], ['Bernhard', '', 'Odermatt'], ['Paul', '', 'Klenerman'], ['Hans', '', 'Hengartner']]",Immunological Reviews,1999,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1999.tb01300.x'],
10.1016/S1074-7613(00)80628-7,"Christen, U., Benke, D., Wolfe, T., et. al, Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP10 gradient, Journal of Clinical Investigation, 2004",cited-by,10.1172/JCI17005,Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP10 gradient,"[['Urs', '', 'Christen'], ['Dirk', '', 'Benke'], ['Tom', '', 'Wolfe'], ['Evelyn', '', 'Rodrigo'], ['Antje', '', 'Rhode'], ['Anna', 'C.', 'Hughes'], ['Michael', 'B. A.', 'Oldstone'], ['Matthias', 'G. von', 'Herrath']]",Journal of Clinical Investigation,2004,[u'http://www.jci.org/articles/view/17005'],
10.1016/S1074-7613(00)80628-7,"Agnellini, P., Wolint, P., Rehr, M., et. al, Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection, Proceedings of The National Academy of Sciences, 2007",cited-by,10.1073/pnas.0610335104,Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection,"[['P.', '', 'Agnellini'], ['P.', '', 'Wolint'], ['M.', '', 'Rehr'], ['J.', '', 'Cahenzli'], ['U.', '', 'Karrer'], ['A.', '', 'Oxenius']]",Proceedings of The National Academy of Sciences,2007,"[u'http://www.pnas.org/cgi/doi/10.1073/pnas.0610335104', u'http://adsabs.harvard.edu/abs/2007PNAS..104.4565A']",
10.1016/S1074-7613(00)80628-7,"Acha-Orbea, H., Finke, D., Attinger, A., et. al, Interplays between mouse mammary tumor virus and the cellular and humoral immune response, Immunological Reviews, 1999",cited-by,10.1111/j.1600-065X.1999.tb01299.x,Interplays between mouse mammary tumor virus and the cellular and humoral immune response,"[['Hans', '', 'Acha-Orbea'], ['Daniela', '', 'Finke'], ['Antoine', '', 'Attinger'], ['Sandie', '', 'Schmid'], ['Nathalie', '', 'Wehrli'], ['Sonia', '', 'Vacheron'], ['Ioannls', '', 'Xenarios'], ['Leonardo', '', 'Scarpellino'], ['Kai-Michael', '', 'Toellner'], ['Ian', 'C. M.', 'MacLennan'], ['Sanjiv', 'A.', 'Luther']]",Immunological Reviews,1999,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-065X.1999.tb01299.x'],
10.1016/S1074-7613(00)80628-7,"Migueles, S., Connors, M., , The role of CD4 + and CD8 + T cells in controlling HIV infection, Current Infectious Disease Reports, 2002",cited-by,10.1007/s11908-002-0014-2,The role of CD4 + and CD8 + T cells in controlling HIV infection,"[['Stephen', 'A.', 'Migueles'], ['Mark', '', 'Connors']]",Current Infectious Disease Reports,2002,"[u'http://www.springerlink.com/index/r84472t048w34467.pdf', u'http://www.springerlink.com/content/r84472t048w34467', u'http://www.springerlink.com/index/10.1007/s11908-002-0014-2', u'http://www.springerlink.com/index/pdf/10.1007/s11908-002-0014-2']",
10.1016/S1074-7613(00)80628-7,"Soudeyns, H., Campi, G., Rizzardi, G., et. al, Initiation of antiretroviral therapy during primary HIV1 infection induces rapid stabilization of the T-cell receptor b chain repertoire and reduces the level of T-cell oligoclonality, , 2000",cited-by,6697314Initiation of antiretroviral therapy during primary HIV1 infection induces rapid stabilization of the T-cell receptor b chain repertoire and reduces the level of T-cell oligoclonality,Initiation of antiretroviral therapy during primary HIV1 infection induces rapid stabilization of the T-cell receptor b chain repertoire and reduces the level of T-cell oligoclonality,"[['Hugo', '', 'Soudeyns'], ['Gabriele', '', 'Campi'], ['G.', 'Paolo', 'Rizzardi'], ['Caterina', '', 'Lenge'], ['James', 'F.', 'Demarest'], ['Giuseppe', '', 'Tambussi'], ['Adriano', '', 'Lazzarin'], ['Daniel', '', 'Kaufmann'], ['Giulia', '', 'Casorati'], ['Lawrence', '', 'Corey'], ['Giuseppe', '', 'Pantaleo']]",,2000,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/95/5/1743.pdf'],
10.1016/S1074-7613(00)80628-7,"Crotzer, V., Christian, R., Brooks, J., et. al, Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines1, , 0",cited-by,11526111Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines1,Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines1,"[['Victoria', 'L.', 'Crotzer'], ['Robert', 'E.', 'Christian'], ['Jill', 'M.', 'Brooks'], ['Jeffrey', '', 'Shabanowitz'], ['Robert', 'E.', 'Settlage'], ['Jarrod', 'A.', 'Marto'], ['M.', '', 'White'], ['Alan', 'B.', 'Rickinson'], ['Donald', 'F.', 'Hunt'], ['Victor', 'H.', 'Engelhard']]",,0,"[u'http://www.jimmunol.org/cgi/reprint/164/12/6120.pdf', u'http://jimmunol.highwire.org/cgi/reprint/164/12/6120.pdf']",
10.1016/S1074-7613(00)80628-7,"SESTER, M., SESTER, U., GARTNER, B., et. al, Dominance of Virus-Specific CD8 T Cells in Human Primary Cytomegalovirus Infection, , 0",cited-by,12376801Dominance of Virus-Specific CD8 T Cells in Human Primary Cytomegalovirus Infection,Dominance of Virus-Specific CD8 T Cells in Human Primary Cytomegalovirus Infection,"[['MARTINA', '', 'SESTER'], ['URBAN', '', 'SESTER'], ['BARBARA', 'C.', 'GARTNER'], ['MATTHIAS', '', 'GIRNDT'], ['ANDREAS', '', 'MEYERHANS'], ['HANS', '', 'KOHLER']]",,0,[u'http://www.uniklinik-saarland.de/mediadb/Uniklinik_Homburg/Kliniken/Nephrologie/PDFs/Sester-M._2002_J.-Am.-Soc.-Nephrol.pdf'],
10.1016/S1074-7613(00)80628-7,"Lucas, M., Karrer, U., Lucas, A., et. al, Viral escape mechanisms - escapology taught by viruses, International Journal of Experimental Pathology, 2001",cited-by,10.1046/j.1365-2613.2001.00204.x,Viral escape mechanisms - escapology taught by viruses,"[['Michaela', '', 'Lucas'], ['URS', '', 'Karrer'], ['Andrew', '', 'Lucas'], ['Paul', '', 'Klenerman']]",International Journal of Experimental Pathology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2613.2001.00204.x'],
10.1016/S1074-7613(00)80628-7,"Maloy, K., Burkhart, C., Junt, T., et. al, CD4 1 T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability, , 0",cited-by,11426999CD4 1 T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability,CD4 1 T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability,"[['Kevin', 'J.', 'Maloy'], ['Christoph', '', 'Burkhart'], ['Tobias', 'M.', 'Junt'], ['Bernhard', '', 'Odermatt'], ['Annette', '', 'Oxenius'], ['Luca', '', 'Piali'], ['Rolf', 'M.', 'Zinkernagel'], ['Hans', '', 'Hengartner']]",,0,[u'http://jem.rupress.org/cgi/reprint/191/12/2159.pdf'],
10.1016/S1074-7613(00)80628-7,"Yi, J., Cox, M., Zajac, A., , T-cell exhaustion: characteristics, causes and conversion, Immunology, 2010",cited-by,10.1111/j.1365-2567.2010.03255.x,"T-cell exhaustion: characteristics, causes and conversion","[['John', 'S.', 'Yi'], ['Maureen', 'A.', 'Cox'], ['Allan', 'J.', 'Zajac']]",Immunology,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2567.2010.03255.x'],
10.1016/S1074-7613(00)80628-7,"Jaye, A., Herberts, C., Jallow, S., et. al, Vigorous but Short-Term Gamma Interferon T-Cell Responses against a Dominant HLA-A*02Restricted Measles Virus Epitope in Patients with Measles, Journal of Virology, 2003",cited-by,10.1128/JVI.77.8.5014-5016.2003,Vigorous but Short-Term Gamma Interferon T-Cell Responses against a Dominant HLA-A*02Restricted Measles Virus Epitope in Patients with Measles,"[['Assan', '', 'Jaye'], ['Carla', 'A.', 'Herberts'], ['Sabelle', '', 'Jallow'], ['Sowsan', '', 'Atabani'], ['Michel', 'R.', 'Klein'], ['Peter', '', 'Hoogerhout'], ['Michael', '', 'Kidd'], ['Cecile', 'A. C. M. van', 'Els'], ['Hilton', 'C.', 'Whittle']]",Journal of Virology,2003,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.8.5014-5016.2003'],
10.1016/S1074-7613(00)80628-7,"Anderson, D., Carlos, M., Nguyen, L., et. al, Overcoming Original (Antigenic) Sin, Clinical Immunology, 2001",cited-by,10.1006/clim.2001.5114,Overcoming Original (Antigenic) Sin,"[['David', 'E.', 'Anderson'], ['Maria', 'P.', 'Carlos'], ['Lynn', '', 'Nguyen'], ['Jos\xc3\xa9', 'V.', 'Torres']]",Clinical Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1521661601951149', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661601951149']",
10.1016/S1074-7613(00)80628-7,"Martinic, M., Herrath, M., , Novel strategies to eliminate persistent viral infections, Trends in Immunology, 2008",cited-by,10.1016/j.it.2007.12.002,Novel strategies to eliminate persistent viral infections,"[['Marianne', 'M.', 'Martinic'], ['Matthias', 'G. von', 'Herrath']]",Trends in Immunology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1471490608000045', u'http://linkinghub.elsevier.com/retrieve/pii/S1471490608000045']",
10.1016/S1074-7613(00)80628-7,"Mallone, R., Nepom, G., , Targeting T Lymphocytes for Immune Monitoring and Intervention in Autoimmune Diabetes, American Journal of Therapeutics, 2005",cited-by,10.1097/01.mjt.0000178772.54396.38,Targeting T Lymphocytes for Immune Monitoring and Intervention in Autoimmune Diabetes,"[['Roberto', '', 'Mallone'], ['Gerald', 'T.', 'Nepom']]",American Journal of Therapeutics,2005,"[u'http://www.hal.inserm.fr/docs/00/26/65/45/PDF/inserm-00266545_edited.pdf', u'http://hal.archives-ouvertes.fr/docs/00/26/65/45/PDF/inserm-00266545_edited.pdf', u'http://www.hal.inserm.fr/docs/00/26/65/45/PDF/HAL-AmJTherapeutics-final.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00045391-200511000-00010']",
10.1016/S1074-7613(00)80628-7,"Zaunders, J., Munier, M., Kaufmann, D., et. al, Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV1 infection, , 2005",cited-by,13920993Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV1 infection,Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV1 infection,"[['John', 'J.', 'Zaunders'], ['Mee', 'Ling', 'Munier'], ['Daniel', 'E.', 'Kaufmann'], ['Susanna', '', 'Ip'], ['Pat', '', 'Grey'], ['Don', '', 'Smith'], ['Tim', '', 'Ramacciotti'], ['Dick', '', 'Quan'], ['Robert', '', 'Finlayson'], ['John', '', 'Kaldor'], ['Eric', 'S.', 'Rosenberg'], ['Bruce', 'D.', 'Walker'], ['David', 'A.', 'Cooper'], ['Anthony', 'D.', 'Kelleher']]",,2005,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/106/5/1660.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2005-01-0206v1.pdf']",
10.1016/S1074-7613(00)80628-7,"Falk, K., Rötzschke, O., Strominger, J., , Antigen-specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306-318, European Journal of Immunology, 2000",cited-by,10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q,Antigen-specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306-318,"[['Kirsten', '', 'Falk'], ['Olaf', '', 'R\xc3\xb6tzschke'], ['Jack', 'L.', 'Strominger']]",European Journal of Immunology,2000,[u'http://doi.wiley.com/10.1002/1521-4141%28200010%2930%3A10%3C3012%3A%3AAID-IMMU3012%3E3.0.CO%3B2-Q'],
10.1016/S1074-7613(00)80628-7,"Frebel, H., Richter, K., Oxenius, A., , How chronic viral infections impact on antigen-specific T-cell responses, European Journal of Immunology, 2010",cited-by,10.1002/eji.200940102,How chronic viral infections impact on antigen-specific T-cell responses,"[['Helge', '', 'Frebel'], ['Kirsten', '', 'Richter'], ['Annette', '', 'Oxenius']]",European Journal of Immunology,2010,[u'http://doi.wiley.com/10.1002/eji.200940102'],
10.1016/S1074-7613(00)80628-7,"Herrath, M., Coon, B., Wolfe, T., , Tolerance Induction with Agonist Peptides Recognized by Autoaggressive Lymphocytes is Transient: Therapeutic Potential for Type 1 Diabetes is Limited and Depends on Time-point of Administration, Choice of Epitope and Adjuvant, Journal of Autoimmunity, 2001",cited-by,10.1006/jaut.2000.0497,"Tolerance Induction with Agonist Peptides Recognized by Autoaggressive Lymphocytes is Transient: Therapeutic Potential for Type 1 Diabetes is Limited and Depends on Time-point of Administration, Choice of Epitope and Adjuvant","[['Matthias', 'G von', 'Herrath'], ['Bryan', '', 'Coon'], ['Tom', '', 'Wolfe']]",Journal of Autoimmunity,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0896841100904979', u'http://linkinghub.elsevier.com/retrieve/pii/S0896841100904979']",
10.1016/S1074-7613(00)80628-7,"Lin, M., Selin, L., Welsh, R., , Evolution of the CD8 T-cell repertoire during infections 1 1 Address for correspondence: Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA, Microbes and Infection, 2000",cited-by,10.1016/S1286-4579(00)01257-0,"Evolution of the CD8 T-cell repertoire during infections 1 1 Address for correspondence: Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA","[['Meei', 'Y', 'Lin'], ['Liisa', 'K', 'Selin'], ['Raymond', 'M', 'Welsh']]",Microbes and Infection,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1286457900012570', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457900012570']",
10.1016/S1074-7613(00)80628-7,"Hunziker, L., Recher, M., Ciurea, A., et. al, Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology, , 2002",cited-by,6959990Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology,Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology,"[['Lukas', '', 'Hunziker'], ['Mike', '', 'Recher'], ['Adrian', '', 'Ciurea'], ['Marianne', 'M. A.', 'Martinic'], ['Bernhard', '', 'Odermatt'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel']]",,2002,[u'http://jem.rupress.org/cgi/reprint/196/8/1039.pdf'],
10.1016/S1074-7613(00)80628-7,"Mothe, B., Stewart, B., Oseroff, C., et. al, Chronic Lymphocytic Choriomeningitis Virus Infection Actively Down-Regulates CD4 T Cell Responses Directed against a Broad Range of Epitopes1, , 0",cited-by,11300516Chronic Lymphocytic Choriomeningitis Virus Infection Actively Down-Regulates CD4 T Cell Responses Directed against a Broad Range of Epitopes1,Chronic Lymphocytic Choriomeningitis Virus Infection Actively Down-Regulates CD4 T Cell Responses Directed against a Broad Range of Epitopes1,"[['Bianca', 'R.', 'Mothe'], ['Barbara', 'S.', 'Stewart'], ['Carla', '', 'Oseroff'], ['Huynh-Hoa', '', 'Bui'], ['Stephanie', '', 'Stogiera'], ['Zacarias', '', 'Garcia'], ['Courtney', '', 'Dow'], ['Maria', 'Pilar', 'Rodriguez-Carreno'], ['Maya', '', 'Kotturi'], ['Valerie', '', 'Pasquetto'], ['Jason', '', 'Botten'], ['Shane', '', 'Crotty'], ['Edith', '', 'Janssen'], ['Michael', 'J.', 'Buchmeier'], ['Alessandro', '', 'Sette']]",,0,[],
10.1016/S1074-7613(00)80628-7,"Villacres, M., Literat, O., Degiacomo, M., et. al, Reduced Type 1 and Type 2 Cytokines in Antiviral Memory T Helper Function Among Women Coinfected with HIV and HCV, Journal of Clinical Immunology, 2005",cited-by,10.1007/s10875-005-2819-x,Reduced Type 1 and Type 2 Cytokines in Antiviral Memory T Helper Function Among Women Coinfected with HIV and HCV,"[['Maria', 'C.', 'Villacres'], ['Oana', '', 'Literat'], ['Marina', '', 'Degiacomo'], ['Wenbo', '', 'Du'], ['Corinna', 'La', 'Rosa'], ['Don', 'J.', 'Diamond'], ['Andrea', '', 'Kovacs']]",Journal of Clinical Immunology,2005,"[u'http://www.springerlink.com/index/g63n321321h4rtk1.pdf', u'http://www.springerlink.com/content/g63n321321h4rtk1', u'http://www.springerlink.com/index/10.1007/s10875-005-2819-x', u'http://www.springerlink.com/index/pdf/10.1007/s10875-005-2819-x']",
10.1016/S1074-7613(00)80628-7,"Herberts, C., Meiring, H., Brink, J., et. al, Dynamics of measles virus protein expression are reflected in the MHC class I epitope display, Molecular Immunology, 2003",cited-by,10.1016/S0161-5890(02)00204-3,Dynamics of measles virus protein expression are reflected in the MHC class I epitope display,"[['Carla', 'A', 'Herberts'], ['Hugo', 'M', 'Meiring'], ['Jacqueline', 'A. M van Gaans-van den', 'Brink'], ['Ed', 'van der', 'Heeft'], ['Martien', 'C. M', 'Poelen'], ['Claire', 'J. P', 'Boog'], ['Ad', 'P. J. M de', 'Jong'], ['C\xc3\xa9cile', 'A. C. M van', 'Els']]",Molecular Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0161589002002043', u'http://linkinghub.elsevier.com/retrieve/pii/S0161589002002043']",
10.1016/S1074-7613(00)80628-7,"Sakai, K., Gatanaga, H., Takata, H., et. al, Comparison of CD4 + T-cell subset distribution in chronically infected HIV + patients with various CD4 nadir counts, Microbes and Infection, 2010",cited-by,10.1016/j.micinf.2010.01.013,Comparison of CD4 + T-cell subset distribution in chronically infected HIV + patients with various CD4 nadir counts,"[['Keiko', '', 'Sakai'], ['Hiroyuki', '', 'Gatanaga'], ['Hiroshi', '', 'Takata'], ['Shinichi', '', 'Oka'], ['Masafumi', '', 'Takiguchi']]",Microbes and Infection,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1286457910000316', u'http://linkinghub.elsevier.com/retrieve/pii/S1286457910000316']",
10.1016/S1074-7613(00)80628-7,"Higgins, A., Mihalyo, M., McGary, P., et. al, CD4 Cell Priming and Tolerization Are Differentially Programmed by APCs upon Initial Engagement1, , 0",cited-by,11300419CD4 Cell Priming and Tolerization Are Differentially Programmed by APCs upon Initial Engagement1,CD4 Cell Priming and Tolerization Are Differentially Programmed by APCs upon Initial Engagement1,"[['Amy', 'D.', 'Higgins'], ['Marianne', 'A.', 'Mihalyo'], ['Patrick', 'W.', 'McGary'], ['Adam', 'J.', 'Adler']]",,0,[u'http://www.jimmunol.org/cgi/reprint/168/11/5573.pdf'],
10.1016/S1074-7613(00)80628-7,"Cox, M., Zajac, A., , Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection, Journal of Biomedicine and Biotechnology, 2010",cited-by,10.1155/2010/159152,Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection,"[['Maureen', 'A.', 'Cox'], ['Allan', 'J.', 'Zajac']]",Journal of Biomedicine and Biotechnology,2010,"[u'http://www.hindawi.com/journals/jbb/2010/159152.html', u'http://downloads.hindawi.com/journals/jbb/2010/159152.pdf']",
10.1016/S1074-7613(00)80628-7,"Zhou, S., Kurt, J., Cerny, A., et. al, MyD88 intrinsically regulates CD4 T-cell responses, Journal of Virology, 2009",cited-by,10.1128/JVI.01770-08,MyD88 intrinsically regulates CD4 T-cell responses,"[['Shenghua', '', 'Zhou'], ['Jones', 'E', 'Kurt'], ['Anna', 'M.', 'Cerny'], ['Melvin', '', 'Chan'], ['Roderick', 'Terry', 'Bronson'], ['Robert', 'W.', 'Finberg']]",Journal of Virology,2009,"[u'http://jvi.asm.org/cgi/reprint/83/4/1625.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01770-08', u'http://mouseion.jax.org/stfb2000_2009/1920', u'http://jvi.asm.org/cgi/content/abstract/83/4/1625']",
10.1016/S1074-7613(00)80628-7,"Singh, A., Wuthrich, M., Klein, B., et. al, Indirect Regulation of CD4 T-Cell Responses by Tumor Necrosis Factor Receptors in an Acute Viral Infection, Journal of Virology, 2007",cited-by,10.1128/JVI.00163-07,Indirect Regulation of CD4 T-Cell Responses by Tumor Necrosis Factor Receptors in an Acute Viral Infection,"[['Anju', '', 'Singh'], ['Marcel', '', 'Wuthrich'], ['Bruce', '', 'Klein'], ['M.', '', 'Suresh']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/12/6502.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00163-07']",
10.1016/S1074-7613(00)80628-7,"Izuma, M., Kobayashi, K., Shiina, M., et. al, In vitro cytokine production of peripheral blood mononuclear cells in response to HCV core antigen stimulation during interferon-β treatment and its relevance to sCD8 and sCD30, Hepatology Research, 2000",cited-by,10.1016/S1386-6346(00)00071-1,In vitro cytokine production of peripheral blood mononuclear cells in response to HCV core antigen stimulation during interferon-β treatment and its relevance to sCD8 and sCD30,"[['Masaaki', '', 'Izuma'], ['Koju', '', 'Kobayashi'], ['Masaaki', '', 'Shiina'], ['Yoshiyuki', '', 'Ueno'], ['Motoyasu', '', 'Ishii'], ['Tooru', '', 'Shimosegawa'], ['Takayoshi', '', 'Toyota'], ['Kazuhiro', '', 'Kakimi'], ['Masaaki', '', 'Miyazawa']]",Hepatology Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1386634600000711', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634600000711']",
10.1016/S1074-7613(00)80628-7,"Dow, C., Oseroff, C., Peters, B., et. al, Lymphocytic Choriomeningitis Virus Infection Yields Overlapping CD4+ and CD8+ T-Cell Responses, Journal of Virology, 2008",cited-by,10.1128/JVI.00435-08,Lymphocytic Choriomeningitis Virus Infection Yields Overlapping CD4+ and CD8+ T-Cell Responses,"[['Courtney', '', 'Dow'], ['Carla', '', 'Oseroff'], ['Bjoern', '', 'Peters'], ['Courtney', '', 'Nance-Sotelo'], ['John', '', 'Sidney'], ['Michael', '', 'Buchmeier'], ['Alessandro', '', 'Sette'], ['Bianca', 'R.', 'Mothe']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/23/11734.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00435-08']",
10.1016/S1074-7613(00)80628-7,"Botten, J., Kotturi, M., , Adaptive immunity to Lymphocytic choriomeningitis virus : new insights into antigenic determinants, Future Virology, 2007",cited-by,10.2217/17460794.2.5.495,Adaptive immunity to Lymphocytic choriomeningitis virus : new insights into antigenic determinants,"[['Jason', 'W', 'Botten'], ['Maya', 'F', 'Kotturi']]",Future Virology,2007,[u'http://www.futuremedicine.com/doi/abs/10.2217/17460794.2.5.495'],
10.1016/S1074-7613(00)80628-7,"Blacher, S., Calberg, C., Kerckhofs, G., et. al, The porous structure of biodegradable scaffolds obtained with supercritical CO 2 as foaming agent, Studies in Surface Science and Catalysis, 2007",cited-by,10.1016/S0167-2991(07)80088-7,The porous structure of biodegradable scaffolds obtained with supercritical CO 2 as foaming agent,"[['S.', '', 'Blacher'], ['C.', '', 'Calberg'], ['G.', '', 'Kerckhofs'], ['A.', '', 'L\xc3\xa9onard'], ['M.', '', 'Wevers'], ['R.', '', 'J\xc3\xa9r\xc3\xb4me'], ['J.-P.', '', 'Pirard']]",Studies in Surface Science and Catalysis,2007,[u'http://www.sciencedirect.com/science/article/pii/S0167299107800887'],
10.1016/S1074-7613(00)80628-7,"Wherry, E., , T cell exhaustion, Nature Immunology, 2011",cited-by,10.1038/ni.2035,T cell exhaustion,"[['E', 'John', 'Wherry']]",Nature Immunology,2011,[u'http://dx.doi.org/10.1038/ni.2035'],
10.1016/S1074-7613(00)80628-7,"Singh, A., Wüthrich, M., Klein, B., et. al, Indirect Regulation of CD4 T Cell Responses by TNF Receptors in an Acute Viral Infection, , 2007",cited-by,5840637Indirect Regulation of CD4 T Cell Responses by TNF Receptors in an Acute Viral Infection,Indirect Regulation of CD4 T Cell Responses by TNF Receptors in an Acute Viral Infection,"[['Anju', '', 'Singh'], ['Marcel', '', 'W\xc3\xbcthrich'], ['Bruce', '', 'Klein'], ['M.', '', 'Suresh']]",,2007,[u'http://jvi.asm.org/cgi/reprint/JVI.00163-07v1.pdf'],
10.1016/S1074-7613(00)80628-7,"Ashour, H., Seif, T., , The role of B cells in the induction of peripheral T cell tolerance, Journal of Leukocyte Biology, 2007",cited-by,10.1189/jlb.0507310,The role of B cells in the induction of peripheral T cell tolerance,"[['Hossam', 'M.', 'Ashour'], ['Tarek', 'M.', 'Seif']]",Journal of Leukocyte Biology,2007,"[u'http://www.jleukbio.org/cgi/reprint/82/5/1033.pdf', u'http://www.jleukbio.org/cgi/doi/10.1189/jlb.0507310']",
10.1016/S1074-7613(00)80628-7,"Yu, X., Bidwell, S., Martin, P., et. al, Visualization, Fate, and Pathogenicity of Antigen-Specific CD81 T Cells in the Graft-Versus-Host Reaction1, , 0",cited-by,"12026624Visualization, Fate, and Pathogenicity of Antigen-Specific CD81 T Cells in the Graft-Versus-Host Reaction1","Visualization, Fate, and Pathogenicity of Antigen-Specific CD81 T Cells in the Graft-Versus-Host Reaction1","[['Xue-Zhong', '', 'Yu'], ['Sasha', '', 'Bidwell'], ['Paul', 'J.', 'Martin'], ['Claudio', '', 'Anasetti']]",,0,[u'http://www.jimmunol.org/cgi/reprint/163/9/4780.pdf'],
10.1016/S1074-7613(00)80628-7,"Adler, A., Higgins, A., Mihalyo, M., , APCs upon Initial Engagement Are Differentially Programmed by CD4 Cell Priming and Tolerization, , 2010",cited-by,11724033APCs upon Initial Engagement Are Differentially Programmed by CD4 Cell Priming and Tolerization,APCs upon Initial Engagement Are Differentially Programmed by CD4 Cell Priming and Tolerization,"[['Adam', 'J.', 'Adler'], ['Amy', 'D.', 'Higgins'], ['Marianne', 'A.', 'Mihalyo']]",,2010,"[u'http://www.jimmunol.org/cgi/reprint/168/11/5573.pdf', u'http://jimmunol.highwire.org/cgi/reprint/168/11/5573.pdf']",
10.1016/S1074-7613(00)80628-7,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1016/S1074-7613(00)80628-7,"Kelleher, A., Finlayson, R., Kaldor, J., et. al, cells during primary HIV1 infection Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector, , 2010",cited-by,14133082cells during primary HIV1 infection Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector,cells during primary HIV1 infection Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector,"[['Anthony', 'D', 'Kelleher'], ['Robert', '', 'Finlayson'], ['John', '', 'Kaldor'], ['Eric', 'S', 'Rosenberg'], ['Bruce', 'D', 'Walker'], ['David', '', 'A'], ['John', 'J', 'Zaunders'], ['Mee', 'Ling', 'Munier'], ['Pat', '', 'Grey']]",,2010,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2005-01-0206v1.pdf'],
10.1016/S1074-7613(00)80628-7,"Singh, N., Chen, C., Schwartz, R., , The Impact of T Cell Intrinsic Antigen Adaptation on Peripheral Immune Tolerance, PLOS Biology, 2006",cited-by,10.1371/journal.pbio.0040340,The Impact of T Cell Intrinsic Antigen Adaptation on Peripheral Immune Tolerance,"[['Nevil', 'J', 'Singh'], ['Chuan', '', 'Chen'], ['Ronald', 'H', 'Schwartz']]",PLOS Biology,2006,[u'http://dx.doi.org/10.1371/journal.pbio.0040340'],
10.1016/S1074-7613(00)80628-7,"Hunziker, L., Martinic, M., Oxenius, A., et. al, CD4+ T-cell–epitope escape mutant virus selected in vivo, Nature Medicine, 2001",cited-by,10.1038/89915,CD4+ T-cell–epitope escape mutant virus selected in vivo,"[['Lukas', '', 'Hunziker'], ['Marianne', 'M. A.', 'Martinic'], ['Annette', '', 'Oxenius'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Zinkernagel'], ['Adrian', '', 'Ciurea']]",Nature Medicine,2001,[u'http://dx.doi.org/10.1038/89915'],
10.1016/S1074-7613(00)80628-7,"Paraskevopoulou, A., Kiosseoglou, V., , Low-cholesterol yolk protein concentrate, , 2000",cited-by,10.1016/S0167-4501(00)80006-0,Low-cholesterol yolk protein concentrate,"[['A.', '', 'Paraskevopoulou'], ['V.', '', 'Kiosseoglou']]",,2000,[u'http://www.sciencedirect.com/science/article/pii/S0167450100800060'],
10.1016/S1074-7613(00)80628-7,"Stohlman, S., Bergmann, C., Ramakrishna, C., , Central Nervous System Infection Cell-Deficient Mice Following Viral Impaired T Cell Immunity in B, , 0",cited-by,10106566Central Nervous System Infection Cell-Deficient Mice Following Viral Impaired T Cell Immunity in B,Central Nervous System Infection Cell-Deficient Mice Following Viral Impaired T Cell Immunity in B,"[['Stephen', 'A.', 'Stohlman'], ['Cornelia', 'C.', 'Bergmann'], ['Chandran', '', 'Ramakrishna']]",,0,[u'http://www.jimmunol.org/cgi/reprint/167/3/1575.pdf'],
10.1016/S1074-7613(00)80628-7,"Fuller, M., Zajac, A., , Responses by High Viral Loads Ablation of CD8 and CD4 T Cell, , 0",cited-by,11187293Responses by High Viral Loads Ablation of CD8 and CD4 T Cell,Responses by High Viral Loads Ablation of CD8 and CD4 T Cell,"[['Michael', 'J.', 'Fuller'], ['Allan', 'J.', 'Zajac']]",,0,[u'http://www.jimmunol.org/cgi/reprint/170/1/477.pdf'],
10.1016/S1074-7613(00)80628-7,"Ciurea, A., Hengartner, H., Adrian, R., et. al, Design Splenectomized Patients and Vaccine Organs: Implications for Dose Reaching Secondary Lymphoid Antibody Responses with Antigen Correlation of T Cell Independence of, , 0",cited-by,11226788Design Splenectomized Patients and Vaccine Organs: Implications for Dose Reaching Secondary Lymphoid Antibody Responses with Antigen Correlation of T Cell Independence of,Design Splenectomized Patients and Vaccine Organs: Implications for Dose Reaching Secondary Lymphoid Antibody Responses with Antigen Correlation of T Cell Independence of,"[['Adrian', '', 'Ciurea'], ['Hans', '', 'Hengartner'], ['Rolf', 'M.', 'Adrian'], ['F.', '', 'Ochsenbein'], ['Daniel', 'D.', 'Pinschewer']]",,0,"[u'http://jimmunol.highwire.org/cgi/reprint/164/12/6296.pdf', u'http://www.jimmunol.org/cgi/reprint/164/12/6296.pdf']",
10.1016/S1074-7613(00)80628-7,"Ahmed, R., Manjunath, N., Baum, L., et. al, Immunity by CD43 Dynamic Regulation of T Cell, , 0",cited-by,11541867Immunity by CD43 Dynamic Regulation of T Cell,Immunity by CD43 Dynamic Regulation of T Cell,"[['Rafi', '', 'Ahmed'], ['N.', '', 'Manjunath'], ['Linda', 'G.', 'Baum'], ['Brad', 'D. Pearce', 'Williams'], ['Marisa', '', 'Galvan'], ['Christian', 'P.', 'Larsen'], ['Thandi', 'M.', 'Onami'], ['Laurie', 'E.', 'Harrington']]",,0,[u'http://www.jimmunol.org/cgi/reprint/168/12/6022.pdf'],
10.1056~NEJMoa011232,"Gerlach JT, Diepolder HM, Jung M-C, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999;117:933-41.",references,10.1016/S0016-5085(99)70353-7,Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C,"[[u'J.', u'Tilman', u'Gerlach'], [u'Helmut', u'M.', u'Diepolder'], [u'Norbert', u'H.', u'Gruener'], [u'Winfried', u'W.', u'Schraut'], [u'Reinhart', u'', u'Zachoval'], [u'Robert', u'', u'Hoffmann'], [u'C.', u'Albrecht', u'Schirren'], [u'Teresa', u'', u'Santantonio'], [u'Gerd', u'R.', u'Pape']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0016508599703537', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508599703537']","[{u'Name': u'cd4+ t cell', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5073}, {u'Name': u'Chronic Disease', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5693}, {u'Name': u'Chronic Hepatitis', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5700}, {u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Immune Response', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 19204}, {u'Name': u'Indexation', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 19478}, {u'Name': u'Mononuclear Cell', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 26057}, {u'Name': u'Acute Phase', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 46973}]"
10.1016/S0016-5085(99)70353-7,"Nascimbeni, M., Rehermann, B., , Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews Immunology, 2005",cited-by,10.1038/nri1573,Immunology of hepatitis B virus and hepatitis C virus infection,"[['Michelina', '', 'Nascimbeni'], ['Barbara', '', 'Rehermann']]",Nature Reviews Immunology,2005,"[u'http://www.nature.com/doifinder/10.1038/nri1573', u'http://dx.doi.org/10.1038/nri1573']",
10.1016/S0016-5085(99)70353-7,"Thimme, R., Oldach, D., Chang, K., et. al, Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, , 2001",cited-by,2949616Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,"[['Robert', '', 'Thimme'], ['David', '', 'Oldach'], ['Kyong-Mi', '', 'Chang'], ['Carola', '', 'Steiger'], ['Stuart', 'C.', 'Ray'], ['Francis', 'V.', 'Chisari']]",,2001,[u'http://jem.rupress.org/cgi/reprint/194/10/1395.pdf'],
10.1016/S0016-5085(99)70353-7,"Bowen, D., Walker, C., , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 2005",cited-by,10.1038/nature04079,Adaptive immune responses in acute and chronic hepatitis C virus infection,"[['David', 'G.', 'Bowen'], ['Christopher', 'M.', 'Walker']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04079', u'http://dx.doi.org/10.1038/nature04079']",
10.1016/S0016-5085(99)70353-7,"Douek, D., Picker, L., Koup, R., , T CELL DYNAMICS IN HIV1 INFECTION, Annual Review of Immunology, 2003",cited-by,10.1146/annurev.immunol.21.120601.141053,T CELL DYNAMICS IN HIV1 INFECTION,"[['Daniel', 'C.', 'Douek'], ['Louis', 'J.', 'Picker'], ['Richard', 'A.', 'Koup']]",Annual Review of Immunology,2003,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.immunol.21.120601.141053'],
10.1016/S0016-5085(99)70353-7,"Boettler, T., Spangenberg, H., Neumann-Haefelin, C., et. al, T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7860-7867.2005,T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection,"[['Tobias', '', 'Boettler'], ['Hans', 'Christian', 'Spangenberg'], ['Christoph', '', 'Neumann-Haefelin'], ['Elisabeth', '', 'Panther'], ['Simonetta', '', 'Urbani'], ['Carlo', '', 'Ferrari'], ['Hubert', 'E.', 'Blum'], ['Fritz', 'von', 'Weizsacker'], ['Robert', '', 'Thimme']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7860.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7860-7867.2005']",
10.1016/S0016-5085(99)70353-7,"Berenguer, M., López-Labrador, F., Wright, T., , Hepatitis C and liver transplantation, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00179-9,Hepatitis C and liver transplantation,"[['Marina', '', 'Berenguer'], ['F.', 'Xavier', 'L\xc3\xb3pez-Labrador'], ['Teresa', 'L.', 'Wright']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801001799', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801001799']",
10.1016/S0016-5085(99)70353-7,"Harari, A., Petitpierre, S., Vallelian, F., et. al, Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy, , 2004",cited-by,6743478Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy,Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy,"[['Alexandre', '', 'Harari'], ['Stephanie', '', 'Petitpierre'], ['Florence', '', 'Vallelian'], ['Giuseppe', '', 'Pantaleo']]",,2004,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/3/966.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2003-04-1203v1.pdf']",
10.1016/S0016-5085(99)70353-7,"Day, C., Lauer, G., Robbins, G., et. al, Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12584-12595.2002,Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection,"[['Cheryl', 'L.', 'Day'], ['Georg', 'M.', 'Lauer'], ['Gregory', 'K.', 'Robbins'], ['Barbara', '', 'McGovern'], ['Alysse', 'G.', 'Wurcel'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12584-12595.2002', u'http://jvi.asm.org/cgi/reprint/76/24/12584.pdf']",
10.1016/S0016-5085(99)70353-7,"Radkowski, M., Gallegos-Orozco, J., Jablonska, J., et. al, Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20518,Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C,"[['Marek', '', 'Radkowski'], ['Juan', 'F.', 'Gallegos-Orozco'], ['Joanna', '', 'Jablonska'], ['Thomas', 'V.', 'Colby'], ['Bozena', '', 'Walewska-Zielecka'], ['Joanna', '', 'Kubicka'], ['Jeffrey', '', 'Wilkinson'], ['Debra', '', 'Adair'], ['Jorge', '', 'Rakela'], ['Tomasz', '', 'Laskus']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20518'],
10.1016/S0016-5085(99)70353-7,"Iyasere, C., Tilton, J., Johnson, A., et. al, Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin2 (IL2) Production and Is Recovered by Exogenous IL2, Journal of Virology, 2003",cited-by,10.1128/JVI.77.20.10900-10909.2003,Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin2 (IL2) Production and Is Recovered by Exogenous IL2,"[['Christiana', '', 'Iyasere'], ['John', 'C.', 'Tilton'], ['Alison', 'J.', 'Johnson'], ['Souheil', '', 'Younes'], ['Bader', '', 'Yassine-Diab'], ['Rafick-Pierre', '', 'Sekaly'], ['William', 'W.', 'Kwok'], ['Stephen', 'A.', 'Migueles'], ['Alisha', 'C.', 'Laborico'], ['W.', 'Lesley', 'Shupert'], ['Claire', 'W.', 'Hallahan'], ['Richard', 'T.', 'Davey'], ['M.', '', 'Dybul'], ['S.', '', 'Vogel'], ['J.', '', 'Metcalf'], ['M.', '', 'Connors']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/20/10900.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.20.10900-10909.2003']",
10.1016/S0016-5085(99)70353-7,"Radziewicz, H., Ibegbu, C., Fernandez, M., et. al, Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression, Journal of Virology, 2007",cited-by,10.1128/JVI.02021-06,Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression,"[['Henry', '', 'Radziewicz'], ['Chris', 'C.', 'Ibegbu'], ['Marina', 'L.', 'Fernandez'], ['Kimberly', 'A.', 'Workowski'], ['Kamil', '', 'Obideen'], ['Mohammad', '', 'Wehbi'], ['Holly', 'L.', 'Hanson'], ['James', 'P.', 'Steinberg'], ['David', '', 'Masopust'], ['E.', 'John', 'Wherry'], ['John', 'D.', 'Altman'], ['Barry', 'T.', 'Rouse'], ['Gordon', 'J.', 'Freeman'], ['Rafi', '', 'Ahmed'], ['Arash', '', 'Grakoui']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/6/2545.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02021-06']",
10.1016/S0016-5085(99)70353-7,"Houghton, M., Abrignani, S., , Prospects for a vaccine against the hepatitis C virus, Nature, 2005",cited-by,10.1038/nature04081,Prospects for a vaccine against the hepatitis C virus,"[['Michael', '', 'Houghton'], ['Sergio', '', 'Abrignani']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04081', u'http://adsabs.harvard.edu/abs/2005Natur.436..961H', u'http://dx.doi.org/10.1038/nature04081']",
10.1016/S0016-5085(99)70353-7,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1016/S0016-5085(99)70353-7,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1016/S0016-5085(99)70353-7,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1016/S0016-5085(99)70353-7,"Douek, D., Picker, L., Koup, R., , TC ELL DYNAMICS IN HIV1 INFECTION, , 2003",cited-by,3833463TC ELL DYNAMICS IN HIV1 INFECTION,TC ELL DYNAMICS IN HIV1 INFECTION,"[['Daniel', 'C.', 'Douek'], ['Louis', 'J.', 'Picker'], ['Richard', 'A.', 'Koup']]",,2003,"[u'http://staff.science.uva.nl/~mdekkers/articles/Douek%20D%202003.pdf', u'http://ubik.microbiol.washington.edu/LabMtg/JournalClub/Douek265.pdf']",
10.1016/S0016-5085(99)70353-7,"Lavillette, D., Morice, Y., Germanidis, G., et. al, Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.10.6023-6034.2005,"Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection","[['Dimitri', '', 'Lavillette'], ['Yoann', '', 'Morice'], ['Georgios', '', 'Germanidis'], ['Peggy', '', 'Donot'], ['Alexandre', '', 'Soulier'], ['Emanuil', '', 'Pagkalos'], ['Georgios', '', 'Sakellariou'], ['Liliane', '', 'Intrator'], ['Birke', '', 'Bartosch'], ['Jean-Michel', '', 'Pawlotsky'], ['F.-L.', '', 'Cosset']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/10/6023.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.10.6023-6034.2005']",
10.1016/S0016-5085(99)70353-7,"Wedemeyer, H., He, X., Nascimbeni, M., et. al, Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1, , 0",cited-by,11243134Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,"[['Heiner', '', 'Wedemeyer'], ['Xiao-Song', '', 'He'], ['Michelina', '', 'Nascimbeni'], ['Anthony', 'R.', 'Davis'], ['Harry', 'B.', 'Greenberg'], ['Jay', 'H.', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Harvey', '', 'Alter'], ['Barbara', '', 'Rehermann']]",,0,[u'http://www.jimmunol.org/cgi/reprint/169/6/3447.pdf'],
10.1016/S0016-5085(99)70353-7,"Altfeld, M., Rosenberg, E., , The role of CD4 + T helper cells in the cytotoxic T lymphocyte response to HIV1, Current Opinion in Immunology, 2000",cited-by,10.1016/S0952-7915(00)00103-5,The role of CD4 + T helper cells in the cytotoxic T lymphocyte response to HIV1,"[['Marcus', '', 'Altfeld'], ['Eric', 'S', 'Rosenberg']]",Current Opinion in Immunology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500001035', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500001035']",
10.1016/S0016-5085(99)70353-7,"Nascimbeni, M., Mizukoshi, E., Bosmann, M., et. al, Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees, Journal of Virology, 2003",cited-by,10.1128/JVI.77.8.4781-4793.2003,Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees,"[['Michelina', '', 'Nascimbeni'], ['Eishiro', '', 'Mizukoshi'], ['Markus', '', 'Bosmann'], ['Marian', 'E.', 'Major'], ['Kathleen', '', 'Mihalik'], ['Charles', 'M.', 'Rice'], ['Stephen', 'M.', 'Feinstone'], ['Barbara', '', 'Rehermann']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/8/4781.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.8.4781-4793.2003']",
10.1016/S0016-5085(99)70353-7,"Timm, J., Lauer, G., Kavanagh, D., et. al, CD8 Epitope Escape and Reversion in Acute HCV Infection, , 2004",cited-by,6776278CD8 Epitope Escape and Reversion in Acute HCV Infection,CD8 Epitope Escape and Reversion in Acute HCV Infection,"[['Joerg', '', 'Timm'], ['Georg', 'M.', 'Lauer'], ['Daniel', 'G.', 'Kavanagh'], ['Isabelle', '', 'Sheridan'], ['Arthur', 'Y.', 'Kim'], ['Michaela', '', 'Lucas'], ['Thillagavathie', '', 'Pillay'], ['Kei', '', 'Ouchi'], ['Laura', 'L.', 'Reyor'], ['Julian', '', 'Schulze'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Nina', '', 'Bhardwaj'], ['Paul', '', 'Klenerman'], ['Bruce', 'D.', 'Walker'], ['Todd', 'M.', 'Allen']]",,2004,[u'http://jem.rupress.org/cgi/reprint/200/12/1593.pdf'],
10.1016/S0016-5085(99)70353-7,"Shoukry, N., Grakoui, A., Houghton, M., et. al, Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection, , 0",cited-by,12359419Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection,Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection,"[['Naglaa', 'H.', 'Shoukry'], ['Arash', '', 'Grakoui'], ['Michael', '', 'Houghton'], ['David', 'Y.', 'Chien'], ['John', '', 'Ghrayeb'], ['Keith', 'A.', 'Reimann'], ['Christopher', 'M.', 'Walker']]",,0,[],
10.1016/S0016-5085(99)70353-7,"Bertoletti, A., Maini, M., , Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?, Current Opinion in Immunology, 2000",cited-by,10.1016/S0952-7915(00)00108-4,Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?,"[['Antonio', '', 'Bertoletti'], ['Mala', 'K', 'Maini']]",Current Opinion in Immunology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500001084', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500001084']",
10.1016/S0016-5085(99)70353-7,"Folgori, A., Capone, S., Ruggeri, L., et. al, A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, 2006",cited-by,10.1038/nm1353,A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees,"[['Antonella', '', 'Folgori'], ['Stefania', '', 'Capone'], ['Lionello', '', 'Ruggeri'], ['Annalisa', '', 'Meola'], ['Elisabetta', '', 'Sporeno'], ['Bruno', 'Bruni', 'Ercole'], ['Monica', '', 'Pezzanera'], ['Rosalba', '', 'Tafi'], ['Mirko', '', 'Arcuri'], ['Elena', '', 'Fattori'], ['Armin', '', 'Lahm'], ['Alessandra', '', 'Luzzago'], ['Alessandra', '', 'Vitelli'], ['Stefano', '', 'Colloca'], ['Riccardo', '', 'Cortese'], ['Alfredo', '', 'Nicosia']]",Nature Medicine,2006,"[u'http://biolog-e.ls.biu.ac.il/faculty/wides/80-440/saritnm1353.pdf', u'http://www.nature.com/doifinder/10.1038/nm1353', u'http://dx.doi.org/10.1038/nm1353']",
10.1016/S0016-5085(99)70353-7,"Lauer, G., Nguyen, T., Day, C., et. al, Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses, Journal of Virology, 2002",cited-by,10.1128/JVI.76.6.2817-2826.2002,Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses,"[['Georg', 'M.', 'Lauer'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Theresa', '', 'Flynn'], ['Katherine', '', 'McGowan'], ['Eric', 'S.', 'Rosenberg'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Lemuel', '', 'Shattuck']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.6.2817-2826.2002', u'http://jvi.asm.org/cgi/reprint/76/6/2817.pdf']",
10.1016/S0016-5085(99)70353-7,"Rockstroh, J., Spengler, U., , HIV and hepatitis C virus co-infection, Lancet Infectious Diseases, 2004",cited-by,10.1016/S1473-3099(04)01059-X,HIV and hepatitis C virus co-infection,"[['J\xc3\xbcrgen', 'Kurt', 'Rockstroh'], ['Ulrich', '', 'Spengler']]",Lancet Infectious Diseases,2004,"[u'http://www.sciencedirect.com/science/article/pii/S147330990401059X', u'http://linkinghub.elsevier.com/retrieve/pii/S147330990401059X']",
10.1016/S0016-5085(99)70353-7,"Spangenberg, H., Viazov, S., Kersting, N., et. al, Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection, Hepatology, 2005",cited-by,10.1002/hep.20856,Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection,"[['Hans', 'Christian', 'Spangenberg'], ['Sergei', '', 'Viazov'], ['Nadine', '', 'Kersting'], ['Christoph', '', 'Neumann-Haefelin'], ['Denise', '', 'McKinney'], ['Michael', '', 'Roggendorf'], ['Fritz', 'von', 'Weizs\xc3\xa4cker'], ['Hubert', 'E.', 'Blum'], ['Robert', '', 'Thimme']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20856'],
10.1016/S0016-5085(99)70353-7,"Kaplan, D., Sugimoto, K., Newton, K., et. al, Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2006.11.044,Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C,"[['David', 'E.', 'Kaplan'], ['Kazushi', '', 'Sugimoto'], ['Kimberly', '', 'Newton'], ['Mary', 'E.', 'Valiga'], ['Fusao', '', 'Ikeda'], ['Ayse', '', 'Aytaman'], ['Frederick', 'A.', 'Nunes'], ['Michael', 'R.', 'Lucey'], ['Barbara', 'A.', 'Vance'], ['Robert', 'H.', 'Vonderheide'], ['K.', 'Rajender', 'Reddy'], ['Jane', 'A.', 'McKeating']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S001650850602525X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850602525X']",
10.1016/S0016-5085(99)70353-7,"Semmo, N., Day, C., Ward, S., et. al, Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection, Hepatology, 2005",cited-by,10.1002/hep.20669,Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection,"[['Nasser', '', 'Semmo'], ['Cheryl', 'L.', 'Day'], ['Scott', 'M.', 'Ward'], ['Michaela', '', 'Lucas'], ['Gillian', '', 'Harcourt'], ['Andrew', '', 'Loughry'], ['Paul', '', 'Klenerman']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20669'],
10.1016/S0016-5085(99)70353-7,"Thomson, M., Nascimbeni, M., Havert, M., et. al, The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.862-870.2003,The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity,"[['Michael', '', 'Thomson'], ['Michelina', '', 'Nascimbeni'], ['Michael', 'B.', 'Havert'], ['Marian', '', 'Major'], ['Sophia', '', 'Gonzales'], ['Harvey', '', 'Alter'], ['Stephen', 'M.', 'Feinstone'], ['Krishna', 'K.', 'Murthy'], ['Barbara', '', 'Rehermann'], ['T.', 'Jake', 'Liang']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.862-870.2003', u'http://jvi.asm.org/cgi/reprint/77/2/862.pdf']",
10.1016/S0016-5085(99)70353-7,"Rehermann, B., , Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence, Journal of Clinical Investigation, 2009",cited-by,10.1172/JCI39133DS1,Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence,"[['Barbara', '', 'Rehermann']]",Journal of Clinical Investigation,2009,"[u'http://www.jci.org/articles/view/39133', u'http://www.jci.org/articles/view/39133#sd']",
10.1016/S0016-5085(99)70353-7,"Neumann-Haefelin, C., Blum, H., Chisari, F., et. al, T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005",cited-by,10.1016/j.jcv.2004.05.008,T cell response in hepatitis C virus infection,"[['C.', '', 'Neumann-Haefelin'], ['H.', 'E.', 'Blum'], ['F.', 'V.', 'Chisari'], ['R.', '', 'Thimme']]",Journal of Clinical Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S138665320400157X', u'http://linkinghub.elsevier.com/retrieve/pii/S138665320400157X']",
10.1016/S0016-5085(99)70353-7,"Ulsenheimer, A., Gerlach, J., Jung, M., et. al, Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection, Hepatology, 2005",cited-by,10.1002/hep.20592,Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection,"[['Axel', '', 'Ulsenheimer'], ['J.', 'Tilman', 'Gerlach'], ['Maria-Christina', '', 'Jung'], ['Norbert', '', 'Gruener'], ['Markus', '', 'Backmund'], ['Teresa', '', 'Santantonio'], ['Winfried', '', 'Schraut'], ['Malte', 'H. J.', 'Heeg'], ['Carl', 'A.', 'Schirren'], ['Reinhart', '', 'Zachoval'], ['Gerd', 'R.', 'Pape'], ['Helmut', 'M.', 'Diepolder']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20592'],
10.1016/S0016-5085(99)70353-7,"Thimme, R., Lohmann, V., Weber, F., , A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2005.12.001,A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus,"[['Robert', '', 'Thimme'], ['Volker', '', 'Lohmann'], ['Friedemann', '', 'Weber']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205002603', u'http://umanitoba.ca/faculties/medicine/units/medical_microbiology/Courses/MicroPath97.705/PDF/Thimme_HCV9_3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205002603']",
10.1016/S0016-5085(99)70353-7,"Hu, K., Vierling, J., Redeker, A., , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00253.x,"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection","[['Ke-Qin', '', 'Hu'], ['John', 'M.', 'Vierling'], ['Allan', 'G.', 'Redeker']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00253.x'],
10.1016/S0016-5085(99)70353-7,"Dominguez, S., Ghosn, J., Valantin, M., et. al, Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients, Aids, 2006",cited-by,10.1097/01.aids.0000226956.02719.fd,Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients,"[['St\xc3\xa9phanie', '', 'Dominguez'], ['Jade', '', 'Ghosn'], ['Marc-Antoine', '', 'Valantin'], ['Aur\xc3\xa9lie', '', 'Schruniger'], ['Anne', '', 'Simon'], ['Philippe', '', 'Bonnard'], ['Eric', '', 'Caumes'], ['Gilles', '', 'Pialoux'], ['Yves', '', 'Benhamou'], ['Vincent', '', 'Thibault'], ['Christine', '', 'Katlama']]",Aids,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-200605120-00009'],
10.1016/S0016-5085(99)70353-7,"Brooks, D., Teyton, L., Oldstone, M., et. al, Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.16.10514-10527.2005,Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection,"[['David', 'G.', 'Brooks'], ['Luc', '', 'Teyton'], ['Michael', 'B. A.', 'Oldstone'], ['Dorian', 'B.', 'McGavern']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/16/10514.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.16.10514-10527.2005']",
10.1016/S0016-5085(99)70353-7,"Ward, S., Fox, B., Brown, P., et. al, Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection, Journal of Hepatology, 2007",cited-by,10.1016/j.jhep.2007.03.023,Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection,"[['Scott', 'M.', 'Ward'], ['Bridget', 'C.', 'Fox'], ['Philip', 'J.', 'Brown'], ['Joy', '', 'Worthington'], ['Stephen', 'B.', 'Fox'], ['Roger', 'W.', 'Chapman'], ['Kenneth', 'A.', 'Fleming'], ['Alison', 'H.', 'Banham'], ['Paul', '', 'Klenerman']]",Journal of Hepatology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0168827807002012', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827807002012']",
10.1016/S0016-5085(99)70353-7,"Glynn, S., Wright, D., Kleinman, S., et. al, Dynamics of viremia in early hepatitis C virus infection, Transfusion, 2005",cited-by,10.1111/j.1537-2995.2005.04390.x,Dynamics of viremia in early hepatitis C virus infection,"[['Simone', 'A.', 'Glynn'], ['David', 'J.', 'Wright'], ['Steven', 'H.', 'Kleinman'], ['Dale', '', 'Hirschkorn'], ['Yongling', '', 'Tu'], ['Charles', '', 'Heldebrant'], ['Richard', '', 'Smith'], ['Cristina', '', 'Giachetti'], ['James', '', 'Gallarda'], ['Michael', 'P.', 'Busch']]",Transfusion,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2005.04390.x'],
10.1016/S0016-5085(99)70353-7,"NORRIS, P., SUMAROKA, M., BRANDER, C., et. al, Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones, Journal of Virology, 2001",cited-by,10.1128/JVI.75.20.9771-9779.2001,Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones,"[['PHILIP', 'J.', 'NORRIS'], ['MARINA', '', 'SUMAROKA'], ['CHRISTIAN', '', 'BRANDER'], ['HOWELL', 'F.', 'MOFFETT'], ['STEVEN', 'L.', 'BOSWELL'], ['TAM', '', 'NGUYEN'], ['YURI', '', 'SYKULEV'], ['BRUCE', 'D.', 'WALKER'], ['ERIC', 'S.', 'ROSENBERG']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/20/9771.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.20.9771-9779.2001']",
10.1016/S0016-5085(99)70353-7,"Firbas, C., Jilma, B., Tauber, E., et. al, Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.03.009,"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects","[['Christa', '', 'Firbas'], ['Bernd', '', 'Jilma'], ['Erich', '', 'Tauber'], ['Vera', '', 'Buerger'], ['Sandra', '', 'Jelovcan'], ['Karen', '', 'Lingnau'], ['Michael', '', 'Buschle'], ['J\xc3\xbcrgen', '', 'Frisch'], ['Christoph', 'S.', 'Klade']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06002738', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06002738']",
10.1016/S0016-5085(99)70353-7,"Zhou, S., Ou, R., Huang, L., et. al, Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3578-3600.2004,Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection,"[['Shenghua', '', 'Zhou'], ['Rong', '', 'Ou'], ['Lei', '', 'Huang'], ['Graeme', 'E.', 'Price'], ['Demetrius', '', 'Moskophidis']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3578.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3578-3600.2004']",
10.1016/S0016-5085(99)70353-7,"Chang, K., , Immunopathogenesis of hepatitis C virus infection, Clinics in Liver Disease, 2003",cited-by,10.1016/S1089-3261(02)00068-5,Immunopathogenesis of hepatitis C virus infection,"[['Kyong-Mi', '', 'Chang']]",Clinics in Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1089326102000685', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326102000685']",
10.1016/S0016-5085(99)70353-7,"Puig, M., Major, M., Mihalik, K., et. al, Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection, Vaccine, 2004",cited-by,10.1016/j.vaccine.2003.09.010,Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection,"[['Montserrat', '', 'Puig'], ['Marian', 'E', 'Major'], ['Kathleen', '', 'Mihalik'], ['Stephen', 'M', 'Feinstone']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03006698', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03006698']",
10.1016/S0016-5085(99)70353-7,"Jeong, S., Qiao, M., Nascimbeni, M., et. al, Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates, Journal of Virology, 2004",cited-by,10.1128/JVI.78.13.6995-7003.2004,Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates,"[['Sook-Hyang', '', 'Jeong'], ['Ming', '', 'Qiao'], ['Michelina', '', 'Nascimbeni'], ['Zongyi', '', 'Hu'], ['Barbara', '', 'Rehermann'], ['Krishna', '', 'Murthy'], ['T.', 'Jake', 'Liang']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/13/6995.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.13.6995-7003.2004']",
10.1016/S0016-5085(99)70353-7,"Steinmann, D., Barth, H., Gissler, B., et. al, Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C, Journal of Virology, 2004",cited-by,10.1128/JVI.78.17.9030-9040.2004,Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C,"[['Daniel', '', 'Steinmann'], ['Heidi', '', 'Barth'], ['Bettina', '', 'Gissler'], ['Peter', '', 'Schurmann'], ['Mohammed', 'I.', 'Adah'], ['J.', 'Tilman', 'Gerlach'], ['Gerd', 'R.', 'Pape'], ['Erik', '', 'Depla'], ['Dirk', '', 'Jacobs'], ['Geert', '', 'Maertens'], ['Arvind', 'H.', 'Patel'], ['Genevieve', '', 'Inchauspe'], ['T.', 'Jake', 'Liang'], ['Hubert', 'E.', 'Blum'], ['Thomas', 'F.', 'Baumert']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/17/9030.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.17.9030-9040.2004']",
10.1016/S0016-5085(99)70353-7,"Hahn, Y., , Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?, Current Opinion in Immunology, 2003",cited-by,10.1016/S0952-7915(03)00076-1,Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?,"[['Young', 'S', 'Hahn']]",Current Opinion in Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0952791503000761', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791503000761']",
10.1016/S0016-5085(99)70353-7,"Yao, Z., Eisen-Vandervelde, A., Waggoner, S., et. al, Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt, Journal of Virology, 2004",cited-by,10.1128/JVI.78.12.6409-6419.2004,Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt,"[['Zhi', 'Qiang', 'Yao'], ['Audrey', '', 'Eisen-Vandervelde'], ['Stephen', 'N.', 'Waggoner'], ['Evan', 'M.', 'Cale'], ['Young', 'S.', 'Hahn']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/12/6409.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.12.6409-6419.2004', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00145-07']",
10.1016/S0016-5085(99)70353-7,"Harari, A., Rizzardi, G., Ellefsen, K., et. al, Analysis Of HIV -1- And CMV Specific Memory CD4 T Cell Responses During Primary and Chronic Infection, , 2002",cited-by,7034753Analysis Of HIV -1- And CMV Specific Memory CD4 T Cell Responses During Primary and Chronic Infection,Analysis Of HIV -1- And CMV Specific Memory CD4 T Cell Responses During Primary and Chronic Infection,"[['Alexandre', '', 'Harari'], ['G.', 'Paolo', 'Rizzardi'], ['Kim', '', 'Ellefsen'], ['Donatella', '', 'Ciuffreda'], ['Patrick', '', 'Champagne'], ['Daniel', '', 'Kaufmann'], ['Amalio', '', 'Tele'], ['Roland', '', 'Sahli'], ['Giuseppe', '', 'Tambussi'], ['Laurent', '', 'Kaiser'], ['Adriano', '', 'Lazzarin'], ['Luc', '', 'Perrin'], ['Giuseppe', '', 'Pantaleo']]",,2002,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/100/4/1381.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2001-11-0080v1.pdf']",
10.1016/S0016-5085(99)70353-7,"Pár, G., Rukavina, D., Podack, E., et. al, Decrease in CD3-negative-CD8dim + and Vδ2/Vγ9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00218-0,"Decrease in CD3-negative-CD8dim + and Vδ2/Vγ9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection","[['Gabriella', '', 'P\xc3\xa1r'], ['Daniel', '', 'Rukavina'], ['Eckhard', 'R', 'Podack'], ['Margit', '', 'Hor\xc3\xa1nyi'], ['J\xc3\xbalia', '', 'Szekeres-Barth\xc3\xb3'], ['G\xc3\xa9za', '', 'Heged\xc3\xbcs'], ['M\xc3\xa1ria', '', 'Pa\xc3\xa1l'], ['L\xc3\xa1szl\xc3\xb3', '', 'Szereday'], ['Gyula', '', 'M\xc3\xb3zsik'], ['Alajos', '', 'P\xc3\xa1r']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802002180', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802002180']",
10.1016/S0016-5085(99)70353-7,"Yusim, K., Richardson, R., Tao, N., et. al, Los Alamos Hepatitis C Immunology Database, Applied Bioinformatics, 2005",cited-by,10.2165/00822942-200504040-00002,Los Alamos Hepatitis C Immunology Database,"[['Karina', '', 'Yusim'], ['Russell', '', 'Richardson'], ['Ning', '', 'Tao'], ['Anita', '', 'Dalwani'], ['Ashish', '', 'Agrawal'], ['James', '', 'Szinger'], ['Robert', '', 'Funkhouser'], ['Bette', '', 'Korber'], ['Carla', '', 'Kuiken']]",Applied Bioinformatics,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00822942-200504040-00002'],
10.1016/S0016-5085(99)70353-7,"Henderson, D., Magnuson, W., , Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.3.546-568.2003,Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting,"[['David', 'K.', 'Henderson'], ['Warren', 'G.', 'Magnuson']]",Clinical Microbiology Reviews,2003,"[u'http://cmr.asm.org/cgi/reprint/16/3/546.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.3.546-568.2003']",
10.1016/S0016-5085(99)70353-7,"Fournillier, A., Wychowski, C., Boucreux, D., et. al, Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites, Journal of Virology, 2001",cited-by,10.1128/JVI.75.24.12088-12097.2001,Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites,"[['A.', '', 'Fournillier'], ['C.', '', 'Wychowski'], ['D.', '', 'Boucreux'], ['T.', 'F.', 'Baumert'], ['J.-C.', '', 'Meunier'], ['D.', '', 'Jacobs'], ['S.', '', 'Muguet'], ['E.', '', 'Depla'], ['G.', '', 'Inchauspe']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/24/12088.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.24.12088-12097.2001']",
10.1016/S0016-5085(99)70353-7,"Freeman, A., Marinos, G., Ffrench, R., et. al, Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001",cited-by,10.1046/j.1440-1711.2001.01036.x,Immunopathogenesis of hepatitis C virus infection,"[['Anthony', 'J', 'Freeman'], ['George', '', 'Marinos'], ['Rosemary', 'A', 'Ffrench'], ['Andrew', 'R', 'Lloyd']]",Immunology and Cell Biology,2001,"[u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2001.01036.x', u'http://dx.doi.org/10.1046/j.1440-1711.2001.01036.x']",
10.1016/S0016-5085(99)70353-7,"Kamal, S., Amin, A., Madwar, M., et. al, Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients, Journal of Virology, 2004",cited-by,10.1128/JVI.78.22.12252-12258.2004,Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients,"[['Sanaa', 'M.', 'Kamal'], ['Ashraf', '', 'Amin'], ['Mohamed', '', 'Madwar'], ['Camilla', 'S.', 'Graham'], ['Qi', '', 'He'], ['Ahmed', 'Al', 'Tawil'], ['Jens', '', 'Rasenack'], ['Tatsunori', '', 'Nakano'], ['Betty', '', 'Robertson'], ['Alaa', '', 'Ismail'], ['Margaret', 'James', 'Koziel']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/22/12252.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.22.12252-12258.2004']",
10.1016/S0016-5085(99)70353-7,"Pawlotsky, J., , The nature of interferon-?? resistance in hepatitis C virus infection, Current Opinion in Infectious Diseases, 2003",cited-by,10.1097/00001432-200312000-00012,The nature of interferon-?? resistance in hepatitis C virus infection,"[['Jean-Michel', '', 'Pawlotsky']]",Current Opinion in Infectious Diseases,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200312000-00012'],
10.1016/S0016-5085(99)70353-7,"Harcourt, G., Hellier, S., Bunce, M., et. al, Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00289.x,Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection,"[['G.', '', 'Harcourt'], ['S.', '', 'Hellier'], ['M.', '', 'Bunce'], ['J.', '', 'Satsangi'], ['J.', '', 'Collier'], ['R.', '', 'Chapman'], ['R.', '', 'Phillips'], ['P.', '', 'Klenerman']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00289.x'],
10.1016/S0016-5085(99)70353-7,"Baumert, T., Wellnitz, S., Aono, S., et. al, Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C, Hepatology, 2000",cited-by,10.1053/jhep.2000.9876,Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C,"[['Thomas', 'F.', 'Baumert'], ['Sabine', '', 'Wellnitz'], ['Shigeaki', '', 'Aono'], ['Jujin', '', 'Satoi'], ['David', '', 'Herion'], ['J.', 'Tilman', 'Gerlach'], ['Gerd', 'R.', 'Pape'], ['Johnson', 'Y. N.', 'Lau'], ['Jay', 'H.', 'Hoofnagle'], ['Hubert', 'E.', 'Blum'], ['T.', 'Jake', 'Liang']]",Hepatology,2000,"[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/Antibodies%20Against%20Hepatitis%20C%20Virus%20Like%20Particles%20and%20Viral%20Clearance%20in%20Acute%20and%20Chronic%20Hepatitis%20C.pdf', u'http://www.sciencedirect.com/science/article/pii/S027091390061666X', u'http://doi.wiley.com/10.1053/jhep.2000.9876']",
10.1016/S0016-5085(99)70353-7,"Missiha, S., Ostrowski, M., Heathcote, E., , Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008",cited-by,10.1053/j.gastro.2008.02.069,Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors,"[['Sharif', 'B.', 'Missiha'], ['Mario', '', 'Ostrowski'], ['E.', 'Jenny', 'Heathcote']]",Gastroenterology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S001650850800348X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850800348X']",
10.1016/S0016-5085(99)70353-7,"Shiina, M., Rehermann, B., , Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function, Hepatology, 2008",cited-by,10.1002/hep.21996,Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function,"[['Masaaki', '', 'Shiina'], ['Barbara', '', 'Rehermann']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.21996'],
10.1016/S0016-5085(99)70353-7,"Kanto, T., Hayashi, N., , Immunopathogenesis of Hepatitis C Virus Infection: Multifaceted Strategies Subverting Innate and Adaptive Immunity, Internal Medicine, 2006",cited-by,10.2169/internalmedicine.45.1530,Immunopathogenesis of Hepatitis C Virus Infection: Multifaceted Strategies Subverting Innate and Adaptive Immunity,"[['Tatsuya', '', 'Kanto'], ['Norio', '', 'Hayashi']]",Internal Medicine,2006,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/internalmedicine/45.1530?from=CrossRef'],
10.1016/S0016-5085(99)70353-7,"Weston, S., Leistikow, R., Reddy, K., et. al, Reconstitution of hepatitis C virus-specific T-cell-mediated immunity after liver transplantation, Hepatology, 2005",cited-by,10.1002/hep.20507,Reconstitution of hepatitis C virus-specific T-cell-mediated immunity after liver transplantation,"[['Scott', 'J.', 'Weston'], ['Rachel', 'L.', 'Leistikow'], ['K.', 'Rajender', 'Reddy'], ['Maria', '', 'Torres'], ['Anne', 'M.', 'Wertheimer'], ['David', 'M.', 'Lewinsohn'], ['Sunwen', '', 'Chou'], ['Michael', 'P.', 'Davey'], ['Christopher', '', 'Corless'], ['Cliona', '', ""O'Farrelly""], ['David', 'R.', 'Nelson'], ['Hugo', 'R.', 'Rosen']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20507'],
10.1016/S0016-5085(99)70353-7,"Bain, C., Parroche, P., Lavergne, J., et. al, Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.19.10460-10469.2004,Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection,"[['Christine', '', 'Bain'], ['Peggy', '', 'Parroche'], ['Jean', 'Pierre', 'Lavergne'], ['Blandine', '', 'Duverger'], ['Claude', '', 'Vieux'], ['Valerie', '', 'Dubois'], ['Florence', '', 'Komurian-Pradel'], ['Christian', '', 'Trepo'], ['Lucette', '', 'Gebuhrer'], ['Glaucia', '', 'Paranhos-Baccala'], ['Francois', '', 'Penin'], ['Genevieve', '', 'Inchauspe']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/19/10460.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.19.10460-10469.2004']",
10.1016/S0016-5085(99)70353-7,"Tsubouchi, E., Horiike, N., Onji, M., , Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection, Journal of Gastroenterology, 2004",cited-by,10.1007/s00535-003-1385-3,Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection,"[['Eiji', '', 'Tsubouchi'], ['Norio', '', 'Horiike'], ['Morikazu', '', 'Onji']]",Journal of Gastroenterology,2004,"[u'http://www.springerlink.com/content/0n5e0vg0pgd7g91q', u'http://www.springerlink.com/index/0n5e0vg0pgd7g91q.pdf', u'http://www.springerlink.com/index/10.1007/s00535-003-1385-3', u'http://www.springerlink.com/index/pdf/10.1007/s00535-003-1385-3']",
10.1016/S0016-5085(99)70353-7,"Qiao, M., Murata, K., Davis, A., et. al, Hepatitis C Virus-Like Particles Combined With Novel Adjuvant Systems Enhance Virus-Specific Immune Responses, , 2003",cited-by,3178921Hepatitis C Virus-Like Particles Combined With Novel Adjuvant Systems Enhance Virus-Specific Immune Responses,Hepatitis C Virus-Like Particles Combined With Novel Adjuvant Systems Enhance Virus-Specific Immune Responses,"[['Ming', '', 'Qiao'], ['Kazumoto', '', 'Murata'], ['Anthony', 'R.', 'Davis'], ['Sook-Hyang', '', 'Jeong'], ['T.', 'Jake', 'Liang']]",,2003,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/immuneresponse.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/immuneresponse.pdf', u'http://www.hawaii.edu/hivandaids/Hepatitis%20C%20Virus%20Combined%20With%20Novel%20Adjuvant%20Systems%20Enhance%20Virus-Specific%20Immune%20Responses.pdf']",
10.1016/S0016-5085(99)70353-7,"Kaplan, D., Sugimoto, K., Ikeda, F., et. al, T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20706,T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C,"[['David', 'E.', 'Kaplan'], ['Kazushi', '', 'Sugimoto'], ['Fusao', '', 'Ikeda'], ['Jason', '', 'Stadanlick'], ['Mary', '', 'Valiga'], ['Kirti', '', 'Shetty'], ['K.', 'Rajender', 'Reddy'], ['Kyong-Mi', '', 'Chang']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20706'],
10.1016/S0016-5085(99)70353-7,"Gremion, C., Cerny, A., , Hepatitis C virus and the immune system: a concise review, Reviews in Medical Virology, 2005",cited-by,10.1002/rmv.466,Hepatitis C virus and the immune system: a concise review,"[['Christel', '', 'Gremion'], ['Andreas', '', 'Cerny']]",Reviews in Medical Virology,2005,[u'http://doi.wiley.com/10.1002/rmv.466'],
10.1016/S0016-5085(99)70353-7,"Zeremski, M., Petrovic, L., Talal, A., , The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2006.00838.x,The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection,"[['M.', '', 'Zeremski'], ['L.', 'M.', 'Petrovic'], ['A.', 'H.', 'Talal']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00838.x'],
10.1016/S0016-5085(99)70353-7,"Gerlach, J., Ulsenheimer, A., Gruner, N., et. al, Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins, Journal of Virology, 2005",cited-by,10.1128/JVI.79.19.12425-12433.2005,Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins,"[['J.', 'T.', 'Gerlach'], ['A.', '', 'Ulsenheimer'], ['N.', 'H.', 'Gruner'], ['M.-C.', '', 'Jung'], ['W.', '', 'Schraut'], ['C.-A.', '', 'Schirren'], ['M.', '', 'Heeg'], ['S.', '', 'Scholz'], ['K.', '', 'Witter'], ['R.', '', 'Zahn'], ['A.', '', 'Vogler'], ['R.', '', 'Zachoval'], ['G.', 'R.', 'Pape'], ['H.', 'M.', 'Diepolder']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/19/12425.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.19.12425-12433.2005']",
10.1016/S0016-5085(99)70353-7,"Rigopoulou, E., Abbott, W., Haigh, P., et. al, Blocking of interleukin-10 receptor—a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus, Clinical Immunology, 2005",cited-by,10.1016/j.clim.2005.06.003,Blocking of interleukin-10 receptor—a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus,"[['Eirini', 'I.', 'Rigopoulou'], ['William', 'G. H.', 'Abbott'], ['Philip', '', 'Haigh'], ['Nikolai', 'V.', 'Naoumov']]",Clinical Immunology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1521661605001816', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661605001816']",
10.1016/S0016-5085(99)70353-7,"Nascimbeni, M., Shin, E., Chiriboga, L., et. al, Peripheral CD4CD8 T cells are differentiated effector memory cells with antiviral functions, , 2004",cited-by,6998253Peripheral CD4CD8 T cells are differentiated effector memory cells with antiviral functions,Peripheral CD4CD8 T cells are differentiated effector memory cells with antiviral functions,"[['Michelina', '', 'Nascimbeni'], ['Eui-Cheol', '', 'Shin'], ['Luis', '', 'Chiriboga'], ['David', 'E.', 'Kleiner'], ['Barbara', '', 'Rehermann']]",,2004,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/104/2/478.pdf'],
10.1016/S0016-5085(99)70353-7,"Day, C., Walker, B., , Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections, , 2003",cited-by,6706064Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections,Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections,"[['Cheryl', 'L.', 'Day'], ['Bruce', 'D.', 'Walker']]",,2003,[u'http://jem.rupress.org/cgi/reprint/198/12/1773.pdf'],
10.1016/S0016-5085(99)70353-7,"Wang, J., Layden, T., Eckels, D., , Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response, Human Immunology, 2003",cited-by,10.1016/S0198-8859(03)00070-3,Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response,"[['Jane', 'H', 'Wang'], ['Thomas', 'J', 'Layden'], ['David', 'D', 'Eckels']]",Human Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0198885903000703', u'http://linkinghub.elsevier.com/retrieve/pii/S0198885903000703']",
10.1016/S0016-5085(99)70353-7,"Kristensen, N., Christensen, J., Thomsen, A., , High numbers of IL2-producing CD8M T cells during viral infection: correlation with stable memory development, , 0",cited-by,10318918High numbers of IL2-producing CD8M T cells during viral infection: correlation with stable memory development,High numbers of IL2-producing CD8M T cells during viral infection: correlation with stable memory development,"[['Nanna', 'Ny', 'Kristensen'], ['Jan', 'Pravsgaard', 'Christensen'], ['Allan', 'Randrup', 'Thomsen']]",,0,[u'http://vir.sgmjournals.org/cgi/reprint/83/9/2123.pdf'],
10.1016/S0016-5085(99)70353-7,"Schulze, J., Lauer, G., Day, C., et. al, Broad Repertoire of the CD4 Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes1, , 0",cited-by,11240672Broad Repertoire of the CD4 Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes1,Broad Repertoire of the CD4 Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes1,"[['Julian', '', 'Schulze'], ['Georg', 'M.', 'Lauer'], ['Cheryl', 'L.', 'Day'], ['Arthur', 'Y.', 'Kim'], ['Kei', '', 'Ouchi'], ['Jared', 'E.', 'Duncan'], ['Alysse', 'G.', 'Wurcel'], ['Joerg', '', 'Timm'], ['Andrea', 'M.', 'Jones'], ['Bianca', '', 'Mothe'], ['Todd', 'M.', 'Allen'], ['Barbara', '', 'McGovern'], ['Lia', '', 'Lewis-Ximenez'], ['John', '', 'Sidney'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker']]",,0,[u'http://www.jimmunol.org/cgi/reprint/175/6/3603.pdf'],
10.1016/S0016-5085(99)70353-7,"Riordan, S., Skinner, N., Kurtovic, J., et. al, Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury, Inflammation Research, 2006",cited-by,10.1007/s00011-006-0082-0,Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury,"[['S.', 'M.', 'Riordan'], ['N.', 'A.', 'Skinner'], ['J.', '', 'Kurtovic'], ['S.', '', 'Locarnini'], ['C.', 'J.', 'McIver'], ['R.', '', 'Williams'], ['K.', '', 'Visvanathan']]",Inflammation Research,2006,"[u'http://www.springerlink.com/content/8835374mv51n7v22', u'http://www.springerlink.com/index/8835374mv51n7v22.pdf', u'http://www.springerlink.com/index/10.1007/s00011-006-0082-0', u'http://www.springerlink.com/index/pdf/10.1007/s00011-006-0082-0']",
10.1016/S0016-5085(99)70353-7,"Bowen, D., Walker, C., , The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.12.013,The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?,"[['David', 'G.', 'Bowen'], ['Christopher', 'M.', 'Walker']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S016882780400618X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780400618X']",
10.1016/S0016-5085(99)70353-7,"Meyer-Olson, D., Shoukry, N., Brady, K., et. al, Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape, , 0",cited-by,11652146Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape,Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape,"[['Dirk', '', 'Meyer-Olson'], ['Naglaa', 'H.', 'Shoukry'], ['Kristen', 'W.', 'Brady'], ['Helen', '', 'Kim'], ['Douglas', 'P.', 'Olson'], ['Kelly', '', 'Hartman'], ['Ayumi', 'K.', 'Shintani'], ['Christopher', 'M.', 'Walker'], ['Spyros', 'A.', 'Kalams']]",,0,"[u'http://jem.rupress.org/cgi/reprint/200/3/307.pdf', u'http://www.mc.vanderbilt.edu/root/pdfs/cfar/Meyer_Olson.pdf']",
10.1016/S0016-5085(99)70353-7,"Alatrakchi, N., Graham, C., Vliet, H., et. al, Hepatitis C Virus (HCV)Specific CD8+ Cells Produce Transforming Growth Factor   That Can Suppress HCVSpecific T-Cell Responses, Journal of Virology, 2007",cited-by,10.1128/JVI.02202-06,Hepatitis C Virus (HCV)Specific CD8+ Cells Produce Transforming Growth Factor   That Can Suppress HCVSpecific T-Cell Responses,"[['Nadia', '', 'Alatrakchi'], ['Camilla', 'S.', 'Graham'], ['Hans', 'J. J. van der', 'Vliet'], ['Kenneth', 'E.', 'Sherman'], ['Mark', 'A.', 'Exley'], ['Margaret', 'James', 'Koziel']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/11/5882.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02202-06']",
10.1016/S0016-5085(99)70353-7,"Tsai, S., Sheen, I., Chien, R., et. al, Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications, Journal of Biomedical Science, 2003",cited-by,10.1007/BF02256004,Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications,"[['Sun-Lung', '', 'Tsai'], ['I-Shyan', '', 'Sheen'], ['Rong-Nan', '', 'Chien'], ['Chia-Min', '', 'Chu'], ['Hsiu-Chu', '', 'Huang'], ['Yen-Ling', '', 'Chuang'], ['Tzong-Hsien', '', 'Lee'], ['Shuen-Kuei', '', 'Liao'], ['Chen-Lung', '', 'Lin'], ['George', 'C.', 'Kuo'], ['Yun-Fan', '', 'Liaw']]",Journal of Biomedical Science,2003,"[u'http://www.springerlink.com/index/f7xl464037855324.pdf', u'http://www.springerlink.com/content/f7xl464037855324', u'http://www.springerlink.com/index/10.1007/BF02256004', u'http://www.springerlink.com/index/pdf/10.1007/BF02256004']",
10.1016/S0016-5085(99)70353-7,"Nelson, D., , THE IMMUNOPATHOGENESIS OF HEPATITIS C VIRUS INFECTION, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70202-6,THE IMMUNOPATHOGENESIS OF HEPATITIS C VIRUS INFECTION,"[['David', 'R.', 'Nelson']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702026', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702026']",
10.1016/S0016-5085(99)70353-7,"Kuntzen, T., Timm, J., Berical, A., et. al, Viral Sequence Evolution in Acute Hepatitis C Virus Infection, Journal of Virology, 2007",cited-by,10.1128/JVI.00995-07,Viral Sequence Evolution in Acute Hepatitis C Virus Infection,"[['Thomas', '', 'Kuntzen'], ['Joerg', '', 'Timm'], ['Andrew', '', 'Berical'], ['Lia', 'L.', 'Lewis-Ximenez'], ['Andrea', '', 'Jones'], ['Brian', '', 'Nolan'], ['J.', 'Schulze zur', 'Wiesch'], ['Bin', '', 'Li'], ['Arne', '', 'Schneidewind'], ['Arthur', 'Y.', 'Kim'], ['Raymond', 'T.', 'Chung'], ['Georg', 'M.', 'Lauer'], ['Todd', 'M.', 'Allen']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/21/11658.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00995-07']",
10.1016/S0016-5085(99)70353-7,"Tilton, J., Luskin, M., Johnson, A., et. al, Changes in Paracrine Interleukin2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load, Journal of Virology, 2007",cited-by,10.1128/JVI.01830-06,"Changes in Paracrine Interleukin2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load","[['John', 'C.', 'Tilton'], ['Marlise', 'R.', 'Luskin'], ['Alison', 'J.', 'Johnson'], ['Maura', '', 'Manion'], ['Claire', 'W.', 'Hallahan'], ['Julia', 'A.', 'Metcalf'], ['Mary', '', 'McLaughlin'], ['Richard', 'T.', 'Davey'], ['M.', '', 'Connors']]",Journal of Virology,2007,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01830-06'],
10.1016/S0016-5085(99)70353-7,"Lloyd, A., Jagger, E., Post, J., et. al, Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection, Immunology and Cell Biology, 2007",cited-by,10.1038/sj.icb.7100010,Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection,"[['Andrew', 'R', 'Lloyd'], ['Emma', '', 'Jagger'], ['Jeffrey', 'J', 'Post'], ['Lee-Ann', '', 'Crooks'], ['William', 'D', 'Rawlinson'], ['Young', 'S', 'Hahn'], ['Rosemary', 'A', 'Ffrench']]",Immunology and Cell Biology,2007,"[u'http://www.nature.com/doifinder/10.1038/sj.icb.7100010', u'http://dx.doi.org/10.1038/sj.icb.7100010']",
10.1016/S0016-5085(99)70353-7,"Rosen, H., , Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury, Liver Transplantation, 2003",cited-by,10.1053/jlts.2003.50253,Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury,"[['Hugo', 'R.', 'Rosen']]",Liver Transplantation,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1527646503808754', u'http://doi.wiley.com/10.1053/jlts.2003.50253']",
10.1016/S0016-5085(99)70353-7,"Waggoner, S., Hall, C., Hahn, Y., , HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL12 production, Journal of Leukocyte Biology, 2007",cited-by,10.1189/jlb.0507268,HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL12 production,"[['Stephen', 'N.', 'Waggoner'], ['Caroline', 'H. T.', 'Hall'], ['Young', 'S.', 'Hahn']]",Journal of Leukocyte Biology,2007,"[u'http://www.jleukbio.org/cgi/rapidpdf/jlb.0507268v1.pdf', u'http://www.jleukbio.org/cgi/reprint/82/6/1407.pdf', u'http://www.jleukbio.org/cgi/doi/10.1189/jlb.0507268']",
10.1016/S0016-5085(99)70353-7,"He, H., Messer, R., Sakaguchi, S., et. al, Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.21.11641-11647.2004,Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection,"[['Hong', '', 'He'], ['Ronald', 'J.', 'Messer'], ['Shimon', '', 'Sakaguchi'], ['Guojun', '', 'Yang'], ['Shelly', 'J.', 'Robertson'], ['Kim', 'J.', 'Hasenkrug']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/21/11641.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.21.11641-11647.2004']",
10.1016/S0016-5085(99)70353-7,"Mueller, T., Mas-Marques, A., Sarrazin, C., et. al, Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection, Journal of Hepatology, 2004",cited-by,10.1016/j.jhep.2004.06.021,Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection,"[['Tobias', '', 'Mueller'], ['Andreas', '', 'Mas-Marques'], ['Christoph', '', 'Sarrazin'], ['Manfred', '', 'Wiese'], ['Juliane', '', 'Halangk'], ['Heiko', '', 'Witt'], ['Golo', '', 'Ahlenstiel'], ['Ulrich', '', 'Spengler'], ['Uwe', '', 'Goebel'], ['Bertram', '', 'Wiedenmann'], ['Eckart', '', 'Schreier'], ['Thomas', '', 'Berg']]",Journal of Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804002776', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804002776']",
10.1016/S0016-5085(99)70353-7,"Anthony, D., Post, A., Valdez, H., et. al, ELISPOT Analysis of Hepatitis C Virus Protein-Specific IFN-γ-Producing Peripheral Blood Lymphocytes in Infected Humans with and without Cirrhosis, Clinical Immunology, 2001",cited-by,10.1006/clim.2001.5018,ELISPOT Analysis of Hepatitis C Virus Protein-Specific IFN-γ-Producing Peripheral Blood Lymphocytes in Infected Humans with and without Cirrhosis,"[['Donald', 'D.', 'Anthony'], ['Anthony', 'B.', 'Post'], ['Hernan', '', 'Valdez'], ['Darrell', 'L.', 'Peterson'], ['Madeleine', '', 'Murphy'], ['Peter', 'S.', 'Heeger']]",Clinical Immunology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1521661601950181', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661601950181']",
10.1016/S0016-5085(99)70353-7,"Brinster, C., Chen, M., Boucreux, D., et. al, Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles, , 0",cited-by,11458315Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles,Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles,"[['C.', '', 'Brinster'], ['M.', '', 'Chen'], ['D.', '', 'Boucreux'], ['G.', '', 'Paranhos-Baccala'], ['F.', '', 'Lemmonier'], ['G.', '', 'Inchauspe']]",,0,[],
10.1016/S0016-5085(99)70353-7,"Wertheimer, A., Miner, C., Lewinsohn, D., et. al, Novel CD4 and CD8 T-Cell Determinants Within the NS3 Protein in Subjects With Spontaneously Resolved HCV Infection, , 0",cited-by,12160314Novel CD4 and CD8 T-Cell Determinants Within the NS3 Protein in Subjects With Spontaneously Resolved HCV Infection,Novel CD4 and CD8 T-Cell Determinants Within the NS3 Protein in Subjects With Spontaneously Resolved HCV Infection,"[['Anne', 'M.', 'Wertheimer'], ['Camette', '', 'Miner'], ['David', 'M.', 'Lewinsohn'], ['Anna', 'W.', 'Sasaki'], ['Ezra', '', 'Kaufman'], ['Hugo', 'R.', 'Rosen']]",,0,[u'http://www.hawaii.edu/hivandaids/Novel%20CD4+%20and%20CD8+%20T-Cell%20In%20Subjects%20With%20Spontaneously%20Resolved%20HCV%20Infection.pdf'],
10.1016/S0016-5085(99)70353-7,"Tang, K., Herrmann, E., Cooksley, H., et. al, Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.05.024,Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy,"[['Kwok', 'H.', 'Tang'], ['Eva', '', 'Herrmann'], ['Helen', '', 'Cooksley'], ['Nick', '', 'Tatman'], ['Shilpa', '', 'Chokshi'], ['Roger', '', 'Williams'], ['Stefan', '', 'Zeuzem'], ['Nikolai', 'V.', 'Naoumov']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805004204', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805004204']",
10.1016/S0016-5085(99)70353-7,"Day, C., Seth, N., Lucas, M., et. al, Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers, Journal of Clinical Investigation, 2003",cited-by,10.1172/JCI18509,Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers,"[['Cheryl', 'L.', 'Day'], ['Nilufer', 'P.', 'Seth'], ['Michaela', '', 'Lucas'], ['Heiner', '', 'Appel'], ['Laurent', '', 'Gauthier'], ['Georg', 'M.', 'Lauer'], ['Gregory', 'K.', 'Robbins'], ['Zbigniew', 'M.', 'Szczepiorkowski'], ['Deborah', 'R.', 'Casson'], ['Raymond', 'T.', 'Chung'], ['Shannon', '', 'Bell'], ['Gillian', '', 'Harcourt'], ['Bruce', 'D.', 'Walker'], ['Paul', '', 'Klenerman'], ['Kai', 'W.', 'Wucherpfennig']]",Journal of Clinical Investigation,2003,[u'http://www.jci.org/articles/view/18509'],
10.1016/S0016-5085(99)70353-7,"Woollard, D., Grakoui, A., Shoukry, N., et. al, Characterization of HCV-specific patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee, Hepatology, 2003",cited-by,10.1053/jhep.2003.50478,Characterization of HCV-specific patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee,"[['David', 'J.', 'Woollard'], ['Arash', '', 'Grakoui'], ['Naglaa', 'H.', 'Shoukry'], ['Krishna', 'K.', 'Murthy'], ['Katherine', 'J.', 'Campbell'], ['Christopher', 'M.', 'Walker']]",Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0270913903008826', u'http://doi.wiley.com/10.1053/jhep.2003.50478']",
10.1016/S0016-5085(99)70353-7,"Somsouk, M., Lauer, G., Casson, D., et. al, Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00391-3,Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression,"[['Ma', '', 'Somsouk'], ['Georg', 'M', 'Lauer'], ['Deborah', '', 'Casson'], ['Adam', '', 'Terella'], ['Cheryl', 'L', 'Day'], ['Bruce', 'D', 'Walker'], ['Raymond', 'T', 'Chung']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503003913', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503003913']",
10.1016/S0016-5085(99)70353-7,"Lechner, F., Cuero, A., Kantzanou, M., et. al, Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers, Reviews in Medical Virology, 2001",cited-by,10.1002/rmv.295,Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers,"[['Franziska', '', 'Lechner'], ['Ana', 'L. Vargas', 'Cuero'], ['Maria', '', 'Kantzanou'], ['Paul', '', 'Klenerman']]",Reviews in Medical Virology,2001,[u'http://doi.wiley.com/10.1002/rmv.295'],
10.1016/S0016-5085(99)70353-7,"Yao, Z., Ray, S., Eisen-Vandervelde, A., et. al, Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway, Viral Immunology, 2001",cited-by,10.1089/08828240152716547,Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway,"[['Zhi', 'Qiang', 'Yao'], ['Suma', '', 'Ray'], ['Audrey', '', 'Eisen-Vandervelde'], ['Stephen', '', 'Waggoner'], ['Young', 'S.', 'Hahn']]",Viral Immunology,2001,[u'http://www.liebertonline.com/doi/abs/10.1089%2F08828240152716547'],
10.1016/S0016-5085(99)70353-7,"Badr, G., Bedard, N., Abdel-Hakeem, M., et. al, Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells, Journal of Virology, 2008",cited-by,10.1128/JVI.01083-08,"Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells","[['Gamal', '', 'Badr'], ['Nathalie', '', 'Bedard'], ['Mohamed', 'S.', 'Abdel-Hakeem'], ['Lydie', '', 'Trautmann'], ['Bernard', '', 'Willems'], ['Jean-Pierre', '', 'Villeneuve'], ['Elias', 'K.', 'Haddad'], ['Rafick', 'P.', 'Sekaly'], ['Julie', '', 'Bruneau'], ['Naglaa', 'H.', 'Shoukry']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10017.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01083-08']",
10.1016/S0016-5085(99)70353-7,"Danta, M., Semmo, N., Fabris, P., et. al, Impact of HIV on Host‐Virus Interactions during Early Hepatitis C Virus Infection, Journal of Infectious Diseases, 2008",cited-by,10.1086/587843,Impact of HIV on Host‐Virus Interactions during Early Hepatitis C Virus Infection,"[['M.', '', 'Danta'], ['N.', '', 'Semmo'], ['P.', '', 'Fabris'], ['D.', '', 'Brown'], ['S.', '', 'Bhagani'], ['P.', '', 'Klenerman']]",Journal of Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/587843'],
10.1016/S0016-5085(99)70353-7,"Berzofsky, J., Ahlers, J., Janik, J., et. al, Progress on new vaccine strategies against chronic viral infections, Journal of Clinical Investigation, 2004",cited-by,10.1172/JCI22674,Progress on new vaccine strategies against chronic viral infections,"[['Jay', 'A.', 'Berzofsky'], ['Jeffrey', 'D.', 'Ahlers'], ['John', '', 'Janik'], ['John', '', 'Morris'], ['SangKon', '', 'Oh'], ['Masaki', '', 'Terabe'], ['Igor', 'M.', 'Belyakov']]",Journal of Clinical Investigation,2004,[u'http://www.jci.org/articles/view/22674'],
10.1056~NEJMoa011232,"Missale G, Bertoni R, Lamonaca V, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-14.",references,10.1172/JCI118842,Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response,"[[u'G', u'', u'Missale'], [u'R', u'', u'Bertoni'], [u'V', u'', u'Lamonaca'], [u'A', u'', u'Valli'], [u'M', u'', u'Massari'], [u'C', u'', u'Mori'], [u'M', u'G', u'Rumi'], [u'M', u'', u'Houghton'], [u'F', u'', u'Fiaccadori'], [u'C', u'', u'Ferrari']]",Journal of Clinical Investigation,1996,[u'http://www.jci.org/articles/view/118842'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Cell Mediated Immune Response', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 50116}]"
10.1172/JCI118842,"Gerlach, J., Diepolder, H., Gruener, N., et. al, Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C, Gastroenterology, 1999",cited-by,10.1016/S0016-5085(99)70353-7,Recurrence of hepatitis C virus after loss of virus-specific CD4 + T-cell response in acute hepatitis C,"[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M.', 'Diepolder'], ['Norbert', 'H.', 'Gruener'], ['Winfried', 'W.', 'Schraut'], ['Reinhart', '', 'Zachoval'], ['Robert', '', 'Hoffmann'], ['C.', 'Albrecht', 'Schirren'], ['Teresa', '', 'Santantonio'], ['Gerd', 'R.', 'Pape']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0016508599703537', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508599703537']",
10.1172/JCI118842,"Thimme, R., Oldach, D., Chang, K., et. al, Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, , 2001",cited-by,2949616Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,"[['Robert', '', 'Thimme'], ['David', '', 'Oldach'], ['Kyong-Mi', '', 'Chang'], ['Carola', '', 'Steiger'], ['Stuart', 'C.', 'Ray'], ['Francis', 'V.', 'Chisari']]",,2001,[u'http://jem.rupress.org/cgi/reprint/194/10/1395.pdf'],
10.1172/JCI118842,"Sette, A., Sidney, J., , Nine major HLA class I supertypes account for the vast preponderance of HLA-A and B polymorphism, Immunogenetics, 1999",cited-by,10.1007/s002510050594,Nine major HLA class I supertypes account for the vast preponderance of HLA-A and B polymorphism,"[['A.', '', 'Sette'], ['J.', '', 'Sidney']]",Immunogenetics,1999,"[u'http://www.springerlink.com/index/ygk89k8j5bfp16ye.pdf', u'http://www.springerlink.com/content/ygk89k8j5bfp16ye', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s002510050594', u'http://www.springerlink.com/index/pdf/10.1007/s002510050594']",
10.1172/JCI118842,"Bowen, D., Walker, C., , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 2005",cited-by,10.1038/nature04079,Adaptive immune responses in acute and chronic hepatitis C virus infection,"[['David', 'G.', 'Bowen'], ['Christopher', 'M.', 'Walker']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04079', u'http://dx.doi.org/10.1038/nature04079']",
10.1172/JCI118842,"Liang, T., Rehermann, B., Seeff, L., et. al, Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C, , 2000",cited-by,"6738512Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","[['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann'], ['Leonard', 'B.', 'Seeff'], ['Jay', 'H.', 'Hoofnagle']]",,2000,[u'http://www.annals.org/content/132/4/296.full.pdf'],
10.1172/JCI118842,"Villano, S., Vlahov, D., Nelson, K., et. al, Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection, Hepatology, 1999",cited-by,10.1002/hep.510290311,Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection,"[['Stephen', 'A.', 'Villano'], ['David', '', 'Vlahov'], ['Kenrad', 'E.', 'Nelson'], ['Sylvia', '', 'Cohn'], ['David', 'L.', 'Thomas']]",Hepatology,1999,"[u'http://journals.pasteur.ac.ir/hepatology/vol29-n3/908.pdf', u'http://doi.wiley.com/10.1002/hep.510290311']",
10.1172/JCI118842,"ZEIN, N., , Clinical Significance of Hepatitis C Virus Genotypes, Clinical Microbiology Reviews, 2000",cited-by,10.1128/CMR.13.2.223-235.2000,Clinical Significance of Hepatitis C Virus Genotypes,"[['NIZAR', 'N.', 'ZEIN']]",Clinical Microbiology Reviews,2000,"[u'http://cmr.asm.org/cgi/reprint/13/2/223.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.13.2.223-235.2000']",
10.1172/JCI118842,"Cramp, M., Rossol, S., Chokshi, S., et. al, Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C, Gastroenterology, 2000",cited-by,10.1016/S0016-5085(00)70217-4,Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C,"[['Matthew', 'E.', 'Cramp'], ['Siegbert', '', 'Rossol'], ['Shilpa', '', 'Chokshi'], ['Patrizia', '', 'Carucci'], ['Roger', '', 'Williams'], ['Nikolai', 'V.', 'Naoumov']]",Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500702174', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500702174']",
10.1172/JCI118842,"Boettler, T., Spangenberg, H., Neumann-Haefelin, C., et. al, T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7860-7867.2005,T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection,"[['Tobias', '', 'Boettler'], ['Hans', 'Christian', 'Spangenberg'], ['Christoph', '', 'Neumann-Haefelin'], ['Elisabeth', '', 'Panther'], ['Simonetta', '', 'Urbani'], ['Carlo', '', 'Ferrari'], ['Hubert', 'E.', 'Blum'], ['Fritz', 'von', 'Weizsacker'], ['Robert', '', 'Thimme']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7860.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7860-7867.2005']",
10.1172/JCI118842,"DIEPOLDER, H., GERLACH, J., ZACHOVAL, R., et. al, Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection, Human Mutation, 1997",cited-by,12321077Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection,Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection,"[['HELMUT', 'M.', 'DIEPOLDER'], ['J', 'ORN-TILMAN', 'GERLACH'], ['REINHART', '', 'ZACHOVAL'], ['ROBERT', 'M.', 'HOFFMANN'], ['MARIA-CHRISTINA', '', 'JUNG'], ['EDDY', 'A.', 'WIERENGA'], ['SIEGFRIED', '', 'SCHOLZ'], ['TERESA', '', 'SANTANTONIO'], ['MICHAEL', '', 'HOUGHTON'], ['SCOTT', '', 'SOUTHWOOD'], ['ALESSANDRO', '', 'SETTE'], ['GERD', 'R.', 'PAPE']]",Human Mutation,1997,[u'http://jvi.asm.org/cgi/reprint/71/8/6011.pdf'],
10.1172/JCI118842,"Bertoletti, A., Ferrari, C., , Kinetics of the immune response during HBV and HCV infection, Hepatology, 2003",cited-by,10.1053/jhep.2003.50310,Kinetics of the immune response during HBV and HCV infection,"[['Antonio', '', 'Bertoletti'], ['Carlo', '', 'Ferrari']]",Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0270913903005032', u'http://hepatitis-central.com/hcv/info/2003/july/hepcinfo4.pdf', u'http://doi.wiley.com/10.1053/jhep.2003.50310']",
10.1172/JCI118842,"Day, C., Lauer, G., Robbins, G., et. al, Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12584-12595.2002,Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection,"[['Cheryl', 'L.', 'Day'], ['Georg', 'M.', 'Lauer'], ['Gregory', 'K.', 'Robbins'], ['Barbara', '', 'McGovern'], ['Alysse', 'G.', 'Wurcel'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12584-12595.2002', u'http://jvi.asm.org/cgi/reprint/76/24/12584.pdf']",
10.1172/JCI118842,"Radziewicz, H., Ibegbu, C., Fernandez, M., et. al, Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression, Journal of Virology, 2007",cited-by,10.1128/JVI.02021-06,Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression,"[['Henry', '', 'Radziewicz'], ['Chris', 'C.', 'Ibegbu'], ['Marina', 'L.', 'Fernandez'], ['Kimberly', 'A.', 'Workowski'], ['Kamil', '', 'Obideen'], ['Mohammad', '', 'Wehbi'], ['Holly', 'L.', 'Hanson'], ['James', 'P.', 'Steinberg'], ['David', '', 'Masopust'], ['E.', 'John', 'Wherry'], ['John', 'D.', 'Altman'], ['Barry', 'T.', 'Rouse'], ['Gordon', 'J.', 'Freeman'], ['Rafi', '', 'Ahmed'], ['Arash', '', 'Grakoui']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/6/2545.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02021-06']",
10.1172/JCI118842,"Houghton, M., Abrignani, S., , Prospects for a vaccine against the hepatitis C virus, Nature, 2005",cited-by,10.1038/nature04081,Prospects for a vaccine against the hepatitis C virus,"[['Michael', '', 'Houghton'], ['Sergio', '', 'Abrignani']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04081', u'http://adsabs.harvard.edu/abs/2005Natur.436..961H', u'http://dx.doi.org/10.1038/nature04081']",
10.1172/JCI118842,"Sarobe, P., Lasarte, J., Casares, N., et. al, Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins, Journal of Virology, 2002",cited-by,10.1128/JVI.76.10.5062-5070.2002,Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins,"[['Pablo', '', 'Sarobe'], ['Juan', 'Jos\xc3\xa9', 'Lasarte'], ['Noelia', '', 'Casares'], ['Ascensi\xc3\xb3n', '', 'L\xc3\xb3pez-D\xc3\xb5'], ['Elena', '', 'Baixeras'], ['Pablo', '', 'Labarga'], ['Nicol\xc3\xa1s', 'Garc\xc3\xb5', '\xc2\xb4'], ['Francisco', '', 'Borr\xc3\xa1s-Cuesta'], ['Jes\xc3\xbas', '', 'Prieto']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/10/5062.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.10.5062-5070.2002']",
10.1172/JCI118842,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1172/JCI118842,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1172/JCI118842,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1172/JCI118842,"Rosen, H., Hinrichs, D., Gretch, D., et. al, Association of multispecific CD4 + response to hepatitis C and severity of recurrence after liver transplantation, Gastroenterology, 1999",cited-by,10.1016/S0016-5085(99)70352-5,Association of multispecific CD4 + response to hepatitis C and severity of recurrence after liver transplantation,"[['Hugo', 'R.', 'Rosen'], ['David', 'J.', 'Hinrichs'], ['David', 'R.', 'Gretch'], ['Margaret', 'J.', 'Koziel'], ['Sunwen', '', 'Chou'], ['Michael', '', 'Houghton'], ['John', '', 'Rabkin'], ['Christopher', 'L.', 'Corless'], ['H.', 'G. Archie', 'Bouwer']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0016508599703525', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508599703525']",
10.1172/JCI118842,"Höhler, T., Kruger, A., Gerken, G., et. al, Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection, Journal of Medical Virology, 1998",cited-by,10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2,Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection,"[['Thomas', '', 'H\xc3\xb6hler'], ['Anke', '', 'Kruger'], ['Guido', '', 'Gerken'], ['Peter', 'M.', 'Schneider'], ['Karl-H.', 'Meyer zum', 'B\xc3\xbcschenfelde'], ['Christian', '', 'Rittner']]",Journal of Medical Virology,1998,[u'http://doi.wiley.com/10.1002/%28SICI%291096-9071%28199803%2954%3A3%3C173%3A%3AAID-JMV5%3E3.0.CO%3B2-2'],
10.1172/JCI118842,"Tai, D., Tsai, S., Chen, Y., et. al, Activation of nuclear factor ?B in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis, Hepatology, 2000",cited-by,10.1002/hep.510310316,Activation of nuclear factor ?B in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis,"[['Dar-In', '', 'Tai'], ['Sun-Lung', '', 'Tsai'], ['Young-Mao', '', 'Chen'], ['Yen-Ling', '', 'Chuang'], ['Cheng-Yuan', '', 'Peng'], ['I-Shyan', '', 'Sheen'], ['Chau-Ting', '', 'Yeh'], ['Kenneth', 'S.', 'Chang'], ['Shao-Nan', '', 'Huang'], ['George', 'C.', 'Kuo'], ['Yun-Fan', '', 'Liaw']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310316'],
10.1172/JCI118842,"Tsai, S., Chen, Y., Chen, M., et. al, Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity, Gastroenterology, 1998",cited-by,10.1016/S0016-5085(98)70268-9,Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity,"[['Sun-Lung', '', 'Tsai'], ['Young-Mao', '', 'Chen'], ['Ming-Huei', '', 'Chen'], ['Chao-Yuan', '', 'Huang'], ['I-Shyan', '', 'Sheen'], ['Chau-Ting', '', 'Yeh'], ['Jyh-Hsiung', '', 'Huang'], ['George', 'C.', 'Kuo'], ['Yun-Fan', '', 'Liaw']]",Gastroenterology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0016508598702689', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508598702689']",
10.1172/JCI118842,"Wedemeyer, H., He, X., Nascimbeni, M., et. al, Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1, , 0",cited-by,11243134Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,"[['Heiner', '', 'Wedemeyer'], ['Xiao-Song', '', 'He'], ['Michelina', '', 'Nascimbeni'], ['Anthony', 'R.', 'Davis'], ['Harry', 'B.', 'Greenberg'], ['Jay', 'H.', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Harvey', '', 'Alter'], ['Barbara', '', 'Rehermann']]",,0,[u'http://www.jimmunol.org/cgi/reprint/169/6/3447.pdf'],
10.1172/JCI118842,"Altfeld, M., Rosenberg, E., , The role of CD4 + T helper cells in the cytotoxic T lymphocyte response to HIV1, Current Opinion in Immunology, 2000",cited-by,10.1016/S0952-7915(00)00103-5,The role of CD4 + T helper cells in the cytotoxic T lymphocyte response to HIV1,"[['Marcus', '', 'Altfeld'], ['Eric', 'S', 'Rosenberg']]",Current Opinion in Immunology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500001035', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500001035']",
10.1172/JCI118842,"RAY, S., WANG, Y., LAEYENDECKER, O., et. al, Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy, , 1999",cited-by,13412001Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy,Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy,"[['STUART', 'C.', 'RAY'], ['YU-MING', '', 'WANG'], ['OLIVER', '', 'LAEYENDECKER'], ['JOHN', 'R.', 'TICEHURST'], ['STEPHEN', 'A.', 'VILLANO'], ['DAVID', 'L.', 'THOMAS']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/4/2938.pdf'],
10.1172/JCI118842,"Nascimbeni, M., Mizukoshi, E., Bosmann, M., et. al, Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees, Journal of Virology, 2003",cited-by,10.1128/JVI.77.8.4781-4793.2003,Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees,"[['Michelina', '', 'Nascimbeni'], ['Eishiro', '', 'Mizukoshi'], ['Markus', '', 'Bosmann'], ['Marian', 'E.', 'Major'], ['Kathleen', '', 'Mihalik'], ['Charles', 'M.', 'Rice'], ['Stephen', 'M.', 'Feinstone'], ['Barbara', '', 'Rehermann']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/8/4781.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.8.4781-4793.2003']",
10.1172/JCI118842,"Bertoletti, A., Maini, M., , Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?, Current Opinion in Immunology, 2000",cited-by,10.1016/S0952-7915(00)00108-4,Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?,"[['Antonio', '', 'Bertoletti'], ['Mala', 'K', 'Maini']]",Current Opinion in Immunology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0952791500001084', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791500001084']",
10.1172/JCI118842,"Folgori, A., Capone, S., Ruggeri, L., et. al, A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, 2006",cited-by,10.1038/nm1353,A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees,"[['Antonella', '', 'Folgori'], ['Stefania', '', 'Capone'], ['Lionello', '', 'Ruggeri'], ['Annalisa', '', 'Meola'], ['Elisabetta', '', 'Sporeno'], ['Bruno', 'Bruni', 'Ercole'], ['Monica', '', 'Pezzanera'], ['Rosalba', '', 'Tafi'], ['Mirko', '', 'Arcuri'], ['Elena', '', 'Fattori'], ['Armin', '', 'Lahm'], ['Alessandra', '', 'Luzzago'], ['Alessandra', '', 'Vitelli'], ['Stefano', '', 'Colloca'], ['Riccardo', '', 'Cortese'], ['Alfredo', '', 'Nicosia']]",Nature Medicine,2006,"[u'http://biolog-e.ls.biu.ac.il/faculty/wides/80-440/saritnm1353.pdf', u'http://www.nature.com/doifinder/10.1038/nm1353', u'http://dx.doi.org/10.1038/nm1353']",
10.1172/JCI118842,"Sarobe, P., Lasarte, J., Zabaleta, A., et. al, Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses, Journal of Virology, 2003",cited-by,10.1128/JVI.77.20.10862-10871.2003,Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses,"[['Pablo', '', 'Sarobe'], ['J.', 'J.', 'Lasarte'], ['Aintzane', '', 'Zabaleta'], ['Laura', '', 'Arribillaga'], ['Ainhoa', '', 'Arina'], ['Ignacio', '', 'Melero'], ['Francisco', '', 'Borras-Cuesta'], ['Jesus', '', 'Prieto']]",Journal of Virology,2003,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.20.10862-10871.2003'],
10.1172/JCI118842,"Koziel, M., , The role of immune responses in the pathogenesis of hepatitis C virus infection, Journal of Viral Hepatitis, 1997",cited-by,10.1111/j.1365-2893.1997.tb00178.x,The role of immune responses in the pathogenesis of hepatitis C virus infection,"[['M.', 'J.', 'Koziel']]",Journal of Viral Hepatitis,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.1997.tb00178.x'],
10.1172/JCI118842,"Rahman, F., Heller, T., Sobao, Y., et. al, Effects of antiviral therapy on the cellular immune response in acute hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20253,Effects of antiviral therapy on the cellular immune response in acute hepatitis C,"[['Fareed', '', 'Rahman'], ['Theo', '', 'Heller'], ['Yuji', '', 'Sobao'], ['Eishiro', '', 'Mizukoshi'], ['Michelina', '', 'Nascimbeni'], ['Harvey', '', 'Alter'], ['Steven', '', 'Herrine'], ['Jay', '', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20253'],
10.1172/JCI118842,"Kaplan, D., Sugimoto, K., Newton, K., et. al, Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2006.11.044,Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C,"[['David', 'E.', 'Kaplan'], ['Kazushi', '', 'Sugimoto'], ['Kimberly', '', 'Newton'], ['Mary', 'E.', 'Valiga'], ['Fusao', '', 'Ikeda'], ['Ayse', '', 'Aytaman'], ['Frederick', 'A.', 'Nunes'], ['Michael', 'R.', 'Lucey'], ['Barbara', 'A.', 'Vance'], ['Robert', 'H.', 'Vonderheide'], ['K.', 'Rajender', 'Reddy'], ['Jane', 'A.', 'McKeating']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S001650850602525X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850602525X']",
10.1172/JCI118842,"Semmo, N., Day, C., Ward, S., et. al, Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection, Hepatology, 2005",cited-by,10.1002/hep.20669,Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection,"[['Nasser', '', 'Semmo'], ['Cheryl', 'L.', 'Day'], ['Scott', 'M.', 'Ward'], ['Michaela', '', 'Lucas'], ['Gillian', '', 'Harcourt'], ['Andrew', '', 'Loughry'], ['Paul', '', 'Klenerman']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20669'],
10.1172/JCI118842,"Beld, M., Penning, M., Lukashov, V., et. al, Evidence That both HIV and HIV-Induced Immunodeficiency Enhance HCV Replication among HCV Seroconverters, Virology, 1998",cited-by,10.1006/viro.1998.9130,Evidence That both HIV and HIV-Induced Immunodeficiency Enhance HCV Replication among HCV Seroconverters,"[['Marcel', '', 'Beld'], ['Maarten', '', 'Penning'], ['Vladimir', '', 'Lukashov'], ['Martin', '', 'McMorrow'], ['Marijke', '', 'Roos'], ['Nadine', '', 'Pakker'], ['Anneke', 'van den', 'Hoek'], ['Jaap', '', 'Goudsmit']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298991309', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298991309']",
10.1172/JCI118842,"Thomson, M., Nascimbeni, M., Havert, M., et. al, The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.862-870.2003,The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity,"[['Michael', '', 'Thomson'], ['Michelina', '', 'Nascimbeni'], ['Michael', 'B.', 'Havert'], ['Marian', '', 'Major'], ['Sophia', '', 'Gonzales'], ['Harvey', '', 'Alter'], ['Stephen', 'M.', 'Feinstone'], ['Krishna', 'K.', 'Murthy'], ['Barbara', '', 'Rehermann'], ['T.', 'Jake', 'Liang']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.862-870.2003', u'http://jvi.asm.org/cgi/reprint/77/2/862.pdf']",
10.1172/JCI118842,"Baumert, T., Vergalla, J., Satoi, J., et. al, Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate, Gastroenterology, 1999",cited-by,10.1016/S0016-5085(99)70290-8,Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate,"[['Thomas', 'F.', 'Baumert'], ['John', '', 'Vergalla'], ['Jujin', '', 'Satoi'], ['Michael', '', 'Thomson'], ['Martin', '', 'Lechmann'], ['David', '', 'Herion'], ['Harry', 'B.', 'Greenberg'], ['Susumu', '', 'Ito'], ['T.', 'Jake', 'Liang']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0016508599702908', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508599702908']",
10.1172/JCI118842,"Rehermann, B., , Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence, Journal of Clinical Investigation, 2009",cited-by,10.1172/JCI39133DS1,Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence,"[['Barbara', '', 'Rehermann']]",Journal of Clinical Investigation,2009,"[u'http://www.jci.org/articles/view/39133', u'http://www.jci.org/articles/view/39133#sd']",
10.1172/JCI118842,"Neumann-Haefelin, C., Blum, H., Chisari, F., et. al, T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005",cited-by,10.1016/j.jcv.2004.05.008,T cell response in hepatitis C virus infection,"[['C.', '', 'Neumann-Haefelin'], ['H.', 'E.', 'Blum'], ['F.', 'V.', 'Chisari'], ['R.', '', 'Thimme']]",Journal of Clinical Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S138665320400157X', u'http://linkinghub.elsevier.com/retrieve/pii/S138665320400157X']",
10.1172/JCI118842,"Morishima, C., Paschal, D., Wang, C., et. al, Decreased NK cell frequency in chronic hepatitis C does not affectex vivo cytolytic killing, Hepatology, 2006",cited-by,10.1002/hep.21073,Decreased NK cell frequency in chronic hepatitis C does not affectex vivo cytolytic killing,"[['Chihiro', '', 'Morishima'], ['Denise', 'M.', 'Paschal'], ['Chia', 'C.', 'Wang'], ['Christina', 'S.', 'Yoshihara'], ['Brent', 'L.', 'Wood'], ['Anthony', 'E. T.', 'Yeo'], ['Scott', 'S.', 'Emerson'], ['Margaret', 'C.', 'Shuhart'], ['David', 'R.', 'Gretch']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21073'],
10.1172/JCI118842,"Ludwig, I., Lekkerkerker, A., Depla, E., et. al, Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation, Journal of Virology, 2004",cited-by,10.1128/JVI.78.15.8322-8332.2004,Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation,"[['Irene', 'S.', 'Ludwig'], ['Annemarie', 'N.', 'Lekkerkerker'], ['Erik', '', 'Depla'], ['Fons', '', 'Bosman'], ['R.', 'J. P.', 'Musters'], ['S.', '', 'Depraetere'], ['Kooijk', 'van', 'Y'], ['T.', 'B. H.', 'Geijtenbeek']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/15/8322.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.15.8322-8332.2004']",
10.1172/JCI118842,"Prezzi, C., Francavilla, V., Schiaffella, E., et. al, Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I,Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection,"[['Caterina', '', 'Prezzi'], ['Vittorio', '', 'Francavilla'], ['Enrico', '', 'Schiaffella'], ['Luigi', '', 'Finocchi'], ['Guglielmo', '', 'Bruno'], ['Alessandro', '', 'Sette'], ['Sergio', '', 'Abrignani'], ['Vincenzo', '', 'Barnaba']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200103%2931%3A3%3C894%3A%3AAID-IMMU894%3E3.0.CO%3B2-I'],
10.1172/JCI118842,"Cramp, M., Carucci, P., Rossol, S., et. al, Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia, Gut, 1999",cited-by,10.1136/gut.44.3.424,Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia,"[['M', 'E', 'Cramp'], ['P', '', 'Carucci'], ['S', '', 'Rossol'], ['S', '', 'Chokshi'], ['G', '', 'Maertens'], ['R', '', 'Williams'], ['N', 'V', 'Naoumov']]",Gut,1999,"[u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.44.3.424']",
10.1172/JCI118842,"Bowen, D., Zen, M., Holz, L., et. al, The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity, Journal of Clinical Investigation, 2004",cited-by,10.1172/JCI21593,The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity,"[['David', 'G.', 'Bowen'], ['Monica', '', 'Zen'], ['Lauren', '', 'Holz'], ['Thomas', '', 'Davis'], ['Geoffrey', 'W.', 'McCaughan'], ['Patrick', '', 'Bertolino']]",Journal of Clinical Investigation,2004,[u'http://www.jci.org/articles/view/21593'],
10.1172/JCI118842,"Ulsenheimer, A., Gerlach, J., Jung, M., et. al, Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection, Hepatology, 2005",cited-by,10.1002/hep.20592,Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection,"[['Axel', '', 'Ulsenheimer'], ['J.', 'Tilman', 'Gerlach'], ['Maria-Christina', '', 'Jung'], ['Norbert', '', 'Gruener'], ['Markus', '', 'Backmund'], ['Teresa', '', 'Santantonio'], ['Winfried', '', 'Schraut'], ['Malte', 'H. J.', 'Heeg'], ['Carl', 'A.', 'Schirren'], ['Reinhart', '', 'Zachoval'], ['Gerd', 'R.', 'Pape'], ['Helmut', 'M.', 'Diepolder']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20592'],
10.1172/JCI118842,"Urbani, S., Amadei, B., Fisicaro, P., et. al, Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses, Hepatology, 2006",cited-by,10.1002/hep.21242,Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses,"[['Simona', '', 'Urbani'], ['Barbara', '', 'Amadei'], ['Paola', '', 'Fisicaro'], ['Daniela', '', 'Tola'], ['Alessandra', '', 'Orlandini'], ['Luca', '', 'Sacchelli'], ['Cristina', '', 'Mori'], ['Gabriele', '', 'Missale'], ['Carlo', '', 'Ferrari']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21242'],
10.1172/JCI118842,"Thimme, R., Lohmann, V., Weber, F., , A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2005.12.001,A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus,"[['Robert', '', 'Thimme'], ['Volker', '', 'Lohmann'], ['Friedemann', '', 'Weber']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205002603', u'http://umanitoba.ca/faculties/medicine/units/medical_microbiology/Courses/MicroPath97.705/PDF/Thimme_HCV9_3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205002603']",
10.1172/JCI118842,"Santantonio, T., Sinisi, E., Guastadisegni, A., et. al, Natural course of acute hepatitis C: a long-term prospective study, Digestive and Liver Disease, 2003",cited-by,10.1016/S1590-8658(03)00007-0,Natural course of acute hepatitis C: a long-term prospective study,"[['T', '', 'Santantonio'], ['E', '', 'Sinisi'], ['A', '', 'Guastadisegni'], ['C', '', 'Casalino'], ['M', '', 'Mazzola'], ['A', '', 'Gentile'], ['G', '', 'Leandro'], ['G', '', 'Pastore']]",Digestive and Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1590865803000070', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865803000070']",
10.1172/JCI118842,"Hu, K., Vierling, J., Redeker, A., , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00253.x,"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection","[['Ke-Qin', '', 'Hu'], ['John', 'M.', 'Vierling'], ['Allan', 'G.', 'Redeker']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00253.x'],
10.1172/JCI118842,"Chang, K., Rehermann, B., Chisari, F., , Immunopathology of hepatitis C, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945025,Immunopathology of hepatitis C,"[['Kyong-Mi', '', 'Chang'], ['Barbara', '', 'Rehermann'], ['Francis', 'V.', 'Chisari']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/content/g7584j0081412582', u'http://www.springerlink.com/index/g7584j0081412582.pdf', u'http://www.springerlink.com/index/10.1007/BF00945025', u'http://www.springerlink.com/index/pdf/10.1007/BF00945025']",
10.1172/JCI118842,"Glynn, S., Wright, D., Kleinman, S., et. al, Dynamics of viremia in early hepatitis C virus infection, Transfusion, 2005",cited-by,10.1111/j.1537-2995.2005.04390.x,Dynamics of viremia in early hepatitis C virus infection,"[['Simone', 'A.', 'Glynn'], ['David', 'J.', 'Wright'], ['Steven', 'H.', 'Kleinman'], ['Dale', '', 'Hirschkorn'], ['Yongling', '', 'Tu'], ['Charles', '', 'Heldebrant'], ['Richard', '', 'Smith'], ['Cristina', '', 'Giachetti'], ['James', '', 'Gallarda'], ['Michael', 'P.', 'Busch']]",Transfusion,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2005.04390.x'],
10.1172/JCI118842,"Firbas, C., Jilma, B., Tauber, E., et. al, Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.03.009,"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects","[['Christa', '', 'Firbas'], ['Bernd', '', 'Jilma'], ['Erich', '', 'Tauber'], ['Vera', '', 'Buerger'], ['Sandra', '', 'Jelovcan'], ['Karen', '', 'Lingnau'], ['Michael', '', 'Buschle'], ['J\xc3\xbcrgen', '', 'Frisch'], ['Christoph', 'S.', 'Klade']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06002738', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06002738']",
10.1172/JCI118842,"Chang, K., , Immunopathogenesis of hepatitis C virus infection, Clinics in Liver Disease, 2003",cited-by,10.1016/S1089-3261(02)00068-5,Immunopathogenesis of hepatitis C virus infection,"[['Kyong-Mi', '', 'Chang']]",Clinics in Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1089326102000685', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326102000685']",
10.1172/JCI118842,"Gaudieri, S., Rauch, A., Park, L., et. al, Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection, Journal of Virology, 2006",cited-by,10.1128/JVI.00912-06,Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection,"[['Silvana', '', 'Gaudieri'], ['Andri', '', 'Rauch'], ['Lawrence', 'P.', 'Park'], ['Elizabeth', '', 'Freitas'], ['Susan', '', 'Herrmann'], ['Gary', '', 'Jeffrey'], ['Wendy', '', 'Cheng'], ['Katja', '', 'Pfafferott'], ['Kiloshni', '', 'Naidoo'], ['Russell', '', 'Chapman'], ['Manuel', '', 'Battegay'], ['Rainer', '', 'Weber'], ['Amalio', '', 'Telenti'], ['Hansjakob', '', 'Furrer'], ['Ian', '', 'James'], ['Michaela', '', 'Lucas'], ['Simon', 'A.', 'Mallal']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/22/11094.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00912-06', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02740-06']",
10.1172/JCI118842,"Dore, G., Freeman, A., Law, M., et. al, Is severe liver disease a common outcome for people with chronic hepatitisC?, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02730.x,Is severe liver disease a common outcome for people with chronic hepatitisC?,"[['Gregory', 'J', 'Dore'], ['Anthony', 'J', 'Freeman'], ['Matthew', '', 'Law'], ['JohnM', '', 'Kaldor']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02730.x'],
10.1172/JCI118842,"Thomas, H., Török, M., Forton, D., et. al, Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80393-6,Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C,"[['Howard.', 'C.', 'Thomas'], ['M.', 'E.', 'T\xc3\xb6r\xc3\xb6k'], ['D.', 'M.', 'Forton'], ['S.', 'D.', 'Taylor-Robinson']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803936', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803936']",
10.1172/JCI118842,"McCaughan, G., Zekry, A., , Mechanisms of HCV reinfection and allograft damage after liver transplantation, Journal of Hepatology, 2004",cited-by,10.1016/j.jhep.2004.01.014,Mechanisms of HCV reinfection and allograft damage after liver transplantation,"[['Geoffrey', 'W', 'McCaughan'], ['Amany', '', 'Zekry']]",Journal of Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S016882780400025X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780400025X']",
10.1172/JCI118842,"Geissler, M., Tokushige, K., Wakita, T., et. al, Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs, Vaccine, 1998",cited-by,10.1016/S0264-410X(97)00236-3,Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs,"[['Michael', '', 'Geissler'], ['Katsutoshi', '', 'Tokushige'], ['Takaji', '', 'Wakita'], ['Vincent', 'R.', 'Zurawski'], ['Jack', 'R.', 'Wands']]",Vaccine,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X97002363', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X97002363']",
10.1172/JCI118842,"Yao, Z., Eisen-Vandervelde, A., Waggoner, S., et. al, Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt, Journal of Virology, 2004",cited-by,10.1128/JVI.78.12.6409-6419.2004,Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt,"[['Zhi', 'Qiang', 'Yao'], ['Audrey', '', 'Eisen-Vandervelde'], ['Stephen', 'N.', 'Waggoner'], ['Evan', 'M.', 'Cale'], ['Young', 'S.', 'Hahn']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/12/6409.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.12.6409-6419.2004', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00145-07']",
10.1172/JCI118842,"Dutoit, V., Ciuffreda, D., Comte, D., et. al, Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection, European Journal of Immunology, 2005",cited-by,10.1002/eji.200535035,Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection,"[['Val\xc3\xa9rie', '', 'Dutoit'], ['Donatella', '', 'Ciuffreda'], ['Denis', '', 'Comte'], ['Jean-Jacques', '', 'Gonvers'], ['Giuseppe', '', 'Pantaleo']]",European Journal of Immunology,2005,[u'http://doi.wiley.com/10.1002/eji.200535035'],
10.1172/JCI118842,"O’Hagan, D., Singh, M., Dong, C., et. al, Cationic microparticles are a potent delivery system for a HCV DNA vaccine, Vaccine, 2004",cited-by,10.1016/j.vaccine.2004.06.037,Cationic microparticles are a potent delivery system for a HCV DNA vaccine,"[['Derek', 'T.', 'O\xe2\x80\x99Hagan'], ['Manmohan', '', 'Singh'], ['Christine', '', 'Dong'], ['Mildred', '', 'Ugozzoli'], ['Kim', '', 'Berger'], ['Edward', '', 'Glazer'], ['Mark', '', 'Selby'], ['Mark', '', 'Wininger'], ['Philip', '', 'Ng'], ['Kevin', '', 'Crawford'], ['Xavier', '', 'Paliard'], ['Steven', '', 'Coates'], ['Michael', '', 'Houghton']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04005250', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04005250']",
10.1172/JCI118842,"Yao, Z., Nguyen, D., Hiotellis, A., et. al, Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1,2, , 2001",cited-by,"6333770Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1,2","Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1,2","[['Zhi', 'Qiang', 'Yao'], ['Duong', 'Tony', 'Nguyen'], ['Apostolos', 'I.', 'Hiotellis'], ['Young', 'S.', 'Hahn']]",,2001,[u'http://www.jimmunol.org/cgi/reprint/167/9/5264.pdf'],
10.1172/JCI118842,"Fournillier, A., Wychowski, C., Boucreux, D., et. al, Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites, Journal of Virology, 2001",cited-by,10.1128/JVI.75.24.12088-12097.2001,Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites,"[['A.', '', 'Fournillier'], ['C.', '', 'Wychowski'], ['D.', '', 'Boucreux'], ['T.', 'F.', 'Baumert'], ['J.-C.', '', 'Meunier'], ['D.', '', 'Jacobs'], ['S.', '', 'Muguet'], ['E.', '', 'Depla'], ['G.', '', 'Inchauspe']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/24/12088.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.24.12088-12097.2001']",
10.1172/JCI118842,"Busch, M., , Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients, Transfusion Clinique Et Biologique, 2001",cited-by,10.1016/S1246-7820(01)00125-2,"Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients","[['M.', 'P', 'Busch']]",Transfusion Clinique Et Biologique,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1246782001001252', u'http://linkinghub.elsevier.com/retrieve/pii/S1246782001001252']",
10.1172/JCI118842,"Freeman, A., Marinos, G., Ffrench, R., et. al, Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001",cited-by,10.1046/j.1440-1711.2001.01036.x,Immunopathogenesis of hepatitis C virus infection,"[['Anthony', 'J', 'Freeman'], ['George', '', 'Marinos'], ['Rosemary', 'A', 'Ffrench'], ['Andrew', 'R', 'Lloyd']]",Immunology and Cell Biology,2001,"[u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2001.01036.x', u'http://dx.doi.org/10.1046/j.1440-1711.2001.01036.x']",
10.1172/JCI118842,"Vidalin, O., Tanaka, E., Spengler, U., et. al, Targeting of Hepatitis C Virus Core Protein for MHC I or MHC II Presentation Does Not Enhance Induction of Immune Responses to DNA Vaccination, Dna and Cell Biology, 1999",cited-by,10.1089/104454999315024,Targeting of Hepatitis C Virus Core Protein for MHC I or MHC II Presentation Does Not Enhance Induction of Immune Responses to DNA Vaccination,"[['O.', '', 'Vidalin'], ['E.', '', 'Tanaka'], ['U.', '', 'Spengler'], ['C.', '', 'Trepo'], ['G.', '', 'Inchauspe']]",Dna and Cell Biology,1999,[u'http://www.liebertonline.com/doi/abs/10.1089%2F104454999315024'],
10.1172/JCI118842,"Mauss, S., Klinker, H., Ulmer, A., et. al, Response to treatment of chronic hepatitis C with interferon α in patients infected with HIV1 is associated with higher CD4+ cell count, Infection, 1998",cited-by,10.1007/BF02768746,Response to treatment of chronic hepatitis C with interferon α in patients infected with HIV1 is associated with higher CD4+ cell count,"[['S.', '', 'Mauss'], ['H.', '', 'Klinker'], ['A.', '', 'Ulmer'], ['R.', '', 'Willers'], ['B.', '', 'Wei\xc3\x9fbrich'], ['H.', '', 'Albrecht'], ['D.', '', 'H\xc3\xa4ussinger'], ['H.', '', 'Jablonowski']]",Infection,1998,"[u'http://www.springerlink.com/content/yu4x81757524xt0q', u'http://www.springerlink.com/index/yu4x81757524xt0q.pdf', u'http://www.springerlink.com/index/10.1007/BF02768746', u'http://www.springerlink.com/index/pdf/10.1007/BF02768746']",
10.1172/JCI118842,"Rollier, C., Depla, E., Drexhage, J., et. al, Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response, Journal of Virology, 2004",cited-by,10.1128/JVI.78.1.187-196.2004,Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response,"[['C.', '', 'Rollier'], ['E.', '', 'Depla'], ['J.', 'A. R.', 'Drexhage'], ['E.', 'J.', 'Verschoor'], ['B.', 'E.', 'Verstrepen'], ['A.', '', 'Fatmi'], ['C.', '', 'Brinster'], ['A.', '', 'Fournillier'], ['J.', 'A.', 'Whelan'], ['M.', '', 'Whelan'], ['D.', '', 'Jacobs'], ['G.', '', 'Maertens'], ['G.', '', 'Inchauspe'], ['J.', 'L.', 'Heeney']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/1/187.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.1.187-196.2004']",
10.1172/JCI118842,"Kamal, S., Amin, A., Madwar, M., et. al, Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients, Journal of Virology, 2004",cited-by,10.1128/JVI.78.22.12252-12258.2004,Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients,"[['Sanaa', 'M.', 'Kamal'], ['Ashraf', '', 'Amin'], ['Mohamed', '', 'Madwar'], ['Camilla', 'S.', 'Graham'], ['Qi', '', 'He'], ['Ahmed', 'Al', 'Tawil'], ['Jens', '', 'Rasenack'], ['Tatsunori', '', 'Nakano'], ['Betty', '', 'Robertson'], ['Alaa', '', 'Ismail'], ['Margaret', 'James', 'Koziel']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/22/12252.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.22.12252-12258.2004']",
10.1172/JCI118842,"Pawlotsky, J., , The nature of interferon-?? resistance in hepatitis C virus infection, Current Opinion in Infectious Diseases, 2003",cited-by,10.1097/00001432-200312000-00012,The nature of interferon-?? resistance in hepatitis C virus infection,"[['Jean-Michel', '', 'Pawlotsky']]",Current Opinion in Infectious Diseases,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200312000-00012'],
10.1172/JCI118842,"Harcourt, G., Hellier, S., Bunce, M., et. al, Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00289.x,Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection,"[['G.', '', 'Harcourt'], ['S.', '', 'Hellier'], ['M.', '', 'Bunce'], ['J.', '', 'Satsangi'], ['J.', '', 'Collier'], ['R.', '', 'Chapman'], ['R.', '', 'Phillips'], ['P.', '', 'Klenerman']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00289.x'],
10.1172/JCI118842,"Forns, X., Bukh, J., Purcell, R., , The challenge of developing a vaccine against hepatitis C virus, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00308-2,The challenge of developing a vaccine against hepatitis C virus,"[['Xavier', '', 'Forns'], ['Jens', '', 'Bukh'], ['Robert', 'H', 'Purcell']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802003082', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802003082']",
10.1172/JCI118842,"Cho, J., Lee, S., Sung, Y., , Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization, Vaccine, 1999",cited-by,10.1016/S0264-410X(98)00333-8,Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization,"[['Jae', 'Ho', 'Cho'], ['Seung', 'Woo', 'Lee'], ['Young', 'Chul', 'Sung']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X98003338', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X98003338']",
10.1172/JCI118842,"Missiha, S., Ostrowski, M., Heathcote, E., , Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008",cited-by,10.1053/j.gastro.2008.02.069,Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors,"[['Sharif', 'B.', 'Missiha'], ['Mario', '', 'Ostrowski'], ['E.', 'Jenny', 'Heathcote']]",Gastroenterology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S001650850800348X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850800348X']",
10.1172/JCI118842,"Shiina, M., Rehermann, B., , Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function, Hepatology, 2008",cited-by,10.1002/hep.21996,Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function,"[['Masaaki', '', 'Shiina'], ['Barbara', '', 'Rehermann']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.21996'],
10.1172/JCI118842,"Sugimoto, K., Kaplan, D., Ikeda, F., et. al, Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.11.6976-6983.2005,Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection,"[['Kazushi', '', 'Sugimoto'], ['David', 'E.', 'Kaplan'], ['Fusao', '', 'Ikeda'], ['Jin', '', 'Ding'], ['Jonathan', '', 'Schwartz'], ['Frederick', 'A.', 'Nunes'], ['Harvey', 'J.', 'Alter'], ['Kyong-Mi', '', 'Chang']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.11.6976-6983.2005', u'http://jvi.asm.org/cgi/reprint/79/11/6976.pdf']",
10.1172/JCI118842,"Bain, C., Parroche, P., Lavergne, J., et. al, Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.19.10460-10469.2004,Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection,"[['Christine', '', 'Bain'], ['Peggy', '', 'Parroche'], ['Jean', 'Pierre', 'Lavergne'], ['Blandine', '', 'Duverger'], ['Claude', '', 'Vieux'], ['Valerie', '', 'Dubois'], ['Florence', '', 'Komurian-Pradel'], ['Christian', '', 'Trepo'], ['Lucette', '', 'Gebuhrer'], ['Glaucia', '', 'Paranhos-Baccala'], ['Francois', '', 'Penin'], ['Genevieve', '', 'Inchauspe']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/19/10460.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.19.10460-10469.2004']",
10.1172/JCI118842,"Qiao, M., Murata, K., Davis, A., et. al, Hepatitis C Virus-Like Particles Combined With Novel Adjuvant Systems Enhance Virus-Specific Immune Responses, , 2003",cited-by,3178921Hepatitis C Virus-Like Particles Combined With Novel Adjuvant Systems Enhance Virus-Specific Immune Responses,Hepatitis C Virus-Like Particles Combined With Novel Adjuvant Systems Enhance Virus-Specific Immune Responses,"[['Ming', '', 'Qiao'], ['Kazumoto', '', 'Murata'], ['Anthony', 'R.', 'Davis'], ['Sook-Hyang', '', 'Jeong'], ['T.', 'Jake', 'Liang']]",,2003,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/immuneresponse.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/immuneresponse.pdf', u'http://www.hawaii.edu/hivandaids/Hepatitis%20C%20Virus%20Combined%20With%20Novel%20Adjuvant%20Systems%20Enhance%20Virus-Specific%20Immune%20Responses.pdf']",
10.1172/JCI118842,"Kim, A., Saab, S., , Treatment of hepatitis C, American Journal of Medicine, 2005",cited-by,10.1016/j.amjmed.2005.01.073,Treatment of hepatitis C,"[['Andrew', 'I.', 'Kim'], ['Sammy', '', 'Saab']]",American Journal of Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0002934305003359', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934305003359']",
10.1172/JCI118842,"Bahra, M., Neumann, U., Jacob, D., et. al, MMF and Calcineurin Taper in Recurrent Hepatitis C After Liver Transplantation: Impact on Histological Course, American Journal of Transplantation, 2005",cited-by,10.1111/j.1600-6143.2004.00706.x,MMF and Calcineurin Taper in Recurrent Hepatitis C After Liver Transplantation: Impact on Histological Course,"[['Marcus', '', 'Bahra'], ['UIF', 'P.', 'Neumann'], ['Dietmar', '', 'Jacob'], ['Gero', '', 'Puhl'], ['Jochen', '', 'Klupp'], ['Jan', 'M.', 'Langrehr'], ['Thomas', '', 'Berg'], ['Peter', '', 'Neuhaus']]",American Journal of Transplantation,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1600-6143.2004.00706.x'],
10.1172/JCI118842,"Kaplan, D., Sugimoto, K., Ikeda, F., et. al, T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20706,T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C,"[['David', 'E.', 'Kaplan'], ['Kazushi', '', 'Sugimoto'], ['Fusao', '', 'Ikeda'], ['Jason', '', 'Stadanlick'], ['Mary', '', 'Valiga'], ['Kirti', '', 'Shetty'], ['K.', 'Rajender', 'Reddy'], ['Kyong-Mi', '', 'Chang']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20706'],
10.1172/JCI118842,"Gremion, C., Cerny, A., , Hepatitis C virus and the immune system: a concise review, Reviews in Medical Virology, 2005",cited-by,10.1002/rmv.466,Hepatitis C virus and the immune system: a concise review,"[['Christel', '', 'Gremion'], ['Andreas', '', 'Cerny']]",Reviews in Medical Virology,2005,[u'http://doi.wiley.com/10.1002/rmv.466'],
10.1172/JCI118842,"Laskus, T., Wilkinson, J., Gallegos-Orozco, J., et. al, Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.06.005,Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion,"[['Tomasz', '', 'Laskus'], ['Jeffrey', '', 'Wilkinson'], ['Juan', 'F.', 'Gallegos-Orozco'], ['Marek', '', 'Radkowski'], ['Debra', 'M.', 'Adair'], ['Marek', '', 'Nowicki'], ['Eva', '', 'Operskalski'], ['Zelma', '', 'Buskell'], ['Leonard', 'B.', 'Seeff'], ['Hugo', '', 'Vargas'], ['Jorge', '', 'Rakela']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504010248', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504010248']",
10.1172/JCI118842,"Vertuani, S., Bazzaro, M., Gualandi, G., et. al, Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals, European Journal of Immunology, 2002",cited-by,10.1002/1521-4141(200201)32:1<144::AID-IMMU144>3.0.CO;2-X,Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals,"[['Simona', '', 'Vertuani'], ['Martina', '', 'Bazzaro'], ['Guido', '', 'Gualandi'], ['Fabiola', '', 'Micheletti'], ['Mauro', '', 'Marastoni'], ['Cinzia', '', 'Fortini'], ['Alessandro', '', 'Canella'], ['Michele', '', 'Marino'], ['Roberto', '', 'Tomatis'], ['Serena', '', 'Traniello'], ['Riccardo', '', 'Gavioli']]",European Journal of Immunology,2002,[u'http://doi.wiley.com/10.1002/1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X'],
10.1172/JCI118842,"Lanford, R., Bigger, C., Bassett, S., et. al, The Chimpanzee Model of Hepatitis C Virus Infections, , 2001",cited-by,5462662The Chimpanzee Model of Hepatitis C Virus Infections,The Chimpanzee Model of Hepatitis C Virus Infections,"[['Robert', 'E.', 'Lanford'], ['Catherine', '', 'Bigger'], ['Suzanne', '', 'Bassett'], ['Gary', '', 'Klimpel']]",,2001,[u'http://dels-old.nas.edu/ilar_n/ilarjournal/42_2/Hep-C-Chimp.pdf'],
10.1172/JCI118842,"Walker, C., , Comparative features of hepatitis C virus infection in humans and chimpanzees, Springer Seminars in Immunopathology, 1997",cited-by,10.1007/BF00945027,Comparative features of hepatitis C virus infection in humans and chimpanzees,"[['Christopher', 'M.', 'Walker']]",Springer Seminars in Immunopathology,1997,"[u'http://www.springerlink.com/index/kg6q7855175ukx07.pdf', u'http://www.springerlink.com/content/kg6q7855175ukx07', u'http://www.springerlink.com/index/10.1007/BF00945027', u'http://www.springerlink.com/index/pdf/10.1007/BF00945027']",
10.1172/JCI118842,"Zeremski, M., Petrovic, L., Talal, A., , The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2006.00838.x,The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection,"[['M.', '', 'Zeremski'], ['L.', 'M.', 'Petrovic'], ['A.', 'H.', 'Talal']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00838.x'],
10.1172/JCI118842,"Gerlach, J., Ulsenheimer, A., Gruner, N., et. al, Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins, Journal of Virology, 2005",cited-by,10.1128/JVI.79.19.12425-12433.2005,Minimal T-Cell-Stimulatory Sequences and Spectrum of HLA Restriction of Immunodominant CD4+ T-Cell Epitopes within Hepatitis C Virus NS3 and NS4 Proteins,"[['J.', 'T.', 'Gerlach'], ['A.', '', 'Ulsenheimer'], ['N.', 'H.', 'Gruner'], ['M.-C.', '', 'Jung'], ['W.', '', 'Schraut'], ['C.-A.', '', 'Schirren'], ['M.', '', 'Heeg'], ['S.', '', 'Scholz'], ['K.', '', 'Witter'], ['R.', '', 'Zahn'], ['A.', '', 'Vogler'], ['R.', '', 'Zachoval'], ['G.', 'R.', 'Pape'], ['H.', 'M.', 'Diepolder']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/19/12425.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.19.12425-12433.2005']",
10.1172/JCI118842,"Rigopoulou, E., Abbott, W., Haigh, P., et. al, Blocking of interleukin-10 receptor—a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus, Clinical Immunology, 2005",cited-by,10.1016/j.clim.2005.06.003,Blocking of interleukin-10 receptor—a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus,"[['Eirini', 'I.', 'Rigopoulou'], ['William', 'G. H.', 'Abbott'], ['Philip', '', 'Haigh'], ['Nikolai', 'V.', 'Naoumov']]",Clinical Immunology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1521661605001816', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661605001816']",
10.1172/JCI118842,"Thoren, F., Romero, A., Lindh, M., et. al, A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals, Journal of Leukocyte Biology, 2004",cited-by,10.1189/jlb.0704387,"A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals","[['Fredrik', '', 'Thoren'], ['Ana', '', 'Romero'], ['Magnus', '', 'Lindh'], ['Claes', '', 'Dahlgren'], ['Kristoffer', '', 'Hellstrand']]",Journal of Leukocyte Biology,2004,"[u'http://www.jleukbio.org/cgi/rapidpdf/jlb.0704387v1.pdf', u'http://www.jleukbio.org/cgi/reprint/76/6/1180.pdf', u'http://www.jleukbio.org/cgi/doi/10.1189/jlb.0704387']",
10.1172/JCI118842,"Brown, P., Neuman, M., , Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines, Clinical Biochemistry, 2001",cited-by,10.1016/S0009-9120(01)00210-7,Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines,"[['Pearl', 'M Jacobson', 'Brown'], ['Manuela', 'G', 'Neuman']]",Clinical Biochemistry,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0009912001002107', u'http://linkinghub.elsevier.com/retrieve/pii/S0009912001002107']",
10.1172/JCI118842,"Sugimoto, K., Stadanlick, J., Ikeda, F., et. al, Influence of Ethnicity in the Outcome of Hepatitis C Virus Infection and Cellular Immune Response, , 0",cited-by,5979386Influence of Ethnicity in the Outcome of Hepatitis C Virus Infection and Cellular Immune Response,Influence of Ethnicity in the Outcome of Hepatitis C Virus Infection and Cellular Immune Response,"[['Kazushi', '', 'Sugimoto'], ['Jason', '', 'Stadanlick'], ['Fusao', '', 'Ikeda'], ['Colleen', '', 'Brensinger'], ['Emma', 'E.', 'Furth'], ['Harvey', 'J.', 'Alter'], ['Kyong-Mi', '', 'Chang']]",,0,[u'http://www.hawaii.edu/hivandaids/Influence%20Of%20Ethnicity%20In%20The%20Outcome%20Of%20Hepatitis%20C%20Virus%20Infection.pdf'],
10.1172/JCI118842,"Day, C., Walker, B., , Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections, , 2003",cited-by,6706064Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections,Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections,"[['Cheryl', 'L.', 'Day'], ['Bruce', 'D.', 'Walker']]",,2003,[u'http://jem.rupress.org/cgi/reprint/198/12/1773.pdf'],
10.1172/JCI118842,"Sugimoto, Y., Kuzushita, N., Takehara, T., et. al, A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00365.x,A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C,"[['Y.', '', 'Sugimoto'], ['N.', '', 'Kuzushita'], ['T.', '', 'Takehara'], ['T.', '', 'Kanto'], ['T.', '', 'Tatsumi'], ['T.', '', 'Miyagi'], ['M.', '', 'Jinushi'], ['K.', '', 'Ohkawa'], ['M.', '', 'Horimoto'], ['A.', '', 'Kasahara'], ['M.', '', 'Hori'], ['Y.', '', 'Sasaki'], ['N.', '', 'Hayashi']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00365.x'],
10.1172/JCI118842,"Arribillaga, L., Cerio, A., Sarobe, P., et. al, Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00456-5,Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus,"[['Laura', '', 'Arribillaga'], ['Ascensi\xc3\xb3n', 'L\xc3\xb3pez D\xc4\xb1\xcc\x81az de', 'Cerio'], ['Pablo', '', 'Sarobe'], ['Noelia', '', 'Casares'], ['Marta', '', 'Gorraiz'], ['Africa', '', 'Vales'], ['Oscar', '', 'Bruna-Romero'], ['Francisco', '', 'Borr\xc3\xa1s-Cuesta'], ['Glaucia', '', 'Paranhos-Baccala'], ['Jes\xc3\xbas', '', 'Prieto'], ['Juan', '', 'Ruiz'], ['Juan', 'Jos\xc3\xa9', 'Lasarte']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02004565', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02004565']",
10.1172/JCI118842,"Alatrakchi, N., Graham, C., Vliet, H., et. al, Hepatitis C Virus (HCV)Specific CD8+ Cells Produce Transforming Growth Factor   That Can Suppress HCVSpecific T-Cell Responses, Journal of Virology, 2007",cited-by,10.1128/JVI.02202-06,Hepatitis C Virus (HCV)Specific CD8+ Cells Produce Transforming Growth Factor   That Can Suppress HCVSpecific T-Cell Responses,"[['Nadia', '', 'Alatrakchi'], ['Camilla', 'S.', 'Graham'], ['Hans', 'J. J. van der', 'Vliet'], ['Kenneth', 'E.', 'Sherman'], ['Mark', 'A.', 'Exley'], ['Margaret', 'James', 'Koziel']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/11/5882.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02202-06']",
10.1172/JCI118842,"Manigold, T., Shin, E., Mizukoshi, E., et. al, Foxp3CD4CD25T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C, , 2006",cited-by,6701099Foxp3CD4CD25T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C,Foxp3CD4CD25T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C,"[['Tobias', '', 'Manigold'], ['Eui-Cheol', '', 'Shin'], ['Eishiro', '', 'Mizukoshi'], ['Kathleen', '', 'Mihalik'], ['Krishna', 'K.', 'Murthy'], ['Charles', 'M.', 'Rice'], ['Ciriaco', 'A.', 'Piccirillo'], ['Barbara', '', 'Rehermann']]",,2006,[],
10.1172/JCI118842,"Ma, X., Forns, X., Gutierrez, R., et. al, DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00304-3,DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice,"[['Xiaoying', '', 'Ma'], ['Xavier', '', 'Forns'], ['Robin', '', 'Gutierrez'], ['Isa', 'K.', 'Mushahwar'], ['Tong', '', 'Wu'], ['Paul', 'J.', 'Payette'], ['Jens', '', 'Bukh'], ['Robert', 'H.', 'Purcell'], ['Heather', 'L.', 'Davis']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02003043', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02003043']",
10.1172/JCI118842,"Nelson, D., , THE IMMUNOPATHOGENESIS OF HEPATITIS C VIRUS INFECTION, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70202-6,THE IMMUNOPATHOGENESIS OF HEPATITIS C VIRUS INFECTION,"[['David', 'R.', 'Nelson']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702026', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702026']",
10.1172/JCI118842,"Averill, L., Lee, W., Karandikar, N., , Differential dysfunction in dendritic cell subsets during chronic HCV infection, , 2007",cited-by,6881535Differential dysfunction in dendritic cell subsets during chronic HCV infection,Differential dysfunction in dendritic cell subsets during chronic HCV infection,"[['Lynn', '', 'Averill'], ['William', 'M.', 'Lee'], ['Nitin', 'J.', 'Karandikar']]",,2007,[u'http://webpath.swmed.edu/research/images/pdfs/2007karandikar_ci2.pdf'],
10.1172/JCI118842,"Piasecki, B., Lewis, J., Reddy, K., et. al, Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population, Hepatology, 2004",cited-by,10.1002/hep.1840400419,"Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population","[['Barbara', 'A.', 'Piasecki'], ['James', 'D.', 'Lewis'], ['K.', 'Rajender', 'Reddy'], ['Scarlett', 'L.', 'Bellamy'], ['Steven', 'B.', 'Porter'], ['Robert', 'M.', 'Weinrieb'], ['Donald', 'D.', 'Stieritz'], ['Kyong-Mi', '', 'Chang']]",Hepatology,2004,"[u'http://www.cceb.upenn.edu/~sbellamy/piasecki.pdf', u'http://doi.wiley.com/10.1002/hep.20384', u'http://doi.wiley.com/10.1002/hep.1840400419']",
10.1056~NEJMoa011232,"Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-82.",references,10.1038/75063,Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C,"[[u'Akinobu', u'', u'Takaki'], [u'Manfred', u'', u'Wiese'], [u'Geert', u'', u'Maertens'], [u'Erik', u'', u'Depla'], [u'Ulrike', u'', u'Seifert'], [u'Anke', u'', u'Liebetrau'], [u'Jeffery', u'L.', u'Miller'], [u'Michael', u'P.', u'Manns'], [u'Barbara', u'', u'Rehermann']]",Nature Medicine,2000,[u'http://dx.doi.org/10.1038/75063'],"[{u'Name': u'cd8+ t cell', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5078}, {u'Name': u'Cellular Immune Response', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5168}, {u'Name': u'Clinical Data', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5949}, {u'Name': u'Cytotoxic T Cells', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 8883}, {u'Name': u'General Population', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 15998}, {u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Long-term Follow Up', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 23445}, {u'Name': u'Acute Phase', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 46973}, {u'Name': u'T Helper Cell', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 71371}]"
10.1038/75063,"Bukh, J., Forns, X., Emerson, S., et. al, Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine Development, Intervirology, 2001",cited-by,10.1159/000050040,Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine Development,"[['Jens', '', 'Bukh'], ['Xavier', '', 'Forns'], ['Suzanne', 'U.', 'Emerson'], ['Robert', 'H.', 'Purcell']]",Intervirology,2001,"[u'http://www.karger.com/doi/10.1159/000050040', u'http://www.online.karger.com/doi/10.1159/000050040']",
10.1038/75063,"Brinster, C., Inchauspé, G., , DNA Vaccines for Hepatitis C Virus, Intervirology, 2001",cited-by,10.1159/000050041,DNA Vaccines for Hepatitis C Virus,"[['Carine', '', 'Brinster'], ['Genevi\xc3\xa8ve', '', 'Inchausp\xc3\xa9']]",Intervirology,2001,"[u'http://www.online.karger.com/doi/10.1159/000050041', u'http://www.karger.com/doi/10.1159/000050041']",
10.1038/75063,"Klenerman, P., Kim, A., , HCV–HIV Coinfection: Simple Messages from a Complex Disease, PLOS Medicine, 2007",cited-by,10.1371/journal.pmed.0040240,HCV–HIV Coinfection: Simple Messages from a Complex Disease,"[['Paul', '', 'Klenerman'], ['Arthur', '', 'Kim']]",PLOS Medicine,2007,"[u'http://dx.doi.org/10.1371/journal.pmed.0040240', u'http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040240']",
10.1038/75063,"Irving, W., , Acute hepatitis C virus infection: a neglected disease?, Gut, 2006",cited-by,10.1136/gut.2005.085407,Acute hepatitis C virus infection: a neglected disease?,"[['W', 'L', 'Irving']]",Gut,2006,"[u'http://dx.doi.org/10.1136/gut.2005.085407', u'http://gut.bmj.com/cgi/doi/10.1136/gut.2005.085407']",
10.1038/75063,"Düesberg, U., Geulen, O., Schneiders, A., et. al, Transient Loss of T-Cell Reactivity in a Patient with Hepatitis C Virus Reinfection, Digestion, 2001",cited-by,10.1159/000048841,Transient Loss of T-Cell Reactivity in a Patient with Hepatitis C Virus Reinfection,"[['Uta', '', 'D\xc3\xbcesberg'], ['Oliver', '', 'Geulen'], ['Angelika', 'M.', 'Schneiders'], ['Rolf', '', 'Kaiser'], ['Hans', 'H.', 'Brackmann'], ['Bertfried', '', 'Matz'], ['Tilman', '', 'Sauerbruch'], ['Ulrich', '', 'Spengler']]",Digestion,2001,"[u'http://www.karger.com/doi/10.1159/000048841', u'http://www.online.karger.com/doi/10.1159/000048841']",
10.1038/75063,"Pfafferott, K., Gaudieri, S., Ulsenheimer, A., et. al, Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity, PLOS One, 2011",cited-by,10.1371/journal.pone.0016797,Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity,"[['Katja', '', 'Pfafferott'], ['Silvana', '', 'Gaudieri'], ['Axel', '', 'Ulsenheimer'], ['Ian', '', 'James'], ['Malte', '', 'Heeg'], ['David', '', 'Nolan'], ['Mina', '', 'John'], ['Andri', '', 'Rauch'], ['Simon', '', 'Mallal'], ['Andrew', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Helmut', 'M.', 'Diepolder'], ['Michaela', '', 'Lucas'], ['Jean-Pierre', '', 'Vartanian']]",PLOS One,2011,"[u'http://adsabs.harvard.edu/abs/2011PLoSO...6E6797P', u'http://dx.doi.org/10.1371/journal.pone.0016797']",
10.1038/75063,"Zarife, M., Reis, E., Meira, G., et. al, IL8 Is Associated with Non-Viremic State and IFN-γ with Biochemical Activity in HCV-Seropositive Blood Donors, Intervirology, 2011",cited-by,10.1159/000318896,IL8 Is Associated with Non-Viremic State and IFN-γ with Biochemical Activity in HCV-Seropositive Blood Donors,"[['Maria', 'Alice S.', 'Zarife'], ['Eliana', 'A. G.', 'Reis'], ['Glenda', 'C.', 'Meira'], ['Theomira', 'M. A.', 'Carmo'], ['Gisele', 'B.', 'Lopes'], ['Emilia', 'C. O. B.', 'Malafaia'], ['Helder', 'R.', 'Silva'], ['Nelma', '', 'Santana'], ['Olindo', 'A.', 'Martins-Filho'], ['Mitermayer', 'G.', 'Reis']]",Intervirology,2011,[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000318896'],
10.1038/75063,"Lukens, J., Dolina, J., Kim, T., et. al, Liver Is Able to Activate Naïve CD8+ T Cells with Dysfunctional Anti-Viral Activity in the Murine System, PLOS One, 2009",cited-by,10.1371/journal.pone.0007619,Liver Is Able to Activate Naïve CD8+ T Cells with Dysfunctional Anti-Viral Activity in the Murine System,"[['John', 'R.', 'Lukens'], ['Joseph', 'S.', 'Dolina'], ['Taeg', 'S.', 'Kim'], ['Robert', 'S.', 'Tacke'], ['Young', 'S.', 'Hahn'], ['Derya', '', 'Unutmaz']]",PLOS One,2009,"[u'http://adsabs.harvard.edu/abs/2009PLoSO...4.7619L', u'http://dx.doi.org/10.1371/journal.pone.0007619']",
10.1038/75063,"Nanda, S., Havert, M., Calderón, G., et. al, Hepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral Clearance, PLOS One, 2008",cited-by,10.1371/journal.pone.0003442,Hepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral Clearance,"[['Santosh', '', 'Nanda'], ['Michael', 'B.', 'Havert'], ['Gloria', 'M.', 'Calder\xc3\xb3n'], ['Michael', '', 'Thomson'], ['Christian', '', 'Jacobson'], ['Daniel', '', 'Kastner'], ['T.', 'Jake', 'Liang'], ['Fu-Sheng', '', 'Wang']]",PLOS One,2008,"[u'http://dx.doi.org/10.1371/journal.pone.0003442', u'http://adsabs.harvard.edu/abs/2008PLoSO...3.3442N']",
10.1038/75063,"Kim, A., Wiesch, J., Kuntzen, T., et. al, Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection, PLOS Medicine, 2006",cited-by,10.1371/journal.pmed.0030492,Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection,"[['Arthur', 'Y', 'Kim'], ['Julian', 'Schulze zur', 'Wiesch'], ['Thomas', '', 'Kuntzen'], ['Joerg', '', 'Timm'], ['Daniel', 'E', 'Kaufmann'], ['Jared', 'E', 'Duncan'], ['Andrea', 'M', 'Jones'], ['Alysse', 'G', 'Wurcel'], ['Benjamin', 'T', 'Davis'], ['Rajesh', 'T', 'Gandhi'], ['Gregory', 'K', 'Robbins'], ['Todd', 'M', 'Allen'], ['Raymond', 'T', 'Chung'], ['Georg', 'M', 'Lauer'], ['Bruce', 'D', 'Walker']]",PLOS Medicine,2006,[u'http://dx.doi.org/10.1371/journal.pmed.0030492'],
10.1056~NEJMoa011232,"Gruener NH, Gerlach TJ, Jung M-C, et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000;181:1528-36.",references,NOT found in MAS
10.1056~NEJMoa011232,"Lechner F, Gruener NH, Urbani S, et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000;30:2479-87.",references,10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained,"[[u'Franziska', u'', u'Lechner'], [u'Norbert', u'H.', u'Gruener'], [u'Simona', u'', u'Urbani'], [u'Jacopo', u'', u'Uggeri'], [u'Teresa', u'', u'Santantonio'], [u'Andreas', u'R.', u'Kammer'], [u'Andreas', u'', u'Cerny'], [u'Rodney', u'', u'Phillips'], [u'Carlo', u'', u'Ferrari'], [u'Gerd', u'R.', u'Pape'], [u'Paul', u'', u'Klenerman']]",European Journal of Immunology,2000,[u'http://doi.wiley.com/10.1002/1521-4141%28200009%2930%3A9%3C2479%3A%3AAID-IMMU2479%3E3.0.CO%3B2-B'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'T Lymphocyte', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 41297}]"
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Dunbar, P., Callan, M., Klenerman, P., et. al, Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections, Nature Medicine, 2002",cited-by,10.1038/nm0402-379,Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections,"[['P.', 'Rod', 'Dunbar'], ['Margaret', '', 'Callan'], ['Paul', '', 'Klenerman'], ['Geraldine', 'M. A.', 'Gillespie'], ['Laura', '', 'Papagno'], ['Graham', 'S.', 'Ogg'], ['Abigail', '', 'King'], ['Franziska', '', 'Lechner'], ['Celsa', 'A.', 'Spina'], ['Susan', '', 'Little'], ['Diane', 'V.', 'Havlir'], ['Douglas', 'D.', 'Richman'], ['Norbert', '', 'Gruener'], ['Gerd', '', 'Pape'], ['Anele', '', 'Waters'], ['Philippa', '', 'Easterbrook'], ['Mariolina', '', 'Salio'], ['Vincenzo', '', 'Cerundolo'], ['Andrew', 'J.', 'McMichael'], ['Sarah', 'L.', 'Rowland-Jones'], ['Victor', '', 'Appay']]",Nature Medicine,2002,"[u'http://www.nature.com/doifinder/10.1038/nm0402-379', u'http://dx.doi.org/10.1038/nm0402-379']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Thimme, R., Oldach, D., Chang, K., et. al, Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, , 2001",cited-by,2949616Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,"[['Robert', '', 'Thimme'], ['David', '', 'Oldach'], ['Kyong-Mi', '', 'Chang'], ['Carola', '', 'Steiger'], ['Stuart', 'C.', 'Ray'], ['Francis', 'V.', 'Chisari']]",,2001,[u'http://jem.rupress.org/cgi/reprint/194/10/1395.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Crispe, I., , Hepatic T cells and liver tolerance, Nature Reviews Immunology, 2003",cited-by,10.1038/nri981,Hepatic T cells and liver tolerance,"[['Ian', 'Nicholas', 'Crispe']]",Nature Reviews Immunology,2003,"[u'http://www.nature.com/doifinder/10.1038/nri981', u'http://dx.doi.org/10.1038/nri981']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"GRUENER, N., LECHNER, F., JUNG, M., et. al, Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus, Journal of Virology, 2001",cited-by,10.1128/JVI.75.12.5550-5558.2001,Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus,"[['NORBERT', 'H.', 'GRUENER'], ['FRANZISKA', '', 'LECHNER'], ['MARIA-CHRISTINA', '', 'JUNG'], ['HELMUT', '', 'DIEPOLDER'], ['TILMAN', '', 'GERLACH'], ['GEORG', '', 'LAUER'], ['BRUCE', '', 'WALKER'], ['JOHN', '', 'SULLIVAN'], ['RODNEY', '', 'PHILLIPS'], ['GERD', 'R.', 'PAPE'], ['PAUL', '', 'KLENERMAN']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/12/5550.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.12.5550-5558.2001']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Bowen, D., Walker, C., , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 2005",cited-by,10.1038/nature04079,Adaptive immune responses in acute and chronic hepatitis C virus infection,"[['David', 'G.', 'Bowen'], ['Christopher', 'M.', 'Walker']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04079', u'http://dx.doi.org/10.1038/nature04079']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Erickson, A., Kimura, Y., Igarashi, S., et. al, The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes, Immunity, 2001",cited-by,10.1016/S1074-7613(01)00245-X,The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes,"[['Ann', 'L', 'Erickson'], ['Yoichi', '', 'Kimura'], ['Suzu', '', 'Igarashi'], ['Jennifer', '', 'Eichelberger'], ['Michael', '', 'Houghton'], ['John', '', 'Sidney'], ['Denise', '', 'McKinney'], ['Alessandro', '', 'Sette'], ['Austin', 'L', 'Hughes'], ['Christopher', 'M', 'Walker']]",Immunity,2001,"[u'http://www.sciencedirect.com/science/article/pii/S107476130100245X', u'http://linkinghub.elsevier.com/retrieve/pii/S107476130100245X']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Boettler, T., Spangenberg, H., Neumann-Haefelin, C., et. al, T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7860-7867.2005,T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection,"[['Tobias', '', 'Boettler'], ['Hans', 'Christian', 'Spangenberg'], ['Christoph', '', 'Neumann-Haefelin'], ['Elisabeth', '', 'Panther'], ['Simonetta', '', 'Urbani'], ['Carlo', '', 'Ferrari'], ['Hubert', 'E.', 'Blum'], ['Fritz', 'von', 'Weizsacker'], ['Robert', '', 'Thimme']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7860.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7860-7867.2005']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Klenerman, P., Hill, A., , T cells and viral persistence: lessons from diverse infections, Nature Immunology, 2005",cited-by,10.1038/ni1241,T cells and viral persistence: lessons from diverse infections,"[['Paul', '', 'Klenerman'], ['Ann', '', 'Hill']]",Nature Immunology,2005,"[u'http://www.nature.com/doifinder/10.1038/ni1241', u'http://dx.doi.org/10.1038/ni1241']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Goulder, P., Altfeld, M., Rosenberg, E., et. al, Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection, Journal of Experimental Medicine, 2001",cited-by,10.1084/jem.193.2.181,Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection,"[['P.', 'J. R.', 'Goulder'], ['M.', 'A.', 'Altfeld'], ['E.', 'S.', 'Rosenberg'], ['T.', '', 'Nguyen'], ['Y.', '', 'Tang'], ['R.', 'L.', 'Eldridge'], ['M.', 'M.', 'Addo'], ['S.', '', 'He'], ['J.', 'S.', 'Muckerjee'], ['M.', 'N.', 'Phillips'], ['M.', '', 'Bunce'], ['S.', 'A.', 'Kalams'], ['R.', 'P.', 'Sekaly'], ['B.', 'D.', 'Walker'], ['C.', '', 'Brander']]",Journal of Experimental Medicine,2001,[u'http://www.jem.org/cgi/doi/10.1084/jem.193.2.181'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Rushbrook, S., Ward, S., Unitt, E., et. al, Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7852-7859.2005,Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection,"[['Simon', 'M.', 'Rushbrook'], ['Scott', 'M.', 'Ward'], ['Esther', '', 'Unitt'], ['Sarah', 'L.', 'Vowler'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Graeme', 'J. M.', 'Alexander']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7852.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7852-7859.2005']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lauer, G., Barnes, E., Lucas, M., et. al, High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.06.015,High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection,"[['Georg', 'M.', 'Lauer'], ['Eleanor', '', 'Barnes'], ['Michaela', '', 'Lucas'], ['Joerg', '', 'Timm'], ['Kei', '', 'Ouchi'], ['Arthur', 'Y.', 'Kim'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Deborah', 'R.', 'Casson'], ['Markus', '', 'Reiser'], ['Geoffrey', '', 'Dusheiko'], ['Todd', 'M.', 'Allen'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Paul', '', 'Klenerman']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504010364', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504010364']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Houghton, M., Abrignani, S., , Prospects for a vaccine against the hepatitis C virus, Nature, 2005",cited-by,10.1038/nature04081,Prospects for a vaccine against the hepatitis C virus,"[['Michael', '', 'Houghton'], ['Sergio', '', 'Abrignani']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04081', u'http://adsabs.harvard.edu/abs/2005Natur.436..961H', u'http://dx.doi.org/10.1038/nature04081']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"WEDEMEYER, H., MIZUKOSHI, E., DAVIS, A., et. al, Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells, Journal of Virology, 2001",cited-by,10.1128/JVI.75.23.11392-11400.2001,Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells,"[['HEINER', '', 'WEDEMEYER'], ['EISHIRO', '', 'MIZUKOSHI'], ['ANTHONY', 'R.', 'DAVIS'], ['JACK', 'R.', 'BENNINK'], ['BARBARA', '', 'REHERMANN']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/23/11392.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.23.11392-11400.2001']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lauer, G., Ouchi, K., Chung, R., et. al, Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities, Journal of Virology, 2002",cited-by,10.1128/JVI.76.12.6104-6113.2002,Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities,"[['Georg', 'M.', 'Lauer'], ['Kei', '', 'Ouchi'], ['Raymond', 'T.', 'Chung'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Deborah', 'R.', 'Purkis'], ['Markus', '', 'Reiser'], ['Arthur', 'Y.', 'Kim'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/12/6104.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.12.6104-6113.2002']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Guidotti, L., Chisari, F., , IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology-mechanisms of Disease, 2006",cited-by,10.1146/annurev.pathol.1.110304.100230,IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS,"[['Luca', 'G.', 'Guidotti'], ['Francis', 'V.', 'Chisari']]",Annual Review of Pathology-mechanisms of Disease,2006,[u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pathol.1.110304.100230'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Goulder, P., Altfeld, M., Rosenberg, E., et. al, Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection, , 0",cited-by,10950327Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection,Substantial Differences in Specificity of HIV-specific Cytotoxic T Cells in Acute and Chronic HIV Infection,"[['Philip', 'J. R.', 'Goulder'], ['Marcus', 'A.', 'Altfeld'], ['Eric', 'S.', 'Rosenberg'], ['Thi', '', 'Nguyen'], ['Yanhua', '', 'Tang'], ['Robert', 'L.', 'Eldridge'], ['Marylyn', 'M.', 'Addo'], ['Suqin', '', 'He'], ['Joia', 'S.', 'Muckerjee'], ['Mary', 'N.', 'Phillips'], ['Michael', '', 'Bunce'], ['Spyros', 'A.', 'Kalams'], ['Rafick', 'P.', 'Sekaly'], ['Bruce', 'D.', 'Walker'], ['Christian', '', 'Brander']]",,0,[u'http://jem.rupress.org/cgi/reprint/193/2/181.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Wieland, S., Chisari, F., , Stealth and Cunning: Hepatitis B and Hepatitis C Viruses, Journal of Virology, 2005",cited-by,10.1128/JVI.79.15.9369-9380.2005,Stealth and Cunning: Hepatitis B and Hepatitis C Viruses,"[['Stefan', 'F.', 'Wieland'], ['Francis', 'V.', 'Chisari']]",Journal of Virology,2005,"[u'http://jvi.highwire.org/cgi/reprint/79/15/9369.pdf', u'http://jvi.asm.org/cgi/reprint/79/15/9369.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.15.9369-9380.2005']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Krutzik, P., Irish, J., Nolan, G., et. al, Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications, Clinical Immunology, 2004",cited-by,10.1016/j.clim.2003.11.009,Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications,"[['Peter', 'O', 'Krutzik'], ['Jonathan', 'M', 'Irish'], ['Garry', 'P', 'Nolan'], ['Omar', 'D', 'Perez']]",Clinical Immunology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1521661603003097', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661603003097']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Urbani, S., Boni, C., Missale, G., et. al, Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12423-12434.2002,Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C,"[['Simona', '', 'Urbani'], ['Carolina', '', 'Boni'], ['Gabriele', '', 'Missale'], ['Gianfranco', '', 'Elia'], ['Cristina', '', 'Cavallo'], ['Marco', '', 'Massari'], ['Giovanni', '', 'Raimondo'], ['Carlo', '', 'Ferrari']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/24/12423.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12423-12434.2002']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lavillette, D., Morice, Y., Germanidis, G., et. al, Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.10.6023-6034.2005,"Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection","[['Dimitri', '', 'Lavillette'], ['Yoann', '', 'Morice'], ['Georgios', '', 'Germanidis'], ['Peggy', '', 'Donot'], ['Alexandre', '', 'Soulier'], ['Emanuil', '', 'Pagkalos'], ['Georgios', '', 'Sakellariou'], ['Liliane', '', 'Intrator'], ['Birke', '', 'Bartosch'], ['Jean-Michel', '', 'Pawlotsky'], ['F.-L.', '', 'Cosset']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/10/6023.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.10.6023-6034.2005']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Wedemeyer, H., He, X., Nascimbeni, M., et. al, Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1, , 0",cited-by,11243134Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,"[['Heiner', '', 'Wedemeyer'], ['Xiao-Song', '', 'He'], ['Michelina', '', 'Nascimbeni'], ['Anthony', 'R.', 'Davis'], ['Harry', 'B.', 'Greenberg'], ['Jay', 'H.', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Harvey', '', 'Alter'], ['Barbara', '', 'Rehermann']]",,0,[u'http://www.jimmunol.org/cgi/reprint/169/6/3447.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Shoukry, N., Grakoui, A., Houghton, M., et. al, Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection, , 0",cited-by,12359419Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection,Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection,"[['Naglaa', 'H.', 'Shoukry'], ['Arash', '', 'Grakoui'], ['Michael', '', 'Houghton'], ['David', 'Y.', 'Chien'], ['John', '', 'Ghrayeb'], ['Keith', 'A.', 'Reimann'], ['Christopher', 'M.', 'Walker']]",,0,[],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Berge, I., Gamadia, L., Lier, R., , Human CD8+ T-cell differentiation in response to viruses, Nature Reviews Immunology, 2003",cited-by,10.1038/nri1254,Human CD8+ T-cell differentiation in response to viruses,"[['Ineke', 'J. M. ten', 'Berge'], ['Laila', 'E.', 'Gamadia'], ['Ren\xc3\xa9', 'A. W. van', 'Lier']]",Nature Reviews Immunology,2003,"[u'http://dx.doi.org/10.1038/nri1254', u'http://www.nature.com/doifinder/10.1038/nri1254']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Ray, R., Ray, R., , Hepatitis C virus core protein: intriguing properties and functional relevance, Fems Microbiology Letters, 2001",cited-by,10.1111/j.1574-6968.2001.tb10796.x,Hepatitis C virus core protein: intriguing properties and functional relevance,"[['Ratna', 'B.', 'Ray'], ['Ranjit', '', 'Ray']]",Fems Microbiology Letters,2001,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1574-6968.2001.tb10796.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Folgori, A., Capone, S., Ruggeri, L., et. al, A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, 2006",cited-by,10.1038/nm1353,A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees,"[['Antonella', '', 'Folgori'], ['Stefania', '', 'Capone'], ['Lionello', '', 'Ruggeri'], ['Annalisa', '', 'Meola'], ['Elisabetta', '', 'Sporeno'], ['Bruno', 'Bruni', 'Ercole'], ['Monica', '', 'Pezzanera'], ['Rosalba', '', 'Tafi'], ['Mirko', '', 'Arcuri'], ['Elena', '', 'Fattori'], ['Armin', '', 'Lahm'], ['Alessandra', '', 'Luzzago'], ['Alessandra', '', 'Vitelli'], ['Stefano', '', 'Colloca'], ['Riccardo', '', 'Cortese'], ['Alfredo', '', 'Nicosia']]",Nature Medicine,2006,"[u'http://biolog-e.ls.biu.ac.il/faculty/wides/80-440/saritnm1353.pdf', u'http://www.nature.com/doifinder/10.1038/nm1353', u'http://dx.doi.org/10.1038/nm1353']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Grabowska, A., Lechner, F., Klenerman, P., et. al, Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200108)31:8<2388::AID-IMMU2388>3.0.CO;2-L,Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection,"[['Anna', 'M.', 'Grabowska'], ['Franziska', '', 'Lechner'], ['Paul', '', 'Klenerman'], ['Paddy', 'J.', 'Tighe'], ['Stephen', '', 'Ryder'], ['Jonathan', 'K.', 'Ball'], ['Brian', 'J.', 'Thomson'], ['William', 'L.', 'Irving'], ['R.', 'Adrian', 'Robins']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200108%2931%3A8%3C2388%3A%3AAID-IMMU2388%3E3.0.CO%3B2-L'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"McKiernan, S., Hagan, R., Curry, M., et. al, Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source, Hepatology, 2004",cited-by,10.1002/hep.20261,"Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source","[['Susan', 'M.', 'McKiernan'], ['Richard', '', 'Hagan'], ['Michael', '', 'Curry'], ['George', 'S. A.', 'McDonald'], ['Alan', '', 'Kelly'], ['Niamh', '', 'Nolan'], ['Anne', '', 'Walsh'], ['John', '', 'Hegarty'], ['Emer', '', 'Lawlor'], ['Dermot', '', 'Kelleher']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20261'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Rahman, F., Heller, T., Sobao, Y., et. al, Effects of antiviral therapy on the cellular immune response in acute hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20253,Effects of antiviral therapy on the cellular immune response in acute hepatitis C,"[['Fareed', '', 'Rahman'], ['Theo', '', 'Heller'], ['Yuji', '', 'Sobao'], ['Eishiro', '', 'Mizukoshi'], ['Michelina', '', 'Nascimbeni'], ['Harvey', '', 'Alter'], ['Steven', '', 'Herrine'], ['Jay', '', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20253'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Cox, A., Mosbruger, T., Lauer, G., et. al, Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20749,Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C,"[['Andrea', 'L.', 'Cox'], ['Timothy', '', 'Mosbruger'], ['Georg', 'M.', 'Lauer'], ['Drew', '', 'Pardoll'], ['David', 'L.', 'Thomas'], ['Stuart', 'C.', 'Ray']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20749'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lauer, G., Nguyen, T., Day, C., et. al, Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses, Journal of Virology, 2002",cited-by,10.1128/JVI.76.6.2817-2826.2002,Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses,"[['Georg', 'M.', 'Lauer'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Theresa', '', 'Flynn'], ['Katherine', '', 'McGowan'], ['Eric', 'S.', 'Rosenberg'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Lemuel', '', 'Shattuck']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.6.2817-2826.2002', u'http://jvi.asm.org/cgi/reprint/76/6/2817.pdf']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Thomson, M., Nascimbeni, M., Havert, M., et. al, The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.862-870.2003,The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity,"[['Michael', '', 'Thomson'], ['Michelina', '', 'Nascimbeni'], ['Michael', 'B.', 'Havert'], ['Marian', '', 'Major'], ['Sophia', '', 'Gonzales'], ['Harvey', '', 'Alter'], ['Stephen', 'M.', 'Feinstone'], ['Krishna', 'K.', 'Murthy'], ['Barbara', '', 'Rehermann'], ['T.', 'Jake', 'Liang']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.862-870.2003', u'http://jvi.asm.org/cgi/reprint/77/2/862.pdf']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Sheridan, I., Pybus, O., Holmes, E., et. al, High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3447-3454.2004,High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression,"[['Isabelle', '', 'Sheridan'], ['Oliver', 'G.', 'Pybus'], ['Edward', 'C.', 'Holmes'], ['Paul', '', 'Klenerman']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3447.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3447-3454.2004']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Urbani, S., Amadei, B., Fisicaro, P., et. al, Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses, Hepatology, 2006",cited-by,10.1002/hep.21242,Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses,"[['Simona', '', 'Urbani'], ['Barbara', '', 'Amadei'], ['Paola', '', 'Fisicaro'], ['Daniela', '', 'Tola'], ['Alessandra', '', 'Orlandini'], ['Luca', '', 'Sacchelli'], ['Cristina', '', 'Mori'], ['Gabriele', '', 'Missale'], ['Carlo', '', 'Ferrari']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21242'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Thimme, R., Lohmann, V., Weber, F., , A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2005.12.001,A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus,"[['Robert', '', 'Thimme'], ['Volker', '', 'Lohmann'], ['Friedemann', '', 'Weber']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205002603', u'http://umanitoba.ca/faculties/medicine/units/medical_microbiology/Courses/MicroPath97.705/PDF/Thimme_HCV9_3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205002603']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Goulding, C., Murphy, A., MacDonald, G., et. al, The CCR5-Δ32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source, Gut, 2005",cited-by,10.1136/gut.2004.055699,The CCR5-Δ32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source,"[['C', '', 'Goulding'], ['A', '', 'Murphy'], ['G', '', 'MacDonald'], ['S', '', 'Barrett'], ['J', '', 'Crowe'], ['J', '', 'Hegarty'], ['S', '', 'McKiernan'], ['D', '', 'Kelleher']]",Gut,2005,"[u'http://webird.tcd.ie/bitstream/2262/33850/1/the+ccr5-delta32+mutation+-+impact+on+disease+outcome+in+individuals+with+hepatitis+c+infection+from+a+single+source..pdf', u'http://www.tara.tcd.ie/bitstream/2262/33850/1/the+ccr5-delta32+mutation+-+impact+on+disease+outcome+in+individuals+with+hepatitis+c+infection+from+a+single+source..pdf', u'http://gut.bmj.com/cgi/doi/10.1136/gut.2004.055699', u'http://dx.doi.org/10.1136/gut.2004.055699']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Herzer, K., Falk, C., Encke, J., et. al, Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.15.8299-8309.2003,Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity,"[['Kerstin', '', 'Herzer'], ['Christine', 'S.', 'Falk'], ['Jens', '', 'Encke'], ['Soren', 'T.', 'Eichhorst'], ['Axel', '', 'Ulsenheimer'], ['Barbara', '', 'Seliger'], ['Peter', 'H.', 'Krammer']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/15/8299.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.15.8299-8309.2003']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Ward, S., Fox, B., Brown, P., et. al, Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection, Journal of Hepatology, 2007",cited-by,10.1016/j.jhep.2007.03.023,Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection,"[['Scott', 'M.', 'Ward'], ['Bridget', 'C.', 'Fox'], ['Philip', 'J.', 'Brown'], ['Joy', '', 'Worthington'], ['Stephen', 'B.', 'Fox'], ['Roger', 'W.', 'Chapman'], ['Kenneth', 'A.', 'Fleming'], ['Alison', 'H.', 'Banham'], ['Paul', '', 'Klenerman']]",Journal of Hepatology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0168827807002012', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827807002012']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Firbas, C., Jilma, B., Tauber, E., et. al, Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.03.009,"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects","[['Christa', '', 'Firbas'], ['Bernd', '', 'Jilma'], ['Erich', '', 'Tauber'], ['Vera', '', 'Buerger'], ['Sandra', '', 'Jelovcan'], ['Karen', '', 'Lingnau'], ['Michael', '', 'Buschle'], ['J\xc3\xbcrgen', '', 'Frisch'], ['Christoph', 'S.', 'Klade']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06002738', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06002738']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Zhou, S., Ou, R., Huang, L., et. al, Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3578-3600.2004,Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection,"[['Shenghua', '', 'Zhou'], ['Rong', '', 'Ou'], ['Lei', '', 'Huang'], ['Graeme', 'E.', 'Price'], ['Demetrius', '', 'Moskophidis']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3578.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3578-3600.2004']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Puig, M., Major, M., Mihalik, K., et. al, Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection, Vaccine, 2004",cited-by,10.1016/j.vaccine.2003.09.010,Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection,"[['Montserrat', '', 'Puig'], ['Marian', 'E', 'Major'], ['Kathleen', '', 'Mihalik'], ['Stephen', 'M', 'Feinstone']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03006698', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03006698']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Hahn, Y., , Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?, Current Opinion in Immunology, 2003",cited-by,10.1016/S0952-7915(03)00076-1,Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?,"[['Young', 'S', 'Hahn']]",Current Opinion in Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0952791503000761', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791503000761']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Pachiadakis, I., Pollara, G., Chain, B., et. al, Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?, Lancet Infectious Diseases, 2005",cited-by,10.1016/S1473-3099(05)70114-6,Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?,"[['Ioannis', '', 'Pachiadakis'], ['Gabriele', '', 'Pollara'], ['Benjamin', 'M', 'Chain'], ['Nikolai', 'V', 'Naoumov']]",Lancet Infectious Diseases,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1473309905701146', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309905701146']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Henderson, D., Magnuson, W., , Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.3.546-568.2003,Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting,"[['David', 'K.', 'Henderson'], ['Warren', 'G.', 'Magnuson']]",Clinical Microbiology Reviews,2003,"[u'http://cmr.asm.org/cgi/reprint/16/3/546.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.3.546-568.2003']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Yao, Z., Nguyen, D., Hiotellis, A., et. al, Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1,2, , 2001",cited-by,"6333770Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1,2","Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1,2","[['Zhi', 'Qiang', 'Yao'], ['Duong', 'Tony', 'Nguyen'], ['Apostolos', 'I.', 'Hiotellis'], ['Young', 'S.', 'Hahn']]",,2001,[u'http://www.jimmunol.org/cgi/reprint/167/9/5264.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Fournillier, A., Wychowski, C., Boucreux, D., et. al, Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites, Journal of Virology, 2001",cited-by,10.1128/JVI.75.24.12088-12097.2001,Induction of Hepatitis C Virus E1 Envelope Protein-Specific Immune Response Can Be Enhanced by Mutation of N-Glycosylation Sites,"[['A.', '', 'Fournillier'], ['C.', '', 'Wychowski'], ['D.', '', 'Boucreux'], ['T.', 'F.', 'Baumert'], ['J.-C.', '', 'Meunier'], ['D.', '', 'Jacobs'], ['S.', '', 'Muguet'], ['E.', '', 'Depla'], ['G.', '', 'Inchauspe']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/24/12088.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.24.12088-12097.2001']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Kamal, S., Amin, A., Madwar, M., et. al, Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients, Journal of Virology, 2004",cited-by,10.1128/JVI.78.22.12252-12258.2004,Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients,"[['Sanaa', 'M.', 'Kamal'], ['Ashraf', '', 'Amin'], ['Mohamed', '', 'Madwar'], ['Camilla', 'S.', 'Graham'], ['Qi', '', 'He'], ['Ahmed', 'Al', 'Tawil'], ['Jens', '', 'Rasenack'], ['Tatsunori', '', 'Nakano'], ['Betty', '', 'Robertson'], ['Alaa', '', 'Ismail'], ['Margaret', 'James', 'Koziel']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/22/12252.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.22.12252-12258.2004']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Bocharov, G., Ludewig, B., Bertoletti, A., et. al, Underwhelming the Immune Response: Effect of Slow Virus Growth on CD8+-T-Lymphocyte Responses, Journal of Virology, 2004",cited-by,10.1128/JVI.78.11.6079.2004,Underwhelming the Immune Response: Effect of Slow Virus Growth on CD8+-T-Lymphocyte Responses,"[['Gennady', '', 'Bocharov'], ['Burkhard', '', 'Ludewig'], ['Antonio', '', 'Bertoletti'], ['Paul', '', 'Klenerman'], ['Tobias', '', 'Junt'], ['Philippe', '', 'Krebs'], ['Tatyana', '', 'Luzyanina'], ['Cristophe', '', 'Fraser'], ['Roy', 'M.', 'Anderson']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/5/2247.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.11.6079.2004', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.5.2247-2254.2004']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Dahari, H., Major, M., Zhang, X., et. al, Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production, Gastroenterology, 2005",cited-by,10.1053/j.gastro.2005.01.049,Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production,"[['Harel', '', 'Dahari'], ['Marian', '', 'Major'], ['Xinan', '', 'Zhang'], ['Kathleen', '', 'Mihalik'], ['Charles', 'M.', 'Rice'], ['Alan', 'S.', 'Perelson'], ['Stephen', 'M.', 'Feinstone'], ['Avidan', 'U.', 'Neumann']]",Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505001617', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505001617']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Gremion, C., Cerny, A., , Hepatitis C virus and the immune system: a concise review, Reviews in Medical Virology, 2005",cited-by,10.1002/rmv.466,Hepatitis C virus and the immune system: a concise review,"[['Christel', '', 'Gremion'], ['Andreas', '', 'Cerny']]",Reviews in Medical Virology,2005,[u'http://doi.wiley.com/10.1002/rmv.466'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Vertuani, S., Bazzaro, M., Gualandi, G., et. al, Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals, European Journal of Immunology, 2002",cited-by,10.1002/1521-4141(200201)32:1<144::AID-IMMU144>3.0.CO;2-X,Effect of interferon-α therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals,"[['Simona', '', 'Vertuani'], ['Martina', '', 'Bazzaro'], ['Guido', '', 'Gualandi'], ['Fabiola', '', 'Micheletti'], ['Mauro', '', 'Marastoni'], ['Cinzia', '', 'Fortini'], ['Alessandro', '', 'Canella'], ['Michele', '', 'Marino'], ['Roberto', '', 'Tomatis'], ['Serena', '', 'Traniello'], ['Riccardo', '', 'Gavioli']]",European Journal of Immunology,2002,[u'http://doi.wiley.com/10.1002/1521-4141%28200201%2932%3A1%3C144%3A%3AAID-IMMU144%3E3.0.CO%3B2-X'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Himoudi, N., Abraham, J., Fournillier, A., et. al, Comparative Vaccine Studies in HLA-A2.1Transgenic Mice Reveal a Clustered Organization of Epitopes Presented in Hepatitis C Virus Natural Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12735-12746.2002,Comparative Vaccine Studies in HLA-A2.1Transgenic Mice Reveal a Clustered Organization of Epitopes Presented in Hepatitis C Virus Natural Infection,"[['Nourredine', '', 'Himoudi'], ['Jean-Daniel', '', 'Abraham'], ['Anne', '', 'Fournillier'], ['Yu', 'Chun', 'Lone'], ['Aurelie', '', 'Joubert'], ['Anne', 'Op De', 'Beeck'], ['Delphine', '', 'Freida'], ['Francois', '', 'Lemonnier'], ['Marie', 'Paule', 'Kieny'], ['Genevieve', '', 'Inchauspe']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/24/12735.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12735-12746.2002']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Meyer-Olson, D., Shoukry, N., Brady, K., et. al, Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape, , 0",cited-by,11652146Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape,Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape,"[['Dirk', '', 'Meyer-Olson'], ['Naglaa', 'H.', 'Shoukry'], ['Kristen', 'W.', 'Brady'], ['Helen', '', 'Kim'], ['Douglas', 'P.', 'Olson'], ['Kelly', '', 'Hartman'], ['Ayumi', 'K.', 'Shintani'], ['Christopher', 'M.', 'Walker'], ['Spyros', 'A.', 'Kalams']]",,0,"[u'http://jem.rupress.org/cgi/reprint/200/3/307.pdf', u'http://www.mc.vanderbilt.edu/root/pdfs/cfar/Meyer_Olson.pdf']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Park, S., Murray, D., John, B., et. al, Biology and significance of T-cell apoptosis in the liver, Immunology and Cell Biology, 2002",cited-by,10.1046/j.1440-1711.2002.01065.x,Biology and significance of T-cell apoptosis in the liver,"[['Sun', '', 'Park'], ['Debbie', '', 'Murray'], ['Beena', '', 'John'], ['I', 'Nicholas', 'Crispe']]",Immunology and Cell Biology,2002,"[u'http://dx.doi.org/10.1046/j.1440-1711.2002.01065.x', u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2002.01065.x']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Diehl, L., Mierlo, G., Fransen, M., et. al, Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance1, , 0",cited-by,10342621Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance1,Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance1,"[['Linda', '', 'Diehl'], ['Geertje', 'J. D. van', 'Mierlo'], ['Marieke', 'F.', 'Fransen'], ['Paul', '', 'Krimpenfort'], ['Cornelis', 'J. M.', 'Melief'], ['Rienk', '', 'Offringa'], ['M.', '', 'Toes']]",,0,[u'http://www.jimmunol.org/cgi/reprint/167/5/2522.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Averill, L., Lee, W., Karandikar, N., , Differential dysfunction in dendritic cell subsets during chronic HCV infection, , 2007",cited-by,6881535Differential dysfunction in dendritic cell subsets during chronic HCV infection,Differential dysfunction in dendritic cell subsets during chronic HCV infection,"[['Lynn', '', 'Averill'], ['William', 'M.', 'Lee'], ['Nitin', 'J.', 'Karandikar']]",,2007,[u'http://webpath.swmed.edu/research/images/pdfs/2007karandikar_ci2.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lloyd, A., Jagger, E., Post, J., et. al, Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection, Immunology and Cell Biology, 2007",cited-by,10.1038/sj.icb.7100010,Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection,"[['Andrew', 'R', 'Lloyd'], ['Emma', '', 'Jagger'], ['Jeffrey', 'J', 'Post'], ['Lee-Ann', '', 'Crooks'], ['William', 'D', 'Rawlinson'], ['Young', 'S', 'Hahn'], ['Rosemary', 'A', 'Ffrench']]",Immunology and Cell Biology,2007,"[u'http://www.nature.com/doifinder/10.1038/sj.icb.7100010', u'http://dx.doi.org/10.1038/sj.icb.7100010']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Soo, H., Garzino-Demo, A., Hong, W., et. al, Expression of a Full-Length Hepatitis C Virus cDNA Up-Regulates the Expression of CC Chemokines MCP-1 and RANTES, Virology, 2002",cited-by,10.1006/viro.2002.1617,Expression of a Full-Length Hepatitis C Virus cDNA Up-Regulates the Expression of CC Chemokines MCP-1 and RANTES,"[['Hui', 'Meng', 'Soo'], ['Alfredo', '', 'Garzino-Demo'], ['Wanjin', '', 'Hong'], ['Yin', 'Hwee', 'Tan'], ['Yee', 'Joo', 'Tan'], ['Phuay-Yee', '', 'Goh'], ['Seng', 'Gee', 'Lim'], ['Siew', 'Pheng', 'Lim']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S004268220291617X', u'http://linkinghub.elsevier.com/retrieve/pii/S004268220291617X']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Mengshol, J., Golden-Mason, L., Rosen, H., , Mechanisms of Disease: HCV-induced liver injury, Nature Clinical Practice Gastroenterology & Hepatology, 2007",cited-by,10.1038/ncpgasthep0961,Mechanisms of Disease: HCV-induced liver injury,"[['John', 'A', 'Mengshol'], ['Lucy', '', 'Golden-Mason'], ['Hugo', 'R', 'Rosen']]",Nature Clinical Practice Gastroenterology & Hepatology,2007,"[u'http://www.nature.com/doifinder/10.1038/ncpgasthep0961', u'http://dx.doi.org/10.1038/ncpgasthep0961']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Brinster, C., Chen, M., Boucreux, D., et. al, Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles, , 0",cited-by,11458315Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles,Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles,"[['C.', '', 'Brinster'], ['M.', '', 'Chen'], ['D.', '', 'Boucreux'], ['G.', '', 'Paranhos-Baccala'], ['F.', '', 'Lemmonier'], ['G.', '', 'Inchauspe']]",,0,[],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Wertheimer, A., Miner, C., Lewinsohn, D., et. al, Novel CD4 and CD8 T-Cell Determinants Within the NS3 Protein in Subjects With Spontaneously Resolved HCV Infection, , 0",cited-by,12160314Novel CD4 and CD8 T-Cell Determinants Within the NS3 Protein in Subjects With Spontaneously Resolved HCV Infection,Novel CD4 and CD8 T-Cell Determinants Within the NS3 Protein in Subjects With Spontaneously Resolved HCV Infection,"[['Anne', 'M.', 'Wertheimer'], ['Camette', '', 'Miner'], ['David', 'M.', 'Lewinsohn'], ['Anna', 'W.', 'Sasaki'], ['Ezra', '', 'Kaufman'], ['Hugo', 'R.', 'Rosen']]",,0,[u'http://www.hawaii.edu/hivandaids/Novel%20CD4+%20and%20CD8+%20T-Cell%20In%20Subjects%20With%20Spontaneously%20Resolved%20HCV%20Infection.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Guglietta, S., Pacciani, V., Scottà, C., et. al, Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection, European Journal of Immunology, 2005",cited-by,10.1002/eji.200526067,Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection,"[['Silvia', '', 'Guglietta'], ['Valentina', '', 'Pacciani'], ['Cristiano', '', 'Scott\xc3\xa0'], ['Luca', '', 'Laurenti'], ['Enea', '', 'Spada'], ['Alfonso', '', 'Mele'], ['Gloria', '', 'Taliani'], ['Antonella', '', 'Folgori'], ['Alessandra', '', 'Vitelli'], ['Lionello', '', 'Ruggeri'], ['Alfredo', '', 'Nicosia'], ['Enza', '', 'Piccolella'], ['Paola', 'Del', 'Porto']]",European Journal of Immunology,2005,[u'http://doi.wiley.com/10.1002/eji.200526067'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Inchauspé, G., Feinstone, S., , Development of a hepatitis C virus vaccine, Clinics in Liver Disease, 2003",cited-by,10.1016/S1089-3261(02)00067-3,Development of a hepatitis C virus vaccine,"[['Genevieve', '', 'Inchausp\xc3\xa9'], ['Stephen', '', 'Feinstone']]",Clinics in Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1089326102000673', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326102000673']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Dolganiuc, A., Kodys, K., Kopasz, A., et. al, Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL10 and IL2 induction, Alcoholism-clinical and Experimental Research, 2003",cited-by,10.1097/01.ALC.0000071745.63433.32,Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL10 and IL2 induction,"[['Angela', '', 'Dolganiuc'], ['Karen', '', 'Kodys'], ['Andrea', '', 'Kopasz'], ['Christopher', '', 'Marshall'], ['Pranoti', '', 'Mandrekar'], ['Gyongyi', '', 'Szabo']]",Alcoholism-clinical and Experimental Research,2003,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00000374-200306000-00020', u'http://works.bepress.com/gyongyi_szabo/28', u'http://escholarship.umassmed.edu/gastroenterology_pp/37', u'http://dx.doi.org/10.1097/01.ALC.0000071745.63433.32']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Park, S., Yang, S., Lee, C., et. al, Efficient induction of T helper 1 CD4 + T-cell responses to hepatitis C virus core and E2 by a DNA prime–adenovirus boost, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00499-7,Efficient induction of T helper 1 CD4 + T-cell responses to hepatitis C virus core and E2 by a DNA prime–adenovirus boost,"[['Su-Hyung', '', 'Park'], ['Se-Hwan', '', 'Yang'], ['Chang', 'Geun', 'Lee'], ['Jin-Won', '', 'Youn'], ['Jun', '', 'Chang'], ['Young', 'Chul', 'Sung']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X03004997', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03004997']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Yao, Z., Eisen-Vandervelde, A., Ray, S., et. al, HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27 Kip1, Virology, 2003",cited-by,10.1016/S0042-6822(03)00419-7,HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27 Kip1,"[['Zhi', 'Qiang', 'Yao'], ['Audrey', '', 'Eisen-Vandervelde'], ['Suma', '', 'Ray'], ['Young', 'S', 'Hahn']]",Virology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0042682203004197', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682203004197']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lechner, F., Cuero, A., Kantzanou, M., et. al, Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers, Reviews in Medical Virology, 2001",cited-by,10.1002/rmv.295,Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers,"[['Franziska', '', 'Lechner'], ['Ana', 'L. Vargas', 'Cuero'], ['Maria', '', 'Kantzanou'], ['Paul', '', 'Klenerman']]",Reviews in Medical Virology,2001,[u'http://doi.wiley.com/10.1002/rmv.295'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Yao, Z., Ray, S., Eisen-Vandervelde, A., et. al, Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway, Viral Immunology, 2001",cited-by,10.1089/08828240152716547,Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway,"[['Zhi', 'Qiang', 'Yao'], ['Suma', '', 'Ray'], ['Audrey', '', 'Eisen-Vandervelde'], ['Stephen', '', 'Waggoner'], ['Young', 'S.', 'Hahn']]",Viral Immunology,2001,[u'http://www.liebertonline.com/doi/abs/10.1089%2F08828240152716547'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Koziel, M., , Cellular Immune Responses against Hepatitis C Virus, Clinical Infectious Diseases, 2005",cited-by,10.1086/429492,Cellular Immune Responses against Hepatitis C Virus,"[['Margaret', 'James', 'Koziel']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429492'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Seifert, U., Liermann, H., Racanelli, V., et. al, Hepatitis C virus mutation affects proteasomal epitope processing, Journal of Clinical Investigation, 2004",cited-by,10.1172/JCI20985,Hepatitis C virus mutation affects proteasomal epitope processing,"[['Ulrike', '', 'Seifert'], ['Heike', '', 'Liermann'], ['Vito', '', 'Racanelli'], ['Anne', '', 'Halenius'], ['Manfred', '', 'Wiese'], ['Heiner', '', 'Wedemeyer'], ['Thomas', '', 'Ruppert'], ['Kay', '', 'Rispeter'], ['Peter', '', 'Henklein'], ['Alice', '', 'Sijts'], ['Hartmut', '', 'Hengel'], ['Peter-M.', '', 'Kloetzel'], ['Barbara', '', 'Rehermann']]",Journal of Clinical Investigation,2004,[u'http://www.jci.org/articles/view/20985'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Scott, L., Perry, C., , Interferon??-2b Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C, Drugs, 2002",cited-by,10.2165/00003495-200262030-00009,Interferon??-2b Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C,"[['Lesley', 'J.', 'Scott'], ['Caroline', 'M.', 'Perry']]",Drugs,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200262030-00009'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Blackard, J., Shata, M., Shire, N., et. al, Acute hepatitis C virus infection: A chronic problem, Hepatology, 2008",cited-by,10.1002/hep.21902,Acute hepatitis C virus infection: A chronic problem,"[['Jason', 'T.', 'Blackard'], ['M.', 'Tarek', 'Shata'], ['Norah', 'J.', 'Shire'], ['Kenneth', 'E.', 'Sherman']]",Hepatology,2008,"[u'http://www.med.upenn.edu/gastro/documents/HepatologyAcuteHCV.pdf', u'http://texasliver.typepad.com/dr_joe_galatis_blog/files/hcv_review_2008.pdf', u'http://doi.wiley.com/10.1002/hep.21902']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Iken, K., Huang, L., Bekele, H., et. al, Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction, Virology, 2006",cited-by,10.1016/j.virol.2005.11.017,Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction,"[['Khadija', '', 'Iken'], ['Lin', '', 'Huang'], ['Hewan', '', 'Bekele'], ['Emmett', 'V.', 'Schmidt'], ['Margaret', 'James', 'Koziel']]",Virology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0042682205007671', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682205007671']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Engler, O., Schwendener, R., Dai, W., et. al, A liposomal peptide vaccine inducing CD8 + T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins, Vaccine, 2004",cited-by,10.1016/j.vaccine.2004.05.009,"A liposomal peptide vaccine inducing CD8 + T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins","[['Olivier', 'B.', 'Engler'], ['Reto', 'A.', 'Schwendener'], ['Wen', 'Juan', 'Dai'], ['Benno', '', 'W\xc3\xb6lk'], ['Werner', '', 'Pichler'], ['Darius', '', 'Moradpour'], ['Thomas', '', 'Brunner'], ['Andreas', '', 'Cerny']]",Vaccine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0400413X', u'http://www.imcr.uzh.ch/static/onkwww/vaccine2.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0400413X']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Mizukoshi, E., Nascimbeni, M., Blaustein, J., et. al, Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies, Journal of Virology, 2002",cited-by,10.1128/JVI.76.12.6093-6103.2002,Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies,"[['Eishiro', '', 'Mizukoshi'], ['Michelina', '', 'Nascimbeni'], ['Joshua', 'B.', 'Blaustein'], ['Kathleen', '', 'Mihalik'], ['Charles', 'M.', 'Rice'], ['T.', 'Jake', 'Liang'], ['Stephen', 'M.', 'Feinstone'], ['Barbara', '', 'Rehermann']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/12/6093.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.12.6093-6103.2002']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Santantonio, T., Wiegand, J., Gerlach, J., , Acute hepatitis C: Current status and remaining challenges, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.07.005,Acute hepatitis C: Current status and remaining challenges,"[['Teresa', '', 'Santantonio'], ['Johannes', '', 'Wiegand'], ['J.', 'Tilman', 'Gerlach']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808004340', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808004340']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Urbani, S., Amadei, B., Fisicaro, P., et. al, Heterologous T cell immunity in severe hepatitis C virus infection, , 0",cited-by,11109906Heterologous T cell immunity in severe hepatitis C virus infection,Heterologous T cell immunity in severe hepatitis C virus infection,"[['Simona', '', 'Urbani'], ['Barbara', '', 'Amadei'], ['Paola', '', 'Fisicaro'], ['Massimo', '', 'Pilli'], ['Gabriele', '', 'Missale'], ['Antonio', '', 'Bertoletti'], ['Carlo', '', 'Ferrari']]",,0,[u'http://jem.rupress.org/cgi/reprint/201/5/675.pdf'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Kamal, S., , Acute Hepatitis C: A Systematic Review, American Journal of Gastroenterology, 2008",cited-by,10.1111/j.1572-0241.2008.01825.x,Acute Hepatitis C: A Systematic Review,"[['Sanaa', 'M.', 'Kamal']]",American Journal of Gastroenterology,2008,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2008.01825.x', u'http://dx.doi.org/10.1111/j.1572-0241.2008.01825.x']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Harcourt, G., Lucas, M., Sheridan, I., et. al, Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00516.x,Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes,"[['G.', 'C.', 'Harcourt'], ['M.', '', 'Lucas'], ['I.', '', 'Sheridan'], ['E.', '', 'Barnes'], ['R.', '', 'Phillips'], ['P.', '', 'Klenerman']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00516.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Palmowski, M., Salio, M., Dunbar, R., et. al, The use of HLA class I tetramers to design a vaccination strategy for melanoma patients, Immunological Reviews, 2002",cited-by,10.1034/j.1600-065X.2002.18814.x,The use of HLA class I tetramers to design a vaccination strategy for melanoma patients,"[['Michael', '', 'Palmowski'], ['Mariolina', '', 'Salio'], ['Rod', 'P.', 'Dunbar'], ['Vincenzo', '', 'Cerundolo']]",Immunological Reviews,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1600-065X.2002.18814.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Wodarz, D., , Ecological and evolutionary principles in immunology, Ecology Letters, 2006",cited-by,10.1111/j.1461-0248.2006.00921.x,Ecological and evolutionary principles in immunology,"[['Dominik', '', 'Wodarz']]",Ecology Letters,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1461-0248.2006.00921.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Gruener, N., Jung, M., Ulsenheimer, A., et. al, Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00303-3,Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response,"[['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Tilman', 'J', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Carl', 'A', 'Schirren'], ['Robert', '', 'Hoffmann'], ['Martin', '', 'W\xc3\xa4chtler'], ['Markus', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802003033', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802003033']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Castello, G., Scala, S., Palmieri, G., et. al, HCV-related hepatocellular carcinoma: From chronic inflammation to cancer, Clinical Immunology, 2010",cited-by,10.1016/j.clim.2009.10.007,HCV-related hepatocellular carcinoma: From chronic inflammation to cancer,"[['Giuseppe', '', 'Castello'], ['Stefania', '', 'Scala'], ['Giuseppe', '', 'Palmieri'], ['Steven', 'A.', 'Curley'], ['Francesco', '', 'Izzo']]",Clinical Immunology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S152166160900847X', u'http://linkinghub.elsevier.com/retrieve/pii/S152166160900847X']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Averill, L., Lee, W., Karandikar, N., , Differential dysfunction in dendritic cell subsets during chronic HCV infection, Clinical Immunology, 2007",cited-by,10.1016/j.clim.2006.12.001,Differential dysfunction in dendritic cell subsets during chronic HCV infection,"[['Lynn', '', 'Averill'], ['William', 'M.', 'Lee'], ['Nitin', 'J.', 'Karandikar']]",Clinical Immunology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1521661606009661', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661606009661']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Kubitschke, A., Bahr, M., Aslan, N., et. al, Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia, European Journal of Clinical Investigation, 2007",cited-by,10.1111/j.1365-2362.2007.01753.x,Induction of hepatitis C virus (HCV)-specific T cells by needle stick injury in the absence of HCV-viraemia,"[['A.', '', 'Kubitschke'], ['M.', 'J.', 'Bahr'], ['N.', '', 'Aslan'], ['C.', '', 'Bader'], ['H.', 'L.', 'Tillmann'], ['C.', '', 'Sarrazin'], ['T.', '', 'Greten'], ['J.', '', 'Wiegand'], ['M.', 'P.', 'Manns'], ['H.', '', 'Wedemeyer']]",European Journal of Clinical Investigation,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2362.2007.01753.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Ulsenheimer, A., Lucas, M., Seth, N., et. al, Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2006.00747.x,Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses,"[['A.', '', 'Ulsenheimer'], ['M.', '', 'Lucas'], ['N.', 'P.', 'Seth'], ['J.', 'Tilman', 'Gerlach'], ['N.', 'H.', 'Gruener'], ['A.', '', 'Loughry'], ['G.', 'R.', 'Pape'], ['K.', 'W.', 'Wucherpfennig'], ['H.', 'M.', 'Diepolder'], ['P.', '', 'Klenerman']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00747.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Miller, N., Bonczyk, J., Nakayama, Y., et. al, Role of Thymic Output in Regulating CD8 T-Cell Homeostasis during Acute and Chronic Viral Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.15.9419-9429.2005,Role of Thymic Output in Regulating CD8 T-Cell Homeostasis during Acute and Chronic Viral Infection,"[['Nicole', 'E.', 'Miller'], ['Jennifer', 'R.', 'Bonczyk'], ['Yumi', '', 'Nakayama'], ['M.', '', 'Suresh']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/15/9419.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.15.9419-9429.2005']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lucas, M., Karrer, U., Lucas, A., et. al, Viral escape mechanisms - escapology taught by viruses, International Journal of Experimental Pathology, 2001",cited-by,10.1046/j.1365-2613.2001.00204.x,Viral escape mechanisms - escapology taught by viruses,"[['Michaela', '', 'Lucas'], ['URS', '', 'Karrer'], ['Andrew', '', 'Lucas'], ['Paul', '', 'Klenerman']]",International Journal of Experimental Pathology,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2613.2001.00204.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Mizukoshi, E., Rehermann, B., , Immune responses and immunity in hepatitis C virus infection, Journal of Gastroenterology, 2001",cited-by,10.1007/s005350170001,Immune responses and immunity in hepatitis C virus infection,"[['Eishiro', '', 'Mizukoshi'], ['Barbara', '', 'Rehermann']]",Journal of Gastroenterology,2001,"[u'http://www.springerlink.com/index/q7eqfejkm4rr2t4g.pdf', u'http://www.springerlink.com/content/q7eqfejkm4rr2t4g', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s005350170001', u'http://www.springerlink.com/index/pdf/10.1007/s005350170001']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Osburn, W., Fisher, B., Dowd, K., et. al, Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection, Gastroenterology, 2010",cited-by,10.1053/j.gastro.2009.09.017,Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection,"[['William', 'O.', 'Osburn'], ['Brian', 'E.', 'Fisher'], ['Kimberly', 'A.', 'Dowd'], ['Giselle', '', 'Urban'], ['Lin', '', 'Liu'], ['Stuart', 'C.', 'Ray'], ['David', 'L.', 'Thomas'], ['Andrea', 'L.', 'Cox']]",Gastroenterology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0016508509016588', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508509016588']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Liang, H., Russell, R., Yonkers, N., et. al, Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells, Journal of Virology, 2009",cited-by,10.1128/JVI.02671-08,Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells,"[['Hua', '', 'Liang'], ['Rodney', 'S.', 'Russell'], ['Nicole', 'L.', 'Yonkers'], ['David', '', 'McDonald'], ['Benigno', '', 'Rodriguez'], ['Clifford', 'V.', 'Harding'], ['Donald', 'D.', 'Anthony']]",Journal of Virology,2009,"[u'http://jvi.asm.org/cgi/reprint/83/11/5693.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02671-08']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Yerly, D., Heckerman, D., Allen, T., et. al, Increased Cytotoxic T-Lymphocyte Epitope Variant Cross-Recognition and Functional Avidity Are Associated with Hepatitis C Virus Clearance, Journal of Virology, 2008",cited-by,10.1128/JVI.02252-07,Increased Cytotoxic T-Lymphocyte Epitope Variant Cross-Recognition and Functional Avidity Are Associated with Hepatitis C Virus Clearance,"[['Daniel', '', 'Yerly'], ['David', '', 'Heckerman'], ['Todd', 'M.', 'Allen'], ['John', 'V.', 'Chisholm'], ['Kellie', '', 'Faircloth'], ['Caitlyn', 'H.', 'Linde'], ['Nicole', '', 'Frahm'], ['Joerg', '', 'Timm'], ['Werner', 'J.', 'Pichler'], ['Andreas', '', 'Cerny'], ['Christian', '', 'Brander']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/6/3147.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02252-07']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Piazzolla, G., Nuzzaci, M., Tortorella, C., et. al, Immunogenic Properties of a Chimeric Plant Virus Expressing a Hepatitis C Virus (HCV)Derived Epitope: New Prospects for an HCV Vaccine, Journal of Clinical Immunology, 2005",cited-by,10.1007/s10875-005-2820-4,Immunogenic Properties of a Chimeric Plant Virus Expressing a Hepatitis C Virus (HCV)Derived Epitope: New Prospects for an HCV Vaccine,"[['G.', '', 'Piazzolla'], ['M.', '', 'Nuzzaci'], ['C.', '', 'Tortorella'], ['E.', '', 'Panella'], ['A.', '', 'Natilla'], ['D.', '', 'Boscia'], ['A.', 'De', 'Stradis'], ['P.', '', 'Piazzolla'], ['S.', '', 'Antonaci']]",Journal of Clinical Immunology,2005,"[u'http://www.springerlink.com/content/m76k710887604q5m', u'http://www.springerlink.com/index/m76k710887604q5m.pdf', u'http://www.springerlink.com/index/10.1007/s10875-005-2820-4', u'http://www.springerlink.com/index/pdf/10.1007/s10875-005-2820-4']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Martin, P., Parroche, P., Chatel, L., et. al, Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.20189,Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen,"[['P.', '', 'Martin'], ['P.', '', 'Parroche'], ['L.', '', 'Chatel'], ['C.', '', 'Barretto'], ['A.', '', 'Beck'], ['C.', '', 'Bain'], ['Y.', 'C.', 'Lone'], ['Anne', '', 'Fournillier']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.20189'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Lancaster, T., Sanders, E., Christie, J., et. al, Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00330.x,Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection,"[['T.', '', 'Lancaster'], ['E.', '', 'Sanders'], ['J.', 'M. L.', 'Christie'], ['C.', '', 'Brooks'], ['S.', '', 'Green'], ['W.', 'M. C.', 'Rosenberg']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00330.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Inchauspé, G., Michel, M., , Vaccines and immunotherapies against hepatitis B and hepatitis C viruses, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2007.00922.x,Vaccines and immunotherapies against hepatitis B and hepatitis C viruses,"[['G.', '', 'Inchausp\xc3\xa9'], ['M.', 'L.', 'Michel']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2007.00922.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Marinho, R., Pinto, R., Santos, M., et. al, Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00496.x,"Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C","[['R.', 'T.', 'Marinho'], ['R.', '', 'Pinto'], ['M.', 'L.', 'Santos'], ['I.', 'V.', 'Lobos'], ['M.', 'C.', 'Moura']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00496.x'],
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Heeg, M., Ulsenheimer, A., Grüner, N., et. al, FOXP3 Expression in Hepatitis C Virus–Specific CD4 + T Cells During Acute Hepatitis C, Gastroenterology, 2009",cited-by,10.1053/j.gastro.2009.06.059,FOXP3 Expression in Hepatitis C Virus–Specific CD4 + T Cells During Acute Hepatitis C,"[['Malte', 'H. J.', 'Heeg'], ['Axel', '', 'Ulsenheimer'], ['Norbert', 'H.', 'Gr\xc3\xbcner'], ['Reinhart', '', 'Zachoval'], ['J.', 'Tilman', 'Gerlach'], ['Bijan', '', 'Raziorrouh'], ['Winfried', '', 'Schraut'], ['Sophia', '', 'Horster'], ['Teresa', '', 'Kauke'], ['Michael', '', 'Spannagl'], ['Helmut', 'M.', 'Diepolder']]",Gastroenterology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0016508509011470', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508509011470']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Klenerman, P., Kim, A., , HCV–HIV Coinfection: Simple Messages from a Complex Disease, PLOS Medicine, 2007",cited-by,10.1371/journal.pmed.0040240,HCV–HIV Coinfection: Simple Messages from a Complex Disease,"[['Paul', '', 'Klenerman'], ['Arthur', '', 'Kim']]",PLOS Medicine,2007,"[u'http://dx.doi.org/10.1371/journal.pmed.0040240', u'http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040240']",
10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B,"Kennedy, P., Urbani, S., Moses, R., et. al, The influence of T cell cross-reactivity on HCV-peptide specific human T cell response, Hepatology, 2006",cited-by,10.1002/hep.21081,The influence of T cell cross-reactivity on HCV-peptide specific human T cell response,"[['Patrick', 'T. F.', 'Kennedy'], ['Simonetta', '', 'Urbani'], ['Rebecca', 'A.', 'Moses'], ['Barbara', '', 'Amadei'], ['Paola', '', 'Fisicaro'], ['Jilly', '', 'Lloyd'], ['Mala', 'K.', 'Maini'], ['Geoffrey', '', 'Dusheiko'], ['Carlo', '', 'Ferrari'], ['Antonio', '', 'Bertoletti']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21081'],
10.1056~NEJMoa011232,"Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-512.",references,10.1084/jem.191.9.1499,Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus,"[[u'F.', u'', u'Lechner'], [u'Dk', u'', u'Wong'], [u'Pr', u'', u'Dunbar']]",Journal of Experimental Medicine,2000,[u'http://www.jem.org/cgi/doi/10.1084/jem.191.9.1499'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Immune Response', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 19204}]"
10.1084/jem.191.9.1499,"Dunbar, P., Callan, M., Klenerman, P., et. al, Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections, Nature Medicine, 2002",cited-by,10.1038/nm0402-379,Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections,"[['P.', 'Rod', 'Dunbar'], ['Margaret', '', 'Callan'], ['Paul', '', 'Klenerman'], ['Geraldine', 'M. A.', 'Gillespie'], ['Laura', '', 'Papagno'], ['Graham', 'S.', 'Ogg'], ['Abigail', '', 'King'], ['Franziska', '', 'Lechner'], ['Celsa', 'A.', 'Spina'], ['Susan', '', 'Little'], ['Diane', 'V.', 'Havlir'], ['Douglas', 'D.', 'Richman'], ['Norbert', '', 'Gruener'], ['Gerd', '', 'Pape'], ['Anele', '', 'Waters'], ['Philippa', '', 'Easterbrook'], ['Mariolina', '', 'Salio'], ['Vincenzo', '', 'Cerundolo'], ['Andrew', 'J.', 'McMichael'], ['Sarah', 'L.', 'Rowland-Jones'], ['Victor', '', 'Appay']]",Nature Medicine,2002,"[u'http://www.nature.com/doifinder/10.1038/nm0402-379', u'http://dx.doi.org/10.1038/nm0402-379']",
10.1084/jem.191.9.1499,"Nascimbeni, M., Rehermann, B., , Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews Immunology, 2005",cited-by,10.1038/nri1573,Immunology of hepatitis B virus and hepatitis C virus infection,"[['Michelina', '', 'Nascimbeni'], ['Barbara', '', 'Rehermann']]",Nature Reviews Immunology,2005,"[u'http://www.nature.com/doifinder/10.1038/nri1573', u'http://dx.doi.org/10.1038/nri1573']",
10.1084/jem.191.9.1499,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1084/jem.191.9.1499,"Thimme, R., Oldach, D., Chang, K., et. al, Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, , 2001",cited-by,2949616Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,"[['Robert', '', 'Thimme'], ['David', '', 'Oldach'], ['Kyong-Mi', '', 'Chang'], ['Carola', '', 'Steiger'], ['Stuart', 'C.', 'Ray'], ['Francis', 'V.', 'Chisari']]",,2001,[u'http://jem.rupress.org/cgi/reprint/194/10/1395.pdf'],
10.1084/jem.191.9.1499,"Kaech, S., Wherry, E., Ahmed, R., , VaccinesEffector and memory T-cell differentiation: implications for vaccine development, Nature Reviews Immunology, 2002",cited-by,10.1038/nri778,VaccinesEffector and memory T-cell differentiation: implications for vaccine development,"[['Susan', 'M.', 'Kaech'], ['E.', 'John', 'Wherry'], ['Rafi', '', 'Ahmed']]",Nature Reviews Immunology,2002,"[u'http://dx.doi.org/10.1038/nri778', u'http://www.nature.com/doifinder/10.1038/nri778']",
10.1084/jem.191.9.1499,"Crispe, I., , Hepatic T cells and liver tolerance, Nature Reviews Immunology, 2003",cited-by,10.1038/nri981,Hepatic T cells and liver tolerance,"[['Ian', 'Nicholas', 'Crispe']]",Nature Reviews Immunology,2003,"[u'http://www.nature.com/doifinder/10.1038/nri981', u'http://dx.doi.org/10.1038/nri981']",
10.1084/jem.191.9.1499,"Wherry, E., Ahmed, R., , Memory CD8 T-Cell Differentiation during Viral Infection, Journal of Virology, 2004",cited-by,10.1128/JVI.78.11.5535-5545.2004,Memory CD8 T-Cell Differentiation during Viral Infection,"[['E.', 'John', 'Wherry'], ['Rafi', '', 'Ahmed']]",Journal of Virology,2004,"[u'http://jvi.highwire.org/cgi/reprint/78/11/5535.pdf', u'http://www.microbio.uab.edu/mic740/papers/11232009/wherry.pdf', u'http://jvi.asm.org/cgi/reprint/78/11/5535.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.11.5535-5545.2004']",
10.1084/jem.191.9.1499,"Feld, J., Hoofnagle, J., , Mechanism of action of interferon and ribavirin in treatment of hepatitis C, Nature, 2005",cited-by,10.1038/nature04082,Mechanism of action of interferon and ribavirin in treatment of hepatitis C,"[['Jordan', 'J.', 'Feld'], ['Jay', 'H.', 'Hoofnagle']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04082', u'http://dx.doi.org/10.1038/nature04082', u'http://adsabs.harvard.edu/abs/2005Natur.436..967F']",
10.1084/jem.191.9.1499,"GRUENER, N., LECHNER, F., JUNG, M., et. al, Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus, Journal of Virology, 2001",cited-by,10.1128/JVI.75.12.5550-5558.2001,Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus,"[['NORBERT', 'H.', 'GRUENER'], ['FRANZISKA', '', 'LECHNER'], ['MARIA-CHRISTINA', '', 'JUNG'], ['HELMUT', '', 'DIEPOLDER'], ['TILMAN', '', 'GERLACH'], ['GEORG', '', 'LAUER'], ['BRUCE', '', 'WALKER'], ['JOHN', '', 'SULLIVAN'], ['RODNEY', '', 'PHILLIPS'], ['GERD', 'R.', 'PAPE'], ['PAUL', '', 'KLENERMAN']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/12/5550.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.12.5550-5558.2001']",
10.1084/jem.191.9.1499,"Simmonds, P., , Genetic diversity and evolution of hepatitis C virus - 15 years on, Journal of General Virology, 2004",cited-by,10.1099/vir.0.80401-0,Genetic diversity and evolution of hepatitis C virus - 15 years on,"[['Peter', '', 'Simmonds']]",Journal of General Virology,2004,"[u'http://jgv.sgmjournals.org/cgi/reprint/85/11/3173.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/vir.0.80401-0']",
10.1084/jem.191.9.1499,"Bowen, D., Walker, C., , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 2005",cited-by,10.1038/nature04079,Adaptive immune responses in acute and chronic hepatitis C virus infection,"[['David', 'G.', 'Bowen'], ['Christopher', 'M.', 'Walker']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04079', u'http://dx.doi.org/10.1038/nature04079']",
10.1084/jem.191.9.1499,"Trifilo, M., Edelmann, K., Teyton, L., et. al, Interleukin10 determines viral clearance or persistence in vivo, Nature Medicine, 2006",cited-by,10.1038/nm1492,Interleukin10 determines viral clearance or persistence in vivo,"[['Matthew', 'J', 'Trifilo'], ['Kurt', 'H', 'Edelmann'], ['Luc', '', 'Teyton'], ['Dorian', 'B', 'McGavern'], ['Michael', 'B A', 'Oldstone'], ['David', 'G', 'Brooks']]",Nature Medicine,2006,"[u'http://www.nature.com/doifinder/10.1038/nm1492', u'http://dx.doi.org/10.1038/nm1492']",
10.1084/jem.191.9.1499,"Altfeld, M., Rosenberg, E., Shankarappa, R., et. al, Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection, Journal of Experimental Medicine, 2001",cited-by,10.1084/jem.193.2.169,Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection,"[['M.', '', 'Altfeld'], ['E.', 'S.', 'Rosenberg'], ['R.', '', 'Shankarappa'], ['J.', 'S.', 'Mukherjee'], ['F.', 'M.', 'Hecht'], ['R.', 'L.', 'Eldridge'], ['M.', 'M.', 'Addo'], ['S.', 'H.', 'Poon'], ['M.', 'N.', 'Phillips'], ['G.', 'K.', 'Robbins'], ['P.', 'E.', 'Sax'], ['S.', '', 'Boswell'], ['J.', 'O.', 'Kahn'], ['C.', '', 'Brander'], ['P.', 'J. R.', 'Goulder'], ['J.', 'A.', 'Levy'], ['J.', 'I.', 'Mullins'], ['B.', 'D.', 'Walker']]",Journal of Experimental Medicine,2001,[u'http://www.jem.org/cgi/doi/10.1084/jem.193.2.169'],
10.1084/jem.191.9.1499,"BIGGER, C., BRASKY, K., LANFORD, R., , DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.7059-7066.2001,DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection,"[['CATHERINE', 'B.', 'BIGGER'], ['KATHLEEN', 'M.', 'BRASKY'], ['ROBERT', 'E.', 'LANFORD']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/15/7059.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.7059-7066.2001']",
10.1084/jem.191.9.1499,"Mongkolsapaya, J., Dejnirattisai, W., Xu, X., et. al, Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever, Nature Medicine, 2003",cited-by,10.1038/nm887,Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever,"[['Juthathip', '', 'Mongkolsapaya'], ['Wanwisa', '', 'Dejnirattisai'], ['Xiao-ning', '', 'Xu'], ['Sirijitt', '', 'Vasanawathana'], ['Nattaya', '', 'Tangthawornchaikul'], ['Aroonrung', '', 'Chairunsri'], ['Siraporn', '', 'Sawasdivorn'], ['Thaneeya', '', 'Duangchinda'], ['Tao', '', 'Dong'], ['Sarah', '', 'Rowland-Jones'], ['Pa-thai', '', 'Yenchitsomanus'], ['Andrew', '', 'McMichael'], ['Prida', '', 'Malasit'], ['Gavin', '', 'Screaton']]",Nature Medicine,2003,"[u'http://dx.doi.org/10.1038/nm887', u'http://www.nature.com/doifinder/10.1038/nm887']",
10.1084/jem.191.9.1499,"Erickson, A., Kimura, Y., Igarashi, S., et. al, The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes, Immunity, 2001",cited-by,10.1016/S1074-7613(01)00245-X,The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes,"[['Ann', 'L', 'Erickson'], ['Yoichi', '', 'Kimura'], ['Suzu', '', 'Igarashi'], ['Jennifer', '', 'Eichelberger'], ['Michael', '', 'Houghton'], ['John', '', 'Sidney'], ['Denise', '', 'McKinney'], ['Alessandro', '', 'Sette'], ['Austin', 'L', 'Hughes'], ['Christopher', 'M', 'Walker']]",Immunity,2001,"[u'http://www.sciencedirect.com/science/article/pii/S107476130100245X', u'http://linkinghub.elsevier.com/retrieve/pii/S107476130100245X']",
10.1084/jem.191.9.1499,"Tseng, C., Klimpel, G., , Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions, Journal of Experimental Medicine, 2002",cited-by,10.1084/jem.20011145,Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions,"[['C.-T.', 'K.', 'Tseng'], ['G.', 'R.', 'Klimpel']]",Journal of Experimental Medicine,2002,[u'http://www.jem.org/cgi/doi/10.1084/jem.20011145'],
10.1084/jem.191.9.1499,"Boettler, T., Spangenberg, H., Neumann-Haefelin, C., et. al, T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7860-7867.2005,T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection,"[['Tobias', '', 'Boettler'], ['Hans', 'Christian', 'Spangenberg'], ['Christoph', '', 'Neumann-Haefelin'], ['Elisabeth', '', 'Panther'], ['Simonetta', '', 'Urbani'], ['Carlo', '', 'Ferrari'], ['Hubert', 'E.', 'Blum'], ['Fritz', 'von', 'Weizsacker'], ['Robert', '', 'Thimme']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7860.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7860-7867.2005']",
10.1084/jem.191.9.1499,"Urbani, S., Amadei, B., Tola, D., et. al, PD1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion, Journal of Virology, 2006",cited-by,10.1128/JVI.01177-06,PD1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion,"[['Simona', '', 'Urbani'], ['Barbara', '', 'Amadei'], ['Daniela', '', 'Tola'], ['Marco', '', 'Massari'], ['Simona', '', 'Schivazappa'], ['Gabriele', '', 'Missale'], ['Carlo', '', 'Ferrari']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/22/11398.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01177-06']",
10.1084/jem.191.9.1499,"Altfeld, M., Rosenberg, E., Shankarappa, R., et. al, Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection, , 0",cited-by,2818688Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection,Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV1 Infection,"[['Marcus', '', 'Altfeld'], ['Eric', 'S.', 'Rosenberg'], ['Raj', '', 'Shankarappa'], ['Joia', 'S.', 'Mukherjee'], ['Frederick', 'M.', 'Hecht'], ['Robert', 'L.', 'Eldridge'], ['Marylyn', 'M.', 'Addo'], ['Samuel', 'H.', 'Poon'], ['Mary', 'N.', 'Phillips'], ['Gregory', 'K.', 'Robbins'], ['Paul', 'E.', 'Sax'], ['Steve', '', 'Boswell'], ['James', 'O.', 'Kahn'], ['Christian', '', 'Brander'], ['Philip', 'J. R.', 'Goulder'], ['Jay', 'A.', 'Levy'], ['James', 'I.', 'Mullins'], ['Bruce', 'D.', 'Walker']]",,0,[u'http://jem.rupress.org/cgi/reprint/193/2/169.pdf'],
10.1084/jem.191.9.1499,"Klenerman, P., Hill, A., , T cells and viral persistence: lessons from diverse infections, Nature Immunology, 2005",cited-by,10.1038/ni1241,T cells and viral persistence: lessons from diverse infections,"[['Paul', '', 'Klenerman'], ['Ann', '', 'Hill']]",Nature Immunology,2005,"[u'http://www.nature.com/doifinder/10.1038/ni1241', u'http://dx.doi.org/10.1038/ni1241']",
10.1084/jem.191.9.1499,"Rushbrook, S., Ward, S., Unitt, E., et. al, Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.12.7852-7859.2005,Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection,"[['Simon', 'M.', 'Rushbrook'], ['Scott', 'M.', 'Ward'], ['Esther', '', 'Unitt'], ['Sarah', 'L.', 'Vowler'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Graeme', 'J. M.', 'Alexander']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/12/7852.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.12.7852-7859.2005']",
10.1084/jem.191.9.1499,"Harari, A., Petitpierre, S., Vallelian, F., et. al, Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy, , 2004",cited-by,6743478Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy,Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV1-infected subjects with progressive disease: changes after antiretroviral therapy,"[['Alexandre', '', 'Harari'], ['Stephanie', '', 'Petitpierre'], ['Florence', '', 'Vallelian'], ['Giuseppe', '', 'Pantaleo']]",,2004,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/3/966.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2003-04-1203v1.pdf']",
10.1084/jem.191.9.1499,"Lauer, G., Barnes, E., Lucas, M., et. al, High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.06.015,High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection,"[['Georg', 'M.', 'Lauer'], ['Eleanor', '', 'Barnes'], ['Michaela', '', 'Lucas'], ['Joerg', '', 'Timm'], ['Kei', '', 'Ouchi'], ['Arthur', 'Y.', 'Kim'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Deborah', 'R.', 'Casson'], ['Markus', '', 'Reiser'], ['Geoffrey', '', 'Dusheiko'], ['Todd', 'M.', 'Allen'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Paul', '', 'Klenerman']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504010364', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504010364']",
10.1084/jem.191.9.1499,"Bertoletti, A., Ferrari, C., , Kinetics of the immune response during HBV and HCV infection, Hepatology, 2003",cited-by,10.1053/jhep.2003.50310,Kinetics of the immune response during HBV and HCV infection,"[['Antonio', '', 'Bertoletti'], ['Carlo', '', 'Ferrari']]",Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0270913903005032', u'http://hepatitis-central.com/hcv/info/2003/july/hepcinfo4.pdf', u'http://doi.wiley.com/10.1053/jhep.2003.50310']",
10.1084/jem.191.9.1499,"Day, C., Lauer, G., Robbins, G., et. al, Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12584-12595.2002,Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection,"[['Cheryl', 'L.', 'Day'], ['Georg', 'M.', 'Lauer'], ['Gregory', 'K.', 'Robbins'], ['Barbara', '', 'McGovern'], ['Alysse', 'G.', 'Wurcel'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12584-12595.2002', u'http://jvi.asm.org/cgi/reprint/76/24/12584.pdf']",
10.1084/jem.191.9.1499,"Tseng, C., Klimpel, G., , Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions, , 0",cited-by,11723217Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions,Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions,"[['Chien-Te', 'K.', 'Tseng'], ['Gary', 'R.', 'Klimpel']]",,0,[u'http://jem.rupress.org/cgi/reprint/195/1/43.pdf'],
10.1084/jem.191.9.1499,"Radziewicz, H., Ibegbu, C., Fernandez, M., et. al, Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression, Journal of Virology, 2007",cited-by,10.1128/JVI.02021-06,Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD1 and Low Levels of CD127 Expression,"[['Henry', '', 'Radziewicz'], ['Chris', 'C.', 'Ibegbu'], ['Marina', 'L.', 'Fernandez'], ['Kimberly', 'A.', 'Workowski'], ['Kamil', '', 'Obideen'], ['Mohammad', '', 'Wehbi'], ['Holly', 'L.', 'Hanson'], ['James', 'P.', 'Steinberg'], ['David', '', 'Masopust'], ['E.', 'John', 'Wherry'], ['John', 'D.', 'Altman'], ['Barry', 'T.', 'Rouse'], ['Gordon', 'J.', 'Freeman'], ['Rafi', '', 'Ahmed'], ['Arash', '', 'Grakoui']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/6/2545.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02021-06']",
10.1084/jem.191.9.1499,"Houghton, M., Abrignani, S., , Prospects for a vaccine against the hepatitis C virus, Nature, 2005",cited-by,10.1038/nature04081,Prospects for a vaccine against the hepatitis C virus,"[['Michael', '', 'Houghton'], ['Sergio', '', 'Abrignani']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature04081', u'http://adsabs.harvard.edu/abs/2005Natur.436..961H', u'http://dx.doi.org/10.1038/nature04081']",
10.1084/jem.191.9.1499,"Bigger, C., Guerra, B., Brasky, K., et. al, Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees, Journal of Virology, 2004",cited-by,10.1128/JVI.78.24.13779-13792.2004,Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees,"[['Catherine', 'B.', 'Bigger'], ['Bernadette', '', 'Guerra'], ['Kathleen', 'M.', 'Brasky'], ['Gene', '', 'Hubbard'], ['Michael', 'R.', 'Beard'], ['Bruce', 'A.', 'Luxon'], ['Stanley', 'M.', 'Lemon'], ['Robert', 'E.', 'Lanford']]",Journal of Virology,2004,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.24.13779-13792.2004'],
10.1084/jem.191.9.1499,"WEDEMEYER, H., MIZUKOSHI, E., DAVIS, A., et. al, Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells, Journal of Virology, 2001",cited-by,10.1128/JVI.75.23.11392-11400.2001,Cross-Reactivity between Hepatitis C Virus and Influenza A Virus Determinant-Specific Cytotoxic T Cells,"[['HEINER', '', 'WEDEMEYER'], ['EISHIRO', '', 'MIZUKOSHI'], ['ANTHONY', 'R.', 'DAVIS'], ['JACK', 'R.', 'BENNINK'], ['BARBARA', '', 'REHERMANN']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/23/11392.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.23.11392-11400.2001']",
10.1084/jem.191.9.1499,"Lauer, G., Ouchi, K., Chung, R., et. al, Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities, Journal of Virology, 2002",cited-by,10.1128/JVI.76.12.6104-6113.2002,Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities,"[['Georg', 'M.', 'Lauer'], ['Kei', '', 'Ouchi'], ['Raymond', 'T.', 'Chung'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Deborah', 'R.', 'Purkis'], ['Markus', '', 'Reiser'], ['Arthur', 'Y.', 'Kim'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/12/6104.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.12.6104-6113.2002']",
10.1084/jem.191.9.1499,"Guidotti, L., Chisari, F., , IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS, Annual Review of Pathology-mechanisms of Disease, 2006",cited-by,10.1146/annurev.pathol.1.110304.100230,IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS,"[['Luca', 'G.', 'Guidotti'], ['Francis', 'V.', 'Chisari']]",Annual Review of Pathology-mechanisms of Disease,2006,[u'http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.pathol.1.110304.100230'],
10.1084/jem.191.9.1499,"Auffermann-Gretzinger, S., Keeffe, E., Levy, S., , Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection, , 2001",cited-by,"6894712Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection","Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection","[['Susanne', '', 'Auffermann-Gretzinger'], ['Emmet', 'B.', 'Keeffe'], ['Shoshana', '', 'Levy']]",,2001,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/97/10/3171.pdf'],
10.1084/jem.191.9.1499,"Kostense, S., Gillespie, G., Joling, J., et. al, High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200103)31:3<677::AID-IMMU677>3.0.CO;2-M,High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function,"[['Stefan', '', 'Kostense'], ['Geraldine', '', 'Gillespie'], ['Jeanine', '', 'Joling'], ['Kristin', '', 'Vandenberghe'], ['Eveline', 'Z.', 'Veenhof'], ['Suzanne', '', 'Jurriaans'], ['Frank', '', 'Miedema']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200103%2931%3A3%3C677%3A%3AAID-IMMU677%3E3.0.CO%3B2-M'],
10.1084/jem.191.9.1499,"Keilholz, U., Weber, J., Finke, J., et. al, Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy, , 0",cited-by,10918494Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy,Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy,"[['Ulrich', '', 'Keilholz'], ['Jeffrey', '', 'Weber'], ['James', 'H.', 'Finke'], ['Dmitry', 'I.', 'Gabrilovich'], ['W.', 'Martin', 'Kast'], ['Mary', 'L.', 'Disis'], ['John', 'M.', 'Kirkwood'], ['Carmen', '', 'Scheibenbogen'], ['Jeff', '', 'Schlom'], ['Vernon', 'C.', 'Maino'], ['H.', 'Kim', 'Lyerly'], ['Peter', 'P.', 'Lee'], ['Walter', '', 'Storkus'], ['Franceso', '', 'Marincola'], ['Alexandra', '', 'Worobec'], ['Michael', 'B.', 'Atkins']]",,0,"[u'http://www.isbtc.org/about/archives/immune_monitoring_2001.pdf', u'http://depts.washington.edu/tumorvac/MultiMedia/Publications/ReviewArticles/2002_JofImmuno_97-138.pdf', u'https://depts.washington.edu/tumorvac/MultiMedia/Publications/ReviewArticles/2002_JofImmuno_97-138.pdf']",
10.1084/jem.191.9.1499,"Wieland, S., Chisari, F., , Stealth and Cunning: Hepatitis B and Hepatitis C Viruses, Journal of Virology, 2005",cited-by,10.1128/JVI.79.15.9369-9380.2005,Stealth and Cunning: Hepatitis B and Hepatitis C Viruses,"[['Stefan', 'F.', 'Wieland'], ['Francis', 'V.', 'Chisari']]",Journal of Virology,2005,"[u'http://jvi.highwire.org/cgi/reprint/79/15/9369.pdf', u'http://jvi.asm.org/cgi/reprint/79/15/9369.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.15.9369-9380.2005']",
10.1084/jem.191.9.1499,"Klebanoff, C., Gattinoni, L., Restifo, N., , CD8+ T-cell memory in tumor immunology and immunotherapy, Immunological Reviews, 2006",cited-by,10.1111/j.0105-2896.2006.00391.x,CD8+ T-cell memory in tumor immunology and immunotherapy,"[['Christopher', 'A.', 'Klebanoff'], ['Luca', '', 'Gattinoni'], ['Nicholas', 'P.', 'Restifo']]",Immunological Reviews,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.0105-2896.2006.00391.x'],
10.1084/jem.191.9.1499,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1084/jem.191.9.1499,"Goulder, P., Tang, Y., Brander, C., et. al, Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children, Journal of Experimental Medicine, 2000",cited-by,10.1084/jem.192.12.1819,Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children,"[['P.', 'J. R.', 'Goulder'], ['Y.', '', 'Tang'], ['C.', '', 'Brander'], ['M.', 'R.', 'Betts'], ['M.', '', 'Altfeld'], ['K.', '', 'Annamalai'], ['A.', '', 'Trocha'], ['S.', '', 'He'], ['E.', 'S.', 'Rosenberg'], ['G.', '', 'Ogg'], ['C.', 'A.', ""O'Callaghan""], ['S.', 'A.', 'Kalams'], ['R.', 'E.', 'McKinney'], ['K.', '', 'Mayer'], ['R.', 'A.', 'Koup'], ['S.', 'I.', 'Pelton'], ['S.', 'K.', 'Burchett'], ['K.', '', 'McIntosh'], ['B.', 'D.', 'Walker']]",Journal of Experimental Medicine,2000,[u'http://www.jem.org/cgi/doi/10.1084/jem.192.12.1819'],
10.1084/jem.191.9.1499,"Contreras, A., Hiasa, Y., He, W., et. al, Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System, Journal of Virology, 2002",cited-by,10.1128/JVI.76.17.8505-8517.2002,Viral RNA Mutations Are Region Specific and Increased by Ribavirin in a Full-Length Hepatitis C Virus Replication System,"[['Ana', 'Maria', 'Contreras'], ['Yoichi', '', 'Hiasa'], ['Wenping', '', 'He'], ['Adam', '', 'Terella'], ['Emmett', 'V.', 'Schmidt'], ['Raymond', 'T.', 'Chung']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/17/8505.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.17.8505-8517.2002']",
10.1084/jem.191.9.1499,"Urbani, S., Boni, C., Missale, G., et. al, Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12423-12434.2002,Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C,"[['Simona', '', 'Urbani'], ['Carolina', '', 'Boni'], ['Gabriele', '', 'Missale'], ['Gianfranco', '', 'Elia'], ['Cristina', '', 'Cavallo'], ['Marco', '', 'Massari'], ['Giovanni', '', 'Raimondo'], ['Carlo', '', 'Ferrari']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/24/12423.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12423-12434.2002']",
10.1084/jem.191.9.1499,"Wedemeyer, H., He, X., Nascimbeni, M., et. al, Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1, , 0",cited-by,11243134Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,Impaired Effector Function of Hepatitis C Virus-Specific CD8 T Cells in Chronic Hepatitis C Virus Infection1,"[['Heiner', '', 'Wedemeyer'], ['Xiao-Song', '', 'He'], ['Michelina', '', 'Nascimbeni'], ['Anthony', 'R.', 'Davis'], ['Harry', 'B.', 'Greenberg'], ['Jay', 'H.', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Harvey', '', 'Alter'], ['Barbara', '', 'Rehermann']]",,0,[u'http://www.jimmunol.org/cgi/reprint/169/6/3447.pdf'],
10.1084/jem.191.9.1499,"Nascimbeni, M., Mizukoshi, E., Bosmann, M., et. al, Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees, Journal of Virology, 2003",cited-by,10.1128/JVI.77.8.4781-4793.2003,Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees,"[['Michelina', '', 'Nascimbeni'], ['Eishiro', '', 'Mizukoshi'], ['Markus', '', 'Bosmann'], ['Marian', 'E.', 'Major'], ['Kathleen', '', 'Mihalik'], ['Charles', 'M.', 'Rice'], ['Stephen', 'M.', 'Feinstone'], ['Barbara', '', 'Rehermann']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/8/4781.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.8.4781-4793.2003']",
10.1084/jem.191.9.1499,"Penna, A., Pilli, M., Zerbini, A., et. al, Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection, Hepatology, 2007",cited-by,10.1002/hep.21541,Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection,"[['Amalia', '', 'Penna'], ['Massimo', '', 'Pilli'], ['Alessandro', '', 'Zerbini'], ['Alessandra', '', 'Orlandini'], ['Sergio', '', 'Mezzadri'], ['Luca', '', 'Sacchelli'], ['Gabriele', '', 'Missale'], ['Carlo', '', 'Ferrari']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21541'],
10.1084/jem.191.9.1499,"Hahn, T., Yoon, J., Alter, H., et. al, Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2006.12.008,Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo,"[['Thomas', 'von', 'Hahn'], ['Joo', 'Chun', 'Yoon'], ['Harvey', '', 'Alter'], ['Charles', 'M.', 'Rice'], ['Barbara', '', 'Rehermann'], ['Peter', '', 'Balfe'], ['Jane', 'A.', 'McKeating']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506025662', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506025662']",
10.1084/jem.191.9.1499,"Timm, J., Lauer, G., Kavanagh, D., et. al, CD8 Epitope Escape and Reversion in Acute HCV Infection, , 2004",cited-by,6776278CD8 Epitope Escape and Reversion in Acute HCV Infection,CD8 Epitope Escape and Reversion in Acute HCV Infection,"[['Joerg', '', 'Timm'], ['Georg', 'M.', 'Lauer'], ['Daniel', 'G.', 'Kavanagh'], ['Isabelle', '', 'Sheridan'], ['Arthur', 'Y.', 'Kim'], ['Michaela', '', 'Lucas'], ['Thillagavathie', '', 'Pillay'], ['Kei', '', 'Ouchi'], ['Laura', 'L.', 'Reyor'], ['Julian', '', 'Schulze'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Nina', '', 'Bhardwaj'], ['Paul', '', 'Klenerman'], ['Bruce', 'D.', 'Walker'], ['Todd', 'M.', 'Allen']]",,2004,[u'http://jem.rupress.org/cgi/reprint/200/12/1593.pdf'],
10.1084/jem.191.9.1499,"Shoukry, N., Grakoui, A., Houghton, M., et. al, Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection, , 0",cited-by,12359419Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection,Memory CD8 � T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection,"[['Naglaa', 'H.', 'Shoukry'], ['Arash', '', 'Grakoui'], ['Michael', '', 'Houghton'], ['David', 'Y.', 'Chien'], ['John', '', 'Ghrayeb'], ['Keith', 'A.', 'Reimann'], ['Christopher', 'M.', 'Walker']]",,0,[],
10.1084/jem.191.9.1499,"Berge, I., Gamadia, L., Lier, R., , Human CD8+ T-cell differentiation in response to viruses, Nature Reviews Immunology, 2003",cited-by,10.1038/nri1254,Human CD8+ T-cell differentiation in response to viruses,"[['Ineke', 'J. M. ten', 'Berge'], ['Laila', 'E.', 'Gamadia'], ['Ren\xc3\xa9', 'A. W. van', 'Lier']]",Nature Reviews Immunology,2003,"[u'http://dx.doi.org/10.1038/nri1254', u'http://www.nature.com/doifinder/10.1038/nri1254']",
10.1084/jem.191.9.1499,"Folgori, A., Capone, S., Ruggeri, L., et. al, A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, 2006",cited-by,10.1038/nm1353,A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees,"[['Antonella', '', 'Folgori'], ['Stefania', '', 'Capone'], ['Lionello', '', 'Ruggeri'], ['Annalisa', '', 'Meola'], ['Elisabetta', '', 'Sporeno'], ['Bruno', 'Bruni', 'Ercole'], ['Monica', '', 'Pezzanera'], ['Rosalba', '', 'Tafi'], ['Mirko', '', 'Arcuri'], ['Elena', '', 'Fattori'], ['Armin', '', 'Lahm'], ['Alessandra', '', 'Luzzago'], ['Alessandra', '', 'Vitelli'], ['Stefano', '', 'Colloca'], ['Riccardo', '', 'Cortese'], ['Alfredo', '', 'Nicosia']]",Nature Medicine,2006,"[u'http://biolog-e.ls.biu.ac.il/faculty/wides/80-440/saritnm1353.pdf', u'http://www.nature.com/doifinder/10.1038/nm1353', u'http://dx.doi.org/10.1038/nm1353']",
10.1084/jem.191.9.1499,"Cerundolo, V., Dunbar, P., Klenerman, P., , Tracking T cells with tetramers: new tales from new tools, Nature Reviews Immunology, 2002",cited-by,10.1038/nri777,Tracking T cells with tetramers: new tales from new tools,"[['Vincenzo', '', 'Cerundolo'], ['P.', 'Rod', 'Dunbar'], ['Paul', '', 'Klenerman']]",Nature Reviews Immunology,2002,"[u'http://dx.doi.org/10.1038/nri777', u'http://www.nature.com/doifinder/10.1038/nri777']",
10.1084/jem.191.9.1499,"Dolganiuc, A., Oak, S., Kodys, K., et. al, Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.08.067,Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation,"[['Angela', '', 'Dolganiuc'], ['Shilpa', '', 'Oak'], ['Karen', '', 'Kodys'], ['Douglas', 'T.', 'Golenbock'], ['Robert', 'W.', 'Finberg'], ['Evelyn', 'A.', 'Kurt-Jones'], ['Gyongyi', '', 'Szabo']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504015689', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504015689', u'http://works.bepress.com/gyongyi_szabo/47', u'http://escholarship.umassmed.edu/gastroenterology_pp/40', u'http://dx.doi.org/10.1053/j.gastro.2004.08.067']",
10.1084/jem.191.9.1499,"Cox, A., Mosbruger, T., Mao, Q., et. al, Cellular immune selection with hepatitis C virus persistence in humans, , 2005",cited-by,6515303Cellular immune selection with hepatitis C virus persistence in humans,Cellular immune selection with hepatitis C virus persistence in humans,"[['Andrea', 'L.', 'Cox'], ['Timothy', '', 'Mosbruger'], ['Qing', '', 'Mao'], ['Zhi', '', 'Liu'], ['Xiao-Hong', '', 'Wang'], ['Hung-Chih', '', 'Yang'], ['John', '', 'Sidney'], ['Alessandro', '', 'Sette'], ['Drew', '', 'Pardoll'], ['David', 'L.', 'Thomas'], ['Stuart', 'C.', 'Ray']]",,2005,[],
10.1084/jem.191.9.1499,"Major, M., Mihalik, K., Puig, M., et. al, Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge, Journal of Virology, 2002",cited-by,10.1128/JVI.76.13.6586-6595.2002,Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge,"[['Marian', 'E.', 'Major'], ['Kathleen', '', 'Mihalik'], ['Montserrat', '', 'Puig'], ['Barbara', '', 'Rehermann'], ['Michelina', '', 'Nascimbeni'], ['Charles', 'M.', 'Rice'], ['Stephen', 'M.', 'Feinstone']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/13/6586.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.13.6586-6595.2002']",
10.1084/jem.191.9.1499,"Grabowska, A., Lechner, F., Klenerman, P., et. al, Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200108)31:8<2388::AID-IMMU2388>3.0.CO;2-L,Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection,"[['Anna', 'M.', 'Grabowska'], ['Franziska', '', 'Lechner'], ['Paul', '', 'Klenerman'], ['Paddy', 'J.', 'Tighe'], ['Stephen', '', 'Ryder'], ['Jonathan', 'K.', 'Ball'], ['Brian', 'J.', 'Thomson'], ['William', 'L.', 'Irving'], ['R.', 'Adrian', 'Robins']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200108%2931%3A8%3C2388%3A%3AAID-IMMU2388%3E3.0.CO%3B2-L'],
10.1084/jem.191.9.1499,"Amara, R., Robinson, H., , T cell vaccines for microbial infections, Nature Medicine, 2005",cited-by,10.1038/nm1212,T cell vaccines for microbial infections,"[['Rama', 'Rao', 'Amara'], ['Harriet', 'L', 'Robinson']]",Nature Medicine,2005,"[u'http://bepast.org/docs/vaccines/t-cell%20vaccines%20for%20microbial%20diseases.pdf', u'http://www.nature.com/doifinder/10.1038/nm1212', u'http://dx.doi.org/10.1038/nm1212']",
10.1084/jem.191.9.1499,"Gamadia, L., Remmerswaal, E., Weel, J., et. al, Primary immune responses to human CMV: a critical role for IFN--producing CD4 T cells in protection against CMV disease, , 2003",cited-by,6696621Primary immune responses to human CMV: a critical role for IFN--producing CD4 T cells in protection against CMV disease,Primary immune responses to human CMV: a critical role for IFN--producing CD4 T cells in protection against CMV disease,"[['Laila', 'E.', 'Gamadia'], ['Ester', 'B. M.', 'Remmerswaal'], ['Jan', 'F.', 'Weel'], ['W.', 'van', 'Lier']]",,2003,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/101/7/2686.pdf'],
10.1084/jem.191.9.1499,"Miller, J., Most, R., Akondy, R., et. al, Human Effector and Memory CD8 + T Cell Responses to Smallpox and Yellow Fever Vaccines, Immunity, 2008",cited-by,10.1016/j.immuni.2008.02.020,Human Effector and Memory CD8 + T Cell Responses to Smallpox and Yellow Fever Vaccines,"[['Joseph', 'D.', 'Miller'], ['Robbert', 'G. van der', 'Most'], ['Rama', 'S.', 'Akondy'], ['John', 'T.', 'Glidewell'], ['Sophia', '', 'Albott'], ['David', '', 'Masopust'], ['Kaja', '', 'Murali-Krishna'], ['Patryce', 'L.', 'Mahar'], ['Srilatha', '', 'Edupuganti'], ['Susan', '', 'Lalor'], ['Stephanie', '', 'Germon'], ['Carlos', 'Del', 'Rio'], ['Silvija', 'I.', 'Staprans'], ['John', 'D.', 'Altman'], ['Mark', 'B.', 'Feinberg'], ['Rafi', '', 'Ahmed']]",Immunity,2008,"[u'http://www.microbio.uab.edu/mic740/papers/10052009/miller.pdf', u'http://www.sciencedirect.com/science/article/pii/S1074761308001945', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761308001945']",
10.1084/jem.191.9.1499,"Rahman, F., Heller, T., Sobao, Y., et. al, Effects of antiviral therapy on the cellular immune response in acute hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20253,Effects of antiviral therapy on the cellular immune response in acute hepatitis C,"[['Fareed', '', 'Rahman'], ['Theo', '', 'Heller'], ['Yuji', '', 'Sobao'], ['Eishiro', '', 'Mizukoshi'], ['Michelina', '', 'Nascimbeni'], ['Harvey', '', 'Alter'], ['Steven', '', 'Herrine'], ['Jay', '', 'Hoofnagle'], ['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20253'],
10.1084/jem.191.9.1499,"Shin, H., Wherry, E., , CD8 T cell dysfunction during chronic viral infection, Current Opinion in Immunology, 2007",cited-by,10.1016/j.coi.2007.06.004,CD8 T cell dysfunction during chronic viral infection,"[['Haina', '', 'Shin'], ['E', 'John', 'Wherry']]",Current Opinion in Immunology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0952791507001082', u'http://linkinghub.elsevier.com/retrieve/pii/S0952791507001082']",
10.1084/jem.191.9.1499,"Cox, A., Mosbruger, T., Lauer, G., et. al, Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C, Hepatology, 2005",cited-by,10.1002/hep.20749,Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C,"[['Andrea', 'L.', 'Cox'], ['Timothy', '', 'Mosbruger'], ['Georg', 'M.', 'Lauer'], ['Drew', '', 'Pardoll'], ['David', 'L.', 'Thomas'], ['Stuart', 'C.', 'Ray']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20749'],
10.1084/jem.191.9.1499,"Fuller, M., Zajac, A., , Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1, , 0",cited-by,5555246Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1,Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1,"[['Michael', 'J.', 'Fuller'], ['Allan', 'J.', 'Zajac']]",,0,[u'http://www.jimmunol.org/cgi/reprint/170/1/477.pdf'],
10.1084/jem.191.9.1499,"Storni, T., Kündig, T., Senti, G., et. al, Immunity in response to particulate antigen-delivery systems, Advanced Drug Delivery Reviews, 2005",cited-by,10.1016/j.addr.2004.09.008,Immunity in response to particulate antigen-delivery systems,"[['Tazio', '', 'Storni'], ['Thomas', 'M.', 'K\xc3\xbcndig'], ['Gabriela', '', 'Senti'], ['P\xc3\xa5l', '', 'Johansen']]",Advanced Drug Delivery Reviews,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X04002066', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X04002066']",
10.1084/jem.191.9.1499,"Lauer, G., Nguyen, T., Day, C., et. al, Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses, Journal of Virology, 2002",cited-by,10.1128/JVI.76.6.2817-2826.2002,Human Immunodeficiency Virus Type 1Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses,"[['Georg', 'M.', 'Lauer'], ['Tam', 'N.', 'Nguyen'], ['Cheryl', 'L.', 'Day'], ['Gregory', 'K.', 'Robbins'], ['Theresa', '', 'Flynn'], ['Katherine', '', 'McGowan'], ['Eric', 'S.', 'Rosenberg'], ['Michaela', '', 'Lucas'], ['Paul', '', 'Klenerman'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker'], ['Lemuel', '', 'Shattuck']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.6.2817-2826.2002', u'http://jvi.asm.org/cgi/reprint/76/6/2817.pdf']",
10.1084/jem.191.9.1499,"Ouyang, Q., Wagner, W., Wikby, A., et. al, Large Numbers of Dysfunctional CD8 + T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old, Journal of Clinical Immunology, 2003",cited-by,10.1023/A:1024580531705,Large Numbers of Dysfunctional CD8 + T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old,"[['Qin', '', 'Ouyang'], ['Wolfgang', 'M.', 'Wagner'], ['Anders', '', 'Wikby'], ['Steffen', '', 'Walter'], ['Geraldine', '', 'Aubert'], ['Anthony', 'I.', 'Dodi'], ['Paul', '', 'Travers'], ['Graham', '', 'Pawelec']]",Journal of Clinical Immunology,2003,"[u'http://www.springerlink.com/content/u0281160r2n65235', u'http://www.springerlink.com/index/u0281160r2n65235.pdf']",
10.1084/jem.191.9.1499,"Ewer, K., Millington, K., Deeks, J., et. al, Dynamic antigen-specific T cell responses after point-source exposure to Mycobacterium tuberculosis, , 2006",cited-by,5471914Dynamic antigen-specific T cell responses after point-source exposure to Mycobacterium tuberculosis,Dynamic antigen-specific T cell responses after point-source exposure to Mycobacterium tuberculosis,"[['Katie', '', 'Ewer'], ['Kerry', 'A.', 'Millington'], ['Jonathan', 'J.', 'Deeks'], ['Lydia', '', 'Alvarez'], ['Gerry', '', 'Bryant'], ['Ajit', '', 'Lalvani']]",,2006,"[u'http://ajrccm.atsjournals.org/cgi/reprint/174/7/831.pdf', u'http://ajrccm.atsjournals.org/cgi/reprint/200511-1783OCv1.pdf', u'http://intl-ajrccm.atsjournals.org/cgi/reprint/174/7/831.pdf']",
10.1084/jem.191.9.1499,"Piccioli, D., Tavarini, S., Nuti, S., et. al, Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.09.014,Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors,"[['Diego', '', 'Piccioli'], ['Simona', '', 'Tavarini'], ['Sandra', '', 'Nuti'], ['Piero', '', 'Colombatto'], ['Maurizia', '', 'Brunetto'], ['Ferruccio', '', 'Bonino'], ['Pietro', '', 'Ciccorossi'], ['Francesca', '', 'Zorat'], ['Gabriele', '', 'Pozzato'], ['Consuelo', '', 'Comar'], ['Sergio', '', 'Abrignani'], ['Andreas', '', 'Wack']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004544', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004544']",
10.1084/jem.191.9.1499,"Hislop, A., Annels, N., Gudgeon, N., et. al, Epitope-specific Evolution of Human CD8 � T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection, , 0",cited-by,10911088Epitope-specific Evolution of Human CD8 � T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection,Epitope-specific Evolution of Human CD8 � T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus Infection,"[['Andrew', 'D.', 'Hislop'], ['Nicola', 'E.', 'Annels'], ['Nancy', 'H.', 'Gudgeon'], ['Alison', 'M.', 'Leese'], ['Alan', 'B.', 'Rickinson']]",,0,[u'http://jem.rupress.org/cgi/reprint/195/7/893.pdf'],
10.1084/jem.191.9.1499,"Spangenberg, H., Viazov, S., Kersting, N., et. al, Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection, Hepatology, 2005",cited-by,10.1002/hep.20856,Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection,"[['Hans', 'Christian', 'Spangenberg'], ['Sergei', '', 'Viazov'], ['Nadine', '', 'Kersting'], ['Christoph', '', 'Neumann-Haefelin'], ['Denise', '', 'McKinney'], ['Michael', '', 'Roggendorf'], ['Fritz', 'von', 'Weizs\xc3\xa4cker'], ['Hubert', 'E.', 'Blum'], ['Robert', '', 'Thimme']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20856'],
10.1084/jem.191.9.1499,"Kaplan, D., Sugimoto, K., Newton, K., et. al, Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2006.11.044,Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C,"[['David', 'E.', 'Kaplan'], ['Kazushi', '', 'Sugimoto'], ['Kimberly', '', 'Newton'], ['Mary', 'E.', 'Valiga'], ['Fusao', '', 'Ikeda'], ['Ayse', '', 'Aytaman'], ['Frederick', 'A.', 'Nunes'], ['Michael', 'R.', 'Lucey'], ['Barbara', 'A.', 'Vance'], ['Robert', 'H.', 'Vonderheide'], ['K.', 'Rajender', 'Reddy'], ['Jane', 'A.', 'McKeating']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S001650850602525X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850602525X']",
10.1084/jem.191.9.1499,"Pawlotsky, J., , Pathophysiology of hepatitis C virus infection and related liver disease, Trends in Microbiology, 2004",cited-by,10.1016/j.tim.2003.12.005,Pathophysiology of hepatitis C virus infection and related liver disease,"[['Jean-Michel', '', 'Pawlotsky']]",Trends in Microbiology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0966842X03003329', u'http://linkinghub.elsevier.com/retrieve/pii/S0966842X03003329']",
10.1084/jem.191.9.1499,"Semmo, N., Day, C., Ward, S., et. al, Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection, Hepatology, 2005",cited-by,10.1002/hep.20669,Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection,"[['Nasser', '', 'Semmo'], ['Cheryl', 'L.', 'Day'], ['Scott', 'M.', 'Ward'], ['Michaela', '', 'Lucas'], ['Gillian', '', 'Harcourt'], ['Andrew', '', 'Loughry'], ['Paul', '', 'Klenerman']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20669'],
10.1084/jem.191.9.1499,"Lanford, R., Guerra, B., Chavez, D., et. al, Cross-Genotype Immunity to Hepatitis C Virus, Journal of Virology, 2004",cited-by,10.1128/JVI.78.3.1575-1581.2004,Cross-Genotype Immunity to Hepatitis C Virus,"[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Deborah', '', 'Chavez'], ['Catherine', '', 'Bigger'], ['Kathleen', 'M.', 'Brasky'], ['Xiao-Hong', '', 'Wang'], ['Stuart', 'C.', 'Ray'], ['David', 'L.', 'Thomas']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/3/1575.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.3.1575-1581.2004']",
10.1084/jem.191.9.1499,"Goulder, P., Tang, Y., Brander, C., et. al, Functionally Inert HIV-specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children, , 0",cited-by,6754943Functionally Inert HIV-specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children,Functionally Inert HIV-specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children,"[['Philip', 'J. R.', 'Goulder'], ['Yanhua', '', 'Tang'], ['Christian', '', 'Brander'], ['Michael', 'R.', 'Betts'], ['Marcus', '', 'Altfeld'], ['Ken', '', 'Annamalai'], ['Alicja', '', 'Trocha'], ['Suqin', '', 'He'], ['Eric', 'S.', 'Rosenberg'], ['Graham', '', 'Ogg'], ['Christopher', 'A.', ""O'Callaghan""], ['Spyros', 'A.', 'Kalams'], ['Ross', 'E.', 'McKinney'], ['Kenneth', '', 'Mayer'], ['Richard', 'A.', 'Koup'], ['Stephen', 'I.', 'Pelton'], ['Sandra', 'K.', 'Burchett'], ['Kenneth', '', 'McIntosh'], ['Bruce', 'D.', 'Walker']]",,0,[u'http://jem.rupress.org/cgi/reprint/192/12/1819.pdf'],
10.1084/jem.191.9.1499,"Neumann-Haefelin, C., McKiernan, S., Ward, S., et. al, Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution, Hepatology, 2006",cited-by,10.1002/hep.21049,Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution,"[['Christoph', '', 'Neumann-Haefelin'], ['Susan', '', 'McKiernan'], ['Scott', '', 'Ward'], ['Sergei', '', 'Viazov'], ['Hans', 'Christian', 'Spangenberg'], ['Thomas', '', 'Killinger'], ['Thomas', 'F.', 'Baumert'], ['Natalja', '', 'Nazarova'], ['Isabelle', '', 'Sheridan'], ['Oliver', '', 'Pybus'], ['Fritz', 'von', 'Weizs\xc3\xa4cker'], ['Michael', '', 'Roggendorf'], ['Dermot', '', 'Kelleher'], ['Paul', '', 'Klenerman'], ['Hubert', 'E.', 'Blum'], ['Robert', '', 'Thimme']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21049'],
10.1084/jem.191.9.1499,"Thomson, M., Nascimbeni, M., Havert, M., et. al, The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.2.862-870.2003,The Clearance of Hepatitis C Virus Infection in Chimpanzees May Not Necessarily Correlate with the Appearance of Acquired Immunity,"[['Michael', '', 'Thomson'], ['Michelina', '', 'Nascimbeni'], ['Michael', 'B.', 'Havert'], ['Marian', '', 'Major'], ['Sophia', '', 'Gonzales'], ['Harvey', '', 'Alter'], ['Stephen', 'M.', 'Feinstone'], ['Krishna', 'K.', 'Murthy'], ['Barbara', '', 'Rehermann'], ['T.', 'Jake', 'Liang']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.2.862-870.2003', u'http://jvi.asm.org/cgi/reprint/77/2/862.pdf']",
10.1084/jem.191.9.1499,"Racanelli, V., Rehermann, B., , Hepatitis C virus infection: when silence is deception, Trends in Immunology, 2003",cited-by,10.1016/S1471-4906(03)00178-9,Hepatitis C virus infection: when silence is deception,"[['Vito', '', 'Racanelli'], ['Barbara', '', 'Rehermann']]",Trends in Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1471490603001789', u'http://linkinghub.elsevier.com/retrieve/pii/S1471490603001789']",
10.1084/jem.191.9.1499,"Lynn, H., Donfield, S., Gomperts, E., et. al, Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs, Journal of Infectious Diseases, 2001",cited-by,10.1086/318539,Hepatitis C Virus Load Is Associated with Human Immunodeficiency Virus Type 1 Disease Progression in Hemophiliacs,"[['Henry', '', 'Lynn'], ['Sharyne', '', 'Donfield'], ['Edward', '', 'Gomperts'], ['David', '', 'Chernoff'], ['Steven', '', 'Arkin']]",Journal of Infectious Diseases,2001,"[u'http://home.ncifcrf.gov/ccr/lgd/staffInfo/staff/pdf/Winkler/winkler_JInfectDis_2001_4_589.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/318539']",
10.1084/jem.191.9.1499,"Rehermann, B., , Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence, Journal of Clinical Investigation, 2009",cited-by,10.1172/JCI39133DS1,Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence,"[['Barbara', '', 'Rehermann']]",Journal of Clinical Investigation,2009,"[u'http://www.jci.org/articles/view/39133', u'http://www.jci.org/articles/view/39133#sd']",
10.1084/jem.191.9.1499,"Boettler, T., Panther, E., Bengsch, B., et. al, Expression of the Interleukin7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection, Journal of Virology, 2006",cited-by,10.1128/JVI.80.7.3532-3540.2006,Expression of the Interleukin7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection,"[['Tobias', '', 'Boettler'], ['Elisabeth', '', 'Panther'], ['Bertram', '', 'Bengsch'], ['Natalja', '', 'Nazarova'], ['Hans', 'Christian', 'Spangenberg'], ['Hubert', 'E.', 'Blum'], ['Robert', '', 'Thimme']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/7/3532.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.80.7.3532-3540.2006']",
10.1084/jem.191.9.1499,"Neumann-Haefelin, C., Blum, H., Chisari, F., et. al, T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005",cited-by,10.1016/j.jcv.2004.05.008,T cell response in hepatitis C virus infection,"[['C.', '', 'Neumann-Haefelin'], ['H.', 'E.', 'Blum'], ['F.', 'V.', 'Chisari'], ['R.', '', 'Thimme']]",Journal of Clinical Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S138665320400157X', u'http://linkinghub.elsevier.com/retrieve/pii/S138665320400157X']",
10.1084/jem.191.9.1499,"Esser, M., Marchese, R., Kierstead, L., et. al, Memory T cells and vaccines, Vaccine, 2003",cited-by,10.1016/S0264-410X(02)00407-3,Memory T cells and vaccines,"[['Mark', 'T.', 'Esser'], ['Rocio', 'D.', 'Marchese'], ['Lisa', 'S.', 'Kierstead'], ['Lynda', 'G.', 'Tussey'], ['Fubao', '', 'Wang'], ['Narendra', '', 'Chirmule'], ['Michael', 'W.', 'Washabaugh']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02004073', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02004073']",
10.1084/jem.191.9.1499,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1084/jem.191.9.1499,"Morishima, C., Paschal, D., Wang, C., et. al, Decreased NK cell frequency in chronic hepatitis C does not affectex vivo cytolytic killing, Hepatology, 2006",cited-by,10.1002/hep.21073,Decreased NK cell frequency in chronic hepatitis C does not affectex vivo cytolytic killing,"[['Chihiro', '', 'Morishima'], ['Denise', 'M.', 'Paschal'], ['Chia', 'C.', 'Wang'], ['Christina', 'S.', 'Yoshihara'], ['Brent', 'L.', 'Wood'], ['Anthony', 'E. T.', 'Yeo'], ['Scott', 'S.', 'Emerson'], ['Margaret', 'C.', 'Shuhart'], ['David', 'R.', 'Gretch']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21073'],
10.1084/jem.191.9.1499,"Bantel, H., Schulze-Osthoff, K., , Apoptosis in hepatitis C virus infection, Cell Death and Differentiation, 2003",cited-by,10.1038/sj.cdd.4401119,Apoptosis in hepatitis C virus infection,"[['H', '', 'Bantel'], ['K', '', 'Schulze-Osthoff']]",Cell Death and Differentiation,2003,"[u'http://dx.doi.org/10.1038/sj.cdd.4401119', u'http://www.nature.com/doifinder/10.1038/sj.cdd.4401119']",
10.1084/jem.191.9.1499,"Prezzi, C., Francavilla, V., Schiaffella, E., et. al, Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection, European Journal of Immunology, 2001",cited-by,10.1002/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I,Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection,"[['Caterina', '', 'Prezzi'], ['Vittorio', '', 'Francavilla'], ['Enrico', '', 'Schiaffella'], ['Luigi', '', 'Finocchi'], ['Guglielmo', '', 'Bruno'], ['Alessandro', '', 'Sette'], ['Sergio', '', 'Abrignani'], ['Vincenzo', '', 'Barnaba']]",European Journal of Immunology,2001,[u'http://doi.wiley.com/10.1002/1521-4141%28200103%2931%3A3%3C894%3A%3AAID-IMMU894%3E3.0.CO%3B2-I'],
10.1084/jem.191.9.1499,"Sheridan, I., Pybus, O., Holmes, E., et. al, High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression, Journal of Virology, 2004",cited-by,10.1128/JVI.78.7.3447-3454.2004,High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression,"[['Isabelle', '', 'Sheridan'], ['Oliver', 'G.', 'Pybus'], ['Edward', 'C.', 'Holmes'], ['Paul', '', 'Klenerman']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/7/3447.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.7.3447-3454.2004']",
10.1084/jem.191.9.1499,"Isogawa, M., Furuichi, Y., Chisari, F., , Oscillating CD8 + T Cell Effector Functions after Antigen Recognition in the Liver, Immunity, 2005",cited-by,10.1016/j.immuni.2005.05.005,Oscillating CD8 + T Cell Effector Functions after Antigen Recognition in the Liver,"[['Masanori', '', 'Isogawa'], ['Yoshihiro', '', 'Furuichi'], ['Francis', 'V.', 'Chisari']]",Immunity,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1074761305001986', u'http://linkinghub.elsevier.com/retrieve/pii/S1074761305001986']",
10.1084/jem.191.9.1499,"Lucas, M., Gadola, S., Meier, U., et. al, Frequency and Phenotype of Circulating V 24/V 11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection, Journal of Virology, 2003",cited-by,10.1128/JVI.77.3.2251-2257.2003,Frequency and Phenotype of Circulating V 24/V 11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection,"[['Michaela', '', 'Lucas'], ['Stephan', '', 'Gadola'], ['Ute', '', 'Meier'], ['Neil', 'T.', 'Young'], ['Gillian', '', 'Harcourt'], ['Anastasios', '', 'Karadimitris'], ['Nikki', '', 'Coumi'], ['Dave', '', 'Brown'], ['Geoff', '', 'Dusheiko'], ['Vincenzo', '', 'Cerundolo'], ['Paul', '', 'Klenerman']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/3/2251.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.3.2251-2257.2003']",
10.1084/jem.191.9.1499,"Tester, I., Smyk-Pearson, S., Wang, P., et. al, Immune evasion versus recovery after acute hepatitis C virus infection from a shared source, , 2005",cited-by,5302171Immune evasion versus recovery after acute hepatitis C virus infection from a shared source,Immune evasion versus recovery after acute hepatitis C virus infection from a shared source,"[['Ian', '', 'Tester'], ['Susan', '', 'Smyk-Pearson'], ['Ping', '', 'Wang'], ['Anne', '', 'Wertheimer'], ['Ermei', '', 'Yao'], ['David', 'M.', 'Lewinsohn'], ['John', 'E.', 'Tavis'], ['Hugo', 'R.', 'Rosen'], ['Saint', '', 'Louis']]",,2005,"[u'http://jem.rupress.org/cgi/reprint/201/11/1725.pdf', u'http://www.uchsc.edu/gastro/documents/pub_h_rosen/Rosen_Lab1.pdf']",
10.1084/jem.191.9.1499,"Amara, R., Villinger, F., Altman, J., et. al, Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00076-2,Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine,"[['Rama', 'Rao', 'Amara'], ['Francois', '', 'Villinger'], ['John', 'D', 'Altman'], ['Shari', 'L', 'Lydy'], ['Shawn', 'P', 'O\xe2\x80\x99Neil'], ['Silvija', 'I', 'Staprans'], ['David', 'C', 'Montefiori'], ['Yan', '', 'Xu'], ['James', 'G', 'Herndon'], ['Linda', 'S', 'Wyatt'], ['Maria', 'Angelito', 'Candido'], ['Natalia', 'L', 'Kozyr'], ['Patricia', 'L', 'Earl'], ['James', 'M', 'Smith'], ['Hak-Ling', '', 'Ma'], ['Bennett', 'D', 'Grimm'], ['Michael', 'L', 'Hulsey'], ['Harold', 'M', 'McClure'], ['Janet', 'M', 'McNicholl'], ['Bernard', '', 'Moss'], ['Harriet', 'L', 'Robinson']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02000762', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02000762']",
10.1084/jem.191.9.1499,"Ulsenheimer, A., Gerlach, J., Jung, M., et. al, Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection, Hepatology, 2005",cited-by,10.1002/hep.20592,Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection,"[['Axel', '', 'Ulsenheimer'], ['J.', 'Tilman', 'Gerlach'], ['Maria-Christina', '', 'Jung'], ['Norbert', '', 'Gruener'], ['Markus', '', 'Backmund'], ['Teresa', '', 'Santantonio'], ['Winfried', '', 'Schraut'], ['Malte', 'H. J.', 'Heeg'], ['Carl', 'A.', 'Schirren'], ['Reinhart', '', 'Zachoval'], ['Gerd', 'R.', 'Pape'], ['Helmut', 'M.', 'Diepolder']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20592'],
10.1084/jem.191.9.1499,"Longman, R., Talal, A., Jacobson, I., et. al, Presence of functional dendritic cells in patients chronically infected with hepatitis C virus, , 0",cited-by,10678077Presence of functional dendritic cells in patients chronically infected with hepatitis C virus,Presence of functional dendritic cells in patients chronically infected with hepatitis C virus,"[['Randy', 'S.', 'Longman'], ['Andrew', 'H.', 'Talal'], ['Ira', 'M.', 'Jacobson'], ['Matthew', 'L.', 'Albert'], ['Charles', 'M.', 'Rice']]",,0,[],
10.1084/jem.191.9.1499,"Urbani, S., Amadei, B., Fisicaro, P., et. al, Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses, Hepatology, 2006",cited-by,10.1002/hep.21242,Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses,"[['Simona', '', 'Urbani'], ['Barbara', '', 'Amadei'], ['Paola', '', 'Fisicaro'], ['Daniela', '', 'Tola'], ['Alessandra', '', 'Orlandini'], ['Luca', '', 'Sacchelli'], ['Cristina', '', 'Mori'], ['Gabriele', '', 'Missale'], ['Carlo', '', 'Ferrari']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21242'],
10.1084/jem.191.9.1499,"Thimme, R., Lohmann, V., Weber, F., , A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2005.12.001,A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus,"[['Robert', '', 'Thimme'], ['Volker', '', 'Lohmann'], ['Friedemann', '', 'Weber']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205002603', u'http://umanitoba.ca/faculties/medicine/units/medical_microbiology/Courses/MicroPath97.705/PDF/Thimme_HCV9_3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205002603']",
10.1084/jem.191.9.1499,"Nakamoto, N., Kaplan, D., Coleclough, J., et. al, Functional Restoration of HCV-Specific CD8 T Cells by PD1 Blockade Is Defined by PD1 Expression and Compartmentalization, Gastroenterology, 2008",cited-by,10.1053/j.gastro.2008.02.033,Functional Restoration of HCV-Specific CD8 T Cells by PD1 Blockade Is Defined by PD1 Expression and Compartmentalization,"[['Nobuhiro', '', 'Nakamoto'], ['David', 'E.', 'Kaplan'], ['Jennifer', '', 'Coleclough'], ['Yun', '', 'Li'], ['Mary', 'E.', 'Valiga'], ['Mary', '', 'Kaminski'], ['Abraham', '', 'Shaked'], ['Kim', '', 'Olthoff'], ['Emma', '', 'Gostick'], ['David', 'A.', 'Price'], ['Gordon', 'J.', 'Freeman'], ['E.', 'John', 'Wherry']]",Gastroenterology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0016508508002849', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508508002849']",
10.1084/jem.191.9.1499,"Abel, M., Sène, D., Pol, S., et. al, Intrahepatic virus-specific IL10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection, Hepatology, 2006",cited-by,10.1002/hep.21438,Intrahepatic virus-specific IL10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection,"[['Michal', '', 'Abel'], ['Damien', '', 'S\xc3\xa8ne'], ['Stanislas', '', 'Pol'], ['Marc', '', 'Bourli\xc3\xa8re'], ['Thierry', '', 'Poynard'], ['Fr\xc3\xa9d\xc3\xa9ric', '', 'Charlotte'], ['Patrice', '', 'Cacoub'], ['Sophie', '', 'Caillat-Zucman']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21438'],
10.1084/jem.191.9.1499,"Baarle, D., Miedema, F., Hovenkamp, E., et. al, Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma, Blood, 2001",cited-by,13699710Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma,Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma,"[['Debbie', 'van', 'Baarle'], ['F.', '', 'Miedema'], ['E.', '', 'Hovenkamp'], ['M.', 'F. C.', 'Callan'], ['K.', 'C.', 'Wolthers'], ['S.', '', 'Kostense'], ['H.', 'G. M.', 'Niesters'], ['A.', 'D. M. E.', 'Osterhaus'], ['A.', 'J.', 'McMichael'], ['Oers', 'van M. H.', 'J']]",Blood,2001,[u'http://publishing.eur.nl/ir/repub/asset/8185/11418474.pdf'],
10.1084/jem.191.9.1499,"Herzer, K., Falk, C., Encke, J., et. al, Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity, Journal of Virology, 2003",cited-by,10.1128/JVI.77.15.8299-8309.2003,Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity,"[['Kerstin', '', 'Herzer'], ['Christine', 'S.', 'Falk'], ['Jens', '', 'Encke'], ['Soren', 'T.', 'Eichhorst'], ['Axel', '', 'Ulsenheimer'], ['Barbara', '', 'Seliger'], ['Peter', 'H.', 'Krammer']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/15/8299.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.15.8299-8309.2003']",
10.1084/jem.191.9.1499,"HEL, Z., NACSA, J., KELSALL, B., et. al, Impairment of Gag-Specific CD8+ T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeficiency Virus mac251- and Simian-Human Immunodeficiency Virus KU2Infected Macaques, Journal of Virology, 2001",cited-by,10.1128/JVI.75.23.11483-11495.2001,Impairment of Gag-Specific CD8+ T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeficiency Virus mac251- and Simian-Human Immunodeficiency Virus KU2Infected Macaques,"[['ZDENEK', '', 'HEL'], ['JANOS', '', 'NACSA'], ['BRIAN', '', 'KELSALL'], ['WEN-PO', '', 'TSAI'], ['NORMAN', '', 'LETVIN'], ['ROBYN', 'WASHINGTON', 'PARKS'], ['ELZBIETA', '', 'TRYNISZEWSKA'], ['LOUIS', '', 'PICKER'], ['MARK', 'G.', 'LEWIS'], ['YVETTE', '', 'EDGHILL-SMITH'], ['MARCIN', '', 'MONIUSZKO'], ['RANAJIT', '', 'PAL'], ['LILJANA', '', 'STEVCEVA'], ['JOHN', 'D.', 'ALTMAN'], ['TODD', 'M.', 'ALLEN'], ['DAVID', '', 'WATKINS'], ['J.', 'V.', 'Torres'], ['J.', 'A.', 'Berzofsky'], ['I.', 'M.', 'Belyakov'], ['W.', '', 'Strober'], ['G.', '', 'Franchini']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/23/11483.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.23.11483-11495.2001']",
10.1056~NEJMoa011232,Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 2000;20:127-41.,references,10.1055/s-2000-9946,Interaction between the Hepatitis C Virus and the Immune System,"[[u'Barbara', u'', u'Rehermann']]",Seminars in Liver Disease,2000,[u'http://www.thieme-connect.de/DOI/DOI?10.1055/s-2000-9946'],"[{u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Immune System', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 19207}]"
10.1055/s-2000-9946,"Thio, C., Gao, X., Goedert, J., et. al, HLA-Cw*04 and Hepatitis C Virus Persistence, Journal of Virology, 2002",cited-by,10.1128/JVI.76.10.4792-4797.2002,HLA-Cw*04 and Hepatitis C Virus Persistence,"[['Chloe', 'L.', 'Thio'], ['Xiaojiang', '', 'Gao'], ['James', 'J.', 'Goedert'], ['David', '', 'Vlahov'], ['Kenrad', 'E.', 'Nelson'], ['Margaret', 'W.', 'Hilgartner'], ['Stephen', 'J.', ""O'Brien""], ['Peter', '', 'Karacki'], ['Jacquie', '', 'Astemborski'], ['Mary', '', 'Carrington'], ['David', 'L.', 'Thomas'], ['Presbyterian', '', 'Hospital-Cornell']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/10/4792.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.10.4792-4797.2002']",
10.1055/s-2000-9946,"Tan, S., Pause, A., Shi, Y., et. al, Hepatitis C therapeutics: current status and emerging strategies, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd937,Hepatitis C therapeutics: current status and emerging strategies,"[['Seng-Lai', '', 'Tan'], ['Arnim', '', 'Pause'], ['Yuguang', '', 'Shi'], ['Nahum', '', 'Sonenberg']]",Nature Reviews Drug Discovery,2002,"[u'http://www.nature.com/doifinder/10.1038/nrd937', u'http://dx.doi.org/10.1038/nrd937']",
10.1055/s-2000-9946,"Semmo, N., Day, C., Ward, S., et. al, Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection, Hepatology, 2005",cited-by,10.1002/hep.20669,Preferential loss of IL2-secreting CD4+ T helper cells in chronic HCV infection,"[['Nasser', '', 'Semmo'], ['Cheryl', 'L.', 'Day'], ['Scott', 'M.', 'Ward'], ['Michaela', '', 'Lucas'], ['Gillian', '', 'Harcourt'], ['Andrew', '', 'Loughry'], ['Paul', '', 'Klenerman']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20669'],
10.1055/s-2000-9946,"Sansonno, D., Dammacco, F., , Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations, Lancet Infectious Diseases, 2005",cited-by,10.1016/S1473-3099(05)70053-0,"Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations","[['Domenico', '', 'Sansonno'], ['Franco', '', 'Dammacco']]",Lancet Infectious Diseases,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1473309905700530', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309905700530']",
10.1055/s-2000-9946,"Hourioux, C., Patient, R., Morin, A., et. al, The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model, Gut, 2007",cited-by,10.1136/gut.2006.108647,The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model,"[['C', '', 'Hourioux'], ['R', '', 'Patient'], ['A', '', 'Morin'], ['E', '', 'Blanchard'], ['A', '', 'Moreau'], ['S', '', 'Trassard'], ['B', '', 'Giraudeau'], ['Philippe', '', 'Roingeard']]",Gut,2007,"[u'http://www.hal.inserm.fr/docs/00/16/77/83/PDF/Gut2007.pdf', u'http://gut.bmj.com/cgi/doi/10.1136/gut.2006.108647']",
10.1055/s-2000-9946,"Henderson, D., Magnuson, W., , Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.3.546-568.2003,Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting,"[['David', 'K.', 'Henderson'], ['Warren', 'G.', 'Magnuson']]",Clinical Microbiology Reviews,2003,"[u'http://cmr.asm.org/cgi/reprint/16/3/546.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.3.546-568.2003']",
10.1055/s-2000-9946,"Busch, M., , Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients, Transfusion Clinique Et Biologique, 2001",cited-by,10.1016/S1246-7820(01)00125-2,"Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients","[['M.', 'P', 'Busch']]",Transfusion Clinique Et Biologique,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1246782001001252', u'http://linkinghub.elsevier.com/retrieve/pii/S1246782001001252']",
10.1055/s-2000-9946,"Sansonno, D., Dammacco, F., , Hepatitis C virus, cryoglobulinaemi a, and vasculitis: immune complex relations, , 0",cited-by,"13050694Hepatitis C virus, cryoglobulinaemi a, and vasculitis: immune complex relations","Hepatitis C virus, cryoglobulinaemi a, and vasculitis: immune complex relations","[['Domenico', '', 'Sansonno'], ['Franco', '', 'Dammacco']]",,0,[],
10.1055/s-2000-9946,"Bukh, J., Forns, X., Emerson, S., et. al, Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine Development, Intervirology, 2001",cited-by,10.1159/000050040,Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine Development,"[['Jens', '', 'Bukh'], ['Xavier', '', 'Forns'], ['Suzanne', 'U.', 'Emerson'], ['Robert', 'H.', 'Purcell']]",Intervirology,2001,"[u'http://www.karger.com/doi/10.1159/000050040', u'http://www.online.karger.com/doi/10.1159/000050040']",
10.1055/s-2000-9946,"Knobler, H., Zhornicky, T., Sandler, A., et. al, Tumor necrosis factor–α–induced insulin resistance may mediate the hepatitis C virus–diabetes association, American Journal of Gastroenterology, 2003",cited-by,10.1111/j.1572-0241.2003.08728.x,Tumor necrosis factor–α–induced insulin resistance may mediate the hepatitis C virus–diabetes association,"[['Hilla', '', 'Knobler'], ['Taiba', '', 'Zhornicky'], ['Alex', '', 'Sandler'], ['Nurit', '', 'Haran'], ['Yafa', '', 'Ashur'], ['Ami', '', 'Schattner']]",American Journal of Gastroenterology,2003,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.08728.x', u'http://dx.doi.org/10.1111/j.1572-0241.2003.08728.x']",
10.1055/s-2000-9946,"Wang, J., Layden, T., Eckels, D., , Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response, Human Immunology, 2003",cited-by,10.1016/S0198-8859(03)00070-3,Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response,"[['Jane', 'H', 'Wang'], ['Thomas', 'J', 'Layden'], ['David', 'D', 'Eckels']]",Human Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0198885903000703', u'http://linkinghub.elsevier.com/retrieve/pii/S0198885903000703']",
10.1055/s-2000-9946,"Tsai, S., Sheen, I., Chien, R., et. al, Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications, Journal of Biomedical Science, 2003",cited-by,10.1007/BF02256004,Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: Tetramer assay and therapeutic implications,"[['Sun-Lung', '', 'Tsai'], ['I-Shyan', '', 'Sheen'], ['Rong-Nan', '', 'Chien'], ['Chia-Min', '', 'Chu'], ['Hsiu-Chu', '', 'Huang'], ['Yen-Ling', '', 'Chuang'], ['Tzong-Hsien', '', 'Lee'], ['Shuen-Kuei', '', 'Liao'], ['Chen-Lung', '', 'Lin'], ['George', 'C.', 'Kuo'], ['Yun-Fan', '', 'Liaw']]",Journal of Biomedical Science,2003,"[u'http://www.springerlink.com/index/f7xl464037855324.pdf', u'http://www.springerlink.com/content/f7xl464037855324', u'http://www.springerlink.com/index/10.1007/BF02256004', u'http://www.springerlink.com/index/pdf/10.1007/BF02256004']",
10.1055/s-2000-9946,"Shata, M., Anthony, D., Carlson, N., et. al, Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00373.x,"Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees","[['M.', 'T.', 'Shata'], ['D.', 'D.', 'Anthony'], ['N.', 'L.', 'Carlson'], ['L.', '', 'Andrus'], ['B.', '', 'Brotman'], ['N.', '', 'Tricoche'], ['P.', '', 'McCormack'], ['A.', '', 'Prince']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00373.x'],
10.1055/s-2000-9946,"Rosen, H., , Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury, Liver Transplantation, 2003",cited-by,10.1053/jlts.2003.50253,Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury,"[['Hugo', 'R.', 'Rosen']]",Liver Transplantation,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1527646503808754', u'http://doi.wiley.com/10.1053/jlts.2003.50253']",
10.1055/s-2000-9946,"Rico, M., Quiroga, J., Subirá, D., et. al, Features of the CD4 + T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(01)00281-1,Features of the CD4 + T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels,"[['Miguel', 'A', 'Rico'], ['Juan', 'A', 'Quiroga'], ['Dolores', '', 'Subir\xc3\xa1'], ['Esteban', '', 'Garcia'], ['Susana', '', 'Casta\xc3\xb1\xc3\xb3n'], ['Matti', '', 'S\xc3\xa4llberg'], ['Geert', '', 'Leroux-Roels'], ['Ola', '', 'Weiland'], ['Margarita', '', 'Pardo'], ['Vicente', '', 'Carre\xc3\xb1o']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801002811', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801002811']",
10.1055/s-2000-9946,"Rumi, M., Filippi, F., Donato, M., et. al, Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00328.x,Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough,"[['M.', 'G.', 'Rumi'], ['F.', 'De', 'Filippi'], ['M.', 'F.', 'Donato'], ['E.', 'Del', 'Ninno'], ['M.', '', 'Colombo']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00328.x'],
10.1055/s-2000-9946,"Duke, S., Canel, C., Rimando, A., et. al, Current and potential exploitation of plant glandular trichome productivity, Advances in Botanical Research, 2000",cited-by,10.1016/S0065-2296(00)31008-4,Current and potential exploitation of plant glandular trichome productivity,"[['S.', 'O', 'Duke'], ['C', '', 'Canel'], ['A.', 'M', 'Rimando'], ['M.', 'R', 'Telle'], ['M.', 'V', 'Duke'], ['R.', 'N', 'Paul']]",Advances in Botanical Research,2000,[u'http://www.sciencedirect.com/science/article/pii/S0065229600310084'],
10.1055/s-2000-9946,"Fried, E., Gurtin, M., , A Unified Treatment of Evolving Interfaces Accounting for Small Deformations and Atomic Transport with Emphasis on Grain-Boundaries and Epitaxy, Advances in Applied Mechanics, 2004",cited-by,10.1016/S0065-2156(04)40001-5,A Unified Treatment of Evolving Interfaces Accounting for Small Deformations and Atomic Transport with Emphasis on Grain-Boundaries and Epitaxy,"[['Eliot', '', 'Fried'], ['Morton', 'E.', 'Gurtin']]",Advances in Applied Mechanics,2004,[u'http://www.sciencedirect.com/science/article/pii/S0065215604400015'],
10.1055/s-2000-9946,"Herring, B., Tsui, R., Peddada, L., et. al, Wide Range of Quasispecies Diversity during Primary Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.7.4340-4346.2005,Wide Range of Quasispecies Diversity during Primary Hepatitis C Virus Infection,"[['Belinda', 'L.', 'Herring'], ['Rose', '', 'Tsui'], ['Lorraine', '', 'Peddada'], ['Michael', '', 'Busch'], ['Eric', 'L.', 'Delwart']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.7.4340-4346.2005', u'http://jvi.asm.org/cgi/reprint/79/7/4340.pdf']",
10.1055/s-2000-9946,"Neuman, M., Brenner, D., Rehermann, B., et. al, Mechanisms of Alcoholic Liver Disease: Cytokines, Alcoholism-clinical and Experimental Research, 2001",cited-by,10.1111/j.1530-0277.2001.tb02404.x,Mechanisms of Alcoholic Liver Disease: Cytokines,"[['Manuela', 'G.', 'Neuman'], ['D.', 'A.', 'Brenner'], ['B.', '', 'Rehermann'], ['J.', '', 'Taieb'], ['S.', '', 'Chollet-Martin'], ['M.', '', 'Cohard'], ['J.', 'J.', 'Garaud'], ['T.', '', 'Poynard'], ['G.', 'G.', 'Katz'], ['R.', 'G.', 'Cameron'], ['N.', 'H.', 'Shear'], ['B.', '', 'Gao'], ['M.', '', 'Takamatsu'], ['M.', '', 'Yamauchi'], ['M.', '', 'Ohata'], ['S.', '', 'Saito'], ['S.', '', 'Maeyama'], ['T.', '', 'Uchikoshi'], ['G.', '', 'Toda'], ['T.', '', 'Kumagi'], ['S.', 'M. F.', 'Akbar'], ['M.', '', 'Abe'], ['K.', '', 'Michitaka'], ['N.', '', 'Horiike'], ['M.', '', 'Onji']]",Alcoholism-clinical and Experimental Research,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1530-0277.2001.tb02404.x'],
10.1055/s-2000-9946,"Roingeard, P., Hourioux, C., , Hepatitis C virus core protein, lipid droplets and steatosis, , 2008",cited-by,"6215957Hepatitis C virus core protein, lipid droplets and steatosis","Hepatitis C virus core protein, lipid droplets and steatosis","[['P.', '', 'Roingeard'], ['C.', '', 'Hourioux']]",,2008,"[u'http://www.hal.inserm.fr/docs/00/21/17/31/PDF/J_Viral_Hepat_HAL.pdf', u'http://www.hal.inserm.fr/docs/00/28/52/04/PDF/JVH2008_roingeard.pdf', u'http://hal.archives-ouvertes.fr/docs/00/28/52/04/PDF/JVH2008_roingeard.pdf']",
10.1055/s-2000-9946,"Sreenarasimhaiah, J., Jaramillo, A., Crippin, J., et. al, Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis, Human Immunology, 2003",cited-by,10.1016/S0198-8859(02)00781-4,Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis,"[['Jayaprakash', '', 'Sreenarasimhaiah'], ['Andr\xc3\xa9s', '', 'Jaramillo'], ['Jeffrey', '', 'Crippin'], ['Mauricio', '', 'Lisker-Melman'], ['William', 'C', 'Chapman'], ['T', '', 'Mohanakumar']]",Human Immunology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0198885902007814', u'http://linkinghub.elsevier.com/retrieve/pii/S0198885902007814']",
10.1055/s-2000-9946,"Troesch, M., Jalbert, E., Canobio, S., et. al, Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV1, Aids, 2005",cited-by,10.1097/01.aids.0000168971.57681.6e,Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV1,"[['Myriam', '', 'Troesch'], ['Emilie', '', 'Jalbert'], ['Sophie', '', 'Canobio'], ['M', 'Rachid', 'Boulassel'], ['Jean-Pierre', '', 'Routy'], ['Nicole', 'F', 'Bernard'], ['Julie', '', 'Bruneau'], ['Normand', '', 'Lapointe'], ['Marc', '', 'Boucher'], ['Hugo', '', 'Soudeyns']]",Aids,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-200505200-00004'],
10.1055/s-2000-9946,"Thio, C., , Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus, Clinics in Liver Disease, 2008",cited-by,10.1016/j.cld.2008.03.002,Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus,"[['Chloe', 'L.', 'Thio']]",Clinics in Liver Disease,2008,"[u'http://www.sciencedirect.com/science/article/pii/S108932610800041X', u'http://linkinghub.elsevier.com/retrieve/pii/S108932610800041X']",
10.1055/s-2000-9946,"Stauber, R., Stadlbauer, V., , Novel approaches for therapy of chronic hepatitis C, Journal of Clinical Virology, 2006",cited-by,10.1016/j.jcv.2006.02.003,Novel approaches for therapy of chronic hepatitis C,"[['Rudolf', 'E.', 'Stauber'], ['Vanessa', '', 'Stadlbauer']]",Journal of Clinical Virology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1386653206000710', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653206000710']",
10.1055/s-2000-9946,"Andreone, P., Gramenzi, A., Cursaro, C., et. al, Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial, Journal of Viral Hepatitis, 2004",cited-by,10.1046/j.1365-2893.2003.00470.x,Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial,"[['P.', '', 'Andreone'], ['A.', '', 'Gramenzi'], ['C.', '', 'Cursaro'], ['F.', '', 'Felline'], ['E.', '', 'Loggi'], ['A.', '', ""D'Errico""], ['M.', '', 'Spinosa'], ['S.', '', 'Lorenzini'], ['M.', '', 'Biselli'], ['M.', '', 'Bernardi']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00470.x'],
10.1055/s-2000-9946,"Karacki, P., Gao, X., Thio, C., et. al, MICA and recovery from hepatitis C virus and hepatitis B virus infections, Genes and Immunity, 2004",cited-by,10.1038/sj.gene.6364065,MICA and recovery from hepatitis C virus and hepatitis B virus infections,"[['P', 'S', 'Karacki'], ['X', '', 'Gao'], ['C', 'L', 'Thio'], ['D', 'L', 'Thomas'], ['J', 'J', 'Goedert'], ['D', '', 'Vlahov'], ['R', 'A', 'Kaslow'], ['S', '', 'Strathdee'], ['M', 'W', 'Hilgartner'], ['S', 'J', ""O'Brien""], ['M', '', 'Carrington']]",Genes and Immunity,2004,"[u'http://www.nature.com/doifinder/10.1038/sj.gene.6364065', u'http://dx.doi.org/10.1038/sj.gene.6364065']",
10.1055/s-2000-9946,"Okuda, K., Yokosuka, O., , Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up, , 0",cited-by,10092677Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up,Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up,"[['Kunio', '', 'Okuda'], ['Osamu', '', 'Yokosuka']]",,0,[u'http://www.wjgnet.com/1007-9327/10/2209.pdf'],
10.1055/s-2000-9946,"Welker, M., Zeuzem, S., , Occult hepatitis C: How convincing are the current data?, Hepatology, 2009",cited-by,10.1002/hep.22706,Occult hepatitis C: How convincing are the current data?,"[['Martin-Walter', '', 'Welker'], ['Stefan', '', 'Zeuzem']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.22706'],
10.1055/s-2000-9946,"Knobler, H., Zhornicky, T., Sandler, A., et. al, Tumor necrosis factor–α–induced insulin resistance may mediate the hepatitis C virus–diabetes association, American Journal of Gastroenterology, 2003",cited-by,10.1016/j.amjgastroenterol.2003.06.002,Tumor necrosis factor–α–induced insulin resistance may mediate the hepatitis C virus–diabetes association,"[['Hilla', '', 'Knobler'], ['Taiba', '', 'Zhornicky'], ['Alex', '', 'Sandler'], ['Nurit', '', 'Haran'], ['Yafa', '', 'Ashur'], ['Ami', '', 'Schattner']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S000292700301832X', u'http://linkinghub.elsevier.com/retrieve/pii/S000292700301832X']",
10.1055/s-2000-9946,"Anand, B., Velez, M., , Assessment of correlation between serum titers of hepatitis c virus and severity of liver disease, , 0",cited-by,11514057Assessment of correlation between serum titers of hepatitis c virus and severity of liver disease,Assessment of correlation between serum titers of hepatitis c virus and severity of liver disease,"[['Bhupinder', 'S.', 'Anand'], ['Maria', '', 'Velez']]",,0,[],
10.1055/s-2000-9946,"Sansonno, D., Tucci, F., Troiani, L., et. al, Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis, Blood, 2008",cited-by,10.1182/blood-2008-02-137455,Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis,"[['D.', '', 'Sansonno'], ['F.', 'A.', 'Tucci'], ['L.', '', 'Troiani'], ['G.', '', 'Lauletta'], ['M.', '', 'Montrone'], ['V.', '', 'Conteduca'], ['L.', '', 'Sansonno'], ['F.', '', 'Dammacco']]",Blood,2008,[u'http://www.bloodjournal.org/cgi/doi/10.1182/blood-2008-02-137455'],
10.1055/s-2000-9946,"Callender, G., Rosen, H., Roszkowski, J., et. al, Identification of a hepatitis C virus–reactive T cell receptor that does not require CD8 for target cell recognition, Hepatology, 2006",cited-by,10.1002/hep.21157,Identification of a hepatitis C virus–reactive T cell receptor that does not require CD8 for target cell recognition,"[['Glenda', 'G.', 'Callender'], ['Hugo', 'R.', 'Rosen'], ['Jeffrey', 'J.', 'Roszkowski'], ['Gretchen', 'E.', 'Lyons'], ['Mingli', '', 'Li'], ['Tamson', '', 'Moore'], ['Natasha', '', 'Brasic'], ['Mark', 'D.', 'McKee'], ['Michael', 'I.', 'Nishimura']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21157'],
10.1055/s-2000-9946,"Israeli, E., Safadi, R., Melhem, A., et. al, Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial, Liver International, 2004",cited-by,10.1111/j.1478-3231.2004.0935.x,Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial,"[['Eran', '', 'Israeli'], ['Rifaat', '', 'Safadi'], ['Alaa', '', 'Melhem'], ['Orit', '', 'Pappo'], ['Oren', '', 'Shibolet'], ['Athalia', '', 'Klein'], ['Nilla', '', 'Hemed'], ['Barbara', '', 'Thalenfeld'], ['Dean', '', 'Engelhardt'], ['Elazar', '', 'Rabbani'], ['Yaron', '', 'Ilan']]",Liver International,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1478-3231.2004.0935.x'],
10.1055/s-2000-9946,"Tsai, S., Lee, T., Chien, R., et. al, A method to increase tetramer staining efficiency of CD8+ T cells with MHC–peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment, Journal of Immunological Methods, 2004",cited-by,10.1016/j.jim.2003.11.005,A method to increase tetramer staining efficiency of CD8+ T cells with MHC–peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment,"[['Sun-Lung', '', 'Tsai'], ['Tzong-Hsien', '', 'Lee'], ['Rong-Nan', '', 'Chien'], ['Shuen-Kuei', '', 'Liao'], ['Chen-Lung', '', 'Lin'], ['George', 'C.', 'Kuo'], ['Yun-Fan', '', 'Liaw']]",Journal of Immunological Methods,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0022175903004381', u'http://linkinghub.elsevier.com/retrieve/pii/S0022175903004381']",
10.1055/s-2000-9946,"Morgan, T., Brenner, D., Everhart, J., et. al, Hepatitis C and Alcohol: Fundamental and Translational Research Directions, Alcoholism-clinical and Experimental Research, 2003",cited-by,10.1097/01.ALC.0000062741.58464.19,Hepatitis C and Alcohol: Fundamental and Translational Research Directions,"[['Timothy', 'R.', 'Morgan'], ['David', '', 'Brenner'], ['James', '', 'Everhart'], ['Samuel', 'W.', 'French'], ['Michael', 'W.', 'Fried'], ['David', 'R.', 'Gretch'], ['Margaret', 'James', 'Koziel'], ['Craig', 'J.', 'McClain'], ['Marion', 'G.', 'Peters'], ['Steven', 'A.', 'Weinman'], ['Diane', 'L.', 'Lucas']]",Alcoholism-clinical and Experimental Research,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00000374-200304000-00019'],
10.1055/s-2000-9946,"Lee, S., MacQuillan, G., Keane, N., et. al, Immunological markers predicting outcome in patients with hepatitis C treated with interferon-α and ribavirin, Immunology and Cell Biology, 2002",cited-by,10.1046/j.1440-1711.2002.01102.x,Immunological markers predicting outcome in patients with hepatitis C treated with interferon-α and ribavirin,"[['Silvia', '', 'Lee'], ['Gerry', 'C', 'MacQuillan'], ['Niamh', 'M', 'Keane'], ['James', '', 'Flexman'], ['Gary', 'P', 'Jeffrey'], ['Martyn', 'AH', 'French'], ['Jean', '', 'Brochier'], ['Patricia', '', 'Price']]",Immunology and Cell Biology,2002,"[u'http://dx.doi.org/10.1046/j.1440-1711.2002.01102.x', u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2002.01102.x']",
10.1055/s-2000-9946,"Roingeard, P., Hourioux, C., , Hepatitis C virus core protein, lipid droplets and steatosis: HCV core, lipid droplets and steatosis, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2007.00953.x,"Hepatitis C virus core protein, lipid droplets and steatosis: HCV core, lipid droplets and steatosis","[['P.', '', 'Roingeard'], ['C.', '', 'Hourioux']]",Journal of Viral Hepatitis,2007,[u'http://doi.wiley.com/10.1111/j.1365-2893.2007.00953.x'],
10.1055/s-2000-9946,"Busch, M., Shafer, K., , Editorial Commentary: Acute‐Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment, Clinical Infectious Diseases, 2005",cited-by,10.1086/428583,"Editorial Commentary: Acute‐Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment","[['Michael', 'P.', 'Busch'], ['Kimberly', 'A. Page', 'Shafer']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/428583'],
10.1055/s-2000-9946,"López-Labrador, F., He, X., Berenguer, M., et. al, The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8+ T cells in patients with chronic infection, Journal of Immunological Methods, 2004",cited-by,10.1016/j.jim.2004.01.023,The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8+ T cells in patients with chronic infection,"[['F.', 'Xavier', 'L\xc3\xb3pez-Labrador'], ['Xiao-Song', '', 'He'], ['Marina', '', 'Berenguer'], ['Ramsey', 'C.', 'Cheung'], ['Teresa', 'L.', 'Wright'], ['Harry', 'B.', 'Greenberg']]",Journal of Immunological Methods,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0022175904000675', u'http://linkinghub.elsevier.com/retrieve/pii/S0022175904000675']",
10.1055/s-2000-9946,"Kondo, Y., Kobayashi, K., Kobayashi, T., et. al, Distribution of the HLA Class I Allele in Chronic Hepatitis C and its Association with Serum ALT Level in Chronic Hepatitis C, Tohoku Journal of Experimental Medicine, 2003",cited-by,10.1620/tjem.201.109,Distribution of the HLA Class I Allele in Chronic Hepatitis C and its Association with Serum ALT Level in Chronic Hepatitis C,"[['Yasuteru', '', 'Kondo'], ['Koju', '', 'Kobayashi'], ['Tomoo', '', 'Kobayashi'], ['Masaaki', '', 'Shiina'], ['Yoshiyuki', '', 'Ueno'], ['Takaomi', '', 'Satoh'], ['Tooru', '', 'Shimosegawa']]",Tohoku Journal of Experimental Medicine,2003,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/tjem/201.109?from=CrossRef'],
10.1055/s-2000-9946,"Andrieu, T., Thibault, V., Malet, I., et. al, Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections, Journal of Clinical Virology, 2003",cited-by,10.1016/S1386-6532(02)00128-2,Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections,"[['T.', '', 'Andrieu'], ['V.', '', 'Thibault'], ['I.', '', 'Malet'], ['J.', '', 'Laporte'], ['B.', '', 'Bauvois'], ['H.', '', 'Agut'], ['A.', '', 'Cahour']]",Journal of Clinical Virology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1386653202001282', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001282']",
10.1055/s-2000-9946,"Bernardin, F., Stramer, S., Rehermann, B., et. al, High levels of subgenomic HCV plasma RNA in immunosilent infections, Virology, 2007",cited-by,10.1016/j.virol.2007.04.003,High levels of subgenomic HCV plasma RNA in immunosilent infections,"[['Flavien', '', 'Bernardin'], ['Susan', 'L.', 'Stramer'], ['Barbara', '', 'Rehermann'], ['Kimberly', '', 'Page-Shafer'], ['Stewart', '', 'Cooper'], ['David', 'R.', 'Bangsberg'], ['Judith', '', 'Hahn'], ['Leslie', '', 'Tobler'], ['Michael', '', 'Busch'], ['Eric', '', 'Delwart']]",Virology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0042682207002516', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682207002516']",
10.1055/s-2000-9946,"TRAPERO-MARUGAN, M., GARCIA-BUEY, L., MUNOZ, C., et. al, Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response, Alimentary Pharmacology & Therapeutics, 2006",cited-by,10.1111/j.1365-2036.2006.02954.x,Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response,"[['M.', '', 'TRAPERO-MARUGAN'], ['L.', '', 'GARCIA-BUEY'], ['C.', '', 'MUNOZ'], ['N.', 'E.', 'QUINTANA'], ['J.', 'A.', 'MORENO-MONTEAGUDO'], ['M.', 'J.', 'BORQUE'], ['M.', 'J.', 'FERNANDEZ'], ['F.', 'R.', 'SALVANES'], ['J.', '', 'MEDINA'], ['R.', '', 'MORENO-OTERO']]",Alimentary Pharmacology & Therapeutics,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2006.02954.x'],
10.1055/s-2000-9946,"Salcedo-Mora, X., Maté, J., Medina, J., et. al, Chronic Hepatitis C and Crohn’s Disease: Nosocomial Infection Treatment with PEG-Interferon plus Ribavirin, Digestion, 2006",cited-by,10.1159/000094787,Chronic Hepatitis C and Crohn’s Disease: Nosocomial Infection Treatment with PEG-Interferon plus Ribavirin,"[['Xamila', '', 'Salcedo-Mora'], ['Jos\xc3\xa9', '', 'Mat\xc3\xa9'], ['Jesus', '', 'Medina'], ['Syong', 'J. Nam', 'Cha'], ['Javier', 'P.', 'Gisbert'], ['Ricardo', '', 'Moreno-Otero']]",Digestion,2006,"[u'http://www.karger.com/doi/10.1159/000094787', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000094787']",
10.1055/s-2000-9946,"Busch, M., Shafer, K., , Acute-Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment, , 2005",cited-by,"6223596Acute-Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment","Acute-Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment","[['Michael', 'P.', 'Busch'], ['Kimberly', 'A. Page', 'Shafer']]",,2005,[u'https://php10.ucsf.edu/ufostudy/pdfs/Busch_2005.pdf'],
10.1055/s-2000-9946,"Rico, M., Ruiz, S., Barril, G., et. al, Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.10551,Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection,"[['Miguel', 'A.', 'Rico'], ['Sara', '', 'Ruiz'], ['Guillermina', '', 'Barril'], ['Juan', 'A.', 'Quiroga'], ['Rafael', '', 'Selgas']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.10551'],
10.1055/s-2000-9946,"Ni, J., Hembrador, E., Bisceglie, A., et. al, Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients1, , 0",cited-by,"12075539Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients1","Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients1","[['Jianhua', '', 'Ni'], ['Edgardo', '', 'Hembrador'], ['Adrian', 'M. Di', 'Bisceglie'], ['Ira', 'M.', 'Jacobson'], ['Andrew', 'H.', 'Talal'], ['David', '', 'Butera'], ['Charles', 'M.', 'Rice'], ['Thomas', 'J.', 'Chambers'], ['Lynn', 'B.', 'Dustin']]",,0,[u'http://www.jimmunol.org/cgi/reprint/170/6/3429.pdf'],
10.1055/s-2000-9946,"Siagris, D., Giannakoulas, N., Christofidou, M., et. al, Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection, Liver International, 2004",cited-by,10.1111/j.1478-3231.2004.0919.x,"Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection","[['D.', '', 'Siagris'], ['N.', '', 'Giannakoulas'], ['M.', '', 'Christofidou'], ['A.', '', 'Tsamandas'], ['A.', '', 'Lekkou'], ['K.', '', 'Thomopoulos'], ['N.', '', 'Zoumbos'], ['Ch.', '', 'Labropoulou-Karatza']]",Liver International,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1478-3231.2004.0919.x'],
10.1055/s-2000-9946,"Neuman, M., Brenner, D., Rehermann, B., et. al, Mechanisms of Alcoholic Liver Disease: Cytokines, Alcoholism-clinical and Experimental Research, 2001",cited-by,10.1097/00000374-200105051-00040,Mechanisms of Alcoholic Liver Disease: Cytokines,"[['Manuela', 'G.', 'Neuman'], ['D.', 'A.', 'Brenner'], ['B.', '', 'Rehermann'], ['J.', '', 'Taieb'], ['S.', '', 'Chollet-Martin'], ['M.', '', 'Cohard'], ['J.', 'J.', 'Garaud'], ['T.', '', 'Poynard'], ['G.', 'G.', 'Katz'], ['R.', 'G.', 'Cameron'], ['N.', 'H.', 'Shear'], ['B.', '', 'Gao'], ['M.', '', 'Takamatsu'], ['M.', '', 'Yamauchi'], ['M.', '', 'Ohata'], ['S.', '', 'Saito'], ['S.', '', 'Maeyama'], ['T.', '', 'Uchikoshi'], ['G.', '', 'Toda'], ['T.', '', 'Kumagi'], ['S.', 'M. F.', 'Akbar'], ['M.', '', 'Abe'], ['K.', '', 'Michitaka'], ['N.', '', 'Horiike'], ['M.', '', 'Onji']]",Alcoholism-clinical and Experimental Research,2001,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00000374-200105051-00040'],
10.1055/s-2000-9946,"Neuman, M., , Mechanisms of alcoholic liver disease: cytokines, Clinical Biochemistry, 2001",cited-by,10.1016/S0009-9120(01)00209-0,Mechanisms of alcoholic liver disease: cytokines,"[['Manuela', 'G', 'Neuman']]",Clinical Biochemistry,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0009912001002090', u'http://linkinghub.elsevier.com/retrieve/pii/S0009912001002090']",
10.1055/s-2000-9946,"Yu, R., Hong, X., Ding, W., et. al, The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population, Journal of Gastroenterology and Hepatology, 2008",cited-by,10.1111/j.1440-1746.2007.05215.x,"The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population","[['Rong-Bin', '', 'Yu'], ['Xin', '', 'Hong'], ['Wei-Liang', '', 'Ding'], ['Yong-Fei', '', 'Tan'], ['Yong-Xiang', '', 'Zhang'], ['Nan-Xiong', '', 'Sun'], ['Guan-Ling', '', 'Wu'], ['Sheng-Wei', '', 'Zhan'], ['Da-Fang', '', 'Ge']]",Journal of Gastroenterology and Hepatology,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2007.05215.x'],
10.1055/s-2000-9946,"Morgan, T., Brenner, D., Everhart, J., et. al, Hepatitis C and Alcohol: Fundamental and Translational Research Directions, Alcoholism-clinical and Experimental Research, 2003",cited-by,10.1111/j.1530-0277.2003.tb04411.x,Hepatitis C and Alcohol: Fundamental and Translational Research Directions,"[['Timothy', 'R.', 'Morgan'], ['David', '', 'Brenner'], ['James', '', 'Everhart'], ['Samuel', 'W.', 'French'], ['Michael', 'W.', 'Fried'], ['David', 'R.', 'Gretch'], ['Margaret', 'James', 'Koziel'], ['Craig', 'J.', 'McClain'], ['Marion', 'G.', 'Peters'], ['Steven', 'A.', 'Weinman'], ['Diane', 'L.', 'Lucas']]",Alcoholism-clinical and Experimental Research,2003,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1530-0277.2003.tb04411.x'],
10.1055/s-2000-9946,"Farci, P., , HEPATITIS C VIRUS, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70200-2,HEPATITIS C VIRUS,"[['Patrizia', '', 'Farci']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702002', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702002']",
10.1055/s-2000-9946,"Kottilil, S., Yan, M., Reitano, K., et. al, Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells, Hepatology, 2009",cited-by,10.1002/hep.23055,Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells,"[['Shyam', '', 'Kottilil'], ['Michael', 'Y.', 'Yan'], ['Kristin', 'N.', 'Reitano'], ['Xiaozhen', '', 'Zhang'], ['Richard', '', 'Lempicki'], ['Gregg', '', 'Roby'], ['Marybeth', '', 'Daucher'], ['Jun', '', 'Yang'], ['Karoll', 'J.', 'Cortez'], ['Marc', '', 'Ghany'], ['Michael', 'A.', 'Polis'], ['Anthony', 'S.', 'Fauci']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.23055'],
10.1055/s-2000-9946,"Wu, C., Barbezange, C., McConnell, I., et. al, Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes, Journal of General Virology, 2008",cited-by,10.1099/vir.0.2008/002634-0,Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes,"[['Changxin', '', 'Wu'], ['Cyril', '', 'Barbezange'], ['Ian', '', 'McConnell'], ['Barbara', 'A.', 'Blacklaws']]",Journal of General Virology,2008,"[u'http://vir.sgmjournals.org/cgi/reprint/89/10/2586.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/vir.0.2008/002634-0']",
10.1055/s-2000-9946,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1055/s-2000-9946,"Salem, M., EL-Demellawy, M., El-Azm, A., , The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus, Cellular Immunology, 2010",cited-by,10.1016/j.cellimm.2010.03.002,The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus,"[['Mohamed', 'L.', 'Salem'], ['Maha', '', 'EL-Demellawy'], ['Abdel', 'Raouf Abou', 'El-Azm']]",Cellular Immunology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S000887491000064X', u'http://linkinghub.elsevier.com/retrieve/pii/S000887491000064X']",
10.1055/s-2000-9946,"Zhang, Y., Liu, Y., Moxley, K., et. al, Transduction of Human T Cells with a Novel T-Cell Receptor Confers Anti-HCV Reactivity, PLOS Pathogens, 2010",cited-by,10.1371/journal.ppat.1001018,Transduction of Human T Cells with a Novel T-Cell Receptor Confers Anti-HCV Reactivity,"[['Yi', '', 'Zhang'], ['Yeuying', '', 'Liu'], ['Kelly', 'M.', 'Moxley'], ['Lucy', '', 'Golden-Mason'], ['Michael', 'G.', 'Hughes'], ['Tongxin', '', 'Liu'], ['Mirjam', 'H. M.', 'Heemskerk'], ['Hugo', 'R.', 'Rosen'], ['Michael', 'I.', 'Nishimura']]",PLOS Pathogens,2010,[u'http://dx.doi.org/10.1371/journal.ppat.1001018'],
10.1055/s-2000-9946,"Sansonno, D., Tucci, F., Troiani, L., et. al, INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS Short Title: CXCL13 in HCV-related cryoglobulinemic vasculitis, , 2008",cited-by,14025815INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS Short Title: CXCL13 in HCV-related cryoglobulinemic vasculitis,INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS Short Title: CXCL13 in HCV-related cryoglobulinemic vasculitis,"[['Domenico', '', 'Sansonno'], ['Felicia', 'Anna', 'Tucci'], ['Laura', '', 'Troiani'], ['Gianfranco', '', 'Lauletta'], ['Michele', '', 'Montrone'], ['Vincenza', '', 'Conteduca'], ['Loredana', '', 'Sansonno'], ['Franco', '', 'Dammacco']]",,2008,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/blood-2008-02-137455v1.pdf'],
10.1055/s-2000-9946,", Clinical Spectrum of Hepatitis-Associated Cryoglobulinemia: Cross-Link between Hematological and Immunological Phenomena, Journal of Medical Sciences(faisalabad), 2007",cited-by,10.3923/jms.2007.31.41,Clinical Spectrum of Hepatitis-Associated Cryoglobulinemia: Cross-Link between Hematological and Immunological Phenomena,[],Journal of Medical Sciences(faisalabad),2007,[u'http://www.scialert.net/abstract/?doi=jms.2007.31.41'],
10.1055/s-2000-9946,"Hassan, M., Kassim, S., Ahmad, M., et. al, Antiproliferative effect of hepatitis C virus on mitogen-stimulated peripheral blood mononuclear cells: Potential role in viral persistence in Egyptian patients, Clinical Biochemistry, 2007",cited-by,10.1016/j.clinbiochem.2007.07.012,Antiproliferative effect of hepatitis C virus on mitogen-stimulated peripheral blood mononuclear cells: Potential role in viral persistence in Egyptian patients,"[['Mahmoud', 'I.', 'Hassan'], ['Samar', 'K.', 'Kassim'], ['Maha', 'I.', 'Ahmad'], ['Shereen', '', 'Fawzy']]",Clinical Biochemistry,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0009912007002950', u'http://linkinghub.elsevier.com/retrieve/pii/S0009912007002950']",
10.1055/s-2000-9946,"Eisenbach, C., Freyse, A., Lupu, C., et. al, Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.04.013,Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse,"[['Christoph', '', 'Eisenbach'], ['Anne', '', 'Freyse'], ['Catalin', 'M.', 'Lupu'], ['Kilian', '', 'Weigand'], ['Evelyn', '', 'Ernst'], ['Birgit', '', 'Hoyler'], ['Wolfgang', '', 'Stremmel'], ['Joachim', 'J.', 'Bugert'], ['Jens', '', 'Encke']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06004403', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06004403']",
10.1055/s-2000-9946,"Hassoun, Z., Gores, G., , What surgeons should know about viral hepatitis and hepatocellular carcinoma, Surgical Oncology Clinics of North America, 2003",cited-by,10.1016/S1055-3207(02)00081-9,What surgeons should know about viral hepatitis and hepatocellular carcinoma,"[['Ziad', '', 'Hassoun'], ['Gregory', 'J', 'Gores']]",Surgical Oncology Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1055320702000819', u'http://linkinghub.elsevier.com/retrieve/pii/S1055320702000819']",
10.1055/s-2000-9946,"Blut, A., , Hepatitis C Virus (HCV), , 2003",cited-by,57386774Hepatitis C Virus (HCV),Hepatitis C Virus (HCV),"[['Arbeitskreis', '', 'Blut']]",,2003,[],
10.1055/s-2000-9946,"Hadžić, N., , Hepatitis C in pregnancy, Archives of Disease in Childhood-fetal and Neonatal Edition, 2001",cited-by,59284500Hepatitis C in pregnancy,Hepatitis C in pregnancy,"[['N', '', 'Hadz\xcc\x8cic\xcc\x81']]",Archives of Disease in Childhood-fetal and Neonatal Edition,2001,[u'http://dx.doi.org/'],
10.1055/s-2000-9946,"Christofidou, M., Jelastopulu, E., Economides, G., et. al, ORIGINAL ARTICLE, , 0",cited-by,10470854ORIGINAL ARTICLE,ORIGINAL ARTICLE,"[['Myrto', '', 'Christofidou'], ['Eleni', '', 'Jelastopulu'], ['George', '', 'Economides'], ['Iris', '', 'Spiliopoulou'], ['Dimitris', '', 'Siagris'], ['Chryssoula', 'Labropoulou-K', 'Karatza'], ['Evangelos', 'D', 'Anastassiou'], ['George', '', 'Dimitracopoulos']]",,0,[u'http://hepmon.com/pdf/Epidemiology_of_Chronic_Hepatitis_C_Viru.pdf'],
10.1055/s-2000-9946,"Shaikh, S., Sadik, M., Hussain, B., , FREQUENCY OF STEATOSIS AND ITS RELATION WITH THE GRADE OF FIBROSIS IN PATIENTS WITH HEPATITIS C, , 0",cited-by,11189095FREQUENCY OF STEATOSIS AND ITS RELATION WITH THE GRADE OF FIBROSIS IN PATIENTS WITH HEPATITIS C,FREQUENCY OF STEATOSIS AND ITS RELATION WITH THE GRADE OF FIBROSIS IN PATIENTS WITH HEPATITIS C,"[['Samiullah', '', 'Shaikh'], ['Memon', '', 'Sadik'], ['Baloch', 'Ghulam', 'Hussain']]",,0,"[u'http://www.pjms.com.pk/issues/aprjun109/pdf/25.article24.pdf', u'http://pjms.com.pk/issues/aprjun109/pdf/25.article24.pdf']",
10.1055/s-2000-9946,"Seid, K., , Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia, , 0",cited-by,"11794667Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia","Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia","[['Kedir', 'Yimer', 'Seid']]",,0,[u'http://etd.aau.edu.et/dspace/bitstream/123456789/551/1/Kedir%20Yimer%20Seid.pdf'],
10.1055/s-2000-9946,"Hassoun, Z., Gores, G., , Clinical Strategies for Chemoprevention of Liver Cancer, , 0",cited-by,10.1007/978-1-59259-768-0_37,Clinical Strategies for Chemoprevention of Liver Cancer,"[['Ziad', '', 'Hassoun'], ['Gregory', 'J.', 'Gores']]",,0,"[u'http://www.springerlink.com/index/j182080g1469172h.pdf', u'http://www.springerlink.com/content/j182080g1469172h']",
10.1056~NEJMoa011232,"Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology 1997;26:226-31.",references,10.1002/hep.510260130,Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa,"[[u'N', u'P', u'Lam'], [u'A', u'U', u'Neumann'], [u'D', u'R', u'Gretch'], [u'T', u'E', u'Wiley'], [u'A', u'S', u'Perelson'], [u'T', u'J', u'Layden']]",Hepatology,1997,[u'http://doi.wiley.com/10.1002/hep.510260130'],"[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}]"
10.1002/hep.510260130,"Davis, G., Wong, J., McHutchison, J., et. al, Early Virologic Response to Treatment With Peginterferon Alfa-2b plus Ribavirin in Patients With Chronic Hepatitis C, , 2003",cited-by,5370493Early Virologic Response to Treatment With Peginterferon Alfa-2b plus Ribavirin in Patients With Chronic Hepatitis C,Early Virologic Response to Treatment With Peginterferon Alfa-2b plus Ribavirin in Patients With Chronic Hepatitis C,"[['Gary', 'L.', 'Davis'], ['John', 'B.', 'Wong'], ['John', 'G.', 'McHutchison'], ['Michael', 'P.', 'Manns'], ['Joann', '', 'Harvey'], ['Janice', '', 'Albrecht']]",,2003,"[u'http://hepatitis-central.com/hcv/info/2003/sept/hepcinfo645.pdf', u'http://www.hepatitis-central.com/hcv/info/2003/sept/hepcinfo645.pdf']",
10.1002/hep.510260130,"Cerny, A., Chisari, F., , Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence, Hepatology, 1999",cited-by,10.1002/hep.510300312,Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence,"[['Andreas', '', 'Cerny'], ['Francis', 'V.', 'Chisari']]",Hepatology,1999,[u'http://doi.wiley.com/10.1002/hep.510300312'],
10.1002/hep.510260130,"Cramp, M., Rossol, S., Chokshi, S., et. al, Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C, Gastroenterology, 2000",cited-by,10.1016/S0016-5085(00)70217-4,Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C,"[['Matthew', 'E.', 'Cramp'], ['Siegbert', '', 'Rossol'], ['Shilpa', '', 'Chokshi'], ['Patrizia', '', 'Carucci'], ['Roger', '', 'Williams'], ['Nikolai', 'V.', 'Naoumov']]",Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500702174', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500702174']",
10.1002/hep.510260130,"Davis, G., , Monitoring of viral levels during therapy of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36798,Monitoring of viral levels during therapy of hepatitis C,"[['Gary', 'L.', 'Davis']]",Hepatology,2002,"[u'http://doi.wiley.com/10.1053/jhep.2002.36798', u'http://doi.wiley.com/10.1002/hep.1840360719']",
10.1002/hep.510260130,"Day, C., Lauer, G., Robbins, G., et. al, Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection, Journal of Virology, 2002",cited-by,10.1128/JVI.76.24.12584-12595.2002,Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection,"[['Cheryl', 'L.', 'Day'], ['Georg', 'M.', 'Lauer'], ['Gregory', 'K.', 'Robbins'], ['Barbara', '', 'McGovern'], ['Alysse', 'G.', 'Wurcel'], ['Rajesh', 'T.', 'Gandhi'], ['Raymond', 'T.', 'Chung'], ['Bruce', 'D.', 'Walker']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.24.12584-12595.2002', u'http://jvi.asm.org/cgi/reprint/76/24/12584.pdf']",
10.1002/hep.510260130,"Zeuzem, S., Herrmann, E., Lee, J., et. al, Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a, Gastroenterology, 2001",cited-by,10.1053/gast.2001.24006,Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a,"[['Stefan', '', 'Zeuzem'], ['Eva', '', 'Herrmann'], ['Jung-Hun', '', 'Lee'], ['Jens', '', 'Fricke'], ['Avidan', 'U.', 'Neumann'], ['Marlene', '', 'Modi'], ['Giuseppe', '', 'Colucci'], ['W.', 'Kurt', 'Roth']]",Gastroenterology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0016508501025355', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508501025355']",
10.1002/hep.510260130,"Pawlotsky, J., Dahari, H., Neumann, A., et. al, Antiviral action of ribavirin in chronic hepatitis C, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2003.12.002,Antiviral action of ribavirin in chronic hepatitis C,"[['Jean-Michel', '', 'Pawlotsky'], ['Harel', '', 'Dahari'], ['Avidan', 'U.', 'Neumann'], ['Christophe', '', 'Hezode'], ['Georgios', '', 'Germanidis'], ['Isabelle', '', 'Lonjon'], ['Laurent', '', 'Castera'], ['Daniel', '', 'Dhumeaux']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503020158', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503020158']",
10.1002/hep.510260130,"Boyer, N., Marcellin, P., , Pathogenesis, diagnosis and management of hepatitis C, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80419-5,"Pathogenesis, diagnosis and management of hepatitis C","[['Nathalie', '', 'Boyer'], ['Patrick', '', 'Marcellin']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800804195', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800804195']",
10.1002/hep.510260130,"PAWLOTSKY, J., , Hepatitis C Virus Resistance to Antiviral Therapy, , 2000",cited-by,6316395Hepatitis C Virus Resistance to Antiviral Therapy,Hepatitis C Virus Resistance to Antiviral Therapy,"[['JEAN-MICHEL', '', 'PAWLOTSKY']]",,2000,"[u'http://hepatitis-central.com/hcv/ifn/resistance/hepatitiscentralresistance.pdf', u'http://www.hepatitis-central.com/hcv/ifn/resistance/hepatitiscentralresistance.pdf', u'http://www.heart-intl.net/HEART/Hepatitis/Comp/HCV-resistanttheropy.pdf']",
10.1002/hep.510260130,"Wang, Y., Youngster, S., Grace, M., et. al, Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications, Advanced Drug Delivery Reviews, 2002",cited-by,10.1016/S0169-409X(02)00027-3,Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications,"[['Yu-Sen', '', 'Wang'], ['Stephen', '', 'Youngster'], ['Michael', '', 'Grace'], ['James', '', 'Bausch'], ['Ronald', '', 'Bordens'], ['Daniel', 'F.', 'Wyss']]",Advanced Drug Delivery Reviews,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X02000273', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X02000273']",
10.1002/hep.510260130,"PAWLOTSKY, J., GERMANIDIS, G., NEUMANN, A., et. al, Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations, , 1998",cited-by,6819868Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations,Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations,"[['JEAN-MICHEL', '', 'PAWLOTSKY'], ['GEORGIOS', '', 'GERMANIDIS'], ['AVIDAN', 'U.', 'NEUMANN'], ['MURIEL', '', 'PELLERIN'], ['PIERRE-OLIVIER', '', 'FRAINAIS'], ['DANIEL', '', 'DHUMEAUX']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/4/2795.pdf'],
10.1002/hep.510260130,", Hepatitis C in African Americans: Summary of a Workshop, Gastroenterology, 2000",cited-by,10.1053/gast.2000.19582,Hepatitis C in African Americans: Summary of a Workshop,[],Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500697871', u'http://www.natap.org/2000/aasld/gastrent.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500697871']",
10.1002/hep.510260130,"Pawlotsky, J., , Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C, Antiviral Research, 2003",cited-by,10.1016/S0166-3542(03)00088-3,Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C,"[['Jean-Michel', '', 'Pawlotsky']]",Antiviral Research,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0166354203000883', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354203000883']",
10.1002/hep.510260130,"Castet, V., Fournier, C., Soulier, A., et. al, Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, 2002",cited-by,10.1128/JVI.76.16.8189-8199.2002,Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro,"[['Valerie', '', 'Castet'], ['Chantal', '', 'Fournier'], ['Alexandre', '', 'Soulier'], ['Rozenn', '', 'Brillet'], ['Joliette', '', 'Coste'], ['Dominique', '', 'Larrey'], ['Daniel', '', 'Dhumeaux'], ['Patrick', '', 'Maurel'], ['J.-M.', '', 'Pawlotsky']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/16/8189.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.16.8189-8199.2002']",
10.1002/hep.510260130,"Bekkering, F., Brouwer, J., Leroux-Roels, G., et. al, Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy, Journal of Hepatology, 1998",cited-by,10.1016/S0168-8278(98)80343-7,Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy,"[['Frank', 'C.', 'Bekkering'], ['Johannes', 'T.', 'Brouwer'], ['Geert', '', 'Leroux-Roels'], ['Hans', 'Van', 'Vlierberghe'], ['Andre', '', 'Elewaut'], ['Solko', 'W.', 'Schalm']]",Journal of Hepatology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0168827898803437', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827898803437']",
10.1002/hep.510260130,"Luxon, B., Grace, M., Brassard, D., et. al, Pegylated interferons for the treatment of chronic hepatitis C infection, Clinical Therapeutics, 2002",cited-by,10.1016/S0149-2918(02)80042-X,Pegylated interferons for the treatment of chronic hepatitis C infection,"[['Bruce', 'A.', 'Luxon'], ['Michael', '', 'Grace'], ['Diana', '', 'Brassard'], ['Ronald', '', 'Bordens']]",Clinical Therapeutics,2002,"[u'http://www.sciencedirect.com/science/article/pii/S014929180280042X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180280042X']",
10.1002/hep.510260130,"Kau, A., Vermehren, J., Sarrazin, C., , Treatment predictors of a sustained virologic response in hepatitis B and C, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.07.013,Treatment predictors of a sustained virologic response in hepatitis B and C,"[['Annika', '', 'Kau'], ['Johannes', '', 'Vermehren'], ['Christoph', '', 'Sarrazin']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808004856', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808004856']",
10.1002/hep.510260130,"Vrolijk, J., Kaul, A., Hansen, B., et. al, A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C, Journal of Virological Methods, 2003",cited-by,10.1016/S0166-0934(03)00134-4,A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C,"[['Jan', 'M.', 'Vrolijk'], ['Artur', '', 'Kaul'], ['Bettina', 'E.', 'Hansen'], ['Volker', '', 'Lohmann'], ['Bart', 'L.', 'Haagmans'], ['Solko', 'W.', 'Schalm'], ['Ralf', '', 'Bartenschlager']]",Journal of Virological Methods,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0166093403001344', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093403001344']",
10.1002/hep.510260130,"Layden, J., Layden, T., Reddy, K., et. al, First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00377.x,First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline,"[['Jennifer', 'E.', 'Layden'], ['Thomas', 'J.', 'Layden'], ['K.', 'Rajender', 'Reddy'], ['Rachel', 'S', 'Levy-Drummer'], ['Jennifer', '', 'Poulakos'], ['Avidan', 'U.', 'Neumann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00377.x'],
10.1002/hep.510260130,"Hu, K., Vierling, J., Redeker, A., , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00253.x,"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection","[['Ke-Qin', '', 'Hu'], ['John', 'M.', 'Vierling'], ['Allan', 'G.', 'Redeker']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00253.x'],
10.1002/hep.510260130,"Pawlotsky, J., , Diagnostic tests for hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80378-X,Diagnostic tests for hepatitis C,"[['Jean-Michel', '', 'Pawlotsky']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S016882789980378X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882789980378X']",
10.1002/hep.510260130,"Jessner, W., Stauber, R., Hackl, F., et. al, Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00396.x,Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection,"[['W.', '', 'Jessner'], ['R.', '', 'Stauber'], ['F.', '', 'Hackl'], ['C.', '', 'Datz'], ['T.', '', 'Watkins-Riedel'], ['H.', '', 'Hofer'], ['A.', '', 'Gangl'], ['H.', '', 'Kessler'], ['P.', '', 'Ferenci']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00396.x'],
10.1002/hep.510260130,", T., , Genotype and viral load as prognostic indicators in the treatment of hepatitis C, Journal of Viral Hepatitis, 2000",cited-by,10.1046/j.1365-2893.2000.00233.x,Genotype and viral load as prognostic indicators in the treatment of hepatitis C,"[['Trepo', '', '']]",Journal of Viral Hepatitis,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2000.00233.x'],
10.1002/hep.510260130,"Layden, T., Layden, J., Reddy, K., et. al, Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00376.x,Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C,"[['Thomas', 'J.', 'Layden'], ['Jennifer', 'E.', 'Layden'], ['K.', 'Rajender', 'Reddy'], ['Rachel', 'S.', 'Levy-Drummer'], ['Jennifer', '', 'Poulakos'], ['Avidan', 'U.', 'Neumann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00376.x'],
10.1002/hep.510260130,"Cornberg, M., Wedemeyer, H., Manns, M., , Treatment of chronic hepatitis C with PEGylated interferon and ribavirin, Current Gastroenterology Reports, 2002",cited-by,10.1007/s11894-002-0034-y,Treatment of chronic hepatitis C with PEGylated interferon and ribavirin,"[['Markus', '', 'Cornberg'], ['Heiner', '', 'Wedemeyer'], ['Michael', 'P.', 'Manns']]",Current Gastroenterology Reports,2002,"[u'http://www.springerlink.com/index/763g5k122367nu04.pdf', u'http://www.springerlink.com/content/763g5k122367nu04', u'http://www.springerlink.com/index/10.1007/s11894-002-0034-y', u'http://www.springerlink.com/index/pdf/10.1007/s11894-002-0034-y']",
10.1002/hep.510260130,"Rosen, H., Ribeiro, R., Weinberger, L., et. al, Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00114-9,Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy,"[['Hugo', 'R.', 'Rosen'], ['Ruy', 'R.', 'Ribeiro'], ['Leor', '', 'Weinberger'], ['Stephanie', '', 'Wolf'], ['Minjun', '', 'Chung'], ['David', 'R.', 'Gretch'], ['Alan', 'S.', 'Perelson']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802001149', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802001149']",
10.1002/hep.510260130,"Foster, G., , Pegylated interferons: chemical and clinical differences, Alimentary Pharmacology & Therapeutics, 2004",cited-by,10.1111/j.1365-2036.2004.02170.x,Pegylated interferons: chemical and clinical differences,"[['G.', 'R.', 'Foster']]",Alimentary Pharmacology & Therapeutics,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2004.02170.x'],
10.1002/hep.510260130,"Strazzabosco, M., Spirli, C., Okolicsanyi, L., , Pathophysiology of the intrahepatic biliary epithelium, Journal of Gastroenterology and Hepatology, 2000",cited-by,10.1046/j.1440-1746.2000.02091.x,Pathophysiology of the intrahepatic biliary epithelium,"[['Mario', '', 'Strazzabosco'], ['Carlo', '', 'Spirli'], ['Lajos', '', 'Okolicsanyi']]",Journal of Gastroenterology and Hepatology,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2000.02091.x'],
10.1002/hep.510260130,"Lanford, R., Guerra, B., Lee, H., et. al, Genomic response to interferon-α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics, Hepatology, 2006",cited-by,10.1002/hep.21167,Genomic response to interferon-α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics,"[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Helen', '', 'Lee'], ['Deborah', '', 'Chavez'], ['Kathleen', 'M.', 'Brasky'], ['Catherine', 'B.', 'Bigger']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21167'],
10.1002/hep.510260130,"Tang, K., Herrmann, E., Cooksley, H., et. al, Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.05.024,Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy,"[['Kwok', 'H.', 'Tang'], ['Eva', '', 'Herrmann'], ['Helen', '', 'Cooksley'], ['Nick', '', 'Tatman'], ['Shilpa', '', 'Chokshi'], ['Roger', '', 'Williams'], ['Stefan', '', 'Zeuzem'], ['Nikolai', 'V.', 'Naoumov']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805004204', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805004204']",
10.1002/hep.510260130,"Zeuzem, S., , Clinical implications of hepatitis C viral kinetics, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80376-6,Clinical implications of hepatitis C viral kinetics,"[['Stefan', '', 'Zeuzem']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803766', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803766']",
10.1002/hep.510260130,"Buti, M., Sanchez-Avila, F., Lurie, Y., et. al, Viral Kinetics in Genotype 1 Chronic Hepatitis C Patients During Therapy With 2 Different Doses of Peginterferon Alfa-2b Plus Ribavirin, , 0",cited-by,6365491Viral Kinetics in Genotype 1 Chronic Hepatitis C Patients During Therapy With 2 Different Doses of Peginterferon Alfa-2b Plus Ribavirin,Viral Kinetics in Genotype 1 Chronic Hepatitis C Patients During Therapy With 2 Different Doses of Peginterferon Alfa-2b Plus Ribavirin,"[['Maria', '', 'Buti'], ['Francisco', '', 'Sanchez-Avila'], ['Yoav', '', 'Lurie'], ['Carlos', '', 'Stalgis'], ['Auristela', 'Vald \xc2\xb4', 'es'], ['Maria', '', 'Martell'], ['Rafael', '', 'Esteban']]",,0,[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/viral%20kinetics%20in%20genotype%201%20chronic%20hepatitis%20c.pdf'],
10.1002/hep.510260130,"Pal, S., Shuhart, M., Thomassen, L., et. al, Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo, Journal of Virology, 2006",cited-by,10.1128/JVI.80.5.2280-2290.2006,Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo,"[['Sampa', '', 'Pal'], ['Margaret', 'C.', 'Shuhart'], ['Lisa', '', 'Thomassen'], ['Scott', 'S.', 'Emerson'], ['Tao', '', 'Su'], ['Nathan', '', 'Feuerborn'], ['John', '', 'Kae'], ['David', 'R.', 'Gretch']]",Journal of Virology,2006,[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.80.5.2280-2290.2006'],
10.1002/hep.510260130,"Shiratori, Y., Perelson, A., Weinberger, L., et. al, Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80373-6,Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta,"[['Yasushi', '', 'Shiratori'], ['Alan', 'S.', 'Perelson'], ['Leor', '', 'Weinberger'], ['Fumio', '', 'Imazeki'], ['Osamu', '', 'Yokosuka'], ['Ryo', '', 'Nakata'], ['Masashi', '', 'Ihori'], ['Katsutaro', '', 'Hirota'], ['Naomi', '', 'Ono'], ['Hisamoto', '', 'Kuroda'], ['Teiji', '', 'Motojima'], ['Masaru', '', 'Nishigaki'], ['Masao', '', 'Omata']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800803736', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800803736']",
10.1002/hep.510260130,"Ferenci, P., , Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies, , 0",cited-by,10758155Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies,Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies,"[['Peter', '', 'Ferenci']]",,0,"[u'http://jac.oxfordjournals.org/cgi/reprint/dkh015v1.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/53/1/15.pdf']",
10.1002/hep.510260130,"Bocher, W., Schuchmann, M., Link, R., et. al, Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy, Liver International, 2006",cited-by,10.1111/j.1478-3231.2005.01239.x,Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy,"[['Wulf', 'O.', 'Bocher'], ['Marcus', '', 'Schuchmann'], ['Ralph', '', 'Link'], ['Heribert', '', 'Hillenbrand'], ['Fareed', '', 'Rahman'], ['Martin', '', 'Sprinzl'], ['Jonas', '', 'Mudter'], ['Hanns', 'F.', 'Lohr'], ['Peter', 'R.', 'Galle']]",Liver International,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1478-3231.2005.01239.x'],
10.1002/hep.510260130,"Funk, G., Jansen, V., Bonhoeffer, S., et. al, Spatial models of virus-immune dynamics, Journal of Theoretical Biology, 2005",cited-by,10.1016/j.jtbi.2004.10.004,Spatial models of virus-immune dynamics,"[['Georg', 'A.', 'Funk'], ['Vincent', 'A. A.', 'Jansen'], ['Sebastian', '', 'Bonhoeffer'], ['Timothy', '', 'Killingback']]",Journal of Theoretical Biology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0022519304004758', u'http://linkinghub.elsevier.com/retrieve/pii/S0022519304004758']",
10.1002/hep.510260130,"Takahashi, M., Saito, H., Higashimoto, M., et. al, Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy, , 2005",cited-by,6752224Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy,Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy,"[['Masahiko', '', 'Takahashi'], ['Hidetsugu', '', 'Saito'], ['Makiko', '', 'Higashimoto'], ['Kazuhiro', '', 'Atsukawa'], ['Hiromasa', '', 'Ishii']]",,2005,[u'http://jcm.asm.org/cgi/reprint/43/1/186.pdf'],
10.1002/hep.510260130,"Morishima, C., Gretch, D., , CLINICAL USE OF HEPATITIS C VIRUS TESTS FOR DIAGNOSIS AND MONITORING DURING THERAPY, Clinics in Liver Disease, 1999",cited-by,10.1016/S1089-3261(05)70235-X,CLINICAL USE OF HEPATITIS C VIRUS TESTS FOR DIAGNOSIS AND MONITORING DURING THERAPY,"[['Chihiro', '', 'Morishima'], ['David', 'R.', 'Gretch']]",Clinics in Liver Disease,1999,"[u'http://www.sciencedirect.com/science/article/pii/S108932610570235X', u'http://linkinghub.elsevier.com/retrieve/pii/S108932610570235X']",
10.1002/hep.510260130,"Rosen, H., Gretch, D., , Hepatitis C virus: current understanding and prospects for future therapies, Molecular Medicine Today, 1999",cited-by,10.1016/S1357-4310(99)01523-3,Hepatitis C virus: current understanding and prospects for future therapies,"[['Hugo', 'R', 'Rosen'], ['David', 'R', 'Gretch']]",Molecular Medicine Today,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1357431099015233', u'http://linkinghub.elsevier.com/retrieve/pii/S1357431099015233']",
10.1002/hep.510260130,"Ribeiro, R., Layden-almer, J., Powers, K., et. al, Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment, , 0",cited-by,5313224Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment,Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment,"[['Ruy', 'M.', 'Ribeiro'], ['Jennifer', '', 'Layden-almer'], ['Kimberly', 'A.', 'Powers'], ['Thomas', 'J.', 'Layden'], ['Alan', 'S.', 'Perelson']]",,0,[u'http://hepatitis-central.com/hcv/info/2003/aug/hepcinfo509.pdf'],
10.1002/hep.510260130,"ASAHINA, Y., IZUMI, N., UCHIHARA, M., et. al, A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta, , 0",cited-by,12344390A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta,A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta,"[['YASUHIRO', '', 'ASAHINA'], ['N', 'AMIKI', 'IZUMI'], ['M', 'ASAKATSU', 'UCHIHARA'], ['O', 'SAMU', 'NOGUCHI'], ['K', 'AORU', 'TSUCHIYA'], ['K', 'OSEI', 'HAMANO'], ['NOBUHIKO', '', 'KANAZAWA'], ['J', 'UN', 'ITAKURA'], ['S', 'HOZO', 'MIYAKE'], ['TAKAHIRO', '', 'SAKAI']]",,0,[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/A%20Potent%20Antiviral%20Effect%20on%20Hepatitis%20C%20Viral%20Dynamics%20by%20High-Dose%20Daily%20Interferon%20Alfa%20Plus%20Ribavirin.pdf'],
10.1002/hep.510260130,"Yu, M., Chuang, W., Dai, C., et. al, Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy, Translational Research, 2006",cited-by,10.1016/j.trsl.2006.04.006,Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy,"[['Ming-Lung', '', 'Yu'], ['Wan-Long', '', 'Chuang'], ['Chia-Yen', '', 'Dai'], ['Li-Po', '', 'Lee'], ['Ming-Yen', '', 'Hsieh'], ['Zu-Yau', '', 'Lin'], ['Shinn-Cherng', '', 'Chen'], ['Ming-Yuh', '', 'Hsieh'], ['Liang-Yen', '', 'Wang'], ['Wen-Yu', '', 'Chang'], ['Sun-Lung', '', 'Tsai'], ['Hsing-Tao', '', 'Kuo']]",Translational Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1931524406003094', u'http://linkinghub.elsevier.com/retrieve/pii/S1931524406003094']",
10.1002/hep.510260130,"Heydtmann, M., Freshwater, D., Dudley, T., et. al, Pegylated Interferon Alpha2b for Patients with HCV Recurrence and Graft Fibrosis Following Liver Transplantation, American Journal of Transplantation, 2006",cited-by,10.1111/j.1600-6143.2006.01255.x,Pegylated Interferon Alpha2b for Patients with HCV Recurrence and Graft Fibrosis Following Liver Transplantation,"[['M.', '', 'Heydtmann'], ['D.', '', 'Freshwater'], ['T.', '', 'Dudley'], ['V.', '', 'Lai'], ['S.', '', 'Palmer'], ['S.', '', 'Hubscher'], ['D.', '', 'Mutimer']]",American Journal of Transplantation,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-6143.2006.01255.x'],
10.1002/hep.510260130,"Cotler, S., Layden, J., Neumann, A., et. al, First phase hepatitis c viral kinetics in previous nonresponders patients, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00401.x,First phase hepatitis c viral kinetics in previous nonresponders patients,"[['S.', 'J.', 'Cotler'], ['J.', 'E.', 'Layden'], ['A.', 'U.', 'Neumann'], ['D.', 'M.', 'Jensen']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00401.x'],
10.1002/hep.510260130,"Shad, J., McHutchison, J., , CURRENT AND FUTURE THERAPIES OF HEPATITIS C, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70169-0,CURRENT AND FUTURE THERAPIES OF HEPATITIS C,"[['Javaid', 'A.', 'Shad'], ['John', 'G.', 'McHutchison']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105701690', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105701690']",
10.1002/hep.510260130,"Fukutomi, T., Nakamuta, M., Fukutomi, M., et. al, Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(00)00044-1,Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy,"[['Takayoshi', '', 'Fukutomi'], ['Makoto', '', 'Nakamuta'], ['Marie', '', 'Fukutomi'], ['Masataka', '', 'Iwao'], ['Hironobu', '', 'Watanabe'], ['Kaichiro', '', 'Hiroshige'], ['Yuichi', '', 'Tanabe'], ['Hajime', '', 'Nawata']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800000441', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800000441']",
10.1002/hep.510260130,"MIHM, U., HERRMANN, E., SARRAZIN, C., et. al, Review article: predicting response in hepatitis C virus therapy, Alimentary Pharmacology & Therapeutics, 2006",cited-by,10.1111/j.1365-2036.2006.02863.x,Review article: predicting response in hepatitis C virus therapy,"[['U.', '', 'MIHM'], ['E.', '', 'HERRMANN'], ['C.', '', 'SARRAZIN'], ['S.', '', 'ZEUZEM']]",Alimentary Pharmacology & Therapeutics,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2006.02863.x'],
10.1002/hep.510260130,"Layden-Almer, J., Cotler, S., Layden, T., , Viral kinetics in the treatment of chronic hepatitis C, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2006.00715.x,Viral kinetics in the treatment of chronic hepatitis C,"[['Jennifer', 'E.', 'Layden-Almer'], ['Scott', 'J.', 'Cotler'], ['Thomas', 'J.', 'Layden']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2006.00715.x'],
10.1002/hep.510260130,"Mangia, A., Villani, M., Minerva, N., et. al, Efficacy of 5 MU of interferon in combination with ribavirin for naı̈ve patients with chronic hepatitis C virus: a randomized controlled trial, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(00)00024-6,Efficacy of 5 MU of interferon in combination with ribavirin for naı̈ve patients with chronic hepatitis C virus: a randomized controlled trial,"[['Alessandra', '', 'Mangia'], ['Maria', 'Rosaria', 'Villani'], ['Nicola', '', 'Minerva'], ['Gioacchino', '', 'Leandro'], ['Donato', '', 'Bacca'], ['Marina', '', 'Cela'], ['Vito', '', 'Carretta'], ['Vito', '', 'Attino'], ['Francesco', '', 'Ventrella'], ['Antonio', '', 'Giangaspero'], ['Angelo', '', 'Andriulli']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800000246', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800000246']",
10.1002/hep.510260130,"CLEMENTI, M., , Quantitative Molecular Analysis of Virus Expression and Replication, , 2000",cited-by,6718219Quantitative Molecular Analysis of Virus Expression and Replication,Quantitative Molecular Analysis of Virus Expression and Replication,"[['MASSIMO', '', 'CLEMENTI']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/6/2030.pdf'],
10.1002/hep.510260130,"Causse, X., Payen, J., Izopet, J., et. al, Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80105-1,Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study,"[['Xavier', '', 'Causse'], ['Jean-Louis', '', 'Payen'], ['Jacques', '', 'Izopet'], ['G\xc3\xa9rard', '', 'Babany'], ['Marie-France', 'Saint-Marc', 'Girardin'], ['F', '', 'Bailly'], ['C', '', 'Housset'], ['A', '', 'Tran'], ['A', '', 'Pariente'], ['JP', '', 'Lagasse'], ['H', '', 'Desmorat'], ['L', '', 'Bettan'], ['F', '', 'Bloch'], ['P', '', 'Couzigou'], ['P', '', 'Chossegros'], ['Puig', 'P', 'Laurent'], ['Y', '', 'Bacq'], ['C', '', 'Douvin'], ['JJ', '', 'Raabe'], ['C', 'Van', 'Lemmens'], ['JP', '', 'Zarski'], ['P', '', 'Bernard'], ['W', '', 'Rozenbaum'], ['D', 'Trois', 'Vallets'], ['D', '', 'Fischer'], ['P', '', 'Sogni'], ['E', '', 'Boucher'], ['N', '', 'Boyer'], ['JM', '', 'Lang'], ['O', '', 'Danne'], ['JC', '', 'Barbare'], ['G', '', 'Force'], ['JC', '', 'Schmit'], ['B', '', 'Mesnard'], ['A', '', 'Gauthier'], ['JD', '', 'Poveda'], ['C', '', 'Sayada'], ['R', '', 'Olivares'], ['F', '', 'Montestruc']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800801051', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800801051']",
10.1002/hep.510260130,"Layden, T., , Principles of interferon induction therapy, American Journal of Medicine, 1999",cited-by,10.1016/S0002-9343(99)00387-3,Principles of interferon induction therapy,"[['Thomas', 'J', 'Layden']]",American Journal of Medicine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0002934399003873', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934399003873']",
10.1002/hep.510260130,"Gretch, D., , USE AND INTERPRETATION OF HCV DIAGNOSTIC TESTS IN THE CLINICAL SETTING, Clinics in Liver Disease, 1997",cited-by,10.1016/S1089-3261(05)70320-2,USE AND INTERPRETATION OF HCV DIAGNOSTIC TESTS IN THE CLINICAL SETTING,"[['David', 'R.', 'Gretch']]",Clinics in Liver Disease,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105703202', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105703202']",
10.1002/hep.510260130,"Lanford, R., Guerra, B., Bigger, C., et. al, Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus, Hepatology, 2007",cited-by,10.1002/hep.21776,Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus,"[['Robert', 'E.', 'Lanford'], ['Bernadette', '', 'Guerra'], ['Catherine', 'B.', 'Bigger'], ['Helen', '', 'Lee'], ['Deborah', '', 'Chavez'], ['Kathleen', 'M.', 'Brasky']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21776'],
10.1002/hep.510260130,"Asahina, Y., Izumi, N., Uchihara, M., et. al, Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00287-3,Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens,"[['Yasuhiro', '', 'Asahina'], ['Namiki', '', 'Izumi'], ['Masakatsu', '', 'Uchihara'], ['Osamu', '', 'Noguchi'], ['Yuki', '', 'Nishimura'], ['Kazunari', '', 'Inoue'], ['Ken', '', 'Ueda'], ['Kaoru', '', 'Tsuchiya'], ['Kosei', '', 'Hamano'], ['Jun', '', 'Itakura'], ['Shozo', '', 'Miyake']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803002873', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803002873']",
10.1002/hep.510260130,"Halfon, P., Pénaranda, G., Bourlière, M., et. al, Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: Implications for clinical management of patients with chronic hepatitis C virus infection, Journal of Medical Virology, 2006",cited-by,10.1002/jmv.20529,Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: Implications for clinical management of patients with chronic hepatitis C virus infection,"[['Philippe', '', 'Halfon'], ['Guillaume', '', 'P\xc3\xa9naranda'], ['Marc', '', 'Bourli\xc3\xa8re'], ['Hac\xc3\xa8ne', '', 'Khiri'], ['Marie-France', '', 'Masseyeff'], ['Denis', '', 'Ouzan']]",Journal of Medical Virology,2006,"[u'http://www.cdlpharma.com/laboratoire_central/halfon_et_al_2006_78_208_jmv.pdf', u'http://doi.wiley.com/10.1002/jmv.20529']",
10.1002/hep.510260130,"Daniel, S., , Chronic Hepatitis C Treatment Patterns in African American Patients: An Update, American Journal of Gastroenterology, 2005",cited-by,10.1111/j.1572-0241.2005.41321.x,Chronic Hepatitis C Treatment Patterns in African American Patients: An Update,"[['Samuel', '', 'Daniel']]",American Journal of Gastroenterology,2005,"[u'http://dx.doi.org/10.1111/j.1572-0241.2005.41321.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2005.41321.x']",
10.1002/hep.510260130,"Badalamenti, S., Catania, A., Lunghi, G., et. al, Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena?, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00417-7,Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena?,"[['Salvatore', '', 'Badalamenti'], ['Anna', '', 'Catania'], ['Giovanna', '', 'Lunghi'], ['Giovanni', '', 'Covini'], ['Elena', '', 'Bredi'], ['Diego', '', 'Brancaccio'], ['Maurizio', '', 'Salvadori'], ['Giovanna', '', 'Como'], ['Claudio', '', 'Ponticelli'], ['Giorgio', '', 'Graziani']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0272638603004177', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as0272638603004177']",
10.1002/hep.510260130,"Shiffman, M., , MANAGEMENT OF INTERFERON THERAPY NONRESPONDERS, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70207-5,MANAGEMENT OF INTERFERON THERAPY NONRESPONDERS,"[['Mitchell', 'L.', 'Shiffman']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702075', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702075']",
10.1002/hep.510260130,"Prestileo, T., Mazzola, G., Lorenzo, F., et. al, Response-adjusted α-interferon therapy for chronic hepatitis C in HIV-infected patients, International Journal of Antimicrobial Agents, 2000",cited-by,10.1016/S0924-8579(00)00259-4,Response-adjusted α-interferon therapy for chronic hepatitis C in HIV-infected patients,"[['Tullio', '', 'Prestileo'], ['Giovanni', '', 'Mazzola'], ['Francesco', 'Di', 'Lorenzo'], ['Piero', '', 'Colletti'], ['Francesco', '', 'Vitale'], ['Donatella', '', 'Ferraro'], ['Rosa', 'Di', 'Stefano'], ['Calogero', '', 'Camm\xc3\xa0']]",International Journal of Antimicrobial Agents,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0924857900002594', u'http://linkinghub.elsevier.com/retrieve/pii/S0924857900002594']",
10.1002/hep.510260130,"Manzin, A., Candela, M., Solforosi, L., et. al, Dynamics of hepatitis C viremia after plasma exchange, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80027-0,Dynamics of hepatitis C viremia after plasma exchange,"[['Aldo', '', 'Manzin'], ['Marco', '', 'Candela'], ['Laura', '', 'Solforosi'], ['Armando', '', 'Gabrielli'], ['Massimo', '', 'Clementi']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899800270', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899800270']",
10.1002/hep.510260130,"Pearlman, B., , Hepatitis C Virus Infection in African Americans, Clinical Infectious Diseases, 2006",cited-by,10.1086/498512,Hepatitis C Virus Infection in African Americans,"[['Brian', 'L.', 'Pearlman']]",Clinical Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/498512'],
10.1002/hep.510260130,"Hadziyannis, S., Koskinas, J., , Differences in epidemiology, liver disease and treatment response among HCV genotypes, Hepatology Research, 2004",cited-by,10.1016/j.hepres.2004.02.011,"Differences in epidemiology, liver disease and treatment response among HCV genotypes","[['Stephanos', 'J', 'Hadziyannis'], ['John', 'S', 'Koskinas']]",Hepatology Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1386634604000701', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634604000701']",
10.1002/hep.510260130,"Weegink, C., Sentjens, R., Beld, M., et. al, Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study, Carcinogenesis, 2003",cited-by,10.1046/j.1365-2893.2003.00421.x,Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study,"[['C.', 'J.', 'Weegink'], ['R.', 'E. J. H.', 'Sentjens'], ['M.', 'G. H. M.', 'Beld'], ['M.', 'G. W.', 'Dijkgraaf'], ['H.', 'W.', 'Reesink']]",Carcinogenesis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00421.x'],
10.1002/hep.510260130,"Marco, V., Ferraro, D., Almasio, P., et. al, Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00370.x,Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction,"[['V.', 'Di', 'Marco'], ['D.', '', 'Ferraro'], ['P.', '', 'Almasio'], ['A.', '', 'Vaccaro'], ['P.', '', 'Parisi'], ['M.', '', 'Cappello'], ['N.', '', 'Cino'], ['R.', 'Di', 'Stefano'], ['Antonio', '', 'Craxi']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00370.x'],
10.1002/hep.510260130,"Shiffman, M., , Pegylated interferons: What role will they play in the treatment of chronic hepatitis c?, Current Gastroenterology Reports, 2001",cited-by,10.1007/s11894-001-0038-z,Pegylated interferons: What role will they play in the treatment of chronic hepatitis c?,"[['Mitchell', 'L.', 'Shiffman']]",Current Gastroenterology Reports,2001,"[u'http://www.springerlink.com/content/2614gt268732x8x8', u'http://www.springerlink.com/index/pdf/10.1007/s11894-001-0038-z', u'http://www.springerlink.com/index/10.1007/s11894-001-0038-z']",
10.1002/hep.510260130,"Layden, T., Lam, N., Wiley, T., , HEPATITIS C VIRAL DYNAMICS, Clinics in Liver Disease, 1999",cited-by,10.1016/S1089-3261(05)70239-7,HEPATITIS C VIRAL DYNAMICS,"[['Thomas', 'J.', 'Layden'], ['Nancy', 'P.', 'Lam'], ['Thelma', 'E.', 'Wiley']]",Clinics in Liver Disease,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702397', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702397']",
10.1002/hep.510260130,"Schalm, S., Brouwer, J., Bekkering, F., et. al, New treatment strategies in non-responder patients with chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80398-5,New treatment strategies in non-responder patients with chronic hepatitis C,"[['Solko', 'W.', 'Schalm'], ['Johannes', 'T.', 'Brouwer'], ['Frank', 'C.', 'Bekkering'], ['Tekla', 'G. J. van', 'Rossum']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803985', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803985']",
10.1002/hep.510260130,"BEKKERING, F., STALGIS, C., MCHUTCHISON, J., et. al, Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model, , 0",cited-by,5353877Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model,Estimation of Early Hepatitis C Viral Clearance in Patients Receiving Daily Interferon and Ribavirin Therapy Using a Mathematical Model,"[['FRANK', 'C.', 'BEKKERING'], ['CARLOS', '', 'STALGIS'], ['JOHN', 'G.', 'MCHUTCHISON'], ['JOHANNES', 'T.', 'BROUWER'], ['ALAN', 'S.', 'PERELSON']]",,0,[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/estimation%20of%20early%20hepatitis%20c%20viral%20clearance%20in%20patients%20receiving%20daily%20interferon%20and%20ribavirin%20therapy%20using%20a%20mathematical%20model.pdf'],
10.1002/hep.510260130,"Davis, G., , COMBINATION TREATMENT WITH INTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C, Clinics in Liver Disease, 1999",cited-by,10.1016/S1089-3261(05)70240-3,COMBINATION TREATMENT WITH INTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C,"[['Gary', 'L.', 'Davis']]",Clinics in Liver Disease,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702403', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702403']",
10.1002/hep.510260130,"Craxï, A., Cammà, C., Giunta, M., , Definition of response to antiviral therapy in chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80394-8,Definition of response to antiviral therapy in chronic hepatitis C,"[['Antonio', '', 'Crax\xc3\xaf'], ['Calogero', '', 'Camm\xc3\xa0'], ['Marco', '', 'Giunta']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803948', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803948']",
10.1002/hep.510260130,"Layden, J., Layden, T., , How can mathematics help us understand HCV?, Gastroenterology, 2001",cited-by,10.1053/gast.2001.24401,How can mathematics help us understand HCV?,"[['Jennifer', 'E.', 'Layden'], ['Thomas', 'J.', 'Layden']]",Gastroenterology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0016508501879361', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508501879361']",
10.1002/hep.510260130,"Iacono, L., , D., , F., et. al, Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy, Alimentary Pharmacology & Therapeutics, 2000",cited-by,10.1046/j.1365-2036.2000.00713.x,Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy,"[['Lo', '', 'Iacono'], ['Diago', '', ''], ['Fernandez-Bermejo', '', ''], ['Vega', '', ''], ['Sanz', '', ''], ['Borque', '', ''], ['Garcia-Buey', '', ''], ['Garcia-Monzon', '', ''], ['Pedreira', '', ''], ['Moreno-Otero', '', '']]",Alimentary Pharmacology & Therapeutics,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2000.00713.x'],
10.1002/hep.510260130,"Tassopoulos, N., Tsantoulas, D., Raptopoulou, M., et. al, A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00406.x,A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1,"[['N.', 'C', 'Tassopoulos'], ['D.', '', 'Tsantoulas'], ['M.', '', 'Raptopoulou'], ['T.', '', 'Vassiliadis'], ['S.', '', 'Kanatakis'], ['E.', '', 'Paraskevas'], ['I.', '', 'Vafiadis'], ['A.', '', 'Avgerinos'], ['C.', '', 'Tzathas'], ['S.', '', 'Manolakopoulos'], ['I.', '', 'Ketikoglou'], ['P.', '', 'Aggelis'], ['K.', '', 'Goritsas'], ['G.', '', 'Giannoulis'], ['G.', 'Hatzis', 'G'], ['K.', '', 'Thomopoulos'], ['E.', '', 'Akriviadis'], ['V.', '', 'Sypsa'], ['A.', '', 'Hatzakis']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00406.x'],
10.1002/hep.510260130,"Jessner, W., Watkins-Riedel, T., Formann, E., et. al, Hepatitis C viral dynamics: basic concept and clinical significance, Journal of Clinical Virology, 2002",cited-by,10.1016/S1386-6532(02)00194-4,Hepatitis C viral dynamics: basic concept and clinical significance,"[['Wolfgang', '', 'Jessner'], ['Thomas', '', 'Watkins-Riedel'], ['Elisabeth', '', 'Formann'], ['Petra', '', 'Steindl-Munda'], ['Peter', '', 'Ferenci']]",Journal of Clinical Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1386653202001944', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001944']",
10.1002/hep.510260130,"Zeuzem, S., , THE KINETICS OF HEPATITIS C VIRUS INFECTION, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70201-4,THE KINETICS OF HEPATITIS C VIRUS INFECTION,"[['Stefan', '', 'Zeuzem']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702014', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702014']",
10.1002/hep.510260130,"Hadziyannis, A., Papaioannou, C., Spanou, F., et. al, Induction interferon therapy in naive patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit, Alimentary Pharmacology & Therapeutics, 2001",cited-by,10.1046/j.1365-2036.2001.00946.x,Induction interferon therapy in naive patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit,"[['A.', 'S.', 'Hadziyannis'], ['C.', '', 'Papaioannou'], ['F.', '', 'Spanou'], ['E.', 'K.', 'Manesis'], ['S.', 'J.', 'Hadziyannis']]",Alimentary Pharmacology & Therapeutics,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2001.00946.x'],
10.1002/hep.510260130,"Cotler, S., Reddy, K., McCone, J., et. al, An Analysis of Acute Changes in Interleukin6 Levels After Treatment of Hepatitis C with Consensus Interferon, Journal of Interferon and Cytokine Research, 2001",cited-by,10.1089/107999001317205132,An Analysis of Acute Changes in Interleukin6 Levels After Treatment of Hepatitis C with Consensus Interferon,"[['Scott', 'J.', 'Cotler'], ['K.', 'Rajender', 'Reddy'], ['Jon', '', 'McCone'], ['Darin', 'L.', 'Wolfe'], ['Anguo', '', 'Liu'], ['Teresa', 'R.', 'Craft'], ['Mary', 'W.', 'Ferris'], ['Andrew', 'J.', 'Conrad'], ['Jeff', '', 'Albrecht'], ['Mary', '', 'Morrissey'], ['Daniel', 'R.', 'Ganger'], ['Howard', '', 'Rosenblate'], ['Lawrence', 'M.', 'Blatt'], ['Donald', 'M.', 'Jensen'], ['Milton', 'W.', 'Taylor']]",Journal of Interferon and Cytokine Research,2001,[u'http://www.liebertonline.com/doi/abs/10.1089%2F107999001317205132'],
10.1002/hep.510260130,"Ferenci, P., Stauber, R., Steindl-Munda, P., et. al, Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial, , 2001",cited-by,10.1097/00042737-200106000-00014,Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial,"[['Peter', '', 'Ferenci'], ['Rudolf', '', 'Stauber'], ['Petra', '', 'Steindl-Munda'], ['Michael', '', 'Gschwantler'], ['Peter', '', 'Fickert'], ['Christian', '', 'Datz'], ['Franz', '', 'Hackl'], ['Wolfgang', '', 'Rainer'], ['Thomas', '', 'Watkins-Riedel'], ['Werner', '', 'Lin'], ['Alfred', '', 'Gangl']]",,2001,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-200106000-00014'],
10.1002/hep.510260130,"Witthöft, T., Möller, B., Wiedmann, K., et. al, Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2007.00871.x,"Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial","[['Th.', '', 'Witth\xc3\xb6ft'], ['B.', '', 'M\xc3\xb6ller'], ['K.', 'H.', 'Wiedmann'], ['St.', '', 'Mauss'], ['R.', '', 'Link'], ['J.', '', 'Lohmeyer'], ['M.', '', 'Lafrenz'], ['C.', 'M.', 'Gelbmann'], ['D.', '', 'H\xc3\xbcppe'], ['C.', '', 'Niederau'], ['U.', '', 'Alshuth']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2007.00871.x'],
10.1002/hep.510260130,"Herrmann, E., Zeuzem, S., , The kinetics of hepatitis C virus, European Journal of Gastroenterology & Hepatology, 2006",cited-by,10.1097/00042737-200604000-00006,The kinetics of hepatitis C virus,"[['Eva', '', 'Herrmann'], ['Stefan', '', 'Zeuzem']]",European Journal of Gastroenterology & Hepatology,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-200604000-00006'],
10.1002/hep.510260130,"Quer, J., Murillo, P., Martell, M., et. al, Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy, Journal of Viral Hepatitis, 2004",cited-by,10.1046/j.1352-0504.2003.00465.x,Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy,"[['J.', '', 'Quer'], ['P.', '', 'Murillo'], ['M.', '', 'Martell'], ['J.', '', 'Gomez'], ['J.', 'I.', 'Esteban'], ['R.', '', 'Esteban'], ['J.', '', 'Guardia']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1352-0504.2003.00465.x'],
10.1002/hep.510260130,"Engler, S., Flechtenmacher, C., Wiedemann, K., et. al, Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection, Journal of Viral Hepatitis, 2004",cited-by,10.1046/j.1352-0504.2003.00463.x,Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection,"[['S.', '', 'Engler'], ['C.', '', 'Flechtenmacher'], ['K.', 'H.', 'Wiedemann'], ['R.', '', 'Gugler'], ['W.', '', 'Stremmel'], ['B.', '', 'Kallinowski']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1352-0504.2003.00463.x'],
10.1002/hep.510260130,"Lédinghen, V., Trimoulet, P., Winnock, M., et. al, Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00071-5,Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone,"[['Victor', 'de', 'L\xc3\xa9dinghen'], ['Pascale', '', 'Trimoulet'], ['Maria', '', 'Winnock'], ['Pierre-Henri', '', 'Bernard'], ['Marc', '', 'Bourli\xc3\xa8re'], ['Isabelle', '', 'Portal'], ['Andr\xc3\xa9-Jean', '', 'R\xc3\xa9my'], ['Nathalie', '', 'Szostak'], ['St\xc3\xa9phane', '', 'L\xc3\xa9vy'], ['Albert', '', 'Tran'], ['Armand', '', 'Abergel'], ['Genevi\xc3\xa8ve', '', 'Ch\xc3\xaane'], ['Herv\xc3\xa9', '', 'Fleury'], ['Patrice', '', 'Couzigou']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802000715', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802000715']",
10.1002/hep.510260130,"Hanabusa, H., , Efficacy of Induction Therapy with High‐Dose Interferon for Patients with Hemophilia and Human Immunodeficiency Virus–Hepatitis C Virus Coinfection, Clinical Infectious Diseases, 2002",cited-by,10.1086/344755,Efficacy of Induction Therapy with High‐Dose Interferon for Patients with Hemophilia and Human Immunodeficiency Virus–Hepatitis C Virus Coinfection,"[['Hideji', '', 'Hanabusa']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/344755'],
10.1002/hep.510260130,"WEDEMEYER, H., WIEGAND, J., CORNBERG, M., et. al, Polyethylene glycol-interferon: Current status in hepatitis C virus therapy, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.17.s3.26.x,Polyethylene glycol-interferon: Current status in hepatitis C virus therapy,"[['HEINER', '', 'WEDEMEYER'], ['JOHANNES', '', 'WIEGAND'], ['MARKUS', '', 'CORNBERG'], ['MICHAEL', 'P', 'MANNS']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.17.s3.26.x'],
10.1002/hep.510260130,"Shiratori, Y., Omata, M., , Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?, Journal of Gastroenterology and Hepatology, 2000",cited-by,10.1046/j.1440-1746.2000.02116.x,Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?,"[['Yasushi', '', 'Shiratori'], ['Masao', '', 'Omata']]",Journal of Gastroenterology and Hepatology,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2000.02116.x'],
10.1002/hep.510260130,"Ahmed, A., Keeffe, E., , OVERVIEW OF INTERFERON THERAPY FOR CHRONIC HEPATITIS C, Clinics in Liver Disease, 1999",cited-by,10.1016/S1089-3261(05)70237-3,OVERVIEW OF INTERFERON THERAPY FOR CHRONIC HEPATITIS C,"[['Aijaz', '', 'Ahmed'], ['Emmet', 'B.', 'Keeffe']]",Clinics in Liver Disease,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702373', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702373']",
10.1002/hep.510260130,"Davis, G., , New schedules of interferon for chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80407-3,New schedules of interferon for chronic hepatitis C,"[['Gary', 'L.', 'Davis']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899804073', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899804073']",
10.1002/hep.510260130,"Dahari, H., Layden-Almer, J., Perelson, A., et. al, Hepatitis C viral kinetics in special populations, Current Hepatitis Reports, 2008",cited-by,10.1007/s11901-008-0022-2,Hepatitis C viral kinetics in special populations,"[['Harel', '', 'Dahari'], ['Jennifer', 'E.', 'Layden-Almer'], ['Alan', 'S.', 'Perelson'], ['Thomas', 'J.', 'Layden']]",Current Hepatitis Reports,2008,"[u'http://www.springerlink.com/index/973g87748tl312vk.pdf', u'http://www.springerlink.com/content/973g87748tl312vk', u'http://www.springerlink.com/index/10.1007/s11901-008-0022-2', u'http://www.springerlink.com/index/pdf/10.1007/s11901-008-0022-2']",
10.1002/hep.510260130,"Firpi, R., Nelson, D., , Current and Future Hepatitis C Therapies, Archives of Medical Research, 2007",cited-by,10.1016/j.arcmed.2006.09.002,Current and Future Hepatitis C Therapies,"[['Roberto', 'J.', 'Firpi'], ['David', 'R.', 'Nelson']]",Archives of Medical Research,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0188440906003092', u'http://linkinghub.elsevier.com/retrieve/pii/S0188440906003092']",
10.1002/hep.510260130,"Nagaki, M., Imose, M., Naiki, T., et. al, Prospective study on early virologic response to treatment with interferon α-2b plus ribavirin in patients with chronic hepatitis C genotype 1b, Hepatology Research, 2005",cited-by,10.1016/j.hepres.2005.08.010,Prospective study on early virologic response to treatment with interferon α-2b plus ribavirin in patients with chronic hepatitis C genotype 1b,"[['Masahito', '', 'Nagaki'], ['Motoaki', '', 'Imose'], ['Takafumi', '', 'Naiki'], ['Kiminori', '', 'Kimura'], ['Hideki', '', 'Hayashi'], ['Masaru', '', 'Shimizu'], ['Hiroo', '', 'Ohnishi'], ['Eiichi', '', 'Tomita'], ['Jun\xe2\x80\x99ichi', '', 'Sugihara'], ['Kazuo', '', 'Amano'], ['Tsutomu', '', 'Sakai'], ['Takao', '', 'Kojima'], ['Naoki', '', 'Katsumura'], ['Yoshimasa', '', 'Kondo'], ['Masao', '', 'Fujimoto'], ['Hisataka', '', 'Moriwaki']]",Hepatology Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1386634605003281', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634605003281']",
10.1002/hep.510260130,"Kim, T., Kim, K., Lim, Y., et. al, Prediction of Treatment Outcome in Chronic Hepatitis C Patients Based on Early Viral Dynamics during High-Dose Induction Interferon and Ribavirin Therapy, Intervirology, 2005",cited-by,10.1159/000084600,Prediction of Treatment Outcome in Chronic Hepatitis C Patients Based on Early Viral Dynamics during High-Dose Induction Interferon and Ribavirin Therapy,"[['Tae', 'Hun', 'Kim'], ['Kyung', 'A.', 'Kim'], ['Young', 'Seok', 'Lim'], ['Geum-youn', '', 'Gwak'], ['Jung-Hwan', '', 'Yoon'], ['Gyeong', 'Hoon', 'Kang'], ['Hyo-Suk', '', 'Lee']]",Intervirology,2005,"[u'http://www.karger.com/doi/10.1159/000084600', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000084600']",
10.1002/hep.510260130,"Ahn, J., Flamm, S., , Peginterferon-2b and ribavirin, Expert Review of Anticancer Therapy, 2004",cited-by,10.1586/14787210.2.1.17,Peginterferon-2b and ribavirin,"[['Joseph', '', 'Ahn'], ['Steven', '', 'Flamm']]",Expert Review of Anticancer Therapy,2004,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.2.1.17'],
10.1002/hep.510260130,"Fattovich, G., Zagni, I., Ribero, M., et. al, A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00538.x,A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone,"[['G.', '', 'Fattovich'], ['I.', '', 'Zagni'], ['M.', 'L.', 'Ribero'], ['E.', '', 'Castagnetti'], ['E.', '', 'Minola'], ['L.', '', 'Lomonaco'], ['C.', '', 'Scattolini'], ['P.', '', 'Fabris'], ['S.', '', 'Boccia'], ['M.', '', 'Giusti'], ['G.', '', 'Abbati'], ['M.', '', 'Felder'], ['P.', '', 'Rovere'], ['A.', '', 'Redaelli'], ['A.', '', 'Tonon'], ['A.', '', 'Tomba'], ['R.', '', 'Montanari'], ['C.', '', 'Paternoster'], ['M.', '', 'Distasi'], ['G.', '', 'Fornaciari'], ['G.', '', 'Tositti'], ['C.', '', 'Rizzo'], ['S.', '', 'Suppressa'], ['M.', '', 'Pantalena'], ['F.', '', 'Noventa'], ['A.', '', 'Tagger']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00538.x'],
10.1002/hep.510260130,"Perez, R., Jimenez, M., Crespo, J., et. al, Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00461.x,Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C,"[['R.', '', 'Perez'], ['M.', '', 'Jimenez'], ['J.', '', 'Crespo'], ['M.', '', 'Diago'], ['J.', '', 'Enriquez'], ['P.', '', 'Vaquero'], ['R.', '', 'Sola'], ['J.', 'L.', 'Olcoz'], ['M.', '', 'Romero'], ['J.', '', 'Salmeron'], ['Ma', 'I.', 'Blanco'], ['Ma', '', 'Ona'], ['S.', '', 'Melon'], ['L.', '', 'Rodrigo']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00461.x'],
10.1002/hep.510260130,"Vlierberghe, H., Leroux-Roels, G., Adler, M., et. al, Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00466.x,Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial,"[['H.', 'Van', 'Vlierberghe'], ['G.', '', 'Leroux-Roels'], ['M.', '', 'Adler'], ['N.', '', 'Bourgeois'], ['F.', '', 'Nevens'], ['Y.', '', 'Horsmans'], ['J.', '', 'Brouwer'], ['I.', '', 'Colle'], ['J.', '', 'Delwaide'], ['R.', '', 'Brenard'], ['B.', '', 'Bastens'], ['J.', '', 'Henrion'], ['R.', 'A.', 'Vries'], ['C.', '', 'Galocsy'], ['P.', '', 'Michielsen'], ['G.', '', 'Robaeys'], ['L.', '', 'Bruckers']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00466.x'],
10.1002/hep.510260130,"Malik, A., Kumar, K., Malet, P., et. al, A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon, Alimentary Pharmacology & Therapeutics, 2002",cited-by,10.1046/j.1365-2036.2002.01201.x,"A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon","[['A.', 'H.', 'Malik'], ['K.', 'S.', 'Kumar'], ['P.', 'F.', 'Malet'], ['G.', '', 'Ostapowicz'], ['G.', '', 'Adams'], ['M.', '', 'Wood'], ['K.', '', 'Yarbrough'], ['A.', '', 'Jones'], ['W.', 'M.', 'Lee']]",Alimentary Pharmacology & Therapeutics,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2002.01201.x'],
10.1002/hep.510260130,"Arends, J., Stuart, J., Baak, L., et. al, Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy, Journal of Viral Hepatitis, 2009",cited-by,10.1111/j.1365-2893.2009.01143.x,Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy,"[['J.', 'E.', 'Arends'], ['J.', 'W. T. Cohen', 'Stuart'], ['L.', 'C.', 'Baak'], ['M.', 'E. van der', 'Ende'], ['K.', 'J. van', 'Erpecum'], ['C.', 'P. M.', 'Simons'], ['G.', 'J.', 'Boland'], ['D.', 'van', 'Baarle'], ['A.', 'I. M.', 'Hoepelman']]",Journal of Viral Hepatitis,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2009.01143.x'],
10.1056~NEJMoa011232,"Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-32.",references,10.1016/S0140-6736(98)07124-4,Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus,"[[u'Thierry', u'', u'Poynard'], [u'Patrick', u'', u'Marcellin'], [u'Samuel', u'S', u'Lee'], [u'Christian', u'', u'Niederau'], [u'Gerald', u'S', u'Minuk'], [u'Gaetano', u'', u'Ideo'], [u'Vincent', u'', u'Bain'], [u'Jenny', u'', u'Heathcote'], [u'Stefan', u'', u'Zeuzem'], [u'Christian', u'', u'Trepo'], [u'Janice', u'', u'Albrecht']]",Lancet,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0140673698071244', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673698071244']","[{u'Name': u'Chronic Infection', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5704}, {u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Randomised Trial', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 34311}]"
10.1016/S0140-6736(98)07124-4,"Strader, D., Wright, T., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20119,"Diagnosis, management, and treatment of hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2004,"[u'http://www.natap.org/2004/pdf/AASLD_Prac._Guide_Hep_C.pdf', u'http://www.hiv.ch/rubriken/hep/US_GL_Hep_C.pdf', u'http://www.texasliver.com/docs/management%20of%20hepatitis%20c%203.pdf', u'http://doi.wiley.com/10.1002/hep.20119']",
10.1016/S0140-6736(98)07124-4,"Lai, C., Ratziu, V., Yuen, M., et. al, Viral hepatitis B, Lancet, 2003",cited-by,10.1016/S0140-6736(03)15108-2,Viral hepatitis B,"[['Ching', 'Lung', 'Lai'], ['Vlad', '', 'Ratziu'], ['Man-Fung', '', 'Yuen'], ['Thierry', '', 'Poynard']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603151082', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603151082', u'https://www.msu.edu/~rosenb98/MS3/Int Med/Viral Hepatitis B - Lancet.pdf', u'http://www.temple.edu/imreports/reading/gi - hepc.pdf', u'http://www.temple.edu/imreports/reading/gi - hepb.pdf']",
10.1016/S0140-6736(98)07124-4,"Imbert-Bismut, F., Ratziu, V., Pieroni, L., et. al, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, 2001",cited-by,10.1016/S0140-6736(00)04258-6,Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study,"[['Fran\xc3\xa7oise', '', 'Imbert-Bismut'], ['Vlad', '', 'Ratziu'], ['Laurence', '', 'Pieroni'], ['Frederic', '', 'Charlotte'], ['Yves', '', 'Benhamou'], ['Thierry', '', 'Poynard']]",Lancet,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600042586', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600042586']",
10.1016/S0140-6736(98)07124-4,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1016/S0140-6736(98)07124-4,"Fried, M., , Side effects of therapy of hepatitis C and their management, Hepatology, 2002",cited-by,10.1053/jhep.2002.36810,Side effects of therapy of hepatitis C and their management,"[['Michael', 'W.', 'Fried']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Side%20Effects%20Of%20Therapy%20Of%20Hepatitis%20C%20And%20Their%20Management.pdf', u'http://doi.wiley.com/10.1002/hep.1840360730', u'http://doi.wiley.com/10.1053/jhep.2002.36810']",
10.1016/S0140-6736(98)07124-4,"Liang, T., Rehermann, B., Seeff, L., et. al, Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C, , 2000",cited-by,"6738512Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C","[['T.', 'Jake', 'Liang'], ['Barbara', '', 'Rehermann'], ['Leonard', 'B.', 'Seeff'], ['Jay', 'H.', 'Hoofnagle']]",,2000,[u'http://www.annals.org/content/132/4/296.full.pdf'],
10.1016/S0140-6736(98)07124-4,"Mehta, S., Cox, A., Hoover, D., et. al, Protection against persistence of hepatitis C, Lancet, 2002",cited-by,10.1016/S0140-6736(02)08435-0,Protection against persistence of hepatitis C,"[['Shruti', 'H', 'Mehta'], ['Andrea', '', 'Cox'], ['Donald', 'R', 'Hoover'], ['Xiao-Hong', '', 'Wang'], ['Qing', '', 'Mao'], ['Stuart', '', 'Ray'], ['Steffanie', 'A', 'Strathdee'], ['David', '', 'Vlahov'], ['David', 'L', 'Thomas']]",Lancet,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0140673602084350', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673602084350']",
10.1016/S0140-6736(98)07124-4,"Imbert-Bismut, F., Ratziu, V., Pieroni, L., et. al, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, , 0",cited-by,11627041Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study,Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study,"[['Fran\xc3\xa7oise', '', 'Imbert-Bismut'], ['Vlad', '', 'Ratziu'], ['Laurence', '', 'Pieroni'], ['Frederic', '', 'Charlotte'], ['Yves', '', 'Benhamou'], ['Thierry', '', 'Poynard']]",,0,"[u'https://loinc.org/meetings/20050606/public-laboratory-workshop-committee-meeting-06-06-2005/handout_h.pdf', u'http://www.natap.org/2001/apr/p_f_index.pdf', u'http://loinc.org/meetings/20050606/public-laboratory-workshop-committee-meeting-06-06-2005/handout_h.pdf']",
10.1016/S0140-6736(98)07124-4,"POLYAK, S., KHABAR, K., PASCHAL, D., et. al, Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response, Journal of Virology, 2001",cited-by,10.1128/JVI.75.13.6095-6106.2001,"Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response","[['STEPHEN', 'J.', 'POLYAK'], ['KHALID', 'S. A.', 'KHABAR'], ['DENISE', 'M.', 'PASCHAL'], ['HEATHER', 'J.', 'EZELLE'], ['GILLES', '', 'DUVERLIE'], ['GLEN', 'N.', 'BARBER'], ['DAVID', 'E.', 'LEVY'], ['NAOFUMI', '', 'MUKAIDA'], ['D.', 'R.', 'Gretch']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/13/6095.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.13.6095-6106.2001']",
10.1016/S0140-6736(98)07124-4,"Diago, M., Escartín, P., Enríquez, J., et. al, Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.05.016,Peginterferon-Alfa2a Plus Ribavirin for 48 Versus 72 Weeks in Patients With Detectable Hepatitis C Virus RNA at Week 4 of Treatment,"[['Mois\xc3\xa9s', '', 'Diago'], ['Pedro', '', 'Escart\xc3\xadn'], ['Jaime', '', 'Enr\xc3\xadquez'], ['Rafael', '', 'B\xc3\xa1rcena'], ['Javier', '', 'Crespo'], ['Ra\xc3\xbal', '', 'Andrade'], ['Ram\xc3\xb3n', '', 'P\xc3\xa9rez'], ['Milagros', '', 'Testillano'], ['Ram\xc3\xb3n', '', 'Planas'], ['Ricard', '', 'Sol\xc3\xa1']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506010705', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506010705']",
10.1016/S0140-6736(98)07124-4,"Poynard, T., McHutchison, J., Goodman, Z., et. al, Is an ?� la carte? combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?, Hepatology, 2000",cited-by,10.1002/hep.510310131,Is an ?� la carte? combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?,"[['Thierry', '', 'Poynard'], ['John', '', 'McHutchison'], ['Zachary', '', 'Goodman'], ['Mei-Hsiu', '', 'Ling'], ['Janice', '', 'Albrecht']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310131'],
10.1016/S0140-6736(98)07124-4,"Sulkowski, M., Thomas, D., , Hepatitis C in the HIV-Infected Person, , 2003",cited-by,5168375Hepatitis C in the HIV-Infected Person,Hepatitis C in the HIV-Infected Person,"[['Mark', 'S.', 'Sulkowski'], ['David', 'L.', 'Thomas']]",,2003,[u'http://www.annals.org/content/138/3/197.full.pdf'],
10.1016/S0140-6736(98)07124-4,"Sylvestre, D., , Treating hepatitis C in methadone maintenance patients: an interim analysis, Drug and Alcohol Dependence, 2002",cited-by,10.1016/S0376-8716(02)00010-8,Treating hepatitis C in methadone maintenance patients: an interim analysis,"[['Diana', 'L', 'Sylvestre']]",Drug and Alcohol Dependence,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0376871602000108', u'http://linkinghub.elsevier.com/retrieve/pii/S0376871602000108']",
10.1016/S0140-6736(98)07124-4,"Dienstag, J., , The role of liver biopsy in chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36381,The role of liver biopsy in chronic hepatitis C,"[['Jules', 'L.', 'Dienstag']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Role%20Of%20Liver%20Biopsy%20In%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36381', u'http://doi.wiley.com/10.1002/hep.1840360720']",
10.1016/S0140-6736(98)07124-4,"Pawlotsky, J., Dahari, H., Neumann, A., et. al, Antiviral action of ribavirin in chronic hepatitis C, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2003.12.002,Antiviral action of ribavirin in chronic hepatitis C,"[['Jean-Michel', '', 'Pawlotsky'], ['Harel', '', 'Dahari'], ['Avidan', 'U.', 'Neumann'], ['Christophe', '', 'Hezode'], ['Georgios', '', 'Germanidis'], ['Isabelle', '', 'Lonjon'], ['Laurent', '', 'Castera'], ['Daniel', '', 'Dhumeaux']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503020158', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503020158']",
10.1016/S0140-6736(98)07124-4,"Yee, T., Griffioen, A., Sabin, C., et. al, The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985, Gut, 2000",cited-by,10.1136/gut.47.6.845,The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985,"[['T', 'T', 'Yee'], ['A', '', 'Griffioen'], ['C', 'A', 'Sabin'], ['G', '', 'Dusheiko'], ['C', 'A', 'Lee']]",Gut,2000,"[u'http://gut.bmj.com/cgi/doi/10.1136/gut.47.6.845', u'http://dx.doi.org/']",
10.1016/S0140-6736(98)07124-4,"Zeuzem, S., Hultcrantz, R., Bourliere, M., et. al, Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3q,qq, , 2004",cited-by,"7021226Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3q,qq","Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3q,qq","[['Stefan', '', 'Zeuzem'], ['Rolf', '', 'Hultcrantz'], ['Marc', '', 'Bourliere'], ['Tobias', '', 'Goeser'], ['Patrick', '', 'Marcellin'], ['Jose', '', 'Sanchez-Tapias'], ['Christoph', '', 'Sarrazin'], ['Joann', '', 'Harvey'], ['Clifford', '', 'Brass'], ['Janice', '', 'Albrecht']]",,2004,[u'http://www.higadocolombia.org/admin/archivos/revistas/articulos/imagen_1.pdf'],
10.1016/S0140-6736(98)07124-4,"POLYAK, S., KHABAR, K., REZEIQ, M., et. al, Elevated Levels of Interleukin8 in Serum Are Associated with Hepatitis C Virus Infection and Resistance to Interferon Therapy, Journal of Virology, 2001",cited-by,10.1128/JVI.75.13.6209-6211.2001,Elevated Levels of Interleukin8 in Serum Are Associated with Hepatitis C Virus Infection and Resistance to Interferon Therapy,"[['STEPHEN', 'J.', 'POLYAK'], ['KHALID', 'S. A.', 'KHABAR'], ['MOHAMMED', '', 'REZEIQ'], ['DAVID', 'R.', 'GRETCH']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.13.6209-6211.2001', u'http://jvi.asm.org/cgi/reprint/75/13/6209.pdf']",
10.1016/S0140-6736(98)07124-4,"Boyer, N., Marcellin, P., , Pathogenesis, diagnosis and management of hepatitis C, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80419-5,"Pathogenesis, diagnosis and management of hepatitis C","[['Nathalie', '', 'Boyer'], ['Patrick', '', 'Marcellin']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800804195', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800804195']",
10.1016/S0140-6736(98)07124-4,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1016/S0140-6736(98)07124-4,"PENIN, F., COMBET, C., GERMANIDIS, G., et. al, Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment, Journal of Virology, 2001",cited-by,10.1128/JVI.75.12.5703-5710.2001,Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment,"[['FRANCOIS', '', 'PENIN'], ['CHRISTOPHE', '', 'COMBET'], ['GEORGIOS', '', 'GERMANIDIS'], ['PIERRE-OLIVIER', '', 'FRAINAIS'], ['GILBERT', '', 'DELEAGE'], ['JEAN-MICHEL', '', 'PAWLOTSKY']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/reprint/75/12/5703.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.12.5703-5710.2001']",
10.1016/S0140-6736(98)07124-4,"Dieterich, D., Wasserman, R., Bräu, N., et. al, Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus–infected patients receiving ribavirin plus interferon alfa, American Journal of Gastroenterology, 2003",cited-by,10.1016/j.amjgastroenterol.2003.08.006,Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus–infected patients receiving ribavirin plus interferon alfa,"[['Douglas', 'T', 'Dieterich'], ['Ronald', '', 'Wasserman'], ['Norbert', '', 'Br\xc3\xa4u'], ['Tarek', 'I', 'Hassanein'], ['Edmund', 'J', 'Bini'], ['Peter', 'J', 'Bowers'], ['Mark', 'S', 'Sulkowski']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003017878', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003017878']",
10.1016/S0140-6736(98)07124-4,"Dammacco, F., Sansonno, D., Piccoli, C., et. al, The cryoglobulins: an overview, European Journal of Clinical Investigation, 2001",cited-by,10.1046/j.1365-2362.2001.00824.x,The cryoglobulins: an overview,"[['F.', '', 'Dammacco'], ['D.', '', 'Sansonno'], ['C.', '', 'Piccoli'], ['F.', 'A.', 'Tucci'], ['V.', '', 'Racanelli']]",European Journal of Clinical Investigation,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2362.2001.00824.x'],
10.1016/S0140-6736(98)07124-4,"Wang, Y., Youngster, S., Grace, M., et. al, Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications, Advanced Drug Delivery Reviews, 2002",cited-by,10.1016/S0169-409X(02)00027-3,Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications,"[['Yu-Sen', '', 'Wang'], ['Stephen', '', 'Youngster'], ['Michael', '', 'Grace'], ['James', '', 'Bausch'], ['Ronald', '', 'Bordens'], ['Daniel', 'F.', 'Wyss']]",Advanced Drug Delivery Reviews,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X02000273', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X02000273']",
10.1016/S0140-6736(98)07124-4,"Pawlotsky, J., , Therapy of hepatitis C: From empiricism to eradication, Hepatology, 2006",cited-by,10.1002/hep.21064,Therapy of hepatitis C: From empiricism to eradication,"[['Jean-Michel', '', 'Pawlotsky']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21064'],
10.1016/S0140-6736(98)07124-4,"Jacobson, I., Brown, R., Freilich, B., et. al, Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial, Hepatology, 2007",cited-by,10.1002/hep.21932,Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial,"[['Ira', 'M.', 'Jacobson'], ['Robert', 'S.', 'Brown'], ['Bradley', '', 'Freilich'], ['Nezam', '', 'Afdhal'], ['Paul', 'Y.', 'Kwo'], ['John', '', 'Santoro'], ['Scott', '', 'Becker'], ['Adil', 'E.', 'Wakil'], ['David', '', 'Pound'], ['Eliot', '', 'Godofsky'], ['Robert', '', 'Strauss'], ['David', '', 'Bernstein'], ['Steven', '', 'Flamm'], ['Mary', 'Pat', 'Pauly'], ['Pabak', '', 'Mukhopadhyay'], ['Louis', 'H.', 'Griffel'], ['Clifford', 'A.', 'Brass']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21932'],
10.1016/S0140-6736(98)07124-4,"Schalm, S., Weiland, O., Hansen, B., et. al, Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials, Gastroenterology, 1999",cited-by,10.1053/gast.1999.0029900408,Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials,"[['Solko', 'W.', 'Schalm'], ['Ola', '', 'Weiland'], ['Bettina', 'E.', 'Hansen'], ['Michele', '', 'Milella'], ['Ming', 'Y.', 'Lai'], ['Anna', '', 'Hollander'], ['Peter', 'P.', 'Michielsen'], ['Antonio', '', 'Bellobuono'], ['Liliana', '', 'Chemello'], ['Giuseppe', '', 'Pastore'], ['Johannes', 'T.', 'Brouwer']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S001650859900164X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650859900164X']",
10.1016/S0140-6736(98)07124-4,"Bruchfeld, A., Stahle, L., Andersson, J., et. al, Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00300.x,Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study,"[['A.', '', 'Bruchfeld'], ['L.', '', 'Stahle'], ['J.', '', 'Andersson'], ['R.', '', 'Schvarcz']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00300.x'],
10.1016/S0140-6736(98)07124-4,"Foster, G., Rockstroh, J., Zeuzem, S., et. al, The way forward in HCV treatment — finding the right path, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2411,The way forward in HCV treatment — finding the right path,"[['Graham', 'R.', 'Foster'], ['J\xc3\xbcrgen', 'K.', 'Rockstroh'], ['Stefan', '', 'Zeuzem'], ['Fabien', '', 'Zoulim'], ['Michael', '', 'Houghton'], ['Michael', 'P.', 'Manns']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2411', u'http://www.nature.com/doifinder/10.1038/nrd2411']",
10.1016/S0140-6736(98)07124-4,"BACKMUND, M., MEYER, K., ZIELONKA, M., et. al, Treatment of Hepatitis C Infection in Injection Drug Users, , 0",cited-by,12082892Treatment of Hepatitis C Infection in Injection Drug Users,Treatment of Hepatitis C Infection in Injection Drug Users,"[['MARKUS', '', 'BACKMUND'], ['K', 'IRSTEN', 'MEYER'], ['M', 'ICHAEL VON', 'ZIELONKA'], ['DIETER', '', 'EICHENLAUB']]",,0,"[u'http://www.hcvu.org/mlib/2007_03_15-Backmund.pdf', u'http://hepcproject.typepad.com/hep_c_project/hepidu.pdf']",
10.1016/S0140-6736(98)07124-4,"Gane, E., Pilmore, H., , Management of chronic viral hepatitis before and after renal transplantation, Transplantation, 2002",cited-by,10.1097/00007890-200208270-00001,Management of chronic viral hepatitis before and after renal transplantation,"[['Edward', '', 'Gane'], ['Helen', '', 'Pilmore']]",Transplantation,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007890-200208270-00001'],
10.1016/S0140-6736(98)07124-4,"Macejak, D., Jensen, K., Jamison, S., et. al, Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes, Hepatology, 2000",cited-by,10.1002/hep.510310331,Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes,"[['Dennis', 'G.', 'Macejak'], ['Kristi', 'L.', 'Jensen'], ['Sharon', 'F.', 'Jamison'], ['Kristal', '', 'Domenico'], ['Elisabeth', 'C.', 'Roberts'], ['Nilabh', '', 'Chaudhary'], ['Ira', 'von', 'Carlowitz'], ['Laurent', '', 'Bellon'], ['Myron', 'J.', 'Tong'], ['Andrew', '', 'Conrad'], ['Pamela', 'A.', 'Pavco'], ['Lawrence', 'M.', 'Blatt']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310331'],
10.1016/S0140-6736(98)07124-4,"Schaefer, M., Schmidt, F., Folwaczny, C., et. al, Adherence and Mental Side Effects During Hepatitis C Treatment With Interferon Alfa and Ribavirin in Psychiatric Risk Groups, , 0",cited-by,5039649Adherence and Mental Side Effects During Hepatitis C Treatment With Interferon Alfa and Ribavirin in Psychiatric Risk Groups,Adherence and Mental Side Effects During Hepatitis C Treatment With Interferon Alfa and Ribavirin in Psychiatric Risk Groups,"[['Martin', '', 'Schaefer'], ['Folkhard', '', 'Schmidt'], ['Christian', '', 'Folwaczny'], ['Reinhard', '', 'Lorenz'], ['Gaby', '', 'Martin'], ['Norbert', '', 'Schindlbeck'], ['Walter', '', 'Heldwein'], ['Michael', '', 'Soyka'], ['Heinz', '', 'Grunze'], ['August', '', 'Koenig'], ['Klaus', '', 'Loeschke']]",,0,"[u'http://www.hawaii.edu/hivandaids/Adherence%20And%20Mental%20Side%20Effects%20During%20Hepatitis%20C%20Treatment%20With%20Interferon%20Alfa%20And%20Ribavirin.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/hepcinfo443.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo443.pdf']",
10.1016/S0140-6736(98)07124-4,"ZUCCHELLI, S., CAPONE, S., FATTORI, E., et. al, Enhancing B and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer, Journal of Virology, 2000",cited-by,10.1128/JVI.74.24.11598-11607.2000,Enhancing B and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer,"[['SILVIA', '', 'ZUCCHELLI'], ['STEFANIA', '', 'CAPONE'], ['ELENA', '', 'FATTORI'], ['ANTONELLA', '', 'FOLGORI'], ['ANNALISE', 'DI', 'MARCO'], ['DANILO', '', 'CASIMIRO'], ['ADAM', 'J.', 'SIMON'], ['RALPH', '', 'LAUFER'], ['NICOLA', 'LA', 'MONICA'], ['RICCARDO', '', 'CORTESE'], ['ALFREDO', '', 'NICOSIA']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/24/11598.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.24.11598-11607.2000']",
10.1016/S0140-6736(98)07124-4,"Bressler, B., Guindi, M., Tomlinson, G., et. al, High Body Mass Index Is an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C, , 0",cited-by,10947312High Body Mass Index Is an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C,High Body Mass Index Is an Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C,"[['Brian', 'L.', 'Bressler'], ['Maha', '', 'Guindi'], ['George', '', 'Tomlinson'], ['Jenny', '', 'Heathcote']]",,0,[u'http://www.hepatitis-central.com/hcv/info/2003/sept/hepcinfo639.pdf'],
10.1016/S0140-6736(98)07124-4,"Zeuzem, S., , Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?, , 2004",cited-by,6791240Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?,Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?,"[['Stefan', '', 'Zeuzem']]",,2004,[u'http://www.annals.org/content/140/5/370.full.pdf'],
10.1016/S0140-6736(98)07124-4,"Knapp, S., Yee, L., Frodsham, A., et. al, Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS1 and PKR, Genes and Immunity, 2003",cited-by,10.1038/sj.gene.6363984,"Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS1 and PKR","[['S', '', 'Knapp'], ['L', 'J', 'Yee'], ['A', 'J', 'Frodsham'], ['B', 'J W', 'Hennig'], ['S', '', 'Hellier'], ['L', '', 'Zhang'], ['M', '', 'Wright'], ['M', '', 'Chiaramonte'], ['M', '', 'Graves'], ['H', 'C', 'Thomas'], ['A', 'V S', 'Hill'], ['M', 'R', 'Thursz']]",Genes and Immunity,2003,"[u'http://www.well.ox.ac.uk/hill/docs/HCV-IFNresponsegenes_Knapp2003.pdf', u'http://www.nature.com/doifinder/10.1038/sj.gene.6363984', u'http://dx.doi.org/10.1038/sj.gene.6363984']",
10.1016/S0140-6736(98)07124-4,"Dalgard, O., Bjøro, K., Hellum, K., et. al, Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up, European Addiction Research, 2002",cited-by,10.1159/000049487,Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up,"[['O.', '', 'Dalgard'], ['K.', '', 'Bj\xc3\xb8ro'], ['K.', '', 'Hellum'], ['B.', '', 'Myrvang'], ['K.', '', 'Skaug'], ['B.', '', 'Gutigard'], ['H.', '', 'Bell']]",European Addiction Research,2002,"[u'http://www.karger.com/doi/10.1159/000049487', u'http://www.online.karger.com/doi/10.1159/000049487']",
10.1016/S0140-6736(98)07124-4,"Castet, V., Fournier, C., Soulier, A., et. al, Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, 2002",cited-by,10.1128/JVI.76.16.8189-8199.2002,Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro,"[['Valerie', '', 'Castet'], ['Chantal', '', 'Fournier'], ['Alexandre', '', 'Soulier'], ['Rozenn', '', 'Brillet'], ['Joliette', '', 'Coste'], ['Dominique', '', 'Larrey'], ['Daniel', '', 'Dhumeaux'], ['Patrick', '', 'Maurel'], ['J.-M.', '', 'Pawlotsky']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/16/8189.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.16.8189-8199.2002']",
10.1016/S0140-6736(98)07124-4,"Westin, J., Lagging, L., Spak, F., et. al, Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00356.x,Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection,"[['J.', '', 'Westin'], ['L.', 'M.', 'Lagging'], ['F.', '', 'Spak'], ['N.', '', 'Aires'], ['E.', '', 'Svensson'], ['M.', '', 'Lindh'], ['A.', 'P.', 'Dhillon'], ['G.', '', 'Norkrans'], ['R.', '', 'Wejstal']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00356.x'],
10.1016/S0140-6736(98)07124-4,"Papatheodoridis, G., Papadimitropoulos, V., Hadziyannis, S., , Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis, Alimentary Pharmacology & Therapeutics, 2001",cited-by,10.1046/j.1365-2036.2001.00979.x,Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis,"[['G.', 'V.', 'Papatheodoridis'], ['V.', 'C.', 'Papadimitropoulos'], ['S.', 'J.', 'Hadziyannis']]",Alimentary Pharmacology & Therapeutics,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2001.00979.x'],
10.1016/S0140-6736(98)07124-4,"Kozlowski, A., Harris, J., , Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C, Journal of Controlled Release, 2001",cited-by,10.1016/S0168-3659(01)00277-2,Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C,"[['Antoni', '', 'Kozlowski'], ['J.', 'Milton', 'Harris']]",Journal of Controlled Release,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168365901002772', u'http://linkinghub.elsevier.com/retrieve/pii/S0168365901002772']",
10.1016/S0140-6736(98)07124-4,"Sulkowski, M., Wasserman, R., Brooks, L., et. al, Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00490.x,Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection,"[['M.', 'S.', 'Sulkowski'], ['R.', '', 'Wasserman'], ['L.', '', 'Brooks'], ['L.', '', 'Ball'], ['R.', '', 'Gish']]",Journal of Viral Hepatitis,2004,"[u'http://www.cpmc.org/advanced/liver/physicians/JViralHepatitis2004.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00490.x']",
10.1016/S0140-6736(98)07124-4,"Zylberberg, H., Benhamou, Y., Lagneaux, J., et. al, Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report, Gut, 2000",cited-by,10.1136/gut.47.5.694,Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report,"[['H', '', 'Zylberberg'], ['Y', '', 'Benhamou'], ['J', 'L', 'Lagneaux'], ['A', '', 'Landau'], ['M-L', '', 'Chaix'], ['H', '', 'Fontaine'], ['M', '', 'Bochet'], ['T', '', 'Poynard'], ['C', '', 'Katlama'], ['G', '', 'Pialoux'], ['C', '', 'Br\xc3\xa9chot'], ['S', '', 'Pol']]",Gut,2000,"[u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.47.5.694']",
10.1016/S0140-6736(98)07124-4,"Meyers, C., Seeff, L., Stehman-Breen, C., et. al, Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00828-X,"Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD","[['Catherine', 'M.', 'Meyers'], ['Leonard', 'B.', 'Seeff'], ['Catherine', 'O.', 'Stehman-Breen'], ['Jay', 'H.', 'Hoofnagle']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S027263860300828X', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as027263860300828x', u'http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/Hep C and GN AJKD 05.pdf']",
10.1016/S0140-6736(98)07124-4,"Thevenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update,"[['T.', '', 'Thevenot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00271.x'],
10.1016/S0140-6736(98)07124-4,"Ludmerer, S., Graham, D., Boots, E., et. al, Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.5.2059-2069.2005,Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay,"[['Steven', 'W.', 'Ludmerer'], ['Donald', 'J.', 'Graham'], ['Evelyn', '', 'Boots'], ['Edward', 'M.', 'Murray'], ['Amy', '', 'Simcoe'], ['Eric', 'J.', 'Markel'], ['Jay', 'A.', 'Grobler'], ['Osvaldo', 'A.', 'Flores'], ['David', 'B.', 'Olsen'], ['Daria', 'J.', 'Hazuda'], ['Robert', 'L.', 'LaFemina']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/5/2059.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.5.2059-2069.2005']",
10.1016/S0140-6736(98)07124-4,"Schaefer, M., Heinz, A., Backmund, M., , Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?, Addiction, 2004",cited-by,10.1111/j.1360-0443.2004.00821.x,Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?,"[['Martin', '', 'Schaefer'], ['Andreas', '', 'Heinz'], ['Markus', '', 'Backmund']]",Addiction,2004,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1360-0443.2004.00821.x'],
10.1016/S0140-6736(98)07124-4,"Dieterich, D., Spivak, J., , Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management, Clinical Infectious Diseases, 2003",cited-by,10.1086/376971,Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management,"[['Douglas', 'T.', 'Dieterich'], ['Jerry', 'L.', 'Spivak']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/376971'],
10.1016/S0140-6736(98)07124-4,"Ho, S., Nguyen, H., Tetrick, L., et. al, Influence of psychiatric diagnoses on interferon-α treatment for chronic hepatitis C in a veteran population, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.03468.x,Influence of psychiatric diagnoses on interferon-α treatment for chronic hepatitis C in a veteran population,"[['Samuel', 'B.', 'Ho'], ['Huy', '', 'Nguyen'], ['Lori', 'L.', 'Tetrick'], ['Greg', 'A.', 'Opitz'], ['Michael', 'L.', 'Basara'], ['Eric', '', 'Dieperink']]",American Journal of Gastroenterology,2001,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.03468.x', u'http://dx.doi.org/10.1111/j.1572-0241.2001.03468.x']",
10.1016/S0140-6736(98)07124-4,"Layden, J., Layden, T., Reddy, K., et. al, First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00377.x,First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline,"[['Jennifer', 'E.', 'Layden'], ['Thomas', 'J.', 'Layden'], ['K.', 'Rajender', 'Reddy'], ['Rachel', 'S', 'Levy-Drummer'], ['Jennifer', '', 'Poulakos'], ['Avidan', 'U.', 'Neumann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00377.x'],
10.1016/S0140-6736(98)07124-4,"Muir, A., Provenzale, D., , A Descriptive Evaluation of Eligibility for Therapy Among Veterans With Chronic Hepatitis C Virus Infection, Journal of Clinical Gastroenterology, 2002",cited-by,10.1097/00004836-200203000-00015,A Descriptive Evaluation of Eligibility for Therapy Among Veterans With Chronic Hepatitis C Virus Infection,"[['Andrew', 'J.', 'Muir'], ['Dawn', '', 'Provenzale']]",Journal of Clinical Gastroenterology,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200203000-00015'],
10.1016/S0140-6736(98)07124-4,"WEINER, A., PALIARD, X., SELBY, M., et. al, Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity, Journal of Virology, 2001",cited-by,10.1128/JVI.75.15.7142-7148.2001,Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity,"[['AMY', 'J.', 'WEINER'], ['XAVIER', '', 'PALIARD'], ['MARK', 'J.', 'SELBY'], ['ANGELICA', '', 'MEDINA-SELBY'], ['DORIS', '', 'COIT'], ['STEVE', '', 'NGUYEN'], ['JOE', '', 'KANSOPON'], ['CHRISTOPHER', 'L.', 'ARIAN'], ['PHILIP', '', 'NG'], ['JEFFERY', '', 'TUCKER'], ['CHUN-TING', '', 'LEE'], ['NOELLE', 'K.', 'POLAKOS'], ['JANG', '', 'HAN'], ['SHIRLEY', '', 'WONG'], ['HUI-HUA', '', 'LU'], ['STEVE', '', 'ROSENBERG'], ['KATHY', 'M.', 'BRASKY'], ['DAVID', '', 'CHIEN'], ['GEORGE', '', 'KUO'], ['M.', '', 'Houghton']]",Journal of Virology,2001,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.75.15.7142-7148.2001', u'http://jvi.asm.org/cgi/reprint/75/15/7142.pdf']",
10.1016/S0140-6736(98)07124-4,"Lee, C., Lu, S., Changchien, C., et. al, Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection, Cancer, 1999",cited-by,10.1002/(SICI)1097-0142(19991001)86:7<1143::AID-CNCR7>3.0.CO;2-Z,"Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection","[['Chuan-Mo', '', 'Lee'], ['Sheng-Nan', '', 'Lu'], ['Chi-Sin', '', 'Changchien'], ['Chau-Ting', '', 'Yeh'], ['Tsung-Teng', '', 'Hsu'], ['Jui-Hsiang', '', 'Tang'], ['Jing-Houng', '', 'Wang'], ['Deng-Yn', '', 'Lin'], ['Chao-Long', '', 'Chen'], ['Wei-Jen', '', 'Chen']]",Cancer,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291097-0142%2819991001%2986%3A7%3C1143%3A%3AAID-CNCR7%3E3.0.CO%3B2-Z'],
10.1016/S0140-6736(98)07124-4,"Berg, T., Sarrazin, C., Herrmann, E., et. al, Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy, , 0",cited-by,12473429Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy,Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy,"[['Thomas', '', 'Berg'], ['Christoph', '', 'Sarrazin'], ['Eva', '', 'Herrmann'], ['Holger', '', 'Hinrichsen'], ['Tilman', '', 'Gerlach'], ['Reinhart', '', 'Zachoval'], ['Bertram', '', 'Wiedenmann'], ['Uwe', '', 'Hopf'], ['Stefan', '', 'Zeuzem']]",,0,[u'http://www.hawaii.edu/hivandaids/Prediction%20Of%20Treatment%20Outcome%20In%20Patients%20With%20Chronic%20Hepatitis%20C%20.pdf'],
10.1016/S0140-6736(98)07124-4,"Benson, C., Kaplan, J., Masur, H., et. al, Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America, Clinical Infectious Diseases, 2005",cited-by,10.1086/427906,"Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America","[['Constance', 'A.', 'Benson'], ['Jonathan', 'E.', 'Kaplan'], ['Henry', '', 'Masur'], ['Alice', '', 'Pau'], ['King', 'K.', 'Holmes']]",Clinical Infectious Diseases,2005,"[u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA.pdf', u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA000875.pdf', u'http://medicine.georgetown.edu/residency/idarticles/hivopportunistic.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427906']",
10.1016/S0140-6736(98)07124-4,"Shiffman, M., , Retreatment of patients with chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36816,Retreatment of patients with chronic hepatitis C,"[['Mitchell', 'L.', 'Shiffman']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Retreatment%20Of%20Patients%20With%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36816', u'http://doi.wiley.com/10.1002/hep.1840360717']",
10.1016/S0140-6736(98)07124-4,"Bourliere, M., Barberin, J., Rotily, M., et. al, Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00319.x,Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users,"[['M.', '', 'Bourliere'], ['J.', 'M.', 'Barberin'], ['M.', '', 'Rotily'], ['V.', '', 'Guagliardo'], ['I.', '', 'Portal'], ['L.', '', 'Lecomte'], ['S.', '', 'Benali'], ['C.', '', 'Boustiere'], ['H.', '', 'Perrier'], ['M.', '', 'Jullien'], ['G.', '', 'Lambot'], ['R.', '', 'Loyer'], ['O.', '', 'LeBars'], ['R.', '', 'Daniel'], ['H.', '', 'Khiri'], ['P.', '', 'Halfon']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00319.x'],
10.1016/S0140-6736(98)07124-4,"Dufour, D., Lott, J., Nolte, F., et. al, Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring, , 0",cited-by,"11010534Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring","Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring","[['D.', 'Robert', 'Dufour'], ['John', 'A.', 'Lott'], ['Frederick', 'S.', 'Nolte'], ['David', 'R.', 'Gretch'], ['Raymond', 'S.', 'Koff'], ['Leonard', 'B.', 'Seeff']]",,0,"[u'http://intl.clinchem.org/cgi/reprint/46/12/2050.pdf', u'http://www.clinchem.org/cgi/reprint/46/12/2050.pdf', u'http://www.med.upenn.edu/gastro/documents/clinicalchem2000_2050-68.pdf']",
10.1016/S0140-6736(98)07124-4,"Iwasaki, Y., Ikeda, H., Araki, Y., et. al, Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C, Hepatology, 2006",cited-by,10.1002/hep.20984,Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C,"[['Yoshiaki', '', 'Iwasaki'], ['Hiroshi', '', 'Ikeda'], ['Yasuyuki', '', 'Araki'], ['Toshiya', '', 'Osawa'], ['Keiji', '', 'Kita'], ['Masaharu', '', 'Ando'], ['Toshinari', '', 'Shimoe'], ['Kouichi', '', 'Takaguchi'], ['Noriaki', '', 'Hashimoto'], ['Toshitsugu', '', 'Kobatake'], ['Minoru', '', 'Tomita'], ['Mitsuhiko', '', 'Kawaguchi'], ['Haruhiko', '', 'Kobashi'], ['Kohsaku', '', 'Sakaguchi'], ['Yasushi', '', 'Shiratori']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.20984'],
10.1016/S0140-6736(98)07124-4,"González-Peralta, R., Kelly, D., Haber, B., et. al, Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics, Hepatology, 2005",cited-by,10.1002/hep.20884,"Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics","[['Regino', 'P.', 'Gonz\xc3\xa1lez-Peralta'], ['Deirdre', 'A.', 'Kelly'], ['Barbara', '', 'Haber'], ['Jean', '', 'Molleston'], ['Karen', 'F.', 'Murray'], ['Maureen', 'M.', 'Jonas'], ['Mark', '', 'Shelton'], ['Giorgina', '', 'Mieli-Vergani'], ['Yoav', '', 'Lurie'], ['Steven', '', 'Martin'], ['Thomas', '', 'Lang'], ['Andrew', '', 'Baczkowski'], ['Michael', '', 'Geffner'], ['Samir', '', 'Gupta'], ['Mark', '', 'Laughlin']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20884'],
10.1016/S0140-6736(98)07124-4,"Asnis, G., Garza, R., , Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches, Journal of Clinical Gastroenterology, 2006",cited-by,10.1097/01.mcg.0000210099.36500.fe,"Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches","[['Gregory', 'M.', 'Asnis'], ['Richard', 'De La', 'Garza']]",Journal of Clinical Gastroenterology,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200604000-00010'],
10.1016/S0140-6736(98)07124-4,"Hasan, F., Asker, H., Al-Khaldi, J., et. al, Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C Genotype 4, American Journal of Gastroenterology, 2004",cited-by,10.1111/j.1572-0241.2004.40077.x,Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C Genotype 4,"[['Fuad', '', 'Hasan'], ['Haifa', '', 'Asker'], ['Jameela', '', 'Al-Khaldi'], ['Iqbal', '', 'Siddique'], ['Misfer', '', 'Al-Ajmi'], ['Salim', '', 'Owaid'], ['Rosh', '', 'Varghese'], ['Basil', '', 'Al-Nakib']]",American Journal of Gastroenterology,2004,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2004.40077.x', u'http://dx.doi.org/10.1111/j.1572-0241.2004.40077.x']",
10.1016/S0140-6736(98)07124-4,"Lee, S., Yu, M., Cheng, P., et. al, Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00590.x,Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan,"[['S.-D.', '', 'Lee'], ['M.-L.', '', 'Yu'], ['P.-N.', '', 'Cheng'], ['M.-Y.', '', 'Lai'], ['Y.-C.', '', 'Chao'], ['S.-J.', '', 'Hwang'], ['W.-Y.', '', 'Chang'], ['T.-T.', '', 'Chang'], ['T.-Y.', '', 'Hsieh'], ['C.-J.', '', 'Liu'], ['D.-S.', '', 'Chen']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2005.00590.x'],
10.1016/S0140-6736(98)07124-4,"Pol, S., Lebray, P., , HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms, Clinical Infectious Diseases, 2004",cited-by,10.1086/381499,HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms,"[['Stanislas', '', 'Pol'], ['Pascal', '', 'Lebray']]",Clinical Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/381499'],
10.1016/S0140-6736(98)07124-4,"Inoue, K., Sekiyama, K., Yamada, M., et. al, Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial, Journal of Gastroenterology, 2003",cited-by,10.1007/s00535-002-1104-5,Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial,"[['Kazuaki', '', 'Inoue'], ['Kazuhiko', '', 'Sekiyama'], ['Masaya', '', 'Yamada'], ['Tsunamasa', '', 'Watanabe'], ['Hiroshi', '', 'Yasuda'], ['Makoto', '', 'Yoshiba']]",Journal of Gastroenterology,2003,"[u'http://www.springerlink.com/index/d9dqty32kc1gajh1.pdf', u'http://www.springerlink.com/content/d9dqty32kc1gajh1']",
10.1016/S0140-6736(98)07124-4,"Donlin, M., Cannon, N., Yao, E., et. al, Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy, Journal of Virology, 2007",cited-by,10.1128/JVI.00487-07,Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy,"[['Maureen', 'J.', 'Donlin'], ['Nathan', 'A.', 'Cannon'], ['Ermei', '', 'Yao'], ['J.', '', 'Li'], ['A.', '', 'Wahed'], ['M.', 'W.', 'Taylor'], ['S.', 'H.', 'Belle'], ['A.', 'M. Di', 'Bisceglie'], ['R.', '', 'Aurora'], ['J.', 'E.', 'Tavis']]",Journal of Virology,2007,"[u'http://jvi.asm.org/cgi/reprint/81/15/8211.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00487-07']",
10.1016/S0140-6736(98)07124-4,"Hayashi, N., Takehara, T., , Antiviral therapy for chronic hepatitis C: past, present, and future, Journal of Gastroenterology, 2006",cited-by,10.1007/s00535-005-1740-7,"Antiviral therapy for chronic hepatitis C: past, present, and future","[['Norio', '', 'Hayashi'], ['Tetsuo', '', 'Takehara']]",Journal of Gastroenterology,2006,"[u'http://www.springerlink.com/index/q5522283407n7832.pdf', u'http://www.springerlink.com/content/q5522283407n7832', u'http://www.springerlink.com/index/10.1007/s00535-005-1740-7', u'http://www.springerlink.com/index/pdf/10.1007/s00535-005-1740-7']",
10.1016/S0140-6736(98)07124-4,"Halfon, P., Trimoulet, P., Bourliere, M., et. al, Hepatitis C Virus Genotyping Based on 5' Noncoding Sequence Analysis (Trugene), Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.5.1771-1773.2001,Hepatitis C Virus Genotyping Based on 5' Noncoding Sequence Analysis (Trugene),"[['P.', '', 'Halfon'], ['P.', '', 'Trimoulet'], ['M.', '', 'Bourliere'], ['H.', '', 'Khiri'], ['V.', 'de', 'Ledinghen'], ['P.', '', 'Couzigou'], ['J.', 'M.', 'Feryn'], ['P.', '', 'Alcaraz'], ['C.', '', 'Renou'], ['H.', 'J. A.', 'Fleury'], ['D.', '', 'Ouzan']]",Journal of Clinical Microbiology,2001,"[u'http://jcm.asm.org/cgi/reprint/39/5/1771.pdf', u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.5.1771-1773.2001']",
10.1016/S0140-6736(98)07124-4,"Wong, J., Koff, R., , Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C A Cost-Effectiveness Analysis, , 0",cited-by,11847113Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C A Cost-Effectiveness Analysis,Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C A Cost-Effectiveness Analysis,"[['John', 'B.', 'Wong'], ['Raymond', 'S.', 'Koff']]",,0,[u'http://www.annals.org/cgi/reprint/133/9/665.pdf'],
10.1016/S0140-6736(98)07124-4,"Lindahl, K., Schvarcz, R., Bruchfeld, A., et. al, Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia, Journal of Viral Hepatitis, 2004",cited-by,10.1046/j.1365-2893.2003.00475.x,Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia,"[['K.', '', 'Lindahl'], ['R.', '', 'Schvarcz'], ['A.', '', 'Bruchfeld'], ['L.', '', 'Stahle']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00475.x'],
10.1016/S0140-6736(98)07124-4,"Dore, G., Freeman, A., Law, M., et. al, Is severe liver disease a common outcome for people with chronic hepatitisC?, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02730.x,Is severe liver disease a common outcome for people with chronic hepatitisC?,"[['Gregory', 'J', 'Dore'], ['Anthony', 'J', 'Freeman'], ['Matthew', '', 'Law'], ['JohnM', '', 'Kaldor']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02730.x'],
10.1016/S0140-6736(98)07124-4,"Martin, P., Carter, D., Fabrizi, F., et. al, HISTOPATHOLOGICAL FEATURES OF HEPATITIS C IN RENAL TRANSPLANT CANDIDATES1, Transplantation, 2000",cited-by,10.1097/00007890-200004150-00045,HISTOPATHOLOGICAL FEATURES OF HEPATITIS C IN RENAL TRANSPLANT CANDIDATES1,"[['Paul', '', 'Martin'], ['D.', '', 'Carter'], ['Fabrizio', '', 'Fabrizi'], ['Vivek', '', 'Dixit'], ['Andrew', 'J.', 'Conrad'], ['Lucy', '', 'Artinian'], ['Val', '', 'Peacock'], ['Steven', '', 'Han'], ['Alan', '', 'Wilkinson'], ['Charles', 'R.', 'Lassman'], ['Gabriel', '', 'Danovitch']]",Transplantation,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007890-200004150-00045'],
10.1016/S0140-6736(98)07124-4,"Thomas, H., Török, M., Forton, D., et. al, Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80393-6,Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C,"[['Howard.', 'C.', 'Thomas'], ['M.', 'E.', 'T\xc3\xb6r\xc3\xb6k'], ['D.', 'M.', 'Forton'], ['S.', 'D.', 'Taylor-Robinson']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803936', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803936']",
10.1016/S0140-6736(98)07124-4,"Akuta, N., Suzuki, F., Kawamura, Y., et. al, Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b, Journal of Medical Virology, 2007",cited-by,10.1002/jmv.20979,Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b,"[['Norio', '', 'Akuta'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Hitomi', '', 'Sezaki'], ['Yoshiyuki', '', 'Suzuki'], ['Tetsuya', '', 'Hosaka'], ['Masahiro', '', 'Kobayashi'], ['Mariko', '', 'Kobayashi'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Hiromitsu', '', 'Kumada']]",Journal of Medical Virology,2007,[u'http://doi.wiley.com/10.1002/jmv.20979'],
10.1016/S0140-6736(98)07124-4,"Payan, C., Roudot-Thoraval, F., Marcellin, P., et. al, Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study, Journal of Viral Hepatitis, 2005",cited-by,10.1111/j.1365-2893.2005.00605.x,Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study,"[['C.', '', 'Payan'], ['F.', '', 'Roudot-Thoraval'], ['P.', '', 'Marcellin'], ['N.', '', 'Bled'], ['G.', '', 'Duverlie'], ['I.', '', 'Fouchard-Hubert'], ['P.', '', 'Trimoulet'], ['P.', '', 'Couzigou'], ['D.', '', 'Cointe'], ['C.', '', 'Chaput'], ['C.', '', 'Henquell'], ['A.', '', 'Abergel'], ['J.', 'M.', 'Pawlotsky'], ['C.', '', 'Hezode'], ['M.', '', 'Coude'], ['A.', '', 'Blanchi'], ['S.', '', 'Alain'], ['V.', '', 'Loustaud-Ratti'], ['P.', '', 'Chevallier'], ['C.', '', 'Trepo'], ['V.', '', 'Gerolami'], ['I.', '', 'Portal'], ['P.', '', 'Halfon'], ['M.', '', 'Bourliere'], ['M.', '', 'Bogard'], ['E.', '', 'Plouvier'], ['C.', '', 'Laffont'], ['G.', '', 'Agius'], ['C.', '', 'Silvain'], ['V.', '', 'Brodard'], ['G.', '', 'Thiefin'], ['C.', '', 'Buffet-Janvresse'], ['G.', '', 'Riachi'], ['F.', '', 'Grattard'], ['T.', '', 'Bourlet'], ['F.', '', 'Stoll-Keller'], ['M.', '', 'Doffoel'], ['J.', '', 'Izopet'], ['K.', '', 'Barange'], ['M.', '', 'Martinot-Peignoux'], ['M.', '', 'Branger'], ['A.', '', 'Rosenberg'], ['P.', '', 'Sogni'], ['M.', 'L.', 'Chaix'], ['S.', '', 'Pol'], ['V.', '', 'Thibault'], ['P.', '', 'Opolon'], ['A.', '', 'Charrois'], ['L.', '', 'Serfaty'], ['B.', '', 'Fouqueray'], ['J.', 'D.', 'Grange'], ['J.', 'J.', 'Lefrere'], ['F.', '', 'Lunel-Fabiani']]",Journal of Viral Hepatitis,2005,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00605.x'],
10.1016/S0140-6736(98)07124-4,"Strader, D., , Understudied populations with hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36991,Understudied populations with hepatitis C,"[['Doris', 'B.', 'Strader']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Understudied%20Populations%20With%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36991', u'http://doi.wiley.com/10.1002/hep.1840360729']",
10.1016/S0140-6736(98)07124-4,"Formann, E., Jessner, W., Bennett, L., et. al, Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00446.x,Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1,"[['E.', '', 'Formann'], ['W.', '', 'Jessner'], ['L.', '', 'Bennett'], ['P.', '', 'Ferenci']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00446.x'],
10.1016/S0140-6736(98)07124-4,"Pavio, N., Lai, M., , The hepatitis C virus persistence: how to evade the immune system?, Journal of Biosciences, 2003",cited-by,10.1007/BF02970148,The hepatitis C virus persistence: how to evade the immune system?,"[['Nicole', '', 'Pavio'], ['Michael', 'M. C.', 'Lai']]",Journal of Biosciences,2003,"[u'http://www.springerlink.com/content/k6x201p3646mt542', u'http://www.springerlink.com/index/k6x201p3646mt542.pdf', u'http://www.springerlink.com/index/10.1007/BF02970148', u'http://www.springerlink.com/index/pdf/10.1007/BF02970148']",
10.1016/S0140-6736(98)07124-4,"Rossum, T., Vulto, A., Hop, W., et. al, Glycyrrhizin-induced reduction of alt in european patients with chronic hepatitis C, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.04049.x,Glycyrrhizin-induced reduction of alt in european patients with chronic hepatitis C,"[['Tekla', 'G J van', 'Rossum'], ['Arnold', 'G.', 'Vulto'], ['Wim', 'C. J.', 'Hop'], ['Solko', 'W.', 'Schalm']]",American Journal of Gastroenterology,2001,"[u'http://dx.doi.org/10.1111/j.1572-0241.2001.04049.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.04049.x']",
10.1016/S0140-6736(98)07124-4,"Wong, V., Fu, A., George, J., et. al, Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis, Clinical Endocrinology, 2002",cited-by,10.1046/j.1365-2265.2002.01553.x,Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis,"[['Vincent', '', 'Wong'], ['Angela', 'Xi-Li', 'Fu'], ['Jacob', '', 'George'], ['N.', 'Wah', 'Cheung']]",Clinical Endocrinology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2265.2002.01553.x'],
10.1016/S0140-6736(98)07124-4,"Snell, N., , Ribavirin - current status of a broad spectrum antiviral agent, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.8.1317,Ribavirin - current status of a broad spectrum antiviral agent,"[['Noel', 'J C', 'Snell']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.8.1317'],
10.1016/S0140-6736(98)07124-4,"Schaefer, M., Hinzpeter, A., Mohmand, A., et. al, Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects, Hepatology, 2007",cited-by,10.1002/hep.21791,Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects,"[['Martin', '', 'Schaefer'], ['Axel', '', 'Hinzpeter'], ['Ariane', '', 'Mohmand'], ['Gesa', '', 'Janssen'], ['Maurice', '', 'Pich'], ['Markus', '', 'Schwaiger'], ['Rahul', '', 'Sarkar'], ['Astrid', '', 'Friebe'], ['Andreas', '', 'Heinz'], ['Michael', '', 'Kluschke'], ['Marlene', '', 'Ziemer'], ['Juri', '', 'Gutsche'], ['Viola', '', 'Weich'], ['Juliane', '', 'Halangk'], ['Thomas', '', 'Berg']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21791'],
10.1016/S0140-6736(98)07124-4,"Jessner, W., Stauber, R., Hackl, F., et. al, Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00396.x,Early viral kinetics on treatment with pegylated interferon-alpha-2a in chronic hepatitis C virus genotype 1 infection,"[['W.', '', 'Jessner'], ['R.', '', 'Stauber'], ['F.', '', 'Hackl'], ['C.', '', 'Datz'], ['T.', '', 'Watkins-Riedel'], ['H.', '', 'Hofer'], ['A.', '', 'Gangl'], ['H.', '', 'Kessler'], ['P.', '', 'Ferenci']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00396.x'],
10.1016/S0140-6736(98)07124-4,"Beld, M., Sentjens, R., Rebers, S., et. al, Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS amplicor HCV monitor, version 2.0, assay, Gut, 2002",cited-by,"12015789Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS amplicor HCV monitor, version 2.0, assay","Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS amplicor HCV monitor, version 2.0, assay","[['Marcel', '', 'Beld'], ['R.', 'E. J. H.', 'Sentjens'], ['Sjoerd', '', 'Rebers'], ['Christine', '', 'Weegink'], ['Jan', '', 'Weel'], ['Cees', '', 'Sol'], ['Ren\xc3\xa9', '', 'Boom']]",Gut,2002,[u'http://jcm.asm.org/cgi/reprint/40/3/788.pdf'],
10.1016/S0140-6736(98)07124-4,"Fontaine, H., Nalpas, B., Poulet, B., et. al, Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C, Human Pathology, 2001",cited-by,10.1053/hupa.2001.28228,Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C,"[['H\xc3\xa9l\xc3\xa8ne', '', 'Fontaine'], ['Bertrand', '', 'Nalpas'], ['Bruno', '', 'Poulet'], ['Fran\xc3\xa7oise', '', 'Carnot'], ['Herv\xc3\xa9', '', 'Zylberberg'], ['Christian', '', 'Brechot'], ['Stanislas', '', 'Pol']]",Human Pathology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0046817701955509', u'http://linkinghub.elsevier.com/retrieve/pii/S0046817701955509']",
10.1016/S0140-6736(98)07124-4,"Fried, M., Shiffman, M., Sterling, R., et. al, A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotype, American Journal of Gastroenterology, 2000",cited-by,10.1111/j.1572-0241.2000.03433.x,"A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotype","[['Michael', 'W.', 'Fried'], ['Mitchell', '', 'Shiffman'], ['Richard', 'K.', 'Sterling'], ['Jeffrey', '', 'Weinstein'], ['Jeffrey', '', 'Crippin'], ['Gabriel', '', 'Garcia'], ['Teresa', 'L.', 'Wright'], ['Hari', '', 'Conjeevaram'], ['K.', 'Rajender', 'Reddy'], ['Joy', '', 'Peter'], ['George', 'A.', 'Cotsonis'], ['Frederick', 'S.', 'Nolte']]",American Journal of Gastroenterology,2000,"[u'http://dx.doi.org/10.1111/j.1572-0241.2000.03433.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2000.03433.x']",
10.1016/S0140-6736(98)07124-4,"Civeira, M., Prieto, J., , Early predictors of response to treatment in patients with chronic hepatitis C, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80409-7,Early predictors of response to treatment in patients with chronic hepatitis C,"[['Maria-Pilar', '', 'Civeira'], ['Jesus', '', 'Prieto']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899804097', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899804097']",
10.1016/S0140-6736(98)07124-4,"Missiha, S., Heathcote, J., Arenovich, T., et. al, Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C, American Journal of Gastroenterology, 2007",cited-by,10.1111/j.1572-0241.2007.01431.x,Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C,"[['Sharif', '', 'Missiha'], ['Jenny', '', 'Heathcote'], ['Tamara', '', 'Arenovich'], ['Kamran', '', 'Khan']]",American Journal of Gastroenterology,2007,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2007.01431.x', u'http://dx.doi.org/10.1111/j.1572-0241.2007.01431.x']",
10.1016/S0140-6736(98)07124-4,"Freeman, A., Marinos, G., Ffrench, R., et. al, Immunopathogenesis of hepatitis C virus infection, Immunology and Cell Biology, 2001",cited-by,10.1046/j.1440-1711.2001.01036.x,Immunopathogenesis of hepatitis C virus infection,"[['Anthony', 'J', 'Freeman'], ['George', '', 'Marinos'], ['Rosemary', 'A', 'Ffrench'], ['Andrew', 'R', 'Lloyd']]",Immunology and Cell Biology,2001,"[u'http://www.nature.com/doifinder/10.1046/j.1440-1711.2001.01036.x', u'http://dx.doi.org/10.1046/j.1440-1711.2001.01036.x']",
10.1016/S0140-6736(98)07124-4,"Soza, A., Everhart, J., Ghany, M., et. al, Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C, , 0",cited-by,11123846Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C,Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C,"[['Alejandro', '', 'Soza'], ['James', 'E.', 'Everhart'], ['Marc', 'G.', 'Ghany'], ['Edward', '', 'Doo'], ['Theo', '', 'Heller'], ['Kittichai', '', 'Promrat'], ['Yoon', '', 'Park'], ['T.', 'Jake', 'Liang'], ['Jay', 'H.', 'Hoofnagle']]",,0,"[u'http://www.hcvadvocate.org/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Neutropenia.pdf', u'https://www250.safesecureweb.com/hcvadvocate/hepatitis/About_Hepatitis_pdf/1.1_Hepatits_C/Neutropenia.pdf']",
10.1016/S0140-6736(98)07124-4,"Zeuzem, S., Berg, T., Moeller, B., et. al, Expert opinion on the treatment of patients with chronic hepatitis C, Journal of Viral Hepatitis, 2009",cited-by,10.1111/j.1365-2893.2008.01012.x,Expert opinion on the treatment of patients with chronic hepatitis C,"[['S.', '', 'Zeuzem'], ['T.', '', 'Berg'], ['B.', '', 'Moeller'], ['H.', '', 'Hinrichsen'], ['S.', '', 'Mauss'], ['H.', '', 'Wedemeyer'], ['C.', '', 'Sarrazin'], ['D.', '', 'Hueppe'], ['E.', '', 'Zehnter'], ['M.', 'P.', 'Manns']]",Journal of Viral Hepatitis,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2008.01012.x'],
10.1016/S0140-6736(98)07124-4,"Laperche, S., Lunel, F., Izopet, J., et. al, Comparison of Hepatitis C Virus NS5b and 5 Noncoding Gene Sequencing Methods in a Multicenter Study, , 2005",cited-by,6555003Comparison of Hepatitis C Virus NS5b and 5 Noncoding Gene Sequencing Methods in a Multicenter Study,Comparison of Hepatitis C Virus NS5b and 5 Noncoding Gene Sequencing Methods in a Multicenter Study,"[['Syria', '', 'Laperche'], ['Francoise', '', 'Lunel'], ['Jacques', '', 'Izopet'], ['Sophie', '', 'Alain'], ['Paul', '', 'Deny'], ['Gilles', '', 'Duverlie'], ['Catherine', '', 'Gaudy'], ['Jean-Michel', '', 'Pawlotsky'], ['Jean-Christophe', '', 'Plantier'], ['Bruno', '', 'Pozzetto'], ['Vincent', '', 'Thibault'], ['Francois', '', 'Tosetti'], ['Jean-Jacques', '', 'Lefrere']]",,2005,[u'http://jcm.asm.org/cgi/reprint/43/2/733.pdf'],
10.1016/S0140-6736(98)07124-4,"Buti, M., Medina, M., Casado, M., et. al, A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2003",cited-by,10.1046/j.1365-2036.2003.01453.x,A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C,"[['M.', '', 'Buti'], ['M.', '', 'Medina'], ['M.', 'A.', 'Casado'], ['J.', 'B.', 'Wong'], ['L.', '', 'Fosbrook'], ['R.', '', 'Esteban']]",Alimentary Pharmacology & Therapeutics,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2003.01453.x'],
10.1016/S0140-6736(98)07124-4,"Pawlotsky, J., , The nature of interferon-?? resistance in hepatitis C virus infection, Current Opinion in Infectious Diseases, 2003",cited-by,10.1097/00001432-200312000-00012,The nature of interferon-?? resistance in hepatitis C virus infection,"[['Jean-Michel', '', 'Pawlotsky']]",Current Opinion in Infectious Diseases,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001432-200312000-00012'],
10.1016/S0140-6736(98)07124-4,"Lin, O., Keeffe, E., , CURRENT TREATMENT STRATEGIES FOR CHRONIC HEPATITIS B AND C, Annual Review of Medicine, 2001",cited-by,10.1146/annurev.med.52.1.29,CURRENT TREATMENT STRATEGIES FOR CHRONIC HEPATITIS B AND C,"[['Otto', 'S.', 'Lin'], ['Emmet', 'B.', 'Keeffe']]",Annual Review of Medicine,2001,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.med.52.1.29'],
10.1016/S0140-6736(98)07124-4,"Neuman, M., Benhamou, J., Malkiewicz, I., et. al, Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C, Clinical Biochemistry, 2001",cited-by,10.1016/S0009-9120(01)00212-0,Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C,"[['Manuela', 'G.', 'Neuman'], ['Jean-Pierre', '', 'Benhamou'], ['Izabella', 'M.', 'Malkiewicz'], ['Raoudha', '', 'Akremi'], ['Neil', 'H.', 'Shear'], ['Tarik', '', 'Asselah'], ['Asma', '', 'Ibrahim'], ['Nathalie', '', 'Boyer'], ['Michelle', '', 'Martinot-Peignoux'], ['Pearl', '', 'Jacobson-Brown'], ['Gady', 'G.', 'Katz'], ['Veronique', 'Le', 'Breton'], ['Gaelle', 'Le', 'Guludec'], ['Ashima', '', 'Suneja'], ['Patrick', '', 'Marcellin']]",Clinical Biochemistry,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0009912001002120', u'http://linkinghub.elsevier.com/retrieve/pii/S0009912001002120']",
10.1016/S0140-6736(98)07124-4,", Treating Hepatitis C Virus Infection in Active Substance Users, Clinical Infectious Diseases, 2005",cited-by,10.1086/427447,Treating Hepatitis C Virus Infection in Active Substance Users,[],Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/427447'],
10.1016/S0140-6736(98)07124-4,"Sterling, R., Hofmann, C., Luketic, V., et. al, Treatment of Chronic Hepatitis C Virus in the Virginia Department of Corrections: Can Compliance Overcome Racial Differences to Response?, American Journal of Gastroenterology, 2004",cited-by,10.1111/j.1572-0241.2004.30310.x,Treatment of Chronic Hepatitis C Virus in the Virginia Department of Corrections: Can Compliance Overcome Racial Differences to Response?,"[['Richard', 'K.', 'Sterling'], ['Charlotte', 'M.', 'Hofmann'], ['Velimir', 'A.', 'Luketic'], ['Arun', 'J.', 'Sanyal'], ['Melissa', 'J.', 'Contos'], ['A.', 'Scott', 'Mills'], ['Mitchell', 'L.', 'Shiffman']]",American Journal of Gastroenterology,2004,"[u'http://dx.doi.org/10.1111/j.1572-0241.2004.30310.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2004.30310.x']",
10.1016/S0140-6736(98)07124-4,"Boyer, N., Castelnau, C., Akremi, R., et. al, A new step toward standardization of serum hepatitis C Virus-RNA quantification in patients with chronic hepatitis C, Hepatology, 2000",cited-by,10.1002/hep.510310324,A new step toward standardization of serum hepatitis C Virus-RNA quantification in patients with chronic hepatitis C,"[['Nathalie', '', 'Boyer'], ['Corinne', '', 'Castelnau'], ['Raoudha', '', 'Akremi'], ['Patrick', '', 'Marcellin']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310324'],
10.1056~NEJMoa011232,"McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.",references,10.1056/NEJM199811193392101,Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C,"[[u'John', u'G.', u'McHutchison'], [u'Stuart', u'C.', u'Gordon'], [u'Eugene', u'R.', u'Schiff'], [u'Mitchell', u'L.', u'Shiffman'], [u'William', u'M.', u'Lee'], [u'Vinod', u'K.', u'Rustgi'], [u'Zachary', u'D.', u'Goodman'], [u'Mei-Hsiu', u'', u'Ling'], [u'Susannah', u'', u'Cort'], [u'Janice', u'K.', u'Albrecht']]",New England Journal of Medicine,1998,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199811193392101'],"[{u'Name': u'Chronic Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5702}]"
10.1056/NEJM199811193392101,"Manns, M., McHutchison, J., Gordon, S., et. al, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, Lancet, 2001",cited-by,10.1016/S0140-6736(01)06102-5,Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial,"[['Michael', 'P', 'Manns'], ['John', 'G', 'McHutchison'], ['Stuart', 'C', 'Gordon'], ['Vinod', 'K', 'Rustgi'], ['Mitchell', '', 'Shiffman'], ['Robert', '', 'Reindollar'], ['Zachary', 'D', 'Goodman'], ['Kenneth', '', 'Koury'], ['Mei-Hsiu', '', 'Ling'], ['Janice', 'K', 'Albrecht']]",Lancet,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0140673601061025', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673601061025']",
10.1056/NEJM199811193392101,"Strader, D., Wright, T., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20119,"Diagnosis, management, and treatment of hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2004,"[u'http://www.natap.org/2004/pdf/AASLD_Prac._Guide_Hep_C.pdf', u'http://www.hiv.ch/rubriken/hep/US_GL_Hep_C.pdf', u'http://www.texasliver.com/docs/management%20of%20hepatitis%20c%203.pdf', u'http://doi.wiley.com/10.1002/hep.20119']",
10.1056/NEJM199811193392101,"Lai, C., Ratziu, V., Yuen, M., et. al, Viral hepatitis B, Lancet, 2003",cited-by,10.1016/S0140-6736(03)15108-2,Viral hepatitis B,"[['Ching', 'Lung', 'Lai'], ['Vlad', '', 'Ratziu'], ['Man-Fung', '', 'Yuen'], ['Thierry', '', 'Poynard']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603151082', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603151082', u'https://www.msu.edu/~rosenb98/MS3/Int Med/Viral Hepatitis B - Lancet.pdf', u'http://www.temple.edu/imreports/reading/gi - hepc.pdf', u'http://www.temple.edu/imreports/reading/gi - hepb.pdf']",
10.1056/NEJM199811193392101,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
10.1056/NEJM199811193392101,"Poynard, T., McHutchison, J., Manns, M., et. al, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 2002",cited-by,10.1053/gast.2002.33023,Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C,"[['Thierry', '', 'Poynard'], ['John', '', 'McHutchison'], ['Michael', '', 'Manns'], ['Christian', '', 'Trepo'], ['Karen', '', 'Lindsay'], ['Zachary', '', 'Goodman'], ['Mei-Hsiu', '', 'Ling'], ['Janice', '', 'Albrecht']]",Gastroenterology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S001650850234959X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850234959X']",
10.1056/NEJM199811193392101,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1056/NEJM199811193392101,"Scarselli, E., Ansuini, H., Cerino, R., et. al, The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, Embo Journal, 2002",cited-by,10.1093/emboj/cdf529,The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus,"[['Elisa', '', 'Scarselli'], ['Helenia', '', 'Ansuini'], ['Raffaele', '', 'Cerino'], ['Rosa', 'Maria', 'Roccasecca'], ['Stefano', '', 'Acali'], ['Gessica', '', 'Filocamo'], ['Cinzia', '', 'Traboni'], ['Alfredo', '', 'Nicosia'], ['Riccardo', '', 'Cortese'], ['Alessandra', '', 'Vitelli']]",Embo Journal,2002,[u'http://www.nature.com/doifinder/10.1093/emboj/cdf529'],
10.1056/NEJM199811193392101,"Sherman, K., Rouster, S., Chung, R., et. al, Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross‐Sectional Analysis of the US Adult AIDS Clinical Trials Group, Clinical Infectious Diseases, 2002",cited-by,10.1086/339042,Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross‐Sectional Analysis of the US Adult AIDS Clinical Trials Group,"[['Kenneth', 'E.', 'Sherman'], ['Susan', 'D.', 'Rouster'], ['Raymond', 'T.', 'Chung'], ['Natasa', '', 'Rajicic']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/339042'],
10.1056/NEJM199811193392101,"Fried, M., , Side effects of therapy of hepatitis C and their management, Hepatology, 2002",cited-by,10.1053/jhep.2002.36810,Side effects of therapy of hepatitis C and their management,"[['Michael', 'W.', 'Fried']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Side%20Effects%20Of%20Therapy%20Of%20Hepatitis%20C%20And%20Their%20Management.pdf', u'http://doi.wiley.com/10.1002/hep.1840360730', u'http://doi.wiley.com/10.1053/jhep.2002.36810']",
10.1056/NEJM199811193392101,"SHIFFMAN, M., BISCEGLIE, A., LINDSAY, K., et. al, Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Who Have Failed Prior Treatment, , 2004",cited-by,6221205Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Who Have Failed Prior Treatment,Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Who Have Failed Prior Treatment,"[['MITCHELL', 'L.', 'SHIFFMAN'], ['ADRIAN', 'M. DI', 'BISCEGLIE'], ['KAREN', 'L.', 'LINDSAY'], ['CHIHIRO', '', 'MORISHIMA'], ['ELIZABETH', 'C.', 'WRIGHT'], ['GREGORY', 'T.', 'EVERSON'], ['ANNA', 'S.', 'LOK'], ['TIMOTHY', 'R.', 'MORGAN'], ['HERBERT', 'L.', 'BONKOVSKY'], ['WILLIAM', 'M.', 'LEE'], ['JULES', 'L.', 'DIENSTAG'], ['MARC', 'G.', 'GHANY'], ['ZACHARY', 'D.', 'GOODMAN'], ['JAMES', 'E.', 'EVERHART']]",,2004,[u'http://gidiv.ucsf.edu/course/things/Shiffman.pdf'],
10.1056/NEJM199811193392101,"Berg, T., Wagner, M., Nasser, S., et. al, Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.02.015,Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin,"[['Thomas', '', 'Berg'], ['Michael', 'von', 'Wagner'], ['Samer', '', 'Nasser'], ['Christoph', '', 'Sarrazin'], ['Tobias', '', 'Heintges'], ['Tilman', '', 'Gerlach'], ['Peter', '', 'Buggisch'], ['Tobias', '', 'Goeser'], ['Jens', '', 'Rasenack'], ['Gerd', 'R.', 'Pape'], ['Wolfgang', 'E.', 'Schmidt'], ['Birgit', '', 'Kallinowski'], ['Hartwig', '', 'Klinker'], ['Ulrich', '', 'Spengler'], ['Peter', '', 'Martus'], ['Ulrich', '', 'Alshuth'], ['Stefan', '', 'Zeuzem']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506002770', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506002770']",
10.1056/NEJM199811193392101,"Nelson, D., Lauwers, G., Lau, J., et. al, Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders, Gastroenterology, 2000",cited-by,10.1016/S0016-5085(00)70134-X,Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders,"[['David', 'R.', 'Nelson'], ['Gregory', 'Y.', 'Lauwers'], ['Johnson', 'Y. N.', 'Lau'], ['Gary', 'L.', 'Davis']]",Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S001650850070134X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850070134X']",
10.1056/NEJM199811193392101,"Dienstag, J., McHutchison, J., , American Gastroenterological Association Technical Review on the Management of Hepatitis C, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2005.11.010,American Gastroenterological Association Technical Review on the Management of Hepatitis C,"[['Jules', 'L.', 'Dienstag'], ['John', 'G.', 'McHutchison']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505022705', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505022705']",
10.1056/NEJM199811193392101,"Poynard, T., McHutchison, J., Goodman, Z., et. al, Is an ?� la carte? combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?, Hepatology, 2000",cited-by,10.1002/hep.510310131,Is an ?� la carte? combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?,"[['Thierry', '', 'Poynard'], ['John', '', 'McHutchison'], ['Zachary', '', 'Goodman'], ['Mei-Hsiu', '', 'Ling'], ['Janice', '', 'Albrecht']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310131'],
10.1056/NEJM199811193392101,"Hauser, P., Khosla, J., Aurora, H., et. al, A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C, Molecular Psychiatry, 2002",cited-by,10.1038/sj.mp.4001119,A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C,"[['P', '', 'Hauser'], ['J', '', 'Khosla'], ['H', '', 'Aurora'], ['J', '', 'Laurin'], ['M', 'A', 'Kling'], ['J', '', 'Hill'], ['M', '', 'Gulati'], ['A', 'J', 'Thornton'], ['R', 'L', 'Schultz'], ['A', 'D', 'Valentine'], ['C', 'A', 'Meyers'], ['C', 'D', 'Howell']]",Molecular Psychiatry,2002,"[u'http://dx.doi.org/10.1038/sj.mp.4001119', u'http://www.nature.com/doifinder/10.1038/sj.mp.4001119']",
10.1056/NEJM199811193392101,"Li, D., Friedman, S., , Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy, Journal of Gastroenterology and Hepatology, 1999",cited-by,10.1046/j.1440-1746.1999.01928.x,Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy,"[['Dan', '', 'Li'], ['Scott', '', 'Friedman']]",Journal of Gastroenterology and Hepatology,1999,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1440-1746.1999.01928.x'],
10.1056/NEJM199811193392101,"Bailon, P., Palleroni, A., Schaffer, C., et. al, Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C, Bioconjugate Chemistry, 2001",cited-by,10.1021/bc000082g,"Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C","[['Pascal', '', 'Bailon'], ['Alicia', '', 'Palleroni'], ['Carol', 'A.', 'Schaffer'], ['Cheryl', 'L.', 'Spence'], ['Wen-Jian', '', 'Fung'], ['Jill', 'E.', 'Porter'], ['George', 'K.', 'Ehrlich'], ['Wen', '', 'Pan'], ['Zhi-Xin', '', 'Xu'], ['Marlene', 'W.', 'Modi'], ['Adrienne', '', 'Farid'], ['Wolfgang', '', 'Berthold'], ['Mary', '', 'Graves']]",Bioconjugate Chemistry,2001,"[u'http://www.ibms.sinica.edu.tw/~sroff/anti-PEG/bailon2001.pdf', u'http://www.ibms.sinica.edu.tw/~sroff/sr_pdf/bailon2001.pdf', u'http://pubs.acs.org/doi/abs/10.1021/bc000082g']",
10.1056/NEJM199811193392101,"Poynard, T., Yuen, M., Ratzin, V., et. al, Viral hepatitis C, Lancet, 2003",cited-by,10.1016/S0140-6736(03)15109-4,Viral hepatitis C,"[['Thierry', '', 'Poynard'], ['Man-Fung', '', 'Yuen'], ['Vlad', '', 'Ratzin'], ['Ching', 'Lung', 'Lai']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603151094', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603151094']",
10.1056/NEJM199811193392101,", Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, 2000",cited-by,10.1086/313842,Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus,[],Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313842'],
10.1056/NEJM199811193392101,"Davis, G., , Monitoring of viral levels during therapy of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36798,Monitoring of viral levels during therapy of hepatitis C,"[['Gary', 'L.', 'Davis']]",Hepatology,2002,"[u'http://doi.wiley.com/10.1053/jhep.2002.36798', u'http://doi.wiley.com/10.1002/hep.1840360719']",
10.1056/NEJM199811193392101,"Dixit, N., Layden-Almer, J., Layden, T., et. al, Modelling how ribavirin improves interferon response rates in hepatitis C virus infection, Nature, 2005",cited-by,10.1038/nature03153,Modelling how ribavirin improves interferon response rates in hepatitis C virus infection,"[['Narendra', 'M.', 'Dixit'], ['Jennifer', 'E.', 'Layden-Almer'], ['Thomas', 'J.', 'Layden'], ['Alan', 'S.', 'Perelson']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature03153', u'http://dx.doi.org/10.1038/nature03153']",
10.1056/NEJM199811193392101,"Tan, S., Katze, M., , How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A, Virology, 2001",cited-by,10.1006/viro.2001.0885,How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A,"[['Seng-Lai', '', 'Tan'], ['Michael', 'G.', 'Katze']]",Virology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0042682201908852', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682201908852']",
10.1056/NEJM199811193392101,"Zdilar, D., Franco-Bronson, K., Buchler, N., et. al, Hepatitis C, interferon alfa, and depression, Hepatology, 2000",cited-by,10.1053/jhep.2000.7880,"Hepatitis C, interferon alfa, and depression","[['Darko', '', 'Zdilar'], ['Kathleen', '', 'Franco-Bronson'], ['Nancy', '', 'Buchler'], ['Joseph', 'A.', 'Locala'], ['Zobair', 'M.', 'Younossi']]",Hepatology,2000,"[u'http://www.hcvu.org/mlib/2007_03_15-Zdilar-HCV_and_Depression.pdf', u'http://doi.wiley.com/10.1053/jhep.2000.7880']",
10.1056/NEJM199811193392101,"Pawlotsky, J., Dahari, H., Neumann, A., et. al, Antiviral action of ribavirin in chronic hepatitis C, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2003.12.002,Antiviral action of ribavirin in chronic hepatitis C,"[['Jean-Michel', '', 'Pawlotsky'], ['Harel', '', 'Dahari'], ['Avidan', 'U.', 'Neumann'], ['Christophe', '', 'Hezode'], ['Georgios', '', 'Germanidis'], ['Isabelle', '', 'Lonjon'], ['Laurent', '', 'Castera'], ['Daniel', '', 'Dhumeaux']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503020158', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503020158']",
10.1056/NEJM199811193392101,"Zeuzem, S., Hultcrantz, R., Bourliere, M., et. al, Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3q,qq, , 2004",cited-by,"7021226Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3q,qq","Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3q,qq","[['Stefan', '', 'Zeuzem'], ['Rolf', '', 'Hultcrantz'], ['Marc', '', 'Bourliere'], ['Tobias', '', 'Goeser'], ['Patrick', '', 'Marcellin'], ['Jose', '', 'Sanchez-Tapias'], ['Christoph', '', 'Sarrazin'], ['Joann', '', 'Harvey'], ['Clifford', '', 'Brass'], ['Janice', '', 'Albrecht']]",,2004,[u'http://www.higadocolombia.org/admin/archivos/revistas/articulos/imagen_1.pdf'],
10.1056/NEJM199811193392101,"Pawlotsky, J., , Hepatitis C virus genetic variability: pathogenic and clinical implications, Clinics in Liver Disease, 2003",cited-by,10.1016/S1089-3261(02)00065-X,Hepatitis C virus genetic variability: pathogenic and clinical implications,"[['Jean-Michel', '', 'Pawlotsky']]",Clinics in Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S108932610200065X', u'http://linkinghub.elsevier.com/retrieve/pii/S108932610200065X']",
10.1056/NEJM199811193392101,"Shoukry, N., Cawthon, A., Walker, C., , CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION, Annual Review of Microbiology, 2004",cited-by,10.1146/annurev.micro.58.030603.123836,CELL-MEDIATED IMMUNITY AND THE OUTCOME OF HEPATITIS C VIRUS INFECTION,"[['Naglaa', 'H.', 'Shoukry'], ['Andrew', 'G.', 'Cawthon'], ['Christopher', 'M.', 'Walker']]",Annual Review of Microbiology,2004,[u'http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.micro.58.030603.123836'],
10.1056/NEJM199811193392101,"Sabile, A., Perlemuter, G., Bono, F., et. al, Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates, Hepatology, 1999",cited-by,10.1002/hep.510300429,Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates,"[['Abdelmajid', '', 'Sabile'], ['Gabriel', '', 'Perlemuter'], ['Fulvia', '', 'Bono'], ['Kyoko', '', 'Kohara'], ['Michinori', '', 'Kohara'], ['Yoshiharu', '', 'Matsuura'], ['Tatsuo', '', 'Miyamura'], ['Giovanna', '', 'Barba']]",Hepatology,1999,[u'http://doi.wiley.com/10.1002/hep.510300429'],
10.1056/NEJM199811193392101,"Dore, G., Law, M., MacDonald, M., et. al, Epidemiology of hepatitis C virus infection in Australia, Journal of Clinical Virology, 2003",cited-by,10.1016/S1386-6532(02)00116-6,Epidemiology of hepatitis C virus infection in Australia,"[['Gregory', 'J', 'Dore'], ['Matthew', '', 'Law'], ['Margaret', '', 'MacDonald'], ['John', 'M', 'Kaldor']]",Journal of Clinical Virology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1386653202001166', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001166']",
10.1056/NEJM199811193392101,"Dieterich, D., Wasserman, R., Bräu, N., et. al, Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus–infected patients receiving ribavirin plus interferon alfa, American Journal of Gastroenterology, 2003",cited-by,10.1016/j.amjgastroenterol.2003.08.006,Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus–infected patients receiving ribavirin plus interferon alfa,"[['Douglas', 'T', 'Dieterich'], ['Ronald', '', 'Wasserman'], ['Norbert', '', 'Br\xc3\xa4u'], ['Tarek', 'I', 'Hassanein'], ['Edmund', 'J', 'Bini'], ['Peter', 'J', 'Bowers'], ['Mark', 'S', 'Sulkowski']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003017878', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003017878']",
10.1056/NEJM199811193392101,"PAWLOTSKY, J., , Hepatitis C Virus Resistance to Antiviral Therapy, , 2000",cited-by,6316395Hepatitis C Virus Resistance to Antiviral Therapy,Hepatitis C Virus Resistance to Antiviral Therapy,"[['JEAN-MICHEL', '', 'PAWLOTSKY']]",,2000,"[u'http://hepatitis-central.com/hcv/ifn/resistance/hepatitiscentralresistance.pdf', u'http://www.hepatitis-central.com/hcv/ifn/resistance/hepatitiscentralresistance.pdf', u'http://www.heart-intl.net/HEART/Hepatitis/Comp/HCV-resistanttheropy.pdf']",
10.1056/NEJM199811193392101,"Wang, Y., Youngster, S., Grace, M., et. al, Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications, Advanced Drug Delivery Reviews, 2002",cited-by,10.1016/S0169-409X(02)00027-3,Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications,"[['Yu-Sen', '', 'Wang'], ['Stephen', '', 'Youngster'], ['Michael', '', 'Grace'], ['James', '', 'Bausch'], ['Ronald', '', 'Bordens'], ['Daniel', 'F.', 'Wyss']]",Advanced Drug Delivery Reviews,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0169409X02000273', u'http://linkinghub.elsevier.com/retrieve/pii/S0169409X02000273']",
10.1056/NEJM199811193392101,"Thomas, D., , Hepatitis C and human immunodeficiency virus infection, Hepatology, 2002",cited-by,10.1053/jhep.2002.36380,Hepatitis C and human immunodeficiency virus infection,"[['David', 'L.', 'Thomas']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Hepatitis%20C%20And%20Human%20Immunodeficiency%20Virus%20Infection.pdf', u'http://doi.wiley.com/10.1002/hep.1840360726', u'http://doi.wiley.com/10.1053/jhep.2002.36380']",
10.1056/NEJM199811193392101,"Pawlotsky, J., , Therapy of hepatitis C: From empiricism to eradication, Hepatology, 2006",cited-by,10.1002/hep.21064,Therapy of hepatitis C: From empiricism to eradication,"[['Jean-Michel', '', 'Pawlotsky']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21064'],
10.1056/NEJM199811193392101,"Jacobson, I., Brown, R., Freilich, B., et. al, Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial, Hepatology, 2007",cited-by,10.1002/hep.21932,Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial,"[['Ira', 'M.', 'Jacobson'], ['Robert', 'S.', 'Brown'], ['Bradley', '', 'Freilich'], ['Nezam', '', 'Afdhal'], ['Paul', 'Y.', 'Kwo'], ['John', '', 'Santoro'], ['Scott', '', 'Becker'], ['Adil', 'E.', 'Wakil'], ['David', '', 'Pound'], ['Eliot', '', 'Godofsky'], ['Robert', '', 'Strauss'], ['David', '', 'Bernstein'], ['Steven', '', 'Flamm'], ['Mary', 'Pat', 'Pauly'], ['Pabak', '', 'Mukhopadhyay'], ['Louis', 'H.', 'Griffel'], ['Clifford', 'A.', 'Brass']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21932'],
10.1056/NEJM199811193392101,"Shiffman, M., Ghany, M., Morgan, T., et. al, Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C, Gastroenterology, 2007",cited-by,10.1053/j.gastro.2006.11.011,Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C,"[['Mitchell', 'L.', 'Shiffman'], ['Marc', 'G.', 'Ghany'], ['Timothy', 'R.', 'Morgan'], ['Elizabeth', 'C.', 'Wright'], ['Gregory', 'T.', 'Everson'], ['Karen', 'L.', 'Lindsay'], ['Anna', 'S. F.', 'Lok'], ['Herbert', 'L.', 'Bonkovsky'], ['Adrian', 'M. Di', 'Bisceglie'], ['William', 'M.', 'Lee'], ['Jules', 'L.', 'Dienstag'], ['David', 'R.', 'Gretch']]",Gastroenterology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506024668', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506024668']",
10.1056/NEJM199811193392101,"Schalm, S., Weiland, O., Hansen, B., et. al, Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials, Gastroenterology, 1999",cited-by,10.1053/gast.1999.0029900408,Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials,"[['Solko', 'W.', 'Schalm'], ['Ola', '', 'Weiland'], ['Bettina', 'E.', 'Hansen'], ['Michele', '', 'Milella'], ['Ming', 'Y.', 'Lai'], ['Anna', '', 'Hollander'], ['Peter', 'P.', 'Michielsen'], ['Antonio', '', 'Bellobuono'], ['Liliana', '', 'Chemello'], ['Giuseppe', '', 'Pastore'], ['Johannes', 'T.', 'Brouwer']]",Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S001650859900164X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650859900164X']",
10.1056/NEJM199811193392101,"Bruchfeld, A., Stahle, L., Andersson, J., et. al, Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00300.x,Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study,"[['A.', '', 'Bruchfeld'], ['L.', '', 'Stahle'], ['J.', '', 'Andersson'], ['R.', '', 'Schvarcz']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00300.x'],
10.1056/NEJM199811193392101,"Nousbaum, J., Polyak, S., Ray, S., et. al, Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy, Journal of Virology, 2000",cited-by,10.1128/JVI.74.19.9028-9038.2000,Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy,"[['J.-B.', '', 'Nousbaum'], ['S.', 'J.', 'Polyak'], ['S.', 'C.', 'Ray'], ['D.', 'G.', 'Sullivan'], ['A.', 'M.', 'Larson'], ['R.', 'L.', 'Carithers'], ['D.', 'R.', 'Gretch']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.19.9028-9038.2000', u'http://jvi.asm.org/cgi/reprint/74/19/9028.pdf']",
10.1056/NEJM199811193392101,"Yanagi, M., Purcell, R., Emerson, S., et. al, Hepatitis C Virus: An Infectious Molecular Clone of a Second Major Genotype (2a) and Lack of Viability of Intertypic 1a and 2a Chimeras, Virology, 1999",cited-by,10.1006/viro.1999.9889,Hepatitis C Virus: An Infectious Molecular Clone of a Second Major Genotype (2a) and Lack of Viability of Intertypic 1a and 2a Chimeras,"[['Masayuki', '', 'Yanagi'], ['Robert', 'H.', 'Purcell'], ['Suzanne', 'U.', 'Emerson'], ['Jens', '', 'Bukh']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299998896', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299998896']",
10.1056/NEJM199811193392101,"Lee, S., Heathcote, E., Reddy, K., et. al, Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD), Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00211-8,Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD),"[['Samuel', 'S', 'Lee'], ['E.', 'Jenny', 'Heathcote'], ['K.', 'Rajender', 'Reddy'], ['Stefan', '', 'Zeuzem'], ['Michael', 'W', 'Fried'], ['Teresa', 'L', 'Wright'], ['Paul', 'J', 'Pockros'], ['Dieter', '', 'H\xc3\xa4ussinger'], ['Coleman', 'I', 'Smith'], ['Amy', '', 'Lin'], ['Stephen', 'C', 'Pappas']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802002118', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802002118']",
10.1056/NEJM199811193392101,"Foster, G., Rockstroh, J., Zeuzem, S., et. al, The way forward in HCV treatment — finding the right path, Nature Reviews Drug Discovery, 2007",cited-by,10.1038/nrd2411,The way forward in HCV treatment — finding the right path,"[['Graham', 'R.', 'Foster'], ['J\xc3\xbcrgen', 'K.', 'Rockstroh'], ['Stefan', '', 'Zeuzem'], ['Fabien', '', 'Zoulim'], ['Michael', '', 'Houghton'], ['Michael', 'P.', 'Manns']]",Nature Reviews Drug Discovery,2007,"[u'http://dx.doi.org/10.1038/nrd2411', u'http://www.nature.com/doifinder/10.1038/nrd2411']",
10.1056/NEJM199811193392101,"Fontana, R., Israel, J., LeClair, P., et. al, Iron reduction before and during interferon therapy of chronic hepatitis�C: Results of a multicenter, randomized, controlled trial, Hepatology, 2000",cited-by,10.1002/hep.510310325,"Iron reduction before and during interferon therapy of chronic hepatitis�C: Results of a multicenter, randomized, controlled trial","[['Robert', 'J.', 'Fontana'], ['Jonathan', '', 'Israel'], ['Paula', '', 'LeClair'], ['Barbara', 'F.', 'Banner'], ['Kristina', '', 'Tortorelli'], ['Norman', '', 'Grace'], ['Robert', 'A.', 'Levine'], ['Gale', '', 'Fiarman'], ['Michael', '', 'Thiim'], ['Anthony', 'S.', 'Tavill'], ['Herbert', 'L.', 'Bonkovsky']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310325'],
10.1056/NEJM199811193392101,"Jen, J., Glue, P., Gupta, S., et. al, Population Pharmacokinetic and Pharmacodynamic Analysis of Ribavirin in Patients With Chronic Hepatitis C, Therapeutic Drug Monitoring, 2000",cited-by,10.1097/00007691-200010000-00010,Population Pharmacokinetic and Pharmacodynamic Analysis of Ribavirin in Patients With Chronic Hepatitis C,"[['J.', 'Frank', 'Jen'], ['Paul', '', 'Glue'], ['Samir', '', 'Gupta'], ['Demetris', '', 'Zambas'], ['Gerald', '', 'Hajian']]",Therapeutic Drug Monitoring,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007691-200010000-00010'],
10.1056/NEJM199811193392101,"BACKMUND, M., MEYER, K., ZIELONKA, M., et. al, Treatment of Hepatitis C Infection in Injection Drug Users, , 0",cited-by,12082892Treatment of Hepatitis C Infection in Injection Drug Users,Treatment of Hepatitis C Infection in Injection Drug Users,"[['MARKUS', '', 'BACKMUND'], ['K', 'IRSTEN', 'MEYER'], ['M', 'ICHAEL VON', 'ZIELONKA'], ['DIETER', '', 'EICHENLAUB']]",,0,"[u'http://www.hcvu.org/mlib/2007_03_15-Backmund.pdf', u'http://hepcproject.typepad.com/hep_c_project/hepidu.pdf']",
10.1056/NEJM199811193392101,"Pawlotsky, J., , Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C, Antiviral Research, 2003",cited-by,10.1016/S0166-3542(03)00088-3,Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C,"[['Jean-Michel', '', 'Pawlotsky']]",Antiviral Research,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0166354203000883', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354203000883']",
10.1056/NEJM199811193392101,"LEYSSEN, P., CLERCQ, E., NEYTS, J., , Perspectives for the Treatment of Infections with Flaviviridae, Clinical Microbiology Reviews, 2000",cited-by,10.1128/CMR.13.1.67-82.2000,Perspectives for the Treatment of Infections with Flaviviridae,"[['PIETER', '', 'LEYSSEN'], ['ERIK', 'DE', 'CLERCQ'], ['JOHAN', '', 'NEYTS']]",Clinical Microbiology Reviews,2000,"[u'http://cmr.asm.org/cgi/doi/10.1128/CMR.13.1.67-82.2000', u'http://cmr.asm.org/cgi/reprint/13/1/67.pdf']",
10.1056/NEJM199811193392101,"Reddy, K., Shiffman, M., Morgan, T., et. al, Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment, Clinical Gastroenterology and Hepatology, 2007",cited-by,10.1016/j.cgh.2006.10.008,Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment,"[['K.', 'Rajender', 'Reddy'], ['Mitchell', 'L.', 'Shiffman'], ['Timothy', 'R.', 'Morgan'], ['Stefan', '', 'Zeuzem'], ['Stephanos', '', 'Hadziyannis'], ['Fayez', 'M.', 'Hamzeh'], ['Teresa', 'L.', 'Wright'], ['Michael', '', 'Fried']]",Clinical Gastroenterology and Hepatology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1542356506010469', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356506010469']",
10.1056/NEJM199811193392101,"Yi, M., Lemon, S., , 3' Nontranslated RNA Signals Required for Replication of Hepatitis C Virus RNA, Journal of Virology, 2003",cited-by,10.1128/JVI.77.6.3557-3568.2003,3' Nontranslated RNA Signals Required for Replication of Hepatitis C Virus RNA,"[['MinKyung', '', 'Yi'], ['Stanley', 'M.', 'Lemon']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/6/3557.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.6.3557-3568.2003']",
10.1056/NEJM199811193392101,"Russo, M., Goldsweig, C., Jacobson, I., et. al, Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety, American Journal of Gastroenterology, 2003",cited-by,10.1016/S0002-9270(03)00308-3,Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety,"[['Mark', 'W', 'Russo'], ['Craig', 'D', 'Goldsweig'], ['Ira', 'M', 'Jacobson'], ['Robert', 'S', 'Brown']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003003083', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003003083']",
10.1056/NEJM199811193392101,"Lavezzo, B., Franchello, A., Smedile, A., et. al, Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00109-5,Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin,"[['Bruna', '', 'Lavezzo'], ['Alessandro', '', 'Franchello'], ['Antonella', '', 'Smedile'], ['Ezio', '', 'David'], ['Anna', '', 'Barbui'], ['Maria', '', 'Torrani'], ['Antonio', '', 'Ottobrelli'], ['Fausto', '', 'Zamboni'], ['Maurizio', '', 'Fadda'], ['Adriana', '', 'Bobbio'], ['Mauro', '', 'Salizzoni'], ['Mario', '', 'Rizzetto']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802001095', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802001095']",
10.1056/NEJM199811193392101,"Kraus, M., Schafer, A., Faller, H., et. al, Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2002",cited-by,10.1046/j.1365-2036.2002.01265.x,Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C,"[['M.', 'R.', 'Kraus'], ['A.', '', 'Schafer'], ['H.', '', 'Faller'], ['H.', '', 'Csef'], ['M.', '', 'Scheurlen']]",Alimentary Pharmacology & Therapeutics,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2002.01265.x'],
10.1056/NEJM199811193392101,"Macejak, D., Jensen, K., Jamison, S., et. al, Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes, Hepatology, 2000",cited-by,10.1002/hep.510310331,Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes,"[['Dennis', 'G.', 'Macejak'], ['Kristi', 'L.', 'Jensen'], ['Sharon', 'F.', 'Jamison'], ['Kristal', '', 'Domenico'], ['Elisabeth', 'C.', 'Roberts'], ['Nilabh', '', 'Chaudhary'], ['Ira', 'von', 'Carlowitz'], ['Laurent', '', 'Bellon'], ['Myron', 'J.', 'Tong'], ['Andrew', '', 'Conrad'], ['Pamela', 'A.', 'Pavco'], ['Lawrence', 'M.', 'Blatt']]",Hepatology,2000,[u'http://doi.wiley.com/10.1002/hep.510310331'],
10.1056/NEJM199811193392101,"Cheung, R., , Epidemiology of hepatitis C virus infection in American veterans, American Journal of Gastroenterology, 2000",cited-by,10.1111/j.1572-0241.2000.01854.x,Epidemiology of hepatitis C virus infection in American veterans,"[['Ramsey', 'C.', 'Cheung']]",American Journal of Gastroenterology,2000,"[u'http://dx.doi.org/10.1111/j.1572-0241.2000.01854.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2000.01854.x']",
10.1056/NEJM199811193392101,"Shiffman, M., Salvatore, J., Hubbard, S., et. al, Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha, Hepatology, 2007",cited-by,10.1002/hep.21712,"Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha","[['Mitchell', 'L.', 'Shiffman'], ['Jennifer', '', 'Salvatore'], ['Sarah', '', 'Hubbard'], ['Angie', '', 'Price'], ['Richard', 'K.', 'Sterling'], ['R.', 'Todd', 'Stravitz'], ['Velimir', 'A.', 'Luketic'], ['Arun', 'J.', 'Sanyal']]",Hepatology,2007,[u'http://doi.wiley.com/10.1002/hep.21712'],
10.1056/NEJM199811193392101,"Mazzaferro, V., Romito, R., Schiavo, M., et. al, Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis, Hepatology, 2006",cited-by,10.1002/hep.21415,Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis,"[['Vincenzo', '', 'Mazzaferro'], ['Raffaele', '', 'Romito'], ['Marcello', '', 'Schiavo'], ['Luigi', '', 'Mariani'], ['Tiziana', '', 'Camerini'], ['Sherrie', '', 'Bhoori'], ['Lorenzo', '', 'Capussotti'], ['Fulvio', '', 'Calise'], ['Riccardo', '', 'Pellicci'], ['Giulio', '', 'Belli'], ['Alessandro', '', 'Tagger'], ['Massimo', '', 'Colombo'], ['Ferruccio', '', 'Bonino'], ['Pietro', '', 'Majno'], ['Josep', 'M.', 'Llovet']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21415'],
10.1056/NEJM199811193392101,"Jain, S., Pemberton, P., Smith, A., et. al, Oxidative stress in chronic hepatitis C: not just a feature of late stage disease, Journal of Hepatology, 2002",cited-by,10.1016/S0168-8278(02)00060-0,Oxidative stress in chronic hepatitis C: not just a feature of late stage disease,"[['Sanjiv', 'K.', 'Jain'], ['Philip', 'W.', 'Pemberton'], ['Alexander', '', 'Smith'], ['Raymond', 'F. T.', 'McMahon'], ['Peter', 'C.', 'Burrows'], ['Ali', '', 'Aboutwerat'], ['Thomas', 'W.', 'Warnes']]",Journal of Hepatology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0168827802000600', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827802000600']",
10.1056/NEJM199811193392101,"Wiley, T., Brown, J., Chan, J., , Hepatitis C infection in African Americans: its natural history and histological progression, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05555.x,Hepatitis C infection in African Americans: its natural history and histological progression,"[['Thelma', 'E.', 'Wiley'], ['Jennifer', '', 'Brown'], ['Juliana', '', 'Chan']]",American Journal of Gastroenterology,2002,"[u'http://dx.doi.org/10.1111/j.1572-0241.2002.05555.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05555.x']",
10.1056/NEJM199811193392101,"Doyle, S., Schreckhise, H., Khuu-Duong, K., et. al, Interleukin29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes, Hepatology, 2006",cited-by,10.1002/hep.21312,Interleukin29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes,"[['Sean', 'E.', 'Doyle'], ['Heidi', '', 'Schreckhise'], ['Kien', '', 'Khuu-Duong'], ['Katherine', '', 'Henderson'], ['Robert', '', 'Rosler'], ['Harold', '', 'Storey'], ['Lena', '', 'Yao'], ['Hong', '', 'Liu'], ['Fariba', '', 'Barahmand-pour'], ['Pallavur', '', 'Sivakumar'], ['Chung', '', 'Chan'], ['Carl', '', 'Birks'], ['Don', '', 'Foster'], ['Christopher', 'H.', 'Clegg'], ['Perdita', '', 'Wietzke-Braun'], ['Sabine', '', 'Mihm'], ['Kevin', 'M.', 'Klucher']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21312'],
10.1056/NEJM199811193392101,"Dalgard, O., Bjøro, K., Hellum, K., et. al, Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up, European Addiction Research, 2002",cited-by,10.1159/000049487,Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up,"[['O.', '', 'Dalgard'], ['K.', '', 'Bj\xc3\xb8ro'], ['K.', '', 'Hellum'], ['B.', '', 'Myrvang'], ['K.', '', 'Skaug'], ['B.', '', 'Gutigard'], ['H.', '', 'Bell']]",European Addiction Research,2002,"[u'http://www.karger.com/doi/10.1159/000049487', u'http://www.online.karger.com/doi/10.1159/000049487']",
10.1056/NEJM199811193392101,"Fabrizi, F., Dulai, G., Dixit, V., et. al, Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients, Alimentary Pharmacology & Therapeutics, 2003",cited-by,10.1046/j.1365-2036.2003.01780.x,Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients,"[['F.', '', 'Fabrizi'], ['G.', '', 'Dulai'], ['V.', '', 'Dixit'], ['S.', '', 'Bunnapradist'], ['P.', '', 'Martin']]",Alimentary Pharmacology & Therapeutics,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2003.01780.x'],
10.1056/NEJM199811193392101,"Snydman, D., , Infection in solid organ transplantation, Transplant Infectious Disease, 1999",cited-by,10.1034/j.1399-3062.1999.10103.x,Infection in solid organ transplantation,"[['D.', 'R.', 'Snydman']]",Transplant Infectious Disease,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1399-3062.1999.10103.x'],
10.1056/NEJM199811193392101,"Ouzan, D., Asselah, T., Desmorat, H., et. al, Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.07.022,Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin,"[['Denis', '', 'Ouzan'], ['Tarik', '', 'Asselah'], ['Herv\xc3\xa9', '', 'Desmorat'], ['Juliette', '', 'Foucher'], ['Marc', '', 'Bourli\xc3\xa8re'], ['Christophe', '', 'Renou'], ['Albert', '', 'Tran'], ['Pascal', '', 'Melin'], ['Christophe', '', 'H\xc3\xa9zode'], ['Michelle', '', 'Chevalier'], ['St\xc3\xa9phane', '', 'Chevaliez'], ['Fran\xc3\xa7ois', '', 'Montestruc']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506016659', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506016659']",
10.1056/NEJM199811193392101,"Castet, V., Fournier, C., Soulier, A., et. al, Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, 2002",cited-by,10.1128/JVI.76.16.8189-8199.2002,Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro,"[['Valerie', '', 'Castet'], ['Chantal', '', 'Fournier'], ['Alexandre', '', 'Soulier'], ['Rozenn', '', 'Brillet'], ['Joliette', '', 'Coste'], ['Dominique', '', 'Larrey'], ['Daniel', '', 'Dhumeaux'], ['Patrick', '', 'Maurel'], ['J.-M.', '', 'Pawlotsky']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/16/8189.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.16.8189-8199.2002']",
10.1056/NEJM199811193392101,"Papatheodoridis, G., Papadimitropoulos, V., Hadziyannis, S., , Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis, Alimentary Pharmacology & Therapeutics, 2001",cited-by,10.1046/j.1365-2036.2001.00979.x,Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis,"[['G.', 'V.', 'Papatheodoridis'], ['V.', 'C.', 'Papadimitropoulos'], ['S.', 'J.', 'Hadziyannis']]",Alimentary Pharmacology & Therapeutics,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2036.2001.00979.x'],
10.1056/NEJM199811193392101,"Sulkowski, M., Wasserman, R., Brooks, L., et. al, Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00490.x,Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection,"[['M.', 'S.', 'Sulkowski'], ['R.', '', 'Wasserman'], ['L.', '', 'Brooks'], ['L.', '', 'Ball'], ['R.', '', 'Gish']]",Journal of Viral Hepatitis,2004,"[u'http://www.cpmc.org/advanced/liver/physicians/JViralHepatitis2004.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00490.x']",
10.1056/NEJM199811193392101,"Maio, G., D'Argenio, P., Stroffolini, T., et. al, Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town, Journal of Hepatology, 2000",cited-by,10.1016/S0168-8278(00)80167-1,Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town,"[['Giuseppe', '', 'Maio'], ['Paolo', '', ""D'Argenio""], ['Tommaso', '', 'Stroffolini'], ['Alessandro', '', 'Bozza'], ['Lea', '', 'Sacco'], ['Maria', 'Elena', 'Tosti'], ['Michele', '', 'Intorcia'], ['Elena', '', 'Fossi'], ['Giovanna', '', ""D'Alessio""], ['Loreta', 'Anesti', 'Kondili'], ['Maria', '', 'Rapicetta'], ['Alfonso', '', 'Mele']]",Journal of Hepatology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0168827800801671', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827800801671']",
10.1056/NEJM199811193392101,"Mo, H., Lu, L., Pilot-Matias, T., et. al, Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.10.4305-4314.2005,Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro,"[['Hongmei', '', 'Mo'], ['Liangjun', '', 'Lu'], ['Tami', '', 'Pilot-Matias'], ['Ron', '', 'Pithawalla'], ['Rubina', '', 'Mondal'], ['Sherie', '', 'Masse'], ['Tatyana', '', 'Dekhtyar'], ['Teresa', '', 'Ng'], ['Gennadiy', '', 'Koev'], ['Vincent', '', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['John', '', 'Pratt'], ['Pam', '', 'Donner'], ['Todd', '', 'Rockway'], ['Clarence', '', 'Maring'], ['Akhteruzzaman', '', 'Molla']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/10/4305.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.10.4305-4314.2005']",
10.1056/NEJM199811193392101,"Roccasecca, R., Ansuini, H., Vitelli, A., et. al, Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2, Journal of Virology, 2003",cited-by,10.1128/JVI.77.3.1856-1867.2003,Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2,"[['RosaMaria', '', 'Roccasecca'], ['Helenia', '', 'Ansuini'], ['Alessandra', '', 'Vitelli'], ['Annalisa', '', 'Meola'], ['Elisa', '', 'Scarselli'], ['Stefano', '', 'Acali'], ['Monica', '', 'Pezzanera'], ['Bruno', 'Bruni', 'Ercole'], ['Jane', '', 'McKeating'], ['Asutosh', '', 'Yagnik'], ['Armin', '', 'Lahm'], ['Anna', '', 'Tramontano'], ['Riccardo', '', 'Cortese'], ['Alfredo', '', 'Nicosia']]",Journal of Virology,2003,"[u'http://jvi.asm.org/cgi/reprint/77/3/1856.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.77.3.1856-1867.2003']",
10.1056/NEJM199811193392101,", B., , M., , T., et. al, Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States, Journal of Viral Hepatitis, 2000",cited-by,10.1046/j.1365-2893.2000.00221.x,Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States,"[['Blatt', '', ''], ['Mutchnick', '', ''], ['Tong', '', ''], ['Klion', '', ''], ['Lebovics', '', ''], ['Freilich', '', ''], ['Bach', '', ''], ['Herrera', '', ''], ['Conrad', '', ''], ['McHutchison', '', '']]",Journal of Viral Hepatitis,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2000.00221.x'],
10.1056/NEJM199811193392101,"Luxon, B., Grace, M., Brassard, D., et. al, Pegylated interferons for the treatment of chronic hepatitis C infection, Clinical Therapeutics, 2002",cited-by,10.1016/S0149-2918(02)80042-X,Pegylated interferons for the treatment of chronic hepatitis C infection,"[['Bruce', 'A.', 'Luxon'], ['Michael', '', 'Grace'], ['Diana', '', 'Brassard'], ['Ronald', '', 'Bordens']]",Clinical Therapeutics,2002,"[u'http://www.sciencedirect.com/science/article/pii/S014929180280042X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180280042X']",
10.1056/NEJM199811193392101,"Zylberberg, H., Benhamou, Y., Lagneaux, J., et. al, Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report, Gut, 2000",cited-by,10.1136/gut.47.5.694,Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report,"[['H', '', 'Zylberberg'], ['Y', '', 'Benhamou'], ['J', 'L', 'Lagneaux'], ['A', '', 'Landau'], ['M-L', '', 'Chaix'], ['H', '', 'Fontaine'], ['M', '', 'Bochet'], ['T', '', 'Poynard'], ['C', '', 'Katlama'], ['G', '', 'Pialoux'], ['C', '', 'Br\xc3\xa9chot'], ['S', '', 'Pol']]",Gut,2000,"[u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.47.5.694']",
10.1056/NEJM199811193392101,"Ishii, N., Watashi, K., Hishiki, T., et. al, Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication, Journal of Virology, 2006",cited-by,10.1128/JVI.80.9.4510-4520.2006,Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication,"[['Naoto', '', 'Ishii'], ['Koichi', '', 'Watashi'], ['Takayuki', '', 'Hishiki'], ['Kaku', '', 'Goto'], ['Daisuke', '', 'Inoue'], ['Makoto', '', 'Hijikata'], ['Takaji', '', 'Wakita'], ['Nobuyuki', '', 'Kato'], ['Kunitada', '', 'Shimotohno']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.80.9.4510-4520.2006', u'http://jvi.asm.org/cgi/reprint/80/9/4510.pdf']",
10.1056/NEJM199811193392101,"Salomon, J., Weinstein, M., Hammitt, J., et. al, Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population, , 2003",cited-by,6310042Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population,Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population,"[['Joshua', 'A.', 'Salomon'], ['Milton', 'C.', 'Weinstein'], ['James', 'K.', 'Hammitt'], ['Sue', 'J.', 'Goldie']]",,2003,[u'http://www.hsph.harvard.edu/faculty/joshua-salomon/files/Salomon_CostEffectivenessHCVTx_JAMA2003.pdf'],
10.1056/NEJM199811193392101,"Meyers, C., Seeff, L., Stehman-Breen, C., et. al, Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00828-X,"Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD","[['Catherine', 'M.', 'Meyers'], ['Leonard', 'B.', 'Seeff'], ['Catherine', 'O.', 'Stehman-Breen'], ['Jay', 'H.', 'Hoofnagle']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S027263860300828X', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as027263860300828x', u'http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/Hep C and GN AJKD 05.pdf']",
10.1056/NEJM199811193392101,"Cheney, I., Lai, V., Zhong, W., et. al, Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma Interferons, Journal of Virology, 2002",cited-by,10.1128/JVI.76.21.11148-11154.2002,"Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma Interferons","[['I.', 'Wayne', 'Cheney'], ['Vicky', 'C. H.', 'Lai'], ['Weidong', '', 'Zhong'], ['Tessa', '', 'Brodhag'], ['Shannon', '', 'Dempsey'], ['Charmaine', '', 'Lim'], ['Zhi', '', 'Hong'], ['Johnson', 'Y. N.', 'Lau'], ['Robert', 'C.', 'Tam']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/21/11148.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.21.11148-11154.2002']",
10.1056/NEJM199811193392101,"Thevenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update,"[['T.', '', 'Thevenot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00271.x'],
10.1056/NEJM199811193392101,"Kwiatkowski, C., Corsi, K., Booth, R., , The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users, Addiction, 2002",cited-by,10.1046/j.1360-0443.2002.00208.x,The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users,"[['Carol', 'F.', 'Kwiatkowski'], ['Karen', 'Fortuin', 'Corsi'], ['Robert', 'E.', 'Booth']]",Addiction,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1360-0443.2002.00208.x'],
10.1056/NEJM199811193392101,"Chen, Z., Weck, K., , Hepatitis C Virus Genotyping: Interrogation of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes 1a and 1b, Journal of Clinical Microbiology, 2002",cited-by,10.1128/JCM.40.9.3127-3134.2002,Hepatitis C Virus Genotyping: Interrogation of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes 1a and 1b,"[['Zhenyu', '', 'Chen'], ['Karen', 'E.', 'Weck']]",Journal of Clinical Microbiology,2002,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.40.9.3127-3134.2002', u'http://jcm.asm.org/cgi/reprint/40/9/3127.pdf']",
10.1056/NEJM199811193392101,"Ludmerer, S., Graham, D., Boots, E., et. al, Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.5.2059-2069.2005,Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay,"[['Steven', 'W.', 'Ludmerer'], ['Donald', 'J.', 'Graham'], ['Evelyn', '', 'Boots'], ['Edward', 'M.', 'Murray'], ['Amy', '', 'Simcoe'], ['Eric', 'J.', 'Markel'], ['Jay', 'A.', 'Grobler'], ['Osvaldo', 'A.', 'Flores'], ['David', 'B.', 'Olsen'], ['Daria', 'J.', 'Hazuda'], ['Robert', 'L.', 'LaFemina']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/5/2059.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.5.2059-2069.2005']",
10.1056/NEJM199811193392101,"Zickmund, S., Hillis, S., Barnett, M., et. al, Hepatitis C virus-infected patients report communication problems with physicians, Hepatology, 2004",cited-by,10.1002/hep.20132,Hepatitis C virus-infected patients report communication problems with physicians,"[['Susan', '', 'Zickmund'], ['Stephen', 'L.', 'Hillis'], ['Mitchell', 'J.', 'Barnett'], ['Laura', '', 'Ippolito'], ['Douglas', 'R.', 'LaBrecque']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo551.pdf', u'http://doi.wiley.com/10.1002/hep.20132']",
10.1056/NEJM199811193392101,"Schaefer, M., Heinz, A., Backmund, M., , Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?, Addiction, 2004",cited-by,10.1111/j.1360-0443.2004.00821.x,Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?,"[['Martin', '', 'Schaefer'], ['Andreas', '', 'Heinz'], ['Markus', '', 'Backmund']]",Addiction,2004,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1360-0443.2004.00821.x'],
10.1056/NEJM199811193392101,"Dieterich, D., Spivak, J., , Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management, Clinical Infectious Diseases, 2003",cited-by,10.1086/376971,Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management,"[['Douglas', 'T.', 'Dieterich'], ['Jerry', 'L.', 'Spivak']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/376971'],
10.1056/NEJM199811193392101,"Ho, S., Nguyen, H., Tetrick, L., et. al, Influence of psychiatric diagnoses on interferon-α treatment for chronic hepatitis C in a veteran population, American Journal of Gastroenterology, 2001",cited-by,10.1111/j.1572-0241.2001.03468.x,Influence of psychiatric diagnoses on interferon-α treatment for chronic hepatitis C in a veteran population,"[['Samuel', 'B.', 'Ho'], ['Huy', '', 'Nguyen'], ['Lori', 'L.', 'Tetrick'], ['Greg', 'A.', 'Opitz'], ['Michael', 'L.', 'Basara'], ['Eric', '', 'Dieperink']]",American Journal of Gastroenterology,2001,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2001.03468.x', u'http://dx.doi.org/10.1111/j.1572-0241.2001.03468.x']",
10.1056/NEJM199811193392101,"Veenstra, D., Higashi, M., Phillips, K., , Assessing the cost-effectiveness of pharmacogenomics, Aaps Journal, 2000",cited-by,10.1208/ps020329,Assessing the cost-effectiveness of pharmacogenomics,"[['David', 'L.', 'Veenstra'], ['Mitchell', 'K.', 'Higashi'], ['Kathryn', 'A.', 'Phillips']]",Aaps Journal,2000,"[u'http://www.springerlink.com/content/55685734858591qt', u'http://www.springerlink.com/index/55685734858591qt.pdf', u'http://www.springerlink.com/index/10.1208/ps020329']",
10.1056/NEJM199811193392101,"Silverman, R., , Viral Encounters with 2',5'-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response, Journal of Virology, 2007",cited-by,10.1128/JVI.01471-07,"Viral Encounters with 2',5'-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response","[['Robert', 'H.', 'Silverman']]",Journal of Virology,2007,"[u'http://jvi.highwire.org/cgi/reprint/81/23/12720.pdf', u'http://www.lerner.ccf.org/cancerbio/silverman/documents/SilvermanJVI.pdf', u'http://jvi.asm.org/cgi/reprint/81/23/12720.pdf', u'http://www.ri.ccf.org/cancerbio/silverman/documents/SilvermanJVI.pdf', u'http://www.lri.ccf.org/cancerbio/silverman/documents/SilvermanJVI.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01471-07']",
10.1056/NEJM199811193392101,"Anand, B., Currie, S., Dieperink, E., et. al, Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.02.023,Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study,"[['Bhupinder', 'S.', 'Anand'], ['Sue', '', 'Currie'], ['Eric', '', 'Dieperink'], ['Edmund', 'J.', 'Bini'], ['Hui', '', 'Shen'], ['Samuel', 'B.', 'Ho'], ['Teresa', '', 'Wright']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506003349', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506003349']",
10.1056/NEJM199811193392101,"Layden, J., Layden, T., Reddy, K., et. al, First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00377.x,First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline,"[['Jennifer', 'E.', 'Layden'], ['Thomas', 'J.', 'Layden'], ['K.', 'Rajender', 'Reddy'], ['Rachel', 'S', 'Levy-Drummer'], ['Jennifer', '', 'Poulakos'], ['Avidan', 'U.', 'Neumann']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00377.x'],
10.1056/NEJM199811193392101,"Muir, A., Provenzale, D., , A Descriptive Evaluation of Eligibility for Therapy Among Veterans With Chronic Hepatitis C Virus Infection, Journal of Clinical Gastroenterology, 2002",cited-by,10.1097/00004836-200203000-00015,A Descriptive Evaluation of Eligibility for Therapy Among Veterans With Chronic Hepatitis C Virus Infection,"[['Andrew', 'J.', 'Muir'], ['Dawn', '', 'Provenzale']]",Journal of Clinical Gastroenterology,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200203000-00015'],
10.1056/NEJM199811193392101,"Elazar, M., Liu, P., Rice, C., et. al, An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication, Journal of Virology, 2004",cited-by,10.1128/JVI.78.20.11393-11400.2004,"An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication","[['Menashe', '', 'Elazar'], ['Ping', '', 'Liu'], ['Charles', 'M.', 'Rice'], ['Jeffrey', 'S.', 'Glenn']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.20.11393-11400.2004', u'http://jvi.asm.org/cgi/reprint/78/20/11393.pdf']",
10.1056/NEJM199811193392101,"Noppornpanth, S., Lien, T., Poovorawan, Y., et. al, Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus, Journal of Virology, 2006",cited-by,10.1128/JVI.00312-06,Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus,"[['Suwanna', '', 'Noppornpanth'], ['Truong', 'Xuan', 'Lien'], ['Yong', '', 'Poovorawan'], ['Saskia', 'L.', 'Smits'], ['Albert', 'D. M. E.', 'Osterhaus'], ['Bart', 'L.', 'Haagmans']]",Journal of Virology,2006,"[u'http://jvi.asm.org/cgi/reprint/80/15/7569.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.00312-06']",
10.1056/NEJM199811193392101,"Benson, C., Kaplan, J., Masur, H., et. al, Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America, Clinical Infectious Diseases, 2005",cited-by,10.1086/427906,"Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America","[['Constance', 'A.', 'Benson'], ['Jonathan', 'E.', 'Kaplan'], ['Henry', '', 'Masur'], ['Alice', '', 'Pau'], ['King', 'K.', 'Holmes']]",Clinical Infectious Diseases,2005,"[u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA.pdf', u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA000875.pdf', u'http://medicine.georgetown.edu/residency/idarticles/hivopportunistic.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427906']",
10.1056/NEJM199811193392101,"Shiffman, M., , Retreatment of patients with chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36816,Retreatment of patients with chronic hepatitis C,"[['Mitchell', 'L.', 'Shiffman']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Retreatment%20Of%20Patients%20With%20Chronic%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36816', u'http://doi.wiley.com/10.1002/hep.1840360717']",
10.1056/NEJM199811193392101,"Bonkovsky, H., Mehta, S., , Hepatitis C: A review and update, Dm Disease-a-month, 2001",cited-by,10.1016/S0011-5029(01)90007-0,Hepatitis C: A review and update,"[['Herbert', 'L.', 'Bonkovsky'], ['Savant', '', 'Mehta']]",Dm Disease-a-month,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0011502901900070', u'http://linkinghub.elsevier.com/retrieve/pii/S0011502901900070']",
10.1056/NEJM199811193392101,"PAWLOTSKY, J., GERMANIDIS, G., FRAINAIS, P., et. al, Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy, , 1999",cited-by,13738108Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy,Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy,"[['JEAN-MICHEL', '', 'PAWLOTSKY'], ['GEORGIOS', '', 'GERMANIDIS'], ['PIERRE-OLIVIER', '', 'FRAINAIS'], ['MAGALI', '', 'BOUVIER'], ['ALEXANDRE', '', 'SOULIER'], ['MURIEL', '', 'PELLERIN'], ['DANIEL', '', 'DHUMEAUX']]",,1999,[u'http://jvi.asm.org/cgi/reprint/73/8/6490.pdf'],
10.1056/NEJM199811193392101,"Schulze-Krebs, A., Preimel, D., Popov, Y., et. al, Hepatitis C Virus-Replicating Hepatocytes Induce Fibrogenic Activation of Hepatic Stellate Cells, Gastroenterology, 2005",cited-by,10.1053/j.gastro.2005.03.089,Hepatitis C Virus-Replicating Hepatocytes Induce Fibrogenic Activation of Hepatic Stellate Cells,"[['Anja', '', 'Schulze-Krebs'], ['Dorothee', '', 'Preimel'], ['Yury', '', 'Popov'], ['Ralf', '', 'Bartenschlager'], ['Volker', '', 'Lohmann'], ['Massimo', '', 'Pinzani'], ['Detlef', '', 'Schuppan']]",Gastroenterology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505008942', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505008942']",
10.1056/NEJM199811193392101,"Bourliere, M., Barberin, J., Rotily, M., et. al, Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users, Journal of Viral Hepatitis, 2002",cited-by,10.1046/j.1365-2893.2002.00319.x,Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users,"[['M.', '', 'Bourliere'], ['J.', 'M.', 'Barberin'], ['M.', '', 'Rotily'], ['V.', '', 'Guagliardo'], ['I.', '', 'Portal'], ['L.', '', 'Lecomte'], ['S.', '', 'Benali'], ['C.', '', 'Boustiere'], ['H.', '', 'Perrier'], ['M.', '', 'Jullien'], ['G.', '', 'Lambot'], ['R.', '', 'Loyer'], ['O.', '', 'LeBars'], ['R.', '', 'Daniel'], ['H.', '', 'Khiri'], ['P.', '', 'Halfon']]",Journal of Viral Hepatitis,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2002.00319.x'],
10.1056/NEJM199811193392101,"Hu, K., Vierling, J., Redeker, A., , Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00253.x,"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection","[['Ke-Qin', '', 'Hu'], ['John', 'M.', 'Vierling'], ['Allan', 'G.', 'Redeker']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00253.x'],
10.1056/NEJM199811193392101,"Iwasaki, Y., Ikeda, H., Araki, Y., et. al, Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C, Hepatology, 2006",cited-by,10.1002/hep.20984,Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C,"[['Yoshiaki', '', 'Iwasaki'], ['Hiroshi', '', 'Ikeda'], ['Yasuyuki', '', 'Araki'], ['Toshiya', '', 'Osawa'], ['Keiji', '', 'Kita'], ['Masaharu', '', 'Ando'], ['Toshinari', '', 'Shimoe'], ['Kouichi', '', 'Takaguchi'], ['Noriaki', '', 'Hashimoto'], ['Toshitsugu', '', 'Kobatake'], ['Minoru', '', 'Tomita'], ['Mitsuhiko', '', 'Kawaguchi'], ['Haruhiko', '', 'Kobashi'], ['Kohsaku', '', 'Sakaguchi'], ['Yasushi', '', 'Shiratori']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.20984'],
10.1056/NEJM199811193392101,"González-Peralta, R., Kelly, D., Haber, B., et. al, Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics, Hepatology, 2005",cited-by,10.1002/hep.20884,"Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics","[['Regino', 'P.', 'Gonz\xc3\xa1lez-Peralta'], ['Deirdre', 'A.', 'Kelly'], ['Barbara', '', 'Haber'], ['Jean', '', 'Molleston'], ['Karen', 'F.', 'Murray'], ['Maureen', 'M.', 'Jonas'], ['Mark', '', 'Shelton'], ['Giorgina', '', 'Mieli-Vergani'], ['Yoav', '', 'Lurie'], ['Steven', '', 'Martin'], ['Thomas', '', 'Lang'], ['Andrew', '', 'Baczkowski'], ['Michael', '', 'Geffner'], ['Samir', '', 'Gupta'], ['Mark', '', 'Laughlin']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20884'],
10.1056~NEJMoa011232,"European Association for the Study of the Liver. EASL International Consensus Conference on hepatitis C: Paris, 26-28, February 1999, consensus statement. J Hepatol 1999;30:956-61.",references,NOT found in MAS
10.1056~NEJMoa011232,"Hwang SJ, Lee SD, Chan CY, Lu RH, Lo KJ. A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 1994;21:831-6.",references,10.1016/S0168-8278(94)80246-7,A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C,"[[u'S', u'', u'HWANG'], [u'S', u'', u'LEE'], [u'C', u'', u'CHAN'], [u'R', u'', u'LU'], [u'K', u'', u'LO']]",Journal of Hepatology,1994,[u'http://linkinghub.elsevier.com/retrieve/pii/S0168827894802467'],"[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Randomized Controlled Trial', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 34323}]"
10.1016/S0168-8278(94)80246-7,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1016/S0168-8278(94)80246-7,"Kamal, S., Fouly, A., Kamel, R., et. al, Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.01.034,Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response,"[['Sanaa', 'M.', 'Kamal'], ['Amr', 'E.', 'Fouly'], ['Refaat', 'R.', 'Kamel'], ['Bridgette', '', 'Hockenjos'], ['Ahmed', 'Al', 'Tawil'], ['Khalifa', 'E.', 'Khalifa'], ['Qi', '', 'He'], ['Margaret', 'J.', 'Koziel'], ['Khairy', 'M. El', 'Naggar'], ['Jens', '', 'Rasenack'], ['Nezam', 'H.', 'Afdhal']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506000618', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506000618']",
10.1016/S0168-8278(94)80246-7,"Thevenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update,"[['T.', '', 'Thevenot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00271.x'],
10.1016/S0168-8278(94)80246-7,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1016/S0168-8278(94)80246-7,"Pearlman, B., , Hepatitis C treatment update, American Journal of Medicine, 2004",cited-by,10.1016/j.amjmed.2004.03.024,Hepatitis C treatment update,"[['Brian', 'L.', 'Pearlman']]",American Journal of Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304003407', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304003407']",
10.1016/S0168-8278(94)80246-7,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1016/S0168-8278(94)80246-7,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1016/S0168-8278(94)80246-7,"Gursoy, M., Gur, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment,"[['Murat', '', 'Gursoy'], ['G.', '', 'Gur'], ['H.', '', 'Arslan'], ['N.', '', 'Ozdemir'], ['S.', '', 'Boyacioglu']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00268.x'],
10.1016/S0168-8278(94)80246-7,"LUO, J., HWANG, S., LAI, C., et. al, Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan, Journal of Gastroenterology and Hepatology, 1998",cited-by,10.1111/j.1440-1746.1998.tb00714.x,"Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan","[['JIING-CHYUAN', '', 'LUO'], ['SHINN-JANG', '', 'HWANG'], ['CHIUNG-RU', '', 'LAI'], ['CHING-LIANG', '', 'LU'], ['CHUNG-PIN', '', 'LI'], ['SHYH-HAW', '', 'TSAY'], ['JAW-CHING', '', 'WU'], ['FULL-YOUNG', '', 'CHANG'], ['SHOU-DONG', '', 'LEE']]",Journal of Gastroenterology and Hepatology,1998,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1998.tb00714.x'],
10.1016/S0168-8278(94)80246-7,"Quin, J., , Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis, Internal Medicine Journal, 1997",cited-by,10.1111/j.1445-5994.1997.tb00985.x,Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis,"[['J.', 'W.', 'Quin']]",Internal Medicine Journal,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.1997.tb00985.x'],
10.1016/S0168-8278(94)80246-7,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
10.1016/S0168-8278(94)80246-7,"Vogel, W., , Treatment of acute hepatitis C virus infection, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80399-7,Treatment of acute hepatitis C virus infection,"[['Wolfgang', '', 'Vogel']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803997', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803997']",
10.1016/S0168-8278(94)80246-7,"Hoofnagle, J., , Therapy of Viral Hepatitis, Digestion, 1998",cited-by,10.1159/000007532,Therapy of Viral Hepatitis,"[['Jay', 'H.', 'Hoofnagle']]",Digestion,1998,"[u'http://www.online.karger.com/doi/10.1159/000007532', u'http://www.karger.com/doi/10.1159/000007532']",
10.1016/S0168-8278(94)80246-7,"Venezia, G., Licata, A., Marco, V., et. al, Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, Digestive and Liver Disease, 2005",cited-by,10.1016/j.dld.2005.06.010,Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b,"[['G.', '', 'Venezia'], ['A.', '', 'Licata'], ['V.', 'Di', 'Marco'], ['A.', '', 'Crax\xc3\xac'], ['P.', 'L.', 'Almasio']]",Digestive and Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1590865805003324', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865805003324']",
10.1016/S0168-8278(94)80246-7,"LUO, J., HWANG, S., LI, C., et. al, Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: Negative role of serum viral titre and genotype, Journal of Gastroenterology and Hepatology, 1998",cited-by,10.1111/j.1440-1746.1998.tb00671.x,Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: Negative role of serum viral titre and genotype,"[['JIING-CHYUAN', '', 'LUO'], ['SHINN-JANG', '', 'HWANG'], ['CHUNG-PIN', '', 'LI'], ['REI-HWA', '', 'LU'], ['CHO-YU', '', 'CHAN'], ['JAW-CHING', '', 'WU'], ['FULL-YOUNG', '', 'CHANG'], ['SHOU-DONG', '', 'LEE']]",Journal of Gastroenterology and Hepatology,1998,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1998.tb00671.x'],
10.1016/S0168-8278(94)80246-7,"Cammà, C., Almasio, P., Craxì, A., , Interferon as treatment for acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02088245,Interferon as treatment for acute hepatitis C,"[['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Antonio', '', 'Crax\xc3\xac']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/vr3137877v301j64.pdf', u'http://www.springerlink.com/content/vr3137877v301j64', u'http://www.springerlink.com/index/10.1007/BF02088245', u'http://www.springerlink.com/index/pdf/10.1007/BF02088245']",
10.1016/S0168-8278(94)80246-7,"Eyster, M., Sanders, J., Goedert, J., , Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia, Haemophilia, 2004",cited-by,10.1046/j.1351-8216.2003.00836.x,Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia,"[['M.', 'E.', 'Eyster'], ['J.', '', 'Sanders'], ['J.', 'J.', 'Goedert']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1351-8216.2003.00836.x'],
10.1016/S0168-8278(94)80246-7,"Davis, G., , TREATMENT OF ACUTE AND CHRONIC HEPATITIS C, Clinics in Liver Disease, 1997",cited-by,10.1016/S1089-3261(05)70325-1,TREATMENT OF ACUTE AND CHRONIC HEPATITIS C,"[['Gary', 'L.', 'Davis']]",Clinics in Liver Disease,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105703251', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105703251']",
10.1016/S0168-8278(94)80246-7,"Colombo, M., , The natural history of hepatitis C, , 1996",cited-by,10.1016/S0950-3528(96)90007-X,The natural history of hepatitis C,"[['Massimo', '', 'Colombo']]",,1996,"[u'http://www.sciencedirect.com/science/article/pii/S095035289690007X', u'http://linkinghub.elsevier.com/retrieve/pii/S095035289690007X']",
10.1016/S0168-8278(94)80246-7,"Corey, K., Mendez-Navarro, J., Gorospe, E., et. al, Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis, Journal of Viral Hepatitis, 2010",cited-by,10.1111/j.1365-2893.2009.01167.x,Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis,"[['K.', 'E.', 'Corey'], ['J.', '', 'Mendez-Navarro'], ['E.', 'C.', 'Gorospe'], ['H.', '', 'Zheng'], ['R.', 'T.', 'Chung']]",Journal of Viral Hepatitis,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2009.01167.x'],
10.1016/S0168-8278(94)80246-7,"Poignet, J., Degos, F., Bouchardeau, F., et. al, Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse, Journal of Hepatology, 1995",cited-by,10.1016/0168-8278(95)80042-5,Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse,"[['Jean-Louis', '', 'Poignet'], ['Fran\xc3\xa7oise', '', 'Degos'], ['Fran\xc3\xa7oise', '', 'Bouchardeau'], ['Philippe', '', 'Chauveau'], ['Anne', 'Marie', 'Courouce']]",Journal of Hepatology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0168827895800425', u'http://linkinghub.elsevier.com/retrieve/pii/0168827895800425']",
10.1016/S0168-8278(94)80246-7,"craxì, A., Marco, V., Cammà, C., et. al, Duration of HCV infection as a predictor of nonresponse to interferon, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087881,Duration of HCV infection as a predictor of nonresponse to interferon,"[['Antonio', '', 'crax\xc3\xac'], ['Vito', 'Di', 'Marco'], ['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Silvio', '', 'Magrin']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/content/x1807m2613532562', u'http://www.springerlink.com/index/x1807m2613532562.pdf', u'http://www.springerlink.com/index/10.1007/BF02087881', u'http://www.springerlink.com/index/pdf/10.1007/BF02087881']",
10.1016/S0168-8278(94)80246-7,"Hwang, S., Luo, J., Chu, C., et. al, Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C, Journal of Gastroenterology, 2001",cited-by,10.1007/s005350170083,"Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C","[['Shinn-Jang', '', 'Hwang'], ['Jiing-Chyuan', '', 'Luo'], ['Chen-Wei', '', 'Chu'], ['Chiung-Ru', '', 'Lai'], ['Shyh-Haw', '', 'Tsay'], ['Full-Young', '', 'Chang'], ['Shou-Dong', '', 'Lee']]",Journal of Gastroenterology,2001,"[u'http://www.springerlink.com/content/0x9r7xynlc4c1u11', u'http://www.springerlink.com/index/0x9r7xynlc4c1u11.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s005350170083', u'http://www.springerlink.com/index/pdf/10.1007/s005350170083']",
10.1016/S0168-8278(94)80246-7,"Luo, J., Hwang, S., Lai, C., et. al, Clinical significance of portal lymphoid aggregates/follicles in Chinese patients with chronic hepatitis C, American Journal of Gastroenterology, 1999",cited-by,10.1016/S0002-9270(99)00059-3,Clinical significance of portal lymphoid aggregates/follicles in Chinese patients with chronic hepatitis C,"[['Jiing-Chyuan', '', 'Luo'], ['Shinn-Jang', '', 'Hwang'], ['Chiung-Ru', '', 'Lai'], ['Ching-Liang', '', 'Lu'], ['Chung-Pin', '', 'Li'], ['Shyh-Haw', '', 'Tsay'], ['Jaw-Ching', '', 'Wu'], ['Full-Young', '', 'Chang'], ['Shou-Dong', '', 'Lee']]",American Journal of Gastroenterology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0002927099000593', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927099000593']",
10.1016/S0168-8278(94)80246-7,"Chu, C., Hwang, S., Luo, J., et. al, Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C, Journal of Gastroenterology and Hepatology, 2001",cited-by,10.1046/j.1440-1746.2001.02422.x,"Comparison of clinical, virologic and pathologic features in patients with acute hepatitis B and C","[['Chen-Wei', '', 'Chu'], ['Shinn-Jang', '', 'Hwang'], ['Jiing-Chyuan', '', 'Luo'], ['Yuan-Jen', '', 'Wang'], ['Rei-Hwa', '', 'Lu'], ['Chiung-Ru', '', 'Lai'], ['Shyh-Haw', '', 'Tsay'], ['Jaw-Ching', '', 'Wu'], ['Full-Young', '', 'Chang'], ['Shou-Dong', '', 'Lee']]",Journal of Gastroenterology and Hepatology,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1440-1746.2001.02422.x'],
10.1016/S0168-8278(94)80246-7,"Morton, T., Kelen, G., , Hepatitis C, Annals of Emergency Medicine, 1998",cited-by,10.1016/S0196-0644(98)70351-8,Hepatitis C,"[['Timothy', 'Allen', 'Morton'], ['Gabor', 'David', 'Kelen']]",Annals of Emergency Medicine,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0196064498703518', u'http://linkinghub.elsevier.com/retrieve/pii/S0196064498703518']",
10.1016/S0168-8278(94)80246-7,"Ogata, K., Ide, T., Kumashiro, R., et. al, Timing of interferon therapy and sources of infection in patients with acute hepatitis C, Hepatology Research, 2006",cited-by,10.1016/j.hepres.2005.08.012,Timing of interferon therapy and sources of infection in patients with acute hepatitis C,"[['Kei', '', 'Ogata'], ['Tatsuya', '', 'Ide'], ['Ryukichi', '', 'Kumashiro'], ['Hiromitsu', '', 'Kumada'], ['Hiroshi', '', 'Yotsuyanagi'], ['Kiwamu', '', 'Okita'], ['Yoshihiro', '', 'Akahane'], ['Shuichi', '', 'Kaneko'], ['Hirohito', '', 'Tsubouchi'], ['Eiji', '', 'Tanaka'], ['Hisataka', '', 'Moriwaki'], ['Shuhei', '', 'Nishiguchi'], ['Shinichi', '', 'Kakumu'], ['Masashi', '', 'Mizokami'], ['Shiro', '', 'Iino'], ['Michio', '', 'Sata']]",Hepatology Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S138663460500330X', u'http://linkinghub.elsevier.com/retrieve/pii/S138663460500330X']",
10.1016/S0168-8278(94)80246-7,"Chu, C., Hwang, S., Lu, R., et. al, Clinical significance of the changes of platelet counts and serum thrombopoietin levels in chronic hepatitis C patients treated with different doses of consensus interferon, Hepatology Research, 2002",cited-by,10.1016/S1386-6346(02)00108-0,Clinical significance of the changes of platelet counts and serum thrombopoietin levels in chronic hepatitis C patients treated with different doses of consensus interferon,"[['Chen-Wei', '', 'Chu'], ['Shinn-Jang', '', 'Hwang'], ['Rei-Hwa', '', 'Lu'], ['Chiung-Ru', '', 'Lai'], ['Jiing-Chyuan', '', 'Luo'], ['Yuan-Jen', '', 'Wang'], ['Full-Young', '', 'Chang'], ['Shou-Dong', '', 'Lee']]",Hepatology Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1386634602001080', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634602001080']",
10.1016/S0168-8278(94)80246-7,"Wiegand, J., Potthoff, A., Manns, M., et. al, Acute hepatitis C infection: Can immunology teach us the right way to treat?, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0025-6,Acute hepatitis C infection: Can immunology teach us the right way to treat?,"[['Johannes', '', 'Wiegand'], ['Andrej', '', 'Potthoff'], ['Michael', 'P.', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/x7212685g77j1132.pdf', u'http://www.springerlink.com/content/x7212685g77j1132', u'http://www.springerlink.com/index/10.1007/s11901-004-0025-6', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0025-6']",
10.1016/S0168-8278(94)80246-7,"Nguyen-Khac, E., , L’hépatite C aiguë en 2005, Gastroenterologie Clinique Et Biologique, 2005",cited-by,10.1016/S0399-8320(05)82180-3,L’hépatite C aiguë en 2005,"[['Eric', '', 'Nguyen-Khac']]",Gastroenterologie Clinique Et Biologique,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0399832005821803', u'http://linkinghub.elsevier.com/retrieve/pii/S0399832005821803']",
10.1016/S0168-8278(94)80246-7,"Rodriguez-Gomez, S., Serna-Higuera, C., Pérez-Villoria, A., et. al, Peginterferon and ribavirin in a patient with acute hepatitis C, American Journal of Gastroenterology, 2003",cited-by,10.1111/j.1572-0241.2003.07656.x,Peginterferon and ribavirin in a patient with acute hepatitis C,"[['Santiago', 'J.', 'Rodriguez-Gomez'], ['Carlos', 'de la', 'Serna-Higuera'], ['Antonio', '', 'P\xc3\xa9rez-Villoria'], ['Juan', '', 'Mart\xc3\xadnez-Moreno'], ['Alejandro', '', 'Betancourt-Gonz\xc3\xa1lez'], ['M.', 'Isabel', 'Martin-Arribas']]",American Journal of Gastroenterology,2003,"[u'http://dx.doi.org/10.1111/j.1572-0241.2003.07656.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.07656.x']",
10.1016/S0168-8278(94)80246-7,"Hoofnagle, J., RESTREPO, J., Jaime, J., et. al, 4 Acute hepatitis C, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80008-3,4 Acute hepatitis C,"[['Jay', 'H.', 'Hoofnagle'], ['JUAN', 'CARLOS', 'RESTREPO'], ['John', '', 'Jaime'], ['Juan', '', 'Carlos'], ['Restrepo', '', 'Guti\xc3\xa9rrez'], ['Guti\xc3\xa9rrez', '', 'Calle']]",Biomedical Research Reports,2000,"[u'http://www.scielo.org.co/pdf/amc/v33n1/v33n1a6.pdf', u'http://www.sciencedirect.com/science/article/pii/S1874532600800083', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800083']",
10.1016/S0168-8278(94)80246-7,"Luo, J., Hwang, S., Lai, C., et. al, Clinical significance of portal lymphoid aggregates/follicles in Chinese patients with chronic hepatitis C, American Journal of Gastroenterology, 1999",cited-by,10.1111/j.1572-0241.1999.01004.x,Clinical significance of portal lymphoid aggregates/follicles in Chinese patients with chronic hepatitis C,"[['Jiing-Chyuan', '', 'Luo'], ['Shinn-Jang', '', 'Hwang'], ['Chiung-Ru', '', 'Lai'], ['Ching-Liang', '', 'Lu'], ['Chung-Pin', '', 'Li'], ['Shyh-Haw', '', 'Tsay'], ['Jaw-Ching', '', 'Wu'], ['Full-Young', '', 'Chang'], ['Shou-Dong', '', 'Lee']]",American Journal of Gastroenterology,1999,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.1999.01004.x', u'http://dx.doi.org/10.1111/j.1572-0241.1999.01004.x']",
10.1016/S0168-8278(94)80246-7,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1016/S0168-8278(94)80246-7,"Thévenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C,"[['T.', '', 'Th\xc3\xa9venot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00271.x'],
10.1016/S0168-8278(94)80246-7,"Gürsoy, M., Gür, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection,"[['Murat', '', 'G\xc3\xbcrsoy'], ['G.', '', 'G\xc3\xbcr'], ['H.', '', 'Arslan'], ['N.', '', '\xc3\x96zdemir']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00268.x'],
10.1016/S0168-8278(94)80246-7,"Lamoglia, R., , Tratamiento de la hepatitis aguda C, , 2006",cited-by,10.1157/13097653,Tratamiento de la hepatitis aguda C,"[['R.', 'Sol\xc3\xa0', 'Lamoglia']]",,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0210570506751974', u'http://linkinghub.elsevier.com/retrieve/pii/S0210570506751974']",
10.1016/S0168-8278(94)80246-7,"Rodríguez-Gómez, S., Serna-Higuera, C., Pérez-Villoria, A., et. al, Peginterferon and ribavirin in a patient with acute hepatitis C, American Journal of Gastroenterology, 2003",cited-by,10.1016/S0002-9270(03)00619-1,Peginterferon and ribavirin in a patient with acute hepatitis C,"[['Santiago', 'J.', 'Rodr\xc3\xadguez-G\xc3\xb3mez'], ['Carlos', 'de la', 'Serna-Higuera'], ['Antonio', '', 'P\xc3\xa9rez-Villoria'], ['Juan', '', 'Mart\xc3\xadnez-Moreno'], ['Alejandro', '', 'Betancourt-Gonz\xc3\xa1lez'], ['M.', 'Isabel', 'Mart\xc3\xadn-Arribas']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003006191', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003006191']",
10.1016/S0168-8278(94)80246-7,"Alscher, D., Bode, J., , Therapie der Hepatitis C, Medizinische Klinik, 1997",cited-by,10.1007/BF03043273,Therapie der Hepatitis C,"[['Dominik', 'M.', 'Alscher'], ['J.', 'Christian', 'Bode']]",Medizinische Klinik,1997,"[u'http://www.springerlink.com/content/2702248261846xx2', u'http://www.springerlink.com/index/2702248261846xx2.pdf', u'http://www.springerlink.com/index/10.1007/BF03043273', u'http://www.springerlink.com/index/pdf/10.1007/BF03043273']",
10.1056~NEJMoa011232,"Viladomiu L, Genesca J, Esteban JI, et al. Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology 1992;15:767-9.",references,10.1002/hep.1840150504,"Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial","[[u'Lluis', u'', u'Viladomiu'], [u'Joan', u'', u'Genesc\xe0'], [u'Juan', u'I.', u'Esteban'], [u'Helena', u'', u'Allende'], [u'Antonio', u'', u'Gonz\xe1lez'], [u'Juan', u'Carlos', u'L\xf3pez-Talavera'], [u'Rafael', u'', u'Esteban'], [u'Jaime', u'', u'Guardia']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840150504'],"[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Randomized Controlled Trial', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 34323}]"
10.1002/hep.1840150504,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1002/hep.1840150504,"Thevenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update,"[['T.', '', 'Thevenot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00271.x'],
10.1002/hep.1840150504,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1002/hep.1840150504,"Honda, M., Kaneko, S., Sakai, A., et. al, Degree of diversity of hepatitis C virus quasispecies and progression of liver disease, Hepatology, 1994",cited-by,10.1002/hep.1840200507,Degree of diversity of hepatitis C virus quasispecies and progression of liver disease,"[['Masao', '', 'Honda'], ['Shuichi', '', 'Kaneko'], ['Akito', '', 'Sakai'], ['Masashi', '', 'Unoura'], ['Seishi', '', 'Murakami'], ['Kenichi', '', 'Kobayashi']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840200507'],
10.1002/hep.1840150504,"Pearlman, B., , Hepatitis C treatment update, American Journal of Medicine, 2004",cited-by,10.1016/j.amjmed.2004.03.024,Hepatitis C treatment update,"[['Brian', 'L.', 'Pearlman']]",American Journal of Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304003407', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304003407']",
10.1002/hep.1840150504,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1002/hep.1840150504,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1002/hep.1840150504,"Gursoy, M., Gur, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment,"[['Murat', '', 'Gursoy'], ['G.', '', 'Gur'], ['H.', '', 'Arslan'], ['N.', '', 'Ozdemir'], ['S.', '', 'Boyacioglu']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00268.x'],
10.1002/hep.1840150504,"Vogel, W., Graziadei, I., Umlauft, F., et. al, High-dose interferon-α 2b treatment prevents chronicity in acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087880,High-dose interferon-α 2b treatment prevents chronicity in acute hepatitis C,"[['Wolfgang', '', 'Vogel'], ['Ivo', '', 'Graziadei'], ['Florian', '', 'Umlauft'], ['Christian', '', 'Datz'], ['Franz', '', 'Hackl'], ['Stefan', '', 'Allinger'], ['Kurt', '', 'Gr\xc3\xbcnewald'], ['Josef', '', 'Patsch']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/h171xx22x8q37l17.pdf', u'http://www.springerlink.com/content/h171xx22x8q37l17', u'http://www.springerlink.com/index/10.1007/BF02087880', u'http://www.springerlink.com/index/pdf/10.1007/BF02087880']",
10.1002/hep.1840150504,"Quin, J., , Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis, Internal Medicine Journal, 1997",cited-by,10.1111/j.1445-5994.1997.tb00985.x,Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis,"[['J.', 'W.', 'Quin']]",Internal Medicine Journal,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.1997.tb00985.x'],
10.1002/hep.1840150504,"Hoofnagle, J., , Therapy of Viral Hepatitis, Digestion, 1998",cited-by,10.1159/000007532,Therapy of Viral Hepatitis,"[['Jay', 'H.', 'Hoofnagle']]",Digestion,1998,"[u'http://www.online.karger.com/doi/10.1159/000007532', u'http://www.karger.com/doi/10.1159/000007532']",
10.1002/hep.1840150504,"Venezia, G., Licata, A., Marco, V., et. al, Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, Digestive and Liver Disease, 2005",cited-by,10.1016/j.dld.2005.06.010,Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b,"[['G.', '', 'Venezia'], ['A.', '', 'Licata'], ['V.', 'Di', 'Marco'], ['A.', '', 'Crax\xc3\xac'], ['P.', 'L.', 'Almasio']]",Digestive and Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1590865805003324', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865805003324']",
10.1002/hep.1840150504,"Yeh, B., Han, K., Oh, S., et. al, Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-α therapy, Journal of Medical Virology, 1996",cited-by,10.1002/(SICI)1096-9071(199606)49:2<95::AID-JMV5>3.0.CO;2-E,Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-α therapy,"[['Byung-Il', '', 'Yeh'], ['Kwang-Hyub', '', 'Han'], ['Seung-Hee', '', 'Oh'], ['Hyon-Suk', '', 'Kim'], ['Suk-Hyun', '', 'Hong'], ['Sang-Hwan', '', 'Oh'], ['Yoon-Soo', '', 'Kim']]",Journal of Medical Virology,1996,[u'http://doi.wiley.com/10.1002/%28SICI%291096-9071%28199606%2949%3A2%3C95%3A%3AAID-JMV5%3E3.0.CO%3B2-E'],
10.1002/hep.1840150504,"Cammà, C., Almasio, P., Craxì, A., , Interferon as treatment for acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02088245,Interferon as treatment for acute hepatitis C,"[['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Antonio', '', 'Crax\xc3\xac']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/vr3137877v301j64.pdf', u'http://www.springerlink.com/content/vr3137877v301j64', u'http://www.springerlink.com/index/10.1007/BF02088245', u'http://www.springerlink.com/index/pdf/10.1007/BF02088245']",
10.1002/hep.1840150504,"Davis, G., , TREATMENT OF ACUTE AND CHRONIC HEPATITIS C, Clinics in Liver Disease, 1997",cited-by,10.1016/S1089-3261(05)70325-1,TREATMENT OF ACUTE AND CHRONIC HEPATITIS C,"[['Gary', 'L.', 'Davis']]",Clinics in Liver Disease,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105703251', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105703251']",
10.1002/hep.1840150504,"Weiland, O., , Interferon therapy in chronic hepatitis C virus infection, Fems Microbiology Reviews, 1994",cited-by,10.1111/j.1574-6976.1994.tb00100.x,Interferon therapy in chronic hepatitis C virus infection,"[['Ola', '', 'Weiland']]",Fems Microbiology Reviews,1994,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1574-6976.1994.tb00100.x'],
10.1002/hep.1840150504,"Verastegui-Aviles, E., Mohar, A., Mota, A., et. al, Combination of radiation therapy and interferon alpha-2b in patients with advanced cervical carcinoma: a pilot study, International Journal of Gynecological Cancer, 1999",cited-by,10.1046/j.1525-1438.1999.99053.x,Combination of radiation therapy and interferon alpha-2b in patients with advanced cervical carcinoma: a pilot study,"[['E.', '', 'Verastegui-Aviles'], ['A.', '', 'Mohar'], ['A.', '', 'Mota'], ['A.', '', 'Guadarrama'], ['J.', 'De La', 'Garza-Salazar']]",International Journal of Gynecological Cancer,1999,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1438.1999.99053.x'],
10.1002/hep.1840150504,"Scotiniotis, I., Brass, C., Malet, P., , Hepatitis C, Journal of General Internal Medicine, 1995",cited-by,10.1007/BF02599887,Hepatitis C,"[['Ilias', '', 'Scotiniotis'], ['Clifford', 'A.', 'Brass'], ['Peter', 'F.', 'Malet']]",Journal of General Internal Medicine,1995,"[u'http://www.springerlink.com/index/q2728h7q648114n1.pdf', u'http://www.springerlink.com/content/q2728h7q648114n1', u'http://www.springerlink.com/index/10.1007/BF02599887', u'http://www.springerlink.com/index/pdf/10.1007/BF02599887']",
10.1002/hep.1840150504,"Poignet, J., Degos, F., Bouchardeau, F., et. al, Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse, Journal of Hepatology, 1995",cited-by,10.1016/0168-8278(95)80042-5,Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse,"[['Jean-Louis', '', 'Poignet'], ['Fran\xc3\xa7oise', '', 'Degos'], ['Fran\xc3\xa7oise', '', 'Bouchardeau'], ['Philippe', '', 'Chauveau'], ['Anne', 'Marie', 'Courouce']]",Journal of Hepatology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0168827895800425', u'http://linkinghub.elsevier.com/retrieve/pii/0168827895800425']",
10.1002/hep.1840150504,"Lampertico, P., Rumi, M., Romeo, R., et. al, A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C, Hepatology, 1994",cited-by,10.1002/hep.1840190105,A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C,"[['Pietro', '', 'Lampertico'], ['Mariagrazia', '', 'Rumi'], ['Raffaella', '', 'Romeo'], ['Antonio', '', 'Craxi'], ['Roberta', '', 'Soffredini'], ['Daniela', '', 'Biassoni'], ['Massimo', '', 'Colombo']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840190105'],
10.1002/hep.1840150504,"craxì, A., Marco, V., Cammà, C., et. al, Duration of HCV infection as a predictor of nonresponse to interferon, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087881,Duration of HCV infection as a predictor of nonresponse to interferon,"[['Antonio', '', 'crax\xc3\xac'], ['Vito', 'Di', 'Marco'], ['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Silvio', '', 'Magrin']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/content/x1807m2613532562', u'http://www.springerlink.com/index/x1807m2613532562.pdf', u'http://www.springerlink.com/index/10.1007/BF02087881', u'http://www.springerlink.com/index/pdf/10.1007/BF02087881']",
10.1002/hep.1840150504,"Flora, K., Schiele, M., Benner, K., et. al, An Outbreak of Acute Hepatitis C Among Recipients of Intravenous Immunoglobulin, Annals of Allergy Asthma & Immunology, 1996",cited-by,10.1016/S1081-1206(10)63416-3,An Outbreak of Acute Hepatitis C Among Recipients of Intravenous Immunoglobulin,"[['Kenneth', '', 'Flora'], ['Mark', '', 'Schiele'], ['Kent', '', 'Benner'], ['Anthony', '', 'Montanaro'], ['Wendy', '', 'Johnston'], ['Ruth', '', 'Whitham']]",Annals of Allergy Asthma & Immunology,1996,"[u'http://www.sciencedirect.com/science/article/pii/S1081120610634163', u'http://linkinghub.elsevier.com/retrieve/pii/S1081120610634163']",
10.1002/hep.1840150504,"Crofts, N., Thompson, S., Kaldor, J., , Epidemiology of the hepatitis C virus, , 0",cited-by,13091937Epidemiology of the hepatitis C virus,Epidemiology of the hepatitis C virus,"[['Nick', '', 'Crofts'], ['Sandy', '', 'Thompson'], ['John', '', 'Kaldor']]",,0,"[u'http://www.foodsecretariat.health.gov.au/internet/main/publishing.nsf/Content/cda-cditech-hepc.htm/$FILE/hepc_epidemiology.pdf', u'http://www.foodsecretariat.health.gov.au/internet/main/publishing.nsf/Content/FB79CD1ECA5FA8A9CA256F180083147E/$File/hepc_epidemiology.pdf', u'http://www6.health.gov.au/internet/main/publishing.nsf/Content/cda-cditech-hepc.htm/$FILE/hepc_epidemiology.pdf']",
10.1002/hep.1840150504,"Lau, J., , Hepatitis C virus: From epidemiology and molecular virology to immunobiology, Hepatology, 1994",cited-by,10.1002/hep.1840200330,Hepatitis C virus: From epidemiology and molecular virology to immunobiology,"[['Johnson', 'Y. N.', 'Lau']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840200330'],
10.1002/hep.1840150504,"Wiegand, J., Potthoff, A., Manns, M., et. al, Acute hepatitis C infection: Can immunology teach us the right way to treat?, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0025-6,Acute hepatitis C infection: Can immunology teach us the right way to treat?,"[['Johannes', '', 'Wiegand'], ['Andrej', '', 'Potthoff'], ['Michael', 'P.', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/x7212685g77j1132.pdf', u'http://www.springerlink.com/content/x7212685g77j1132', u'http://www.springerlink.com/index/10.1007/s11901-004-0025-6', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0025-6']",
10.1002/hep.1840150504,"Jonas, M., , VIRAL HEPATITIS, Clinics in Liver Disease, 2000",cited-by,10.1016/S1089-3261(05)70145-8,VIRAL HEPATITIS,"[['Maureen', 'M.', 'Jonas']]",Clinics in Liver Disease,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105701458', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105701458']",
10.1002/hep.1840150504,"Chen, P., Hwang, L., Chang, L., et. al, Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications, Journal of Gastroenterology, 1993",cited-by,10.1007/BF02989209,Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications,"[['Pei-Jer', '', 'Chen'], ['Lih-Hwa', '', 'Hwang'], ['Li-Yen', '', 'Chang'], ['Jia-Horng', '', 'Kao'], ['Ding-Shinn', '', 'Chen']]",Journal of Gastroenterology,1993,"[u'http://www.springerlink.com/content/874314260253t153', u'http://www.springerlink.com/index/874314260253t153.pdf', u'http://www.springerlink.com/index/10.1007/BF02989209', u'http://www.springerlink.com/index/pdf/10.1007/BF02989209']",
10.1002/hep.1840150504,"Rodriguez-Gomez, S., Serna-Higuera, C., Pérez-Villoria, A., et. al, Peginterferon and ribavirin in a patient with acute hepatitis C, American Journal of Gastroenterology, 2003",cited-by,10.1111/j.1572-0241.2003.07656.x,Peginterferon and ribavirin in a patient with acute hepatitis C,"[['Santiago', 'J.', 'Rodriguez-Gomez'], ['Carlos', 'de la', 'Serna-Higuera'], ['Antonio', '', 'P\xc3\xa9rez-Villoria'], ['Juan', '', 'Mart\xc3\xadnez-Moreno'], ['Alejandro', '', 'Betancourt-Gonz\xc3\xa1lez'], ['M.', 'Isabel', 'Martin-Arribas']]",American Journal of Gastroenterology,2003,"[u'http://dx.doi.org/10.1111/j.1572-0241.2003.07656.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.07656.x']",
10.1002/hep.1840150504,"Hoofnagle, J., RESTREPO, J., Jaime, J., et. al, 4 Acute hepatitis C, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80008-3,4 Acute hepatitis C,"[['Jay', 'H.', 'Hoofnagle'], ['JUAN', 'CARLOS', 'RESTREPO'], ['John', '', 'Jaime'], ['Juan', '', 'Carlos'], ['Restrepo', '', 'Guti\xc3\xa9rrez'], ['Guti\xc3\xa9rrez', '', 'Calle']]",Biomedical Research Reports,2000,"[u'http://www.scielo.org.co/pdf/amc/v33n1/v33n1a6.pdf', u'http://www.sciencedirect.com/science/article/pii/S1874532600800083', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800083']",
10.1002/hep.1840150504,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1002/hep.1840150504,"Thévenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C,"[['T.', '', 'Th\xc3\xa9venot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00271.x'],
10.1002/hep.1840150504,"Gürsoy, M., Gür, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection,"[['Murat', '', 'G\xc3\xbcrsoy'], ['G.', '', 'G\xc3\xbcr'], ['H.', '', 'Arslan'], ['N.', '', '\xc3\x96zdemir']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00268.x'],
10.1002/hep.1840150504,"GUAN, R., HO, K., KANG, J., et. al, The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis, Alimentary Pharmacology & Therapeutics, 2007",cited-by,10.1111/j.1365-2036.1995.tb00441.x,The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis,"[['R.', '', 'GUAN'], ['K.', 'Y.', 'HO'], ['J.', 'Y.', 'KANG'], ['I.', '', 'YAP'], ['K.', 'A.', 'GWEE'], ['C.', 'C.', 'TAN']]",Alimentary Pharmacology & Therapeutics,2007,[u'http://doi.wiley.com/10.1111/j.1365-2036.1995.tb00441.x'],
10.1002/hep.1840150504,"Rodríguez-Gómez, S., Serna-Higuera, C., Pérez-Villoria, A., et. al, Peginterferon and ribavirin in a patient with acute hepatitis C, American Journal of Gastroenterology, 2003",cited-by,10.1016/S0002-9270(03)00619-1,Peginterferon and ribavirin in a patient with acute hepatitis C,"[['Santiago', 'J.', 'Rodr\xc3\xadguez-G\xc3\xb3mez'], ['Carlos', 'de la', 'Serna-Higuera'], ['Antonio', '', 'P\xc3\xa9rez-Villoria'], ['Juan', '', 'Mart\xc3\xadnez-Moreno'], ['Alejandro', '', 'Betancourt-Gonz\xc3\xa1lez'], ['M.', 'Isabel', 'Mart\xc3\xadn-Arribas']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003006191', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003006191']",
10.1002/hep.1840150504,"Bailly, F., Trepo, C., , Traitement de l'hépatite virale C, Medecine Et Maladies Infectieuses, 1995",cited-by,10.1016/S0399-077X(05)80900-X,Traitement de l'hépatite virale C,"[['F.', '', 'Bailly'], ['C.', '', 'Trepo']]",Medecine Et Maladies Infectieuses,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0399077X0580900X', u'http://linkinghub.elsevier.com/retrieve/pii/S0399077X0580900X']",
10.1002/hep.1840150504,"Tran, T., Poordad, F., Martin, P., , Treatment of hepatitis C, Reviews in Medical Virology, 1993",cited-by,10.1002/rmv.1980030403,Treatment of hepatitis C,"[['Tram', 'T.', 'Tran'], ['Fred', '', 'Poordad'], ['Paul', '', 'Martin']]",Reviews in Medical Virology,1993,"[u'http://www.congrex.ch/escmidsummerschool2008/pdf/educationalmaterial/l13_rockstroh_treatment_hepatitis_intro.pdf', u'http://doi.wiley.com/10.1002/rmv.1980030403', u'http://www.springerlink.com/index/10.1007/s11901-003-0008-z', u'http://www.springerlink.com/index/pdf/10.1007/s11901-003-0008-z']",
10.1002/hep.1840150504,"Schiff, E., , Hepatitis C among health care providers: Risk factors and possible prophylaxis, Hepatology, 1992",cited-by,10.1002/hep.1840160528,Hepatitis C among health care providers: Risk factors and possible prophylaxis,"[['Eugene', 'R.', 'Schiff']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840160528'],
10.1056~NEJMoa011232,"Lampertico P, Rumi M, Romeo R, et al. A multicenter randomized controlled trial of recombinant interferon-a2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19-22.",references,10.1002/hep.1840190105,A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C,"[[u'Pietro', u'', u'Lampertico'], [u'Mariagrazia', u'', u'Rumi'], [u'Raffaella', u'', u'Romeo'], [u'Antonio', u'', u'Craxi'], [u'Roberta', u'', u'Soffredini'], [u'Daniela', u'', u'Biassoni'], [u'Massimo', u'', u'Colombo']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840190105'],"[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Randomized Controlled Trial', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 34323}]"
10.1002/hep.1840190105,"Cicardi, M., Mannucci, P., Castelli, R., et. al, Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate, Transfusion, 1995",cited-by,10.1046/j.1537-2995.1995.35395184276.x,Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate,"[['M.', '', 'Cicardi'], ['P.', 'M.', 'Mannucci'], ['R.', '', 'Castelli'], ['M.', 'G.', 'Rumi'], ['A.', '', 'Agostoni']]",Transfusion,1995,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1537-2995.1995.35395184276.x'],
10.1002/hep.1840190105,"Davis, G., , TREATMENT OF ACUTE AND CHRONIC HEPATITIS C, Clinics in Liver Disease, 1997",cited-by,10.1016/S1089-3261(05)70325-1,TREATMENT OF ACUTE AND CHRONIC HEPATITIS C,"[['Gary', 'L.', 'Davis']]",Clinics in Liver Disease,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105703251', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105703251']",
10.1002/hep.1840190105,"Wiegand, J., Potthoff, A., Manns, M., et. al, Acute hepatitis C infection: Can immunology teach us the right way to treat?, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0025-6,Acute hepatitis C infection: Can immunology teach us the right way to treat?,"[['Johannes', '', 'Wiegand'], ['Andrej', '', 'Potthoff'], ['Michael', 'P.', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/x7212685g77j1132.pdf', u'http://www.springerlink.com/content/x7212685g77j1132', u'http://www.springerlink.com/index/10.1007/s11901-004-0025-6', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0025-6']",
10.1002/hep.1840190105,"Thévenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C,"[['T.', '', 'Th\xc3\xa9venot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00271.x'],
10.1002/hep.1840190105,"Gürsoy, M., Gür, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection,"[['Murat', '', 'G\xc3\xbcrsoy'], ['G.', '', 'G\xc3\xbcr'], ['H.', '', 'Arslan'], ['N.', '', '\xc3\x96zdemir']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00268.x'],
10.1002/hep.1840190105,"GUAN, R., HO, K., KANG, J., et. al, The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis, Alimentary Pharmacology & Therapeutics, 2007",cited-by,10.1111/j.1365-2036.1995.tb00441.x,The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis,"[['R.', '', 'GUAN'], ['K.', 'Y.', 'HO'], ['J.', 'Y.', 'KANG'], ['I.', '', 'YAP'], ['K.', 'A.', 'GWEE'], ['C.', 'C.', 'TAN']]",Alimentary Pharmacology & Therapeutics,2007,[u'http://doi.wiley.com/10.1111/j.1365-2036.1995.tb00441.x'],
10.1002/hep.1840190105,"Alscher, D., Bode, J., , Therapie der Hepatitis C, Medizinische Klinik, 1997",cited-by,10.1007/BF03043273,Therapie der Hepatitis C,"[['Dominik', 'M.', 'Alscher'], ['J.', 'Christian', 'Bode']]",Medizinische Klinik,1997,"[u'http://www.springerlink.com/content/2702248261846xx2', u'http://www.springerlink.com/index/2702248261846xx2.pdf', u'http://www.springerlink.com/index/10.1007/BF03043273', u'http://www.springerlink.com/index/pdf/10.1007/BF03043273']",
10.1056~NEJMoa011232,"Alberti A, Chemello L, Belussi F, Pontisso P, Tisminetzky S, Gerotto M. Outcome of acute hepatitis C and role of interferon alpha therapy. In: Nishioka KSH, Oda T, eds. Viral hepatitis and liver disease. Tokyo, Japan: Springer-Verlag, 1994:604-60.",references,NOT found in MAS
10.1056~NEJMoa011232,"Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Cooperative Study Group. Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Gastroenterology 1994; 107:805-11",references,NOT found in MAS
10.1056~NEJMoa011232,"Omata M, Yokosuka O, Takano S, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991;338:914-5.",references,10.1016/0140-6736(91)91774-O,Resolution of acute hepatitis C after therapy with natural beta interferon,"[[u'M', u'', u'OMATA']]",Lancet,1991,[u'http://linkinghub.elsevier.com/retrieve/pii/014067369191774O'],"[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}]"
10.1016/0140-6736(91)91774-O,"Okada, S., Akahane, Y., Suzuki, H., et. al, The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients, Hepatology, 1992",cited-by,10.1002/hep.1840160302,The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients,"[['Shun-Ichi', '', 'Okada'], ['Yoshihirc', '', 'Akahane'], ['Hiroshi', '', 'Suzuki'], ['Hiroaki', '', 'Okamoto'], ['Shunji', '', 'Mishiro']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840160302'],
10.1016/0140-6736(91)91774-O,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1016/0140-6736(91)91774-O,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1016/0140-6736(91)91774-O,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1016/0140-6736(91)91774-O,"Kamal, S., Fouly, A., Kamel, R., et. al, Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.01.034,Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response,"[['Sanaa', 'M.', 'Kamal'], ['Amr', 'E.', 'Fouly'], ['Refaat', 'R.', 'Kamel'], ['Bridgette', '', 'Hockenjos'], ['Ahmed', 'Al', 'Tawil'], ['Khalifa', 'E.', 'Khalifa'], ['Qi', '', 'He'], ['Margaret', 'J.', 'Koziel'], ['Khairy', 'M. El', 'Naggar'], ['Jens', '', 'Rasenack'], ['Nezam', 'H.', 'Afdhal']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506000618', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506000618']",
10.1016/0140-6736(91)91774-O,"Simon, N., Couroucé, A., Lemarrec, N., et. al, A twelve year natural history of hepatitis C virus infection in hemodialyzed patients, Kidney International, 1994",cited-by,10.1038/ki.1994.301,A twelve year natural history of hepatitis C virus infection in hemodialyzed patients,"[['Nicole', '', 'Simon'], ['Anne-Marie', '', 'Courouc\xc3\xa9'], ['Nadine', '', 'Lemarrec'], ['Christian', '', 'Tr\xc3\xa9po'], ['St\xc3\xa9phane', '', 'Ducamp']]",Kidney International,1994,"[u'http://www.nature.com/doifinder/10.1038/ki.1994.301', u'http://dx.doi.org/10.1038/ki.1994.301']",
10.1016/0140-6736(91)91774-O,"Thevenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update,"[['T.', '', 'Thevenot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00271.x'],
10.1016/0140-6736(91)91774-O,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1016/0140-6736(91)91774-O,"Rosen, H., , Acquisition of hepatitis C by a conjunctival splash, American Journal of Infection Control, 1997",cited-by,10.1016/S0196-6553(97)90011-0,Acquisition of hepatitis C by a conjunctival splash,"[['Hugo', 'R.', 'Rosen']]",American Journal of Infection Control,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0196655397900110', u'http://linkinghub.elsevier.com/retrieve/pii/S0196655397900110']",
10.1016/0140-6736(91)91774-O,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1016/0140-6736(91)91774-O,"Viladomiu, L., Genescà, J., Esteban, J., et. al, Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial, Hepatology, 1992",cited-by,10.1002/hep.1840150504,"Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial","[['Lluis', '', 'Viladomiu'], ['Joan', '', 'Genesc\xc3\xa0'], ['Juan', 'I.', 'Esteban'], ['Helena', '', 'Allende'], ['Antonio', '', 'Gonz\xc3\xa1lez'], ['Juan', 'Carlos', 'L\xc3\xb3pez-Talavera'], ['Rafael', '', 'Esteban'], ['Jaime', '', 'Guardia']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840150504'],
10.1016/0140-6736(91)91774-O,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1016/0140-6736(91)91774-O,"Kanazawa, Y., Hayashi, N., Mita, E., et. al, Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients, Hepatology, 1994",cited-by,10.1002/hep.1840200504,Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients,"[['Yoshiyuki', '', 'Kanazawa'], ['Norio', '', 'Hayashi'], ['Eiji', '', 'Mita'], ['Tiancheng', '', 'Li'], ['Hideki', '', 'Hagiwara'], ['Akinori', '', 'Kasahara'], ['Hideyuki', '', 'Fusamoto'], ['Takenobu', '', 'Kamada']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840200504'],
10.1016/0140-6736(91)91774-O,"McRae, B., Picker, L., Seventer, G., , Human recombinant interferon-β influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors, European Journal of Immunology, 1997",cited-by,10.1002/eji.1830271026,Human recombinant interferon-β influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors,"[['Bradford', 'L.', 'McRae'], ['Louis', 'J.', 'Picker'], ['Gijs', 'A. van', 'Seventer']]",European Journal of Immunology,1997,[u'http://doi.wiley.com/10.1002/eji.1830271026'],
10.1016/0140-6736(91)91774-O,"Omata, M., Yoshida, H., Shiratori, Y., , Prevention of Hepatocellular Carcinoma and Its Recurrence in Chronic Hepatitis C Patients by Interferon Therapy, Clinical Gastroenterology and Hepatology, 2005",cited-by,10.1016/S1542-3565(05)00713-5,Prevention of Hepatocellular Carcinoma and Its Recurrence in Chronic Hepatitis C Patients by Interferon Therapy,"[['Masao', '', 'Omata'], ['Haruhiko', '', 'Yoshida'], ['Yasushi', '', 'Shiratori']]",Clinical Gastroenterology and Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1542356505007135', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356505007135']",
10.1016/0140-6736(91)91774-O,"Vosnides, G., , Hepatitis C in renal transplanation, Kidney International, 1997",cited-by,10.1038/ki.1997.403,Hepatitis C in renal transplanation,"[['Gregory', 'G', 'Vosnides']]",Kidney International,1997,"[u'http://www.nature.com/doifinder/10.1038/ki.1997.403', u'http://dx.doi.org/10.1038/ki.1997.403']",
10.1016/0140-6736(91)91774-O,"Higuchi, M., Tanaka, E., Kiyosawa, K., , Epidemiology and Clinical Aspects on Hepatitis C, , 0",cited-by,10910108Epidemiology and Clinical Aspects on Hepatitis C,Epidemiology and Clinical Aspects on Hepatitis C,"[['Makoto', '', 'Higuchi'], ['Eiji', '', 'Tanaka'], ['Kendo', '', 'Kiyosawa']]",,0,[u'http://www.nih.go.jp/JJID/R-19.pdf'],
10.1016/0140-6736(91)91774-O,"Vogel, W., Graziadei, I., Umlauft, F., et. al, High-dose interferon-α 2b treatment prevents chronicity in acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087880,High-dose interferon-α 2b treatment prevents chronicity in acute hepatitis C,"[['Wolfgang', '', 'Vogel'], ['Ivo', '', 'Graziadei'], ['Florian', '', 'Umlauft'], ['Christian', '', 'Datz'], ['Franz', '', 'Hackl'], ['Stefan', '', 'Allinger'], ['Kurt', '', 'Gr\xc3\xbcnewald'], ['Josef', '', 'Patsch']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/h171xx22x8q37l17.pdf', u'http://www.springerlink.com/content/h171xx22x8q37l17', u'http://www.springerlink.com/index/10.1007/BF02087880', u'http://www.springerlink.com/index/pdf/10.1007/BF02087880']",
10.1016/0140-6736(91)91774-O,"TAKAGI, H., UEHARA, M., KAKIZAKI, S., et. al, Accidental transmission of HCV and treatment with interferon, Journal of Gastroenterology and Hepatology, 1998",cited-by,10.1111/j.1440-1746.1998.01564.x,Accidental transmission of HCV and treatment with interferon,"[['HITOSHI', '', 'TAKAGI'], ['MASAHIRO', '', 'UEHARA'], ['SATORU', '', 'KAKIZAKI'], ['HITOMI', '', 'TAKAHASHI'], ['JIROU', '', 'TAKEZAWA'], ['KENJI', '', 'KABEYA'], ['KEN', '', 'SATOH'], ['AKIRA', '', 'KOJIMA'], ['SHUICHI', '', 'SAITO'], ['TATSUHIKO', '', 'MATSUMOTO'], ['YOSHIAKI', '', 'HASHIMOTO'], ['TAKEHIKO', '', 'ABE'], ['TOSHIHIKO', '', 'YAMADA'], ['KAZUKO', '', 'KONAKA'], ['RYUYA', '', 'SHIMODA'], ['HISASHI', '', 'TAKAYAMA'], ['KEN', '', 'TAKEHARA'], ['TAKEAKI', '', 'NAGAMINE'], ['MASATOMO', '', 'MORI']]",Journal of Gastroenterology and Hepatology,1998,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1998.01564.x'],
10.1016/0140-6736(91)91774-O,"ASAHINA, Y., IZUMI, N., UCHIHARA, M., et. al, A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta, , 0",cited-by,12344390A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta,A Potent Antiviral Effect on Hepatitis C Viral Dynamics in Serum and Peripheral Blood Mononuclear Cells During Combination Therapy With High-Dose Daily Interferon Alfa Plus Ribavirin and Intravenous Twice-Daily Treatment With Interferon Beta,"[['YASUHIRO', '', 'ASAHINA'], ['N', 'AMIKI', 'IZUMI'], ['M', 'ASAKATSU', 'UCHIHARA'], ['O', 'SAMU', 'NOGUCHI'], ['K', 'AORU', 'TSUCHIYA'], ['K', 'OSEI', 'HAMANO'], ['NOBUHIKO', '', 'KANAZAWA'], ['J', 'UN', 'ITAKURA'], ['S', 'HOZO', 'MIYAKE'], ['TAKAHIRO', '', 'SAKAI']]",,0,[u'http://www.infeksiyon.org/docs/pdf/literaturden_secmeler/A%20Potent%20Antiviral%20Effect%20on%20Hepatitis%20C%20Viral%20Dynamics%20by%20High-Dose%20Daily%20Interferon%20Alfa%20Plus%20Ribavirin.pdf'],
10.1016/0140-6736(91)91774-O,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
10.1016/0140-6736(91)91774-O,"Omata, M., Yoshida, H., , Prevention and treatment of hepatocellular carcinoma, Liver Transplantation, 2004",cited-by,10.1002/lt.20046,Prevention and treatment of hepatocellular carcinoma,"[['Masao', '', 'Omata'], ['Haruhiko', '', 'Yoshida']]",Liver Transplantation,2004,[u'http://doi.wiley.com/10.1002/lt.20046'],
10.1016/0140-6736(91)91774-O,"Gong, G., Lai, L., Jiang, Y., et. al, HCV replication in PBMC and its influence on interferon therapy, , 2003",cited-by,14188411HCV replication in PBMC and its influence on interferon therapy,HCV replication in PBMC and its influence on interferon therapy,"[['Guo-Zhong', '', 'Gong'], ['Li-Ying', '', 'Lai'], ['Yong-Fang', '', 'Jiang'], ['Yan', '', 'He'], ['Xian-Shi', '', 'Su']]",,2003,[u'http://www.wjgnet.com/1007-9327/9/291.pdf'],
10.1016/0140-6736(91)91774-O,"Vogel, W., , Treatment of acute hepatitis C virus infection, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80399-7,Treatment of acute hepatitis C virus infection,"[['Wolfgang', '', 'Vogel']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803997', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803997']",
10.1016/0140-6736(91)91774-O,"Hoofnagle, J., , Therapy of Viral Hepatitis, Digestion, 1998",cited-by,10.1159/000007532,Therapy of Viral Hepatitis,"[['Jay', 'H.', 'Hoofnagle']]",Digestion,1998,"[u'http://www.online.karger.com/doi/10.1159/000007532', u'http://www.karger.com/doi/10.1159/000007532']",
10.1016/0140-6736(91)91774-O,"Durand, J., Kaplanski, G., Richard, M., et. al, Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction, British Journal of Dermatology, 1993",cited-by,10.1111/j.1365-2133.1993.tb00189.x,Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction,"[['J.', 'M.', 'Durand'], ['G', '', 'Kaplanski'], ['M.', 'A.', 'Richard'], ['P.', '', 'Lefevre'], ['N.', '', 'Quiles'], ['C.', '', 'Trepo'], ['J.', '', 'Soubeyrand']]",British Journal of Dermatology,1993,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.1993.tb00189.x'],
10.1016/0140-6736(91)91774-O,"Asahina, Y., Izumi, N., Uchihara, M., et. al, Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00287-3,Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens,"[['Yasuhiro', '', 'Asahina'], ['Namiki', '', 'Izumi'], ['Masakatsu', '', 'Uchihara'], ['Osamu', '', 'Noguchi'], ['Yuki', '', 'Nishimura'], ['Kazunari', '', 'Inoue'], ['Ken', '', 'Ueda'], ['Kaoru', '', 'Tsuchiya'], ['Kosei', '', 'Hamano'], ['Jun', '', 'Itakura'], ['Shozo', '', 'Miyake']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803002873', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803002873']",
10.1016/0140-6736(91)91774-O,"Cammà, C., Almasio, P., Craxì, A., , Interferon as treatment for acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02088245,Interferon as treatment for acute hepatitis C,"[['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Antonio', '', 'Crax\xc3\xac']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/vr3137877v301j64.pdf', u'http://www.springerlink.com/content/vr3137877v301j64', u'http://www.springerlink.com/index/10.1007/BF02088245', u'http://www.springerlink.com/index/pdf/10.1007/BF02088245']",
10.1016/0140-6736(91)91774-O,"NAKANO, Y., KIYOSAWA, K., SODEYAMA, T., et. al, Acute hepatitis C transmitted by needlestick accident despite short duration interferon treatment, Journal of Gastroenterology and Hepatology, 1995",cited-by,10.1111/j.1440-1746.1995.tb01355.x,Acute hepatitis C transmitted by needlestick accident despite short duration interferon treatment,"[['YOSHIYUKI', '', 'NAKANO'], ['KENDO', '', 'KIYOSAWA'], ['TAKESHI', '', 'SODEYAMA'], ['EIJI', '', 'TANAKA'], ['AKIHIRO', '', 'MATSUMOTO'], ['TETSUYA', '', 'ICHIJO'], ['MASASHI', '', 'MIZOKAMI'], ['SEIICHI', '', 'FURUTA']]",Journal of Gastroenterology and Hepatology,1995,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1995.tb01355.x'],
10.1016/0140-6736(91)91774-O,"Arai, Y., Noda, K., Enomoto, N., et. al, A prospective study of hepatitis C virus infection after needlestick accidents, Liver, 2008",cited-by,10.1111/j.1600-0676.1996.tb00755.x,A prospective study of hepatitis C virus infection after needlestick accidents,"[['Yumi', '', 'Arai'], ['Katsuhisa', '', 'Noda'], ['Norihiro', '', 'Enomoto'], ['Keiichi', '', 'Arai'], ['Yukinori', '', 'Yamada'], ['Kunio', '', 'Suzuki'], ['Harumasa', '', 'Yoshihara']]",Liver,2008,[u'http://doi.wiley.com/10.1111/j.1600-0676.1996.tb00755.x'],
10.1016/0140-6736(91)91774-O,"Festi, D., Sandri, L., Mazzella, G., et. al, Safety of interferon β treatment for chronic HCV hepatitis, , 2004",cited-by,5900181Safety of interferon β treatment for chronic HCV hepatitis,Safety of interferon β treatment for chronic HCV hepatitis,"[['D', '', 'Festi'], ['L', '', 'Sandri'], ['G', '', 'Mazzella'], ['E', '', 'Rod'], ['T', '', 'Sacco'], ['T', '', 'Staniscia'], ['S', '', 'Capodicasa'], ['A', '', 'Vestito'], ['A', '', 'Colecchia']]",,2004,"[u'http://wjg.wjgnet.com/1007-9327/10/12.pdf', u'http://www.wjgnet.com/1007-9327/10/12.pdf']",
10.1016/0140-6736(91)91774-O,"Cheng, P., Marcellin, P., Bacon, B., et. al, Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00514.x,Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients,"[['P.-N.', '', 'Cheng'], ['P.', '', 'Marcellin'], ['B.', '', 'Bacon'], ['G.', '', 'Farrell'], ['I.', '', 'Parsons'], ['T.', '', 'Wee'], ['T.-T.', '', 'Chang']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00514.x'],
10.1016/0140-6736(91)91774-O,"Tanaka, E., Kiyosawa, K., , Natural history of acute hepatitis C, Journal of Gastroenterology and Hepatology, 2000",cited-by,10.1046/j.1440-1746.2000.02112.x,Natural history of acute hepatitis C,"[['Eiji', '', 'Tanaka'], ['Kendo', '', 'Kiyosawa']]",Journal of Gastroenterology and Hepatology,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2000.02112.x'],
10.1016/0140-6736(91)91774-O,"Pérez, R., Pravia, R., Artímez, M., et. al, Clinical efficacy of intramuscular human interferon-β vs interferon-α2b for the treatment of chronic hepatitis C, Journal of Viral Hepatitis, 1995",cited-by,10.1111/j.1365-2893.1995.tb00014.x,Clinical efficacy of intramuscular human interferon-β vs interferon-α2b for the treatment of chronic hepatitis C,"[['R.', '', 'P\xc3\xa9rez'], ['R.', '', 'Pravia'], ['M.', 'L.', 'Art\xc3\xadmez'], ['F.', '', 'Giganto'], ['M.', '', 'Rodr\xc3\xadguez'], ['J.', 'L. S.', 'Lombra\xc3\xb1a'], ['L.', '', 'Rodrigo']]",Journal of Viral Hepatitis,1995,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.1995.tb00014.x'],
10.1016/0140-6736(91)91774-O,"Davis, G., , TREATMENT OF ACUTE AND CHRONIC HEPATITIS C, Clinics in Liver Disease, 1997",cited-by,10.1016/S1089-3261(05)70325-1,TREATMENT OF ACUTE AND CHRONIC HEPATITIS C,"[['Gary', 'L.', 'Davis']]",Clinics in Liver Disease,1997,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105703251', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105703251']",
10.1016/0140-6736(91)91774-O,"Dusheiko, G., , Treatment and prevention of chronic viral hepatitis, Pharmacology & Therapeutics, 1995",cited-by,10.1016/0163-7258(94)00056-9,Treatment and prevention of chronic viral hepatitis,"[['G.', 'M.', 'Dusheiko']]",Pharmacology & Therapeutics,1995,"[u'http://www.sciencedirect.com/science/article/pii/0163725894000569', u'http://linkinghub.elsevier.com/retrieve/pii/0163725894000569']",
10.1016/0140-6736(91)91774-O,"Chung, H., Kudo, M., Kumada, T., et. al, Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel, Journal of Gastroenterology, 2003",cited-by,10.1007/s00535-003-1156-1,"Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel","[['Hobyung', '', 'Chung'], ['Masatoshi', '', 'Kudo'], ['Takashi', '', 'Kumada'], ['Shinji', '', 'Katsushima'], ['Akihiro', '', 'Okano'], ['Takefumi', '', 'Nakamura'], ['Yukio', '', 'Osaki'], ['Katsuji', '', 'Kohigashi'], ['Yukitaka', '', 'Yamashita'], ['Hideshi', '', 'Komori'], ['Shinichi', '', 'Nishiuma']]",Journal of Gastroenterology,2003,"[u'http://www.springerlink.com/content/j275bp1bydtgr11l', u'http://www.springerlink.com/index/j275bp1bydtgr11l.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00535-003-1156-1', u'http://www.springerlink.com/index/pdf/10.1007/s00535-003-1156-1']",
10.1016/0140-6736(91)91774-O,"Al-Khatib, K., Williams, B., Silverman, R., et. al, Absence of PKR Attenuates the Anti-HSV-1 Activity of an Adenoviral Vector Expressing Murine IFN, Journal of Interferon and Cytokine Research, 2002",cited-by,10.1089/107999002760274872,Absence of PKR Attenuates the Anti-HSV-1 Activity of an Adenoviral Vector Expressing Murine IFN,"[['Khaldun', '', 'Al-Khatib'], ['Bryan', 'R. G.', 'Williams'], ['Robert', 'H.', 'Silverman'], ['William', 'P.', 'Halford'], ['Daniel', 'J. J.', 'Carr']]",Journal of Interferon and Cytokine Research,2002,[u'http://www.liebertonline.com/doi/abs/10.1089%2F107999002760274872'],
10.1016/0140-6736(91)91774-O,"Weiland, O., , Interferon therapy in chronic hepatitis C virus infection, Fems Microbiology Reviews, 1994",cited-by,10.1111/j.1574-6976.1994.tb00100.x,Interferon therapy in chronic hepatitis C virus infection,"[['Ola', '', 'Weiland']]",Fems Microbiology Reviews,1994,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1574-6976.1994.tb00100.x'],
10.1016/0140-6736(91)91774-O,"Rosengren, A., Nyman, T., Syyrakki, S., et. al, Proteomic and transcriptomic characterization of interferon-?-induced human primary T helper cells, Proteomics, 2005",cited-by,10.1002/pmic.200400967,Proteomic and transcriptomic characterization of interferon-?-induced human primary T helper cells,"[['Arsi', 'T.', 'Rosengren'], ['Tuula', 'A.', 'Nyman'], ['Saija', '', 'Syyrakki'], ['Sampsa', '', 'Matikainen'], ['Riitta', '', 'Lahesmaa']]",Proteomics,2005,[u'http://doi.wiley.com/10.1002/pmic.200400967'],
10.1016/0140-6736(91)91774-O,"Corey, K., Mendez-Navarro, J., Gorospe, E., et. al, Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis, Journal of Viral Hepatitis, 2010",cited-by,10.1111/j.1365-2893.2009.01167.x,Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis,"[['K.', 'E.', 'Corey'], ['J.', '', 'Mendez-Navarro'], ['E.', 'C.', 'Gorospe'], ['H.', '', 'Zheng'], ['R.', 'T.', 'Chung']]",Journal of Viral Hepatitis,2010,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2009.01167.x'],
10.1016/0140-6736(91)91774-O,"Matsuyama, S., Henmi, S., Ichihara, N., et. al, Protective effects of murine recombinant interferon-β administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00097-8,"Protective effects of murine recombinant interferon-β administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection","[['S', '', 'Matsuyama'], ['S', '', 'Henmi'], ['N', '', 'Ichihara'], ['S', '', 'Sone'], ['T', '', 'Kikuchi'], ['T', '', 'Ariga'], ['F', '', 'Taguchi']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200000978', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200000978']",
10.1016/0140-6736(91)91774-O,"Villa, E., Trande, P., Grottola, A., et. al, Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02088244,Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus,"[['Erica', '', 'Villa'], ['Paolo', '', 'Trande'], ['Antonella', '', 'Grottola'], ['Paola', '', 'Buttafoco'], ['Anna', 'Maria', 'Rebecchi'], ['Tommaso', '', 'Stroffolini'], ['Francesco', '', 'Callea'], ['Annalisa', '', 'Merighi'], ['Lorenzo', '', 'Camellini'], ['Patrizia', '', 'Zoboli'], ['Rossella', '', 'Cosenza'], ['Lucia', '', 'Miglioli'], ['Paola', '', 'Loria'], ['Rossella', '', 'Iori'], ['Nicola', '', 'Carulli'], ['Federico', '', 'Manenti']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/content/n40p8jl5370u7575', u'http://www.springerlink.com/index/n40p8jl5370u7575.pdf', u'http://www.springerlink.com/index/10.1007/BF02088244', u'http://www.springerlink.com/index/pdf/10.1007/BF02088244']",
10.1016/0140-6736(91)91774-O,"Itoh, Y., Okanoue, T., Sakamoto, S., et. al, Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon, Digestive Diseases and Sciences, 1995",cited-by,10.1007/BF02063248,Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon,"[['Yoshito', '', 'Itoh'], ['Takeshi', '', 'Okanoue'], ['Shinichi', '', 'Sakamoto'], ['Kenichi', '', 'Nishioji'], ['Kohichiroh', '', 'Yasui'], ['Masafumi', '', 'Sakamoto'], ['Kei', '', 'Kashima']]",Digestive Diseases and Sciences,1995,"[u'http://www.springerlink.com/index/g769386671u732kp.pdf', u'http://www.springerlink.com/content/g769386671u732kp', u'http://www.springerlink.com/index/10.1007/BF02063248', u'http://www.springerlink.com/index/pdf/10.1007/BF02063248']",
10.1016/0140-6736(91)91774-O,"Scotiniotis, I., Brass, C., Malet, P., , Hepatitis C, Journal of General Internal Medicine, 1995",cited-by,10.1007/BF02599887,Hepatitis C,"[['Ilias', '', 'Scotiniotis'], ['Clifford', 'A.', 'Brass'], ['Peter', 'F.', 'Malet']]",Journal of General Internal Medicine,1995,"[u'http://www.springerlink.com/index/q2728h7q648114n1.pdf', u'http://www.springerlink.com/content/q2728h7q648114n1', u'http://www.springerlink.com/index/10.1007/BF02599887', u'http://www.springerlink.com/index/pdf/10.1007/BF02599887']",
10.1016/0140-6736(91)91774-O,"Alam, J., , Interferon-β treatment of human disease, Current Opinion in Biotechnology, 1995",cited-by,10.1016/0958-1669(95)80113-8,Interferon-β treatment of human disease,"[['John', 'J', 'Alam']]",Current Opinion in Biotechnology,1995,"[u'http://www.sciencedirect.com/science/article/pii/0958166995801138', u'http://linkinghub.elsevier.com/retrieve/pii/0958166995801138']",
10.1016/0140-6736(91)91774-O,"Lampertico, P., Rumi, M., Romeo, R., et. al, A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C, Hepatology, 1994",cited-by,10.1002/hep.1840190105,A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C,"[['Pietro', '', 'Lampertico'], ['Mariagrazia', '', 'Rumi'], ['Raffaella', '', 'Romeo'], ['Antonio', '', 'Craxi'], ['Roberta', '', 'Soffredini'], ['Daniela', '', 'Biassoni'], ['Massimo', '', 'Colombo']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840190105'],
10.1016/0140-6736(91)91774-O,"Sata, M., Ide, T., Noguchi, S., et. al, Timing of IFN therapy initiation for acute hepatitis C after accidental needlestick, Journal of Hepatology, 1997",cited-by,10.1016/S0168-8278(97)80192-4,Timing of IFN therapy initiation for acute hepatitis C after accidental needlestick,"[['Michio', '', 'Sata'], ['Tatsuya', '', 'Ide'], ['Seiji', '', 'Noguchi'], ['Osamu', '', 'Hashimoto'], ['Ryukichi', '', 'Kumashiro'], ['Hiroshi', '', 'Suzuki'], ['Kyuichi', '', 'Tanikawa']]",Journal of Hepatology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0168827897801924', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827897801924']",
10.1016/0140-6736(91)91774-O,"craxì, A., Marco, V., Cammà, C., et. al, Duration of HCV infection as a predictor of nonresponse to interferon, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087881,Duration of HCV infection as a predictor of nonresponse to interferon,"[['Antonio', '', 'crax\xc3\xac'], ['Vito', 'Di', 'Marco'], ['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Silvio', '', 'Magrin']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/content/x1807m2613532562', u'http://www.springerlink.com/index/x1807m2613532562.pdf', u'http://www.springerlink.com/index/10.1007/BF02087881', u'http://www.springerlink.com/index/pdf/10.1007/BF02087881']",
10.1016/0140-6736(91)91774-O,"Sato, S., Fujiyama, S., Tanaka, M., et. al, IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection, Digestive Diseases and Sciences, 1994",cited-by,10.1007/BF02088141,IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection,"[['Shinjiro', '', 'Sato'], ['Shigetoshi', '', 'Fujiyama'], ['Motohiko', '', 'Tanaka'], ['Masafumi', '', 'Goto'], ['Yuko', '', 'Taura'], ['Shin-Ichi', '', 'Kawano'], ['Tatsuo', '', 'Sato'], ['Hiroyuki', '', 'Yasuo']]",Digestive Diseases and Sciences,1994,"[u'http://www.springerlink.com/content/p3v3443887857747', u'http://www.springerlink.com/index/p3v3443887857747.pdf', u'http://www.springerlink.com/index/10.1007/BF02088141', u'http://www.springerlink.com/index/pdf/10.1007/BF02088141']",
10.1016/0140-6736(91)91774-O,"Omata, M., Lesmana, L., Tateishi, R., et. al, Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, 2010",cited-by,10.1007/s12072-010-9165-7,Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma,"[['Masao', '', 'Omata'], ['Laurentius', 'A.', 'Lesmana'], ['Ryosuke', '', 'Tateishi'], ['Shi-Ming', '', 'Lin'], ['Haruhiko', '', 'Yoshida'], ['Masatoshi', '', 'Kudo'], ['Jeong', 'Min', 'Lee'], ['Byung', 'Ihn', 'Choi'], ['Ronnie', 'T. P.', 'Poon'], ['Shuichiro', '', 'Shiina'], ['Ann', 'Lii', 'Cheng'], ['Ji-Dong', '', 'Jia'], ['Shuntaro', '', 'Obi'], ['Kwang', 'Hyub', 'Han'], ['Wasim', '', 'Jafri'], ['Pierce', '', 'Chow'], ['Seng', 'Gee', 'Lim'], ['Yogesh', 'K.', 'Chawla'], ['Unggul', '', 'Budihusodo'], ['Rino', 'A.', 'Gani'], ['C.', 'Rinaldi', 'Lesmana'], ['Terawan', 'Agus', 'Putranto'], ['Yun', 'Fan', 'Liaw'], ['Shiv', 'Kumar', 'Sarin']]",Hepatology International,2010,"[u'http://www.springerlink.com/index/wvqn379453p77h71.pdf', u'http://www.springerlink.com/content/wvqn379453p77h71', u'http://www.springerlink.com/index/10.1007/s12072-010-9165-7', u'http://www.springerlink.com/index/pdf/10.1007/s12072-010-9165-7']",
10.1016/0140-6736(91)91774-O,"Cheney, C., Chopra, S., Graham, C., , HEPATITIS C, Infectious Disease Clinics of North America, 2000",cited-by,10.1016/S0891-5520(05)70125-2,HEPATITIS C,"[['Catherine', 'Petruff', 'Cheney'], ['Sanjiv', '', 'Chopra'], ['Camilla', '', 'Graham']]",Infectious Disease Clinics of North America,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005701252', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005701252']",
10.1016/0140-6736(91)91774-O,"Myers, B., Irving, W., Holungsworth, R., et. al, Hepatitis C virus infection in multi-transfused children with haematological malignancy, British Journal of Haematology, 1995",cited-by,10.1111/j.1365-2141.1995.tb05327.x,Hepatitis C virus infection in multi-transfused children with haematological malignancy,"[['B.', '', 'Myers'], ['W.', '', 'Irving'], ['R.', '', 'Holungsworth'], ['D.', '', 'Readett'], ['J.', 'S.', 'Lilleyman'], ['G.', '', 'Dolan']]",British Journal of Haematology,1995,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.1995.tb05327.x'],
10.1016/0140-6736(91)91774-O,"Crofts, N., Thompson, S., Kaldor, J., , Epidemiology of the hepatitis C virus, , 0",cited-by,13091937Epidemiology of the hepatitis C virus,Epidemiology of the hepatitis C virus,"[['Nick', '', 'Crofts'], ['Sandy', '', 'Thompson'], ['John', '', 'Kaldor']]",,0,"[u'http://www.foodsecretariat.health.gov.au/internet/main/publishing.nsf/Content/cda-cditech-hepc.htm/$FILE/hepc_epidemiology.pdf', u'http://www.foodsecretariat.health.gov.au/internet/main/publishing.nsf/Content/FB79CD1ECA5FA8A9CA256F180083147E/$File/hepc_epidemiology.pdf', u'http://www6.health.gov.au/internet/main/publishing.nsf/Content/cda-cditech-hepc.htm/$FILE/hepc_epidemiology.pdf']",
10.1016/0140-6736(91)91774-O,"Saito, T., Watanabe, H., Shao, L., et. al, Transmission of hepatitis C virus quasispecies between human adults, Hepatology Research, 2004",cited-by,10.1016/j.hepres.2004.07.007,Transmission of hepatitis C virus quasispecies between human adults,"[['Takafumi', '', 'Saito'], ['Hisayoshi', '', 'Watanabe'], ['Li', '', 'Shao'], ['Kazuo', '', 'Okumoto'], ['Etsuko', '', 'Hattori'], ['Mai', '', 'Sanjo'], ['Keiko', '', 'Misawa'], ['Akihiko', '', 'Suzuki'], ['Tadashi', '', 'Takeda'], ['Kazuhiko', '', 'Sugahara'], ['Jun-itsu', '', 'Ito'], ['Koji', '', 'Saito'], ['Hitoshi', '', 'Togashi'], ['Sumio', '', 'Kawata']]",Hepatology Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1386634604002104', u'http://linkinghub.elsevier.com/retrieve/pii/S1386634604002104']",
10.1016/0140-6736(91)91774-O,"Omata, M., Takano, S., , Occurrence of hepatocellular carcinoma in chronic viral hepatitis, Cancer Chemotherapy and Pharmacology, 1994",cited-by,10.1007/BF00686690,Occurrence of hepatocellular carcinoma in chronic viral hepatitis,"[['Masao', '', 'Omata'], ['Susumu', '', 'Takano']]",Cancer Chemotherapy and Pharmacology,1994,"[u'http://www.springerlink.com/index/n121336152u57628.pdf', u'http://www.springerlink.com/content/n121336152u57628', u'http://www.springerlink.com/index/10.1007/BF00686690', u'http://www.springerlink.com/index/pdf/10.1007/BF00686690']",
10.1016/0140-6736(91)91774-O,"Jakschies, D., Zachoval, R., Müller, R., et. al, Strong transient expression of the type I interferon–induced MxA protein in hepatitis A but not in acute hepatitis B and C, Hepatology, 1994",cited-by,10.1002/hep.1840190409,Strong transient expression of the type I interferon–induced MxA protein in hepatitis A but not in acute hepatitis B and C,"[['Detlef', '', 'Jakschies'], ['Reinhardt', '', 'Zachoval'], ['Rainer', '', 'M\xc3\xbcller'], ['Michael', '', 'Manns'], ['Klaus-Ulrich', '', 'Nolte'], ['Heinz-Kurt', '', 'Hochkeppel'], ['Michel-Andre', '', 'Horisberger'], ['Helmuth', '', 'Deicher'], ['Peter', 'Von', 'Wussow']]",Hepatology,1994,[u'http://doi.wiley.com/10.1002/hep.1840190409'],
10.1016/0140-6736(91)91774-O,"YANO, M., , Advances in hepatitis C: Seroepidemiology and natural history, Journal of Gastroenterology and Hepatology, 1992",cited-by,10.1111/j.1440-1746.1992.tb01036.x,Advances in hepatitis C: Seroepidemiology and natural history,"[['MICHITAMI', '', 'YANO']]",Journal of Gastroenterology and Hepatology,1992,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.1992.tb01036.x'],
10.1016/0140-6736(91)91774-O,"Masuzaki, R., Yoshida, H., Omata, M., , Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis, Oncology, 2010",cited-by,10.1159/000315225,Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis,"[['Ryota', '', 'Masuzaki'], ['Haruhiko', '', 'Yoshida'], ['Masao', '', 'Omata']]",Oncology,2010,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000315225', u'http://www.karger.com/doi/10.1159/000315225']",
10.1016/0140-6736(91)91774-O,"Nukaya, H., Ohno, T., Sakakibara, K., et. al, Accidental exposure to HCV antibody-positive blood in hospital and pre-emptive one-shot interferon alpha-2b treatment, Hepatology Research, 2007",cited-by,10.1111/j.1872-034X.2007.00033.x,Accidental exposure to HCV antibody-positive blood in hospital and pre-emptive one-shot interferon alpha-2b treatment,"[['Haruhiko', '', 'Nukaya'], ['Tomoyoshi', '', 'Ohno'], ['Kenji', '', 'Sakakibara'], ['Atunaga', '', 'Kato'], ['Izumi', '', 'Hasegawa'], ['Seijiro', '', 'Matunaga'], ['Masayuki', '', 'Endo'], ['Yoshito', '', 'Tanaka'], ['Noboru', '', 'Hirashima'], ['Yasuhito', '', 'Tanaka'], ['Etsuro', '', 'Orito'], ['Takashi', '', 'Joh'], ['Masashi', '', 'Mizokami']]",Hepatology Research,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1872-034X.2007.00033.x'],
10.1016/0140-6736(91)91774-O,"Ogata, K., Ide, T., Kumashiro, R., et. al, Timing of interferon therapy and sources of infection in patients with acute hepatitis C, Hepatology Research, 2006",cited-by,10.1016/j.hepres.2005.08.012,Timing of interferon therapy and sources of infection in patients with acute hepatitis C,"[['Kei', '', 'Ogata'], ['Tatsuya', '', 'Ide'], ['Ryukichi', '', 'Kumashiro'], ['Hiromitsu', '', 'Kumada'], ['Hiroshi', '', 'Yotsuyanagi'], ['Kiwamu', '', 'Okita'], ['Yoshihiro', '', 'Akahane'], ['Shuichi', '', 'Kaneko'], ['Hirohito', '', 'Tsubouchi'], ['Eiji', '', 'Tanaka'], ['Hisataka', '', 'Moriwaki'], ['Shuhei', '', 'Nishiguchi'], ['Shinichi', '', 'Kakumu'], ['Masashi', '', 'Mizokami'], ['Shiro', '', 'Iino'], ['Michio', '', 'Sata']]",Hepatology Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S138663460500330X', u'http://linkinghub.elsevier.com/retrieve/pii/S138663460500330X']",
10.1016/0140-6736(91)91774-O,"Visona, K., Baez, F., Taylor, L., et. al, Impact of Hepatitis B and Hepatitis C Virus Infections in a Hematology-Oncology Unit at a Children's Hospital in Nicaragua, 1997 to 1999, Clinical and Vaccine Immunology, 2002",cited-by,10.1128/CDLI.9.3.622-626.2002,"Impact of Hepatitis B and Hepatitis C Virus Infections in a Hematology-Oncology Unit at a Children's Hospital in Nicaragua, 1997 to 1999","[['K.', '', 'Visona'], ['Fulgencio', '', 'Baez'], ['Lizeth', '', 'Taylor'], ['R.', '', 'Berrios'], ['B.', '', 'Leon'], ['Carlos', '', 'Pacheco'], ['R.', '', 'Jiron'], ['Ronald', 'B.', 'Luftig'], ['M.', 'Mercedes', 'Somarriba']]",Clinical and Vaccine Immunology,2002,"[u'http://cdli.asm.org/cgi/reprint/9/3/622.pdf', u'http://cdli.asm.org/cgi/doi/10.1128/CDLI.9.3.622-626.2002']",
10.1016/0140-6736(91)91774-O,"DUSHEIKO, G., , Rolling review-the pathogenesis, diagnosis and management of viral hepatitis, Alimentary Pharmacology & Therapeutics, 2007",cited-by,10.1111/j.1365-2036.1994.tb00283.x,"Rolling review-the pathogenesis, diagnosis and management of viral hepatitis","[['G.', 'M.', 'DUSHEIKO']]",Alimentary Pharmacology & Therapeutics,2007,[u'http://doi.wiley.com/10.1111/j.1365-2036.1994.tb00283.x'],
10.1016/0140-6736(91)91774-O,"Moreno-Otero, R., Trapero-Marugán, M., Gómez-Domínguez, E., et. al, Is interferon-beta an alternative treatment for chronic hepatitis C?, , 2006",cited-by,6258406Is interferon-beta an alternative treatment for chronic hepatitis C?,Is interferon-beta an alternative treatment for chronic hepatitis C?,"[['Ricardo', '', 'Moreno-Otero'], ['Mar\xc3\xada', '', 'Trapero-Marug\xc3\xa1n'], ['Elena', '', 'G\xc3\xb3mez-Dom\xc3\xadnguez'], ['Luisa', '', 'Garc\xc3\xada-Buey'], ['Jos\xc3\xa9A', '', 'Moreno-Monteagudo']]",,2006,[u'http://www.wjgnet.com/1007-9327/12/2730.pdf'],
10.1016/0140-6736(91)91774-O,"Takeda, T., Tatsumi, N., Nakayama, Y., et. al, Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20233,Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens,"[['Tadashi', '', 'Takeda'], ['Nobuyuki', '', 'Tatsumi'], ['Yuji', '', 'Nakayama'], ['Takahiro', '', 'Yasuda'], ['Shuhei', '', 'Nishiguchi'], ['Shuichi', '', 'Seki']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20233'],
10.1016/0140-6736(91)91774-O,"Wiegand, J., Potthoff, A., Manns, M., et. al, Acute hepatitis C infection: Can immunology teach us the right way to treat?, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0025-6,Acute hepatitis C infection: Can immunology teach us the right way to treat?,"[['Johannes', '', 'Wiegand'], ['Andrej', '', 'Potthoff'], ['Michael', 'P.', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/x7212685g77j1132.pdf', u'http://www.springerlink.com/content/x7212685g77j1132', u'http://www.springerlink.com/index/10.1007/s11901-004-0025-6', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0025-6']",
10.1016/0140-6736(91)91774-O,"Jonas, M., , VIRAL HEPATITIS, Clinics in Liver Disease, 2000",cited-by,10.1016/S1089-3261(05)70145-8,VIRAL HEPATITIS,"[['Maureen', 'M.', 'Jonas']]",Clinics in Liver Disease,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105701458', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105701458']",
10.1016/0140-6736(91)91774-O,"Terrault, N., Feinman, S., , Interferons for viral hepatitis, Transfusion Medicine Reviews, 1995",cited-by,10.1016/S0887-7963(05)80029-X,Interferons for viral hepatitis,"[['Norah', '', 'Terrault'], ['S.', 'Victor', 'Feinman']]",Transfusion Medicine Reviews,1995,"[u'http://www.sciencedirect.com/science/article/pii/S088779630580029X', u'http://linkinghub.elsevier.com/retrieve/pii/S088779630580029X']",
10.1016/0140-6736(91)91774-O,"Chen, P., Hwang, L., Chang, L., et. al, Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications, Journal of Gastroenterology, 1993",cited-by,10.1007/BF02989209,Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications,"[['Pei-Jer', '', 'Chen'], ['Lih-Hwa', '', 'Hwang'], ['Li-Yen', '', 'Chang'], ['Jia-Horng', '', 'Kao'], ['Ding-Shinn', '', 'Chen']]",Journal of Gastroenterology,1993,"[u'http://www.springerlink.com/content/874314260253t153', u'http://www.springerlink.com/index/874314260253t153.pdf', u'http://www.springerlink.com/index/10.1007/BF02989209', u'http://www.springerlink.com/index/pdf/10.1007/BF02989209']",
10.1016/0140-6736(91)91774-O,"Tassopoulos, N., Koutelou, M., Papatheodoridis, G., et. al, Treatment of acute nonA, non-B hepatitis with interferon alpha-2b, Infection, 1992",cited-by,10.1007/BF02033074,"Treatment of acute nonA, non-B hepatitis with interferon alpha-2b","[['N.', 'C.', 'Tassopoulos'], ['Maria', '', 'Koutelou'], ['G.', '', 'Papatheodoridis'], ['Th.', '', 'Giannikakis'], ['Melpomeni', '', 'Paraloglou-Ioannides'], ['Helen', '', 'Polychronaki'], ['A.', '', 'Hatzakis']]",Infection,1992,"[u'http://www.springerlink.com/content/g814r2g91405630j', u'http://www.springerlink.com/index/10.1007/BF02033074', u'http://www.springerlink.com/index/pdf/10.1007/BF02033074']",
10.1016/0140-6736(91)91774-O,"Nguyen-Khac, E., , L’hépatite C aiguë en 2005, Gastroenterologie Clinique Et Biologique, 2005",cited-by,10.1016/S0399-8320(05)82180-3,L’hépatite C aiguë en 2005,"[['Eric', '', 'Nguyen-Khac']]",Gastroenterologie Clinique Et Biologique,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0399832005821803', u'http://linkinghub.elsevier.com/retrieve/pii/S0399832005821803']",
10.1016/0140-6736(91)91774-O,"OMATA, M., YOSHIDA, H., SHIRATORI, Y., et. al, Progression from chronic hepatitis to hepatocellular carcinoma: Natural course and treatments, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.17.s3.41.x,Progression from chronic hepatitis to hepatocellular carcinoma: Natural course and treatments,"[['MASAO', '', 'OMATA'], ['HARUHIKO', '', 'YOSHIDA'], ['YASUSHI', '', 'SHIRATORI'], ['SHUICHIRO', '', 'SHIINA']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.17.s3.41.x'],
10.1016/0140-6736(91)91774-O,"Hoofnagle, J., RESTREPO, J., Jaime, J., et. al, 4 Acute hepatitis C, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80008-3,4 Acute hepatitis C,"[['Jay', 'H.', 'Hoofnagle'], ['JUAN', 'CARLOS', 'RESTREPO'], ['John', '', 'Jaime'], ['Juan', '', 'Carlos'], ['Restrepo', '', 'Guti\xc3\xa9rrez'], ['Guti\xc3\xa9rrez', '', 'Calle']]",Biomedical Research Reports,2000,"[u'http://www.scielo.org.co/pdf/amc/v33n1/v33n1a6.pdf', u'http://www.sciencedirect.com/science/article/pii/S1874532600800083', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800083']",
10.1016/0140-6736(91)91774-O,"Main, J., , Hepatitis C: Clinical aspects, Journal of Infection, 1995",cited-by,10.1016/S0163-4453(95)80003-4,Hepatitis C: Clinical aspects,"[['Janice', '', 'Main']]",Journal of Infection,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0163445395800034', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445395800034']",
10.1016/0140-6736(91)91774-O,"Yokosuka, O., Ito, Y., Sakuma, J., et. al, Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein, Digestive Diseases and Sciences, 1993",cited-by,10.1007/BF01316791,Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein,"[['Osamu', '', 'Yokosuka'], ['Yoshimi', '', 'Ito'], ['Jun', '', 'Sakuma'], ['Fumio', '', 'Imazeki'], ['Masao', '', 'Ohto'], ['Masao', '', 'Omata']]",Digestive Diseases and Sciences,1993,"[u'http://www.springerlink.com/index/q42w461852xh0664.pdf', u'http://www.springerlink.com/content/q42w461852xh0664', u'http://www.springerlink.com/index/10.1007/BF01316791', u'http://www.springerlink.com/index/pdf/10.1007/BF01316791']",
10.1016/0140-6736(91)91774-O,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1016/0140-6736(91)91774-O,"Hirashima, N., Tanaka, Y., Kobayashi, K., et. al, A case of acute hepatitis C, most likely by interlovers sexual transmission, cured by peginterferon α2a therapy, Kanzo, 2009",cited-by,10.2957/kanzo.50.644,"A case of acute hepatitis C, most likely by interlovers sexual transmission, cured by peginterferon α2a therapy","[['Noboru', '', 'Hirashima'], ['Yasuto', '', 'Tanaka'], ['Keiko', '', 'Kobayashi'], ['Masaaki', '', 'Shimada'], ['Hiroaki', '', 'Iwase'], ['Hidemi', '', 'Goto']]",Kanzo,2009,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/kanzo/50.644?from=CrossRef'],
10.1016/0140-6736(91)91774-O,"Ahn, S., Lee, H., Kim, Y., et. al, Recombinant Interferon-Beta-1α Plus Ribavirin for the Treatment of Chronic HCV Infection: A Prospective, Randomized, Comparative Pilot Study, Gut and Liver, 2009",cited-by,10.5009/gnl.2009.3.1.20,"Recombinant Interferon-Beta-1α Plus Ribavirin for the Treatment of Chronic HCV Infection: A Prospective, Randomized, Comparative Pilot Study","[['Sang', 'Hoon', 'Ahn'], ['Hyun', 'Woong', 'Lee'], ['Yong', 'Soo', 'Kim'], ['Ja', 'Kyung', 'Kim'], ['Kwang-Hyub', '', 'Han'], ['Chae', 'Yoon', 'Chon'], ['Young', 'Myoung', 'Moon']]",Gut and Liver,2009,[u'http://synapse.koreamed.org/DOIx.php?id=10.5009/gnl.2009.3.1.20'],
10.1016/0140-6736(91)91774-O,"Thévenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C,"[['T.', '', 'Th\xc3\xa9venot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00271.x'],
10.1016/0140-6736(91)91774-O,"WENDLING, P., , Folate Use Before Conception May Avert Preterm Birth, , 2008",cited-by,10.1016/S0029-7437(08)70134-4,Folate Use Before Conception May Avert Preterm Birth,"[['PATRICE', '', 'WENDLING']]",,2008,[u'http://www.sciencedirect.com/science/article/pii/S0029743708701344'],
10.1016/0140-6736(91)91774-O,"GUAN, R., HO, K., KANG, J., et. al, The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis, Alimentary Pharmacology & Therapeutics, 2007",cited-by,10.1111/j.1365-2036.1995.tb00441.x,The effect of polyunsaturated phosphatidyl choline in the treatment of acute viral hepatitis,"[['R.', '', 'GUAN'], ['K.', 'Y.', 'HO'], ['J.', 'Y.', 'KANG'], ['I.', '', 'YAP'], ['K.', 'A.', 'GWEE'], ['C.', 'C.', 'TAN']]",Alimentary Pharmacology & Therapeutics,2007,[u'http://doi.wiley.com/10.1111/j.1365-2036.1995.tb00441.x'],
10.1016/0140-6736(91)91774-O,"Liaw, Y., Omata, M., Sarin, S., , Responding to the progress in hepatology: beyond the boundaries, Hepatology International, 2007",cited-by,10.1007/s12072-007-5002-z,Responding to the progress in hepatology: beyond the boundaries,"[['Yun-Fan', '', 'Liaw'], ['Masao', '', 'Omata'], ['Shiv', 'Kumar', 'Sarin']]",Hepatology International,2007,"[u'http://www.springerlink.com/index/yw700663883652uu.pdf', u'http://www.springerlink.com/content/yw700663883652uu', u'http://www.springerlink.com/index/10.1007/s12072-007-5002-z', u'http://www.springerlink.com/index/pdf/10.1007/s12072-007-5002-z']",
10.1016/0140-6736(91)91774-O,"Kogure, T., Ueno, Y., Kanno, N., et. al, Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury, , 2006",cited-by,5987322Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury,Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury,"[['Takayuki', '', 'Kogure'], ['Yoshiyuki', '', 'Ueno'], ['Noriatsu', '', 'Kanno'], ['Koji', '', 'Fukushima'], ['Yoko', '', 'Yamagiwa'], ['Futoshi', '', 'Nagasaki'], ['Eiji', '', 'Kakazu'], ['Yasunori', '', 'Matsuda'], ['Osamu', '', 'Kido'], ['Yu', '', 'Nakagome'], ['Masashi', '', 'Ninomiya'], ['Tooru', '', 'Shimosegawa']]",,2006,[u'http://www.wjgnet.com/1007-9327/12/4757.pdf'],
10.1016/0140-6736(91)91774-O,"Lamoglia, R., , Tratamiento de la hepatitis aguda C, , 2006",cited-by,10.1157/13097653,Tratamiento de la hepatitis aguda C,"[['R.', 'Sol\xc3\xa0', 'Lamoglia']]",,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0210570506751974', u'http://linkinghub.elsevier.com/retrieve/pii/S0210570506751974']",
10.1016/0140-6736(91)91774-O,"Ohata, K., Yano, K., Yatsuhashi, H., et. al, Natural Interferon α Treatment and Interferon α Receptor 2 Levels in Acute Hepatitis C, Digestive Diseases and Sciences, 2004",cited-by,10.1023/B:DDAS.0000017453.79349.46,Natural Interferon α Treatment and Interferon α Receptor 2 Levels in Acute Hepatitis C,"[['Kazuyuki', '', 'Ohata'], ['Koji', '', 'Yano'], ['Hiroshi', '', 'Yatsuhashi'], ['Manabu', '', 'Daikoku'], ['Michiaki', '', 'Koga'], ['Katsumi', '', 'Eguchi'], ['Michitami', '', 'Yano']]",Digestive Diseases and Sciences,2004,"[u'http://www.springerlink.com/content/m446300024465448', u'http://www.springerlink.com/index/m446300024465448.pdf', u'http://www.springerlink.com/openurl.asp?id=doi:10.1023/B:DDAS.0000017453.79349.46']",
10.1016/0140-6736(91)91774-O,"OMATA, M., , Modalities of prevention of recurrence after tumor ablation/resection of HCC, Journal of Gastroenterology and Hepatology, 2004",cited-by,10.1111/j.1440-1746.2004.03685.x,Modalities of prevention of recurrence after tumor ablation/resection of HCC,"[['MASAO', '', 'OMATA']]",Journal of Gastroenterology and Hepatology,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1440-1746.2004.03685.x'],
10.1016/0140-6736(91)91774-O,"Izumi, N., K, C., , How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C, Journal of Gastroenterology, 2001",cited-by,10.1007/s005350170117,How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C,"[['Namiki', '', 'Izumi'], ['Chayama', '', 'K']]",Journal of Gastroenterology,2001,"[u'http://www.springerlink.com/index/n0mqbdmdwmn107p8.pdf', u'http://www.springerlink.com/content/n0mqbdmdwmn107p8', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s005350170117', u'http://www.springerlink.com/index/pdf/10.1007/s005350170117']",
10.1016/0140-6736(91)91774-O,"Okuno, T., Arai, K., Shindo, M., , Efficacy of interferon therapy for patients who develop chronic hepatitis C after an acute coruse of hepatitis, Journal of Hepatology, 1997",cited-by,10.1016/S0168-8278(97)80098-0,Efficacy of interferon therapy for patients who develop chronic hepatitis C after an acute coruse of hepatitis,"[['Tadao', '', 'Okuno'], ['Ken', '', 'Arai'], ['Michiko', '', 'Shindo']]",Journal of Hepatology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0168827897800980', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827897800980']",
10.1016/0140-6736(91)91774-O,"Dusheiko, G., , Summary: antiviral treatment of hepatitis C virus, Antiviral Research, 1996",cited-by,10.1016/0166-3542(95)00923-X,Summary: antiviral treatment of hepatitis C virus,"[['G.', 'M.', 'Dusheiko']]",Antiviral Research,1996,"[u'http://www.sciencedirect.com/science/article/pii/016635429500923X', u'http://linkinghub.elsevier.com/retrieve/pii/016635429500923X']",
10.1016/0140-6736(91)91774-O,"Treichel, U., Büschenfelde, K., Gerken, G., , Hepatitic C virus infection and autoimmunity : clinical features, diagnostic tools and therapeutical aspects, Medecine Et Maladies Infectieuses, 1995",cited-by,10.1016/S0399-077X(05)80899-6,"Hepatitic C virus infection and autoimmunity : clinical features, diagnostic tools and therapeutical aspects","[['U.', '', 'Treichel'], ['K.-H.', 'Meyer Zum', 'B\xc3\xbcschenfelde'], ['G.', '', 'Gerken']]",Medecine Et Maladies Infectieuses,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0399077X05808996', u'http://linkinghub.elsevier.com/retrieve/pii/S0399077X05808996']",
10.1016/0140-6736(91)91774-O,"Bailly, F., Trepo, C., , Traitement de l'hépatite virale C, Medecine Et Maladies Infectieuses, 1995",cited-by,10.1016/S0399-077X(05)80900-X,Traitement de l'hépatite virale C,"[['F.', '', 'Bailly'], ['C.', '', 'Trepo']]",Medecine Et Maladies Infectieuses,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0399077X0580900X', u'http://linkinghub.elsevier.com/retrieve/pii/S0399077X0580900X']",
10.1016/0140-6736(91)91774-O,"Tran, T., Poordad, F., Martin, P., , Treatment of hepatitis C, Reviews in Medical Virology, 1993",cited-by,10.1002/rmv.1980030403,Treatment of hepatitis C,"[['Tram', 'T.', 'Tran'], ['Fred', '', 'Poordad'], ['Paul', '', 'Martin']]",Reviews in Medical Virology,1993,"[u'http://www.congrex.ch/escmidsummerschool2008/pdf/educationalmaterial/l13_rockstroh_treatment_hepatitis_intro.pdf', u'http://doi.wiley.com/10.1002/rmv.1980030403', u'http://www.springerlink.com/index/10.1007/s11901-003-0008-z', u'http://www.springerlink.com/index/pdf/10.1007/s11901-003-0008-z']",
10.1016/0140-6736(91)91774-O,"Schiff, E., , Hepatitis C among health care providers: Risk factors and possible prophylaxis, Hepatology, 1992",cited-by,10.1002/hep.1840160528,Hepatitis C among health care providers: Risk factors and possible prophylaxis,"[['Eugene', 'R.', 'Schiff']]",Hepatology,1992,[u'http://doi.wiley.com/10.1002/hep.1840160528'],
10.1016/0140-6736(91)91774-O,"Inaba, K., Fukuhara, S., Ito, T., et. al, Blood Dendritic Cell Subsets by IFNs Differential Regulation of Human, , 0",cited-by,11175487Blood Dendritic Cell Subsets by IFNs Differential Regulation of Human,Blood Dendritic Cell Subsets by IFNs Differential Regulation of Human,"[['Kayo', '', 'Inaba'], ['Shirou', '', 'Fukuhara'], ['Tomoki', '', 'Ito'], ['Ryuichi', '', 'Amakawa'], ['Muneo', '', 'Inaba']]",,0,[u'http://www.jimmunol.org/cgi/reprint/166/5/2961.pdf'],
10.1016/0140-6736(91)91774-O,"Seventer, G., McRae, B., , Development IL12 Production and Th1 Cell Type I IFNs Inhibit Human Dendritic Cell, , 0",cited-by,11221477Development IL12 Production and Th1 Cell Type I IFNs Inhibit Human Dendritic Cell,Development IL12 Production and Th1 Cell Type I IFNs Inhibit Human Dendritic Cell,"[['Gijs', 'A. van', 'Seventer'], ['Bradford', 'L.', 'McRae']]",,0,[u'http://www.jimmunol.org/cgi/reprint/160/9/4298.pdf'],
10.1016/0140-6736(91)91774-O,"Monjardino, J., , Hepatitis C Virus: Infection and Immunity, , 0",cited-by,10.1007/978-94-011-1428-8_4,Hepatitis C Virus: Infection and Immunity,"[['J.', '', 'Monjardino']]",,0,"[u'http://www.springerlink.com/content/v03j7pp05014l645', u'http://www.springerlink.com/index/v03j7pp05014l645.pdf']",
10.1056~NEJMoa011232,"Ohnishi K, Nomura F, Nakano M. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 1991;86:1041-9.",references,NOT found in MAS
10.1056~NEJMoa011232,"Tassopoulos NC, Koutelou MG, Papatheodoridis G, et al. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 1993;34:Suppl:S130-S132.",references,10.1136/gut.34.2_Suppl.S130,"Recombinant human interferon alfa-2b treatment for acute nonA, non-B hepatitis","[[u'N', u'C', u'Tassopoulos'], [u'M', u'G', u'Koutelou'], [u'G', u'', u'Papatheodoridis'], [u'H', u'', u'Polychronaki'], [u'I', u'', u'Delladetsima'], [u'T', u'', u'Giannikakis'], [u'A', u'', u'Todoulos'], [u'A', u'', u'Toliopoulos'], [u'A', u'', u'Hatzakis']]",Gut,1993,"[u'http://dx.doi.org/', u'http://gut.bmj.com/cgi/doi/10.1136/gut.34.2_Suppl.S130']","[{u'Name': u'Alanine Aminotransferase', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 1138}, {u'Name': u'Chronic Hepatitis', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5700}, {u'Name': u'Controlled Trial', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 7912}, {u'Name': u'Hepatitis C Virus', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17870}, {u'Name': u'Pilot Study', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 31238}, {u'Name': u'Recombinant Human', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 67477}]"
10.1136/gut.34.2_Suppl.S130,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1136/gut.34.2_Suppl.S130,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1136/gut.34.2_Suppl.S130,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1136/gut.34.2_Suppl.S130,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1136/gut.34.2_Suppl.S130,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1136/gut.34.2_Suppl.S130,"Gursoy, M., Gur, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment,"[['Murat', '', 'Gursoy'], ['G.', '', 'Gur'], ['H.', '', 'Arslan'], ['N.', '', 'Ozdemir'], ['S.', '', 'Boyacioglu']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00268.x'],
10.1136/gut.34.2_Suppl.S130,"Venezia, G., Licata, A., Marco, V., et. al, Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, Digestive and Liver Disease, 2005",cited-by,10.1016/j.dld.2005.06.010,Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b,"[['G.', '', 'Venezia'], ['A.', '', 'Licata'], ['V.', 'Di', 'Marco'], ['A.', '', 'Crax\xc3\xac'], ['P.', 'L.', 'Almasio']]",Digestive and Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1590865805003324', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865805003324']",
10.1136/gut.34.2_Suppl.S130,"Cammà, C., Almasio, P., Craxì, A., , Interferon as treatment for acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02088245,Interferon as treatment for acute hepatitis C,"[['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Antonio', '', 'Crax\xc3\xac']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/vr3137877v301j64.pdf', u'http://www.springerlink.com/content/vr3137877v301j64', u'http://www.springerlink.com/index/10.1007/BF02088245', u'http://www.springerlink.com/index/pdf/10.1007/BF02088245']",
10.1136/gut.34.2_Suppl.S130,"Palmović, D., Kurelac, I., Crnjaković-Palmović, J., , The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha, Infection, 1994",cited-by,10.1007/BF01716714,The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha,"[['D.', '', 'Palmovi\xc4\x87'], ['I.', '', 'Kurelac'], ['Jasenka', '', 'Crnjakovi\xc4\x87-Palmovi\xc4\x87']]",Infection,1994,"[u'http://www.springerlink.com/content/r7m78p2863754456', u'http://www.springerlink.com/index/10.1007/BF01716714', u'http://www.springerlink.com/index/pdf/10.1007/BF01716714']",
10.1136/gut.34.2_Suppl.S130,"craxì, A., Marco, V., Cammà, C., et. al, Duration of HCV infection as a predictor of nonresponse to interferon, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087881,Duration of HCV infection as a predictor of nonresponse to interferon,"[['Antonio', '', 'crax\xc3\xac'], ['Vito', 'Di', 'Marco'], ['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Silvio', '', 'Magrin']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/content/x1807m2613532562', u'http://www.springerlink.com/index/x1807m2613532562.pdf', u'http://www.springerlink.com/index/10.1007/BF02087881', u'http://www.springerlink.com/index/pdf/10.1007/BF02087881']",
10.1136/gut.34.2_Suppl.S130,"Hoofnagle, J., RESTREPO, J., Jaime, J., et. al, 4 Acute hepatitis C, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80008-3,4 Acute hepatitis C,"[['Jay', 'H.', 'Hoofnagle'], ['JUAN', 'CARLOS', 'RESTREPO'], ['John', '', 'Jaime'], ['Juan', '', 'Carlos'], ['Restrepo', '', 'Guti\xc3\xa9rrez'], ['Guti\xc3\xa9rrez', '', 'Calle']]",Biomedical Research Reports,2000,"[u'http://www.scielo.org.co/pdf/amc/v33n1/v33n1a6.pdf', u'http://www.sciencedirect.com/science/article/pii/S1874532600800083', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800083']",
10.1136/gut.34.2_Suppl.S130,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1136/gut.34.2_Suppl.S130,"Gürsoy, M., Gür, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection,"[['Murat', '', 'G\xc3\xbcrsoy'], ['G.', '', 'G\xc3\xbcr'], ['H.', '', 'Arslan'], ['N.', '', '\xc3\x96zdemir']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00268.x'],
10.1056~NEJMoa011232,"Palmovic D, Kurelac I, Crnjakovic-Palmovic J. The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha. Infection 1994;22:222-3.",references,10.1007/BF01716714,The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha,"[[u'D.', u'', u'Palmovi\u0107'], [u'I.', u'', u'Kurelac'], [u'Jasenka', u'', u'Crnjakovi\u0107-Palmovi\u0107']]",Infection,1994,"[u'http://www.springerlink.com/content/r7m78p2863754456', u'http://www.springerlink.com/index/10.1007/BF01716714', u'http://www.springerlink.com/index/pdf/10.1007/BF01716714']","[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}]"
10.1007/BF01716714,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1007/BF01716714,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1007/BF01716714,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1007/BF01716714,"Gursoy, M., Gur, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment,"[['Murat', '', 'Gursoy'], ['G.', '', 'Gur'], ['H.', '', 'Arslan'], ['N.', '', 'Ozdemir'], ['S.', '', 'Boyacioglu']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00268.x'],
10.1007/BF01716714,"Quin, J., , Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis, Internal Medicine Journal, 1997",cited-by,10.1111/j.1445-5994.1997.tb00985.x,Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis,"[['J.', 'W.', 'Quin']]",Internal Medicine Journal,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.1997.tb00985.x'],
10.1007/BF01716714,"Venezia, G., Licata, A., Marco, V., et. al, Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, Digestive and Liver Disease, 2005",cited-by,10.1016/j.dld.2005.06.010,Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b,"[['G.', '', 'Venezia'], ['A.', '', 'Licata'], ['V.', 'Di', 'Marco'], ['A.', '', 'Crax\xc3\xac'], ['P.', 'L.', 'Almasio']]",Digestive and Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1590865805003324', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865805003324']",
10.1007/BF01716714,"Cammà, C., Almasio, P., Craxì, A., , Interferon as treatment for acute hepatitis C, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02088245,Interferon as treatment for acute hepatitis C,"[['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Antonio', '', 'Crax\xc3\xac']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/vr3137877v301j64.pdf', u'http://www.springerlink.com/content/vr3137877v301j64', u'http://www.springerlink.com/index/10.1007/BF02088245', u'http://www.springerlink.com/index/pdf/10.1007/BF02088245']",
10.1007/BF01716714,"craxì, A., Marco, V., Cammà, C., et. al, Duration of HCV infection as a predictor of nonresponse to interferon, Digestive Diseases and Sciences, 1996",cited-by,10.1007/BF02087881,Duration of HCV infection as a predictor of nonresponse to interferon,"[['Antonio', '', 'crax\xc3\xac'], ['Vito', 'Di', 'Marco'], ['Calogero', '', 'Camm\xc3\xa0'], ['Piero', '', 'Almasio'], ['Silvio', '', 'Magrin']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/content/x1807m2613532562', u'http://www.springerlink.com/index/x1807m2613532562.pdf', u'http://www.springerlink.com/index/10.1007/BF02087881', u'http://www.springerlink.com/index/pdf/10.1007/BF02087881']",
10.1007/BF01716714,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1007/BF01716714,"Gürsoy, M., Gür, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection,"[['Murat', '', 'G\xc3\xbcrsoy'], ['G.', '', 'G\xc3\xbcr'], ['H.', '', 'Arslan'], ['N.', '', '\xc3\x96zdemir']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00268.x'],
10.1007/BF01716714,"Ohata, K., Yano, K., Yatsuhashi, H., et. al, Natural Interferon α Treatment and Interferon α Receptor 2 Levels in Acute Hepatitis C, Digestive Diseases and Sciences, 2004",cited-by,10.1023/B:DDAS.0000017453.79349.46,Natural Interferon α Treatment and Interferon α Receptor 2 Levels in Acute Hepatitis C,"[['Kazuyuki', '', 'Ohata'], ['Koji', '', 'Yano'], ['Hiroshi', '', 'Yatsuhashi'], ['Manabu', '', 'Daikoku'], ['Michiaki', '', 'Koga'], ['Katsumi', '', 'Eguchi'], ['Michitami', '', 'Yano']]",Digestive Diseases and Sciences,2004,"[u'http://www.springerlink.com/content/m446300024465448', u'http://www.springerlink.com/index/m446300024465448.pdf', u'http://www.springerlink.com/openurl.asp?id=doi:10.1023/B:DDAS.0000017453.79349.46']",
10.1056~NEJMoa011232,"Vogel W, Graziadei I, Umlauft F, et al. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig Dis Sci 1996;41:Suppl:81S-85S.",references,10.1007/BF02087880,High-dose interferon-α 2b treatment prevents chronicity in acute hepatitis C,"[[u'Wolfgang', u'', u'Vogel'], [u'Ivo', u'', u'Graziadei'], [u'Florian', u'', u'Umlauft'], [u'Christian', u'', u'Datz'], [u'Franz', u'', u'Hackl'], [u'Stefan', u'', u'Allinger'], [u'Kurt', u'', u'Gr\xfcnewald'], [u'Josef', u'', u'Patsch']]",Digestive Diseases and Sciences,1996,"[u'http://www.springerlink.com/index/h171xx22x8q37l17.pdf', u'http://www.springerlink.com/content/h171xx22x8q37l17', u'http://www.springerlink.com/index/10.1007/BF02087880', u'http://www.springerlink.com/index/pdf/10.1007/BF02087880']","[{u'Name': u'Chronic Infection', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5704}, {u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Pilot Study', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 31238}, {u'Name': u'Complete Response', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 50547}, {u'Name': u'High Dose', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 56448}]"
10.1007/BF02087880,"Strader, D., Wright, T., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20119,"Diagnosis, management, and treatment of hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2004,"[u'http://www.natap.org/2004/pdf/AASLD_Prac._Guide_Hep_C.pdf', u'http://www.hiv.ch/rubriken/hep/US_GL_Hep_C.pdf', u'http://www.texasliver.com/docs/management%20of%20hepatitis%20c%203.pdf', u'http://doi.wiley.com/10.1002/hep.20119']",
10.1007/BF02087880,"Ghany, M., Strader, D., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009",cited-by,10.1002/hep.22759,"Diagnosis, management, and treatment of hepatitis C: An update","[['Marc', 'G.', 'Ghany'], ['Doris', 'B.', 'Strader'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2009,"[u'http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/diagnosis_of_hep_c_update.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Hepatitis%20C%20UPDATE.pdf', u'http://www.sklid.com/news/uploadfiles/20094122357635.pdf', u'http://www.coloradoguidelines.org/pdf/hepatitisbc/Diagnosis_of_HEP_C_Update_Aug%20_09.pdf', u'http://www.paml.com/Files/Miscellaneous/Hep%20C%20Diagnosis,Manage,Treatment%20Apr%202009.pdf', u'http://doi.wiley.com/10.1002/hep.22759', u'http://zuberi.biz/guidelines/AASLD_HEP_C_2009.pdf']",
10.1007/BF02087880,"Thevenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update,"[['T.', '', 'Thevenot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00271.x'],
10.1007/BF02087880,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1007/BF02087880,"Gilleece, Y., Browne, R., Asboe, D., et. al, Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24Week Course of Pegylated Interferon and Ribavirin, Jaids-journal of Acquired Immune Deficiency Syndromes, 2005",cited-by,10.1097/01.qai.0000174930.64145.a9,Transmission of Hepatitis C Virus Among HIV-Positive Homosexual Men and Response to a 24Week Course of Pegylated Interferon and Ribavirin,"[['Yvonne', 'C', 'Gilleece'], ['Rita', 'E', 'Browne'], ['David', '', 'Asboe'], ['Mark', '', 'Atkins'], ['Sundhiya', '', 'Mandalia'], ['Mark', '', 'Bower'], ['Brian', 'G', 'Gazzard'], ['Mark', 'R', 'Nelson']]",Jaids-journal of Acquired Immune Deficiency Syndromes,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00126334-200509010-00007'],
10.1007/BF02087880,"Gursoy, M., Gur, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment, Journal of Viral Hepatitis, 2001",cited-by,10.1046/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment,"[['Murat', '', 'Gursoy'], ['G.', '', 'Gur'], ['H.', '', 'Arslan'], ['N.', '', 'Ozdemir'], ['S.', '', 'Boyacioglu']]",Journal of Viral Hepatitis,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2001.00268.x'],
10.1007/BF02087880,"Strader, D., Wright, T., Thomas, D., et. al, AASLD PRACTICE GUIDELINE Diagnosis, Management, and Treatment of Hepatitis C, , 0",cited-by,"13235656AASLD PRACTICE GUIDELINE Diagnosis, Management, and Treatment of Hepatitis C","AASLD PRACTICE GUIDELINE Diagnosis, Management, and Treatment of Hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",,0,"[u'https://www.aasld.org/practiceguidelines/Practice%20Guideline%20Archive/Diagnosis,%20Management%20and%20Treatment%20of%20Hepatitis%20C.pdf', u'http://www.congrex.ch/escmidsummerschool2008/pdf/pdfs/rockstroh_references/strader_2004.pdf', u'http://www.eloizaquintela.com.br/guide_lines/hepatite c.pdf']",
10.1007/BF02087880,"Wedemeyer, H., Wiegand, J., Cornberg, M., et. al, Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20221,Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C,"[['Heiner', '', 'Wedemeyer'], ['Johannes', '', 'Wiegand'], ['Markus', '', 'Cornberg'], ['Michael', 'P.', 'Manns']]",Hepatology,2004,[u'http://doi.wiley.com/10.1002/hep.20221'],
10.1007/BF02087880,"Quin, J., , Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis, Internal Medicine Journal, 1997",cited-by,10.1111/j.1445-5994.1997.tb00985.x,Interferon therapy for acute hepatitis C viral infection - a review by meta-analysis,"[['J.', 'W.', 'Quin']]",Internal Medicine Journal,1997,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.1997.tb00985.x'],
10.1007/BF02087880,"Delwaide, J., Bourgeois, N., Gerard, C., et. al, Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response, Alimentary Pharmacology & Therapeutics, 2004",cited-by,10.1111/j.1365-2036.2004.02023.x,Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response,"[['J.', '', 'Delwaide'], ['N.', '', 'Bourgeois'], ['C.', '', 'Gerard'], ['S.', 'De', 'Maeght'], ['F.', '', 'Mokaddem'], ['E.', '', 'Wain'], ['B.', '', 'Bastens'], ['J.', '', 'Fevery'], ['M.', '', 'Gehenot'], ['O.', 'Le', 'Moine'], ['J.', 'P.', 'Martinet'], ['G.', '', 'Robaeys'], ['B.', '', 'Servais'], ['M.', 'Van', 'Gossum'], ['H.', 'Van', 'Vlierberghe']]",Alimentary Pharmacology & Therapeutics,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2004.02023.x'],
10.1007/BF02087880,"Kamal, S., , Acute Hepatitis C: A Systematic Review, American Journal of Gastroenterology, 2008",cited-by,10.1111/j.1572-0241.2008.01825.x,Acute Hepatitis C: A Systematic Review,"[['Sanaa', 'M.', 'Kamal']]",American Journal of Gastroenterology,2008,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2008.01825.x', u'http://dx.doi.org/10.1111/j.1572-0241.2008.01825.x']",
10.1007/BF02087880,"Cornberg, M., Deterding, K., Manns, M., , Present and future therapy for hepatitis C virus, Expert Review of Anti-infective Therapy, 2006",cited-by,10.1586/14787210.4.5.781,Present and future therapy for hepatitis C virus,"[['Markus', '', 'Cornberg'], ['Katja', '', 'Deterding'], ['Michael', 'P', 'Manns']]",Expert Review of Anti-infective Therapy,2006,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.4.5.781'],
10.1007/BF02087880,"Fabris, P., Tositti, G., Giordani, M., et. al, Three times weekly versus daily dose α-interferon treatment in patients with acute hepatitis C, American Journal of Gastroenterology, 2002",cited-by,10.1111/j.1572-0241.2002.05508.x,Three times weekly versus daily dose α-interferon treatment in patients with acute hepatitis C,"[['Paolo', '', 'Fabris'], ['Giulia', '', 'Tositti'], ['Maria', 'Teresa', 'Giordani'], ['Domenico', '', 'Infantolino'], ['Fausto', 'de', 'Lalla']]",American Journal of Gastroenterology,2002,"[u'http://dx.doi.org/10.1111/j.1572-0241.2002.05508.x', u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2002.05508.x']",
10.1007/BF02087880,"Wiegand, J., Deterding, K., Cornberg, M., et. al, Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn346,Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon,"[['J.', '', 'Wiegand'], ['K.', '', 'Deterding'], ['M.', '', 'Cornberg'], ['H.', '', 'Wedemeyer']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn346'],
10.1007/BF02087880,"Wiegand, J., Potthoff, A., Manns, M., et. al, Acute hepatitis C infection: Can immunology teach us the right way to treat?, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0025-6,Acute hepatitis C infection: Can immunology teach us the right way to treat?,"[['Johannes', '', 'Wiegand'], ['Andrej', '', 'Potthoff'], ['Michael', 'P.', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/x7212685g77j1132.pdf', u'http://www.springerlink.com/content/x7212685g77j1132', u'http://www.springerlink.com/index/10.1007/s11901-004-0025-6', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0025-6']",
10.1007/BF02087880,"Piasecki, B., Reddy, K., Chang, K., , Acute hepatitis C: To treat or not to treat?, Hepatology, 2003",cited-by,10.1002/hep.510350631,Acute hepatitis C: To treat or not to treat?,"[['Barbara', 'A.', 'Piasecki'], ['K.', 'Rajender', 'Reddy'], ['Kyong-Mi', '', 'Chang']]",Hepatology,2003,[u'http://doi.wiley.com/10.1002/hep.510350631'],
10.1007/BF02087880,"Puro, V., Carli, G., Soldani, F., et. al, Raccomandazioni per la gestione delle esposizioni occupazionali a virus dell'epatite B e C negli operatori sanitari, , 2003",cited-by,13888966Raccomandazioni per la gestione delle esposizioni occupazionali a virus dell'epatite B e C negli operatori sanitari,Raccomandazioni per la gestione delle esposizioni occupazionali a virus dell'epatite B e C negli operatori sanitari,"[['Vincenzo', '', 'Puro'], ['Gabriella', 'De', 'Carli'], ['Fabio', '', 'Soldani'], ['Stefania', '', 'Cicalini'], ['Giuseppe', '', 'Ippolito']]",,2003,"[u'http://www.ccm-network.it/documenti_Ccm/prg_area1/Inf_Oss/LG_naz/Raccom_esposiz_occupaz_epatite_B-C.pdf', u'http://www.inmi.it/news/lineeguida/raccomandazioni-epatiteb-c_operatorisanitari.pdf']",
10.1007/BF02087880,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1007/BF02087880,"Dintsios, C., Haverkamp, A., Wiegand, J., et. al, Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany, European Journal of Gastroenterology & Hepatology, 2010",cited-by,10.1097/MEG.0b013e32832c7b2e,Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany,"[['Charalabos-Markos', '', 'Dintsios'], ['Alexander', '', 'Haverkamp'], ['Johannes', '', 'Wiegand'], ['Tilman', '', 'Gerlach'], ['Heiner', '', 'Wedemeyer'], ['Gerd', '', 'Pape'], ['Michael', 'Peter', 'Manns'], ['Christian', '', 'Krauth']]",European Journal of Gastroenterology & Hepatology,2010,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00042737-201003000-00004'],
10.1007/BF02087880,"Thévenot, T., Regimbeau, C., Ratziu, V., et. al, Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00271.x,Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update: Interferon randomized trials in hepatitis C,"[['T.', '', 'Th\xc3\xa9venot'], ['C.', '', 'Regimbeau'], ['V.', '', 'Ratziu'], ['V.', '', 'Leroy'], ['P.', '', 'Opolon'], ['T.', '', 'Poynard']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00271.x'],
10.1007/BF02087880,"Gürsoy, M., Gür, G., Arslan, H., et. al, Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection, Journal of Viral Hepatitis, 2008",cited-by,10.1111/j.1365-2893.2001.00268.x,Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment: Interferon treatment for acute hepatitis C virus infection,"[['Murat', '', 'G\xc3\xbcrsoy'], ['G.', '', 'G\xc3\xbcr'], ['H.', '', 'Arslan'], ['N.', '', '\xc3\x96zdemir']]",Journal of Viral Hepatitis,2008,[u'http://doi.wiley.com/10.1111/j.1365-2893.2001.00268.x'],
10.1007/BF02087880,"Raffenne, L., Bodard, L., Meudec, A., , Accidents d’exposition au sang : conduite à tenir, , 2005",cited-by,10.1016/j.emcmed.2004.12.001,Accidents d’exposition au sang : conduite à tenir,"[['L.', '', 'Raffenne'], ['L.', '', 'Bodard'], ['A.', '', 'Meudec']]",,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1762419304001870', u'http://linkinghub.elsevier.com/retrieve/pii/S1762419304001870']",
10.1007/BF02087880,"Trépo, C., Merle, P., Bailly, F., , Traitements des hépatites C, Revue De Medecine Interne, 1997",cited-by,10.1016/S0248-8663(97)80280-9,Traitements des hépatites C,"[['C', '', 'Tr\xc3\xa9po'], ['P', '', 'Merle'], ['F', '', 'Bailly']]",Revue De Medecine Interne,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0248866397802809', u'http://linkinghub.elsevier.com/retrieve/pii/S0248866397802809']",
10.1056~NEJMoa011232,"Lee WM, Shiffman ML, Gnann JW Jr, Samanta A, Alam J. A trial of interferon beta 1a (IFN b1a) for 4 weeks for therapy of acute hepatitis C. Hepatology 1996;24:Suppl:275A. abstract.",references,NOT found in MAS
10.1056~NEJMoa011232,"Pimstone NR, Powell JS, Kotfila R, Pimstone DJ, Davidson L. High dose (780 MIU/52 weeks) interferon monotherapy is highly effective treatment for acute hepatitis C. Gastroenterology 2000;118:Suppl:A960. abstract.",references,10.1016/S0016-5085(00)85982-X,High dose (780 MIU/52 weeks) interferon monotherapy is highly effective treatment for acute hepatitis C,"[[u'Neville', u'R.', u'Pimstone'], [u'Jerry', u'S.', u'Powell'], [u'Ronald', u'', u'Kotfila'], [u'Daniel', u'J.', u'Pimstone'], [u'Leslie', u'', u'Davidson']]",Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S001650850085982X', u'http://linkinghub.elsevier.com/retrieve/pii/S001650850085982X']","[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'High Dose', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 56448}]"
10.1016/S0016-5085(00)85982-X,"Strader, D., Wright, T., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004",cited-by,10.1002/hep.20119,"Diagnosis, management, and treatment of hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2004,"[u'http://www.natap.org/2004/pdf/AASLD_Prac._Guide_Hep_C.pdf', u'http://www.hiv.ch/rubriken/hep/US_GL_Hep_C.pdf', u'http://www.texasliver.com/docs/management%20of%20hepatitis%20c%203.pdf', u'http://doi.wiley.com/10.1002/hep.20119']",
10.1016/S0016-5085(00)85982-X,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1016/S0016-5085(00)85982-X,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1016/S0016-5085(00)85982-X,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1016/S0016-5085(00)85982-X,"Henderson, D., Magnuson, W., , Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.3.546-568.2003,Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting,"[['David', 'K.', 'Henderson'], ['Warren', 'G.', 'Magnuson']]",Clinical Microbiology Reviews,2003,"[u'http://cmr.asm.org/cgi/reprint/16/3/546.pdf', u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.3.546-568.2003']",
10.1016/S0016-5085(00)85982-X,"Strader, D., Wright, T., Thomas, D., et. al, AASLD PRACTICE GUIDELINE Diagnosis, Management, and Treatment of Hepatitis C, , 0",cited-by,"13235656AASLD PRACTICE GUIDELINE Diagnosis, Management, and Treatment of Hepatitis C","AASLD PRACTICE GUIDELINE Diagnosis, Management, and Treatment of Hepatitis C","[['Doris', 'B.', 'Strader'], ['Teresa', '', 'Wright'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",,0,"[u'https://www.aasld.org/practiceguidelines/Practice%20Guideline%20Archive/Diagnosis,%20Management%20and%20Treatment%20of%20Hepatitis%20C.pdf', u'http://www.congrex.ch/escmidsummerschool2008/pdf/pdfs/rockstroh_references/strader_2004.pdf', u'http://www.eloizaquintela.com.br/guide_lines/hepatite c.pdf']",
10.1016/S0016-5085(00)85982-X,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1056~NEJMoa011232,"Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001;33:321-7.",references,10.1053/jhep.2001.22112,Acute hepatitis C,"[[u'Jennie', u'R.', u'Orland'], [u'Teresa', u'L.', u'Wright'], [u'Stewart', u'', u'Cooper']]",Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270913901023321', u'http://doi.wiley.com/10.1053/jhep.2001.22112']","[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}]"
10.1053/jhep.2001.22112,"Thimme, R., Oldach, D., Chang, K., et. al, Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, , 2001",cited-by,2949616Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection,"[['Robert', '', 'Thimme'], ['David', '', 'Oldach'], ['Kyong-Mi', '', 'Chang'], ['Carola', '', 'Steiger'], ['Stuart', 'C.', 'Ray'], ['Francis', 'V.', 'Chisari']]",,2001,[u'http://jem.rupress.org/cgi/reprint/194/10/1395.pdf'],
10.1053/jhep.2001.22112,"Dienstag, J., McHutchison, J., , American Gastroenterological Association Technical Review on the Management of Hepatitis C, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2005.11.010,American Gastroenterological Association Technical Review on the Management of Hepatitis C,"[['Jules', 'L.', 'Dienstag'], ['John', 'G.', 'McHutchison']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505022705', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505022705']",
10.1053/jhep.2001.22112,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1053/jhep.2001.22112,"Lavillette, D., Morice, Y., Germanidis, G., et. al, Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, 2005",cited-by,10.1128/JVI.79.10.6023-6034.2005,"Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection","[['Dimitri', '', 'Lavillette'], ['Yoann', '', 'Morice'], ['Georgios', '', 'Germanidis'], ['Peggy', '', 'Donot'], ['Alexandre', '', 'Soulier'], ['Emanuil', '', 'Pagkalos'], ['Georgios', '', 'Sakellariou'], ['Liliane', '', 'Intrator'], ['Birke', '', 'Bartosch'], ['Jean-Michel', '', 'Pawlotsky'], ['F.-L.', '', 'Cosset']]",Journal of Virology,2005,"[u'http://jvi.asm.org/cgi/reprint/79/10/6023.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.79.10.6023-6034.2005']",
10.1053/jhep.2001.22112,"Kamal, S., Fouly, A., Kamel, R., et. al, Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.01.034,Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response,"[['Sanaa', 'M.', 'Kamal'], ['Amr', 'E.', 'Fouly'], ['Refaat', 'R.', 'Kamel'], ['Bridgette', '', 'Hockenjos'], ['Ahmed', 'Al', 'Tawil'], ['Khalifa', 'E.', 'Khalifa'], ['Qi', '', 'He'], ['Margaret', 'J.', 'Koziel'], ['Khairy', 'M. El', 'Naggar'], ['Jens', '', 'Rasenack'], ['Nezam', 'H.', 'Afdhal']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506000618', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506000618']",
10.1053/jhep.2001.22112,"Stramer, S., Glynn, S., Kleinman, S., et. al, Detection of HIV1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid-Amplification Testing, , 2010",cited-by,5546248Detection of HIV1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid-Amplification Testing,Detection of HIV1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid-Amplification Testing,"[['Susan', 'L.', 'Stramer'], ['Simone', 'A.', 'Glynn'], ['Steven', 'H.', 'Kleinman'], ['D.', 'Michael', 'Strong'], ['Sally', '', 'Caglioti'], ['David', 'J.', 'Wright'], ['Roger', 'Y.', 'Dodd'], ['Michael', 'P.', 'Busch'], ['Rockville', '', 'Westat']]",,2010,"[u'http://nejm.highwire.org/cgi/reprint/351/8/760.pdf', u'http://www.aebt.org/web/investigacion/2004investigacion/Stramer%2704.pdf', u'http://content.nejm.org/cgi/reprint/351/8/760.pdf', u'https://content.nejm.org/cgi/reprint/351/8/760.pdf', u'http://intl-content.nejm.org/cgi/reprint/351/8/760.pdf', u'http://171.66.123.143/cgi/reprint/351/8/760.pdf']",
10.1053/jhep.2001.22112,"Wiegand, J., Buggisch, P., Boecher, W., et. al, Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study, Hepatology, 2006",cited-by,10.1002/hep.21043,Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II study,"[['Johannes', '', 'Wiegand'], ['Peter', '', 'Buggisch'], ['Wulf', '', 'Boecher'], ['Stefan', '', 'Zeuzem'], ['Cornelia', 'M.', 'Gelbmann'], ['Thomas', '', 'Berg'], ['Wolfgang', '', 'Kauffmann'], ['Birgit', '', 'Kallinowski'], ['Markus', '', 'Cornberg'], ['Elmar', '', 'Jaeckel'], ['Heiner', '', 'Wedemeyer'], ['Michael', 'P.', 'Manns']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21043'],
10.1053/jhep.2001.22112,"Neumann-Haefelin, C., Blum, H., Chisari, F., et. al, T cell response in hepatitis C virus infection, Journal of Clinical Virology, 2005",cited-by,10.1016/j.jcv.2004.05.008,T cell response in hepatitis C virus infection,"[['C.', '', 'Neumann-Haefelin'], ['H.', 'E.', 'Blum'], ['F.', 'V.', 'Chisari'], ['R.', '', 'Thimme']]",Journal of Clinical Virology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S138665320400157X', u'http://linkinghub.elsevier.com/retrieve/pii/S138665320400157X']",
10.1053/jhep.2001.22112,"Alberti, A., Boccato, S., Vario, A., , Therapy of acute hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36808,Therapy of acute hepatitis C,"[['Alfredo', '', 'Alberti'], ['Silvia', '', 'Boccato'], ['Alessandro', '', 'Vario']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Therapy%20Of%20Acute%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36808', u'http://doi.wiley.com/10.1002/hep.1840360725']",
10.1053/jhep.2001.22112,"Santantonio, T., Fasano, M., Sinisi, E., et. al, Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.11.021,Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance,"[['Teresa', '', 'Santantonio'], ['Massimo', '', 'Fasano'], ['Emanuele', '', 'Sinisi'], ['Angela', '', 'Guastadisegni'], ['Caterina', '', 'Casalino'], ['Michele', '', 'Mazzola'], ['Ruggiero', '', 'Francavilla'], ['Giuseppe', '', 'Pastore']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804005380', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804005380']",
10.1053/jhep.2001.22112,"Santantonio, T., Sinisi, E., Guastadisegni, A., et. al, Natural course of acute hepatitis C: a long-term prospective study, Digestive and Liver Disease, 2003",cited-by,10.1016/S1590-8658(03)00007-0,Natural course of acute hepatitis C: a long-term prospective study,"[['T', '', 'Santantonio'], ['E', '', 'Sinisi'], ['A', '', 'Guastadisegni'], ['C', '', 'Casalino'], ['M', '', 'Mazzola'], ['A', '', 'Gentile'], ['G', '', 'Leandro'], ['G', '', 'Pastore']]",Digestive and Liver Disease,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1590865803000070', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865803000070']",
10.1053/jhep.2001.22112,"Licata, A., Bona, D., Schepis, F., et. al, When and how to treat acute hepatitis C?, Journal of Hepatology, 2003",cited-by,10.1016/S0168-8278(03)00461-6,When and how to treat acute hepatitis C?,"[['Anna', '', 'Licata'], ['Danilo', 'Di', 'Bona'], ['Filippo', '', 'Schepis'], ['Lillian', '', 'Shahied'], ['Calogero', '', 'Camm\xc3\xa0']]",Journal of Hepatology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0168827803004616', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827803004616']",
10.1053/jhep.2001.22112,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1053/jhep.2001.22112,"Heimer, R., Clair, S., Grau, L., et. al, Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities, Addiction, 2002",cited-by,10.1046/j.1360-0443.2002.t01-1-00211.x,Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities,"[['Robert', '', 'Heimer'], ['Scott', '', 'Clair'], ['Lauretta', 'E.', 'Grau'], ['Ricky', 'N.', 'Bluthenthal'], ['Patricia', 'A.', 'Marshall'], ['Merrill', '', 'Singer']]",Addiction,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1360-0443.2002.t01-1-00211.x'],
10.1053/jhep.2001.22112,"Busch, M., , Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients, Transfusion Clinique Et Biologique, 2001",cited-by,10.1016/S1246-7820(01)00125-2,"Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients","[['M.', 'P', 'Busch']]",Transfusion Clinique Et Biologique,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1246782001001252', u'http://linkinghub.elsevier.com/retrieve/pii/S1246782001001252']",
10.1053/jhep.2001.22112,"Grant, W., Jhaveri, R., McHutchison, J., et. al, Trends in health care resource use for hepatitis C virus infection in the United States, Hepatology, 2005",cited-by,10.1002/hep.20941,Trends in health care resource use for hepatitis C virus infection in the United States,"[['William', 'C.', 'Grant'], ['Ravi', 'R.', 'Jhaveri'], ['John', 'G.', 'McHutchison'], ['Kevin', 'A.', 'Schulman'], ['Teresa', 'L.', 'Kauf']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20941'],
10.1053/jhep.2001.22112,"Izopet, J., Sandres-Sauné, K., Kamar, N., et. al, Incidence of HCV infection in French hemodialysis units: A prospective study, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20415,Incidence of HCV infection in French hemodialysis units: A prospective study,"[['Jacques', '', 'Izopet'], ['Karine', '', 'Sandres-Saun\xc3\xa9'], ['Nassim', '', 'Kamar'], ['Gilles', '', 'Salama'], ['Martine', '', 'Dubois'], ['Christophe', '', 'Pasquier'], ['Lionel', '', 'Rostaing']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20415'],
10.1053/jhep.2001.22112,"Busch, M., Glynn, S., Stramer, S., et. al, Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors, Transfusion, 2006",cited-by,10.1111/j.1537-2995.2006.00745.x,Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors,"[['Michael', 'P.', 'Busch'], ['Simone', 'A.', 'Glynn'], ['Susan', 'L.', 'Stramer'], ['Jennie', '', 'Orland'], ['Edward', 'L.', 'Murphy'], ['David', 'J.', 'Wright'], ['Steven', '', 'Kleinman']]",Transfusion,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2006.00745.x'],
10.1053/jhep.2001.22112,"Scott, L., Perry, C., , Interferon??-2b Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C, Drugs, 2002",cited-by,10.2165/00003495-200262030-00009,Interferon??-2b Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C,"[['Lesley', 'J.', 'Scott'], ['Caroline', 'M.', 'Perry']]",Drugs,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003495-200262030-00009'],
10.1053/jhep.2001.22112,"Gowans, E., Jones, K., Bharadwaj, M., et. al, Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus, Journal of Clinical Virology, 2004",cited-by,10.1016/j.jcv.2004.03.006,Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus,"[['Eric', 'J', 'Gowans'], ['Kathryn', 'L', 'Jones'], ['Mandvi', '', 'Bharadwaj'], ['David', 'C', 'Jackson']]",Journal of Clinical Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1386653204000800', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653204000800']",
10.1053/jhep.2001.22112,"Meunier, J., Russell, R., Goossens, V., et. al, Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus, Journal of Virology, 2008",cited-by,10.1128/JVI.01872-07,Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus,"[['Jean-Christophe', '', 'Meunier'], ['Rodney', 'S.', 'Russell'], ['Vera', '', 'Goossens'], ['Sofie', '', 'Priem'], ['Hugo', '', 'Walter'], ['Erik', '', 'Depla'], ['Ann', '', 'Union'], ['Kristina', 'N.', 'Faulk'], ['Jens', '', 'Bukh'], ['Suzanne', 'U.', 'Emerson'], ['Robert', 'H.', 'Purcell']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/2/966.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01872-07']",
10.1053/jhep.2001.22112,"Santantonio, T., Wiegand, J., Gerlach, J., , Acute hepatitis C: Current status and remaining challenges, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.07.005,Acute hepatitis C: Current status and remaining challenges,"[['Teresa', '', 'Santantonio'], ['Johannes', '', 'Wiegand'], ['J.', 'Tilman', 'Gerlach']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808004340', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808004340']",
10.1053/jhep.2001.22112,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
10.1053/jhep.2001.22112,"Ishii, S., Koziel, M., , Immune responses during acute and chronic infection with hepatitis C virus, Clinical Immunology, 2008",cited-by,10.1016/j.clim.2008.03.525,Immune responses during acute and chronic infection with hepatitis C virus,"[['Shigeaki', '', 'Ishii'], ['Margaret', 'James', 'Koziel']]",Clinical Immunology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1521661608006165', u'http://linkinghub.elsevier.com/retrieve/pii/S1521661608006165']",
10.1053/jhep.2001.22112,"Venezia, G., Licata, A., Marco, V., et. al, Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b, Digestive and Liver Disease, 2005",cited-by,10.1016/j.dld.2005.06.010,Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b,"[['G.', '', 'Venezia'], ['A.', '', 'Licata'], ['V.', 'Di', 'Marco'], ['A.', '', 'Crax\xc3\xac'], ['P.', 'L.', 'Almasio']]",Digestive and Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1590865805003324', u'http://linkinghub.elsevier.com/retrieve/pii/S1590865805003324']",
10.1053/jhep.2001.22112,"Goyal, A., Kazim, S., Sakhuja, P., et. al, Association of TNF? polymorphism with disease severity among patients infected with hepatitis C virus, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.10533,Association of TNF? polymorphism with disease severity among patients infected with hepatitis C virus,"[['Ankur', '', 'Goyal'], ['Syed', 'N.', 'Kazim'], ['Puja', '', 'Sakhuja'], ['Veena', '', 'Malhotra'], ['Naveen', '', 'Arora'], ['Shiv', 'K.', 'Sarin']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.10533'],
10.1053/jhep.2001.22112,"Gordon, S., , New insights into acute hepatitis C, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00807-2,New insights into acute hepatitis C,"[['Stuart', 'C.', 'Gordon']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503008072', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503008072']",
10.1053/jhep.2001.22112,"Zakaria, S., Fouad, R., Shaker, O., et. al, Changing Patterns of Acute Viral Hepatitis at a Major Urban Referral Center in Egypt, Clinical Infectious Diseases, 2007",cited-by,10.1086/511074,Changing Patterns of Acute Viral Hepatitis at a Major Urban Referral Center in Egypt,"[['Soheir', '', 'Zakaria'], ['Rabab', '', 'Fouad'], ['Olfat', '', 'Shaker'], ['Sami', '', 'Zaki'], ['Ahmed', '', 'Hashem'], ['Gamal', '', 'Esmat'], ['Serag', '', 'Zakaria']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/511074'],
10.1053/jhep.2001.22112,"Page-Shafer, K., Pappalardo, B., Tobler, L., et. al, Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates, , 0",cited-by,6522537Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates,Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates,"[['Kimberly', '', 'Page-Shafer'], ['Brandee', 'L.', 'Pappalardo'], ['Leslie', 'H.', 'Tobler'], ['Bruce', 'H.', 'Phelps'], ['Brian', 'R.', 'Edlin'], ['Andrew', 'R.', 'Moss'], ['Teresa', 'L.', 'Wright'], ['David', 'J.', 'Wright'], ['Thomas', 'R.', ""O'Brien""], ['Sally', '', 'Caglioti'], ['Michael', 'P.', 'Busch']]",,0,[u'http://jcm.asm.org/cgi/reprint/46/2/499.pdf'],
10.1053/jhep.2001.22112,"Wiegand, J., Deterding, K., Cornberg, M., et. al, Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon a, , 2008",cited-by,6628515Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon a,Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon a,"[['Johannes', '', 'Wiegand'], ['Katja', '', 'Deterding'], ['Markus', '', 'Cornberg'], ['Heiner', '', 'Wedemeyer']]",,2008,"[u'http://jac.oxfordjournals.org/cgi/reprint/dkn346v1.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/62/5/860.pdf']",
10.1053/jhep.2001.22112,"Weigand, K., Stremmel, W., Encke, J., , Treatment of hepatitis C virus infection, , 2007",cited-by,6934404Treatment of hepatitis C virus infection,Treatment of hepatitis C virus infection,"[['Kilian', '', 'Weigand'], ['Wolfgang', '', 'Stremmel'], ['Jens', '', 'Encke']]",,2007,[u'http://www.wjgnet.com/1007-9327/13/1897.pdf'],
10.1053/jhep.2001.22112,"Gaafary, M., Rekacewicz, C., Abdel-Rahman, A., et. al, Surveillance of acute hepatitis C in Cairo, Egypt, Journal of Medical Virology, 2005",cited-by,10.1002/jmv.20392,"Surveillance of acute hepatitis C in Cairo, Egypt","[['Maha', 'M. El', 'Gaafary'], ['Claire', '', 'Rekacewicz'], ['Amira', 'Gamal', 'Abdel-Rahman'], ['Mohamed', 'Farouk', 'Allam'], ['Mostafa', 'El', 'Hosseiny'], ['Mohamed', 'Abdel', 'Hamid'], ['Fran\xc3\xa7oise', '', 'Colombani'], ['Yehia', '', 'Sultan'], ['Saeed', '', 'El-Aidy'], ['Arnaud', '', 'Fontanet'], ['Mostafa', 'Kamal', 'Mohamed']]",Journal of Medical Virology,2005,[u'http://doi.wiley.com/10.1002/jmv.20392'],
10.1053/jhep.2001.22112,"Currie, S., Ryan, J., Tracy, D., et. al, A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus, Drug and Alcohol Dependence, 2008",cited-by,10.1016/j.drugalcdep.2007.09.011,A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus,"[['Sue', 'L.', 'Currie'], ['James', 'C.', 'Ryan'], ['Daniel', '', 'Tracy'], ['Teresa', 'L.', 'Wright'], ['Sally', '', 'George'], ['Rosemary', '', 'McQuaid'], ['Michael', '', 'Kim'], ['Hui', '', 'Shen'], ['Alexander', '', 'Monto']]",Drug and Alcohol Dependence,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0376871607003705', u'http://linkinghub.elsevier.com/retrieve/pii/S0376871607003705']",
10.1053/jhep.2001.22112,"Marinho, R., Pinto, R., Santos, M., et. al, Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus, Liver International, 2004",cited-by,10.1111/j.1478-3231.2004.0947.x,Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus,"[['Rui', 'T.', 'Marinho'], ['Ruth', 'M.', 'Pinto'], ['Maria', 'L.', 'Santos'], ['Miguel', 'Carneiro de', 'Moura']]",Liver International,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1478-3231.2004.0947.x'],
10.1053/jhep.2001.22112,"Coppola, N., Pisapia, R., Marrocco, C., et. al, Anti-HCV IgG avidity index in acute hepatitis C, Journal of Clinical Virology, 2007",cited-by,10.1016/j.jcv.2007.07.005,Anti-HCV IgG avidity index in acute hepatitis C,"[['Nicola', '', 'Coppola'], ['Raffaella', '', 'Pisapia'], ['Cecilia', '', 'Marrocco'], ['Salvatore', '', 'Martini'], ['Luisa', 'Maria', 'Vatiero'], ['Vincenzo', '', 'Messina'], ['Gilda', '', 'Tonziello'], ['Caterina', '', 'Sagnelli'], ['Pietro', '', 'Filippini'], ['Felice', '', 'Piccinino'], ['Evangelista', '', 'Sagnelli']]",Journal of Clinical Virology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207002533', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207002533']",
10.1053/jhep.2001.22112,"Busch, M., Shafer, K., , Editorial Commentary: Acute‐Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment, Clinical Infectious Diseases, 2005",cited-by,10.1086/428583,"Editorial Commentary: Acute‐Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment","[['Michael', 'P.', 'Busch'], ['Kimberly', 'A. Page', 'Shafer']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/428583'],
10.1053/jhep.2001.22112,"BROUARD, C., PRADAT, P., DELAROCQUE-ASTAGNEAU, E., et. al, Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France, Epidemiology and Infection, 2008",cited-by,10.1017/S0950268807009417,Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France,"[['C.', '', 'BROUARD'], ['P.', '', 'PRADAT'], ['E.', '', 'DELAROCQUE-ASTAGNEAU'], ['C.', '', 'SILVAIN']]",Epidemiology and Infection,2008,[u'http://www.journals.cambridge.org/abstract_S0950268807009417'],
10.1053/jhep.2001.22112,"Talal, A., Canchis, P., Jacobson, I., , The HCV and HIV coinfected patient: What have we learned about pathophysiology?, Current Gastroenterology Reports, 2002",cited-by,10.1007/s11894-002-0033-z,The HCV and HIV coinfected patient: What have we learned about pathophysiology?,"[['Andrew', 'H.', 'Talal'], ['P.', 'Wilfredo', 'Canchis'], ['Ira', 'M.', 'Jacobson']]",Current Gastroenterology Reports,2002,"[u'http://www.springerlink.com/content/x262r6216x3418r7', u'http://www.springerlink.com/index/x262r6216x3418r7.pdf', u'http://www.springerlink.com/index/10.1007/s11894-002-0033-z', u'http://www.springerlink.com/index/pdf/10.1007/s11894-002-0033-z']",
10.1053/jhep.2001.22112,"Molina, S., Missé, D., Roche, S., et. al, Identification of apolipoprotein C-III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection, Proteomics Clinical Applications, 2008",cited-by,10.1002/prca.200800020,Identification of apolipoprotein C-III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection,"[['Sonia', '', 'Molina'], ['Doroth\xc3\xa9e', '', 'Miss\xc3\xa9'], ['St\xc3\xa9phane', '', 'Roche'], ['St\xc3\xa9phanie', '', 'Badiou'], ['Jean-Paul', '', 'Cristol'], ['Claude', '', 'Bonfils'], ['Jean-Fran\xc3\xa7ois', '', 'Dierick'], ['Francisco', '', 'Veas'], ['Thierry', '', 'Levayer'], ['Dominique', '', 'Bonnefont-Rousselot'], ['Patrick', '', 'Maurel'], ['Joliette', '', 'Coste'], ['Chantal', '', 'Fournier-Wirth']]",Proteomics Clinical Applications,2008,"[u'http://gemi.mpl.ird.fr/OPM/Misse/Molina%202008.pdf', u'http://doi.wiley.com/10.1002/prca.200800020']",
10.1053/jhep.2001.22112,"Albert, M., Decalf, J., Pol, S., , Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C, Journal of Hepatology, 2008",cited-by,10.1016/j.jhep.2008.09.002,Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C,"[['Matthew', 'L.', 'Albert'], ['J\xc3\xa9r\xc3\xa9mie', '', 'Decalf'], ['Stanislas', '', 'Pol']]",Journal of Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0168827808006041', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827808006041']",
10.1053/jhep.2001.22112,"Busch, M., Shafer, K., , Acute-Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment, , 2005",cited-by,"6223596Acute-Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment","Acute-Phase Hepatitis C Virus Infection: Implications for Research, Diagnosis, and Treatment","[['Michael', 'P.', 'Busch'], ['Kimberly', 'A. Page', 'Shafer']]",,2005,[u'https://php10.ucsf.edu/ufostudy/pdfs/Busch_2005.pdf'],
10.1053/jhep.2001.22112,"Sagnelli, E., Coppola, N., Marrocco, C., et. al, Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.12.027,Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres,"[['Evangelista', '', 'Sagnelli'], ['Nicola', '', 'Coppola'], ['Cecilia', '', 'Marrocco'], ['Giancarlo', '', 'Coviello'], ['Martina', '', 'Battaglia'], ['Vincenzo', '', 'Messina'], ['Giovanni', '', 'Rossi'], ['Caterina', '', 'Sagnelli'], ['Carlo', '', 'Scolastico'], ['Pietro', '', 'Filippini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805000668', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805000668']",
10.1053/jhep.2001.22112,"Golstein, P., Delforge, M., Deviere, J., et. al, Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C, Journal of Viral Hepatitis, 2004",cited-by,10.1046/j.1365-2893.2003.00478.x,Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C,"[['P.', 'E.', 'Golstein'], ['M.', 'L.', 'Delforge'], ['J.', '', 'Deviere'], ['P.', '', 'Marcellin']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00478.x'],
10.1053/jhep.2001.22112,"Monserrat, J., Pablo, R., Reyes, E., et. al, Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients, Critical Care, 2009",cited-by,10.1186/cc7731,Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients,"[['Jorge', '', 'Monserrat'], ['Raul', 'de', 'Pablo'], ['Eduardo', '', 'Reyes'], ['David', '', 'D\xc3\xadaz'], ['Hugo', '', 'Barcenilla'], ['Manuel', 'R', 'Zapata'], ['Antonio', 'De la', 'Hera'], ['Alfredo', '', 'Prieto'], ['Melchor', '', '\xc3\x81lvarez-Mon']]",Critical Care,2009,"[u'http://www.springerlink.com/index/y672tmh733pg6577.pdf', u'http://ccforum.com/content/13/1/R26', u'http://ccforum.com/content/13/2/127', u'http://ccforum.com/content/13/3/412', u'http://www.biomedcentral.com/content/pdf/cc7731.pdf', u'http://www.springerlink.com/content/y672tmh733pg6577']",
10.1053/jhep.2001.22112,"Nelson, K., Shan, H., , Confirmatory testing of hepatitis C virus–positive enzyme immunoassay results in limited-resource countries: should it be attempted?, Transfusion, 2008",cited-by,10.1111/j.1537-2995.2008.01696.x,Confirmatory testing of hepatitis C virus–positive enzyme immunoassay results in limited-resource countries: should it be attempted?,"[['Kenrad', 'E.', 'Nelson'], ['Hua', '', 'Shan']]",Transfusion,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2008.01696.x'],
10.1053/jhep.2001.22112,"Okamoto, N., Yotsuyanagi, H., Ooka, S., et. al, Autoantibodies to CD69 in Patients with Chronic Hepatitis Type C: A Candidate Marker for Predicting the Response to Interferon Therapy, Intervirology, 2003",cited-by,10.1159/000068126,Autoantibodies to CD69 in Patients with Chronic Hepatitis Type C: A Candidate Marker for Predicting the Response to Interferon Therapy,"[['Nahoko', '', 'Okamoto'], ['Hiroshi', '', 'Yotsuyanagi'], ['Seido', '', 'Ooka'], ['Toshihiro', '', 'Matsui'], ['Manae', 'Suzuki', 'Kurokawa'], ['Michihiro', '', 'Suzuki'], ['Shiro', '', 'Iino'], ['Kusuki', '', 'Nishioka'], ['Tomohiro', '', 'Kato']]",Intervirology,2003,"[u'http://www.online.karger.com/doi/10.1159/000068126', u'http://www.karger.com/doi/10.1159/000068126']",
10.1053/jhep.2001.22112,"Wiegand, J., Deterding, K., Cornberg, M., et. al, Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon, Journal of Antimicrobial Chemotherapy, 2008",cited-by,10.1093/jac/dkn346,Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon,"[['J.', '', 'Wiegand'], ['K.', '', 'Deterding'], ['M.', '', 'Cornberg'], ['H.', '', 'Wedemeyer']]",Journal of Antimicrobial Chemotherapy,2008,[u'http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkn346'],
10.1053/jhep.2001.22112,"Morillas, R., Montoliu, S., Planas, R., , Hepatitis C, , 2005",cited-by,10.1016/S1134-2072(05)71167-1,Hepatitis C,"[['R.', 'M.', 'Morillas'], ['S.', '', 'Montoliu'], ['R.', '', 'Planas']]",,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1134207205711671', u'http://linkinghub.elsevier.com/retrieve/pii/S1134207205711671']",
10.1053/jhep.2001.22112,"Jaeckel, E., Wedemeyer, H., Wiegand, J., et. al, Acute hepatitis C virus infection: to treat or not to treat?, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.02.041,Acute hepatitis C virus infection: to treat or not to treat?,"[['E.', '', 'Jaeckel'], ['H.', '', 'Wedemeyer'], ['J.', '', 'Wiegand'], ['M.', 'P.', 'Manns']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504003154', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504003154']",
10.1053/jhep.2001.22112,"Wiegand, J., Potthoff, A., Manns, M., et. al, Acute hepatitis C infection: Can immunology teach us the right way to treat?, Current Hepatitis Reports, 2004",cited-by,10.1007/s11901-004-0025-6,Acute hepatitis C infection: Can immunology teach us the right way to treat?,"[['Johannes', '', 'Wiegand'], ['Andrej', '', 'Potthoff'], ['Michael', 'P.', 'Manns'], ['Heiner', '', 'Wedemeyer']]",Current Hepatitis Reports,2004,"[u'http://www.springerlink.com/index/x7212685g77j1132.pdf', u'http://www.springerlink.com/content/x7212685g77j1132', u'http://www.springerlink.com/index/10.1007/s11901-004-0025-6', u'http://www.springerlink.com/index/pdf/10.1007/s11901-004-0025-6']",
10.1053/jhep.2001.22112,"Strasak, A., Kim, A., Lauer, G., et. al, Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil, BMC Infectious Diseases, 2011",cited-by,10.1186/1471-2334-11-15,"Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil","[['Alexander', 'M', 'Strasak'], ['Arthur', 'Y', 'Kim'], ['Georg', 'M', 'Lauer'], ['Paulo', 'S de', 'Sousa'], ['Cleber', 'F', 'Ginuino'], ['Carlos', 'A', 'Fernandes'], ['Carlos', 'E', 'Velloso'], ['Adilson', 'J de', 'Almeida'], ['Jaqueline', 'M de', 'Oliveira'], ['Clara', 'F', 'Yoshida'], ['Julian', 'Schulze zur', 'Wiesch'], ['Gl\xc3\xa1ucia', '', 'Paranhos-Baccal\xc3\xa1'], ['Stefan', '', 'Lang'], ['Larry', 'J', 'Brant'], ['Hanno', '', 'Ulmer'], ['Susanne', '', 'Strohmaier'], ['Lalit', '', 'Kaltenbach'], ['Elisabeth', '', 'Lampe'], ['Lia', 'L', 'Lewis-Ximenez']]",BMC Infectious Diseases,2011,"[u'http://www.biomedcentral.com/1471-2334/11/15', u'http://www.biomedcentral.com/content/pdf/1471-2334-11-15.pdf', u'http://www.springerlink.com/content/dur5rw168711102t', u'http://www.springerlink.com/index/dur5rw168711102t.pdf']",
10.1053/jhep.2001.22112,"Matthews, G., Dore, G., Grebely, J., , Treatment of acute HCV infection, Nature Reviews Gastroenterology & Hepatology, 2011",cited-by,10.1038/nrgastro.2011.32,Treatment of acute HCV infection,"[['Gail', 'V.', 'Matthews'], ['Gregory', 'J.', 'Dore'], ['Jason', '', 'Grebely']]",Nature Reviews Gastroenterology & Hepatology,2011,[u'http://dx.doi.org/10.1038/nrgastro.2011.32'],
10.1053/jhep.2001.22112,"Hung, C., Lu, S., Wang, J., et. al, Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2008.01.049,Identified cases of acute hepatitis C from computerized laboratory database: A hospital-based epidemiological and clinical study,"[['Chao-Hung', '', 'Hung'], ['Sheng-Nan', '', 'Lu'], ['Jing-Houng', '', 'Wang'], ['Shu-Fen', '', 'Hung'], ['Chien-Hung', '', 'Chen'], ['Tsung-Hui', '', 'Hu'], ['Chuan-Mo', '', 'Lee'], ['Chi-Sin', '', 'Changchien']]",Journal of Infection,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0163445308000868', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445308000868']",
10.1053/jhep.2001.22112,"Raja, N., Singh, N., Janjua, K., , Hepatitis C virus infection: An enigma continues, , 2006",cited-by,5613962Hepatitis C virus infection: An enigma continues,Hepatitis C virus infection: An enigma continues,"[['Nadeem', 'Sajjad', 'Raja'], ['Nishi', 'Nihar', 'Singh'], ['Khalid', 'Abbas', 'Janjua']]",,2006,[u'http://www.medicinetoday.com.pk/pdf/july-sep2006/Review%20-%20Hep%20C.pdf'],
10.1053/jhep.2001.22112,"Nguyen-Khac, E., , L’hépatite C aiguë en 2005, Gastroenterologie Clinique Et Biologique, 2005",cited-by,10.1016/S0399-8320(05)82180-3,L’hépatite C aiguë en 2005,"[['Eric', '', 'Nguyen-Khac']]",Gastroenterologie Clinique Et Biologique,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0399832005821803', u'http://linkinghub.elsevier.com/retrieve/pii/S0399832005821803']",
10.1053/jhep.2001.22112,"Cacoub, P., Benhamou, Y., , Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C, Revue De Medecine Interne, 2002",cited-by,10.1016/S0248-8663(02)00660-4,Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C,"[['P.', '', 'Cacoub'], ['Y.', '', 'Benhamou']]",Revue De Medecine Interne,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0248866302006604', u'http://linkinghub.elsevier.com/retrieve/pii/S0248866302006604']",
10.1053/jhep.2001.22112,"Hoofnagle, J., RESTREPO, J., Jaime, J., et. al, 4 Acute hepatitis C, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80008-3,4 Acute hepatitis C,"[['Jay', 'H.', 'Hoofnagle'], ['JUAN', 'CARLOS', 'RESTREPO'], ['John', '', 'Jaime'], ['Juan', '', 'Carlos'], ['Restrepo', '', 'Guti\xc3\xa9rrez'], ['Guti\xc3\xa9rrez', '', 'Calle']]",Biomedical Research Reports,2000,"[u'http://www.scielo.org.co/pdf/amc/v33n1/v33n1a6.pdf', u'http://www.sciencedirect.com/science/article/pii/S1874532600800083', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800083']",
10.1053/jhep.2001.22112,"Garten, R., Lai, S., Zhang, J., et. al, Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China, , 0",cited-by,12144383Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China,Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China,"[['Rebecca', 'J', 'Garten'], ['Sheng-Han', '', 'Lai'], ['Jin-Bing', '', 'Zhang'], ['Wei', '', 'Liu'], ['Jie', '', 'Chen'], ['Xiao-Fang', '', 'Yu']]",,0,[u'http://www.wjgnet.com/1007-9327/14/1878.pdf'],
10.1053/jhep.2001.22112,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
10.1053/jhep.2001.22112,"Santos, B., Sousa, P., Mena, F., et. al, Chronic hepatitis C – Assessment in civil law: A case study, Journal of Forensic and Legal Medicine, 2010",cited-by,10.1016/j.jflm.2009.09.007,Chronic hepatitis C – Assessment in civil law: A case study,"[['Bruno', 'Miguel', 'Santos'], ['Paula', '', 'Sousa'], ['Filomena', '', 'Mena'], ['Gra\xc3\xa7a', 'Santos', 'Costa'], ['Francisco', '', 'Corte-Real'], ['Duarte', 'Nuno', 'Vieira']]",Journal of Forensic and Legal Medicine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1752928X09001553', u'http://linkinghub.elsevier.com/retrieve/pii/S1752928X09001553']",
10.1053/jhep.2001.22112,"Zuberi, B., Zuberi, F., Hasan, S., et. al, FREQUENCY OF ACUTE HEPATITIS C AFTER NEEDLE STICK INJURY AND ITS TREATMENT OUTCOME, , 2009",cited-by,6507616FREQUENCY OF ACUTE HEPATITIS C AFTER NEEDLE STICK INJURY AND ITS TREATMENT OUTCOME,FREQUENCY OF ACUTE HEPATITIS C AFTER NEEDLE STICK INJURY AND ITS TREATMENT OUTCOME,"[['Bader', 'Faiyaz', 'Zuberi'], ['Faisal', 'Faiyaz', 'Zuberi'], ['Syed', 'Raizul', 'Hasan'], ['Raj', '', 'Kumar'], ['Sajjad', 'Ali', 'Memon'], ['Salahuddin', '', 'Afsar']]",,2009,[u'http://www.pjms.com.pk/issues/octdec109/pdf/13.article12.pdf'],
10.1053/jhep.2001.22112,"Coppola, N., Pisapia, R., Tonziello, G., et. al, Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.08.009,Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index,"[['Nicola', '', 'Coppola'], ['Raffaella', '', 'Pisapia'], ['Gilda', '', 'Tonziello'], ['Addolorata', '', 'Masiello'], ['Salvatore', '', 'Martini'], ['Mariantonietta', '', 'Pisaturo'], ['Vincenzo', '', 'Messina'], ['Caterina', '', 'Sagnelli'], ['Margherita', '', 'Macera'], ['Giuseppe', '', 'Signoriello'], ['Evangelista', '', 'Sagnelli']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209003874', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209003874']",
10.1053/jhep.2001.22112,"Martín, M., García, E., Herrera, J., , Hepatitis por el virus C. Hepatitis por el virus B y otros virus hepatotropos, , 2008",cited-by,10.1016/S0211-3449(08)73113-8,Hepatitis por el virus C. Hepatitis por el virus B y otros virus hepatotropos,"[['M.', 'L. Galve', 'Mart\xc3\xadn'], ['E.', 'Navarrete', 'Garc\xc3\xada'], ['J.', 'Iborra', 'Herrera']]",,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0211344908731138', u'http://linkinghub.elsevier.com/retrieve/pii/S0211344908731138']",
10.1053/jhep.2001.22112,"Handra-Luca, A., Tengher, I., Ziol, M., , Aspects histopathologiques des infections à virus hépatotropes, Revue Francophone Des Laboratoires, 2007",cited-by,10.1016/S1773-035X(07)80028-1,Aspects histopathologiques des infections à virus hépatotropes,"[['Adriana', '', 'Handra-Luca'], ['Iulia', '', 'Tengher'], ['Marianne', '', 'Ziol']]",Revue Francophone Des Laboratoires,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1773035X07800281', u'http://linkinghub.elsevier.com/retrieve/pii/S1773035X07800281']",
10.1053/jhep.2001.22112,"Lamoglia, R., , Tratamiento de la hepatitis aguda C, , 2006",cited-by,10.1157/13097653,Tratamiento de la hepatitis aguda C,"[['R.', 'Sol\xc3\xa0', 'Lamoglia']]",,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0210570506751974', u'http://linkinghub.elsevier.com/retrieve/pii/S0210570506751974']",
10.1053/jhep.2001.22112,"CANADIAN, A., , MANAGEMENT OF VIRAL HEPATITIS, , 2004",cited-by,12340969MANAGEMENT OF VIRAL HEPATITIS,MANAGEMENT OF VIRAL HEPATITIS,"[['A', '', 'CANADIAN']]",,2004,"[u'http://www.hepatology.ca/cm/FileLib/ViralHepatitisCanadianConsensus2004.pdf', u'http://www.hepatology.ca/cm/filelib/consensus_english_aug_04.pdf']",
10.1053/jhep.2001.22112,"Pawlotsky, J., , THE PROS OF ANTIVIRAL THERAPY IN ACUTE HEPATITIS C VIRUS INFECTION AND USE OF ANTIVIRALS FOR POSTEXPOSURE PROPHYLAXIS, , 0",cited-by,5120397THE PROS OF ANTIVIRAL THERAPY IN ACUTE HEPATITIS C VIRUS INFECTION AND USE OF ANTIVIRALS FOR POSTEXPOSURE PROPHYLAXIS,THE PROS OF ANTIVIRAL THERAPY IN ACUTE HEPATITIS C VIRUS INFECTION AND USE OF ANTIVIRALS FOR POSTEXPOSURE PROPHYLAXIS,"[['Jean-Michel', '', 'Pawlotsky']]",,0,[u'http://www1.easl.ch/PGC/A.%20JM%20Pawlotsky.pdf'],
10.1053/jhep.2001.22112,"Franciscus, A., Davis, G., , The NIH Consensus Conference on the Management of Hepatitis C: 2002. Part 3, , 0",cited-by,5758502The NIH Consensus Conference on the Management of Hepatitis C: 2002. Part 3,The NIH Consensus Conference on the Management of Hepatitis C: 2002. Part 3,"[['Alan', '', 'Franciscus'], ['Gary', 'L.', 'Davis']]",,0,"[u'https://www250.safesecureweb.com/hcvadvocate/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf3.pdf', u'https://www250.safesecureweb.com/hcvadvocate/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf2.pdf', u'http://www.hcvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf3.pdf', u'http://www.hcvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf2.pdf', u'http://www.hcvadvocate.org/news/newsupdates_pdf/2.2_conference_reports/nihconf4.pdf', u'http://www.hcvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/nihconf1.pdf']",
10.1053/jhep.2001.22112,"Mikrobiyoloji, K., , İstanbul Eğitim ve Araştirma Hastanesi İnfeksiyon Hastaliklari ve, , 0",cited-by,11026317İstanbul Eğitim ve Araştirma Hastanesi İnfeksiyon Hastaliklari ve,İstanbul Eğitim ve Araştirma Hastanesi İnfeksiyon Hastaliklari ve,"[['Klinik', '', 'Mikrobiyoloji']]",,0,[u'http://www.istanbulsaglik.gov.tr/w/tez/pdf/enfeksiyon/dr_habip_gedik.pdf'],
10.1053/jhep.2001.22112,"Weltman, M., Commander, W., Talley, N., , Chronic hepatitis C infection: a review and update on treatment strategies, , 0",cited-by,11103616Chronic hepatitis C infection: a review and update on treatment strategies,Chronic hepatitis C infection: a review and update on treatment strategies,"[['Martin', 'D', 'Weltman'], ['Wing', '', 'Commander'], ['Nicholas', 'J', 'Talley']]",,0,[u'http://www.defence.gov.au/health/infocentre/journals/adfhj_apr03/adfhealth_4_1_27-33.pdf'],
10.1053/jhep.2001.22112,"Saghir, M., Shaheen, N., Shah, M., , Comparative Evaluation of Trace Metals in the Blood of Hepatitis C Patients and Healthy Donors, Biological Trace Element Research, 0",cited-by,10.1007/s12011-010-8930-8,Comparative Evaluation of Trace Metals in the Blood of Hepatitis C Patients and Healthy Donors,"[['Mehwish', '', 'Saghir'], ['Nazia', '', 'Shaheen'], ['Munir', 'H.', 'Shah']]",Biological Trace Element Research,0,"[u'http://www.springerlink.com/content/x65q132h0827k535', u'http://www.springerlink.com/index/x65q132h0827k535.pdf']",
10.1053/jhep.2001.22112,"Susser, S., Dragan, A., Zeuzem, S., et. al, Viral Infections by Hepatotropic Viruses, , 0",cited-by,10.1007/978-3-642-04519-6_9,Viral Infections by Hepatotropic Viruses,"[['Simone', '', 'Susser'], ['Anette', '', 'Dragan'], ['Stefan', '', 'Zeuzem'], ['Christoph', '', 'Sarrazin'], ['Jay', 'H.', 'Lefkowitch'], ['Henryk', '', 'Dancygier']]",,0,"[u'http://www.springerlink.com/index/h214137744v14032.pdf', u'http://www.springerlink.com/content/h214137744v14032']",
10.1053/jhep.2001.22112,"White, P., Ullah, S., Donaldson, A., et. al, Encouraging junior community netball players to learn correct safe landing technique, Journal of Science and Medicine in Sport, 0",cited-by,10.1016/j.jsams.2011.08.004,Encouraging junior community netball players to learn correct safe landing technique,"[['Peta', 'E.', 'White'], ['Shahid', '', 'Ullah'], ['Alex', '', 'Donaldson'], ['Leonie', '', 'Otago'], ['Natalie', '', 'Saunders'], ['Maria', '', 'Romiti'], ['Caroline', 'F.', 'Finch']]",Journal of Science and Medicine in Sport,0,[u'http://www.sciencedirect.com/science/article/pii/S1440244011001538'],
10.1056~NEJMoa011232,"Santantonio T, Mazzola M, Guastadisegni A, Casalino C, Pastore G. A cohort study of acute hepatitis C virus (HVC) infection: natural course and outcome. Hepatology 1999;30:Suppl:205A. abstract.",references,NOT found in MAS
10.1056~NEJMoa011232,"Seef LB. Natural history of hepatitis C. In: Schiff ER, Hoofnagle JH, The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF NEW SOUTH WALES on September 1, 2014. For personal use only. No other uses without permission. Copyright © 2001 Massachusetts Medical Society. All rights reserved. TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b N Engl J Med, Vol. 345, No. 20 · November 15, 2001 · www.nejm.org · 1457 eds. Update on viral hepatitis: syllabus of the 2000 AASLD postgraduate course. Alexandria, Va.: American Association for the Study of Liver Diseases, 2000:112-8.",references,NOT found in MAS
10.1056~NEJMoa011232,"Vogt M, Lang T, Frösner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999;341:866-70.",references,10.1056/NEJM199909163411202,Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening,"[[u'Manfred', u'', u'Vogt'], [u'Thomas', u'', u'Lang'], [u'Gert', u'', u'Fr\xf6sner'], [u'Christiane', u'', u'Klingler'], [u'Anna', u'F.', u'Sendl'], [u'Anita', u'', u'Zeller'], [u'Baldur', u'', u'Wiebecke'], [u'Barbara', u'', u'Langer'], [u'Hans', u'', u'Meisner'], [u'John', u'', u'Hess']]",New England Journal of Medicine,1999,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199909163411202'],"[{u'Name': u'Blood Donor', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 3677}, {u'Name': u'Cardiac Surgery', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 4837}, {u'Name': u'Clinical Outcome', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 5965}, {u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}]"
10.1056/NEJM199909163411202,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
10.1056/NEJM199909163411202,"Hoofnagle, J., , Course and outcome of hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36227,Course and outcome of hepatitis C,"[['Jay', 'H.', 'Hoofnagle']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Course%20And%20Outcome%20Of%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36227', u'http://doi.wiley.com/10.1002/hep.1840360704']",
10.1056/NEJM199909163411202,"Ghany, M., Strader, D., Thomas, D., et. al, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009",cited-by,10.1002/hep.22759,"Diagnosis, management, and treatment of hepatitis C: An update","[['Marc', 'G.', 'Ghany'], ['Doris', 'B.', 'Strader'], ['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Hepatology,2009,"[u'http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/diagnosis_of_hep_c_update.pdf', u'http://www.aasld.org/practiceguidelines/Documents/Hepatitis%20C%20UPDATE.pdf', u'http://www.sklid.com/news/uploadfiles/20094122357635.pdf', u'http://www.coloradoguidelines.org/pdf/hepatitisbc/Diagnosis_of_HEP_C_Update_Aug%20_09.pdf', u'http://www.paml.com/Files/Miscellaneous/Hep%20C%20Diagnosis,Manage,Treatment%20Apr%202009.pdf', u'http://doi.wiley.com/10.1002/hep.22759', u'http://zuberi.biz/guidelines/AASLD_HEP_C_2009.pdf']",
10.1056/NEJM199909163411202,"Freeman, A., Dore, G., Law, M., et. al, Estimating progression to cirrhosis in chronic hepatitis C virus infection, Hepatology, 2001",cited-by,10.1053/jhep.2001.27831,Estimating progression to cirrhosis in chronic hepatitis C virus infection,"[['Anthony', 'J.', 'Freeman'], ['Gregory', 'J.', 'Dore'], ['Matthew', 'G.', 'Law'], ['Max', '', 'Thorpe'], ['Jan', 'Von', 'Overbeck'], ['Andrew', 'R.', 'Lloyd'], ['George', '', 'Marinos'], ['John', 'M.', 'Kaldor']]",Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270913901810934', u'http://www.sciencedirect.com/science/article/pii/S0270913901333190', u'http://doi.wiley.com/10.1053/jhep.2001.27831']",
10.1056/NEJM199909163411202,"Leandro, G., Mangia, A., Hui, J., et. al, Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2006.03.014,"Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data","[['Gioacchino', '', 'Leandro'], ['Alessandra', '', 'Mangia'], ['Jason', '', 'Hui'], ['Paolo', '', 'Fabris'], ['Guido', '', 'Colloredo'], ['Luigi', 'E.', 'Adinolfi'], ['Tarik', '', 'Asselah'], ['Julie', 'R.', 'Jonsson'], ['Antonina', '', 'Smedile'], ['Norah', '', 'Terrault'], ['Valerio', '', 'Pazienza'], ['Maria', 'Teresa', 'Giordani'], ['Emiliano', '', 'Giostra'], ['Aurelio', '', 'Sonzogni'], ['Giuseppe', '', 'Ruggiero'], ['Patrick', '', 'Marcellin'], ['Elizabeth', 'E.', 'Powell'], ['Jacob', '', 'George'], ['Francesco', '', 'Negro']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508506005634', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508506005634']",
10.1056/NEJM199909163411202,"Dienstag, J., McHutchison, J., , American Gastroenterological Association Technical Review on the Management of Hepatitis C, Gastroenterology, 2006",cited-by,10.1053/j.gastro.2005.11.010,American Gastroenterological Association Technical Review on the Management of Hepatitis C,"[['Jules', 'L.', 'Dienstag'], ['John', 'G.', 'McHutchison']]",Gastroenterology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0016508505022705', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508505022705']",
10.1056/NEJM199909163411202,"Gerlach, J., Diepolder, H., Zachoval, R., et. al, Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication, Gastroenterology, 2003",cited-by,10.1016/S0016-5085(03)00668-1,"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance 1 1 The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication","[['J.', 'Tilman', 'Gerlach'], ['Helmut', 'M', 'Diepolder'], ['Reinhart', '', 'Zachoval'], ['Norbert', 'H', 'Gruener'], ['Maria-Christina', '', 'Jung'], ['Axel', '', 'Ulsenheimer'], ['Winfried', 'W', 'Schraut'], ['C.', 'albrecht', 'Schirren'], ['M', '', 'Waechtler'], ['M', '', 'Backmund'], ['Gerd', 'R', 'Pape']]",Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0016508503006681', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508503006681']",
10.1056/NEJM199909163411202,"Yee, T., Griffioen, A., Sabin, C., et. al, The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985, Gut, 2000",cited-by,10.1136/gut.47.6.845,The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985,"[['T', 'T', 'Yee'], ['A', '', 'Griffioen'], ['C', 'A', 'Sabin'], ['G', '', 'Dusheiko'], ['C', 'A', 'Lee']]",Gut,2000,"[u'http://gut.bmj.com/cgi/doi/10.1136/gut.47.6.845', u'http://dx.doi.org/']",
10.1056/NEJM199909163411202,"Micallef, J., Kaldor, J., Dore, G., , Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies, Journal of Viral Hepatitis, 2006",cited-by,10.1111/j.1365-2893.2005.00651.x,Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,"[['J.', 'M.', 'Micallef'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2005.00651.x'],
10.1056/NEJM199909163411202,"Hofer, H., Watkins-Riedel, T., Janata, O., et. al, Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load, , 2003",cited-by,5418107Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,Spontaneous Viral Clearance in Patients With Acute Hepatitis C Can Be Predicted by Repeated Measurements of Serum Viral Load,"[['Harald', '', 'Hofer'], ['Thomas', '', 'Watkins-Riedel'], ['Oskar', '', 'Janata'], ['Edward', '', 'Penner'], ['Heidemarie', '', 'Holzmann'], ['Petra', '', 'Steindl-Munda'], ['Alfred', '', 'Gangl'], ['Peter', '', 'Ferenci']]",,2003,"[u'http://www.hawaii.edu/hivandaids/Spontaneous%20Viral%20Clearance%20In%20Patients%20With%20Acute%20Hepatitis%20C%20Can%20Be.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/spontaneous.pdf']",
10.1056/NEJM199909163411202,", Hepatitis C in African Americans: Summary of a Workshop, Gastroenterology, 2000",cited-by,10.1053/gast.2000.19582,Hepatitis C in African Americans: Summary of a Workshop,[],Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0016508500697871', u'http://www.natap.org/2000/aasld/gastrent.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508500697871']",
10.1056/NEJM199909163411202,"Bellentani, S., Tiribelli, C., , The spectrum of liver disease in the general population: lesson from the Dionysos study, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00151-9,The spectrum of liver disease in the general population: lesson from the Dionysos study,"[['Stefano', '', 'Bellentani'], ['Claudio', '', 'Tiribelli']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801001519', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801001519']",
10.1056/NEJM199909163411202,"Thomas, D., Seeff, L., , Natural History of Hepatitis C, Clinics in Liver Disease, 2005",cited-by,10.1016/j.cld.2005.05.003,Natural History of Hepatitis C,"[['David', 'L.', 'Thomas'], ['Leonard', 'B.', 'Seeff']]",Clinics in Liver Disease,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105000358', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105000358']",
10.1056/NEJM199909163411202,"Muzzi, A., Leandro, G., Rubbia-Brandt, L., et. al, Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.09.022,Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients,"[['Alba', '', 'Muzzi'], ['Gioacchino', '', 'Leandro'], ['Laura', '', 'Rubbia-Brandt'], ['Richard', '', 'James'], ['Olivia', '', 'Keiser'], ['Raffaele', '', 'Malinverni'], ['Jean-Fran\xc3\xa7ois', '', 'Dufour'], ['Beat', '', 'Helbling'], ['Antoine', '', 'Hadengue'], ['Jean-Jacques', '', 'Gonvers'], ['Beat', '', 'M\xc3\xbcllhaupt'], ['Andreas', '', 'Cerny'], ['Mario', 'U.', 'Mondelli'], ['Francesco', '', 'Negro']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004696', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004696']",
10.1056/NEJM199909163411202,"Casiraghi, M., Paschale, M., Biffi, R., et. al, Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth, Hepatology, 2004",cited-by,10.1002/hep.20030,Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth,"[['Maria', 'Antonietta', 'Casiraghi'], ['Massimo', 'De', 'Paschale'], ['Renato', '', 'Biffi'], ['Agnese', '', 'Assi'], ['Giorgio', '', 'Binelli'], ['Alessandro', 'Remo', 'Zanetti']]",Hepatology,2004,"[u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo416.pdf', u'http://doi.wiley.com/10.1002/hep.20030']",
10.1056/NEJM199909163411202,"Jacobson, K., Murray, K., Zellos, A., et. al, An Analysis of Published Trials of Interferon Monotherapy in Children With Chronic Hepatitis C, Journal of Pediatric Gastroenterology and Nutrition, 2002",cited-by,10.1097/00005176-200201000-00013,An Analysis of Published Trials of Interferon Monotherapy in Children With Chronic Hepatitis C,"[['Karen', 'R.', 'Jacobson'], ['Karen', '', 'Murray'], ['Aglaia', '', 'Zellos'], ['Kathleen', 'B.', 'Schwarz']]",Journal of Pediatric Gastroenterology and Nutrition,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200201000-00013'],
10.1056/NEJM199909163411202,"Meyers, C., Seeff, L., Stehman-Breen, C., et. al, Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD, American Journal of Kidney Diseases, 2003",cited-by,10.1016/S0272-6386(03)00828-X,"Hepatitis C and renal disease: an update 1 1 Summary of a workshop held October 21 to 22, 2002, in the Lister Hill Auditorium, The National Institutes of Health, Bethesda, MD","[['Catherine', 'M.', 'Meyers'], ['Leonard', 'B.', 'Seeff'], ['Catherine', 'O.', 'Stehman-Breen'], ['Jay', 'H.', 'Hoofnagle']]",American Journal of Kidney Diseases,2003,"[u'http://www.sciencedirect.com/science/article/pii/S027263860300828X', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=as027263860300828x', u'http://web.me.com/rogerrodby/RUMC_Renal_Resident_Orientation/Reading_List_files/Hep C and GN AJKD 05.pdf']",
10.1056/NEJM199909163411202,"Jara, P., Resti, M., Hierro, L., et. al, Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children, Clinical Infectious Diseases, 2003",cited-by,10.1086/345908,Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children,"[['Paloma', '', 'Jara'], ['Massimo', '', 'Resti'], ['Loreto', '', 'Hierro'], ['Raffaella', '', 'Giacchino'], ['Cristiana', '', 'Barbera'], ['Lucia', '', 'Zancan'], ['Carlo', '', 'Crivellaro'], ['Etienne', '', 'Sokal'], ['Chiara', '', 'Azzari'], ['Maria', '', 'Guido'], ['Flavia', '', 'Bortolotti']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/345908'],
10.1056/NEJM199909163411202,"Jonas, M., , Children with hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36799,Children with hepatitis C,"[['Maureen', 'M.', 'Jonas']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Children%20With%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360722', u'http://doi.wiley.com/10.1053/jhep.2002.36799']",
10.1056/NEJM199909163411202,"Chen, S., Morgan, T., , The Natural History of Hepatitis C Virus (HCV) Infection, , 2006",cited-by,5725803The Natural History of Hepatitis C Virus (HCV) Infection,The Natural History of Hepatitis C Virus (HCV) Infection,"[['Stephen', 'L.', 'Chen'], ['Timothy', 'R.', 'Morgan']]",,2006,"[u'http://www.hawaii.edu/hivandaids/The_Natural_History_of_Hepatitis_C_Virus_(HCV)_Infection.pdf', u'http://www.medsci.org/v03p0047.pdf']",
10.1056/NEJM199909163411202,"Freeman, A., Law, M., Kaldor, J., et. al, Predicting progression to cirrhosis in chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00436.x,Predicting progression to cirrhosis in chronic hepatitis C virus infection,"[['A.', 'J.', 'Freeman'], ['M.', 'G.', 'Law'], ['J.', 'M.', 'Kaldor'], ['G.', 'J.', 'Dore']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00436.x'],
10.1056/NEJM199909163411202,"Roth, W., Weber, M., Buhr, S., et. al, Yield of HCV and HIV1 NAT after screening of 3.6 million blood donations in central Europe, Transfusion, 2002",cited-by,10.1046/j.1537-2995.2002.00129.x,Yield of HCV and HIV1 NAT after screening of 3.6 million blood donations in central Europe,"[['W.', 'Kurt', 'Roth'], ['Marijke', '', 'Weber'], ['Sylvia', '', 'Buhr'], ['Christian', '', 'Drosten'], ['Wolfgang', '', 'Weichert'], ['Walid', '', 'Sireis'], ['Doris', '', 'Hedges'], ['Erhard', '', 'Seifried']]",Transfusion,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2002.00129.x'],
10.1056/NEJM199909163411202,"Benson, C., Kaplan, J., Masur, H., et. al, Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America, Clinical Infectious Diseases, 2005",cited-by,10.1086/427906,"Treating Opportunistic Infections among HIV‐Infected Adults and Adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America","[['Constance', 'A.', 'Benson'], ['Jonathan', 'E.', 'Kaplan'], ['Henry', '', 'Masur'], ['Alice', '', 'Pau'], ['King', 'K.', 'Holmes']]",Clinical Infectious Diseases,2005,"[u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA.pdf', u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_AA000875.pdf', u'http://medicine.georgetown.edu/residency/idarticles/hivopportunistic.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427906']",
10.1056/NEJM199909163411202,"Prati, D., , Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review, Journal of Hepatology, 2006",cited-by,10.1016/j.jhep.2006.07.003,Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review,"[['Daniele', '', 'Prati']]",Journal of Hepatology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016882780600376X', u'http://linkinghub.elsevier.com/retrieve/pii/S016882780600376X']",
10.1056/NEJM199909163411202,"Seeff, L., , 5 Natural history of hepatitis C, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80009-5,5 Natural history of hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Biomedical Research Reports,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1874532600800095', u'http://www.hbvadvocate.org/news/NewsUpdates_pdf/2.2_Conference_Reports/EASL_2002_Agenda/Section1/Fattovich.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800095']",
10.1056/NEJM199909163411202,"Maheshwari, A., Ray, S., Thuluvath, P., , Acute hepatitis C, Lancet, 2008",cited-by,10.1016/S0140-6736(08)61116-2,Acute hepatitis C,"[['Anurag', '', 'Maheshwari'], ['Stuart', '', 'Ray'], ['Paul', 'J', 'Thuluvath']]",Lancet,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0140673608611162', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673608611162']",
10.1056/NEJM199909163411202,"Mohamed, M., Abdel-Hamid, M., Mikhail, N., et. al, Intrafamilial transmission of hepatitis C in Egypt, Hepatology, 2005",cited-by,10.1002/hep.20811,Intrafamilial transmission of hepatitis C in Egypt,"[['Mostafa', 'K.', 'Mohamed'], ['Mohamed', '', 'Abdel-Hamid'], ['Nabiel', 'N.', 'Mikhail'], ['Fatma', '', 'Abdel-Aziz'], ['Ahmed', '', 'Medhat'], ['Laurence', 'S.', 'Magder'], ['Alan', 'D.', 'Fix'], ['G.', 'Thomas', 'Strickland']]",Hepatology,2005,[u'http://doi.wiley.com/10.1002/hep.20811'],
10.1056/NEJM199909163411202,"Lanford, R., Bigger, C., , Advances in Model Systems for Hepatitis C Virus Research, Virology, 2002",cited-by,10.1006/viro.2001.1316,Advances in Model Systems for Hepatitis C Virus Research,"[['Robert', 'E.', 'Lanford'], ['Catherine', '', 'Bigger']]",Virology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0042682201913169', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682201913169']",
10.1056/NEJM199909163411202,"Rustgi, V., , The epidemiology of hepatitis C infection in the United States, Journal of Gastroenterology, 2007",cited-by,10.1007/s00535-007-2064-6,The epidemiology of hepatitis C infection in the United States,"[['Vinod', 'K.', 'Rustgi']]",Journal of Gastroenterology,2007,"[u'http://www.springerlink.com/content/q7vq67646m677427', u'http://www.springerlink.com/index/q7vq67646m677427.pdf', u'http://www.springerlink.com/index/10.1007/s00535-007-2064-6', u'http://www.springerlink.com/index/pdf/10.1007/s00535-007-2064-6']",
10.1056/NEJM199909163411202,"Guido, M., Bortolotti, F., Leandro, G., et. al, Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?, American Journal of Gastroenterology, 2003",cited-by,10.1016/S0002-9270(02)06015-X,Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?,"[['Maria', '', 'Guido'], ['Flavia', '', 'Bortolotti'], ['Gioacchino', '', 'Leandro'], ['Paloma', '', 'Jara'], ['Loreto', '', 'Hierro'], ['Javier', '', 'Larrauri'], ['Cristiana', '', 'Barbera'], ['Raffaella', '', 'Giacchino'], ['Lucia', '', 'Zancan'], ['Fiorella', '', 'Balli'], ['Carlo', '', 'Crivellaro'], ['Emilio', '', 'Cristina'], ['Angela', '', 'Pucci'], ['Massimo', '', 'Rugge']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S000292700206015X', u'http://linkinghub.elsevier.com/retrieve/pii/S000292700206015X']",
10.1056/NEJM199909163411202,"Bialek, S., Terrault, N., , The Changing Epidemiology and Natural History of Hepatitis C Virus Infection, Clinics in Liver Disease, 2006",cited-by,10.1016/j.cld.2006.08.003,The Changing Epidemiology and Natural History of Hepatitis C Virus Infection,"[['Stephanie', 'R.', 'Bialek'], ['Norah', 'A.', 'Terrault']]",Clinics in Liver Disease,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1089326106000183', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326106000183']",
10.1056/NEJM199909163411202,"Feld, J., Liang, T., , Hepatitis C — identifying patients with progressive liver injury, Hepatology, 2006",cited-by,10.1002/hep.21065,Hepatitis C — identifying patients with progressive liver injury,"[['Jordan', 'J.', 'Feld'], ['T.', 'Jake', 'Liang']]",Hepatology,2006,[u'http://doi.wiley.com/10.1002/hep.21065'],
10.1056/NEJM199909163411202,"Minola, E., Prati, D., Suter, F., et. al, Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C, , 2002",cited-by,6641928Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C,Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C,"[['Eliseo', '', 'Minola'], ['Daniele', '', 'Prati'], ['Fredy', '', 'Suter'], ['Franco', '', 'Maggiolo'], ['Flavio', '', 'Caprioli'], ['Aurelio', '', 'Sonzogni'], ['Mirella', '', 'Fraquelli'], ['Silvia', '', 'Paggi'], ['Dario', '', 'Conte'], ['Ospedali', '', 'Riuniti']]",,2002,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2001-12-0192v1.pdf'],
10.1056/NEJM199909163411202,"KING, S., ROBERTS, E., , Mother-to-infant transmission of hepatitis B virus, Biomedicine & Pharmacotherapy, 1990",cited-by,10.1016/0753-3322(90)90139-Z,Mother-to-infant transmission of hepatitis B virus,"[['SUSAN', 'M.', 'KING'], ['EVE', 'A.', 'ROBERTS']]",Biomedicine & Pharmacotherapy,1990,"[u'http://www.natap.org/2001/sep/mother_to_infant.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/075333229090139Z']",
10.1056/NEJM199909163411202,"LEE, C., DUSHEIKO, G., , The natural history and antiviral treatment of hepatitis C in haemophilia, Haemophilia, 2002",cited-by,10.1046/j.1365-2516.2002.00620.x,The natural history and antiviral treatment of hepatitis C in haemophilia,"[['C.', '', 'LEE'], ['G.', '', 'DUSHEIKO']]",Haemophilia,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.2002.00620.x'],
10.1056/NEJM199909163411202,"Strickland, D., Riely, C., Patrick, C., et. al, Hepatitis C infection among survivors of childhood cancer, , 0",cited-by,11812237Hepatitis C infection among survivors of childhood cancer,Hepatitis C infection among survivors of childhood cancer,"[['Donald', 'K.', 'Strickland'], ['Caroline', 'A.', 'Riely'], ['Christian', 'C.', 'Patrick'], ['Dana', '', 'Jones-Wallace'], ['James', 'M.', 'Boyett'], ['Bradford', '', 'Waters'], ['Jaquelyn', 'Fitch', 'Fleckenstein'], ['Patrick', 'J.', 'Dean'], ['Rene', '', 'Davila'], ['Tony', 'E.', 'Caver'], ['Melissa', 'M.', 'Hudson']]",,0,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/95/10/3065.pdf'],
10.1056/NEJM199909163411202,"Messick, K., Sanders, J., Goedert, J., et. al, Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders, Haemophilia, 2001",cited-by,10.1046/j.1365-2516.2001.00559.x,Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders,"[['K.', '', 'Messick'], ['J.', 'C.', 'Sanders'], ['J.', 'J.', 'Goedert'], ['M.', 'E.', 'Eyster']]",Haemophilia,2001,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.2001.00559.x'],
10.1056/NEJM199909163411202,"Myers, R., Patel, K., Pianko, S., et. al, The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C, Journal of Viral Hepatitis, 2003",cited-by,10.1046/j.1365-2893.2003.00387.x,The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C,"[['R.', 'P.', 'Myers'], ['K.', '', 'Patel'], ['S.', '', 'Pianko'], ['T.', '', 'Poynard'], ['J.', 'G.', 'McHutchison']]",Journal of Viral Hepatitis,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2893.2003.00387.x'],
10.1056/NEJM199909163411202,"Mofenson, L., Oleske, J., Serchuck, L., et. al, Treating Opportunistic Infections among HIV‐Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America, Clinical Infectious Diseases, 2005",cited-by,10.1086/427295,"Treating Opportunistic Infections among HIV‐Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America","[['Lynne', 'M.', 'Mofenson'], ['James', '', 'Oleske'], ['Leslie', '', 'Serchuck'], ['Russell', 'Van', 'Dyke'], ['Cathy', '', 'Wilfert']]",Clinical Infectious Diseases,2005,"[u'http://aidsinfo.nih.gov/contentfiles/TreatmentofOI_Children.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/427295']",
10.1056/NEJM199909163411202,"Piasecki, B., Lewis, J., Reddy, K., et. al, Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population, Hepatology, 2004",cited-by,10.1002/hep.1840400419,"Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population","[['Barbara', 'A.', 'Piasecki'], ['James', 'D.', 'Lewis'], ['K.', 'Rajender', 'Reddy'], ['Scarlett', 'L.', 'Bellamy'], ['Steven', 'B.', 'Porter'], ['Robert', 'M.', 'Weinrieb'], ['Donald', 'D.', 'Stieritz'], ['Kyong-Mi', '', 'Chang']]",Hepatology,2004,"[u'http://www.cceb.upenn.edu/~sbellamy/piasecki.pdf', u'http://doi.wiley.com/10.1002/hep.20384', u'http://doi.wiley.com/10.1002/hep.1840400419']",
10.1056/NEJM199909163411202,"Yoshizawa, H., Tanaka, J., Miyakawa, Y., , National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population, Intervirology, 2006",cited-by,10.1159/000087257,National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population,"[['Hiroshi', '', 'Yoshizawa'], ['Junko', '', 'Tanaka'], ['Yuzo', '', 'Miyakawa']]",Intervirology,2006,"[u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000087257', u'http://www.karger.com/doi/10.1159/000087257']",
10.1056/NEJM199909163411202,"McMahon, B., Hennessy, T., Christensen, C., et. al, Epidemiology and risk factors for hepatitis C in Alaska Natives, Hepatology, 2004",cited-by,10.1002/hep.20046,Epidemiology and risk factors for hepatitis C in Alaska Natives,"[['Brian', 'J.', 'McMahon'], ['Thomas', 'W.', 'Hennessy'], ['Carol', '', 'Christensen'], ['Dana', '', 'Bruden'], ['Daniel', 'G.', 'Sullivan'], ['Chriss', '', 'Homan'], ['Heike', '', 'Deubner'], ['Michael', 'G.', 'Bruce'], ['Stephen', '', 'Livingston'], ['James', '', 'Williams'], ['David', 'R.', 'Gretch']]",Hepatology,2004,"[u'http://www.anthc.org/chs/crs/hep/upload/a2004-001.pdf', u'http://www.hepatitis-central.com/hcv/info/2004/info/hepcinfo970.pdf', u'http://hepatitis-central.com/hcv/info/2004/info/hepcinfo970.pdf', u'http://doi.wiley.com/10.1002/hep.20046']",
10.1056/NEJM199909163411202,"Ahmed, A., Keeffe, E., , Chronic hepatitis C with normal aminotransferase levels, Gastroenterology, 2004",cited-by,10.1053/j.gastro.2004.02.073,Chronic hepatitis C with normal aminotransferase levels,"[['Aijaz', '', 'Ahmed'], ['Emmet', 'B', 'Keeffe']]",Gastroenterology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0016508504004809', u'http://linkinghub.elsevier.com/retrieve/pii/S0016508504004809']",
10.1056/NEJM199909163411202,"Bernardin, F., Tobler, L., Walsh, I., et. al, Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia, Hepatology, 2008",cited-by,10.1002/hep.22184,Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia,"[['Flavien', '', 'Bernardin'], ['Leslie', '', 'Tobler'], ['Irina', '', 'Walsh'], ['Joan', 'Dunn', 'Williams'], ['Mike', '', 'Busch'], ['Eric', '', 'Delwart']]",Hepatology,2008,[u'http://doi.wiley.com/10.1002/hep.22184'],
10.1056/NEJM199909163411202,"Delwaide, J., Bourgeois, N., Gerard, C., et. al, Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response, Alimentary Pharmacology & Therapeutics, 2004",cited-by,10.1111/j.1365-2036.2004.02023.x,Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response,"[['J.', '', 'Delwaide'], ['N.', '', 'Bourgeois'], ['C.', '', 'Gerard'], ['S.', 'De', 'Maeght'], ['F.', '', 'Mokaddem'], ['E.', '', 'Wain'], ['B.', '', 'Bastens'], ['J.', '', 'Fevery'], ['M.', '', 'Gehenot'], ['O.', 'Le', 'Moine'], ['J.', 'P.', 'Martinet'], ['G.', '', 'Robaeys'], ['B.', '', 'Servais'], ['M.', 'Van', 'Gossum'], ['H.', 'Van', 'Vlierberghe']]",Alimentary Pharmacology & Therapeutics,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2036.2004.02023.x'],
10.1056/NEJM199909163411202,"Kleinman, S., Lelie, N., Busch, M., , Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion, Transfusion, 2009",cited-by,10.1111/j.1537-2995.2009.02322.x,"Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion","[['Steven', 'H.', 'Kleinman'], ['Nico', '', 'Lelie'], ['Michael', 'P.', 'Busch']]",Transfusion,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1537-2995.2009.02322.x'],
10.1056/NEJM199909163411202,"Jhaveri, R., Grant, W., Kauf, T., et. al, The burden of hepatitis C virus infection in children: Estimated direct medical costs over a 10-year period, Journal of Pediatrics, 2006",cited-by,10.1016/j.jpeds.2005.10.031,The burden of hepatitis C virus infection in children: Estimated direct medical costs over a 10-year period,"[['Ravi', '', 'Jhaveri'], ['William', '', 'Grant'], ['Teresa', 'L.', 'Kauf'], ['John', '', 'McHutchison']]",Journal of Pediatrics,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0022347605010036', u'http://linkinghub.elsevier.com/retrieve/pii/S0022347605010036']",
10.1056/NEJM199909163411202,"Wong, W., Terrault, N., , Update on Chronic Hepatitis C, Clinical Gastroenterology and Hepatology, 2005",cited-by,10.1016/S1542-3565(05)00247-8,Update on Chronic Hepatitis C,"[['Winnie', '', 'Wong'], ['Norah', '', 'Terrault']]",Clinical Gastroenterology and Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1542356505002478', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356505002478']",
10.1056/NEJM199909163411202,"Goedert, J., Brown, D., Hoots, K., et. al, Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia, Haemophilia, 2004",cited-by,10.1111/j.1365-2516.2004.00997.x,Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia,"[['J.', 'J.', 'Goedert'], ['D.', 'L.', 'Brown'], ['K.', '', 'Hoots'], ['K.', 'E.', 'Sherman']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2516.2004.00997.x'],
10.1056/NEJM199909163411202,"Guido, M., Bortolotti, F., Leandro, G., et. al, Fibrosis in Chronic Hepatitis C Acquired in Infancy: Is It Only a Matter of Time?, American Journal of Gastroenterology, 2003",cited-by,10.1111/j.1572-0241.2003.07293.x,Fibrosis in Chronic Hepatitis C Acquired in Infancy: Is It Only a Matter of Time?,"[['Maria', '', 'Guido'], ['Flavia', '', 'Bortolotti'], ['Gioacchino', '', 'Leandro'], ['Paloma', '', 'Jara'], ['Loreto', '', 'Hierro'], ['Javier', '', 'Larrauri'], ['Cristiana', '', 'Barbera'], ['Raffaella', '', 'Giacchino'], ['Lucia', '', 'Zancan'], ['Fiorella', '', 'Balli'], ['Carlo', '', 'Crivellaro'], ['Emilio', '', 'Cristina'], ['Angela', '', 'Pucci'], ['Massimo', '', 'Rugge']]",American Journal of Gastroenterology,2003,"[u'http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.07293.x', u'http://dx.doi.org/10.1111/j.1572-0241.2003.07293.x']",
10.1056/NEJM199909163411202,"Jackson, J., , Hepatitis C and the skin, Dermatologic Clinics, 2002",cited-by,10.1016/S0733-8635(02)00013-X,Hepatitis C and the skin,"[['J.', 'Mark', 'Jackson']]",Dermatologic Clinics,2002,"[u'http://www.sciencedirect.com/science/article/pii/S073386350200013X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386350200013X']",
10.1056/NEJM199909163411202,"Sezaki, H., Suzuki, F., Kawamura, Y., et. al, Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads, Digestive Diseases and Sciences, 2009",cited-by,10.1007/s10620-008-0500-y,Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads,"[['Hitomi', '', 'Sezaki'], ['Fumitaka', '', 'Suzuki'], ['Yusuke', '', 'Kawamura'], ['Hiromi', '', 'Yatsuji'], ['Tetsuya', '', 'Hosaka'], ['Norio', '', 'Akuta'], ['Masahiro', '', 'Kobayashi'], ['Yoshiyuki', '', 'Suzuki'], ['Satoshi', '', 'Saitoh'], ['Yasuji', '', 'Arase'], ['Kenji', '', 'Ikeda'], ['Yuzo', '', 'Miyakawa'], ['Hiromitsu', '', 'Kumada']]",Digestive Diseases and Sciences,2009,"[u'http://www.springerlink.com/content/e63232l537q8128t', u'http://www.springerlink.com/index/e63232l537q8128t.pdf', u'http://www.springerlink.com/index/10.1007/s10620-008-0500-y', u'http://www.springerlink.com/index/pdf/10.1007/s10620-008-0500-y']",
10.1056/NEJM199909163411202,"Levine, R., Sanderson, S., Murray, F., et. al, Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D, Clinical Gastroenterology and Hepatology, 2006",cited-by,10.1016/j.cgh.2006.05.028,Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D,"[['Robert', 'A.', 'Levine'], ['Schuyler', 'O.', 'Sanderson'], ['Frank', '', 'Murray'], ['Elaine', '', 'Kay'], ['John', '', 'Hegarty'], ['Niamh', '', 'Nolan'], ['Dermot', '', 'Kelleher'], ['George', '', 'Mcdonald'], ['J.', 'Conor', 'O\xe2\x80\x99Keane'], ['John', '', 'Crowe']]",Clinical Gastroenterology and Hepatology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1542356506004976', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356506004976']",
10.1056/NEJM199909163411202,"Plunkett, B., Grobman, W., , Routine hepatitis C virus screening in pregnancy: A cost-effectiveness analysis, American Journal of Obstetrics and Gynecology, 2005",cited-by,10.1016/j.ajog.2004.10.600,Routine hepatitis C virus screening in pregnancy: A cost-effectiveness analysis,"[['Beth', 'A.', 'Plunkett'], ['William', 'A.', 'Grobman']]",American Journal of Obstetrics and Gynecology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0002937804018046', u'http://linkinghub.elsevier.com/retrieve/pii/S0002937804018046']",
10.1056/NEJM199909163411202,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
10.1056/NEJM199909163411202,", Epidemiology and Natural History of Hepatitis C Virus Infection in Injection Drug Users: Implications for Treatment, Clinical Infectious Diseases, 2005",cited-by,10.1086/427440,Epidemiology and Natural History of Hepatitis C Virus Infection in Injection Drug Users: Implications for Treatment,[],Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/427440'],
10.1056/NEJM199909163411202,"Fontana, R., Everson, G., Tuteja, S., et. al, Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis, Clinical Gastroenterology and Hepatology, 2004",cited-by,10.1016/S1542-3565(04)00002-3,Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis,"[['Robert', 'J', 'Fontana'], ['Gregory', 'T', 'Everson'], ['Sony', '', 'Tuteja'], ['Hugo', 'E', 'Vargas'], ['Mitchell', 'L', 'Shiffman']]",Clinical Gastroenterology and Hepatology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1542356504000023', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356504000023']",
10.1056/NEJM199909163411202,"RERKSUPPAPHOL, S., HARDIKAR, W., DORE, G., , Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children, Journal of Gastroenterology and Hepatology, 2004",cited-by,10.1111/j.1440-1746.2004.03463.x,Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children,"[['SANGUANSAK', '', 'RERKSUPPAPHOL'], ['WINITA', '', 'HARDIKAR'], ['GREGORY', 'J', 'DORE']]",Journal of Gastroenterology and Hepatology,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1440-1746.2004.03463.x'],
10.1056/NEJM199909163411202,"Slowik, M., Jhaveri, R., , Hepatitis B and C Viruses in Infants and Young Children, Seminars in Pediatric Infectious Diseases, 2005",cited-by,10.1053/j.spid.2005.06.009,Hepatitis B and C Viruses in Infants and Young Children,"[['May', 'K.', 'Slowik'], ['Ravi', '', 'Jhaveri']]",Seminars in Pediatric Infectious Diseases,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1045187005000713', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187005000713']",
10.1056/NEJM199909163411202,"Iorio, R., Giannattasio, A., Sepe, A., et. al, Chronic Hepatitis C in Childhood: An 18‐Year Experience, Clinical Infectious Diseases, 2005",cited-by,10.1086/497141,Chronic Hepatitis C in Childhood: An 18‐Year Experience,"[['Raffaele', '', 'Iorio'], ['Antonietta', '', 'Giannattasio'], ['Angela', '', 'Sepe'], ['Luigi', 'Maria', 'Terracciano'], ['Raffaella', '', 'Vecchione'], ['Angela', '', 'Vegnente']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/497141'],
10.1056/NEJM199909163411202,"Seeff, L., , Why is there such difficulty in defining the natural history of hepatitis C?, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40101161.x,Why is there such difficulty in defining the natural history of hepatitis C?,"[['Leonard', 'B.', 'Seeff']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40101161.x'],
10.1056/NEJM199909163411202,"Elisofon, S., Jonas, M., , Hepatitis B and C in Children: Current Treatment and Future Strategies, Clinics in Liver Disease, 2006",cited-by,10.1016/j.cld.2005.10.005,Hepatitis B and C in Children: Current Treatment and Future Strategies,"[['Scott', 'A.', 'Elisofon'], ['Maureen', 'M.', 'Jonas']]",Clinics in Liver Disease,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105000930', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105000930']",
10.1056/NEJM199909163411202,"Rumbo, C., Fawaz, R., Emre, S., et. al, Hepatitis C in Children: A Quaternary Referral Center Perspective, Journal of Pediatric Gastroenterology and Nutrition, 2006",cited-by,10.1097/01.mpg.0000228117.52229.32,Hepatitis C in Children: A Quaternary Referral Center Perspective,"[['Carolina', '', 'Rumbo'], ['Rima', 'L.', 'Fawaz'], ['Sukru', 'H.', 'Emre'], ['Frederick', 'J.', 'Suchy'], ['Nanda', '', 'Kerkar'], ['Raffaella', 'A.', 'Morotti'], ['Benjamin', 'L.', 'Shneider']]",Journal of Pediatric Gastroenterology and Nutrition,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200608000-00013'],
10.1056/NEJM199909163411202,"Barshes, N., Udell, I., Lee, T., et. al, The natural history of hepatitis C virus in pediatric liver transplant recipients, Liver Transplantation, 2006",cited-by,10.1002/lt.20793,The natural history of hepatitis C virus in pediatric liver transplant recipients,"[['Neal', 'R.', 'Barshes'], ['Ian', 'W.', 'Udell'], ['Timothy', 'C.', 'Lee'], ['Christine', 'A.', ""O'Mahony""], ['Saul', 'J.', 'Karpen'], ['Beth', 'A.', 'Carter'], ['John', 'A.', 'Goss']]",Liver Transplantation,2006,[u'http://doi.wiley.com/10.1002/lt.20793'],
10.1056/NEJM199909163411202,"Castellino, S., Lensing, S., Riely, C., et. al, The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort, , 2004",cited-by,6747039The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort,The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort,"[['Sharon', '', 'Castellino'], ['Shelly', '', 'Lensing'], ['Caroline', '', 'Riely'], ['Shesh', 'N.', 'Rai'], ['Rene', '', 'Davila'], ['Randall', 'T.', 'Hayden'], ['Jackie', '', 'Fleckenstein'], ['Mark', '', 'Levstik'], ['Shari', '', 'Taylor'], ['Patrick', 'J.', 'Dean'], ['Sarah', '', 'Kippenbrock'], ['Jennifer', '', 'Pope'], ['Jeanne', '', 'Carr'], ['Donald', 'K.', 'Strickland'], ['Melissa', 'M.', 'Hudson']]",,2004,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/7/2460.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2003-07-2565v1.pdf']",
10.1056/NEJM199909163411202,"Oliver, W., Beynen, F., Nuttall, G., et. al, Blood loss in infants and children for open heart operations: albumin 5% versus Fresh-Frozen plasma in the prime, Annals of Thoracic Surgery, 2003",cited-by,10.1016/S0003-4975(02)04991-3,Blood loss in infants and children for open heart operations: albumin 5% versus Fresh-Frozen plasma in the prime,"[['William', 'C', 'Oliver'], ['Froukje', 'M', 'Beynen'], ['Gregory', 'A', 'Nuttall'], ['Darrell', 'R', 'Schroeder'], ['Mark', 'H', 'Ereth'], ['Joseph', 'A', 'Dearani'], ['Francisco', 'J', 'Puga']]",Annals of Thoracic Surgery,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0003497502049913', u'http://linkinghub.elsevier.com/retrieve/pii/S0003497502049913']",
10.1056/NEJM199909163411202,"McCaughan, G., Zekry, A., , Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection, Transplant Infectious Disease, 2000",cited-by,10.1034/j.1399-3062.2000.020403.x,Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection,"[['G.', 'W.', 'McCaughan'], ['A.', '', 'Zekry']]",Transplant Infectious Disease,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1034%2Fj.1399-3062.2000.020403.x'],
10.1056/NEJM199909163411202,"Eyster, M., Sanders, J., Goedert, J., , Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia, Haemophilia, 2004",cited-by,10.1046/j.1351-8216.2003.00836.x,Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia,"[['M.', 'E.', 'Eyster'], ['J.', '', 'Sanders'], ['J.', 'J.', 'Goedert']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1351-8216.2003.00836.x'],
10.1056/NEJM199909163411202,"Pembrey, L., Newell, M., Tovo, P., , The management of HCV infected pregnant women and their children European paediatric HCV network, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2005.06.002,The management of HCV infected pregnant women and their children European paediatric HCV network,"[['Lucy', '', 'Pembrey'], ['Marie-Louise', '', 'Newell'], ['Pier-Angelo', '', 'Tovo']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827805004174', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827805004174']",
10.1056/NEJM199909163411202,"Yeung, L., King, S., Roberts, E., , Spontaneous clearance of childhood hepatitis C virus infection, Journal of Viral Hepatitis, 2007",cited-by,10.1111/j.1365-2893.2007.00873.x,Spontaneous clearance of childhood hepatitis C virus infection,"[['L.', 'T. F.', 'Yeung'], ['S.', 'M.', 'King'], ['E.', 'A.', 'Roberts']]",Journal of Viral Hepatitis,2007,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2893.2007.00873.x'],
10.1056/NEJM199909163411202,"Ferenci, P., Ferenci, S., Datz, C., et. al, Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s, Journal of Hepatology, 2007",cited-by,10.1016/j.jhep.2007.01.023,Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s,"[['Peter', '', 'Ferenci'], ['Stefan', '', 'Ferenci'], ['Christian', '', 'Datz'], ['Ingo', '', 'Rezman'], ['Wilhelm', '', 'Oberaigner'], ['Reinhild', '', 'Strauss']]",Journal of Hepatology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0168827807000736', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827807000736']",
10.1056/NEJM199909163411202,"LUBAN, N., , Transfusion Safety: Where Are We Today?, Annals of The New York Academy of Sciences, 2005",cited-by,10.1196/annals.1345.040,Transfusion Safety: Where Are We Today?,"[['NAOMI', 'L. C.', 'LUBAN']]",Annals of The New York Academy of Sciences,2005,[u'http://blackwell-synergy.com/doi/abs/10.1196/annals.1345.040'],
10.1056/NEJM199909163411202,"Pearlman, B., , Hepatitis C Infection: A Clinical Review, Southern Medical Journal, 2004",cited-by,10.1097/01.SMJ.0000118903.35704.30,Hepatitis C Infection: A Clinical Review,"[['Brian', 'L.', 'Pearlman']]",Southern Medical Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00007611-200404000-00014'],
10.1056/NEJM199909163411202,"Puetz, J., Thrower, M., Kane, R., et. al, Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center, Haemophilia, 2004",cited-by,10.1046/j.1365-2516.2003.00843.x,Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center,"[['J.', '', 'Puetz'], ['M.', '', 'Thrower'], ['R.', '', 'Kane'], ['J.', '', 'Bouhasin']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1365-2516.2003.00843.x'],
10.1056/NEJM199909163411202,"Cividini, A., Cerino, A., Muzzi, A., et. al, Kinetics and Significance of Serum Hepatitis C Virus Core Antigen in Patients with Acute Hepatitis C, , 2003",cited-by,11905210Kinetics and Significance of Serum Hepatitis C Virus Core Antigen in Patients with Acute Hepatitis C,Kinetics and Significance of Serum Hepatitis C Virus Core Antigen in Patients with Acute Hepatitis C,"[['Agostino', '', 'Cividini'], ['Antonella', '', 'Cerino'], ['Alba', '', 'Muzzi'], ['Milena', '', 'Furione'], ['Chiara', '', 'Rebucci'], ['Laura', '', 'Segagni'], ['Marta', '', 'Gatti'], ['Vincenzo', '', 'Barnaba'], ['Mario', 'U.', 'Mondelli'], ['Fondazione', 'A.', 'Cesalpino'], ['Policlinico', '', 'Umberto']]",,2003,[u'http://jcm.asm.org/cgi/reprint/41/5/2144.pdf'],
10.1056/NEJM199909163411202,"Weigand, K., Stremmel, W., Encke, J., , Treatment of hepatitis C virus infection, , 2007",cited-by,6934404Treatment of hepatitis C virus infection,Treatment of hepatitis C virus infection,"[['Kilian', '', 'Weigand'], ['Wolfgang', '', 'Stremmel'], ['Jens', '', 'Encke']]",,2007,[u'http://www.wjgnet.com/1007-9327/13/1897.pdf'],
10.1056/NEJM199909163411202,"Posthouwer, D., Wolters, V., Fischer, K., et. al, Hepatitis C infection in children with haemophilia: a pilot study, Haemophilia, 2004",cited-by,10.1111/j.1365-2516.2004.01038.x,Hepatitis C infection in children with haemophilia: a pilot study,"[['D.', '', 'Posthouwer'], ['V.', 'M.', 'Wolters'], ['K.', '', 'Fischer'], ['R.', 'H. J.', 'Houwen'], ['H.', 'M.', 'Berg'], ['E.', 'P.', 'Mauser-Bunschoten']]",Haemophilia,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2516.2004.01038.x'],
10.1056/NEJM199909163411202,"Lee, P., Wang, J., Tung, H., et. al, A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan, Transactions of The Royal Society of Tropical Medicine and Hygiene, 2004",cited-by,10.1016/j.trstmh.2003.10.013,A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan,"[['Pei-Lun', '', 'Lee'], ['Jing-Houng', '', 'Wang'], ['Hung-Da', '', 'Tung'], ['Chuan-Mo', '', 'Lee'], ['Sheng-Nan', '', 'Lu']]",Transactions of The Royal Society of Tropical Medicine and Hygiene,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0035920304000343', u'http://linkinghub.elsevier.com/retrieve/pii/S0035920304000343']",
10.1056/NEJM199909163411202,"Tanaka, J., Kumada, H., Ikeda, K., et. al, Natural histories of hepatitis C virus infection in men and women simulated by the Markov model, Journal of Medical Virology, 2003",cited-by,10.1002/jmv.10406,Natural histories of hepatitis C virus infection in men and women simulated by the Markov model,"[['Junko', '', 'Tanaka'], ['Hiromitsu', '', 'Kumada'], ['Kenji', '', 'Ikeda'], ['Kazuaki', '', 'Chayama'], ['Masaaki', '', 'Mizui'], ['Kunihiko', '', 'Hino'], ['Keiko', '', 'Katayama'], ['Junko', '', 'Kumagai'], ['Yutaka', '', 'Komiya'], ['Yuzo', '', 'Miyakawa'], ['Hiroshi', '', 'Yoshizawa']]",Journal of Medical Virology,2003,[u'http://doi.wiley.com/10.1002/jmv.10406'],
10.1056/NEJM199909163411202,"Uto, H., Stuver, S., Hayashi, K., et. al, Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study, Hepatology, 2009",cited-by,10.1002/hep.23002,Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study,"[['Hirofumi', '', 'Uto'], ['Sherri', 'O.', 'Stuver'], ['Katsuhiro', '', 'Hayashi'], ['Kotaro', '', 'Kumagai'], ['Fumisato', '', 'Sasaki'], ['Shuji', '', 'Kanmura'], ['Masatsugu', '', 'Numata'], ['Akihiro', '', 'Moriuchi'], ['Susumu', '', 'Hasegawa'], ['Makoto', '', 'Oketani'], ['Akio', '', 'Ido'], ['Kazunori', '', 'Kusumoto'], ['Satoru', '', 'Hasuike'], ['Kenji', '', 'Nagata'], ['Michinori', '', 'Kohara'], ['Hirohito', '', 'Tsubouchi']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.23002'],
10.1056/NEJM199909163411202,"Zhang, M., Rosenberg, P., Brown, D., et. al, Correlates of Spontaneous Clearance of Hepatitis C Virus among People with Hemophilia, , 2005",cited-by,6981492Correlates of Spontaneous Clearance of Hepatitis C Virus among People with Hemophilia,Correlates of Spontaneous Clearance of Hepatitis C Virus among People with Hemophilia,"[['Mingdong', '', 'Zhang'], ['Philip', 'S.', 'Rosenberg'], ['Deborah', 'L.', 'Brown'], ['Liliana', '', 'Preiss'], ['Barbara', 'A.', 'Konkle'], ['M.', 'Elaine', 'Eyster'], ['James', 'J.', 'Goedert']]",,2005,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/107/3/892.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2005-07-2781v1.pdf']",
10.1056/NEJM199909163411202,"El-Raziky, M., El-Hawary, M., El-Koofy, N., et. al, Hepatitis C virus infection in Egyptian children: single centre experience, Journal of Viral Hepatitis, 2004",cited-by,10.1111/j.1365-2893.2004.00535.x,Hepatitis C virus infection in Egyptian children: single centre experience,"[['M.', 'S.', 'El-Raziky'], ['M.', '', 'El-Hawary'], ['N.', '', 'El-Koofy'], ['S.', '', 'Okasha'], ['M.', '', 'Kotb'], ['K.', '', 'Salama'], ['G.', '', 'Esmat'], ['A.', 'M.', 'Abouzied'], ['H.', '', 'El-Karaksy']]",Journal of Viral Hepatitis,2004,[u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1365-2893.2004.00535.x'],
10.1056/NEJM199909163411202,"Hardikar, W., , Hepatitis C in childhood, Journal of Gastroenterology and Hepatology, 2002",cited-by,10.1046/j.1440-1746.2002.02731.x,Hepatitis C in childhood,"[['Winita', '', 'Hardikar']]",Journal of Gastroenterology and Hepatology,2002,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1440-1746.2002.02731.x'],
10.1056/NEJM199909163411202,"Ceci, O., Margiotta, M., Marello, F., et. al, High rate of spontaneous viral clearance in a cohort of vertically infected hepatitis C virus infants: what lies behind?, Journal of Hepatology, 2001",cited-by,10.1016/S0168-8278(01)00205-7,High rate of spontaneous viral clearance in a cohort of vertically infected hepatitis C virus infants: what lies behind?,"[['Oronzo', '', 'Ceci'], ['Marcella', '', 'Margiotta'], ['Fiorino', '', 'Marello'], ['Ruggiero', '', 'Francavilla'], ['Enzo', '', 'Lerardi'], ['Pasquale', '', 'Loizzi'], ['Luigi', '', 'Impedovo'], ['Antonio', '', 'Francavilla']]",Journal of Hepatology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168827801002057', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827801002057']",
10.1056/NEJM199909163411202,"Rodrigue, J., Balistreri, W., Haber, B., et. al, Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes, Journal of Pediatric Gastroenterology and Nutrition, 2009",cited-by,10.1097/MPG.0b013e318185998f,"Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes","[['James', 'R', 'Rodrigue'], ['William', '', 'Balistreri'], ['Barbara', '', 'Haber'], ['Maureen', 'M', 'Jonas'], ['Parvathi', '', 'Mohan'], ['Jean', 'P', 'Molleston'], ['Karen', 'F', 'Murray'], ['Michael', 'R', 'Narkewicz'], ['Philip', '', 'Rosenthal'], ['Lesley', 'J', 'Smith'], ['Kathleen', 'B', 'Schwarz'], ['Patricia', '', 'Robuck'], ['Bruce', '', 'Barton'], ['Regino', 'P', 'Gonz\xc3\xa1lez-Peralta']]",Journal of Pediatric Gastroenterology and Nutrition,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200903000-00019'],
10.1056/NEJM199909163411202,"Pellicano, R., Ménard, A., Rizzetto, M., et. al, Helicobacter species and liver diseases: association or causation?, Lancet Infectious Diseases, 2008",cited-by,10.1016/S1473-3099(08)70066-5,Helicobacter species and liver diseases: association or causation?,"[['Rinaldo', '', 'Pellicano'], ['Armelle', '', 'M\xc3\xa9nard'], ['Mario', '', 'Rizzetto'], ['Francis', '', 'M\xc3\xa9graud']]",Lancet Infectious Diseases,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1473309908700665', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309908700665']",
10.1056/NEJM199909163411202,"Hayashi, P., Bisceglie, A., , The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis, Medical Clinics of North America, 2005",cited-by,10.1016/j.mcna.2004.08.014,The progression of hepatitis B– and C–infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis,"[['Paul', 'H.', 'Hayashi'], ['Adrian', 'M. Di', 'Bisceglie']]",Medical Clinics of North America,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0025712504001361', u'http://linkinghub.elsevier.com/retrieve/pii/S0025712504001361']",
10.1056/NEJM199909163411202,"Kirk, G., Zhang, M., , Hepatocellular Carcinoma: Paradigm of Preventive Oncology, Cancer Journal, 2004",cited-by,10.1097/00130404-200403000-00002,Hepatocellular Carcinoma: Paradigm of Preventive Oncology,"[['Gregory', '', 'Kirk'], ['Mingdong', '', 'Zhang']]",Cancer Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00130404-200403000-00002'],
10.1056/NEJM199909163411202,"El-Kamary, S., Serwint, J., Joffe, A., et. al, Prevalence of hepatitis C virus infection in urban children, Journal of Pediatrics, 2003",cited-by,10.1016/S0022-3476(03)00278-6,Prevalence of hepatitis C virus infection in urban children,"[['Samer', 'S.', 'El-Kamary'], ['Janet', 'R.', 'Serwint'], ['Alain', '', 'Joffe'], ['Mathuram', '', 'Santosham'], ['Anne', 'K.', 'Duggan']]",Journal of Pediatrics,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0022347603002786', u'http://linkinghub.elsevier.com/retrieve/pii/S0022347603002786']",
10.1056/NEJM199909163411202,"Khella, S., Souayah, N., , Hepatitis C: A Review of its Neurologic Complications, Neurologist, 2002",cited-by,10.1097/00127893-200203000-00004,Hepatitis C: A Review of its Neurologic Complications,"[['Sami', 'L.', 'Khella'], ['Nizar', '', 'Souayah']]",Neurologist,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00127893-200203000-00004'],
10.1056/NEJM199909163411202,"Lackner, H., Moser, A., Deutsch, J., et. al, Interferon-a and Ribavirin in Treating Children and Young Adults With Chronic Hepatitis C After Malignancy, , 0",cited-by,11345482Interferon-a and Ribavirin in Treating Children and Young Adults With Chronic Hepatitis C After Malignancy,Interferon-a and Ribavirin in Treating Children and Young Adults With Chronic Hepatitis C After Malignancy,"[['Herwig', '', 'Lackner'], ['Andrea', '', 'Moser'], ['Johann', '', 'Deutsch'], ['Harald', 'H.', 'Kessler'], ['Martin', '', 'Benesch'], ['Reinhold', '', 'Kerbl'], ['Wolfgang', '', 'Schwinger'], ['Hans-Jurgen', '', 'Dornbusch'], ['Karl-Heinz', '', 'Preisegger'], ['Christian', '', 'Urban']]",,0,"[u'http://pediatrics.aappublications.org/cgi/reprint/106/4/e53.pdf', u'http://intl-pediatrics.aappublications.org/cgi/reprint/106/4/e53.pdf']",
10.1056/NEJM199909163411202,"Ueno, Y., Sollano, J., Farrell, G., , Prevention of hepatocellular carcinoma complicating chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2009",cited-by,10.1111/j.1440-1746.2009.05814.x,Prevention of hepatocellular carcinoma complicating chronic hepatitis C,"[['Yoshiyuki', '', 'Ueno'], ['Jose', 'D', 'Sollano'], ['Geoffrey', 'C', 'Farrell']]",Journal of Gastroenterology and Hepatology,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1746.2009.05814.x'],
10.1056/NEJM199909163411202,"Terrault, N., Im, K., Boylan, R., et. al, Fibrosis Progression in African Americans and Caucasian Americans With Chronic Hepatitis C, Clinical Gastroenterology and Hepatology, 2008",cited-by,10.1016/j.cgh.2008.08.006,Fibrosis Progression in African Americans and Caucasian Americans With Chronic Hepatitis C,"[['Norah', 'A.', 'Terrault'], ['Kelly', '', 'Im'], ['Ross', '', 'Boylan'], ['Peter', '', 'Bacchetti'], ['David', 'E.', 'Kleiner'], ['Robert', 'J.', 'Fontana'], ['Jay', 'H.', 'Hoofnagle'], ['Steven', 'H.', 'Belle']]",Clinical Gastroenterology and Hepatology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1542356508008379', u'http://linkinghub.elsevier.com/retrieve/pii/S1542356508008379']",
10.1056/NEJM199909163411202,"Canobio, S., Guilbert, C., Troesch, M., et. al, Differing Patterns of Liver Disease Progression and Hepatitis C Virus (HCV) Quasispecies Evolution in Children Vertically Coinfected with HCV and Human Immunodeficiency Virus Type 1, , 2004",cited-by,6773340Differing Patterns of Liver Disease Progression and Hepatitis C Virus (HCV) Quasispecies Evolution in Children Vertically Coinfected with HCV and Human Immunodeficiency Virus Type 1,Differing Patterns of Liver Disease Progression and Hepatitis C Virus (HCV) Quasispecies Evolution in Children Vertically Coinfected with HCV and Human Immunodeficiency Virus Type 1,"[['Sophie', '', 'Canobio'], ['Cynthia', 'M.', 'Guilbert'], ['Myriam', '', 'Troesch'], ['Johanne', '', 'Samson'], ['Mireille', '', 'Lemay'], ['Veronique', 'Anne', 'Pelletier'], ['Anne-Claude', '', 'Bernard-Bonnin'], ['Rafal', '', 'Kozielski'], ['Normand', '', 'Lapointe'], ['Steven', 'R.', 'Martin'], ['Hugo', '', 'Soudeyns']]",,2004,[u'http://jcm.asm.org/cgi/reprint/42/9/4365.pdf'],
10.1056/NEJM199909163411202,"Delgado-Borrego, A., Jonas, M., , Treatment options for hepatitis C infection in children, Current Treatment Options in Gastroenterology, 2004",cited-by,10.1007/s11938-004-0050-0,Treatment options for hepatitis C infection in children,"[['Aymin', '', 'Delgado-Borrego'], ['Maureen', 'M.', 'Jonas']]",Current Treatment Options in Gastroenterology,2004,"[u'http://www.springerlink.com/content/9822443748241205', u'http://www.springerlink.com/index/9822443748241205.pdf', u'http://www.springerlink.com/index/10.1007/s11938-004-0050-0', u'http://www.springerlink.com/index/pdf/10.1007/s11938-004-0050-0']",
10.1056/NEJM199909163411202,"Goodgame, B., Shaheen, N., Galanko, J., et. al, The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?, American Journal of Gastroenterology, 2003",cited-by,10.1016/S0002-9270(03)00663-4,The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?,"[['Boone', '', 'Goodgame'], ['Nicholas', 'J', 'Shaheen'], ['Joseph', '', 'Galanko'], ['Hashem', 'B', 'El-Serag']]",American Journal of Gastroenterology,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0002927003006634', u'http://linkinghub.elsevier.com/retrieve/pii/S0002927003006634']",
10.1056/NEJM199909163411202,"Menozzi, D., Udulutch, T., Llosa, A., et. al, HCV lookback in the United States:effectiveness of an extended lookback program, Transfusion, 2000",cited-by,10.1046/j.1537-2995.2000.40111393.x,HCV lookback in the United States:effectiveness of an extended lookback program,"[['Delia', '', 'Menozzi'], ['Troy', '', 'Udulutch'], ['Augusto', 'E.', 'Llosa'], ['Susan', 'A.', 'Galel']]",Transfusion,2000,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1537-2995.2000.40111393.x'],
10.1056/NEJM199909163411202,"González-Peralta, R., Langham, M., Andres, J., et. al, Hepatocellular Carcinoma in 2 Young Adolescents With Chronic Hepatitis C, Journal of Pediatric Gastroenterology and Nutrition, 2009",cited-by,10.1097/MPG.0b013e318170af04,Hepatocellular Carcinoma in 2 Young Adolescents With Chronic Hepatitis C,"[['Regino', 'P', 'Gonz\xc3\xa1lez-Peralta'], ['Max', 'R', 'Langham'], ['Joel', 'M', 'Andres'], ['Parvathi', '', 'Mohan'], ['Paul', 'M', 'Colombani'], ['Mary', 'K', 'Alford'], ['Kathleen', 'B', 'Schwarz']]",Journal of Pediatric Gastroenterology and Nutrition,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005176-200905000-00019'],
10.1056/NEJM199909163411202,"Stribling, R., Sussman, N., Vierling, J., , Treatment of Hepatitis C Infection, Gastroenterology Clinics of North America, 2006",cited-by,10.1016/j.gtc.2006.05.003,Treatment of Hepatitis C Infection,"[['Rise', '', 'Stribling'], ['Norman', '', 'Sussman'], ['John', 'M.', 'Vierling']]",Gastroenterology Clinics of North America,2006,"[u'http://www.sciencedirect.com/science/article/pii/S088985530600032X', u'http://linkinghub.elsevier.com/retrieve/pii/S088985530600032X']",
10.1056/NEJM199909163411202,"MAOR, Y., BASHARI, D., KENET, G., et. al, Hepatitis C at the Israeli National Hemophilia Center, Haemophilia, 2006",cited-by,10.1111/j.1365-2516.2006.01178.x,Hepatitis C at the Israeli National Hemophilia Center,"[['Y.', '', 'MAOR'], ['D.', '', 'BASHARI'], ['G.', '', 'KENET'], ['S.', '', 'LALEZARI'], ['A.', '', 'LUBETSKY'], ['J.', '', 'LUBOSHITZ'], ['J.', 'M.', 'SCHAPIRO'], ['B.', '', 'AVIDAN'], ['S.', '', 'BAR-MEIR'], ['U.', '', 'MARTINOWITZ']]",Haemophilia,2006,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2516.2006.01178.x'],
10.1056~NEJMoa011232,"Locasciulli A, Testa M, Pontisso P, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997;90:4628-33. Copyright © 2001 Massachusetts Medical Society. The New England Journal of Medicine Downloaded from nejm.org at UNIVERSITY OF NEW SOUTH WALES on September 1, 2014. For personal use only. No other uses without permission. Copyright © 2001 Massachusetts Medical Society. All rights reserved.",references,11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"[[u'Anna', u'', u'Locasciulli'], [u'Marina', u'', u'Testa'], [u'Patrizia', u'', u'Pontisso'], [u'Luisa', u'', u'Benvegnu'], [u'Donatella', u'', u'Fraschini'], [u'Adele', u'', u'Corbetta'], [u'Franco', u'', u'Noventa'], [u'Giuseppe', u'', u'Masera'], [u'Alfredo', u'', u'Alberti']]",,0,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/90/11/4628.pdf'],"[{u'Name': u'Hepatitis C', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 17869}, {u'Name': u'Natural History', u'PublicationCount': 0, u'__type': u'Keyword:http://research.microsoft.com', u'CitationCount': 0, u'ID': 27121}]"
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Seeff, L., , Natural history of chronic hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36806,Natural history of chronic hepatitis C,"[['Leonard', 'B.', 'Seeff']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Natural%20History%20Of%20Chronic%20Hepatitis%20C.pdf', u'http://www.hcvu.org/mlib/2007_03_14-Seefe_Hepatology_Natural_History_2002.pdf', u'http://doi.wiley.com/10.1053/jhep.2002.36806', u'http://doi.wiley.com/10.1002/hep.1840360706']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Jonas, M., , Children with hepatitis C, Hepatology, 2002",cited-by,10.1053/jhep.2002.36799,Children with hepatitis C,"[['Maureen', 'M.', 'Jonas']]",Hepatology,2002,"[u'http://www.hawaii.edu/hivandaids/Children%20With%20Hepatitis%20C.pdf', u'http://doi.wiley.com/10.1002/hep.1840360722', u'http://doi.wiley.com/10.1053/jhep.2002.36799']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Murakami, C., McDonald, G., Strasser, S., et. al, Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors, , 2010",cited-by,14245661Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors,Cirrhosis of the Liver in Long-Term Marrow Transplant Survivors,"[['Carol', 'S.', 'Murakami'], ['George', 'B.', 'McDonald'], ['Simone', 'I.', 'Strasser'], ['Keith', 'M.', 'Sullivan'], ['David', '', 'Myerson'], ['Catherine', 'L.', 'Spurgeon'], ['Barry', '', 'Storer'], ['H.', '', 'Gary']]",,2010,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/93/10/3259.pdf'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Oeffinger, K., , Longitudinal risk-based health care for adult survivors of childhood cancer, Current Problems in Cancer, 2003",cited-by,10.1016/S0147-0272(03)00031-X,Longitudinal risk-based health care for adult survivors of childhood cancer,"[['Kevin', 'C.', 'Oeffinger']]",Current Problems in Cancer,2003,"[u'http://www.sciencedirect.com/science/article/pii/S014702720300031X', u'http://linkinghub.elsevier.com/retrieve/pii/S014702720300031X']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Bialek, S., Terrault, N., , The Changing Epidemiology and Natural History of Hepatitis C Virus Infection, Clinics in Liver Disease, 2006",cited-by,10.1016/j.cld.2006.08.003,The Changing Epidemiology and Natural History of Hepatitis C Virus Infection,"[['Stephanie', 'R.', 'Bialek'], ['Norah', 'A.', 'Terrault']]",Clinics in Liver Disease,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1089326106000183', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326106000183']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Strickland, D., Riely, C., Patrick, C., et. al, Hepatitis C infection among survivors of childhood cancer, , 0",cited-by,11812237Hepatitis C infection among survivors of childhood cancer,Hepatitis C infection among survivors of childhood cancer,"[['Donald', 'K.', 'Strickland'], ['Caroline', 'A.', 'Riely'], ['Christian', 'C.', 'Patrick'], ['Dana', '', 'Jones-Wallace'], ['James', 'M.', 'Boyett'], ['Bradford', '', 'Waters'], ['Jaquelyn', 'Fitch', 'Fleckenstein'], ['Patrick', 'J.', 'Dean'], ['Rene', '', 'Davila'], ['Tony', 'E.', 'Caver'], ['Melissa', 'M.', 'Hudson']]",,0,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/95/10/3065.pdf'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Mohan, P., Colvin, C., Glymph, C., et. al, Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children, Journal of Pediatrics, 2007",cited-by,10.1016/j.jpeds.2006.11.037,Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children,"[['Parvathi', '', 'Mohan'], ['Camilla', '', 'Colvin'], ['Chevelle', '', 'Glymph'], ['Roma', 'R.', 'Chandra'], ['David', 'E.', 'Kleiner'], ['Kantilal', 'M.', 'Patel'], ['Naomi', 'L. C.', 'Luban'], ['Harvey', 'J.', 'Alter']]",Journal of Pediatrics,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0022347606011103', u'http://linkinghub.elsevier.com/retrieve/pii/S0022347606011103']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Mondelli, M., Cerino, A., Cividini, A., , Acute hepatitis C: diagnosis and management, Journal of Hepatology, 2005",cited-by,10.1016/j.jhep.2004.10.017,Acute hepatitis C: diagnosis and management,"[['Mario', 'U.', 'Mondelli'], ['Antonella', '', 'Cerino'], ['Agostino', '', 'Cividini']]",Journal of Hepatology,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0168827804004908', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827804004908']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Shiffman, M., , Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation, Liver Transplantation, 2003",cited-by,10.1053/jlts.2003.50254,Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation,"[['Mitchell', 'L.', 'Shiffman']]",Liver Transplantation,2003,"[u'http://www.sciencedirect.com/science/article/pii/S152764650380761X', u'http://doi.wiley.com/10.1053/jlts.2003.50254']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Castellino, S., Lensing, S., Riely, C., et. al, The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort, , 2004",cited-by,6747039The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort,The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort,"[['Sharon', '', 'Castellino'], ['Shelly', '', 'Lensing'], ['Caroline', '', 'Riely'], ['Shesh', 'N.', 'Rai'], ['Rene', '', 'Davila'], ['Randall', 'T.', 'Hayden'], ['Jackie', '', 'Fleckenstein'], ['Mark', '', 'Levstik'], ['Shari', '', 'Taylor'], ['Patrick', 'J.', 'Dean'], ['Sarah', '', 'Kippenbrock'], ['Jennifer', '', 'Pope'], ['Jeanne', '', 'Carr'], ['Donald', 'K.', 'Strickland'], ['Melissa', 'M.', 'Hudson']]",,2004,"[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/7/2460.pdf', u'http://bloodjournal.hematologylibrary.org/cgi/reprint/2003-07-2565v1.pdf']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Ruiz-Moreno, M., Leal-Orozco, A., Millàn, A., , Hepatitis C virus infection in children, Journal of Hepatology, 1999",cited-by,10.1016/S0168-8278(99)80388-2,Hepatitis C virus infection in children,"[['M.', '', 'Ruiz-Moreno'], ['A.', '', 'Leal-Orozco'], ['A.', '', 'Mill\xc3\xa0n']]",Journal of Hepatology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0168827899803882', u'http://linkinghub.elsevier.com/retrieve/pii/S0168827899803882']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Jonas, M., , TREATMENT OF CHRONIC HEPATITIS C IN PEDIATRIC PATIENTS, Clinics in Liver Disease, 1999",cited-by,10.1016/S1089-3261(05)70243-9,TREATMENT OF CHRONIC HEPATITIS C IN PEDIATRIC PATIENTS,"[['Maureen', 'M.', 'Jonas']]",Clinics in Liver Disease,1999,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702439', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702439']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Urgancı, N., Gulec, S., Dogan, S., et. al, Interferon and ribavirin treatment results of patients with HBV–HCV co-infection cured of childhood malignancies, International Journal of Infectious Diseases, 2006",cited-by,10.1016/j.ijid.2006.07.002,Interferon and ribavirin treatment results of patients with HBV–HCV co-infection cured of childhood malignancies,"[['Nafiye', '', 'Urganc\xc4\xb1'], ['Seda', '', 'Gulec'], ['Sema', '', 'Dogan'], ['Asiye', '', 'Nuhoglu']]",International Journal of Infectious Diseases,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1201971206001391', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971206001391']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Gerner, P., Wirth, S., Wintermeyer, P., et. al, Prevalence of hepatitis C virus infection in children admitted to an urban hospital, Journal of Infection, 2006",cited-by,10.1016/j.jinf.2005.04.004,Prevalence of hepatitis C virus infection in children admitted to an urban hospital,"[['Patrick', '', 'Gerner'], ['Stefan', '', 'Wirth'], ['Philip', '', 'Wintermeyer'], ['Alexander', '', 'Walz'], ['Andreas', '', 'Jenke']]",Journal of Infection,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0163445305000964', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445305000964']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Vogt, M., Mühlbauer, F., Braun, S., et. al, Prevalence and Risk Factors of Hepatitis C Infection after Cardiac Surgery in Childhood before and after Blood Donor Screening, Infection, 2004",cited-by,10.1007/s15010-004-2209-y,Prevalence and Risk Factors of Hepatitis C Infection after Cardiac Surgery in Childhood before and after Blood Donor Screening,"[['M.', '', 'Vogt'], ['F.', '', 'M\xc3\xbchlbauer'], ['S.', 'L.', 'Braun'], ['T.', '', 'Lang'], ['R.', '', 'Busch'], ['R.', '', 'Lange'], ['G.', '', 'Fr\xc3\xb6sner'], ['J.', '', 'Hess']]",Infection,2004,"[u'http://www.springerlink.com/index/yud4jta6bc91012v.pdf', u'http://www.springerlink.com/content/yud4jta6bc91012v', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s15010-004-2209-y', u'http://www.springerlink.com/index/pdf/10.1007/s15010-004-2209-y']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Jonas, M., , CHALLENGES IN THE TREATMENT OF HEPATITIS C IN CHILDREN, Clinics in Liver Disease, 2001",cited-by,10.1016/S1089-3261(05)70209-9,CHALLENGES IN THE TREATMENT OF HEPATITIS C IN CHILDREN,"[['Maureen', 'M.', 'Jonas']]",Clinics in Liver Disease,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105702099', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105702099']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Visona, K., Baez, F., Taylor, L., et. al, Impact of Hepatitis B and Hepatitis C Virus Infections in a Hematology-Oncology Unit at a Children's Hospital in Nicaragua, 1997 to 1999, Clinical and Vaccine Immunology, 2002",cited-by,10.1128/CDLI.9.3.622-626.2002,"Impact of Hepatitis B and Hepatitis C Virus Infections in a Hematology-Oncology Unit at a Children's Hospital in Nicaragua, 1997 to 1999","[['K.', '', 'Visona'], ['Fulgencio', '', 'Baez'], ['Lizeth', '', 'Taylor'], ['R.', '', 'Berrios'], ['B.', '', 'Leon'], ['Carlos', '', 'Pacheco'], ['R.', '', 'Jiron'], ['Ronald', 'B.', 'Luftig'], ['M.', 'Mercedes', 'Somarriba']]",Clinical and Vaccine Immunology,2002,"[u'http://cdli.asm.org/cgi/reprint/9/3/622.pdf', u'http://cdli.asm.org/cgi/doi/10.1128/CDLI.9.3.622-626.2002']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Jonas, M., , 20 Hepatitis C in children, Biomedical Research Reports, 2000",cited-by,10.1016/S1874-5326(00)80024-1,20 Hepatitis C in children,"[['Maureen', 'M.', 'Jonas']]",Biomedical Research Reports,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1874532600800241', u'http://linkinghub.elsevier.com/retrieve/pii/S1874532600800241']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Jonas, M., , VIRAL HEPATITIS, Clinics in Liver Disease, 2000",cited-by,10.1016/S1089-3261(05)70145-8,VIRAL HEPATITIS,"[['Maureen', 'M.', 'Jonas']]",Clinics in Liver Disease,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1089326105701458', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326105701458']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Chang, M., , Treatment of chronic hepatitis C virus infection in children, Best Practice & Research in Clinical Gastroenterology, 2000",cited-by,10.1053/bega.1999.0080,Treatment of chronic hepatitis C virus infection in children,"[['Mei-Hwei', '', 'Chang']]",Best Practice & Research in Clinical Gastroenterology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S152169189990080X', u'http://linkinghub.elsevier.com/retrieve/doi/10.1053/bega.1999.0080']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Zhang, L., Ulgiati, S., Yang, Z., et. al, Emergy evaluation and economic analysis of three wetland fish farming systems in Nansi Lake area, China, Journal of Environmental Management, 2011",cited-by,10.1016/j.jenvman.2010.10.005,"Emergy evaluation and economic analysis of three wetland fish farming systems in Nansi Lake area, China","[['L.', 'X.', 'Zhang'], ['S.', '', 'Ulgiati'], ['Z.', 'F.', 'Yang'], ['B.', '', 'Chen']]",Journal of Environmental Management,2011,[u'http://www.sciencedirect.com/science/article/pii/S0301479710003336'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Stevens, M., Edmond, M., , Health Care–Associated Transmission of Hepatitis B and C in Oncology Care, Clinics in Liver Disease, 2010",cited-by,10.1016/j.cld.2009.11.006,Health Care–Associated Transmission of Hepatitis B and C in Oncology Care,"[['Michael', 'P.', 'Stevens'], ['Michael', 'B.', 'Edmond']]",Clinics in Liver Disease,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1089326109000877', u'http://linkinghub.elsevier.com/retrieve/pii/S1089326109000877']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Cacoub, P., Benhamou, Y., , Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C, Revue De Medecine Interne, 2002",cited-by,10.1016/S0248-8663(02)00660-4,Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C,"[['P.', '', 'Cacoub'], ['Y.', '', 'Benhamou']]",Revue De Medecine Interne,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0248866302006604', u'http://linkinghub.elsevier.com/retrieve/pii/S0248866302006604']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Bhatia, S., Landier, W., Toogood, A., et. al, Adolescent and Young Adult Cancer Survivors: Late Effects of Treatment, , 0",cited-by,10.1007/978-3-540-68152-6_27,Adolescent and Young Adult Cancer Survivors: Late Effects of Treatment,"[['Smita', '', 'Bhatia'], ['Wendy', '', 'Landier'], ['Andrew', 'A.', 'Toogood'], ['Michael', '', 'Hawkins']]",,0,"[u'http://www.springerlink.com/index/j741x41303t61627.pdf', u'http://www.springerlink.com/content/j741x41303t61627']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Hudson, M., Oeffinger, K., , Future Health of Survivors of Adolescent and Young Adult Cancer, , 0",cited-by,10.1007/978-3-540-68152-6_30,Future Health of Survivors of Adolescent and Young Adult Cancer,"[['Melissa', 'M.', 'Hudson'], ['Kevin', 'C.', 'Oeffinger']]",,0,"[u'http://www.springerlink.com/content/p271814862446667', u'http://www.springerlink.com/index/p271814862446667.pdf']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Torres, H., Davila, M., , Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer, Nature Reviews Clinical Oncology, 2012",cited-by,10.1038/nrclinonc.2012.1,Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer,"[['Harrys', 'A.', 'Torres'], ['Marta', '', 'Davila']]",Nature Reviews Clinical Oncology,2012,[u'http://dx.doi.org/10.1038/nrclinonc.2012.1'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"AECKEL, E., ORNBERG, M., EDEMEYER, H., et. al, TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b, , 2010",cited-by,13591527TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,TREATMENT OF ACUTE HEPATITIS C WITH INTERFERON ALFA-2b,"[['E', 'LMAR J', 'AECKEL'], ['M', 'ARKUS C', 'ORNBERG'], ['H', 'EINER W', 'EDEMEYER'], ['T', 'ERESA S', 'ANTANTONIO'], ['J', 'ULIKA M', 'AYER'], ['M', 'YRGA Z', 'ANKEL'], ['G', '', 'IUSEPPE'], ['P', '', 'ASTORE'], ['M', 'ANFRED D', 'IETRICH'], ['C', 'HRISTIAN T', 'RAUTWEIN'], ['P.', 'M', 'ANNS']]",,2010,"[u'http://content.nejm.org/cgi/reprint/345/20/1452.pdf?ck=nck', u'http://www.drugpolicy.org/docuploads/nejmoa011232v1.pdf']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Carr, J., Strickland, D., Hudson, M., et. al, Hospital hepatitis C seropositive cohort childhood cancer: an update of the St Jude Children's Research The epidemiology of chronic hepatitis C infection in survivors of, , 2010",cited-by,14092230Hospital hepatitis C seropositive cohort childhood cancer: an update of the St Jude Children's Research The epidemiology of chronic hepatitis C infection in survivors of,Hospital hepatitis C seropositive cohort childhood cancer: an update of the St Jude Children's Research The epidemiology of chronic hepatitis C infection in survivors of,"[['Jeanne', '', 'Carr'], ['Donald', 'K.', 'Strickland'], ['Melissa', 'M.', 'Hudson'], ['Jackie', '', 'Fleckenstein'], ['Mark', '', 'Levstik'], ['Shari', '', 'Taylor'], ['Patrick', 'J.', 'Dean'], ['Sarah', '', 'Kippenbrock'], ['Jennifer', '', 'Pope'], ['Sharon', '', 'Castellino'], ['Shelly', '', 'Lensing'], ['Caroline', '', 'Riely'], ['Shesh', 'N.', 'Rai'], ['Rene', '', 'Davila'], ['Randall', 'T.', 'Hayden']]",,2010,[u'http://bloodjournal.hematologylibrary.org/cgi/reprint/103/7/2460.pdf'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Fioredda, F., Moser, A., Bertoluzzo, L., et. al, Natural course of HCV infection in childhood cancer survivors, Supportive Care in Cancer, 2010",cited-by,10.1007/s00520-009-0763-7,Natural course of HCV infection in childhood cancer survivors,"[['Francesca', '', 'Fioredda'], ['Andrea', '', 'Moser'], ['Luisella', '', 'Bertoluzzo'], ['Herwig', '', 'Lackner'], ['Raffaella', '', 'Giacchino'], ['Milena', '', 'LaSpina'], ['Luisella', '', 'Lazier'], ['Caterina', '', 'Riva'], ['Mareva', '', 'Giacchino'], ['Donatella', '', 'Fraschini'], ['Eva', '', 'Frey'], ['Angela', '', 'Sementa'], ['Angela', '', 'Pistorio'], ['Riccardo', '', 'Haupt']]",Supportive Care in Cancer,2010,"[u'http://www.springerlink.com/content/fg27q1q6k342gh95', u'http://www.springerlink.com/index/fg27q1q6k342gh95.pdf', u'http://www.springerlink.com/index/10.1007/s00520-009-0763-7', u'http://www.springerlink.com/index/pdf/10.1007/s00520-009-0763-7']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Cesaro, S., Bortolotti, F., Petris, M., et. al, An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy, Pediatric Blood & Cancer, 2010",cited-by,10.1002/pbc.22438,An updated follow-up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy,"[['Simone', '', 'Cesaro'], ['Flavia', '', 'Bortolotti'], ['Maria', 'Grazia', 'Petris'], ['Alessandra', '', 'Brugiolo'], ['Maria', '', 'Guido'], ['Modesto', '', 'Carli']]",Pediatric Blood & Cancer,2010,[u'http://doi.wiley.com/10.1002/pbc.22438'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Kenny-Walsh, E., , Increased liver-related mortality to hepatitis C viremia defined on the 20th anniversary of its identification, Hepatology, 2009",cited-by,10.1002/hep.23107,Increased liver-related mortality to hepatitis C viremia defined on the 20th anniversary of its identification,"[['Elizabeth', '', 'Kenny-Walsh']]",Hepatology,2009,[u'http://doi.wiley.com/10.1002/hep.23107'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"MOSTAFA, A., EBEID, E., MANSOUR, T., et. al, Seroprevalence of Hepatitis B and C in Pediatric Malignanices, , 2003",cited-by,13641116Seroprevalence of Hepatitis B and C in Pediatric Malignanices,Seroprevalence of Hepatitis B and C in Pediatric Malignanices,"[['ALI', '', 'MOSTAFA'], ['EMAD', '', 'EBEID'], ['TAREK', '', 'MANSOUR'], ['MANAL', '', 'AMIN'], ['IMAN', '', 'SIDHOM'], ['ASHRAF', '', 'KHAIRY'], ['HOSSAM', 'EL', 'ZOMOR']]",,2003,[u'http://www.nci.edu.eg/Journal/2003%20march/Can.5.pdf'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Paul, A., Hawkins, S., McCarrick, J., et. al, DARHT-II energy analyzer, , 2003",cited-by,10.1109/PAC.2003.1289178,DARHT-II energy analyzer,"[['Arthur', 'C.', 'Paul'], ['Steven', '', 'Hawkins'], ['J.', '', 'McCarrick'], ['James', '', 'Sullivan'], ['J.', '', 'Watson'], ['G.', '', 'Westenskow'], ['S.', '', 'Eylon'], ['T.', 'J.', 'Fessenden'], ['W.', '', 'Nexsen']]",,2003,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01289178', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1289178', u'http://www.osti.gov/servlets/purl/15003854/', u'http://adsabs.harvard.edu/abs/2003pac..conf.2533P']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Knöll, A., Helmig, M., Peters, O., et. al, Hepatitis C Virus Transmission in a Pediatric Oncology Ward: Analysis of an Outbreak and Review of the Literature, Laboratory Investigation, 2001",cited-by,10.1038/labinvest.3780234,Hepatitis C Virus Transmission in a Pediatric Oncology Ward: Analysis of an Outbreak and Review of the Literature,"[['Antje', '', 'Kn\xc3\xb6ll'], ['Magdalena', '', 'Helmig'], ['Ove', '', 'Peters'], ['Wolfgang', '', 'Jilg']]",Laboratory Investigation,2001,[u'http://dx.doi.org/10.1038/labinvest.3780234'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Bernard, O., , L'hépatite C chez l'enfant, , 2000",cited-by,10.1016/S0987-7983(00)80151-6,L'hépatite C chez l'enfant,"[['O.', '', 'Bernard']]",,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0987798300801516', u'http://linkinghub.elsevier.com/retrieve/pii/S0987798300801516']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Oeffinger, K., , Commissioned Report Provided to the National Cancer Policy Board LONGITUDINAL CANCER-RELATED HEALTH CARE FOR ADULT SURVIVORS OF CHILDHOOD CANCER, , 0",cited-by,10131109Commissioned Report Provided to the National Cancer Policy Board LONGITUDINAL CANCER-RELATED HEALTH CARE FOR ADULT SURVIVORS OF CHILDHOOD CANCER,Commissioned Report Provided to the National Cancer Policy Board LONGITUDINAL CANCER-RELATED HEALTH CARE FOR ADULT SURVIVORS OF CHILDHOOD CANCER,"[['Kevin', 'C.', 'Oeffinger']]",,0,[u'http://www.iom.edu/~/media/Files/Activity%20Files/Disease/NCPF/BackgroundPaperLongitudinalCancerRelatedHealthCareforAdultSurvivorsofChildhoodCancer.ashx'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Oeffinger, K., Hudson, M., , Foundations for Providing Risk-based Health Care for Survivors Long-term Complications Following Childhood and Adolescent Cancer, , 0",cited-by,11247127Foundations for Providing Risk-based Health Care for Survivors Long-term Complications Following Childhood and Adolescent Cancer,Foundations for Providing Risk-based Health Care for Survivors Long-term Complications Following Childhood and Adolescent Cancer,"[['Kevin', 'C.', 'Oeffinger'], ['Melissa', 'M.', 'Hudson']]",,0,"[u'http://intl-caonline.amcancersoc.org/cgi/reprint/54/4/208.pdf', u'http://caonline.amcancersoc.org/cgi/reprint/54/4/208.pdf', u'http://www.childrens.com/Specialties/documents/CCBD/CA2004article.pdf']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Seid, K., , Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia, , 0",cited-by,"11794667Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia","Serological and Molecular Characterization of Hepatitis B, C and D Viruses Infections among Health Professionals in Ras Desta and Tikur Anbessa Hospitals, Addis Ababa, Ethiopia","[['Kedir', 'Yimer', 'Seid']]",,0,[u'http://etd.aau.edu.et/dspace/bitstream/123456789/551/1/Kedir%20Yimer%20Seid.pdf'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Rapicetta, M., , First research project on viral hepatitis: etiopathogenesis and diagnosis (1997-1999) Progress report, , 0",cited-by,14184234First research project on viral hepatitis: etiopathogenesis and diagnosis (1997-1999) Progress report,First research project on viral hepatitis: etiopathogenesis and diagnosis (1997-1999) Progress report,"[['Maria', '', 'Rapicetta']]",,0,[u'http://www.iss.it/binary/publ/publi/0001.1109840598.pdf'],
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Mirzaee, M., Yaghobi, R., Ramzi, M., et. al, The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies, Molecular Biology Reports, 0",cited-by,10.1007/s11033-011-0851-x,The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies,"[['Mitra', '', 'Mirzaee'], ['Ramin', '', 'Yaghobi'], ['Mani', '', 'Ramzi'], ['Mahdi', 'Roshan', 'Nia']]",Molecular Biology Reports,0,"[u'http://www.springerlink.com/content/q028272u86635631', u'http://www.springerlink.com/index/q028272u86635631.pdf']",
11917594Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia,"Davila, M., Torres, H., , Management of Reactivation of Hepatitis B and Hepatitis C During Antineoplastic Therapy, , 0",cited-by,10.1007/978-1-60761-644-3_17,Management of Reactivation of Hepatitis B and Hepatitis C During Antineoplastic Therapy,"[['Marta', '', 'Davila'], ['Harrys', 'A.', 'Torres']]",,0,"[u'http://www.springerlink.com/index/u785t22623n18413.pdf', u'http://www.springerlink.com/content/u785t22623n18413']",
